RACLOPRIDE: A selective dopamine D2 receptor antagonist, used as a radioligand in PET neuroimaging studies.
3,4-DICHLOROISOCOUMARIN: An irreversible serine protease inhibitor used in biochemical research to study enzyme mechanisms.
WITHAFERIN A: A steroidal lactone derived from Withania somnifera, exhibiting anti-inflammatory, anti-angiogenic, and anti-cancer properties.
ANGIOTENSIN II: A potent vasoconstrictor peptide hormone that plays a crucial role in regulating blood pressure and fluid balance.
NERATINIB: An irreversible pan-HER tyrosine kinase inhibitor used for the treatment of HER2-positive breast cancer.
CEP-9722: An orally available inhibitor of the poly(ADP-ribose) polymerase (PARP) enzymes, investigated for cancer therapy.
ETORPHINE: An extremely potent semi-synthetic opioid analgesic primarily used for tranquilizing large animals.
COMPOUND 8E [PMID: 24432909]: An experimental PIM kinase inhibitor described in the literature, with potential anti-cancer activity.
GDC-0339: An experimental, selective inhibitor of the ERK1/2 kinases, being studied for cancer treatment.
RYANODINE: A plant alkaloid that acts on ryanodine receptors, modulating intracellular calcium release in muscle and neurons.
IMATINIB: A tyrosine kinase inhibitor that targets BCR-ABL, c-KIT, and PDGFR, used to treat CML and GIST.
CLODRONIC ACID: A first-generation bisphosphonate drug used to treat bone disorders such as osteoporosis and Paget's disease.
PLATINUM: A chemical element whose coordination complexes, such as cisplatin, are widely used as chemotherapeutic agents.
OXYTETRACYCLINE ANHYDROUS: A broad-spectrum tetracycline antibiotic in its anhydrous form, used to treat bacterial infections.
BENZENETHIOL: An organosulfur compound, also known as thiophenol, used as a reactive chemical intermediate.
CISPLATIN: A platinum-based chemotherapy drug that crosslinks DNA, inducing apoptosis in cancer cells.
ARBUTAMINE: A synthetic catecholamine that acts as a cardiac stimulant by activating beta-adrenergic receptors.
DIBUCAINE: A potent, long-acting local anesthetic of the amide type.
[125I]TYR11-SRIF-14: A radioiodinated somatostatin analogue used in receptor binding assays and autoradiography.
NINTEDANIB ESYLATE: A multi-target tyrosine kinase inhibitor used to treat idiopathic pulmonary fibrosis and certain cancers.
DIPIVEFRIN HYDROCHLORIDE: A prodrug of epinephrine, used as eye drops to treat open-angle glaucoma.
LANOTEPLASE: A recombinant plasminogen activator designed for thrombolytic therapy in acute myocardial infarction.
VERNAKALANT HYDROCHLORIDE: An antiarrhythmic agent used for the rapid conversion of recent onset atrial fibrillation to sinus rhythm.
MT-3724: An experimental engineered toxin body targeting CD20-positive cells, studied for B-cell malignancies.
TAMOXIFEN: A selective estrogen receptor modulator (SERM) used in the treatment and prevention of ER-positive breast cancer.
MAREIN: A flavonoid glycoside found in plants like Coreopsis, with antioxidant and anti-inflammatory properties.
PHENOLPHTHALEIN: A chemical compound commonly used as a pH indicator and historically as a laxative.
TETRABENAZINE: A vesicular monoamine transporter 2 (VMAT2) inhibitor used to treat hyperkinetic movement disorders like Huntington's disease.
NOSCAPINE: A non-narcotic opium alkaloid used as a cough suppressant, with potential anti-cancer activity.
REMOXIPRIDE: An atypical antipsychotic agent that acts as a selective dopamine D2 receptor antagonist.
NEUROPEPTIDE B-29: The endogenous 29-amino acid form of neuropeptide B, involved in regulating feeding and energy homeostasis.
RM65: An experimental compound, likely a research chemical with a specific biological target.
AVUTOMETINIB: An experimental dual RAF/MEK inhibitor being investigated for the treatment of various cancers.
ABEXINOSTAT: An orally available histone deacetylase (HDAC) inhibitor studied for the treatment of follicular lymphoma and other cancers.
DACTINOMYCIN: An actinomycin antibiotic that inhibits transcription by binding to DNA, used as a chemotherapeutic agent.
AMSILAROTENE: A synthetic retinoid X receptor (RXR) selective agonist with potential anti-cancer and anti-inflammatory effects.
SGI-1776: An experimental PIM kinase inhibitor that was investigated for the treatment of hematological cancers.
AMLODIPINE BESYLATE: A long-acting calcium channel blocker used to treat hypertension and coronary artery disease.
THEONELLASTEROL E: A marine-derived sterol with specific biological activities, often studied for its unique structure.
CENISERTIB: An experimental inhibitor of Aurora kinases, studied for its potential in cancer therapy.
LINIFANIB: A multi-target tyrosine kinase inhibitor that primarily targets VEGFR and PDGFR.
BAZEDOXIFENE: A third-generation selective estrogen receptor modulator (SERM) used for the prevention of postmenopausal osteoporosis.
TOZASERTIB: An experimental inhibitor of Aurora kinases A, B, and C, investigated for cancer treatment.
CYC-116: An orally available inhibitor of Aurora kinases and Cyclin-Dependent Kinases (CDKs).
S-NITROSOGLUTATHIONE: An endogenous signaling molecule that serves as a major biological reservoir of nitric oxide (NO).
E324: A research chemical or compound identifier, likely with a specific biological target under investigation.
NABUMETONE: A non-steroidal anti-inflammatory drug (NSAID) used to treat arthritis and pain.
[SAR9,MET(O2)11]SP: A synthetic analogue of Substance P, a neuropeptide involved in pain and inflammation signaling.
VASOPRESSIN TANNATE: A long-acting formulation of vasopressin, an antidiuretic hormone used to treat diabetes insipidus.
PITAVASTATIN MAGNESIUM: A statin drug used to lower cholesterol and prevent cardiovascular disease.
CARBETAPENTANE CITRATE: A non-opioid antitussive agent used for cough suppression.
ANTI-PD-L1 MONOCLONAL ANTIBODY MDX-1105: Also known as BMS-936559, an early investigational immune checkpoint inhibitor targeting PD-L1.
BIX-01294: A selective inhibitor of the G9a histone methyltransferase, used as a tool in epigenetic research.
PADNARSERTIB: An experimental inhibitor of the enzyme CDC7 kinase, studied for cancer therapy.
BMS-599626: A potent and selective inhibitor of the ErbB1 (EGFR) and ErbB2 (HER2) tyrosine kinases.
ENMD-2076: An orally active, selective multi-target kinase inhibitor, primarily targeting Aurora A and VEGFR.
PICROTOXIN: A non-competitive antagonist of the GABA-A receptor, acting as a convulsant and stimulant.
CNS-5161: An experimental NMDA receptor antagonist that was investigated for neuropathic pain.
THIOURACIL: An anti-thyroid drug that inhibits the production of thyroid hormones.
BCG VACCINE: A vaccine for tuberculosis (TB) disease, also used as an immunotherapy for bladder cancer.
LAMIVUDINE: A nucleoside reverse transcriptase inhibitor (NRTI) used to treat HIV/AIDS and chronic hepatitis B.
AM404: An active metabolite of paracetamol, which acts as a cannabinoid reuptake inhibitor and TRPV1 agonist.
N-ARACHIDONYL-&GAMMA;-AMINOBUTYRIC ACID: An endogenous lipid that acts as an agonist for the GPR55 receptor.
CER-002: A synthetic HDL mimetic designed to promote reverse cholesterol transport.
CORTICOTROPIN-RELEASING FACTOR: A peptide hormone and neurotransmitter involved in the stress response.
CLOTIAZEPAM: A thienodiazepine drug which is a benzodiazepine analog, possessing anxiolytic and anticonvulsant properties.
BUPROPION HYDROCHLORIDE: An atypical antidepressant and smoking cessation aid that acts as a norepinephrine-dopamine reuptake inhibitor.
SELUMETINIB: A MEK 1/2 inhibitor used for the treatment of neurofibromatosis type I.
MESALAMINE: An anti-inflammatory drug used to treat inflammatory bowel diseases like ulcerative colitis and Crohn's disease.
REBAMIPIDE: A gastroprotective agent used for mucosal protection, healing of gastroduodenal ulcers, and treatment of gastritis.
NAVOCAFTOR: A corrector of the CFTR protein, investigated for the treatment of cystic fibrosis.
GILTERITINIB: A tyrosine kinase inhibitor that targets FLT3 and AXL, used for acute myeloid leukemia with FLT3 mutations.
MITOXANTRONE: A topoisomerase II inhibitor and anthracenedione agent used in chemotherapy and for multiple sclerosis.
CI-1040: An early, highly selective MEK inhibitor that was studied in clinical trials for cancer.
BUPARLISIB HYDROCHLORIDE: An experimental pan-PI3K inhibitor investigated for various cancers.
RETINOIC ACID AGENT: A class of compounds derived from vitamin A that play important roles in cell growth and differentiation.
IBRUTINIB: A small molecule that inhibits Bruton's tyrosine kinase (BTK), used to treat B-cell cancers.
MILADEMETAN: An experimental MDM2 inhibitor that reactivates the p53 tumor suppressor pathway.
PALBOCICLIB: A selective inhibitor of cyclin-dependent kinases CDK4 and CDK6, used for HR-positive breast cancer.
ERIBULIN MESYLATE: A non-taxane microtubule dynamics inhibitor used to treat metastatic breast cancer.
GW843682X: A selective inhibitor of cyclin-dependent kinase 2 (CDK2).
CERITINIB: A potent anaplastic lymphoma kinase (ALK) inhibitor used to treat ALK-positive non-small cell lung cancer.
SRT-1720: A selective activator of the SIRT1 enzyme, studied for its potential metabolic and anti-aging effects.
4-BENZYLOXYANILINE: A chemical intermediate used in the synthesis of various compounds.
X-396: An experimental anaplastic lymphoma kinase (ALK) inhibitor.
UMIFENOVIR: A broad-spectrum antiviral agent used for the treatment of influenza in some countries.
Y27632: A selective inhibitor of the ROCK (Rho-associated coiled-coil forming protein kinase) signaling pathway.
DALUTRAFUSP ALFA: A recombinant fusion protein being investigated for cancer immunotherapy.
ELOBIXIBAT: An ileal bile acid transporter (IBAT) inhibitor used for the treatment of chronic constipation.
PHENYLEPHRINE: A selective alpha-1 adrenergic receptor agonist used primarily as a decongestant and to increase blood pressure.
PEXMETINIB: An experimental MEK inhibitor that was investigated for cancer therapy.
METHYLPREDNISOLONE SODIUM SUCCINATE: A synthetic glucocorticoid used for its potent anti-inflammatory and immunosuppressive effects.
FLUVASTATIN: A statin drug used to lower cholesterol levels and prevent cardiovascular events.
PACLITAXEL: A mitotic inhibitor used in chemotherapy that stabilizes microtubules.
PREGABALIN: An anticonvulsant and anxiolytic drug used to treat epilepsy, neuropathic pain, and generalized anxiety disorder.
TASOSARTAN: An angiotensin II receptor antagonist that was developed for the treatment of hypertension.
FARICIMAB: A bispecific antibody targeting Ang-2 and VEGF-A, used to treat neovascular age-related macular degeneration.
EVEROLIMUS: An mTOR inhibitor used as an immunosuppressant and for the treatment of various cancers.
CLINDAMYCIN HYDROCHLORIDE: A lincosamide antibiotic used to treat a variety of bacterial infections.
TYRPHOSTIN A9: A tyrosine kinase inhibitor used in research to study signal transduction pathways.
DESIPRAMINE: A tricyclic antidepressant that primarily acts as a norepinephrine reuptake inhibitor.
SERTINDOLE: An atypical antipsychotic agent used for the treatment of schizophrenia.
NEPAFENAC: A non-steroidal anti-inflammatory drug (NSAID) used as an ophthalmic solution to treat pain and inflammation associated with cataract surgery.
FULVESTRANT: A selective estrogen receptor degrader (SERD) used to treat hormone receptor-positive metastatic breast cancer.
PRAZOSIN HYDROCHLORIDE: An alpha-1 blocker used to treat high blood pressure, PTSD, and symptoms of an enlarged prostate.
LUMACAFTOR: A CFTR protein corrector used in combination with ivacaftor for cystic fibrosis with specific mutations.
PRILIXIMAB: An experimental chimeric monoclonal antibody targeting the CD4 receptor, studied for autoimmune diseases.
SOFALCONE: A gastroprotective agent that stimulates prostaglandin synthesis, used for peptic ulcers.
DEXAMETHASONE: A potent synthetic glucocorticoid with anti-inflammatory and immunosuppressant effects.
PADSEVONIL: An experimental drug that acts as a modulator of GABA-A receptors, studied for epilepsy.
AZD6538: An experimental compound, likely a drug candidate with a specific target.
LV-2172: A research chemical or compound identifier.
TARENFLURBIL: An experimental NSAID and gamma-secretase modulator that was studied for Alzheimer's disease.
CHELERYTHRINE: A natural benzophenanthridine alkaloid that acts as a potent, selective inhibitor of Protein Kinase C (PKC).
INSULIN, REGULAR, HUMAN: A short-acting form of human insulin used to control blood sugar in people with diabetes.
2MD: A chemical identifier, possibly an abbreviation for a specific research compound.
2,3-DIHYDROXY-4-METHOXY-4'-ETHOXYBENZOPHENONE: A chemical compound, likely a UV absorber or chemical intermediate.
CILENGITIDE: An experimental cyclic peptide that inhibits integrins, studied as an anti-angiogenic cancer therapy.
WB 4101: A classic selective alpha-1 adrenergic receptor antagonist used in pharmacological research.
ALPROSTADIL: A synthetic form of prostaglandin E1 used to treat erectile dysfunction and to keep the ductus arteriosus open in newborns.
CHLORAMBUCIL: A nitrogen mustard alkylating agent used in the treatment of chronic lymphocytic leukemia.
CYTARABINE: A chemotherapy agent, primarily used in the treatment of acute myeloid leukemia and lymphomas.
ADIPIPLON: An experimental non-benzodiazepine anxiolytic and hypnotic drug.
ANTIBIOTIC: A general class of antimicrobial substances active against bacteria.
VILANTEROL: An ultra-long-acting beta-2 adrenergic agonist (ultra-LABA) used in combination to treat COPD.
BAY 61-3606: A selective inhibitor of spleen tyrosine kinase (Syk).
YOHIMBINE: An indole alkaloid derived from the bark of the yohimbe tree, acting as an alpha-2 adrenergic antagonist.
PROPANTHELINE BROMIDE: An antimuscarinic agent used to treat excessive sweating, cramps, and spasms.
R-L3: A research chemical or compound identifier.
CHLORPROTHIXENE: A typical antipsychotic of the thioxanthene class.
COMPOUND 58 [PMID: 25037917]: An experimental beta-lactamase inhibitor described in the specified publication.
THIORIDAZINE: A typical antipsychotic of the piperidine phenothiazine class.
(-)-YM796: An experimental compound studied for its neuroprotective effects and potential in Alzheimer's disease.
GNE-131: A research chemical, likely a kinase inhibitor developed by Genentech.
TOLVAPTAN: A selective vasopressin receptor 2 antagonist used to treat hyponatremia.
HUMAN CHORIONIC GONADOTROPIN: A hormone produced during pregnancy, used therapeutically to treat infertility and other conditions.
APIGENIN: A natural flavonoid found in many plants, with antioxidant, anti-inflammatory, and anti-cancer properties.
BEFIRADOL: An experimental analgesic agent that acts as a highly selective full agonist of the kappa-opioid receptor.
LOBELINE HYDROCHLORIDE: An alkaloid derived from the Indian tobacco plant, historically used as a smoking cessation aid.
NONIVAMIDE: A synthetic capsaicin analog, used as a topical analgesic and as an active ingredient in pepper spray.
NEFAZODONE: An atypical antidepressant that acts as a serotonin antagonist and reuptake inhibitor.
AT-7519: An experimental multi-cyclin-dependent kinase (CDK) inhibitor.
HALAZEPAM: A benzodiazepine derivative with anxiolytic, sedative, and anticonvulsant properties.
GLUTETHIMIDE: A hypnotic sedative drug that was used for the treatment of insomnia.
CETHROMYCIN: A ketolide antibiotic studied for the treatment of respiratory tract infections.
CLOBAZAM: A benzodiazepine used as an anxiolytic and as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome.
PINOMETOSTOSTAT: An experimental DOT1L inhibitor being investigated for the treatment of MLL-rearranged leukemia.
ROLAPITANT: A neurokinin-1 (NK1) receptor antagonist used to prevent delayed chemotherapy-induced nausea and vomiting.
AXITINIB: A small-molecule tyrosine kinase inhibitor that targets VEGFR, used to treat renal cell carcinoma.
ENCLOMIPHENE CITRATE: The trans-isomer of clomiphene, a selective estrogen receptor modulator used to treat male hypogonadism.
NALTREXONE HYDROCHLORIDE: An opioid receptor antagonist used to manage alcohol and opioid dependence.
OT-730: An experimental agent that inhibits both folate receptor alpha and beta.
NVP-TAE 226: A dual inhibitor of focal adhesion kinase (FAK) and insulin-like growth factor I receptor (IGF-IR).
BMS-986020: An oral lysophosphatidic acid receptor 1 (LPA1) antagonist studied for idiopathic pulmonary fibrosis.
LACTOSE: A disaccharide sugar composed of galactose and glucose that is found in milk.
ERGOTAMINE: An ergot alkaloid used for the treatment of acute migraine attacks.
AZITHROMYCIN: A macrolide antibiotic used to treat a wide variety of bacterial infections.
METHYLERGONOVINE: An ergot alkaloid used for the prevention and control of postpartum hemorrhage.
INDAPAMIDE: A thiazide-like diuretic used to treat hypertension and edema.
COMPOUND 13R [PMID: 23639540]: An experimental compound, likely an inhibitor of the BRPF1 bromodomain, as described in the publication.
RG-7256: An experimental compound, possibly a research chemical with a specific biological target.
NOR-BINALTORPHIMINE: A highly selective kappa-opioid receptor antagonist used in research.
LIRAGLUTIDE: A glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes and obesity.
MOLIBRESIB: An experimental bromodomain and extra-terminal domain (BET) inhibitor.
AS95: A research chemical or compound identifier.
CARBOPLATIN: A platinum-based chemotherapy drug used to treat various types of cancer.
ARIMOCLOMOL: An experimental drug that amplifies the heat shock protein response, studied for neurodegenerative diseases.
TERAZOSIN HYDROCHLORIDE: An alpha-1 antagonist used to treat symptoms of an enlarged prostate and high blood pressure.
CONATUMUMAB: An experimental human monoclonal antibody that targets the death receptor 5 (DR5), studied as a cancer therapy.
COMPOUND 17 [PMID: 23642479]: An experimental PARP1 inhibitor described in the specified publication.
ANDROGRAPHOLide: A labdane diterpenoid that is the main bioactive component of the Andrographis paniculata plant, with various medicinal properties.
VERATRIDINE: A neurotoxin that activates voltage-gated sodium channels, used in research.
ALLISAN: A chemical compound, possibly an older name or a specific formulation.
FORETINIB: A multi-kinase inhibitor that targets MET, RON, AXL, TIE-2, and VEGFR.
RAMIPRIL: An ACE inhibitor used to treat high blood pressure and congestive heart failure.
HISTAMINE: An organic nitrogenous compound involved in local immune responses, as a regulator of physiological functions in the gut, and as a neurotransmitter.
(R)-UH 301: A selective 5-HT1A receptor antagonist used in pharmacological research.
GLOFITAMAB: A bispecific monoclonal antibody that targets CD20 on B cells and CD3 on T cells, used for lymphoma.
HG2+: The divalent mercury cation, a toxic heavy metal ion.
LARGAZOLE: A natural cyclic peptide that acts as a potent histone deacetylase (HDAC) inhibitor.
DEMCIZUMAB: An experimental monoclonal antibody that targets the Notch signaling pathway protein DLL4.
RISPERIDONE: An atypical antipsychotic used to treat schizophrenia, bipolar disorder, and irritability associated with autism.
CARFILZOMIB: A proteasome inhibitor used to treat multiple myeloma.
FLUDROCORTISONE ACETATE: A synthetic corticosteroid with potent mineralocorticoid effects, used to treat adrenal insufficiency.
EPTIFIBATIDE: An antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class.
FASUDIL: A Rho-kinase inhibitor used for the treatment of cerebral vasospasm.
PHENETHYL ISOTHIOCYANATE: A natural isothiocyanate found in cruciferous vegetables, with potential chemopreventive properties.
MINAPRINE: An atypical antidepressant agent that was used for the treatment of depression.
ASCORBIC ACID: Also known as Vitamin C, an essential nutrient involved in the repair of tissue and the enzymatic production of certain neurotransmitters.
METHACHOLINE CHLORIDE: A synthetic choline ester that acts as a non-selective muscarinic receptor agonist, used in the bronchial challenge test.
E6201: An experimental TLR7 and TLR9 agonist being studied as a vaccine adjuvant and immunotherapy.
PYRROLIDINE DITHIOCARBAMIC ACID, AMMONIUM SALT: A potent inhibitor of the NF-kappaB signaling pathway.
PHENOBARBITAL: A barbiturate used as an anticonvulsant to treat various types of seizures.
MYCOPHENOLATE: An immunosuppressant drug used to prevent rejection in organ transplantation.
CPN-219: A research chemical or compound identifier.
IVABRADINE HYDROCHLORIDE: A medication that lowers the heart rate, used for symptomatic stable angina pectoris and heart failure.
METHANDROSTENOLONE: An androgen and anabolic steroid, commonly known as Dianabol.
PSORA-4: A selective inhibitor of the KCa3.1 potassium channel.
CGS 15943: A potent non-xanthine adenosine receptor antagonist used in research.
OZORALIZUMAB: An experimental nanobody that targets TNF-alpha, being studied for inflammatory diseases.
QUININE: A medication used to treat malaria and babesiosis.
DOXAZOSIN MESYLATE: An alpha-1 blocker used to treat symptoms of benign prostatic hyperplasia and hypertension.
[PHAA1,D-TYR(ET)2,VAL4,LYS6,TYR-NH28,DES-GLY9]AVP: A complex peptide analogue, likely a modified vasopressin receptor ligand.
DIAZOXIDE: A potassium channel activator used to treat low blood sugar due to various causes.
AMIKACIN: An aminoglycoside antibiotic used to treat a number of serious bacterial infections.
ABT-560: An experimental compound, possibly a research chemical with a specific biological target.
TRIPARANOL: A drug that was used to lower cholesterol but was withdrawn due to severe side effects.
SURAMIN: A medication used to treat sleeping sickness and river blindness.
THYMOL IODIDE: An antiseptic compound, a mixture of iodine derivatives of thymol.
TNF-ALPHA: Tumor Necrosis Factor-alpha, a pro-inflammatory cytokine involved in systemic inflammation.
MANGOSTIN: A natural xanthonoid compound found in the mangosteen fruit, with antioxidant and other biological activities.
DANAZOL: A synthetic steroid with anti-gonadotropic activity, used to treat endometriosis and fibrocystic breast disease.
(-)-TERTATOLOL: A beta-adrenergic receptor antagonist (beta-blocker).
CEDIRANIB: A potent multi-target tyrosine kinase inhibitor of VEGFR and c-Kit.
BUTABARBITAL: A barbiturate with an intermediate duration of action, used as a sedative and hypnotic.
TRILOSTANE: An inhibitor of steroid hormone synthesis, used in the treatment of Cushing's syndrome.
KAEMPFEROL: A natural flavonol found in a variety of plants, with antioxidant and anti-inflammatory properties.
ODANACATIB: An experimental inhibitor of the enzyme cathepsin K, studied for the treatment of osteoporosis.
BI-167107: A research chemical or compound identifier.
TRIMETREXATE: An antifolate chemotherapy agent.
PAGOCLONE: A non-benzodiazepine anxiolytic drug of the cyclopyrrolone family.
SAPANISERTIB: An experimental dual TORC1/TORC2 inhibitor.
LEDIPASVIR: An antiviral drug used in combination with sofosbuvir for the treatment of hepatitis C.
CODRITUZUMAB: An experimental monoclonal antibody that targets glypican-3, studied for hepatocellular carcinoma.
PAMIDRONATE: A nitrogen-containing bisphosphonate used to treat bone metastases and hypercalcemia.
PAXALISIB: An experimental dual PI3K/mTOR inhibitor.
BW-A1433: A research chemical or compound identifier.
HEPARIN: An anticoagulant (blood thinner) used to prevent and treat blood clots.
CONIVAPTAN: A non-peptide vasopressin receptor antagonist.
MARIMASTAT: A broad-spectrum matrix metalloproteinase (MMP) inhibitor.
ARHALOFENATE: An experimental drug that was studied for gout and type 2 diabetes.
GW405833: A research chemical or compound identifier, likely a specific receptor ligand.
FLUOROURACIL: A chemotherapy agent, often abbreviated as 5-FU, used to treat various cancers.
DEHYDRATED ALCOHOL: Ethanol in a concentrated form, used medically as a sclerosing agent.
PAROXETINE HYDROCHLORIDE, HEMIHYDRATE: A selective serotonin reuptake inhibitor (SSRI) used as an antidepressant.
LY-255283: A research chemical, likely a specific receptor antagonist.
PANOBINOSTAT: A non-selective histone deacetylase (HDAC) inhibitor used to treat multiple myeloma.
GEMFIBROZIL: A fibrate drug used to lower lipid levels.
TICLOPIDINE: An antiplatelet drug of the thienopyridine family.
ULIMORELIN HYDROCHLORIDE: An experimental ghrelin receptor agonist.
SAR-566658: An experimental antibody-drug conjugate targeting the CA6 antigen.
2X-121: An experimental PARP inhibitor.
TANNIC ACID: A specific type of tannin, a polyphenol with astringent properties.
TRICLOSAN: An antibacterial and antifungal agent.
METHOTREXATE: An antimetabolite and antifolate drug used in chemotherapy and for autoimmune diseases.
ANTIDEPRESSANT AGENT: A general class of drugs used to treat major depressive disorder and other conditions.
ERW1041E: A research chemical or compound identifier.
LEBRIKIZUMAB: An experimental monoclonal antibody that targets interleukin 13 (IL-13).
IBUPROFEN, SODIUM SALT: The sodium salt of ibuprofen, a common non-steroidal anti-inflammatory drug (NSAID).
SULFAMETHOXAZOLE: A sulfonamide bacteriostatic antibiotic.
SULOCTIDIL: A vasoactive drug that was used for cerebrovascular and peripheral vascular disorders.
OCTREOTIDE ACETATE: A synthetic analogue of somatostatin, used to treat acromegaly and certain tumors.
VINCRISTINE: A vinca alkaloid used in chemotherapy, which works by inhibiting microtubule formation.
PENTOSAN POLYSULFATE: A semi-synthetic polysulfated xylan used to treat interstitial cystitis.
VARDENAFIL: A PDE5 inhibitor used to treat erectile dysfunction.
BMS-536924: An experimental small-molecule inhibitor of the insulin-like growth factor-1 receptor (IGF-1R).
NICOTINE POLACRILEX: A formulation of nicotine bound to an ion-exchange resin, used in nicotine replacement therapy.
ABEMACICLIB: A selective inhibitor of cyclin-dependent kinases CDK4 and CDK6, used for HR-positive breast cancer.
VISTUSERTIB: An experimental dual mTORC1/mTORC2 inhibitor.
GITOXIN: A cardiac glycoside, similar to digoxin, found in the foxglove plant.
ITOPRIDE: A prokinetic agent used for the treatment of gastrointestinal motility disorders.
MRS1505: A research chemical, likely a specific receptor ligand.
5-HYDROXYMETHYL-2-FURFURAL: A chemical compound derived from the dehydration of certain sugars.
ERLOTINIB: A tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR).
COMPOUND 9 [PMID: 3514912]: An experimental compound, likely an inhibitor of the BRD9 bromodomain, as described in the publication.
THREO-3-METHYLGLUTAMATE: A chemical analogue of glutamate, used in neuroscience research.
BITHIONOL: An anthelmintic and antibacterial compound.
PROPRANOLOL HYDROCHLORIDE: A non-selective beta-blocker used to treat high blood pressure, angina, and other conditions.
AZACITIDINE: A chemotherapy agent, a chemical analogue of cytidine, used to treat myelodysplastic syndrome.
COBIMETINIB: A MEK inhibitor used in combination with a BRAF inhibitor for melanoma with specific mutations.
ERGOCRISTINE: An ergot alkaloid.
PZM21: An experimental opioid analgesic that is biased toward G-protein signaling, with fewer side effects.
APOMORPHINE: A non-selective dopamine agonist used to treat Parkinson's disease.
ZIPRASIDONE: An atypical antipsychotic used to treat schizophrenia and bipolar disorder.
PIFUSERTIB: An experimental AKT inhibitor.
PF-562271: A potent, selective inhibitor of focal adhesion kinase (FAK).
L689560: A research chemical, a selective glycine site antagonist of the NMDA receptor.
BUTALBITAL: A barbiturate with an intermediate duration of action, often used in combination products for tension headaches.
ERYTHROMYCIN: A macrolide antibiotic used to treat a number of bacterial infections.
LADUVIGLUSIB: An experimental GSK-3 inhibitor being studied for various conditions.
6-O-BENZYLGUANINE: An agent that depletes the DNA repair protein MGMT, used to enhance chemotherapy.
QUINAGOLIDE: A selective D2 receptor agonist used to treat conditions associated with hyperprolactinemia.
N-(5-{4-CHLORO-3-[(2-HYDROXYETHYL)SULFAMOYL]PHENYL}-4-METHYL-1,3-THIAZOL-2-YL)ACETAMIDE: A chemical compound with a complex name, likely a specific enzyme inhibitor or receptor ligand from a patent or publication.
TRIAZOLAM: A short-acting benzodiazepine primarily used for the short-term treatment of severe insomnia.
ESKETAMINE: The S-enantiomer of ketamine, a dissociative anesthetic used as a rapid-acting antidepressant.
CHLORAMPHENICOL SODIUM SUCCINATE: A prodrug of chloramphenicol, a broad-spectrum antibiotic.
AV-101: An experimental NMDA receptor antagonist that targets the glycine binding site.
DAVUNETIDE: An experimental neuropeptide studied for its neuroprotective effects.
LETROZOLE: An aromatase inhibitor used to treat hormonally-responsive breast cancer in postmenopausal women.
PEMBROLIZUMAB: An immune checkpoint inhibitor (anti-PD-1 antibody) used for the treatment of various cancers.
KW-2449: An experimental multi-kinase inhibitor that targets Hsp90, Flt3, and ABL.
BRIAKINUMAB: An experimental monoclonal antibody that targets interleukin-12 and interleukin-23.
ZEARALENONE: A mycotoxin with potent estrogenic activity, produced by fungi.
AESCULIOSIDE IIA: A saponin compound found in some plants.
CARBENOXOLONE: A derivative of glycyrrhetinic acid used for peptic ulcers and other inflammatory conditions.
BENZQUINAMIDE: An antiemetic agent that was used to prevent and treat nausea and vomiting.
ZALUNFIBAN: An experimental antiplatelet agent.
NTE-1: A research chemical or compound identifier.
SB 242084: A selective 5-HT2C receptor antagonist used in research.
MELPHALAN: A nitrogen mustard alkylating agent used in chemotherapy to treat multiple myeloma and ovarian cancer.
N-ETHYLMALEIMIDE: A reactive chemical used in biochemistry to modify cysteine residues in proteins.
ETANERCEPT-SZZS: A biosimilar of Etanercept, a TNF inhibitor used for autoimmune diseases.
ETHACRYNIC ACID: A loop diuretic used to treat high blood pressure and edema.
SRT2104: A selective SIRT1 activator that was studied for metabolic diseases.
DEQUALINIUM: An antiseptic and disinfectant agent with broad antimicrobial activity.
GANAXOLONE: A synthetic neuroactive steroid that acts as a positive allosteric modulator of the GABAA receptor.
SILVER SULFADIAZINE: A topical antibacterial cream used for the prevention and treatment of wound infections in burns.
ASPIRIN: A non-steroidal anti-inflammatory drug (NSAID) used to reduce pain, fever, and inflammation, and as an antiplatelet agent.
TRAMADOL: An opioid pain medication used to treat moderate to moderately severe pain.
DACINOSTAT: An experimental histone deacetylase (HDAC) inhibitor.
EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR: A class of drugs that block the action of EGFR, used in cancer therapy.
PHLOROGLUCINOL: An organic compound used as an antispasmodic agent.
CYCLOHEXIMIDE: An inhibitor of protein synthesis in eukaryotic cells, used in biomedical research.
ALARELIN: A synthetic analogue of gonadotropin-releasing hormone (GnRH).
GUGGULSTERONE: A plant sterol found in the resin of the guggul plant, studied for its effect on cholesterol.
TICLOPIDINE HYDROCHLORIDE: An antiplatelet drug used to prevent stroke.
NILOTINIB: A tyrosine kinase inhibitor that targets BCR-ABL, used to treat chronic myelogenous leukemia.
AM-6120: A research chemical or compound identifier.
ORBIFLOXACIN: A fluoroquinolone antibiotic used in veterinary medicine.
GÃ– 6983: A broad-spectrum protein kinase inhibitor, primarily targeting PKC isoforms.
XANOMELINE: An experimental muscarinic acetylcholine receptor agonist studied for Alzheimer's disease and schizophrenia.
SELURAMPANEL: An experimental AMPA receptor antagonist that was studied for epilepsy.
MISOPROSTOL: A synthetic prostaglandin E1 analogue used to prevent NSAID-induced gastric ulcers and to induce labor.
E4031: A research chemical that blocks the hERG potassium channel.
PUMOSETRAG: An experimental 5-HT3 receptor antagonist studied for irritable bowel syndrome.
OLAPARIB: A PARP inhibitor used for the treatment of certain types of cancer, particularly those with BRCA mutations.
DOXACURIUM CHLORIDE: A neuromuscular-blocking drug or skeletal muscle relaxant.
PLOZALIZUMAB: An experimental monoclonal antibody that targets the CD40 ligand.
URACIL: One of the four nucleobases in the nucleic acid of RNA.
RESERPINE: An indole alkaloid used as an antipsychotic and antihypertensive drug.
DACTOLISIB: An experimental dual PI3K/mTOR inhibitor.
MICHLER'S KETONE: A chemical intermediate used in the synthesis of dyes and pigments.
TRICHOSTATIN A: An organic compound that acts as an antifungal antibiotic and selectively inhibits histone deacetylase (HDAC) enzymes.
LORAZEPAM: A benzodiazepine medication used to treat anxiety disorders, trouble sleeping, and seizures.
CILASTATIN: A dehydropeptidase-I inhibitor, co-administered with the antibiotic imipenem to prevent its degradation.
METHOHEXITAL SODIUM: A short-acting barbiturate anesthetic agent.
MOFAROTENE: An experimental synthetic retinoid.
2-(2'-METHOXYPHENYL)-1H-INDOLE: A chemical compound, likely a synthetic intermediate or a specific receptor ligand.
CASOXIN C: A peptide derived from casein protein, with opioid-like activity.
AZD8835: An experimental selective PI3K alpha/delta inhibitor.
METHOTRIMEPRAZINE: A typical antipsychotic of the phenothiazine class.
IVOSIDENIB: A small molecule inhibitor of isocitrate dehydrogenase 1 (IDH1), used for acute myeloid leukemia with IDH1 mutations.
CLOZAPINE: An atypical antipsychotic medication used for treatment-resistant schizophrenia.
ORPHENADRINE HYDROCHLORIDE: A muscarinic antagonist and H1 histamine antagonist used as a skeletal muscle relaxant.
SEVOFLURANE: An inhaled general anesthetic.
VORICONAZOLE: A triazole antifungal medication used to treat serious fungal infections.
LEXIBULIN: An experimental vascular disrupting agent studied for cancer.
ANGIOGENESIS INHIBITOR: A class of drugs that inhibit the growth of new blood vessels, used in cancer therapy.
PENTOXIFYLLINE: A xanthine derivative used as a drug to treat muscle pain in people with peripheral artery disease.
ROFLUMILAST: A selective inhibitor of the enzyme phosphodiesterase-4 (PDE4), used to treat COPD.
PROTEIN S: A vitamin K-dependent plasma glycoprotein that functions as a cofactor for activated protein C in the degradation of coagulation factors.
PEXIDARTINIB HYDROCHLORIDE: A CSF1R kinase inhibitor used for the treatment of tenosynovial giant cell tumor.
CHLORDIAZEPOXIDE: A benzodiazepine drug used to treat anxiety, insomnia, and symptoms of withdrawal from alcohol and other drugs.
S-49076: An experimental multi-target kinase inhibitor.
MASITINIB: An experimental tyrosine-kinase inhibitor being studied for various cancers, inflammatory diseases, and neurodegenerative disorders.
DIGOXIN: A cardiac glycoside medication used to manage various heart conditions, most commonly atrial fibrillation.
DANUSERTIB: An experimental multi-kinase inhibitor targeting Aurora kinases.
E6801: A research chemical or compound identifier.
5,7-DICHLOROKYNURENIC ACID: A potent and selective antagonist of the glycine site of the NMDA receptor.
MESTANOLONE: An androgen and anabolic steroid.
IDARUBICIN: An anthracycline chemotherapy drug used to treat acute myeloid leukemia.
FLURAZEPAM: A long-acting benzodiazepine used for the treatment of insomnia.
ANTI-CD40 MONOCLONAL ANTIBODY CHI LOB 7/4: An experimental immunosuppressive monoclonal antibody targeting the CD40 receptor.
NELFINAVIR: A protease inhibitor used to treat HIV/AIDS.
LITHIUM: A chemical element and its salts are used as a psychiatric medication, primarily for bipolar disorder.
RECOMBINANT INTERLEUKIN-2: A manufactured form of the IL-2 cytokine, used as an immunotherapy for cancer.
UROFOLLITROPIN: A purified form of follicle-stimulating hormone (FSH) extracted from urine, used to treat infertility.
SUFENTANIL: A potent synthetic opioid analgesic, used for anesthesia and analgesia.
PROTOKYLOL HYDROCHLORIDE: A beta-adrenergic receptor agonist that was used as a bronchodilator.
DECAMETHONIUM: A short-acting depolarizing neuromuscular-blocking drug.
MRS1041: A research chemical, likely a specific receptor ligand.
XYLAZINE: An alpha-2 adrenergic agonist used for sedation, anesthesia, and analgesia in veterinary medicine.
[125I]SAUVAGINE (FROG): A radioiodinated form of sauvagine, a peptide related to corticotropin-releasing factor.
MEPIVACAINE HYDROCHLORIDE: A local anesthetic of the amide type.
ETHCHLORVYNOL: A sedative and hypnotic medication that was used for the treatment of insomnia.
CYPROHEPTADINE HYDROCHLORIDE: A first-generation antihistamine with anticholinergic, antiserotonergic, and local anesthetic properties.
GENTIAN VIOLET CATION: A triphenylmethane dye with antibacterial, antifungal, and anthelmintic properties.
BUSULFAN: An alkylating agent used in chemotherapy, particularly for chronic myelogenous leukemia.
PRAZEPAM: A benzodiazepine derivative with anxiolytic, anticonvulsant, and sedative properties.
THEOPHYLLINE SODIUM GLYCINATE: A salt of theophylline, a methylxanthine drug used for respiratory diseases such as COPD and asthma.
SULPIRIDE: An atypical antipsychotic drug of the benzamide class.
SULOCHRIN: A fungal metabolite with various biological activities.
PARTHENOLIDE: A sesquiterpene lactone found in the plant feverfew, with anti-inflammatory properties.
RECOMBINANT MONOCYTE CHEMOATTRACTANT PROTEIN-1: A manufactured form of the CCL2 cytokine, involved in inflammation and immune response.
CHLORMEZANONE: A muscle relaxant and anxiolytic drug.
N(6)-CYCLOHEXYLADENOSINE: A selective agonist for the adenosine A1 receptor, used in research.
CELECOXIB: A non-steroidal anti-inflammatory drug (NSAID) that specifically inhibits COX-2.
DRONEDARONE HYDROCHLORIDE: An antiarrhythmic medication used for atrial fibrillation and atrial flutter.
ALTANSERIN: A selective 5-HT2A receptor antagonist used in research.
HT-0712: An experimental drug that was studied for its potential to improve memory and cognitive function.
FR122047: A research chemical, a selective prostaglandin E2 receptor antagonist.
BREXANOLONE: A neuroactive steroid, a positive allosteric modulator of the GABAA receptor, used for postpartum depression.
INFLIXIMAB-DYYB: A biosimilar of infliximab, a TNF inhibitor used for autoimmune diseases.
PERICIAZINE: A typical antipsychotic of the phenothiazine class.
CRIZOTINIB: A tyrosine kinase inhibitor that targets ALK, ROS1, and MET, used for non-small cell lung cancer.
PROTEASOME INHIBITOR: A class of drugs that block the action of proteasomes, used primarily for cancer therapy.
GO-6976: A potent inhibitor of several protein kinases, including PKC.
R116031: A research chemical or compound identifier.
ORANTINIB: An experimental tyrosine kinase inhibitor that targets EGFR, PDGFR, and FGFR.
NITROXOLINE: An antibiotic used for urinary tract infections.
DIMETHYLFORMAMIDE: An organic solvent commonly used in chemical reactions.
TRIAZENE COMPOUND: A class of organic compounds containing the triazene functional group.
OXYPHENBUTAZONE: A non-steroidal anti-inflammatory drug (NSAID).
AMBUNOL: A research chemical or compound identifier.
PF-04691502: An experimental dual PI3K/mTOR inhibitor.
ANTICONVULSANT AGENT: A general class of drugs used to treat epileptic seizures.
METHYLPHENIDATE HYDROCHLORIDE: A central nervous system stimulant used to treat ADHD and narcolepsy.
VOXTALISIB: An experimental dual PI3K/mTOR inhibitor.
INAVOLISIB: An experimental selective PI3K alpha inhibitor.
GR 196429: A research chemical or compound identifier.
BITHIONOLATE SODIUM: The sodium salt of bithionol, an anthelmintic agent.
DIHYDROSPHINGOSINE: An intermediate in the biosynthesis of sphingosine, a component of sphingolipids.
PASIREOTIDE: A somatostatin analog used to treat Cushing's disease and acromegaly.
CLOFAZIMINE: An anti-leprosy drug with anti-inflammatory and immunomodulatory effects.
KOS-1584: An experimental Hsp90 inhibitor.
UR-PG131A: A research chemical or compound identifier.
FILOREXANT: An experimental orexin receptor antagonist studied for insomnia.
QUETIAPINE FUMARATE: An atypical antipsychotic used to treat schizophrenia, bipolar disorder, and major depressive disorder.
NAVITOCLAX: An experimental BCL-2 family inhibitor that induces apoptosis, studied for cancer.
AMITRIPTYLINE HYDROCHLORIDE: A tricyclic antidepressant used to treat a number of mental illnesses.
HSD1590: A research chemical or compound identifier.
RG-7600: A research chemical or compound identifier.
CLINDAMYCIN: A lincosamide antibiotic used for a variety of bacterial infections.
AROTINOID ACID: A synthetic retinoid with potential antineoplastic activity.
LY-2090314: An experimental inhibitor of the enzyme GSK-3.
FOSBRETABULIN TROMETHAMINE: A vascular disrupting agent that was studied for cancer therapy.
MAYTANSINE: A potent microtubule inhibitor, the parent compound of several antibody-drug conjugates.
PYROGALLOL RED: A dye used in colorimetric assays.
PD-0166285: A research chemical, a selective FGF receptor tyrosine kinase inhibitor.
ACETAZOLAMIDE: A carbonic anhydrase inhibitor used to treat glaucoma, epilepsy, and acute mountain sickness.
CXCL12-(1-17): A peptide fragment of the CXCL12 chemokine.
TARIQUIDAR: An experimental P-glycoprotein inhibitor designed to overcome multidrug resistance in cancer.
VINORELBINE: A vinca alkaloid chemotherapy agent used to treat various types of cancer.
QUAZEPAM: A long-acting benzodiazepine used for the treatment of insomnia.
CEFOXITIN SODIUM: A second-generation cephalosporin antibiotic.
EMODIC ACID: A natural anthraquinone derivative found in some plants.
I-ABOPX: A research chemical, a selective cannabinoid CB2 receptor antagonist.
LEVOFLOXACIN ANHYDROUS: A broad-spectrum fluoroquinolone antibiotic.
DCG-IV: A selective group II metabotropic glutamate receptor agonist.
INDOCYANINE GREEN ACID FORM: A cyanine dye used in medical diagnostics.
RETASPIMYCIN: An Hsp90 inhibitor that was studied in clinical trials for cancer.
VAPITADINE: A research chemical or compound identifier.
METIPRANOLOL: A non-selective beta-blocker used in eye drops to treat glaucoma.
PRX-08066: An experimental selective 5-HT2B receptor antagonist.
GSK-690693: An experimental pan-Akt inhibitor.
DOMPERIDONE: A dopamine antagonist used as an antiemetic and prokinetic agent.
DINOPROST TROMETHAMINE: A synthetic form of prostaglandin F2-alpha, used to induce labor and terminate pregnancy.
TP0556351: A research chemical or compound identifier.
AFT-II: A research chemical or compound identifier.
MSX-2: A research chemical or compound identifier.
FINGOLIMOD-PHOSPHATE: The active metabolite of fingolimod, a sphingosine-1-phosphate receptor modulator used for multiple sclerosis.
NIK INHIBITOR 12F: A specific inhibitor of NF-kappa-B-inducing kinase (NIK).
KETANSERIN: A 5-HT2A receptor antagonist used as an antihypertensive agent.
EICOSATETRANOIC ACID: A polyunsaturated fatty acid.
VORINOSTAT: A histone deacetylase (HDAC) inhibitor used to treat cutaneous T-cell lymphoma.
ADEFOVIR DIPIVOXIL: An antiviral drug, a nucleotide analogue reverse transcriptase inhibitor, used for chronic hepatitis B.
MPEP: A selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5).
COMPOUND 11 [PMID: 16413183]: An experimental compound described in the specified publication.
TRAMETINIB DIMETHYL SULFOXIDE: A MEK inhibitor used to treat melanoma with BRAF mutations.
PRAVASTATIN SODIUM: A statin drug used to lower cholesterol and prevent cardiovascular disease.
PHENYTOIN SODIUM: An anti-seizure medication.
ESZOPICLONE: A non-benzodiazepine hypnotic agent used for the treatment of insomnia.
VACCINE: A biological preparation that provides active acquired immunity to a particular infectious disease.
ZK-93423: A benzodiazepine receptor partial inverse agonist.
MELATONIN: A hormone primarily released by the pineal gland at night, involved in regulating the sleep-wake cycle.
LABETALOL: A beta-blocker used to treat high blood pressure.
DALCETRAPIB: An experimental drug that was intended to raise HDL cholesterol levels.
GSK2982772: A research chemical or compound identifier.
CENOBAMATE: An anti-seizure medication used for the treatment of partial-onset seizures.
MERCAPTOPURINE: A medication used for cancer and autoimmune diseases.
ANDROGEN RECEPTOR ANTAGONIST ONC1-0013B: An experimental selective androgen receptor antagonist.
MASOPROCOL: A drug that was used topically to treat actinic keratosis.
VINCRISTINE SULFATE: A chemotherapy agent used to treat various types of cancer.
THERAPEUTIC IMMUNE GLOBULIN: A preparation of antibodies used to provide passive immunity.
HEAT (BE2254): A research chemical or compound identifier.
PHENDIMETRAZINE: A sympathomimetic stimulant used as an appetite suppressant.
HYDROCORTISONE SODIUM PHOSPHATE: A corticosteroid used to treat a variety of inflammatory and autoimmune conditions.
CROLIBULIN: An experimental vascular disrupting agent and microtubule inhibitor.
CODEINE ANHYDROUS: An opiate used to treat pain, coughing, and diarrhea.
PF-03814735: An experimental multi-target kinase inhibitor.
GEDATOLISIB: An experimental dual PI3K/mTOR inhibitor.
NMRA-140: An experimental M4 muscarinic receptor positive allosteric modulator.
SRIF-28: Somatostatin-28, a peptide hormone that regulates the endocrine system.
NPY-(2-36) (PIG): A peptide fragment of Neuropeptide Y.
TETRACYCLINE: A broad-spectrum polyketide antibiotic.
MONOCILLIN I: A natural product with biological activity.
PYRAZINAMIDE: A medication used to treat tuberculosis.
MIDODRINE: A vasopressor/antihypotensive agent used to treat symptomatic orthostatic hypotension.
GSK4112: A selective agonist for the Rev-ErbA orphan nuclear receptors.
AST-487: An experimental irreversible inhibitor of EGFR and ErbB2.
MECASERMIN: A recombinant form of human insulin-like growth factor 1 (IGF-1).
SLC-391: An experimental compound being investigated for Alzheimer's disease.
TASELISIB: An experimental selective PI3K alpha inhibitor.
H2O2: Hydrogen peroxide, a chemical compound used as an oxidizer, bleaching agent, and antiseptic.
D(CH2)5[TYR(ME)2,THR4,TYR-NH29]OVT: A complex peptide analogue, likely a modified oxytocin/vasopressin receptor ligand.
NORGESTIMATE: A progestin used in combination with an estrogen as an oral contraceptive.
BAFETINIB: An experimental dual Src/Abl kinase inhibitor.
GAMBOGIC ACID: A natural xanthonoid with potent anticancer and anti-inflammatory activity.
EXEMESTANE: An aromatase inhibitor used to treat ER-positive breast cancer.
GW441756X: A selective inhibitor of the TrkA tyrosine kinase.
RUCAPARIB: A PARP inhibitor used for the treatment of ovarian and prostate cancer, particularly those with BRCA mutations.
TOLFENAMIC ACID: A non-steroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation, especially for migraine.
IPH-2101: An experimental monoclonal antibody that targets killer-cell immunoglobulin-like receptors (KIRs), studied for cancer immunotherapy.
MARAVIROC: An entry inhibitor (CCR5 antagonist) used to treat HIV infection.
AZD1305: An experimental ion channel blocker that was investigated for the treatment of atrial fibrillation.
MURAGLITAZAR: An experimental dual PPAR alpha/gamma agonist that was studied for type 2 diabetes.
ALACIZUMAB PEGOL: An experimental anti-VEGF antibody fragment conjugated to polyethylene glycol, studied as an anti-angiogenic agent.
RISANKIZUMAB: A monoclonal antibody that targets interleukin-23 (IL-23), used to treat psoriasis and Crohn's disease.
M4205: An experimental ATR kinase inhibitor being investigated for cancer therapy.
EMIXUSTAT HYDROCHLORIDE: An inhibitor of retinal pigment epithelium-specific 65 kDa protein (RPE65), studied for Stargardt disease.
RESIQUIMOD: An immune response modifier that acts as a Toll-like receptor 7 and 8 (TLR7/8) agonist.
AMPICILLIN TRIHYDRATE: A beta-lactam antibiotic used to treat a wide variety of bacterial infections.
ALVOCIDIB: An experimental cyclin-dependent kinase (CDK) inhibitor studied for the treatment of various cancers.
INGENOL MEBUTATE: A substance found in the sap of the plant Euphorbia peplus, used topically to treat actinic keratosis.
ALLOPURINOL: A xanthine oxidase inhibitor used to decrease uric acid levels and treat gout.
ESTROGEN: A primary female sex hormone responsible for the development and regulation of the female reproductive system.
MEPAZINE ACETATE: An older typical antipsychotic of the phenothiazine class.
DIHYDROERGOTAMINE MESYLATE: An ergot alkaloid used for the acute treatment of migraine and cluster headaches.
ENFORTUMAB VEDOTIN-EJFV: An antibody-drug conjugate that targets Nectin-4, used to treat urothelial cancer.
PARICALCITOL: A synthetic analog of vitamin D used to treat secondary hyperparathyroidism.
RITUXIMAB: A chimeric monoclonal antibody that targets the CD20 protein, used to treat certain autoimmune diseases and cancers.
VERAPAMIL: A calcium channel blocker used to treat hypertension, angina, and certain heart rhythm disorders.
POTASSIUM DICHROMATE: A common inorganic chemical reagent, used as an oxidizing agent in various laboratory and industrial applications.
DOLUTEGRAVIR SODIUM: An integrase inhibitor used for the treatment of HIV infection.
PHA-767491: An experimental dual inhibitor of the cell cycle kinases Cdc7 and Cdk9.
DAIDZEIN: An isoflavone compound found in soybeans and other legumes, classified as a phytoestrogen.
NERISPIRDINE: An experimental neuronal potassium channel opener that was studied for Alzheimer's disease.
XL228: An experimental multi-kinase inhibitor targeting IGF-1R, Src, Abl, and Aurora kinases.
MACIMORELIN ACETATE: A ghrelin receptor agonist used in the diagnosis of adult growth hormone deficiency.
DOXYCYCLINE ANHYDROUS: The anhydrous form of doxycycline, a broad-spectrum tetracycline antibiotic.
PANITUMUMAB: A fully human monoclonal antibody that targets the epidermal growth factor receptor (EGFR).
6-HYDROXYFLAVONE: A flavonoid compound with various biological activities, including antioxidant effects.
BUTYRIC ACID: A short-chain fatty acid produced by gut bacteria, important for colon health.
ZOPICLONE: A non-benzodiazepine hypnotic agent used for the short-term treatment of insomnia.
YM298198: A selective antagonist of the metabotropic glutamate receptor 1 (mGluR1).
SUCCIMER: A chelating agent used to treat heavy metal poisoning, particularly lead, mercury, and arsenic.
RETASPIMYCIN HYDROCHLORIDE: An Hsp90 inhibitor that was studied in clinical trials for cancer.
AGOMELATINE: An atypical antidepressant that acts as a melatonergic agonist and 5-HT2C antagonist.
QUINIDINE SULFATE: An antiarrhythmic agent used to treat certain types of irregular heartbeats.
AZINTUXIZUMAB VEDOTIN: An experimental antibody-drug conjugate targeting the C4.4a antigen.
BENZTROPINE: An anticholinergic drug used to treat symptoms of Parkinson's disease and drug-induced parkinsonism.
MRS2179: A selective antagonist of the P2Y1 purinergic receptor, used in research.
MEQUITAZINE: A second-generation antihistamine and anticholinergic.
CETUXIMAB: A chimeric monoclonal antibody that targets the epidermal growth factor receptor (EGFR), used for cancer treatment.
[125I]BH-NMB (HUMAN, MOUSE, RAT): A radioiodinated form of neuromedin B used in receptor binding studies.
RETAPAMULIN: A topical pleuromutilin antibiotic used to treat bacterial skin infections.
TAK-733: An experimental, potent, and selective MEK inhibitor.
METHYLTHIONINIUM CHLORIDE: Also known as methylene blue, a dye and medication with various uses, including treating methemoglobinemia.
FERULIC ACID: A phenolic compound found in plant cell walls, with antioxidant properties.
DF3016A: A research chemical or compound identifier.
MECHLORETHAMINE HYDROCHLORIDE: A nitrogen mustard alkylating agent used in chemotherapy.
ATORVASTATIN CALCIUM TRIHYDRATE: A statin drug used to lower cholesterol and prevent cardiovascular disease.
DEFACTINIB: An experimental focal adhesion kinase (FAK) inhibitor.
NERATINIB MALEATE: The maleate salt of neratinib, an irreversible pan-HER tyrosine kinase inhibitor.
AZD-6482: An experimental prostaglandin D2 receptor antagonist.
THYROTROPIN-RELEASING HORMONE: A hypothalamic hormone that stimulates the release of TSH and prolactin from the pituitary.
COMPOUND 1 [PMID: 11425539]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
RS-25344: A research chemical or compound identifier.
RGB-286638: An experimental multi-cyclin-dependent kinase (CDK) inhibitor.
INTERFERON ALFA: A type of cytokine used as an immunotherapy and antiviral agent.
NIACIN: Also known as Vitamin B3, used to treat high cholesterol and pellagra.
ZALIFRELIMAB: An experimental monoclonal antibody that targets the CTLA-4 immune checkpoint.
GLESATINIB: An experimental multi-kinase inhibitor targeting AXL and MET.
FLUFENAMIC ACID: A non-steroidal anti-inflammatory drug (NSAID) of the anthranilic acid derivative class.
TIVOZANIB: A potent and selective VEGFR tyrosine kinase inhibitor used for renal cell carcinoma.
NAVARIXIN: An experimental CXCR1/CXCR2 receptor antagonist studied for inflammatory conditions.
FRESOLIMUMAB: An experimental monoclonal antibody that neutralizes transforming growth factor beta (TGF-beta).
WX-UK1: A synthetic inhibitor of the urokinase-type plasminogen activator (uPA).
ASP4058: A research chemical or compound identifier.
6-METHYLFLAVONE: A synthetic flavonoid derivative with potential biological activities.
PENTOBARBITAL SODIUM: A short-acting barbiturate used as a sedative, hypnotic, and for anesthesia.
1D09C3: A research chemical or compound identifier.
PICTILISIB: An experimental pan-PI3K inhibitor.
HUMAN GIP(3-42)NH2: A truncated form of gastric inhibitory polypeptide, an endogenous DPP-4 inhibitor.
BELINOSTAT: A histone deacetylase (HDAC) inhibitor used to treat peripheral T-cell lymphoma.
MS8815: A research chemical or compound identifier.
ELTOPRAZINE: A 5-HT1A/1B receptor agonist that was studied as an anti-aggressive agent.
METHYLPARABEN: A preservative commonly used in cosmetics, personal care products, and food.
SEMAGACESTAT: An experimental gamma-secretase inhibitor that was studied for Alzheimer's disease.
TRETINOIN: A derivative of vitamin A, used topically to treat acne and other skin conditions.
IDAZOXAN: An alpha-2 adrenergic and imidazoline receptor antagonist used in research.
ISAM-140: An experimental P2X7 receptor antagonist.
(+/-)-ERIODICTYOL: A flavonoid found in citrus fruits and herbs, with antioxidant and anti-inflammatory properties.
LEIUROTOXIN I: A peptide toxin from scorpion venom that blocks small-conductance calcium-activated potassium channels.
NEOCEPTIN-3: A research chemical or compound identifier.
ETG-5773: A research chemical or compound identifier.
TOPIRAMATE: An anticonvulsant medication used to treat epilepsy and prevent migraines.
GEFITINIB: A tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR).
RECOMBINANT TUMOR NECROSIS FACTOR FAMILY PROTEIN: A general class of manufactured proteins from the TNF superfamily, used in research and therapy.
DOVITINIB: A multi-target tyrosine kinase inhibitor that targets FGFR, VEGFR, and PDGFR.
CIDOFOVIR ANHYDROUS: An antiviral medication used to treat cytomegalovirus (CMV) retinitis in AIDS patients.
CLOTRIMAZOLE: An azole antifungal medication used to treat various fungal infections.
REPOTRECTINIB: A next-generation tyrosine kinase inhibitor that targets ROS1 and TRK.
TEMAZEPAM: A benzodiazepine used for the short-term treatment of insomnia.
M1160: A research chemical or compound identifier.
TCDD: 2,3,7,8-Tetrachlorodibenzodioxin, a persistent environmental pollutant and known carcinogen.
PG-901: A research chemical or compound identifier.
AZ8838: An experimental P2X7 receptor antagonist.
NIMESULIDE: A non-steroidal anti-inflammatory drug (NSAID) with pain and fever-reducing properties.
OXYPURINOL: The active metabolite of allopurinol, which also inhibits xanthine oxidase.
BENOXINATE HYDROCHLORIDE: A local anesthetic used as eye drops for ophthalmic procedures.
PERETINOIN: An acyclic retinoid that was studied for the prevention of hepatocellular carcinoma.
BROMPERIDOL: A typical antipsychotic of the butyrophenone class.
FLUOROMETHOLONE: A synthetic glucocorticoid used in ophthalmic preparations to treat eye inflammation.
DIMDAZENIL: An experimental partial agonist of the benzodiazepine site of the GABAA receptor.
CP-195543: A research chemical or compound identifier.
COMPOUND 2 [PMID: 19230660]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
PGN-9856: A research chemical or compound identifier.
ILGINATINIB: An experimental multi-kinase inhibitor.
2MESADP: A stable analogue of adenosine diphosphate (ADP), used as a P2Y receptor agonist.
PEPTIDE LIGAND 2 [PMID: 19055415]: A specific peptide ligand for a receptor, as described in the publication.
CALCIPOTRIENE: A synthetic vitamin D3 analog used topically for the treatment of psoriasis.
VEMURAFENIB: A potent inhibitor of the BRAF V600E mutated kinase, used to treat melanoma.
ROVAZOLAC: A research chemical or compound identifier.
NEZULCITINIB: An experimental JAK inhibitor.
COTININE: The predominant metabolite of nicotine, used as a biomarker for tobacco exposure.
DILPACIMAB: An experimental monoclonal antibody.
APREPITANT: A neurokinin-1 (NK1) receptor antagonist used to prevent chemotherapy-induced nausea and vomiting.
MIDOSTAURIN: A multi-target kinase inhibitor used to treat acute myeloid leukemia and systemic mastocytosis.
METHYLNALTREXONE: A peripherally acting mu-opioid receptor antagonist used to treat opioid-induced constipation.
TOCAINIDE HYDROCHLORIDE: An antiarrhythmic agent of the local anesthetic type.
MK-6913: A research chemical or compound identifier.
GANITUMAB: An experimental monoclonal antibody that targets the insulin-like growth factor 1 receptor (IGF-1R).
TG100-801: A research chemical or compound identifier.
NAMINIDIL: A research chemical or compound identifier.
6-AMINOCAPROIC ACID: An antifibrinolytic agent used to treat bleeding disorders.
[125I][TYR4]GHRELIN (HUMAN): A radioiodinated form of the hormone ghrelin, used in receptor studies.
TETRAMETHYLAMMONIUM: A quaternary ammonium cation used as a chemical reagent.
GNE-3511: An experimental LRRK2 kinase inhibitor.
GNE-7883: A research chemical or compound identifier.
THYROXINE: The main hormone secreted into the bloodstream by the thyroid gland, also known as T4.
DESVENLAFAXINE SUCCINATE: A serotonin-norepinephrine reuptake inhibitor (SNRI) used as an antidepressant.
EPINEPHRINE BITARTRATE: The bitartrate salt of epinephrine, a hormone and neurotransmitter used to treat severe allergic reactions.
PILARALISIB: An experimental pan-PI3K inhibitor.
LUMATEPERONE: An atypical antipsychotic used for the treatment of schizophrenia and bipolar depression.
ETOMIDATE: A short-acting intravenous anesthetic agent.
IMGATUZUMAB: An experimental monoclonal antibody that targets the epidermal growth factor receptor (EGFR).
NECA: A non-selective adenosine receptor agonist used in research.
TESTOSTERONE: The primary male sex hormone and an anabolic steroid.
TREQUINSIN HYDROCHLORIDE: A potent phosphodiesterase inhibitor that was studied as a vasodilator.
CARMINIC ACID: A red glucosidal hydroxyanthrapurin that is the coloring matter in cochineal.
IMIPRAMINE HYDROCHLORIDE: A tricyclic antidepressant.
ARVERAPAMIL: A calcium channel blocker, an analogue of verapamil.
NOREPINEPHRINE: A catecholamine that functions as a hormone and neurotransmitter, also known as noradrenaline.
WKYMVM: A synthetic hexapeptide that acts as a potent agonist for formyl peptide receptors.
COMPOUND 47 [PMID: 18800762]: An experimental compound, likely a kinase inhibitor, described in the publication.
PROBENECID: A medication that increases uric acid excretion in the urine, used to treat gout.
NITROFURANTOIN, MACROCRYSTALS: An antibiotic used to treat urinary tract infections.
ECONAZOLE NITRATE: A topical azole antifungal agent.
ANDROSTENEDIONE: A steroid hormone that is a precursor to testosterone and estrogen.
DOSIMERTINIB: A research chemical or compound identifier.
THALIDOMIDE: An immunomodulatory drug used to treat multiple myeloma and leprosy.
SAG1.3: A research chemical or compound identifier.
ADP&BETA;S: A stable, non-hydrolyzable analogue of ADP.
HALOBETASOL: A very high-potency topical corticosteroid.
GANCOTAMAB: An experimental monoclonal antibody.
MECLOFENAMATE: A non-steroidal anti-inflammatory drug (NSAID).
TOLCAPONE: A COMT inhibitor used in the treatment of Parkinson's disease.
TOLUIC ACID: A substituted benzoic acid, an organic compound.
RHAMNETIN: A natural O-methylated flavonol.
SULFONE ANTI-INFECTIVE AGENT: A class of antibacterial drugs containing the sulfone group.
ADX10059: An experimental negative allosteric modulator of the mGluR5 receptor.
OLANZAPINE: An atypical antipsychotic used to treat schizophrenia and bipolar disorder.
ESCULETIN: A derivative of coumarin with antioxidant and anti-inflammatory properties.
OMBITASVIR/PARITAPREVIR/RITONAVIR: A combination drug used for the treatment of hepatitis C.
NILVADIPINE: A calcium channel blocker used to treat hypertension.
BT-11: A research chemical or compound identifier.
DX-2507: An experimental inhibitor of the plasma kallikrein enzyme.
LY341495: A potent and selective group II metabotropic glutamate receptor antagonist.
COMPOUND 9 [PMID: 15615544]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
DABRAFENIB: A potent inhibitor of the BRAF V600E mutated kinase, used to treat melanoma.
F16357: A research chemical or compound identifier.
EBSELEN: A synthetic organoselenium compound with antioxidant and anti-inflammatory activity.
EMBELIN: A natural benzoquinone compound with various biological activities, including anti-cancer effects.
CEP-1347: An experimental inhibitor of mixed-lineage kinases (MLKs).
CIPARGAMIN: An experimental antimalarial drug.
GRINIMIBINE: A research chemical or compound identifier.
METHYLDOPA ANHYDROUS: An alpha-2 adrenergic agonist used as an antihypertensive agent.
HARMAN: A beta-carboline alkaloid with various neurological effects.
HESPERETIN: A flavanone glycoside found in citrus fruits.
SUVECALTAMIDE: An experimental drug that was studied for epilepsy.
[3H]BSP: A radiolabeled compound, likely used in binding assays.
CHLORTETRACYCLINE HYDROCHLORIDE: A tetracycline antibiotic.
FLUTICASONE: A synthetic corticosteroid used to treat asthma and allergic rhinitis.
SF1126: An experimental RGD-conjugated pan-PI3K inhibitor.
LAPATINIB: A dual tyrosine kinase inhibitor that targets EGFR and HER2/neu.
ZM447439: An experimental, potent, and selective Aurora kinase inhibitor.
PROPAFENONE: An antiarrhythmic medication used to treat atrial fibrillation.
DOCEBENONE: An experimental drug that was studied for Friedreich's ataxia.
MOCETINOSTAT: An experimental histone deacetylase (HDAC) inhibitor.
THIOPENTAL SODIUM: An ultra-short-acting barbiturate used for general anesthesia.
ZOLANTIDINE: A highly selective H2 receptor antagonist used in research.
MK-2461: An experimental c-Met kinase inhibitor.
GSK'547: A research chemical or compound identifier.
VITAMIN B12: Also known as cobalamin, an essential vitamin involved in metabolism.
LAROTRECTINIB SULFATE: A potent and selective inhibitor of TRK kinases, used for TRK fusion-positive cancers.
BAY 55-9837: A research chemical or compound identifier.
COMPOUND 2 [PMID: 25408830]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
VINBLASTINE SULFATE: A vinca alkaloid chemotherapy agent used to treat various cancers.
7,8-DIHYDROXYFLAVONE: A natural flavonoid that acts as a potent agonist of the TrkB receptor.
AVAGACESTAT: An experimental gamma-secretase inhibitor that was studied for Alzheimer's disease.
SUNITINIB: A multi-target tyrosine kinase inhibitor used to treat renal cell carcinoma and GIST.
FENFLURAMINE HYDROCHLORIDE: A medication used for the treatment of seizures associated with Dravet syndrome.
VERUBECESTAT: An experimental BACE1 inhibitor that was studied for Alzheimer's disease.
DIETHYLSTILBESTROL: A synthetic non-steroidal estrogen that was used for various indications.
IBRITUMOMAB TIUXETAN: A radioimmunotherapy agent, a monoclonal antibody targeting CD20.
PHENAZOPYRIDINE HYDROCHLORIDE: A medication used to relieve symptoms caused by urinary tract infections.
REFAMETINIB: An experimental MEK inhibitor.
CP608,039: A research chemical or compound identifier.
COMPOUND 18 [PMID: 20873740]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
&ALPHA;-BUNGAROTOXIN: A neurotoxin from snake venom that irreversibly binds to nicotinic acetylcholine receptors.
ANAGRELIDE HYDROCHLORIDE: A medication used to treat essential thrombocythemia.
BREXPIPRAZOLE: An atypical antipsychotic that acts as a D2 and 5-HT1A partial agonist.
BRUCINE: A toxic alkaloid, similar to strychnine.
CATECHIN: A type of natural phenol and antioxidant, a flavan-3-ol.
MK-571: A potent and selective antagonist of the CysLT1 receptor, used in research.
DENBUFYLLINE: A xanthine derivative that acts as a phosphodiesterase inhibitor.
CYCLOPENTYLADENOSINE: A selective agonist for the adenosine A1 receptor.
COMPOUND 14 [PMID: 18800762]: An experimental compound, likely a kinase inhibitor, described in the publication.
TRYPAN BLUE: A stain used to selectively color dead tissues or cells blue.
CARVEDILOL: A beta-blocker used to treat high blood pressure and congestive heart failure.
DOXEPIN HYDROCHLORIDE: A tricyclic antidepressant used to treat depression, anxiety, and insomnia.
REMTOLUMAB: An experimental monoclonal antibody.
VARENICLINE: A prescription medication used to treat nicotine addiction.
CCL23: A small cytokine belonging to the CC chemokine family.
ADENOSINE: A purine nucleoside that plays a key role in energy transfer and signal transduction.
COMPOUND 27D [PMID: 28231433]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
ASTERRIC ACID: A natural product with biological activity.
ALISERTIB: An experimental Aurora kinase A inhibitor.
METHOXYVONE: A synthetic isoflavone.
LG190178: A research chemical or compound identifier.
RECOMBINANT HUMAN STEM CELL FACTOR: A manufactured form of the SCF cytokine, which plays a role in hematopoiesis.
NABIXIMOLS: A specific extract of the cannabis plant, used to treat spasticity in multiple sclerosis.
TRIAMTERENE: A potassium-sparing diuretic used in combination with other drugs for hypertension and edema.
ALENDRONATE SODIUM: A bisphosphonate drug used to treat osteoporosis and Paget's disease of bone.
B-TPMF: A research chemical or compound identifier.
TORIN 2: A potent and selective ATP-competitive mTOR inhibitor.
CDK1/2/4 INHIBITOR AG-024322: An experimental inhibitor of cyclin-dependent kinases 1, 2, and 4.
DOCOSAPENTAENOIC ACID: A polyunsaturated fatty acid.
HEXACHLOROPHENE: An organochlorine compound that was used as a disinfectant and antiseptic.
RECOMBINANT 70-KD HEAT-SHOCK PROTEIN: A manufactured form of the Hsp70 protein, involved in protein folding and stress response.
IL-6: Interleukin-6, a pro-inflammatory cytokine and an anti-inflammatory myokine.
ASENAPINE MALEATE: An atypical antipsychotic used to treat schizophrenia and bipolar disorder.
HALCINONIDE: A high-potency topical corticosteroid.
CVX-060: An experimental antibody-drug conjugate targeting VEGFR2.
SODIUM CHLORIDE: A common salt, an essential compound in nutrition and used in various medical applications.
WNY0824: A research chemical or compound identifier.
ZM-306416: An experimental inhibitor of the VEGFR1 tyrosine kinase.
FIRUGLIPEL: A research chemical or compound identifier.
LACTOSE, ANHYDROUS: The anhydrous form of lactose, a sugar found in milk.
UROKINASE: A thrombolytic (clot-busting) drug, a serine protease.
ZINC CHLORIDE: A chemical compound used in various applications, including as a disinfectant and in supplements.
MAPROTILINE: A tetracyclic antidepressant.
BUSPIRONE HYDROCHLORIDE: An anxiolytic drug of the azapirone class.
IONOMYCIN: An ionophore that transports calcium ions, used in research to raise intracellular calcium levels.
GPI-1485: An experimental neurotrophic compound that was studied for Parkinson's disease.
ZAFIRLUKAST: A leukotriene receptor antagonist used for the maintenance treatment of asthma.
VANDETANIB: A multi-target tyrosine kinase inhibitor that targets VEGFR, EGFR, and RET.
TIVANTINIB: An experimental, non-ATP competitive, selective inhibitor of the c-Met receptor tyrosine kinase.
APATORSEN: An experimental antisense oligonucleotide that targets Hsp27.
AZD-8186: An experimental selective PI3K beta/delta inhibitor.
VELIPARIB: An experimental PARP inhibitor.
CLEBOPRIDE: A dopamine D2 receptor antagonist with antiemetic and prokinetic properties.
DASATINIB ANHYDROUS: The anhydrous form of dasatinib, a multi-target kinase inhibitor used for leukemia.
TOMIVOSERTIB: An experimental inhibitor of the MNK1/2 kinases.
LUCITANIB: An experimental multi-kinase inhibitor targeting VEGFR, FGFR, and PDGFR.
RUXOLITINIB: A Janus kinase (JAK) inhibitor used to treat myelofibrosis and polycythemia vera.
R1295: A research chemical or compound identifier.
DOCETAXEL ANHYDROUS: The anhydrous form of docetaxel, a chemotherapy agent of the taxane family.
MITOGEN-ACTIVATED PROTEIN KINASE KINASE INHIBITOR: A general class of drugs that inhibit MEK enzymes in the MAPK/ERK pathway.
CAELYX: A brand name for pegylated liposomal doxorubicin, a chemotherapy agent.
JUGLONE: A natural phenolic compound found in walnuts, with allelopathic and other biological effects.
ENDOTHELIN-1: A potent vasoconstrictor peptide.
DESLORATADINE: A second-generation antihistamine used to treat allergies.
BUTOBARBITAL: A barbiturate with a short to intermediate duration of action.
CHLOROTHIAZIDE SODIUM: A thiazide diuretic used to treat high blood pressure and edema.
ETHACRYNATE SODIUM: The sodium salt of ethacrynic acid, a loop diuretic.
LEVOBETAXOLOL HYDROCHLORIDE: A selective beta-1 blocker used as eye drops to treat glaucoma.
NIMOTUZUMAB: An experimental monoclonal antibody that targets the epidermal growth factor receptor (EGFR).
CHLORTHALIDONE: A thiazide-like diuretic used to treat high blood pressure and edema.
PERPHENAZINE: A typical antipsychotic of the phenothiazine class.
PAZOPANIB: A multi-target tyrosine kinase inhibitor used to treat renal cell carcinoma and soft tissue sarcoma.
VENLAFAXINE HYDROCHLORIDE: A serotonin-norepinephrine reuptake inhibitor (SNRI) used as an antidepressant.
CANAGLIFLOZIN: An SGLT2 inhibitor used to treat type 2 diabetes.
TEDUGLUTIDE: A glucagon-like peptide-2 (GLP-2) analog used to treat short bowel syndrome.
CIPEPOFOL: An experimental intravenous anesthetic agent.
DESOGESTREL: A progestin used in hormonal contraceptives.
ADO-TRASTUZUMAB EMTANSINE: An antibody-drug conjugate consisting of the antibody trastuzumab linked to the cytotoxic agent emtansine.
PSB36: A selective adenosine A1 receptor antagonist.
CABAZITAXEL: A semi-synthetic taxane chemotherapy agent used to treat prostate cancer.
BQ123: A selective endothelin receptor type A (ETA) antagonist.
VINORELBINE TARTRATE: The tartrate salt of vinorelbine, a vinca alkaloid chemotherapy agent.
ACAMPROSATE CALCIUM: A medication used to manage alcohol dependence.
AMANTADINE HYDROCHLORIDE: An antiviral and anti-parkinsonian drug.
FELBAMATE: An anticonvulsant used in the treatment of epilepsy.
TETRAHYDROZOLINE HYDROCHLORIDE: A vasoconstrictor and decongestant used in eye drops.
NAPHAZOLINE HYDROCHLORIDE: A decongestant that acts as an alpha-adrenergic agonist.
AJMALICINE: An indole alkaloid with antihypertensive properties.
NIMODIPINE: A calcium channel blocker used to prevent cerebral vasospasm.
NANDROLONE DECANOATE: An androgen and anabolic steroid.
ZN2+: The divalent zinc cation, an essential trace element.
NADOLOL: A non-selective beta-blocker used to treat high blood pressure and angina.
GANDOTINIB: An experimental JAK2 inhibitor.
OCRIPLASMIN: A recombinant form of the enzyme plasmin, used to treat vitreomacular adhesion.
JNJ-7706621: An experimental multi-cyclin-dependent kinase (CDK) inhibitor.
CLOMIPRAMINE: A tricyclic antidepressant used to treat major depressive disorder and obsessive-compulsive disorder.
TOLTERODINE: An antimuscarinic drug used to treat urinary incontinence.
CHLORDIAZEPOXIDE HYDROCHLORIDE: A benzodiazepine used to treat anxiety and alcohol withdrawal.
ALPRAZOLAM: A short-acting benzodiazepine used to manage anxiety and panic disorders.
MIDAZOLAM HYDROCHLORIDE: A short-acting benzodiazepine used for anesthesia, sedation, and seizures.
ISOFLURANE: An inhaled general anesthetic.
PHA-793887: An experimental multi-cyclin-dependent kinase (CDK) inhibitor.
DALFOPRISTIN: A streptogramin antibiotic, used in combination with quinupristin.
SPECTINOMYCIN HYDROCHLORIDE: An aminocyclitol antibiotic used to treat gonorrhea.
GABAPENTIN ENACARBIL: A prodrug of gabapentin, an anticonvulsant.
CHLOROPROCAINE: A short-acting local anesthetic of the ester type.
PROCAINE HYDROCHLORIDE: A local anesthetic drug of the amino ester group.
MEPHENYTOIN: An anticonvulsant of the hydantoin class.
TETRACAINE: A potent local anesthetic of the ester type.
ZONISAMIDE: An anticonvulsant and carbonic anhydrase inhibitor.
METHSUXIMIDE: An anticonvulsant of the succinimide class.
SACUBITRIL: A neprilysin inhibitor used in combination with valsartan for heart failure.
PARITAPREVIR: An antiviral drug used for the treatment of hepatitis C.
OXTRIPHYLLINE: A xanthine derivative used as a bronchodilator.
IXAZOMIB CITRATE: A proteasome inhibitor used to treat multiple myeloma.
FIMEPINOSTAT: An experimental dual PI3K and HDAC inhibitor.
DS-7423: A research chemical or compound identifier.
BRICICLIB: An experimental cyclin-dependent kinase (CDK) inhibitor.
VANTICTUMAB: An experimental monoclonal antibody that targets Frizzled receptors.
ATILMOTIN: A research chemical or compound identifier.
RG-1530: A research chemical or compound identifier.
EVENAMIDE: An experimental voltage-gated sodium channel blocker.
UCN-01: An experimental kinase inhibitor that targets PKC and Chk1.
VX-702: An experimental p38 MAPK inhibitor.
ODELEPRAN: An experimental drug that was studied for depression.
LEMBOREXANT: A dual orexin receptor antagonist used for the treatment of insomnia.
AZD2516: A research chemical or compound identifier.
PRATOSARTAN: An experimental angiotensin II receptor antagonist.
SURINABANT: An experimental cannabinoid receptor type 1 (CB1) antagonist.
VOFOPITANT: An experimental neurokinin-1 (NK1) receptor antagonist.
RELCOVAPTAN: An experimental vasopressin V1a receptor antagonist.
FRAKEFAMIDE: An experimental enkephalinase inhibitor.
GW468816: A research chemical or compound identifier.
CADMIUM DICHLORIDE: A toxic inorganic compound of cadmium and chlorine.
CNV2197944: A research chemical or compound identifier.
SSR180711: An experimental glycine transporter 1 (GlyT1) inhibitor.
TRAXOPRODIL: An experimental NMDA receptor antagonist.
OSIMERTINIB: A third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor.
PACRITINIB: A Janus kinase (JAK) inhibitor used to treat myelofibrosis.
VATALANIB: An experimental multi-target tyrosine kinase inhibitor targeting VEGFR.
FOSTAMATINIB: A spleen tyrosine kinase (Syk) inhibitor used to treat chronic immune thrombocytopenia.
SARIZOTAN HYDROCHLORIDE: An experimental drug that was studied for Parkinson's disease.
ESMIRTAZAPINE MALEATE: The (S)-enantiomer of mirtazapine, an antidepressant.
TARANABANT: An experimental cannabinoid receptor type 1 (CB1) inverse agonist.
ESUBERAPROST: A research chemical or compound identifier.
NALDEMEDINE: A peripherally acting mu-opioid receptor antagonist used for opioid-induced constipation.
RALFINAMIDE: An experimental drug that was studied for neuropathic pain.
IFERANSERIN: A selective 5-HT2A receptor antagonist.
PRIDOPIDINE: An experimental drug being studied for Huntington's disease.
FLINDOKALNER: A research chemical or compound identifier.
DICYCLOMINE HYDROCHLORIDE: An anticholinergic drug used to treat symptoms of irritable bowel syndrome.
DEXMECAMYLAMINE: An experimental nicotinic acetylcholine receptor antagonist.
FULRANUMAB: An experimental monoclonal antibody that targets nerve growth factor (NGF).
PATRITUMAB: An experimental monoclonal antibody that targets HER3.
LINTUZUMAB: An experimental monoclonal antibody that targets CD33.
LERDELIMUMAB: An experimental monoclonal antibody that targets TGF-beta.
INTEPIRDINE: An experimental 5-HT6 receptor antagonist that was studied for Alzheimer's disease.
FOSBRETABULIN DISODIUM: A salt of fosbretabulin, a vascular disrupting agent.
TROPIFEXOR: An experimental farnesoid X receptor (FXR) agonist.
LITRONESIB: An experimental inhibitor of the mitotic kinesin Eg5.
ERTUMAXOMAB: An experimental trifunctional antibody that targets HER2/neu and CD3.
AD-159: A research chemical or compound identifier.
DIHYDROSTREPTOMYCIN SULFATE: An aminoglycoside antibiotic.
METHAQUALONE HYDROCHLORIDE: A sedative and hypnotic medication.
PERHEXILINE MALEATE: An anti-anginal agent.
ZIMELDINE HYDROCHLORIDE: A selective serotonin reuptake inhibitor (SSRI) that was withdrawn from the market.
EPRATUZUMAB: An experimental monoclonal antibody that targets CD22.
APOMAB: An experimental monoclonal antibody that targets the death receptor 5 (DR5).
J591 177LU: A radioimmunoconjugate targeting the prostate-specific membrane antigen (PSMA).
AMISULPRIDE: An atypical antipsychotic used to treat psychosis in schizophrenia and bipolar disorder.
IDRAPARINUX: An experimental long-acting synthetic anticoagulant.
CLOTHIAPINE: A typical antipsychotic of the dibenzothiazepine class.
BIVATUZUMAB: An experimental antibody-drug conjugate.
ORG-37684: A research chemical or compound identifier.
SB 221284: A research chemical or compound identifier.
VASOACTIVE INTESTINAL PEPTIDE: A peptide hormone with various functions, including vasodilation.
SOVAPREVIR: An experimental antiviral drug for hepatitis C.
ZIMLOVISERTIB: An experimental IRAK4 kinase inhibitor.
OLINCIGUAT: An experimental soluble guanylate cyclase (sGC) stimulator.
TETOMILAST: An experimental phosphodiesterase-4 (PDE4) inhibitor.
RADEZOLID: An oxazolidinone antibiotic.
ACORAMIDIS: An experimental transthyretin stabilizer for amyloidosis.
BALOXAVIR: An antiviral medication for treatment of influenza A and B.
TESOFENSINE: An experimental serotonin-norepinephrine-dopamine reuptake inhibitor studied for obesity.
VUPANORSEN SODIUM: An experimental antisense oligonucleotide targeting ANGPTL3.
ATACIGUAT: An experimental soluble guanylate cyclase (sGC) activator.
FE 203799: A research chemical or compound identifier.
ACEBILUSTAT: An experimental leukotriene A4 hydrolase inhibitor.
VOPRATELIMAB: An experimental monoclonal antibody that targets the ICOS receptor.
CDX-1140: An experimental monoclonal antibody that targets CD40.
CARPERITIDE: A recombinant form of human atrial natriuretic peptide.
SPIRAMYCIN: A macrolide antibiotic.
FEPIXNEBART: An experimental monoclonal antibody.
PRI-724: An experimental CBP/beta-catenin antagonist.
CTS-1027: An experimental matrix metalloproteinase (MMP) inhibitor.
EDRALBRUTINIB: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
VUNAKIZUMAB: An experimental monoclonal antibody.
SOCAZOLIMAB: An experimental monoclonal antibody targeting PD-L1.
IBOCTADEKIN: A recombinant form of interleukin-18.
RESIMMUNE: A research chemical or compound identifier.
MYCOPHENOLATE SODIUM: The sodium salt of mycophenolic acid, an immunosuppressant.
E-7016: A research chemical or compound identifier.
EFLEPEDOCOKIN ALFA: A recombinant form of interleukin-22.
MILATAXEL: An experimental taxane derivative.
FINGOLIMOD LAURYL SULFATE: A salt form of fingolimod, a sphingosine-1-phosphate receptor modulator.
ROBINETIN: A natural flavonol with antioxidant properties.
INDUSATUMAB VEDOTIN: An experimental antibody-drug conjugate targeting CD19.
ANASTROZOLE: An aromatase inhibitor used to treat breast cancer.
ALPELISIB: A PI3K alpha inhibitor used to treat certain types of breast cancer.
AKT INHIBITOR MK2206: An experimental allosteric inhibitor of the AKT kinase.
NG-25: An experimental inhibitor of the LRRK2 kinase.
EGEN-001: An experimental gene therapy product.
RALIMETINIB MESYLATE: An experimental p38 MAPK inhibitor.
&ALPHA;-CONOTOXIN GI: A peptide neurotoxin from cone snail venom that blocks nicotinic acetylcholine receptors.
SORAFENIB: A multi-kinase inhibitor used to treat kidney, liver, and thyroid cancer.
AFATINIB: A tyrosine kinase inhibitor that targets EGFR and HER2.
MYRICETIN: A natural flavonol with antioxidant and other biological properties.
XANTHONE: An organic compound that forms the structural core of many natural products.
MORIN: A flavonol compound with antioxidant properties.
STILONIUM IODIDE: An antispasmodic agent.
(R,S)-IFENPRODIL: A non-competitive antagonist of the NMDA receptor.
ISOBOLDINE: An aporphine alkaloid with anti-inflammatory and other activities.
ISOSILYBIN B: A flavonolignan, a component of silymarin from milk thistle.
AESCULIOSIDE IIIF: A saponin compound found in some plants.
JTC-801: A potent and selective nociceptin/orphanin FQ (NOP) receptor antagonist.
PHENAMIPHOS: An organophosphate nematicide and insecticide.
NOCODAZOLE: A microtubule-destabilizing agent used in cell biology research.
LEUCINE: An essential amino acid, important for protein synthesis.
GSK9772: A research chemical or compound identifier.
MEFLOQUINE HYDROCHLORIDE: An antimalarial drug.
HALICLONADIAMINE: A marine alkaloid with biological activity.
ETAZOLATE: A research chemical with anxiolytic-like effects.
GW5074: A selective inhibitor of the c-Raf kinase.
LIMONIN: A limonoid compound found in citrus fruits.
INDOLE-3-BUTYRIC ACID: A plant hormone in the auxin family.
ANGUIDIN: A mycotoxin with cytotoxic properties.
APRUTUMAB IXADOTIN: An experimental antibody-drug conjugate.
CHLORPROMAZINE HYDROCHLORIDE: A typical antipsychotic medication.
SOMATOSTATIN: A peptide hormone that regulates the endocrine system and affects neurotransmission.
BIS(DIMETHYLAMINETHIOCARBONYL)MONOSULFIDE: A chemical compound, likely a vulcanization accelerator or intermediate.
DAIDZIN: A natural isoflavone found in soybeans.
PIRENOXINE: A medication used in eye drops, claimed to prevent or treat cataracts.
NEVIRAPINE: A non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV/AIDS.
RILUZOLE: A medication used to treat amyotrophic lateral sclerosis (ALS).
CAFFEIC ACID: A natural phenolic compound with antioxidant properties.
NICARDIPINE: A calcium channel blocker used to treat high blood pressure and angina.
NIFUROXAZIDE: An oral nitrofuran antibiotic used for colitis and diarrhea.
BELACTOSIN A: A natural product that acts as a proteasome inhibitor.
NORTRIPTYLINE HYDROCHLORIDE: A tricyclic antidepressant.
PYRITHIONE: An organosulfur compound used as an antifungal and antibacterial agent.
PIRARUBICIN: An anthracycline antibiotic used in chemotherapy.
TRIFLUOPERAZINE HYDROCHLORIDE: A typical antipsychotic of the phenothiazine class.
IRIGINOL HEXAACEATATE: A chemical compound derived from a natural product.
CHLORPROMAZINE: A typical antipsychotic medication.
STICTIC ACID: A lichen acid with biological activities.
DEHYDROVARIABILIN: A marine natural product.
INDOMETHACIN: A non-steroidal anti-inflammatory drug (NSAID).
CEFUROXIME AXETIL: A second-generation cephalosporin antibiotic.
DECITABINE: A hypomethylating agent used to treat myelodysplastic syndrome.
SCOULERINE: A protoberberine alkaloid found in certain plants.
APOGOSSYPOL: A derivative of gossypol with anticancer activity.
ETILEFRINE: A sympathomimetic amine used as a cardiac stimulant and vasopressor.
PIRSIDOMINE: A nitric oxide donor that was studied as an anti-anginal agent.
COLCHICEINE: A metabolite of colchicine.
SB203580: A potent and selective inhibitor of the p38 MAP kinase.
ZAPRINAST: A phosphodiesterase inhibitor, primarily of PDE5 and PDE6.
ACIVICIN: An antibiotic with antitumor activity that inhibits glutamine-dependent enzymes.
BENZOQUINONE: An organic compound, a basic building block for many biologically active substances.
ISOVELLERAL: A fungal metabolite with pungent and antimicrobial properties.
ZERANOL: A non-steroidal estrogen agonist.
NICLOSAMIDE: An anthelmintic medication used to treat tapeworm infestations.
PHORBOL 12-MYRISTATE 13-ACETATE: A potent tumor promoter and protein kinase C activator, used in research.
DICUMAROL: An anticoagulant that functions as a vitamin K antagonist.
VOACANGINE: An indole alkaloid with various biological activities.
ACID BLUE 129: A synthetic dye.
CONGO RED: A dye and pH indicator, historically used to diagnose amyloidosis.
CEFAMANDOLE SODIUM: A second-generation cephalosporin antibiotic.
TANDUTINIB: An experimental multi-kinase inhibitor targeting FLT3, PDGFR, and c-Kit.
CARMUSTINE: A nitrogen mustard alkylating agent used in chemotherapy, particularly for brain tumors.
CRYPTOTANSHINONE: A natural compound from Salvia miltiorrhiza with various biological activities.
NILUTAMIDE: A non-steroidal antiandrogen used to treat prostate cancer.
LOMOFUNGIN: An antibiotic with antifungal and antibacterial activity.
LEVONORGESTREL: A progestin used in hormonal contraceptives and emergency contraception.
TENONITROZOLE: An antiprotozoal drug.
ALEXIDINE HYDROCHLORIDE: An antiseptic agent with broad antimicrobial activity.
MITONAFIDE: An experimental anticancer agent that intercalates into DNA.
RILMENIDINE HEMIFUMARATE: An antihypertensive agent that acts on imidazoline receptors.
PHENYLGLYOXAL: A chemical reagent used to modify arginine residues in proteins.
BITHIONOLOXIDE: A metabolite of bithionol.
(R)-&ALPHA;-METHYLHISTAMINE: A selective agonist for the histamine H3 receptor.
MAYTANSINOL: A potent microtubule inhibitor, the parent alcohol of the maytansinoid class of anticancer agents.
(R)-PINOCEMBRIN: The R-enantiomer of pinocembrin, a flavonoid with neuroprotective and anti-inflammatory properties.
DIAZEPAM: A long-acting benzodiazepine used to treat anxiety, seizures, muscle spasms, and alcohol withdrawal.
RABEPRAZOLE: A proton pump inhibitor (PPI) that decreases stomach acid production, used to treat GERD and peptic ulcers.
HYGROMYCIN B: An aminoglycoside antibiotic that inhibits protein synthesis, used in molecular biology for selection.
BARASERTIB-HQPA: A salt form of barasertib, an experimental Aurora kinase B inhibitor.
PRALIDOXIME IODIDE: An oxime used as an antidote to organophosphate poisoning.
QUERCITRIN: A glycoside of the flavonoid quercetin, with antioxidant and anti-inflammatory effects.
GALLIC ACID: A phenolic acid found in various plants, with antioxidant and astringent properties.
ZALCITABINE: A nucleoside reverse transcriptase inhibitor (NRTI) that was used to treat HIV/AIDS.
IRSOGLADINE MALEATE: A medication used for gastritis and peptic ulcers, which enhances gastric mucosal integrity.
ROSE BENGAL: A stain used in ophthalmology to identify damaged conjunctival and corneal cells.
COLCHICINE: A medication used to treat gout and BehÃ§et's disease, which works by inhibiting microtubule polymerization.
4-NONYLPHENOL: An industrial chemical used in the manufacture of antioxidants, lubricating oil additives, and plasticizers.
[125I]LH: Radioiodinated Luteinizing Hormone, used in receptor binding assays.
RIBOPRINE: An immunosuppressive drug, an analogue of purine.
OXATOMIDE: A first-generation antihistamine with mast cell stabilizing properties.
GW290597X: A research chemical or compound identifier.
FLUCONAZOLE: A triazole antifungal medication used to treat a variety of fungal infections.
PITAVASTATIN CALCIUM: A statin drug used to lower cholesterol levels.
PLICAMYCIN: An antineoplastic antibiotic that inhibits RNA synthesis by binding to DNA.
GAMMA-LINOLENIC ACID: An omega-6 fatty acid found in various plant oils.
CIS-RESVERATROL: An isomer of resveratrol, a stilbenoid natural phenol.
FUROXAN: A class of heterocyclic compounds that act as nitric oxide donors.
FENARIMOL: A fungicide that inhibits ergosterol biosynthesis.
U-0126: A potent and selective non-competitive inhibitor of the kinases MEK1 and MEK2.
CDK9 INHIBITOR PRT2527: An experimental, potent, and selective inhibitor of cyclin-dependent kinase 9.
EQUILIN: An estrogen hormone, primarily found in pregnant mares.
HEXESTROL: A synthetic non-steroidal estrogen.
TOLONIUM CHLORIDE: Also known as Toluidine Blue, a dye used as a stain in histology and as a diagnostic aid.
CYCLOPROPARADICICOL: A research chemical or compound identifier.
ROCURONIUM: A non-depolarizing neuromuscular-blocking drug used in anesthesia.
TO-901317: A potent synthetic agonist for the liver X receptor (LXR).
DOXORUBICIN HYDROCHLORIDE: A widely used anthracycline chemotherapy agent that intercalates into DNA.
NANAOMYCIN: A type of quinone antibiotic.
HAEMATOXYLIN: A natural dye extracted from the heartwood of logwood trees, used in histology.
OXYBENZONE: A common ingredient in sunscreens that absorbs UV-B and short-wave UV-A rays.
4-HYDROXY-3,5-DIMETHYL-5-(2-METHYL-BUTA-1,3-DIENYL)-5H-THIOPHEN-2-ONE: A complex organic compound, likely a natural product or synthetic intermediate.
RAPASTINEL: An experimental antidepressant that acts as a partial agonist of the NMDA receptor glycine site.
GITOXIGENIN: A cardiotonic steroid, the aglycone of gitoxin.
SCH 57790: A research chemical or compound identifier.
2-CHLOROADENOSINE: An adenosine analog that acts as an agonist for adenosine receptors.
METHAPHIT: An irreversible antagonist of the phencyclidine (PCP) binding site of the NMDA receptor.
FPL64176: A calcium channel activator used in research.
PROCATEROL HYDROCHLORIDE: A short-acting beta-2 adrenergic receptor agonist used as a bronchodilator.
EDARAVONE: A free radical scavenger used to treat stroke and amyotrophic lateral sclerosis (ALS).
HEMICHOLINIUM-3: An inhibitor of the high-affinity choline transporter, used in neuroscience research.
BMS-182874: A research chemical or compound identifier.
GW7647: A potent and selective agonist for the PPAR-alpha receptor.
AMPHOTERICIN B LIPOSOMAL: A liposomal formulation of the antifungal drug amphotericin B, used for serious fungal infections.
DEMETHOXYCURCUMIN: A natural curcuminoid compound found in turmeric.
(R)-NFPS: A research chemical or compound identifier.
ITRACONAZOLE: A triazole antifungal agent used to treat a broad range of fungal infections.
ESTRADIOL VALERATE: A synthetic estrogen used in hormone therapy and hormonal contraception.
RICININE: A toxic alkaloid found in the castor bean plant.
5-FLUOROINDOLE-2-CARBOXYLIC ACID: A chemical intermediate used in the synthesis of various compounds.
DEQUALINIUM CHLORIDE: An antiseptic and disinfectant agent with broad antimicrobial activity.
BORIC ACID: A weak Lewis acid of boron often used as an antiseptic, insecticide, and flame retardant.
CHLORPYRAMIN HYDROCHLORIDE: A first-generation antihistamine.
HELIPARVIFOLINE: A natural alkaloid with potential biological activities.
CYPROTERONE ACETATE: A steroidal antiandrogen and progestin used to treat androgen-related conditions.
NAPROXEN SODIUM: A non-steroidal anti-inflammatory drug (NSAID) used to treat pain, fever, and inflammation.
CARBENOXOLONE SODIUM: The sodium salt of carbenoxolone, used for peptic ulcers.
TYRPHOSTIN 51: A research chemical that inhibits tyrosine kinases.
SANGUINARINE SULFATE: The sulfate salt of sanguinarine, a toxic alkaloid with antimicrobial and anti-inflammatory properties.
FERRUGINENE B: A natural product with a specific chemical structure.
ANGUSTIBALIN: A natural product with a specific chemical structure.
METHYLERGONOVINE MALEATE: An ergot alkaloid used to prevent or treat postpartum hemorrhage.
SARAFLOXACIN HYDROCHLORIDE: A fluoroquinolone antibiotic used in veterinary medicine.
DOCUSATE: A stool softener used to treat constipation.
MITOBRONITOL: An alkylating agent that was used as an anticancer drug.
FLUAZINAM: A fungicide used in agriculture.
RIMONABANT: An anorectic anti-obesity drug that was withdrawn from the market due to severe psychiatric side effects.
DIHYDROTANSHINONE I: A natural compound from Salvia miltiorrhiza with various biological activities.
AZD-1080: An experimental GSK-3 inhibitor that was studied for Alzheimer's disease.
SIMVASTATIN: A statin drug used to lower cholesterol and reduce the risk of cardiovascular disease.
ETIDRONIC ACID: A first-generation bisphosphonate used to treat Paget's disease of bone.
LY-294002: A potent and selective inhibitor of phosphoinositide 3-kinases (PI3Ks), widely used in research.
MK-0893: An experimental drug that was studied for its effects on cholesterol metabolism.
FAMOXADONE: A fungicide that inhibits the mitochondrial respiratory chain.
AMINACRINE HYDROCHLORIDE: A topical antiseptic and fluorescent dye.
AMENTOFLAVONE: A biflavonoid found in a number of plants, with various biological activities.
DIPHYLLIN: A natural lignan with antiviral and anticancer properties.
DIENESTROL: A synthetic non-steroidal estrogen.
AMCINAFIDE: A research chemical or compound identifier.
METHOXYVERAPAMIL HYDROCHLORIDE: A calcium channel blocker, also known as D600, used in research.
IMMUNOTOXIN: A class of artificial proteins consisting of a targeting portion linked to a toxin.
BENZBROMARONE: A uricosuric agent used in the treatment of gout.
FLUSPIRILENE: A long-acting typical antipsychotic of the diphenylbutylpiperidine class.
ROTTLERIN: A natural polyphenol that was initially described as a PKC inhibitor, but has multiple targets.
BAICALEIN: A flavone found in the plant Scutellaria baicalensis, with antioxidant and anti-inflammatory effects.
PD-118057: A research chemical, a selective adenosine A2A receptor agonist.
KAMEBANIN: A natural diterpenoid compound.
SALICYLURIC ACID: A metabolite of salicylic acid (aspirin).
CYPATE: A cyanine-based fluorescent dye used for near-infrared imaging.
CYCLOTHIAZIDE: A thiazide diuretic used to treat hypertension and edema.
CHLORMADINONE ACETATE: A steroidal progestin with antiandrogen activity.
CUCURBITACIN D: A natural triterpenoid compound with cytotoxic properties.
PHENELZINE: A monoamine oxidase inhibitor (MAOI) used as an antidepressant.
PIRAGLIATIN: An experimental glucokinase activator that was studied for type 2 diabetes.
SECRAMINE A: A research chemical or compound identifier.
PROPYLPYRAZOLETRIOL: A synthetic compound that acts as an agonist for the cannabinoid receptor 2 (CB2).
DIFLUNISAL: A non-steroidal anti-inflammatory drug (NSAID) of the salicylate class.
E232: A research chemical or compound identifier.
ANTHRALIN: A topical medication used for the treatment of psoriasis.
METCONAZOLE: A triazole fungicide.
PIPERTRAMINE AMIDE: A research chemical or compound identifier.
INDIRUBIN-3'-MONOXIME: A derivative of indirubin, which is an inhibitor of cyclin-dependent kinases (CDKs).
TETRADECYLTHIOACETIC ACID: A modified fatty acid with effects on lipid metabolism.
BRONOPOL: An organic compound with broad antimicrobial activity, used as a preservative.
APICIDIN: A cyclic tetrapeptide that acts as a histone deacetylase (HDAC) inhibitor.
OXAPIUM IODIDE: A quaternary ammonium compound with anticholinergic properties.
IODOCARB: A preservative with antifungal and antibacterial properties.
CINNARIZINE: A first-generation antihistamine and calcium channel blocker.
2'-METHOXYFORMONONETIN: A natural isoflavone compound.
SIMETRIDE: A research chemical or compound identifier.
MRS1220: A potent and selective antagonist of the adenosine A3 receptor.
ALLETHRIN: A synthetic pyrethroid insecticide.
MALINAMIDE: A research chemical or compound identifier.
BARDOXOLONE METHYL: An experimental antioxidant inflammation modulator.
HELIOMYCIN: An antibiotic compound.
DIGITOXIN: A cardiac glycoside used to treat congestive heart failure.
TUBASTATIN A: A potent and selective inhibitor of the histone deacetylase 6 (HDAC6).
DICHLOROACETIC ACID: A chemical compound that has been studied for its potential anticancer effects.
FIDUXOSIN: An experimental drug that was studied for benign prostatic hyperplasia.
FENRETINIDE: A synthetic retinoid that has been investigated for cancer chemoprevention and therapy.
LASALOCID A SODIUM: An ionophore antibiotic used in veterinary medicine.
MOFEGILINE: An irreversible monoamine oxidase B (MAO-B) inhibitor.
VALRUBICIN: An anthracycline chemotherapy agent used for bladder cancer.
MK-2206: An experimental allosteric inhibitor of the AKT kinase.
RIMEGEPANT: A CGRP receptor antagonist used for the acute treatment of migraine.
TENOXICAM: A non-steroidal anti-inflammatory drug (NSAID).
PHENYLBUTAZONE: A non-steroidal anti-inflammatory drug (NSAID) for short-term use in inflammatory conditions.
MI-503: An experimental inhibitor of the menin-MLL interaction for cancer therapy.
FUTUXIMAB/MODOTUXIMAB MIXTURE: A combination of two experimental monoclonal antibodies.
1-NAPHTHYLISOTHIOCYANATE: A chemical used in research to induce liver injury in animal models.
IPATASERTIB: An experimental AKT inhibitor being studied for various cancers.
FLUORESCEIN: A fluorescent dye widely used in microscopy and diagnostics.
QUIFENADINE: A second-generation antihistamine.
GW779439X: A research chemical, an inhibitor of the TrkA kinase.
REMDESIVIR: A broad-spectrum antiviral medication used for the treatment of COVID-19.
DIPHENYLUREA: A chemical compound, a basic structure for some biologically active molecules.
TACEDINALINE: An experimental histone deacetylase (HDAC) inhibitor.
GERONTOXANTHONE I: A natural xanthone compound.
PROPYLPARABEN: A preservative commonly used in cosmetics and pharmaceuticals.
2,6-DIMETHOXYQUINONE: A chemical compound, a derivative of quinone.
CEFMETAZOLE: A second-generation cephalosporin antibiotic.
ALLOXAN: A toxic chemical compound used in research to induce diabetes in animal models.
SYROSINGOPINE: An antihypertensive drug that depletes catecholamines.
AZTREONAM: A monobactam antibiotic used to treat a variety of bacterial infections.
AZD1480: An experimental Janus kinase (JAK) inhibitor.
TEPOTINIB: A MET kinase inhibitor used to treat non-small cell lung cancer with MET mutations.
CABOZANTINIB S-MALATE: The malate salt of cabozantinib, a multi-kinase inhibitor.
IBUTAMOREN: An experimental growth hormone secretagogue.
REGORAFENIB: A multi-kinase inhibitor used to treat colorectal cancer, GIST, and hepatocellular carcinoma.
X-82: An experimental multi-target tyrosine kinase inhibitor.
GUANADREL SULFATE: An antihypertensive drug that acts as an adrenergic neuron blocking agent.
FEXAGRATINIB: An experimental FGFR inhibitor.
PROMAZINE HYDROCHLORIDE: A typical antipsychotic of the phenothiazine class.
DINACICLIB: An experimental multi-cyclin-dependent kinase (CDK) inhibitor.
NIFEDIPINE: A calcium channel blocker used to treat hypertension and angina.
EPIPODOPHYLLOTOXIN COMPOUND: A class of compounds, including etoposide, that inhibit topoisomerase II.
PUROMYCIN: An aminonucleoside antibiotic that inhibits protein synthesis.
RIBAVIRIN: An antiviral medication used to treat RSV infection, hepatitis C, and some viral hemorrhagic fevers.
CW85319: A research chemical or compound identifier.
IL-10: Interleukin-10, an anti-inflammatory cytokine.
STAUROSPORINE: A natural product that is a potent, broad-spectrum protein kinase inhibitor.
ZM336372: A selective inhibitor of the Raf-1 kinase.
PILOCARPINE HYDROCHLORIDE: A muscarinic receptor agonist used to treat glaucoma and dry mouth.
PD-98059: A selective inhibitor of the kinase MEK1, used in research.
CITALOPRAM: A selective serotonin reuptake inhibitor (SSRI) used as an antidepressant.
PRASTERONE: Also known as dehydroepiandrosterone (DHEA), a steroid hormone.
INTERLEUKIN-11: A cytokine that stimulates the production of platelets.
RAS INHIBITOR: A general class of drugs that target the Ras signaling pathway.
MITOMYCIN: A chemotherapy agent that acts as a DNA crosslinker.
IH636 GRAPE SEED PROANTHOCYANIDIN EXTRACT: A specific extract from grape seeds with antioxidant properties.
RECOMBINANT FAS LIGAND: A manufactured form of the Fas ligand protein, which induces apoptosis.
RECOMBINANT CD40-LIGAND: A manufactured form of the CD40L protein, involved in immune activation.
EPOETIN ALFA: A recombinant form of human erythropoietin, used to treat anemia.
OXYCODONE: An opioid medication used for the relief of moderate to severe pain.
TETRANDRINE: A natural bis-benzylisoquinoline alkaloid with anti-inflammatory and other activities.
TOLMETIN SODIUM: A non-steroidal anti-inflammatory drug (NSAID).
ATROPINE: An antimuscarinic agent used to treat bradycardia, and as an antidote for certain poisonings.
O6-BENZYLGUANINE: An agent that depletes the DNA repair protein MGMT, used to enhance chemotherapy.
RECOMBINANT HEPATOCYTE GROWTH FACTOR: A manufactured form of the HGF protein, which promotes cell growth and regeneration.
IXABEPILONE: A semi-synthetic analog of epothilone B, a microtubule inhibitor used in chemotherapy.
CHLORZOXAZONE: A centrally acting muscle relaxant.
VENETOCLAX: A BCL-2 inhibitor used to treat chronic lymphocytic leukemia and acute myeloid leukemia.
MANNITOL: An osmotic diuretic used to decrease pressure in the eyes or around the brain.
IMMUNOSUPPRESSANT: A general class of drugs that suppress or reduce the strength of the body's immune system.
TIRATRICOL: A thyroid hormone analog.
RALTITREXED: An antifolate chemotherapy drug that inhibits the enzyme thymidylate synthase.
FARNESYL TRANSFERASE INHIBITOR: A class of experimental cancer drugs that target the farnesyltransferase enzyme.
CAPECITABINE: A chemotherapy agent that is a prodrug of 5-fluorouracil (5-FU).
PROPOFOL: A short-acting intravenous anesthetic agent.
SODIUM BUTYRATE: The sodium salt of butyric acid, which has been studied for its effects on gene expression.
MPA: An abbreviation that can stand for multiple compounds, such as mycophenolic acid.
ARECAIDINE PROPARGYL ESTER: A research chemical, a derivative of arecaidine.
IL-18: Interleukin-18, a pro-inflammatory cytokine.
DEXTROAMPHETAMINE SULFATE: A central nervous system stimulant used to treat ADHD and narcolepsy.
ROFECOXIB: A selective COX-2 inhibitor (NSAID) that was withdrawn from the market due to cardiovascular risks.
EPIGALLOCATECHIN GALLATE: A major catechin found in green tea, with antioxidant properties.
RECOMBINANT INTERLEUKIN-1: A manufactured form of the IL-1 cytokine, involved in inflammation.
ACELLULAR DERMAL MATRIX: A biological mesh made from donated human skin, used in reconstructive surgery.
BENZO(A)PYRENE-7,8-DIOL 9,10-EPOXIDE: The ultimate carcinogenic metabolite of benzo[a]pyrene.
CYCLOOXYGENASE INHIBITOR: A class of drugs that inhibit COX enzymes, including NSAIDs.
BECLOMETHASONE DIPROPIONATE: A potent synthetic glucocorticoid used as an inhaler for asthma.
1,4-DIMETHOXYANTHRAQUINONE: A chemical compound, a derivative of anthraquinone.
DINITROCHLOROBENZENE: A chemical compound used in research to induce a contact hypersensitivity response.
MEGESTROL ACETATE: A progestin used as an appetite stimulant and for the treatment of breast and endometrial cancer.
DIDANOSINE: A nucleoside reverse transcriptase inhibitor (NRTI) used to treat HIV/AIDS.
BINETRAKIN: An experimental recombinant protein that inhibits the interleukins IL-4 and IL-13.
THEOPHYLLINE: A methylxanthine drug used to treat respiratory diseases such as COPD and asthma.
PANCREATIC PROTEOLYTIC ENZYMES: A class of enzymes from the pancreas that break down proteins.
PANTOPRAZOLE SODIUM: A proton pump inhibitor (PPI) used to treat GERD and peptic ulcers.
RHENIUM RE 186 ETIDRONATE: A radiopharmaceutical that was used for the palliative treatment of bone pain from cancer metastases.
PHOSPHATIDYLINOSITIDE 3-KINASE INHIBITOR: A class of drugs that inhibit PI3K enzymes, used in cancer therapy.
LEVODOPA: A precursor to dopamine, used to treat Parkinson's disease.
METHAQUALONE: A sedative and hypnotic medication.
LEFLUNOMIDE: A disease-modifying antirheumatic drug (DMARD) used to treat rheumatoid arthritis.
ISOSORBIDE MONONITRATE: A nitrate vasodilator used to prevent angina pectoris.
IRINOTECAN HYDROCHLORIDE: A topoisomerase I inhibitor used in chemotherapy, particularly for colorectal cancer.
RUBOXISTAURIN: An experimental inhibitor of protein kinase C beta.
BRYOSTATIN 1: A natural macrolide lactone that modulates protein kinase C.
SELECTIVE ESTROGEN RECEPTOR MODULATOR: A class of drugs (SERMs) that act on the estrogen receptor.
ENDOTHELIN RECEPTOR ANTAGONIST: A class of drugs that block endothelin receptors, used for pulmonary hypertension.
INOSITOL: A carbohydrate that is part of the vitamin B complex, involved in cell signaling.
RECOMBINANT HEREGULIN: A manufactured form of heregulin, a ligand for ErbB receptors.
ASTEMIZOLE: A second-generation antihistamine that was withdrawn from the market due to cardiac side effects.
BAY-11-7085: An inhibitor of the IKK kinase, which blocks NF-kappaB activation.
RANITIDINE HYDROCHLORIDE: An H2 receptor antagonist that decreases stomach acid production.
SIROLIMUS: An mTOR inhibitor used as an immunosuppressant to prevent organ transplant rejection.
ADENOVIRUS VECTOR: A modified adenovirus used as a vehicle to deliver genetic material in gene therapy.
AZASERINE: An antibiotic with antitumor activity that is an antagonist of glutamine.
LIF: Leukemia Inhibitory Factor, a cytokine that has various effects on cell differentiation and growth.
THERAPEUTIC STEROID HORMONE: A general class of steroid hormones used for medical treatment.
MITOXANTRONE HYDROCHLORIDE: The hydrochloride salt of mitoxantrone, a chemotherapy agent.
PROGESTIN: A synthetic progestogen that has effects similar to progesterone.
ERENUMAB: A monoclonal antibody that targets the CGRP receptor, used to prevent migraine.
TAS-115: An experimental multi-kinase inhibitor targeting MET and VEGFR.
SANDOSTATIN: A brand name for octreotide, a somatostatin analog.
TOREMIFENE: A selective estrogen receptor modulator (SERM) used to treat metastatic breast cancer.
PROXIBARBAL: A barbiturate derivative.
ADRIAMYCIN: A brand name for doxorubicin, a widely used chemotherapy agent.
HALOFUGINONE: A coccidiostat used in veterinary medicine, with antifibrotic and other activities.
CEMIPLIMAB-RWLC: A monoclonal antibody that targets the PD-1 immune checkpoint receptor.
ANALOG 3 [VLATTAS ET AL., 1996]: A specific chemical analog described in a 1996 publication by Vlattas et al.
INFIGRATINIB: A selective FGFR kinase inhibitor used to treat cholangiocarcinoma.
COMPOUND 19A [PMID: 21855335]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
ESTROGENS: A category of primary female sex hormones.
IPILIMUMAB: An immune checkpoint inhibitor (anti-CTLA-4 antibody) used for the treatment of melanoma.
DICLOFENAC SODIUM: A non-steroidal anti-inflammatory drug (NSAID) used to treat pain and inflammatory conditions.
LOSARTAN POTASSIUM: An angiotensin II receptor antagonist used to treat high blood pressure.
ETHOSUXIMIDE: An anticonvulsant used to treat absence seizures.
EMAPALUMAB-LZSG: A monoclonal antibody that targets interferon-gamma, used for hemophagocytic lymphohistiocytosis.
VELTUZUMAB: An experimental monoclonal antibody that targets CD20.
PAREGORIC: A camphorated tincture of opium, used as an antidiarrheal and antitussive agent.
FOSDENOPTERIN: A medication used for the treatment of molybdenum cofactor deficiency type A.
AVATROMBOPAG: A thrombopoietin receptor agonist used to treat thrombocytopenia.
ROXINDOLE: An experimental antipsychotic and antidepressant agent.
BMS-561392: A research chemical or compound identifier.
CYANOPEPTOLIN SS: A cyclic peptide natural product.
BELUMOSUDIL: A Rho-associated coiled-coil kinase 2 (ROCK2) inhibitor used to treat chronic graft-versus-host disease.
VITAMIN B2: Also known as riboflavin, an essential vitamin.
VITAMIN E: A group of fat-soluble compounds with antioxidant activities.
CARBIMAZOLE: An anti-thyroid drug used to treat hyperthyroidism.
DAPHNORIN: A natural product with a specific chemical structure.
NORTRIPTYLINE: A tricyclic antidepressant.
SERTRALINE HYDROCHLORIDE: A selective serotonin reuptake inhibitor (SSRI) used as an antidepressant.
EMETINE: An alkaloid that was used as an emetic and to treat amebiasis.
FLOXACILLIN: A narrow-spectrum beta-lactam antibiotic of the penicillin class.
BEPRIDIL: A calcium channel blocker that was used to treat angina.
SAR260301: An experimental PI3K beta inhibitor.
FELODIPINE: A calcium channel blocker used to treat hypertension.
MITOTANE: A medication used in the treatment of adrenocortical carcinoma.
OSPEMIFENE: A selective estrogen receptor modulator (SERM) used to treat dyspareunia.
ACALABRUTINIB: A second-generation Bruton's tyrosine kinase (BTK) inhibitor used for certain types of lymphoma.
NIVOLUMAB: An immune checkpoint inhibitor (anti-PD-1 antibody) used for the treatment of various cancers.
MIGALASTAT: A pharmacological chaperone used for the treatment of Fabry disease.
PIRENZEPINE: A selective M1 muscarinic receptor antagonist that was used for peptic ulcers.
COMPOUND 28 [PMID: 18324760]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
USTEKINUMAB: A monoclonal antibody that targets interleukin-12 and interleukin-23, used for psoriasis and Crohn's disease.
MK-5046: A research chemical or compound identifier.
RIBOCICLIB: A selective inhibitor of cyclin-dependent kinases CDK4 and CDK6, used for HR-positive breast cancer.
UPADACITINIB: A Janus kinase (JAK) inhibitor used to treat rheumatoid arthritis and other autoimmune diseases.
N-DESMETHYLCLOZAPINE: The major metabolite of clozapine, which also has pharmacological activity.
EFGARTIGIMOD ALFA: A neonatal Fc receptor (FcRn) blocker used to treat myasthenia gravis.
MUSCARINIC TOXIN 7: A peptide toxin from snake venom that is a selective M1 muscarinic receptor antagonist.
BRAF INHIBITOR BGB-3245: An experimental inhibitor of the BRAF kinase.
INTERFERON ALFA-N1: A form of interferon alfa, a cytokine used in immunotherapy.
TENOFOVIR DISOPROXIL FUMARATE: A prodrug of tenofovir, a nucleotide reverse transcriptase inhibitor used for HIV and hepatitis B.
COL-1: A research chemical or compound identifier.
METHYLENE BLUE ANHYDROUS: The anhydrous form of methylene blue, a dye and medication.
THIOTEPA: An alkylating agent used in chemotherapy.
GABAPENTIN: An anticonvulsant medication used to treat seizures and neuropathic pain.
ACYCLOVIR: An antiviral medication primarily used for the treatment of herpes simplex virus infections.
LAMOTRIGINE: An anticonvulsant medication used to treat epilepsy and bipolar disorder.
DEHYDROXYMETHYLEPOXYQUINOMICIN: A natural product with antibiotic activity.
RAVULIZUMAB: A long-acting monoclonal antibody that inhibits the complement component C5.
ACENOCOUMAROL: An anticoagulant that functions as a vitamin K antagonist.
DANUGLIPRON: An experimental GLP-1 receptor agonist studied for type 2 diabetes.
AVELUMAB: An immune checkpoint inhibitor (anti-PD-L1 antibody) used for cancer therapy.
ATEZOLIZUMAB: An immune checkpoint inhibitor (anti-PD-L1 antibody) used for cancer therapy.
SNS-032: An experimental multi-cyclin-dependent kinase (CDK) inhibitor.
DESMETRAMADOL: The main active metabolite of tramadol, an opioid analgesic.
SPIRONOLACTONE: A potassium-sparing diuretic used to treat fluid build-up, high blood pressure, and heart failure.
ETOPOSIDE: A topoisomerase II inhibitor used in chemotherapy.
VELPATASVIR: An antiviral drug used in combination for the treatment of hepatitis C.
ONDANSETRON HYDROCHLORIDE: A 5-HT3 receptor antagonist used to prevent nausea and vomiting.
TAPENTADOL: An opioid pain medication.
OLUTASIDENIB: An inhibitor of mutant isocitrate dehydrogenase-1 (IDH1).
TRIAMCINOLONE: A synthetic corticosteroid used to treat various skin conditions, allergies, and rheumatic disorders.
CREATINE: An organic compound that helps to supply energy to cells, particularly muscle cells.
TENOFOVIR: A nucleotide reverse transcriptase inhibitor (NtRTI) used to treat HIV and hepatitis B.
ARSENIC TRIOXIDE: An inorganic compound used to treat acute promyelocytic leukemia.
CUDC-101: An experimental multi-target inhibitor of HDAC, EGFR, and HER2.
VALPROIC ACID: A medication used to treat epilepsy, bipolar disorder, and to prevent migraines.
VOLASERTIB: An experimental inhibitor of the Polo-like kinase 1 (Plk1).
ALFIMEPRASE: An experimental thrombolytic agent.
VISMODEGIB: An inhibitor of the Hedgehog signaling pathway, used to treat basal-cell carcinoma.
PYRILAMINE MALEATE: A first-generation antihistamine.
ANAMORELIN: An experimental ghrelin receptor agonist studied for cancer cachexia.
VON WILLEBRAND FACTOR: A blood glycoprotein involved in hemostasis.
TRIPELENNAMINE HYDROCHLORIDE: A first-generation antihistamine.
AR-42: An experimental histone deacetylase (HDAC) inhibitor.
AZATADINE MALEATE: A first-generation antihistamine.
BUCLIZINE HYDROCHLORIDE: A first-generation antihistamine used as an antiemetic.
ISONIAZID: An antibiotic used as a first-line agent for the prevention and treatment of tuberculosis.
ORTICUMAB: An experimental monoclonal antibody.
METHYSERGIDE MALEATE: A serotonin receptor antagonist that was used for the prophylaxis of migraine.
ETHOPROPAZINE HYDROCHLORIDE: An anticholinergic drug of the phenothiazine class used for parkinsonism.
CHIDAMIDE: A histone deacetylase (HDAC) inhibitor used to treat lymphoma.
CLEVIDIPINE: A short-acting calcium channel blocker used for intravenous treatment of severe hypertension.
DEVIMISTAT: An experimental agent that inhibits enzymes in the pyruvate dehydrogenase complex.
ESMIRTAZAPINE: The (S)-enantiomer of mirtazapine, an antidepressant.
METOCLOPRAMIDE HYDROCHLORIDE: A dopamine D2 receptor antagonist used as an antiemetic and prokinetic agent.
DEXTROMETHORPHAN HYDROBROMIDE: A widely used cough suppressant.
LISINOPRIL ANHYDROUS: An ACE inhibitor used to treat high blood pressure, heart failure, and after heart attacks.
TAVILERMIDE: An experimental drug that was studied for dry eye disease.
MM-111: An experimental bispecific antibody targeting HER2 and HER3.
1.ALPHA.-HYDROXYVITAMIN D5: A synthetic analog of vitamin D.
ONTUXIZUMAB: An experimental monoclonal antibody that targets the endosialin (TEM1) protein.
TAFLUPROST: A prostaglandin analogue used as an ophthalmic solution to control the progression of glaucoma.
MUPARFOSTAT: An experimental anticancer agent.
LOPERAMIDE: A medication used to decrease the frequency of diarrhea.
DEXTROAMPHETAMINE ADIPATE: A salt of dextroamphetamine, a central nervous system stimulant.
SOMATROPIN (RECOMBINANT DNA ORIGIN): A recombinant form of human growth hormone.
HYDROMORPHONE HYDROCHLORIDE: A potent opioid pain medication.
NORELGESTROMIN: A progestin used in combination with an estrogen as a contraceptive patch.
VALILTRAMIPROSATE: An experimental drug that was studied for Alzheimer's disease.
TROFINETIDE: A synthetic analog of the tripeptide GPE, used to treat Rett syndrome.
NONACOG ALFA: A recombinant form of human coagulation factor IX.
BOSUTINIB: A tyrosine kinase inhibitor used to treat chronic myelogenous leukemia.
AMPHETAMINE ASPARTATE: A salt of amphetamine, a central nervous system stimulant.
INTERFERON ALFA-2B: A form of interferon alfa, used to treat various cancers and viral infections.
BLEOMYCIN: A chemotherapy agent that works by causing DNA strand breaks.
ANILERIDINE HYDROCHLORIDE: An opioid analgesic.
IDRONOXIL: An experimental anticancer agent.
PONESIMOD: A sphingosine-1-phosphate receptor 1 (S1P1) modulator used for multiple sclerosis.
PIRFENIDONE: An anti-fibrotic drug used for the treatment of idiopathic pulmonary fibrosis.
DEXAMETHASONE ACETATE: The acetate salt of dexamethasone, a potent glucocorticoid.
SAFINAMIDE: A monoamine oxidase B (MAO-B) inhibitor used as an add-on therapy for Parkinson's disease.
FIRATEGRAST: An experimental alpha-4 integrin antagonist.
PRAMLINTIDE: A synthetic analog of the hormone amylin, used to treat diabetes.
HYDROCORTISONE BUTYRATE: A topical corticosteroid.
TEPLIZUMAB: A monoclonal antibody that targets CD3, used to delay the onset of type 1 diabetes.
TONABERSAT: An experimental drug that was studied for migraine prevention.
TRANDOLAPRIL: An ACE inhibitor used to treat high blood pressure.
ZANAMIVIR: An antiviral neuraminidase inhibitor used to treat influenza.
VALSARTAN: An angiotensin II receptor antagonist used to treat high blood pressure and heart failure.
VAPREOTIDE: A somatostatin analog.
VARESPLADIB: An experimental inhibitor of the enzyme phospholipase A2.
MIGLUSTAT: An inhibitor of the enzyme glucosylceramide synthase, used to treat Gaucher disease.
CLIDINIUM: An antimuscarinic agent used to treat peptic ulcer disease.
ERGOLOID MESYLATES, USP: A combination of three ergot alkaloids, used to treat dementia and age-related cognitive impairment.
AMLEXANOX: An anti-inflammatory drug used to treat aphthous ulcers.
ESTAZOLAM: A benzodiazepine medication used for the short-term treatment of insomnia.
FLUMETHASONE PIVALATE: A topical corticosteroid.
FUROSEMIDE: A loop diuretic used to treat fluid build-up due to heart failure, liver scarring, or kidney disease.
GLICLAZIDE: A sulfonylurea drug used to treat type 2 diabetes.
GOLIMUMAB: A monoclonal antibody that targets TNF-alpha, used for autoimmune diseases.
HYDROXYUREA: A chemotherapy and myelosuppressive agent used to treat various cancers and sickle cell disease.
ISOFLUROPHATE: An irreversible cholinesterase inhibitor, an organophosphate compound.
LIOTHYRONINE: A synthetic form of the thyroid hormone triiodothyronine (T3).
MESORIDAZINE: A typical antipsychotic of the phenothiazine class.
MEPHOBARBITAL: A barbiturate used as a sedative and anticonvulsant.
METHYSERGIDE: A serotonin receptor antagonist that was used for the prophylaxis of migraine.
MILRINONE: A phosphodiesterase 3 inhibitor used for acute decompensated heart failure.
METHIXENE: An anticholinergic drug.
PENTAZOCINE: An opioid pain medication.
SECRETIN: A hormone that regulates secretions in the stomach, pancreas, and liver.
THIETHYLPERAZINE: A typical antipsychotic of the phenothiazine class, used as an antiemetic.
TIROFIBAN: An antiplatelet drug, a glycoprotein IIb/IIIa inhibitor.
LANSOPRAZOLE: A proton pump inhibitor (PPI) used to treat GERD and peptic ulcers.
CIMETIDINE: An H2 receptor antagonist that decreases stomach acid production.
CINOLAZEPAM: A benzodiazepine derivative.
ABARELIX: A gonadotropin-releasing hormone (GnRH) antagonist.
ESTROGENS, CONJUGATED (USP): A mixture of estrogen hormones, used in hormone replacement therapy.
DINOPROSTONE: A synthetic form of prostaglandin E2, used to induce labor.
DIMENHYDRINATE: An over-the-counter drug used to treat motion sickness and nausea.
PERGOLIDE MESYLATE: A dopamine receptor agonist that was used to treat Parkinson's disease.
DICHLORPHENAMIDE: A carbonic anhydrase inhibitor used to treat glaucoma and certain types of paralysis.
FLUDIAZEPAM: A benzodiazepine derivative.
ALFUZOSIN HYDROCHLORIDE: An alpha-1 blocker used to treat benign prostatic hyperplasia.
PHENYLEPHRINE BITARTRATE: A salt of phenylephrine, a decongestant and vasopressor.
GALANTAMINE: A medication used to treat mild to moderate dementia of the Alzheimer's type.
HEXOBARBITAL: A short-acting barbiturate derivative.
LOFEXIDINE: An alpha-2 adrenergic receptor agonist used to manage opioid withdrawal symptoms.
METHADYL ACETATE: A synthetic opioid analgesic.
METHOXAMINE: A selective alpha-1 adrenergic receptor agonist used as a vasopressor.
TOLAZOLINE HYDROCHLORIDE: A non-selective competitive alpha-adrenergic antagonist.
NITRAZEPAM: A benzodiazepine used to treat insomnia.
PINDOLOL: A non-selective beta-blocker with partial beta-adrenergic agonist activity.
PROCATEROL: A short-acting beta-2 adrenergic receptor agonist used as a bronchodilator.
PROCHLORPERAZINE: A typical antipsychotic and antiemetic.
SUMATRIPTAN: A triptan drug used for the treatment of migraine and cluster headaches.
DYPHYLLINE: A xanthine derivative with bronchodilator and vasodilator effects.
VIGABATRIN: An anticonvulsant used to treat epilepsy, particularly infantile spasms.
BELATACEPT: A fusion protein used as an immunosuppressant in kidney transplantation.
DECAMETHONIUM BROMIDE: A short-acting depolarizing neuromuscular-blocking drug.
FOMEPIZOLE: A medication used to treat methanol and ethylene glycol poisoning.
EP-7041: A research chemical or compound identifier.
EVORPACEPT: An experimental CD47-blocking fusion protein for cancer immunotherapy.
PEMRAMETOSTAT: An experimental E-selectin antagonist.
FADRACICLIB: An experimental cyclin-dependent kinase (CDK) inhibitor.
PI3K P110BETA/DELTA INHIBITOR KA2237: An experimental inhibitor of the PI3K beta and delta isoforms.
SELITRECTINIB: An experimental pan-TRK inhibitor.
KHK2455: A research chemical or compound identifier.
CPI-1205: An experimental EZH2 inhibitor.
ANTI-MET MONOCLONAL ANTIBODY MIXTURE SYM015: A mixture of two monoclonal antibodies targeting the MET receptor.
SECOBARBITAL SODIUM: A short-acting barbiturate used as a sedative and hypnotic.
UBROGEPANT: A CGRP receptor antagonist used for the acute treatment of migraine.
SERLOPITANT: An experimental neurokinin-1 (NK1) receptor antagonist.
GAVILIMOMAB: An experimental monoclonal antibody that targets CD40L.
LIXIVAPTAN: An experimental vasopressin V2 receptor antagonist.
ZOLPIDEM TARTRATE: A non-benzodiazepine hypnotic agent used for the short-term treatment of insomnia.
DUTASTERIDE: A 5-alpha-reductase inhibitor used to treat benign prostatic hyperplasia.
DESMOPRESSIN: A synthetic analogue of vasopressin used to treat diabetes insipidus and bedwetting.
DENILEUKIN DIFTITOX: A fusion protein combining interleukin-2 with diphtheria toxin, used for cutaneous T-cell lymphoma.
INTERFERON GAMMA-1B: A recombinant form of the cytokine interferon-gamma, used for chronic granulomatous disease.
MORICIZINE HYDROCHLORIDE: An antiarrhythmic medication.
OXCARBAZEPINE: An anticonvulsant used to treat epilepsy.
CRENEZUMAB: An experimental monoclonal antibody that targets amyloid-beta, studied for Alzheimer's disease.
PRILOCAINE HYDROCHLORIDE: A local anesthetic of the amide type.
FOSPHENYTOIN: A water-soluble prodrug of phenytoin, an anti-seizure medication.
RALINEPAG: An experimental prostacyclin receptor agonist.
GSK-3117391: A research chemical or compound identifier.
TT-301: A research chemical or compound identifier.
NEBENTAN: An experimental endothelin receptor antagonist.
ROMAZARIT: An experimental disease-modifying antirheumatic drug (DMARD).
DINOPROST: A naturally occurring prostaglandin F2-alpha, used to induce labor.
SCH442416: A selective antagonist of the adenosine A2A receptor.
SILTUXIMAB: A monoclonal antibody that targets interleukin-6, used for multicentric Castleman's disease.
RAGAGLITAZAR: An experimental dual PPAR alpha/gamma agonist.
LENVATINIB MESYLATE: The mesylate salt of lenvatinib, a multi-kinase inhibitor.
BLINATUMOMAB: A bispecific T-cell engager (BiTE) antibody that targets CD19 and CD3.
METELIMUMAB: An experimental monoclonal antibody that targets TGF-beta.
ELSAMITRUCIN: An experimental anticancer agent.
IBALIZUMAB: A monoclonal antibody that targets the CD4 receptor, used to treat HIV.
FADROZOLE: An aromatase inhibitor.
TIPIRACIL HYDROCHLORIDE: A thymidine phosphorylase inhibitor, co-administered with trifluridine.
ELOTUZUMAB: A monoclonal antibody that targets SLAMF7, used to treat multiple myeloma.
EVODENOSON: An experimental selective adenosine A2A receptor agonist.
EPTASTIGMINE: An experimental cholinesterase inhibitor that was studied for Alzheimer's disease.
PHENACEMIDE: An anticonvulsant drug.
CS-8080: A research chemical or compound identifier.
D-METHIONINE: An enantiomer of the essential amino acid methionine.
BMS-852927: A research chemical or compound identifier.
COXSACKIEVIRUS A21: An oncolytic virus being studied for cancer therapy.
SU-014813: An experimental inhibitor of the PDGFR tyrosine kinase.
PYRUVIC ACID: A key intermediate in several metabolic pathways.
METHOXYFLURANE: An inhaled analgesic agent.
ROXADUSTAT: A HIF prolyl-hydroxylase inhibitor used to treat anemia associated with chronic kidney disease.
TUROFEXORATE ISOPROPYL: An experimental FXR agonist.
PEMIROLAST: A mast cell stabilizer used to treat allergic conjunctivitis.
AEW-541: An experimental inhibitor of the insulin-like growth factor-1 receptor (IGF-1R).
MESMULOGENE ANCOVACIVEC: An experimental oncolytic virus therapy.
FELYPRESSIN: A synthetic analogue of vasopressin, used as a vasoconstrictor.
MOTEXAFIN LUTETIUM: An experimental photosensitizer used in photodynamic therapy.
LUTROPIN ALFA: A recombinant form of human luteinizing hormone (LH).
AGERAFENIB: An experimental RAF kinase inhibitor.
CEP-5214: A research chemical or compound identifier.
MK-5108: An experimental Aurora kinase A inhibitor.
CARMOTEROL: An experimental ultra-long-acting beta-2 adrenergic agonist.
ATIPRIMOD: An experimental immunomodulatory agent.
PALOMID-529: An experimental drug that inhibits the PI3K/Akt/mTOR pathway.
IZORLISIB: An experimental PI3K delta inhibitor.
ABT-102: An experimental TRPV1 antagonist.
CYSTEAMINE HYDROCHLORIDE: A medication used to treat cystinosis.
MK-0812: A research chemical or compound identifier.
KU-60019: A potent and selective inhibitor of the ATM kinase.
KENPAULLONE: An inhibitor of several cyclin-dependent kinases (CDKs) and GSK-3.
SULCARDINE SULFATE: An antiarrhythmic agent.
(+)-JQ1: A potent and selective inhibitor of the BET family of bromodomains.
TOPSALYSIN: A modified form of the PSA protein, used in gene therapy approaches.
AMILOMOTIDE: An experimental immunomodulatory peptide.
ADRIFORANT: An experimental histamine H4 receptor antagonist.
CR 1447: A research chemical or compound identifier.
THR-18: A research chemical or compound identifier.
PRINABEREL: An experimental selective estrogen receptor beta (ER-beta) agonist.
INIPARIB: An experimental PARP inhibitor that was studied for the treatment of various cancers.
MT-3995: A research chemical or compound identifier.
ANLOTINIB: A multi-target tyrosine kinase inhibitor used to treat non-small cell lung cancer and soft tissue sarcoma.
BMS-582949: An experimental p38 MAP kinase inhibitor.
BENTAMAPIMOD: An experimental p38 MAP kinase inhibitor studied for inflammatory diseases.
TRV-120027: An experimental biased ligand of the angiotensin II type 1 receptor.
TIMOLUMAB: An experimental monoclonal antibody.
DUPILUMAB: A monoclonal antibody that targets the IL-4 and IL-13 receptors, used for atopic dermatitis and asthma.
TALACOTUZUMAB: An experimental monoclonal antibody that targets CD123.
RONICICLIB: An experimental multi-cyclin-dependent kinase (CDK) inhibitor.
POLATUZUMAB VEDOTIN: An antibody-drug conjugate that targets CD79b, used to treat diffuse large B-cell lymphoma.
LUSUTROMBOPAG: A thrombopoietin receptor agonist used to treat thrombocytopenia.
PERAMPANEL: An anti-seizure medication that acts as a selective non-competitive antagonist of the AMPA receptor.
MEDETOMIDINE: A potent alpha-2 adrenergic agonist used as a sedative and analgesic in veterinary medicine.
METHIMAZOLE: An anti-thyroid drug used to treat hyperthyroidism.
ACECLIDINE: A muscarinic acetylcholine receptor agonist.
SPIROGLUMIDE: A research chemical, an antagonist of cholecystokinin receptors.
PROSAVIN: An experimental gene therapy for Parkinson's disease.
RG7342: A research chemical or compound identifier.
POZIOTINIB: An experimental pan-HER kinase inhibitor studied for non-small cell lung cancer.
NADOFARAGENE FIRADENOVEC: A gene therapy that delivers interferon alfa-2b, used for bladder cancer.
AUTOLOGOUS CD19 CAR-EXPRESSING CD4+/CD8+ T-CELLS MB-CART19.1: A specific formulation of CAR-T cell therapy targeting CD19.
AUTOLOGOUS ANTI-CD19 CAR-EXPRESSING T-LYMPHOCYTES CLIC-1901: Another specific formulation of CAR-T cell therapy targeting CD19.
FESOTERODINE: An antimuscarinic drug used to treat overactive bladder.
AMINOSALICYLIC ACID: A medication used to treat tuberculosis and inflammatory bowel disease.
AZIMILIDE: An experimental antiarrhythmic drug that blocks potassium channels.
EPLIVANSERIN FUMARATE: An experimental selective 5-HT2A receptor inverse agonist.
CHLORMETHIAZOLE: A sedative and hypnotic drug with anticonvulsant properties.
CR-3465: A research chemical or compound identifier.
BERTILIMUMAB: An experimental monoclonal antibody that targets eotaxin-1.
PARP INHIBITOR E7016: An experimental inhibitor of the PARP enzyme for cancer therapy.
TALADEGIB: An experimental inhibitor of the Hedgehog signaling pathway.
NEFLAMAPIMOD: An experimental p38 MAP kinase alpha inhibitor studied for neurological disorders.
DONITRIPTAN: An experimental triptan drug that was studied for migraine.
CAPMATINIB: A MET kinase inhibitor used to treat non-small cell lung cancer with MET mutations.
XL-999: An experimental multi-kinase inhibitor.
VELUSETRAG: An experimental 5-HT4 receptor agonist studied for gastroparesis.
SAMOTOLISIB: An experimental dual PI3K/mTOR inhibitor.
BATEFENTEROL: An experimental bifunctional molecule with muscarinic antagonist and beta-2 agonist activity.
GSK-189254: A selective histamine H3 receptor antagonist/inverse agonist.
SB-773812: A selective inhibitor of the kinase Plk1.
ONO-2333MS: A research chemical or compound identifier.
ASP7991: A research chemical or compound identifier.
RELUGOLIX: A gonadotropin-releasing hormone (GnRH) antagonist used to treat prostate cancer and uterine fibroids.
AZD1446: An experimental neuronal nicotinic acetylcholine receptor agonist.
TEZAMPANEL: An experimental AMPA/kainate receptor antagonist.
DASOLAMPANEL: An experimental AMPA receptor antagonist.
OBETICHOLIC ACID: A farnesoid X receptor (FXR) agonist used to treat primary biliary cholangitis.
MILODISTIM: An experimental agent designed to stimulate neutrophil production.
DARIGABAT: An experimental GABAA receptor modulator studied for epilepsy.
FLUMATINIB: A tyrosine kinase inhibitor used to treat chronic myeloid leukemia in China.
AMOSULALOL: A medication that acts as both an alpha and beta blocker, used for hypertension.
BARBITURATE: A class of drugs that act as central nervous system depressants.
MODAFINIL: A wakefulness-promoting agent used to treat narcolepsy and shift work sleep disorder.
BERMEKIMAB: An experimental monoclonal antibody that targets interleukin-1 alpha.
EMRICASAN: An experimental pan-caspase inhibitor studied for liver diseases.
MIZORIBINE: An immunosuppressive drug used in Japan for rheumatoid arthritis and lupus nephritis.
APRICOXIB: An experimental selective COX-2 inhibitor.
4-PHENYLBUTYRIC ACID: A medication used to treat urea cycle disorders.
TANESPIMYCIN: An Hsp90 inhibitor that was studied in clinical trials for cancer.
MONALIZUMAB: An experimental monoclonal antibody that targets the NKG2A receptor for cancer immunotherapy.
ALDOXORUBICIN: A prodrug of doxorubicin designed to target tumors.
TIRASEMTIV: An experimental fast skeletal muscle troponin activator.
SNS-314: An experimental Aurora kinase inhibitor.
LX2931: A research chemical or compound identifier.
CLEVUDINE: An antiviral drug that was studied for the treatment of hepatitis B.
ZURANOLONE: A neuroactive steroid that acts as a GABAA receptor positive allosteric modulator, used for postpartum depression.
ECOPIPAM: An experimental selective dopamine D1/D5 receptor antagonist.
TROXACITABINE: An experimental nucleoside analog chemotherapy agent.
TOZASERTIB LACTATE: The lactate salt of tozasertib, an Aurora kinase inhibitor.
ATRELEUTON: An inhibitor of the 5-lipoxygenase enzyme, studied for asthma.
BENZODEPA: An alkylating agent that was used as a cancer chemotherapeutic.
ANACETRAPIB: An experimental CETP inhibitor that was studied to raise HDL cholesterol.
CANDOXATRIL: An experimental neutral endopeptidase inhibitor.
EPERISONE: A centrally acting muscle relaxant.
CARISBAMATE: An experimental drug that was studied for epilepsy.
ENSITUXIMAB: An experimental monoclonal antibody targeting the 5T4 antigen.
(S)-UH 301: The S-enantiomer of UH 301, a selective 5-HT1A receptor antagonist.
[3H]ROBALZOTAN: A radiolabeled form of robalzotan, a 5-HT1A receptor agonist.
L-775,606: A research chemical, a selective dopamine D4 receptor antagonist.
STX-100: An experimental monoclonal antibody that targets the integrin alpha-v beta-6.
[3H]LY334370: A radiolabeled form of a selective 5-HT1F receptor agonist.
LASMIDITAN: A selective 5-HT1F receptor agonist used for the acute treatment of migraine.
5-CT: 5-Carboxamidotryptamine, a potent but non-selective 5-HT receptor agonist.
BROMOCRIPTINE: A dopamine agonist used to treat Parkinson's disease, hyperprolactinemia, and type 2 diabetes.
CINTREDEKIN BESUDOTOX: An experimental targeted therapy consisting of interleukin-13 linked to a bacterial toxin.
SB 228357: A research chemical or compound identifier.
SB357134: A selective inhibitor of the p38 MAP kinase.
LP-44: A potent and selective 5-HT7 receptor agonist.
CAROTUXIMAB: An experimental monoclonal antibody targeting the endosialin (TEM1) protein.
ASCIMINIB: An allosteric inhibitor of the BCR-ABL1 tyrosine kinase, used for chronic myeloid leukemia.
BW B70C: A research chemical or compound identifier.
WP814: A research chemical or compound identifier.
K-604: An experimental antiarrhythmic drug.
TL13-112: A research chemical or compound identifier.
SORBINIL: An experimental aldose reductase inhibitor that was studied for diabetic complications.
CEP-37440: An experimental dual inhibitor of the FAK and ALK kinases.
RO-70-0004: A research chemical or compound identifier.
XYLOMETAZOLINE: A topical decongestant that acts as an alpha-adrenergic agonist.
DROMOSTANOLONE: An androgen and anabolic steroid.
COMPOUND I3 [PMID: 23428964]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
METRIBOLONE: A potent synthetic androgen and anabolic steroid.
IMARADENANT: An experimental adenosine A2A receptor antagonist studied for cancer immunotherapy.
NAMODENOSON: An experimental adenosine A3 receptor agonist.
CV-1808: A selective adenosine A2 receptor agonist.
PSB1115: A research chemical or compound identifier.
MRS1476: A research chemical or compound identifier.
AURORA KINASE INHIBITOR II: A specific chemical inhibitor of Aurora kinases used in research.
[LEU14, &PSI; 13-14)]BOMBESIN: A synthetic analogue of the peptide bombesin.
COMPOUND 8A [PMID: 24900283]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
LEVOBUNOLOL: A non-selective beta-blocker used in eye drops to treat glaucoma.
PRENALTEROL: A selective beta-1 adrenergic receptor partial agonist.
BUPRANOLOL: A non-selective beta-blocker.
FORMOTEROL FUMARATE: A long-acting beta-2 adrenergic agonist (LABA) used to treat asthma and COPD.
ZYBT1: A research chemical or compound identifier.
BI-2536: A potent inhibitor of the Polo-like kinase 1 (Plk1).
BIIB091: An experimental IRAK4 kinase inhibitor.
XD1: A research chemical or compound identifier.
[DES-ARG10]KALLIDIN: A metabolite of kallidin that is a B1 receptor agonist.
CHROMAN 28: A research chemical or compound identifier.
NPC 18565: A research chemical or compound identifier.
[HYP3,TYR(ME)8]BK: A synthetic analogue of bradykinin.
RIBOSOMAL PROTEIN S19: A component of the 40S ribosomal subunit.
RPR121154: A research chemical or compound identifier.
COMPOUND 3 [PMID: 14640538]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
SQ-24,798: A research chemical or compound identifier.
AS101: An immunomodulatory compound with various biological activities.
ZICONOTIDE: A synthetic peptide that blocks N-type calcium channels, used to treat severe chronic pain.
MDX-210: An experimental bispecific antibody targeting HER2/neu and Fc-gamma receptor I.
VBY-825: A research chemical or compound identifier.
COMPOUND 4G [PMID: 22595175]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 23 [PMID: 35944849]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
[125I]CCL7 (HUMAN): A radioiodinated form of the chemokine CCL7 (MCP-3).
[3H]L365260: A radiolabeled cholecystokinin receptor antagonist.
BMS COMPOUND 87B: A research chemical or compound identifier from Bristol Myers Squibb.
LAZUCIRNON: A research chemical or compound identifier.
CCL24: A small cytokine belonging to the CC chemokine family, also known as eotaxin-2.
[125I]CCL27 (HUMAN): A radioiodinated form of the chemokine CCL27.
SIMUROSERTIB: An experimental inhibitor of the IKK-epsilon and TBK1 kinases.
CLAZAKIZUMAB: An experimental monoclonal antibody that targets interleukin-6 (IL-6).
BAMOCAFTOR: A research chemical or compound identifier.
OXAPROZIN: A non-steroidal anti-inflammatory drug (NSAID).
PIROXICAM-BETA-CYCLODEXTRIN: A formulation of the NSAID piroxicam with cyclodextrin to improve solubility.
UROCORTIN 2: A peptide related to corticotropin-releasing factor that acts on the CRF2 receptor.
GOMILIXIMAB: An experimental monoclonal antibody that targets the CD23 antigen.
PLERIXAFOR: A CXCR4 antagonist used to mobilize hematopoietic stem cells.
AMINOPURVALANOL A: A derivative of purvalanol A, an inhibitor of cyclin-dependent kinases (CDKs).
CROZBACICLIB: An experimental cyclin-dependent kinase (CDK) inhibitor.
CDK4 INHIBITOR II: A specific chemical inhibitor of CDK4 used in research.
VTX-11E: A research chemical or compound identifier.
R547: An experimental multi-cyclin-dependent kinase (CDK) inhibitor.
ATUVECICLIB: An experimental multi-cyclin-dependent kinase (CDK) inhibitor.
ABIRATERONE ACETATE: A medication used to treat prostate cancer, which inhibits the enzyme CYP17A1.
COMPOUND 4D [PMID: 20655626]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 30 [PMID: 22239545]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
ORDESEKIMAB: An experimental monoclonal antibody.
AMINOETHOXYVINYLGLYCINE: An inhibitor of the enzyme ACC synthase, involved in ethylene biosynthesis in plants.
BNTX: An abbreviation, possibly for a research compound or a product from BioNTech.
FENTANYL CITRATE: A potent synthetic opioid analgesic.
ATICAPRANT: An experimental kappa-opioid receptor antagonist.
ENDOMORPHIN-1: An endogenous opioid peptide with high affinity for the mu-opioid receptor.
BU08028: An experimental opioid receptor ligand with a mixed agonist-antagonist profile.
DH376: A research chemical or compound identifier.
S312: A research chemical or compound identifier.
(+)-S-14297: A research chemical or compound identifier.
SKF-76783: A research chemical or compound identifier.
CABERGOLINE: A dopamine agonist used to treat hyperprolactinemia and Parkinson's disease.
POCIREDIR: A research chemical or compound identifier.
COMPOUND 34 [PMID: 24749861]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
JBJ-09-063: A research chemical or compound identifier.
GSK343: A selective inhibitor of the EZH2 histone methyltransferase.
PD 174265: A research chemical or compound identifier.
TUCATINIB: A tyrosine kinase inhibitor that targets HER2, used for HER2-positive breast cancer.
NE10790: A research chemical or compound identifier.
COMPOUND 31 [PMID: 17963374]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
LY2077855: A research chemical or compound identifier.
FASIGLIFAM: An experimental GPR40 receptor agonist that was studied for type 2 diabetes.
ZILTIVEKIMAB: An experimental monoclonal antibody that targets the interleukin-6 ligand.
PALMITATE: The salt or ester of palmitic acid, a common saturated fatty acid.
TUG-424: A research chemical, an agonist for the free fatty acid receptor 1 (GPR40).
COMPOUND 8H [PMID: 22765894]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
TINENGOTINIB: An experimental multi-kinase inhibitor targeting FGFR, VEGFR, and Aurora kinases.
ERDAFITINIB: An FGFR kinase inhibitor used to treat urothelial cancer with FGFR alterations.
ANHYDROUS TACROLIMUS: The anhydrous form of tacrolimus, an immunosuppressant drug used after organ transplant.
TASURGRATINIB: An experimental FGFR inhibitor.
SLF: An abbreviation, possibly for a research compound or ligand.
N36: A research chemical or compound identifier.
BIMATOPROST (FREE ACID FORM): The active form of bimatoprost, a prostaglandin analogue used for glaucoma.
L838417: An experimental compound that acts as a partial agonist at the benzodiazepine site of the GABAA receptor.
FLUMAZENIL: A benzodiazepine receptor antagonist used to reverse the effects of benzodiazepines.
ZK93426: A research chemical, a benzodiazepine receptor partial agonist.
TBPS: A non-competitive antagonist of the GABAA receptor, used in research.
[125I]SPEXIN-1: A radioiodinated form of the neuropeptide spexin.
M1145: A research chemical or compound identifier.
NNC-711: A selective GABA uptake inhibitor.
GROWTH DIFFERENTIATION FACTOR 15: A protein of the TGF-beta superfamily, also known as GDF15.
NBQX: A competitive antagonist of the AMPA/kainate receptor.
PIRACETAM: A nootropic drug of the racetam family.
ZOLBETUXIMAB: An experimental monoclonal antibody that targets Claudin-18.2.
DOMOIC ACID: A neurotoxin that acts as a potent agonist for kainate receptors.
SERINE, D-: An enantiomer of the amino acid serine, which acts as a co-agonist at the NMDA receptor.
LY233053: A research chemical, an AMPA/kainate receptor antagonist.
HOMOQUINOLINIC ACID: A potent excitotoxin and NMDA receptor agonist.
[3H]MDL105519: A radiolabeled selective antagonist of the glycine site of the NMDA receptor.
ATRIAL NATRIURETIC PEPTIDE: A peptide hormone secreted by heart muscle cells.
ANUMIGILIMAB: An experimental monoclonal antibody.
CHR-3996: An experimental aminopeptidase inhibitor.
RESMINOSTAT: An experimental histone deacetylase (HDAC) inhibitor.
LECANEMAB: A monoclonal antibody that targets amyloid-beta protofibrils, used for Alzheimer's disease.
J27644: A research chemical or compound identifier.
LONAFARNIB: A farnesyltransferase inhibitor used to treat progeria and progeroid laminopathies.
DIMETHYLHISTAPRODIFEN: A research chemical, a histamine H1 receptor agonist.
(&PLUSMN;)-TRANS-H2-PAT: A research chemical or compound identifier.
JNJ-39758979: An experimental histamine H4 receptor antagonist.
BMS-823778: A research chemical or compound identifier.
COMPOUND 1A [PMID: 2153213]: An experimental compound described in a 1991 publication (PMID is for 1991).
COMPOUND 6A [PATIL ET AL., 1989]: A specific chemical compound described in a 1989 publication by Patil et al.
EDRECOLOMAB: An experimental monoclonal antibody that targets the EpCAM antigen.
COMPOUND 3A [PMID: 21444206]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 15 [PMID: 25313322]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
AM281: A potent antagonist for the cannabinoid CB1 receptor.
TRYPTANTHRIN: A natural indole quinazoline alkaloid with various biological activities.
AMG-780: An experimental monoclonal antibody that targets the sclerostin protein.
AS1949490: A research chemical or compound identifier.
ISOXSUPRINE HYDROCHLORIDE: A vasodilator used to treat symptoms of cerebrovascular and peripheral vascular disease.
COMPOUND 2E [PMID: 19013076]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
ARN19874: A research chemical or compound identifier.
BETAHISTINE: A medication used to treat MÃ©niÃ¨re's disease.
FR181157: A research chemical or compound identifier.
BEZAFIBRATE: A fibrate drug used to lower cholesterol and triglycerides.
PICROTOXININ: The active component of picrotoxin, a GABAA receptor antagonist.
FILGOTINIB: A Janus kinase (JAK) inhibitor used to treat rheumatoid arthritis and ulcerative colitis.
U69593: A potent and selective kappa-opioid receptor agonist.
CARBETOCIN: A long-acting oxytocin analogue used to control postpartum hemorrhage.
CIPROFIBRATE: A fibrate drug used for treating hyperlipidemia.
LYSOPHOSPHATIDYLCHOLINE: A class of phospholipids involved in various signaling pathways.
SEMAXANIB: An experimental tyrosine kinase inhibitor that targets VEGFR2.
DC-EBIO: A research chemical that activates calcium-activated potassium channels.
UCL1684: A potent and selective blocker of small-conductance calcium-activated potassium (SK) channels.
CATUMAXOMAB: A trifunctional antibody that targets EpCAM, CD3, and the Fc-gamma receptor.
TOLBUTAMIDE: A first-generation sulfonylurea drug used to treat type 2 diabetes.
PRENYLAMINE: A calcium channel blocker that was used for angina pectoris.
XE991: A potent blocker of KCNQ (Kv7) potassium channels.
COMPOUND 5 [PMID: 22533316]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
ABSCISIC ACID: A plant hormone involved in various developmental processes and stress responses.
COMPOUND 20 [PMID: 30998356]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
GSK2646264: A research chemical or compound identifier.
MEDI-4212: An experimental antibody-drug conjugate.
COMPOUND 23 [PMID: 17600705]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
JAK3 INHIBITOR VI: A specific chemical inhibitor of the Janus kinase 3.
PF-9363: A research chemical or compound identifier.
CC-90011: An experimental LSD1 inhibitor.
TENOFOVIR ALAFENAMIDE: A prodrug of tenofovir, a nucleotide reverse transcriptase inhibitor for HIV and hepatitis B.
COMPOUND 16 [PMID: 17480064]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
&ALPHA;-MSH: Alpha-Melanocyte-stimulating hormone, a peptide hormone with various physiological roles.
BIIB-022: A research chemical or compound identifier.
125I-MCH: A radioiodinated form of melanin-concentrating hormone.
CORTICOTROPHIN-RELEASING HORMONE: A peptide hormone and neurotransmitter involved in the stress response.
IMC-3C5: An experimental monoclonal antibody that targets the VEGFR2 receptor.
VEBRELTINIB: An experimental c-Met kinase inhibitor.
[3H]R214127: A radiolabeled compound, likely a receptor ligand.
[3H]LY341495: A radiolabeled group II metabotropic glutamate receptor antagonist.
COMPOUND 4 [PMID: 21105727]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
TB-403: An experimental monoclonal antibody that targets placental growth factor (PlGF).
MS432: A research chemical or compound identifier.
ZAPNOMETINIB: An experimental c-Met kinase inhibitor.
ARECOLINE: A natural alkaloid found in the areca nut, which acts as a muscarinic receptor agonist.
F105: A research chemical or compound identifier.
TRIHEXYPHENIDYL: An anticholinergic medication used to treat Parkinson's disease.
[3H]ACETYLCHOLINE: A radiolabeled form of the neurotransmitter acetylcholine.
MUSCARINIC TOXIN 1: A peptide toxin from snake venom that is a selective M1 muscarinic receptor antagonist.
[3H]QNB: A radiolabeled form of quinuclidinyl benzilate, a muscarinic receptor antagonist.
DOTHIEPIN: A tricyclic antidepressant.
SILAHEXOCYCLIUM: A research chemical or compound identifier.
DARIFENACIN: An antimuscarinic drug used to treat overactive bladder.
WIN 51,708: An experimental antiviral compound.
SABCOMELINE: An experimental M1 muscarinic receptor partial agonist that was studied for Alzheimer's disease.
PD-360324: A research chemical or compound identifier.
OTENZEPAD: A selective M2 muscarinic receptor antagonist.
CEVIMELINE: A muscarinic receptor agonist used to treat dry mouth.
OXYBUTYNIN: An antimuscarinic medication used to treat overactive bladder.
PD 102807: A research chemical, a selective dopamine D4 receptor antagonist.
METHSCOPOLAMINE: An antimuscarinic agent.
AFDX384: A selective M2/M4 muscarinic receptor antagonist.
P-F-HHSID: A research chemical, a selective M1 muscarinic receptor agonist.
MEDI-6469: An experimental monoclonal antibody.
UCSF3384: A research chemical or compound identifier.
DIFLUOROAGOMELATINE: A research chemical or compound identifier.
S22153: A research chemical or compound identifier.
ADL5859: An experimental delta-opioid receptor agonist.
EWB-3-14: A research chemical or compound identifier.
METHADONE HYDROCHLORIDE: A synthetic opioid analgesic used for chronic pain and opioid maintenance therapy.
BC-III: A research chemical or compound identifier.
[3H]CTOP: A radiolabeled selective mu-opioid receptor antagonist.
E2.3: A research chemical or compound identifier.
PL-3994: An experimental natriuretic peptide receptor-A agonist.
FARALIMOMAB: An experimental monoclonal antibody that targets the CD40 receptor.
LY2087101: A research chemical or compound identifier.
AVAPRITINIB: A potent kinase inhibitor that targets KIT and PDGFRA, used for GIST and systemic mastocytosis.
COMPOUND 22 [PMID: 20462760]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
CP 99994: A potent and selective neurokinin-1 (NK1) receptor antagonist.
ENTRECTINIB: A tyrosine kinase inhibitor that targets TRK, ROS1, and ALK, used for specific fusion-positive cancers.
[125I][MEPHE7]NKB: A radioiodinated form of neurokinin B.
SELNOFLAST: A research chemical or compound identifier.
SB 235375: A research chemical or compound identifier.
[125I]NEUROMEDIN U-8 (PIG): A radioiodinated form of the neuropeptide neuromedin U.
[ARG14LYS15]N/OFQ: A synthetic analogue of nociceptin/orphanin FQ.
JMV457: A research chemical, a neurotensin receptor antagonist.
DIQUAFOSOL TETRASODIUM: A P2Y2 receptor agonist used in eye drops to treat dry eye disease.
GLYCYRRHIZIC ACID: A major sweet-tasting compound from licorice root, with various biological activities.
ETIFOXINE: An anxiolytic and anticonvulsant drug that modulates the GABAA receptor.
L-372662: A research chemical or compound identifier.
ARGIPRESSIN: A synthetic form of vasopressin, an antidiuretic hormone.
MRS2279: A selective antagonist of the P2Y1 purinergic receptor.
PHYSOSTIGMINE SALICYLATE: A reversible cholinesterase inhibitor used to treat glaucoma and as an antidote.
ATP&GAMMA;S: A non-hydrolyzable analogue of ATP, used in biochemical research.
RP-52770: A research chemical or compound identifier.
AMLODIPINE BENZOATE: The benzoate salt of amlodipine, a calcium channel blocker.
ATGLISTATIN: A potent and selective inhibitor of adipose triglyceride lipase (ATGL).
LYS[Z(NO2)]-VAL: A research chemical or compound identifier.
SELADELPAR: An experimental selective PPAR-delta agonist.
ANDEXANET ALFA: A reversal agent for factor Xa inhibitors.
LINOLEIC ACID: An omega-6 polyunsaturated fatty acid.
ROSIGLITAZONE: A thiazolidinedione (TZD) antidiabetic drug that acts as a PPAR-gamma agonist.
VONOPRAZAN FUMARATE: A potassium-competitive acid blocker used to treat acid-related disorders.
PIK-III: A research chemical, a selective PI4KIIIbeta inhibitor.
COMPOUND 27 [PMID: 35834807]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
GILMELISIB: An experimental PI3K inhibitor.
RV6153: A research chemical or compound identifier.
AZELNIDIPINE: A calcium channel blocker used to treat hypertension.
IDELALISIB: A PI3K delta inhibitor used to treat certain types of blood cancers.
PIK-108: An experimental multi-PI3K inhibitor.
TG-100-115: A research chemical or compound identifier.
5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE: A chemical compound, likely a specific enzyme inhibitor.
AMDIZALISIB: An experimental PI3K delta inhibitor.
AZ2: A research chemical or compound identifier.
DEZAPELISIB: An experimental PI3K inhibitor.
CYCLIC GMP: Cyclic guanosine monophosphate, a second messenger molecule in cell signaling.
COMPOUND 19 [PMID: 22142545]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
ODEVIXIBAT: An ileal bile acid transporter (IBAT) inhibitor used to treat cholestatic pruritus.
CRISABOROLE: A non-steroidal topical medication used for the treatment of atopic dermatitis.
LEO 239652: A research chemical or compound identifier.
RO20-1724: A selective phosphodiesterase-4 (PDE4) inhibitor.
ODESIVIMAB: An experimental monoclonal antibody.
SR12813: A research chemical or compound identifier.
ARI-3531: A research chemical or compound identifier.
ALIROCUMAB: A monoclonal antibody that targets PCSK9, used to lower LDL cholesterol.
[ALA1,12,AIB3,GLN10,HARG11,TRP14]PTH-(1-14)-NH2: A complex peptide analogue of parathyroid hormone.
[TRP23,TYR36]PTHRP-(1-36)-NH2 (HUMAN): A synthetic peptide analogue of parathyroid hormone-related protein.
PTHRP-(7-34) (HUMAN, RAT, MOUSE): A fragment of parathyroid hormone-related protein.
LIFASTUZUMAB VEDOTIN: An experimental antibody-drug conjugate targeting NaPi2b.
BALAMAPIMOD: An experimental p38 MAP kinase inhibitor.
QRFP26 (26RFA): A neuropeptide that is the endogenous ligand for the GPR103 receptor.
L779450: An experimental inhibitor of the Raf kinase.
COMPOUND 24 [PMID: 36723914]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
SRT-2104: A selective SIRT1 activator that was studied for metabolic diseases.
GNE-3500: An experimental c-Met kinase inhibitor.
CD2314: A research chemical or compound identifier.
BRANEBRUTINIB: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
FLIZASERTIB: An experimental inhibitor of the Polo-like kinase 1 (Plk1).
SR1555: A research chemical or compound identifier.
25-HYDROXYCHOLESTEROL: A metabolite of cholesterol, an oxysterol.
HJC 0350: A research chemical or compound identifier.
COMPOUND 23 [PMID: 35816678]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
BI-D1870: A potent inhibitor of the RSK family of kinases.
ML290: A research chemical or compound identifier.
COMPOUND 7B [HAFTCHENARY ET AL., 2013]: A specific chemical compound described in a 2013 publication by Haftchenary et al.
INSL3: Insulin-like peptide 3, a hormone primarily produced in the testes.
SB-747651A: A research chemical or compound identifier.
COMPOUND 16 [PMID: 26794040]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
DIHYDROSPHINGOSINE 1-PHOSPHATE: A bioactive lipid molecule, also known as sphingosine-1-phosphate.
COMPOUND 5C [PMID: 27894870]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
SPM-354: A research chemical or compound identifier.
COMPOUND 2C [PMID: 24900538]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
DANAPAROID: An anticoagulant consisting of a mixture of heparanoids.
FLUOXETINE HYDROCHLORIDE: A selective serotonin reuptake inhibitor (SSRI) used as an antidepressant.
BIM 23197: A research chemical, a somatostatin receptor antagonist.
EDOTREOTIDE: A somatostatin analog used in peptide receptor radionuclide therapy.
DOSTARLIMAB: An immune checkpoint inhibitor (anti-PD-1 antibody) used for endometrial cancer.
BIM 23268: A research chemical, a somatostatin receptor agonist.
3M-002: An experimental Toll-like receptor 7 (TLR7) agonist.
IMIQUIMOD: An immune response modifier that acts as a Toll-like receptor 7 (TLR7) agonist, used topically.
IXAZOMIB: A proteasome inhibitor used to treat multiple myeloma.
PABINAFUSP ALFA: An experimental fusion protein for the treatment of Hunter syndrome.
NAPTUMOMAB ESTAFENATOX: An experimental targeted cancer therapy.
TALTIRELIN: A thyrotropin-releasing hormone (TRH) analog.
NAFAMOSTAT: A serine protease inhibitor used as an anticoagulant and for pancreatitis.
PYRAZOLOPYRIMIDINE 4N: A research chemical or compound identifier.
AMTB: A research chemical, a TRPC4/TRPC5 channel blocker.
MG2+: The divalent magnesium cation, an essential mineral.
A778317: A research chemical or compound identifier.
LDC1267: A research chemical or compound identifier.
PHI: Peptide histidine isoleucine, a peptide hormone.
LVP: Lysine vasopressin, a form of the hormone vasopressin.
TRU-015: An experimental protein therapeutic targeting CD20.
[PP1-17,ALA31,AIB32]NPY (HUMAN): A complex peptide analogue of Neuropeptide Y.
ONO-8539: A research chemical or compound identifier.
PF-04457845: An experimental fatty acid amide hydrolase (FAAH) inhibitor.
HDM2 INHIBITOR MK-8242: An experimental inhibitor of the MDM2-p53 interaction.
PF-05175157: An experimental ACC inhibitor.
RG-4733: A research chemical or compound identifier.
ALK/TRK INHIBITOR TSR-011: An experimental inhibitor of the ALK and TRK kinases.
ALECTINIB: A potent and selective ALK inhibitor used to treat non-small cell lung cancer.
PD173074: A potent and selective inhibitor of the FGFR tyrosine kinase.
ARS-1620: An experimental covalent inhibitor of KRAS G12C mutant protein.
DURVALUMAB: An immune checkpoint inhibitor (anti-PD-L1 antibody) used for cancer therapy.
ENVAFOLIMAB: An experimental single-domain antibody that targets PD-L1.
ZENOCUTUZUMAB: An experimental bispecific antibody targeting HER2 and HER3.
ASPACYTARABINE: An experimental chemotherapy agent.
JQEZ5: A research chemical or compound identifier.
TISAGENLECLEUCEL: A CAR-T cell therapy targeting CD19, used for certain types of leukemia and lymphoma.
MAP855: A research chemical or compound identifier.
DNA-DEPENDENT PROTEIN KINASE-TARGETING SIDNA DT01: An experimental DNA-PK inhibitor.
BRAFV600/PI3K INHIBITOR ASN003: An experimental dual inhibitor of BRAF V600 and PI3K.
TENALISIB: An experimental dual PI3K delta/gamma inhibitor.
EDIFOLIGIDE: An experimental transcription factor decoy.
CAFICRESTAT: An experimental aldose reductase inhibitor.
HSP90 INHIBITOR XL888: An experimental inhibitor of the Hsp90 protein.
GSK-1004723: A research chemical or compound identifier.
PLB1003: A research chemical or compound identifier.
CDX-3379: An experimental monoclonal antibody that targets the ErbB3 receptor.
AZD3463: An experimental GPR55 receptor antagonist.
OLVEREMBATINIB: A third-generation BCR-ABL tyrosine kinase inhibitor.
KO-947: An experimental ERK1/2 inhibitor.
ASG-5ME: An experimental antibody-drug conjugate.
VANDORTUZUMAB VEDOTIN: An experimental antibody-drug conjugate targeting STEAP1.
CRENOLANIB: A potent inhibitor of PDGFR and FLT3 kinases.
RIPRETINIB: A broad-spectrum kinase inhibitor that targets KIT and PDGFRA, used for GIST.
ADAVOSERTIB: An experimental inhibitor of the WEE1 kinase.
SULTHIAME: An anticonvulsant and carbonic anhydrase inhibitor.
SOTORASIB: A covalent inhibitor of the KRAS G12C mutant protein, used for non-small cell lung cancer.
DS-1062: An experimental antibody-drug conjugate targeting TROP2.
PERIFOSINE: An experimental alkylphospholipid that inhibits the Akt signaling pathway.
EBDAROKIMAB: An experimental monoclonal antibody.
BISANTRENE: An anthracenedione derivative with anticancer activity.
GDC-0879: An experimental inhibitor of the BRAF kinase.
TOPOTECAN HYDROCHLORIDE: A topoisomerase I inhibitor used in chemotherapy.
TIROFIBAN HYDROCHLORIDE: An antiplatelet drug, a glycoprotein IIb/IIIa inhibitor.
GSK-3174998: A research chemical or compound identifier.
EFAROXAN: An alpha-2 adrenergic and imidazoline receptor antagonist.
FENAMIDONE: A fungicide that inhibits the mitochondrial respiratory chain.
CHLORPHENIRAMINE POLISTIREX: An extended-release formulation of chlorpheniramine, a first-generation antihistamine.
EMD-1201081: A research chemical or compound identifier.
VORASIDENIB: An experimental inhibitor of mutant IDH1 and IDH2 enzymes.
AMAROGENTIN: A natural bitter compound with various biological activities.
TEBOTELIMAB: An experimental bispecific antibody targeting PD-1 and LAG-3.
MOSAPRIDE: A prokinetic agent that acts as a 5-HT4 receptor agonist.
ISOCHLOROGENIC ACID A: A natural phenolic compound with antioxidant properties.
AZD7268: A research chemical or compound identifier.
QUIZARTINIB: A potent FLT3 kinase inhibitor used to treat acute myeloid leukemia with FLT3 mutations.
MEDROXYPROGESTERONE: A progestin hormone used in hormonal contraception and hormone replacement therapy.
QUISINOSTAT: An experimental histone deacetylase (HDAC) inhibitor.
VIRULIZIN: An experimental immunotherapy agent.
GIMSILUMAB: An experimental monoclonal antibody that targets GM-CSF.
MNK1 INHIBITOR: A class of drugs that inhibit the MNK1 kinase.
REBIMASTAT: An experimental matrix metalloproteinase (MMP) inhibitor.
ACETOPHENAZINE: A typical antipsychotic of the phenothiazine class.
&ALPHA;-CONOTOXIN-GIC: A peptide neurotoxin from cone snail venom.
(R)-16 [PMID: 32267688]: An experimental compound described in the specified publication.
OSORESNONTRINE: A research chemical or compound identifier.
COMPOUND 19A [PMID: 26506089]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
TIPIFARNIB: A farnesyltransferase inhibitor studied for various cancers.
REVAMILAST: An experimental phosphodiesterase-4 (PDE4) inhibitor.
LOXAPINE: A typical antipsychotic used to treat schizophrenia.
INCOBOTULINUMTOXINA: A form of botulinum toxin type A, used for cosmetic and medical purposes.
2,2',4,4',5,5'-HEXACHLOROBIPHENYL: A specific polychlorinated biphenyl (PCB) congener.
ADERBASIB: An experimental AKT inhibitor.
ANCROD: An enzyme from snake venom that defibrinogenates blood.
SALACINOL: A natural product that inhibits alpha-glucosidase enzymes.
SETOGEPRAM: A research chemical or compound identifier.
ZSTK474: An experimental pan-PI3K inhibitor.
XL418: A research chemical or compound identifier.
UNFRACTIONATED HEPARIN: A widely used anticoagulant.
MEDICA 16: A research chemical or compound identifier.
PLOCABULIN: An experimental microtubule inhibitor with vascular disrupting properties.
DIHYDROERGOCRISTINE: An ergot alkaloid.
PRILOCAINE: A local anesthetic of the amide type.
DRUGSATFDA.NDA:008378: An identifier for a drug application submitted to the FDA.
BINIMETINIB: A MEK inhibitor used in combination with a BRAF inhibitor for melanoma.
ZEMIRCICLIB: An experimental cyclin-dependent kinase (CDK) inhibitor.
GSK690693: An experimental pan-Akt inhibitor.
OMIPALISIB: An experimental dual PI3K/mTOR inhibitor.
PI3K/MTOR KINASE INHIBITOR PF-04691502: An experimental dual inhibitor of PI3K and mTOR.
TANNIN PYROGALLOL: A type of tannin, a polyphenol.
TRAZODONE: An antidepressant that acts as a serotonin antagonist and reuptake inhibitor.
GLASDEGIB: An inhibitor of the Hedgehog signaling pathway, used for acute myeloid leukemia.
BUTORPHANOL: An opioid pain medication with mixed agonist-antagonist activity.
ACLARUBICIN: An anthracycline antibiotic used in chemotherapy.
AM095: A research chemical or compound identifier.
SCLEROTIORIN: A fungal metabolite with various biological activities.
MLKL COMPOUND 1: A specific chemical inhibitor of the MLKL protein.
D(CH2)5[D-ILE2,ILE4,ALA-NH29]AVP: A complex peptide analogue of vasopressin.
2-ARACHIDONOYLGLYCEROL: An endocannabinoid, an endogenous agonist of the cannabinoid receptors.
BROXYQUINOLINE: An antiseptic agent.
ARFORMOTEROL: A long-acting beta-2 adrenergic agonist (LABA) used to treat COPD.
RUTHENIUM RED: An inorganic dye that blocks calcium channels.
PYROTINIB: A tyrosine kinase inhibitor that targets EGFR and HER2.
METAMIZOLE SODIUM: A non-opioid analgesic and antipyretic drug.
ENZALUTAMIDE: A non-steroidal antiandrogen used to treat prostate cancer.
METYROSINE: An inhibitor of the enzyme tyrosine hydroxylase, used to treat pheochromocytoma.
TIOXOLONE: A keratolytic agent used in the treatment of acne and other skin conditions.
CP55940: A synthetic cannabinoid that acts as a potent full agonist for both the CB1 and CB2 receptors.
SOFITUZUMAB VEDOTIN: An experimental antibody-drug conjugate targeting the protein C4.4a.
RUTAECARPINE: An alkaloid compound from the plant Evodia rutaecarpa with various pharmacological effects.
FEBUXOSTAT: A non-purine selective inhibitor of xanthine oxidase used to treat gout.
CCT196969: An experimental inhibitor of the AKT kinase.
2-(INDOLIN-1YL)-MELATONIN: A chemical derivative of melatonin.
KOPARIN: A research chemical or compound identifier.
PERAZINE: A typical antipsychotic of the phenothiazine class.
TESTOSTERONE PROPIONATE: A short-acting ester of testosterone, an androgen and anabolic steroid.
R-SPONDIN-3: A protein that is a ligand for LGR receptors and potentiates Wnt/beta-catenin signaling.
GLYCOSYLATED RECOMBINANT HUMAN INTERLEUKIN-7: A form of the cytokine IL-7 with added sugar chains, used in research and therapy.
CLORAZEPATE: A long-acting benzodiazepine used to treat anxiety, seizures, and alcohol withdrawal.
SOVATELTIDE: An experimental endothelin B receptor agonist studied for acute ischemic stroke.
RETIFANLIMAB: An experimental monoclonal antibody that targets the PD-1 immune checkpoint receptor.
DORZOLAMIDE: A carbonic anhydrase inhibitor used in eye drops to treat glaucoma.
PANULISIB: An experimental dual PI3K/mTOR inhibitor.
BENZO(K)FLUORANTHENE: A polycyclic aromatic hydrocarbon (PAH), which is a known carcinogen.
CP-547632: An experimental inhibitor of the VEGFR2 tyrosine kinase.
BP-CCL3: A research chemical or compound identifier.
BRIVANIB: An experimental multi-kinase inhibitor that targets VEGFR and FGFR.
AURIN: A triphenylmethane dye.
TC14012: A peptide antagonist of the CXCR4 and CXCR7 chemokine receptors.
Z-YVAD-FMK: A specific, irreversible inhibitor of caspase-1.
[125I]CXCL8 (HUMAN): A radioiodinated form of the chemokine CXCL8 (IL-8).
OZANEZUMAB: An experimental monoclonal antibody that targets Nogo-A.
ERBSTATIN: A natural product that acts as a tyrosine kinase inhibitor.
LGB321: A research chemical or compound identifier.
RADICICOL: A natural product that inhibits the Hsp90 protein.
TREBANANIB: An experimental anti-angiogenic agent that sequesters angiopoietins 1 and 2.
SF-1126: An experimental RGD-conjugated pan-PI3K inhibitor.
D-ALPHA-TOCOPHEROL ACETATE: A form of Vitamin E, an antioxidant.
CARBAMAZEPINE: An anticonvulsant medication used to treat epilepsy and neuropathic pain.
SULINDAC SULFIDE: The active metabolite of the NSAID sulindac, which inhibits COX enzymes.
PEGVISOMANT: A growth hormone receptor antagonist used to treat acromegaly.
GABOXADOL: An experimental drug that acts as a GABAA receptor agonist, studied for insomnia and anxiety.
BATIMASTAT: A broad-spectrum matrix metalloproteinase (MMP) inhibitor.
(1S,3R)-ACPD: A selective agonist for metabotropic glutamate receptors.
COMPOUND 35 [PMID: 20684608]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
METHYLPREDNISOLONE: A synthetic glucocorticoid used for its anti-inflammatory and immunosuppressive effects.
LY2389575: A research chemical or compound identifier.
TAK-715: An experimental inhibitor of the p38 MAP kinase.
PROSTAGLANDIN B1: A type of prostaglandin, a lipid compound with diverse hormone-like effects.
PIOGLITAZONE HYDROCHLORIDE: A thiazolidinedione (TZD) antidiabetic drug that acts as a PPAR-gamma agonist.
RO5028442: A research chemical or compound identifier.
ANABASINE: A pyridine alkaloid found in the tree tobacco plant.
NITROBENZYLMERCAPTOPURINE RIBONUCLEOSIDE: An inhibitor of nucleoside transport.
VIDOFLUDIMUS: An experimental immunomodulatory drug that inhibits dihydroorotate dehydrogenase.
PAN-HER KINASE INHIBITOR AC480: A broad-spectrum inhibitor of the HER family of tyrosine kinases.
SAMIDORPHAN L-MALATE: The malate salt of samidorphan, an opioid receptor antagonist.
PODOFILOX: A topical medication used to treat genital warts, derived from podophyllotoxin.
CLASCOTERONE: A topical androgen receptor inhibitor used to treat acne.
INAMRINONE: A phosphodiesterase 3 inhibitor that was used for congestive heart failure.
COMPOUND 68 [PMID: 24900699]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 4G [PMID: 21316219]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
QUINIDINE: An antiarrhythmic agent and antimalarial drug.
C3: An abbreviation that can stand for multiple compounds, such as complement component 3.
QRFP43 (43RFA): A neuropeptide that is an endogenous ligand for the GPR103 receptor.
REBASTINIB: An experimental tyrosine kinase inhibitor that targets Tie2.
BUTAPROST: A selective agonist for the prostaglandin E2 receptor EP2 subtype.
CEPHALOCHROMIN: A fungal metabolite with biological activity.
RECOMBINANT FRACTALKINE: A manufactured form of the chemokine CX3CL1.
BUTABARBITAL SODIUM: The sodium salt of butabarbital, a sedative and hypnotic.
CILOMILAST: An experimental phosphodiesterase-4 (PDE4) inhibitor studied for COPD.
(20S,21S)-FLUOROCAMPTOTHECIN: A fluorinated derivative of the topoisomerase I inhibitor camptothecin.
HISTRELIN ACETATE: A gonadotropin-releasing hormone (GnRH) agonist used to treat prostate cancer and precocious puberty.
LLY-283: A research chemical or compound identifier.
PEGINTERFERON ALFA-2B: A pegylated form of interferon alfa-2b, used to treat hepatitis C and B.
AESCULIOSIDE IVB: A saponin compound found in some plants.
PATULIN: A mycotoxin produced by several species of fungi.
ISRADIPINE: A calcium channel blocker used to treat hypertension.
ENDOXIFEN: The active metabolite of tamoxifen, a selective estrogen receptor modulator.
NITROBENZENE: An organic compound used as a chemical intermediate.
ALITRETINOIN: A retinoid used topically to treat skin lesions in Kaposi's sarcoma.
DIHYDREXIDINE: A potent and full agonist of the dopamine D1/D5 receptors.
ANTI-BCMA CAR T CELLS PREPARATION: A general term for CAR-T cell therapies targeting the BCMA protein.
CURCUMIN PYRAZOLE: A synthetic derivative of curcumin with enhanced biological activity.
PF-05230907: An experimental monoclonal antibody that targets the angiopoietin-2 protein.
2,4,6-TRIBROMOPHENOL: An organic compound used as a fungicide and wood preservative.
ROMIDEPSIN: A histone deacetylase (HDAC) inhibitor used to treat cutaneous T-cell lymphoma.
CGP13501: A research chemical, a GABAB receptor antagonist.
SODIUM OXYBATE: The sodium salt of gamma-hydroxybutyrate (GHB), used to treat narcolepsy.
CHLORAMPHENICOL: A broad-spectrum antibiotic.
COMPOUND 5 [TOMASSI ET AL., 2020]: A specific chemical compound described in a 2020 publication by Tomassi et al.
FLUOROSALAN: An antiseptic agent.
PEXACERFONT: An experimental corticotropin-releasing factor receptor 1 antagonist.
SB 277011-A: A selective dopamine D3 receptor antagonist.
APITEGROMAB: An experimental monoclonal antibody that targets myostatin.
AMORFRUTIN A: A natural product from the licorice plant with antidiabetic properties.
HINOKITIOL: A natural monoterpenoid with broad antimicrobial and anti-inflammatory activities.
HARMINE: A beta-carboline alkaloid that acts as a reversible inhibitor of monoamine oxidase A (MAO-A).
CRISDESALAZINE: An experimental drug that was studied for inflammatory bowel disease.
SUPROFEN: A non-steroidal anti-inflammatory drug (NSAID).
JMR-132: A research chemical or compound identifier.
D(CH2)5[TYR(ME)2,THR4,TYR(3125I)-NH29]OVT: A complex, radiolabeled peptide analogue of oxytocin/vasopressin.
BUTINOLINE: An antispasmodic agent.
TYRPHOSTIN AG 555: A research chemical that inhibits the EGFR tyrosine kinase.
PTH-(1-34) (RAT): A fragment of rat parathyroid hormone.
DERAZANTINIB: An experimental pan-FGFR kinase inhibitor.
ARIPIPRAZOLE LAUROXIL: A long-acting injectable formulation of the atypical antipsychotic aripiprazole.
MK-2201: A research chemical or compound identifier.
SHIKONIN: A natural naphthoquinone compound from the plant Lithospermum erythrorhizon, with anti-inflammatory and anticancer effects.
CHLORANIL: An organic compound, a chlorinated derivative of quinone.
AMG-900: A potent and selective inhibitor of Aurora kinases.
ISOORIENTIN: A flavonoid compound found in various plants.
PSAMMAPLIN A: A marine natural product with HDAC and DNA methyltransferase inhibitory activity.
PRAMLINTIDE ACETATE: The acetate salt of pramlintide, an amylin analog used to treat diabetes.
GMQ: An abbreviation, possibly for a research compound.
TC-E 5005: An experimental inhibitor of the enzyme JNK.
EPZ020411: A research chemical or compound identifier.
ENDO-ATROPINE: An isomer of atropine.
OXYCARBOXIN: A systemic fungicide.
AZD3965: An experimental inhibitor of the monocarboxylate transporter 1 (MCT1).
FLUOXYMESTERONE: A potent androgen and anabolic steroid.
PATUPILONE: An experimental microtubule inhibitor of the epothilone class.
ILOPERIDONE: An atypical antipsychotic used to treat schizophrenia.
AVOBENZONE: An oil-soluble ingredient used in sunscreen products to absorb the full spectrum of UVA rays.
CHLOROTHIAZIDE: A thiazide diuretic used to treat high blood pressure and edema.
EGFR INHIBITOR 57: A specific chemical inhibitor of the EGFR kinase.
EPINEPHRINE: A hormone and neurotransmitter, also known as adrenaline, used to treat severe allergic reactions and cardiac arrest.
LUTETIUM DOTATATE LU-177: A radiopharmaceutical used in peptide receptor radionuclide therapy for neuroendocrine tumors.
4-(3-PYRIDIN-2-YL-1H-PYRAZOL-4-YL)QUINOLINE: A chemical compound, likely a specific kinase inhibitor.
PHENTOLAMINE MESYLATE: A non-selective alpha-adrenergic antagonist used to treat hypertensive emergencies.
ALPHA-ADRENERGIC AGONIST: A class of drugs that stimulate alpha-adrenergic receptors.
TRICETIN: A natural flavonol compound.
SB 224289: A selective 5-HT1B receptor antagonist.
TERFENADINE: A second-generation antihistamine that was withdrawn from the market due to cardiac side effects.
FINASTERIDE: A 5-alpha-reductase inhibitor used to treat benign prostatic hyperplasia and male pattern baldness.
TIBOLONE: A synthetic steroid hormone used for postmenopausal hormone replacement therapy.
WIN55212-2: A potent cannabinoid receptor agonist used in research.
TYRPHOSTIN B48: A research chemical that inhibits tyrosine kinases.
OTS964: An experimental inhibitor of the kinase TOPK.
CCT241161: An experimental inhibitor of the kinase PRAK.
OPHIOBOLIN O: A natural product with biological activity.
CCPA: A potent and selective adenosine A1 receptor agonist.
BMS-777607: A potent and selective inhibitor of the MET tyrosine kinase.
AMPICILLIN (ANHYDROUS): The anhydrous form of the antibiotic ampicillin.
ZUCAPSAICIN: A topical analgesic that acts as a TRPV1 receptor agonist.
NN-DIMETHYL-D-ERYTHROSPHINGOSINE: A chemical compound related to sphingolipids.
ECADOTRIL: A prodrug of sinorphan, a neutral endopeptidase inhibitor.
ENDOSULFAN: An organochlorine insecticide and acaricide that has been banned globally.
&ALPHA;&BETA;-MEATP: A stable, non-hydrolyzable analogue of ATP, which acts as a P2X receptor antagonist.
ERYTHROMYCIN STEARATE: The stearate salt of the macrolide antibiotic erythromycin.
CXCL2: A small cytokine belonging to the CXC chemokine family, also known as MIP-2-alpha.
GASTRIC INHIBITORY POLYPEPTIDE: A hormone that stimulates insulin secretion, also known as GIP.
DIAMIDE 7: A research chemical or compound identifier.
HEME: An iron-containing porphyrin compound that forms the non-protein part of hemoglobin and other biological molecules.
PAXILLINE: A fungal neurotoxin that blocks high-conductance calcium-activated potassium (BK) channels.
GABACULINE HYDROCHLORIDE: An irreversible inhibitor of GABA aminotransferase.
LUTETIUM LU 177 DOTATATE: A radiopharmaceutical used for neuroendocrine tumor therapy.
DS37001789: A research chemical or compound identifier.
LP-12: A potent and selective 5-HT7 receptor agonist.
ZK110841: A research chemical or compound identifier.
HYDROCODONE: An opioid medication used to treat severe pain.
FLUTAMIDE: A non-steroidal antiandrogen used to treat prostate cancer.
VILAZODONE HYDROCHLORIDE: An antidepressant that acts as a serotonin reuptake inhibitor and 5-HT1A partial agonist.
PROTOAPIGENONE: A natural flavonoid compound.
DABUZALGRON: An experimental melatonin receptor agonist.
6-HYDROXYMELATONIN: The major metabolite of melatonin.
LARAZOTIDE ACETATE: An experimental drug that was studied for celiac disease.
ATENOLOL: A selective beta-1 blocker used to treat hypertension and angina.
MACIMORELIN: A ghrelin receptor agonist used to diagnose adult growth hormone deficiency.
CEP-7055: A research chemical or compound identifier.
LUF7602: A research chemical or compound identifier.
DOPAMINE: A neurotransmitter that plays several important roles in the brain and body.
BI-847325: An experimental dual inhibitor of MEK and Aurora kinases.
ERYASPASE: An enzyme therapy, L-asparaginase encapsulated in red blood cells.
PIMETHIXENE: A first-generation antihistamine and anticholinergic.
MECLIZINE: A first-generation antihistamine used to treat motion sickness and vertigo.
CAMPTOTHECIN: A natural alkaloid that inhibits the enzyme topoisomerase I.
GEMCITABINE: A nucleoside analog used in chemotherapy for various cancers.
BEVANTOLOL: A beta-blocker with partial beta-adrenergic agonist activity.
SR59230A: A selective beta-3 adrenergic receptor antagonist.
MIFEPRISTONE: A medication used to induce medical abortion and as an emergency contraceptive.
PACLITAXEL DOCOSAHEXAENOIC ACID: A conjugate of paclitaxel and DHA designed to target tumors.
KC706: An experimental immunomodulatory agent.
HUMAN THYMOSIN-FRACTION 5: A preparation of peptides from the thymus gland.
HEXADECYLTRIMETHYLAMMONIUM CHLORIDE: A quaternary ammonium antiseptic and surfactant.
SPIROXATRINE: A potent and selective 5-HT1A receptor antagonist.
DINALINE: A research chemical or compound identifier.
CORONOPILIN: A natural sesquiterpene lactone with anti-inflammatory activity.
COMPOUND 5K [PMID: 23528296]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
ELINAFIDE: An experimental anticancer agent that intercalates into DNA.
TEMOZOLOMIDE: An oral alkylating agent used as a treatment for some brain cancers.
SANGUINARIUM: A research chemical or compound identifier.
SOTRASTAURIN: An experimental inhibitor of protein kinase C (PKC).
NAPHMETHONIUM: A research chemical or compound identifier.
MEDROXYPROGESTERONE ACETATE: A progestin hormone used in hormonal contraception and hormone replacement therapy.
PARP/TANKYRASE INHIBITOR 2X-121: An experimental dual inhibitor of PARP and tankyrase enzymes.
HELENALIN: A sesquiterpene lactone with potent anti-inflammatory and anticancer properties.
&BETA;-D-HYDROXYBUTYRIC ACID: A ketone body produced by the liver from fatty acids.
MOCLOBEMIDE: A reversible inhibitor of monoamine oxidase A (RIMA) used as an antidepressant.
BETHANECHOL: A parasympathomimetic choline carbamate that selectively stimulates muscarinic receptors.
VENADAPARIB: An experimental PARP inhibitor.
BORTEZOMIB: A proteasome inhibitor used to treat multiple myeloma and mantle cell lymphoma.
MANUMYCIN A: A natural product that acts as a farnesyltransferase inhibitor.
SELINEXOR: A selective inhibitor of nuclear export (SINE) used to treat multiple myeloma.
VIDUPIPRANT: An experimental prostaglandin D2 receptor 2 (DP2) antagonist.
FEDRATINIB: A Janus kinase (JAK) inhibitor used to treat myelofibrosis.
COPANLISIB: A PI3K inhibitor used to treat follicular lymphoma.
SG-005: A research chemical or compound identifier.
ESFLURBIPROFEN: The S-enantiomer of flurbiprofen, a non-steroidal anti-inflammatory drug (NSAID).
BIIB-023: An experimental monoclonal antibody that targets the VLA-4 integrin.
DYNORPHIN A-(1-8): A fragment of the endogenous opioid peptide dynorphin A.
IBANDRONATE: A bisphosphonate drug used to treat osteoporosis.
NEFAZODONE HYDROCHLORIDE: The hydrochloride salt of the antidepressant nefazodone.
ETHOXZOLAMIDE: A carbonic anhydrase inhibitor.
COMPOUND 1O [PMID: 24210504]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
ARAMCHOL: An experimental fatty acid bile acid conjugate studied for fatty liver disease.
VITAMIN B6: A vitamin that the body needs for several functions, also known as pyridoxine.
ERYTHROMYCIN GLUCEPTATE: A salt of the antibiotic erythromycin.
PEGINTERFERON ALFA-2A: A pegylated form of interferon alfa-2a, used to treat hepatitis C and B.
FLUDARABINE: A purine analog used in chemotherapy for leukemia and lymphoma.
LEVOMILNACIPRAN HYDROCHLORIDE: A serotonin-norepinephrine reuptake inhibitor (SNRI) used as an antidepressant.
AFM13: An experimental bispecific antibody that targets CD30 and CD16A.
APV207010A: A research chemical or compound identifier.
NIRAPARIB: A PARP inhibitor used to treat ovarian cancer.
RTOXA-43: A research chemical or compound identifier.
PRINOMASTAT: An experimental matrix metalloproteinase (MMP) inhibitor.
AUTOLOGOUS PSMA-4SCAR-EXPRESSING T-CELLS 4SCAR-PSMA: A specific formulation of CAR-T cell therapy targeting PSMA.
ALTENUSIN: A fungal metabolite with various biological activities.
BOSENTAN ANHYDROUS: The anhydrous form of bosentan, an endothelin receptor antagonist used for pulmonary hypertension.
AMINOPTERIN: An antifolate drug that was used in chemotherapy.
NKY80: A research chemical or compound identifier.
AMCENESTRANT: An experimental selective estrogen receptor degrader (SERD).
TEGASEROD MALEATE: A 5-HT4 agonist used for irritable bowel syndrome with constipation.
PHENINDIONE: An anticoagulant that functions as a vitamin K antagonist.
BEGACESTAT: An experimental gamma-secretase inhibitor that was studied for Alzheimer's disease.
GUANETHIDINE: An antihypertensive drug that acts as an adrenergic neuron blocking agent.
VUF5574: A research chemical or compound identifier.
MK-0752: An experimental gamma-secretase inhibitor.
RILOTUMUMAB: An experimental monoclonal antibody that targets the HGF/MET pathway.
1-METHYLCYCLOPROPANECARBOXYLIC ACID: A chemical compound.
TRAMIPROSATE: An experimental drug that was studied for Alzheimer's disease.
CYCLOPHOSPHAMIDE: A nitrogen mustard alkylating agent used in chemotherapy and as an immunosuppressant.
ISONIPECOTIC ACID: A chemical compound, a derivative of piperidine.
COMPOUND 13 [PMID: 34333981]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
CANNABINOL: A non-psychoactive cannabinoid found in the cannabis plant.
TEBUFENOZIDE: An insecticide that acts as an ecdysone agonist.
DL-TBOA: A non-transportable blocker of glutamate transporters.
RITLECITINIB: A dual inhibitor of JAK3 and TEC family kinases, used for alopecia areata.
BENODANIL: A systemic fungicide.
TT-232: A synthetic somatostatin analog with anticancer activity.
XL820: A research chemical or compound identifier.
LL-37: An antimicrobial peptide found in humans.
FUDOSTEINE: A mucolytic agent.
L-732,138: A potent and selective antagonist of the neurokinin-1 (NK1) receptor.
IRX4310: A research chemical or compound identifier.
FERRUGINENE C: A natural product with a specific chemical structure.
AMILORIDE HYDROCHLORIDE: A potassium-sparing diuretic.
FOTEMUSTINE: A nitrosourea alkylating agent used in chemotherapy.
ACETYLCYSTEINE: A medication used to treat paracetamol overdose and to loosen thick mucus.
ATUZABRUTINIB: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
GERANYL BIPHOSPHONATE: A research chemical or compound identifier.
FUTUXIMAB: An experimental monoclonal antibody.
CAFFEIC ACID PHENETHYL ESTER: A natural compound from propolis with anti-inflammatory and other activities.
NAGRESTIPEN: A recombinant protein that stimulates neutrophil production.
VALPROPYLHYDROXAMIC ACID: A research chemical or compound identifier.
ARC-239: A selective alpha-2B/2C adrenergic receptor antagonist.
DEBIO-1347: An experimental inhibitor of the IAP protein family.
L-LACTIC ACID: The L-enantiomer of lactic acid, a key intermediate in metabolism.
[3H]DIPRENORPHINE: A radiolabeled non-selective opioid receptor antagonist.
AUTOLOGOUS DENDRITIC CELLS TRANSDUCED WITH WILD-TYPE P53 ADENOVIRUS VACCINE: A type of cancer vaccine.
PROGABIDE: A prodrug of GABA, which was used as an anticonvulsant.
METHYLCURCUMIN: A synthetic derivative of curcumin.
METHOXYARACHIDONOYL FLUOROPHOSPHONATE: An irreversible inhibitor of the FAAH enzyme.
GSK4716: A selective agonist for the GPR40 receptor.
MK-7145: A research chemical or compound identifier.
COMPOUND 1 [PMID: 24900526]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
GYROPHORIC ACID: A lichen acid with biological activities.
APTIGANEL: An experimental non-competitive NMDA receptor antagonist.
SINIGRIN: A glucosinolate found in some plants of the Brassicaceae family.
ACE INHIBITOR: A class of drugs that inhibit angiotensin-converting enzyme, used for hypertension.
FLUNISOLIDE ANHYDROUS: The anhydrous form of flunisolide, a corticosteroid used for asthma.
N-METHYL LTC4: A research chemical or compound identifier.
E-101 SOLUTION: A specific formulation, likely a research solution.
BENFURACARB: A carbamate insecticide.
BRONCHODILATOR: A class of drugs that widen the bronchi and bronchioles.
FLUORESCEIN DIACETATE: A non-fluorescent compound that is hydrolyzed by esterases inside cells to the fluorescent fluorescein.
HORMONE THERAPY AGENT: A general class of drugs used in hormone therapy.
PROPARACAINE: A local anesthetic used as eye drops.
ROCILETINIB: An experimental third-generation EGFR inhibitor.
FLUPHENAZINE ENANTHATE: A long-acting injectable typical antipsychotic.
GONADORELIN ACETATE: A synthetic form of gonadotropin-releasing hormone (GnRH).
AMPHETAMINE ADIPATE: A salt of amphetamine, a central nervous system stimulant.
ESOMEPRAZOLE SODIUM: A proton pump inhibitor (PPI) used to treat GERD.
MIRTAZAPINE: An atypical antidepressant.
NITROGLYCERIN: A nitrate vasodilator used to treat and prevent angina.
SODIUM NITROPRUSSIDE: A potent vasodilator used for hypertensive emergencies.
ISOSORBIDE DINITRATE: A nitrate vasodilator used for angina pectoris.
TOLAZAMIDE: A first-generation sulfonylurea drug used to treat type 2 diabetes.
GLIPIZIDE: A second-generation sulfonylurea drug used to treat type 2 diabetes.
ACETOHEXAMIDE: A first-generation sulfonylurea drug used to treat type 2 diabetes.
CANAKINUMAB: A monoclonal antibody that targets interleukin-1 beta, used for inflammatory diseases.
SUCCINYLCHOLINE: A short-acting depolarizing neuromuscular-blocking drug.
THIAMYLAL SODIUM: An ultra-short-acting barbiturate anesthetic.
LYPRESSIN: A synthetic form of the hormone vasopressin.
N-ARACHIDONOYLGLYCINE: An endogenous lipid that acts as a signaling molecule.
PROPIDIUM: A fluorescent dye that intercalates into DNA, used to stain cells.
SB-242235: A research chemical or compound identifier.
DIMETHOMORPH: A fungicide that affects cell wall formation.
METIZOLINE: A research chemical or compound identifier.
BASILIXIMAB: A monoclonal antibody that targets the CD25 receptor, used to prevent organ transplant rejection.
ETHOTOIN: An anticonvulsant of the hydantoin class.
DISOPYRAMIDE PHOSPHATE: An antiarrhythmic medication.
ETIDOCAINE HYDROCHLORIDE: A long-acting local anesthetic of the amide type.
RUFINAMIDE: An anticonvulsant used for seizures associated with Lennox-Gastaut syndrome.
PROPOXYCAINE HYDROCHLORIDE: A local anesthetic of the ester type.
PROPAFENONE HYDROCHLORIDE: The hydrochloride salt of the antiarrhythmic propafenone.
PROPARACAINE HYDROCHLORIDE: The hydrochloride salt of the local anesthetic proparacaine.
INDECAINIDE HYDROCHLORIDE: An antiarrhythmic medication.
GREPAFLOXACIN HYDROCHLORIDE: A fluoroquinolone antibiotic that was withdrawn from the market.
ESLICARBAZEPINE ACETATE: A prodrug of eslicarbazepine, an anticonvulsant.
DESVENLAFAXINE FUMARATE: A salt of the antidepressant desvenlafaxine.
CANGRELOR TETRASODIUM: An antiplatelet drug, a P2Y12 inhibitor.
SONIDEGIB: An inhibitor of the Hedgehog signaling pathway, used to treat basal-cell carcinoma.
VK5211: An experimental selective androgen receptor modulator (SARM).
RELACORILANT: An experimental glucocorticoid receptor antagonist.
MIRANSERTIB: An experimental AKT inhibitor.
AZD-7451: A research chemical or compound identifier.
TOVORAFENIB: A novel type II RAF inhibitor for cancers with BRAF alterations.
HENATINIB: An experimental tyrosine kinase inhibitor.
D-3263: A research chemical or compound identifier.
PESAMPATOR: An experimental AMPA receptor positive allosteric modulator.
LUNACALCIPOL: An experimental vitamin D analog.
INT131: An experimental selective estrogen receptor modulator (SERM).
FX-005: A research chemical or compound identifier.
FRUQUINTINIB: A selective VEGFR inhibitor used to treat colorectal cancer.
KW-2450: A research chemical or compound identifier.
GALUNISERTIB: An experimental TGF-beta receptor I kinase inhibitor.
RAF-265: An experimental dual inhibitor of BRAF and VEGFR2.
BAVISANT: An experimental histamine H3 receptor antagonist/inverse agonist.
PATIDEGIB: An experimental inhibitor of the Hedgehog signaling pathway.
SAMIDORPHAN: An opioid receptor antagonist.
MAVOGLURANT: An experimental negative allosteric modulator of the mGluR5 receptor.
NAXIFYLLINE: A research chemical or compound identifier.
AZD1981: An experimental prostaglandin D2 receptor 2 (DP2) antagonist.
MK3207: A research chemical or compound identifier.
PBF-680: An experimental adenosine A1 receptor antagonist.
SRX246: An experimental vasopressin V1a receptor antagonist.
INDANTADOL: An experimental NMDA receptor antagonist and monoamine reuptake inhibitor.
ASM-024: An experimental nicotinic acetylcholine receptor agonist.
KETOPROFEN: A non-steroidal anti-inflammatory drug (NSAID).
TESAGLITAZAR: An experimental dual PPAR alpha/gamma agonist.
MOMELOTINIB: A Janus kinase (JAK) inhibitor used to treat myelofibrosis.
ALEPLASININ: A research chemical or compound identifier.
DUVOGLUSTAT HYDROCHLORIDE: An experimental glucosylceramide synthase inhibitor.
ERTUGLIFLOZIN: An SGLT2 inhibitor used to treat type 2 diabetes.
OMECAMTIV MECARBIL: An experimental cardiac myosin activator studied for heart failure.
AFEGOSTAT TARTRATE: An experimental glucosylceramide synthase inhibitor.
FORODESINE HYDROCHLORIDE: An inhibitor of purine nucleoside phosphorylase (PNP).
OBATOCLAX MESYLATE: An experimental BCL-2 family inhibitor.
BIRINAPANT: An experimental SMAC mimetic that antagonizes IAP proteins.
IRINOTECAN SUCROSOFATE: A formulation of the chemotherapy drug irinotecan.
ALPRENOLOL: A non-selective beta-blocker.
GUSELKUMAB: A monoclonal antibody that targets interleukin-23, used for psoriasis.
EPTINEZUMAB: A monoclonal antibody that targets CGRP, used to prevent migraine.
ICI-118551: A highly selective beta-2 adrenergic receptor antagonist.
VEPALIMOMAB: An experimental monoclonal antibody.
MAB-425: A research chemical or compound identifier.
NI-0801: An experimental monoclonal antibody.
IRATUMUMAB: An experimental monoclonal antibody that targets CD30.
AMISELIMOD HYDROCHLORIDE: An experimental sphingosine-1-phosphate receptor 1 (S1P1) modulator.
OPICINUMAB: An experimental monoclonal antibody that targets LINGO-1.
L19IL2: An experimental immunocytokine combining an antibody targeting fibronectin with interleukin-2.
AMG-557: A research chemical or compound identifier.
RONTALIZUMAB: An experimental monoclonal antibody that targets interferon-alpha.
YTTRIUM Y 90 CLIVATUZUMAB TETRAXETAN: A radioimmunoconjugate targeting the MUC1 antigen.
BB-10901: An experimental recombinant protein.
EMIBETUZUMAB: An experimental monoclonal antibody.
MAVRILIMUMAB: An experimental monoclonal antibody that targets the GM-CSF receptor.
BENZYDAMINE HYDROCHLORIDE: A locally acting non-steroidal anti-inflammatory drug (NSAID).
DIMETHINDENE: A first-generation antihistamine and anticholinergic.
ANGIOTENSIN II ACETATE: The acetate salt of the hormone angiotensin II.
TOSITUMOMAB 131I: A radioimmunotherapy agent, a monoclonal antibody targeting CD20.
CNTO-5825: An experimental monoclonal antibody that targets interleukin-13.
MEDI-570: A research chemical or compound identifier.
AVATROMBOPAG MALEATE: The maleate salt of avatrombopag, a thrombopoietin receptor agonist.
RAFOXANIDE: An anthelmintic used in veterinary medicine.
PF-06651600: An experimental JAK3 inhibitor.
ZANUBRUTINIB: A second-generation Bruton's tyrosine kinase (BTK) inhibitor used for certain types of lymphoma.
RG-7841: A research chemical or compound identifier.
VADADUSTAT: An experimental HIF prolyl-hydroxylase inhibitor studied for anemia.
NITRENDIPINE: A calcium channel blocker used to treat hypertension.
CADONILIMAB: An experimental bispecific antibody targeting PD-1 and CTLA-4.
PELABRESIB: An experimental BET inhibitor.
BDTX189: An experimental allosteric inhibitor of EGFR and HER2 with specific mutations.
SERDEXMETHYLPHENIDATE CHLORIDE: A prodrug of dexmethylphenidate, a CNS stimulant.
CIPROFLOXACIN: A broad-spectrum fluoroquinolone antibiotic.
DU 125530: A research chemical or compound identifier.
TALSACLIDINE: An M1 muscarinic receptor partial agonist that was studied for Alzheimer's disease.
ELRANATAMAB: An experimental bispecific antibody targeting BCMA and CD3.
DAGLUTRIL: A research chemical or compound identifier.
APILIMOD MESYLATE: An experimental inhibitor of the PIKfyve kinase.
CD40 LIGAND: A protein that is primarily expressed on activated T cells.
VERDIPERSTAT: An experimental myeloperoxidase inhibitor.
VELIFLAPON: An experimental inhibitor of the 5-lipoxygenase-activating protein (FLAP).
ERFONRILIMAB: An experimental monoclonal antibody.
PF-4136309: An experimental ghrelin receptor antagonist.
LMB-100: An experimental immunotoxin targeting the mesothelin protein.
SIREMADLIN: An experimental MDM2 inhibitor.
TRAZPIROBEN: An experimental dopamine D2/D3 receptor antagonist.
ELINZANETANT: An experimental neurokinin-1,3 receptor antagonist.
BIRICODAR: An experimental P-glycoprotein inhibitor designed to overcome multidrug resistance.
ALDUMASTAT: A research chemical or compound identifier.
METFORMIN HYDROCHLORIDE: The hydrochloride salt of metformin, a first-line medication for type 2 diabetes.
DIMETHYL YELLOW: A pH indicator.
4-AMINO-[1,2]NAPHTHOQUINONE: A chemical compound.
SULFISOXAZOLE: A sulfonamide bacteriostatic antibiotic.
CRYPTOCHINONE B: A natural product with biological activity.
BISANHYDRORUTILANTINONE: A natural product with biological activity.
MECLOFENAMATE SODIUM: The sodium salt of meclofenamic acid, an NSAID.
RUTIN: A flavonoid glycoside found in many plants, with antioxidant properties.
PERMETHRIN: A synthetic pyrethroid insecticide, used as a medication for scabies and lice.
ANTIMYCIN A: An inhibitor of the mitochondrial electron transport chain.
TETRABUTYLAMMONIUM BROMIDE: A quaternary ammonium salt used as a phase transfer catalyst.
SUBEROHYDROXAMIC ACID: A research chemical or compound identifier.
ALACHLOR: An herbicide of the chloroacetanilide class.
IOXYNIL: An herbicide.
IODOQUINOL: An amebicide used to treat intestinal infections.
RIBOFLAVIN: Also known as Vitamin B2, an essential vitamin.
OLSALAZINE: An anti-inflammatory drug used in the treatment of ulcerative colitis.
PRALIDOXIME CATION: The active cation of pralidoxime, an antidote for organophosphate poisoning.
SB 206553: A selective 5-HT2B/2C receptor antagonist.
AMINODIMETHOXYQUINAZOLINYLPIPERAZINE: A complex chemical name, likely a specific receptor ligand.
DIBENZ[A,H]ANTHRACENE: A polycyclic aromatic hydrocarbon (PAH), a potent carcinogen.
1-AZAKENPAULLONE: A synthetic inhibitor of the GSK-3 kinase.
RAUWOLSCINE: An alkaloid that acts as an alpha-2 adrenergic receptor antagonist.
PICLIDENOSON: An experimental selective adenosine A3 receptor agonist.
ETICLOPRIDE: A selective dopamine D2 receptor antagonist.
DIMETHYLPHENYLPIPERAZINIUM IODIDE: A potent agonist of neuronal nicotinic acetylcholine receptors.
THEONELLASTEROL H: A marine-derived sterol.
N-ACETYLCOLCHINOL: A derivative of colchicine.
BROMHEXINE HYDROCHLORIDE: A mucolytic agent used in the treatment of respiratory disorders.
LITHOCHOLIC ACID: A secondary bile acid.
FEPRAZONE: A non-steroidal anti-inflammatory drug (NSAID).
GW631581B: A research chemical or compound identifier.
HALOPERIDOL DECANOATE: A long-acting injectable typical antipsychotic.
2-METHOXY-1,4-NAPHTHOQUINONE: A chemical compound with biological activity.
ISOTRETINOIN: A retinoid medication used primarily for severe acne.
CARTEOLOL: A non-selective beta-blocker used in eye drops to treat glaucoma.
VU0080241: A research chemical or compound identifier.
1,4-DICHLOROBENZENE: An organic compound used as a pesticide and deodorant.
METHYL 7-DESHYDROXYPYROGALLIN-4-CARBOXYLATE: A chemical compound derived from a natural product.
PF-04620110: An experimental DGAT1 inhibitor.
PROCHLORAZ: A fungicide.
MORICIZINE: An antiarrhythmic medication.
ALOSETRON HYDROCHLORIDE: A 5-HT3 antagonist used for severe diarrhea-predominant irritable bowel syndrome.
TANSHINONE IIA: A major bioactive compound from the herb Salvia miltiorrhiza.
TAMOXIFEN CITRATE: The citrate salt of tamoxifen, a selective estrogen receptor modulator.
UCCF-029: A research chemical or compound identifier.
PREDNISOLONE: A synthetic glucocorticoid with anti-inflammatory and immunosuppressant effects.
SB-431542: A potent and selective inhibitor of the ALK5 receptor kinase.
THIOINOSINE: A sulfur-containing analogue of the nucleoside inosine.
CHELERYTHRINE CHLORIDE: The chloride salt of chelerythrine, a PKC inhibitor.
BREFELDIN A: A fungal metabolite that inhibits protein transport from the endoplasmic reticulum to the Golgi apparatus.
TYRPHOSTIN AG 879: A research chemical that inhibits the Trk family of tyrosine kinases.
DIMETHYLPINOCEMBRIN: A derivative of the flavonoid pinocembrin.
BROMOCRIPTINE MESYLATE: The mesylate salt of bromocriptine, a dopamine agonist.
S-TRITYL-L-CYSTEINE: An inhibitor of the mitotic kinesin Eg5.
17-OCTADECYNOIC ACID: A fatty acid with a triple bond.
GAMBOGIC AMIDE: A synthetic derivative of gambogic acid.
SULFURETIN: A natural aurone chalconoid.
SILIBININ: The major active constituent of silymarin, the extract from milk thistle seeds.
HYDROXYLAMMONIUM CHLORIDE: The hydrochloride salt of hydroxylamine.
DEXMEDETOMIDINE HYDROCHLORIDE: A potent alpha-2 adrenergic agonist used for sedation.
6-AZAURIDINE: An antimetabolite that inhibits pyrimidine biosynthesis.
EMTRICITABINE: A nucleoside reverse transcriptase inhibitor (NRTI) used to treat HIV.
CARDAMOMIN: A natural chalconoid with anti-inflammatory and anticancer properties.
FLUOCINOLONE ACETONIDE: A potent topical corticosteroid.
CYSTEINE: A semi-essential proteinogenic amino acid.
ARTEMISININ: A medication used to treat malaria.
IMETIT DIHYDROBROMIDE: A potent and selective histamine H3 receptor agonist.
FORMETOREX: A stimulant drug that was studied as an appetite suppressant.
FENTICLOR: An antibacterial and antifungal agent.
AMINOQUINURIDE: A research chemical or compound identifier.
ROSMARINIC ACID: A natural polyphenol with antioxidant and anti-inflammatory properties.
LORATADINE: A second-generation antihistamine used to treat allergies.
PHENACETIN: A pain-relieving and fever-reducing drug that was withdrawn due to side effects.
TAMSULOSIN HYDROCHLORIDE: An alpha-1 blocker used to treat benign prostatic hyperplasia.
CHLORHEXIDINE GLUCONATE: A disinfectant and antiseptic used for skin disinfection and in mouthwashes.
CUDRAFLAVONE B: A natural biflavonoid.
IMETIT: A potent and selective histamine H3 receptor agonist.
GW775608X: A research chemical or compound identifier.
MP-412: A research chemical or compound identifier.
2-PHENYLPHENOL: An organic compound used as a disinfectant and fungicide.
8-CYCLOPENTYLTHEOPHYLLINE: A potent and selective adenosine A1 receptor antagonist.
U50488: A potent and selective kappa-opioid receptor agonist.
PARBENDAZOLE: An anthelmintic drug.
METHYLISOTHIOCYANATE: A chemical compound used as a fumigant.
WIN 62,577: An experimental anti-inflammatory agent.
CARMINE: A pigment of a bright-red color obtained from the cochineal insect.
U101958: A research chemical or compound identifier.
FENOFIBRIC ACID: The active metabolite of fenofibrate, a fibrate drug.
CEPHALEXIN ANHYDROUS: The anhydrous form of cephalexin, a first-generation cephalosporin antibiotic.
IODO-WILLARDIINE: A selective AMPA/kainate receptor agonist.
NIZOFENONE: An experimental neuroprotective drug.
AMOXICILLIN ANHYDROUS: The anhydrous form of amoxicillin, a beta-lactam antibiotic.
TYRAMINE: A naturally occurring monoamine compound that acts as a catecholamine releasing agent.
BROMOCRESOL GREEN: A pH indicator.
DIETHYLSTILBESTROL DIPROPIONATE: A synthetic non-steroidal estrogen.
ISOETHARINE MESYLATE: A short-acting beta-2 adrenergic receptor agonist used as a bronchodilator.
RITANSERIN: A potent and selective 5-HT2A receptor antagonist.
BYAKANGELICIN: A natural furanocoumarin with various biological activities.
ABIETIC ACID: The primary component of rosin, a natural resin from pine trees.
DIPICOLINIC ACID: A chemical compound that is a constituent of bacterial spores.
6-CL-MLT: A research chemical or compound identifier.
DICLAZURIL: A coccidiostat used in veterinary medicine to treat protozoal infections.
CHLOROXURON: An herbicide of the phenylurea class.
CARBAZOLE: A heterocyclic aromatic organic compound.
LOMATIN: A natural coumarin compound.
TRIBROMOACETIC ACID: A halogenated derivative of acetic acid.
ISOCONAZOLE: An azole antifungal medication.
METHANESULFONIC ACID METHYL ESTER: A chemical reagent, a methylating agent.
DUVOGLUSTAT: An experimental glucosylceramide synthase inhibitor.
MERCURIC IODIDE: A toxic inorganic compound of mercury and iodine.
DILTIAZEM HYDROCHLORIDE: A calcium channel blocker used to treat hypertension and angina.
PREDNISONE: A synthetic corticosteroid used for its anti-inflammatory and immunosuppressant effects.
2'H,4H-[2,8'-BICHROMEN]-4-ONE: A complex chemical name for a specific flavonoid-like compound.
MONO-N-ACETYL DAPSONE: The major metabolite of the antibacterial drug dapsone.
SALICYLHYDROXAMIC ACID: A chemical compound that inhibits urease enzymes.
CGP7930: A positive allosteric modulator of the GABAB receptor.
OMEPRAZOLE MAGNESIUM: The magnesium salt of omeprazole, a proton pump inhibitor.
AESCULIOSIDE IIIB: A saponin compound found in some plants.
RADANAMYCIN: A research chemical or compound identifier.
PICONOL: A research chemical or compound identifier.
PIMETHIXENE MALEATE: A salt of pimethixene, a first-generation antihistamine.
PRIDINOL METHANESULFONATE: The methanesulfonate salt of pridinol, a centrally acting muscle relaxant.
METFORMIN: A first-line medication for the treatment of type 2 diabetes.
SAPONARIN: A flavonoid glycoside found in various plants.
AMPEROZIDE: An atypical antipsychotic that acts on serotonin receptors.
METHOXSALEN: A medication used along with UVA radiation for psoriasis and vitiligo.
MICONAZOLE NITRATE: A topical azole antifungal agent.
2'H,4H-[2,5'-BICHROMEN]-4-ONE: A complex chemical name for a specific flavonoid-like compound.
FENOLDOPAM BROMIDE: A selective dopamine D1 receptor partial agonist used as an antihypertensive agent.
CEFTRIAXONE: A third-generation cephalosporin antibiotic.
DESERPIDINE: An antihypertensive drug, a rauwolfia alkaloid.
FORMONONETIN: An isoflavone phytoestrogen found in various plants and herbs.
AZELAIC ACID: A dicarboxylic acid used to treat acne and rosacea.
CANDESARTAN CILEXETIL: A prodrug of candesartan, an angiotensin II receptor antagonist.
HU-210: A potent synthetic cannabinoid used in research.
NOBILAMIDE B: A natural product with biological activity.
SPIRAMIDE: A research chemical or compound identifier.
DICHLORODIPHENYLDICHLOROETHYLENE: A metabolite of the insecticide DDT, commonly known as DDE.
LABETALOL HYDROCHLORIDE: A beta-blocker used to treat high blood pressure.
VANIPREVIR: An antiviral drug that was studied for the treatment of hepatitis C.
ABT702: An experimental adenosine A1 receptor agonist.
CYSTAMINE HYDROCHLORIDE: The hydrochloride salt of cystamine.
PIROCTONE: An antifungal and antibacterial compound used in anti-dandruff shampoos.
DCMU: An herbicide that inhibits photosynthesis by blocking electron flow.
ISORHAMNETIN: A natural O-methylated flavonol.
DACLATASVIR: An antiviral drug used in combination for the treatment of hepatitis C.
NETUPITANT: A neurokinin-1 (NK1) receptor antagonist used to prevent chemotherapy-induced nausea and vomiting.
RALOXIFENE HYDROCHLORIDE: A selective estrogen receptor modulator (SERM) used to treat and prevent osteoporosis.
ROPIVACAINE: A long-acting local anesthetic of the amide type.
ROSUVASTATIN: A statin drug used to lower cholesterol and prevent cardiovascular disease.
AT9283: An experimental multi-kinase inhibitor targeting Aurora kinases and JAK.
DACARBAZINE: An alkylating agent used in the chemotherapy of various cancers, including melanoma.
METHYLMERCAPTOPURINE RIBOSIDE: A metabolite of the immunosuppressant drug azathioprine.
ANTIMALARIAL AGENT: A general class of drugs used to prevent or treat malaria.
DIFFERENTIATION INDUCER: A class of agents that promote the differentiation of cells.
OLTIPRAZ: An experimental chemopreventive agent.
ANTINEOPLASTIC VACCINE: A type of vaccine designed to treat or prevent cancer.
TETANUS TOXOID: A vaccine used to prevent tetanus.
PROPIONIBACTERIUM ACNES: A bacterium linked to the skin condition of acne.
ANAKINRA: A recombinant form of the interleukin-1 receptor antagonist, used for rheumatoid arthritis.
CLOMIPHENE CITRATE: A selective estrogen receptor modulator (SERM) used to treat infertility in women.
MEDICATION: A general term for a substance used for medical treatment.
FREUND'S ADJUVANT: An emulsion used to boost the immune response in animal research.
ANTINEOPLASTIC AGENT: A general class of drugs that inhibit or prevent the growth and spread of tumors.
IRBESARTAN: An angiotensin II receptor antagonist used to treat high blood pressure.
DRONABINOL: The psychoactive component of cannabis, delta-9-tetrahydrocannabinol (THC), used medically.
FAS LIGAND: A protein that binds to the Fas receptor and induces apoptosis.
LYCOPENE: A bright red carotenoid pigment and phytochemical found in tomatoes and other red fruits.
PENICILLIN: A group of beta-lactam antibiotics used to treat a wide range of bacterial infections.
ANABOLIC STEROID: A class of steroid hormones that promote cell growth and division.
SELENOMETHIONINE: A naturally occurring amino acid containing selenium.
HEXAMETHYLENE BISACETAMIDE: A chemical compound that can induce cell differentiation.
BETA-NAPHTHOFLAVONE: A synthetic flavonoid that is a potent inducer of cytochrome P450 enzymes.
ZOLEDRONIC ACID ANHYDROUS: The anhydrous form of zoledronic acid, a potent bisphosphonate.
BENZTHIAZIDE: A thiazide diuretic used to treat hypertension and edema.
TYRPHOSTIN 23: A research chemical that inhibits tyrosine kinases.
ACITRETIN: A second-generation retinoid used for the treatment of severe psoriasis.
RO 31-8220: A potent inhibitor of protein kinase C (PKC).
HYCANTHONE: An anthelmintic drug that was used to treat schistosomiasis.
ICRF-193: A catalytic inhibitor of topoisomerase II.
NOVOBIOCIN: An aminocoumarin antibiotic that inhibits bacterial DNA gyrase.
THYROTROPIN: Also known as Thyroid-Stimulating Hormone (TSH), a pituitary hormone.
MITOGEN-ACTIVATED PROTEIN KINASE INHIBITOR: A class of drugs that inhibit MAPK enzymes.
DIURETIC: A class of drugs that promote increased production of urine.
ANESTHETIC AGENT: A general class of drugs that induce a reversible loss of sensation.
CYCLOSPORINE: An immunosuppressant drug used to prevent rejection in organ transplantation.
PAMIDRONATE DISODIUM: The disodium salt of pamidronate, a bisphosphonate.
GINGER ALLERGENIC EXTRACT: An extract from ginger used in allergy testing.
BACLOFEN: A centrally acting muscle relaxant used to treat spasticity.
HYDROXYCHLOROQUINE: A medication used to treat malaria and certain autoimmune diseases.
MEROPENEM ANHYDROUS: The anhydrous form of meropenem, a broad-spectrum carbapenem antibiotic.
STAVUDINE: A nucleoside reverse transcriptase inhibitor (NRTI) used to treat HIV/AIDS.
TAZAROTENE: A third-generation topical retinoid used for psoriasis and acne.
ESTRONE: An estrogen hormone secreted by the ovary and adipose tissue.
7-HYDROXYCHLORPROMAZINE: A metabolite of the antipsychotic drug chlorpromazine.
BENZPHETAMINE: A sympathomimetic amine used as a short-term appetite suppressant.
XANTHYLETIN: A natural coumarin compound with biological activities.
EVODIAMINE: An alkaloid extract from the plant Evodia rutaecarpa.
ANTAZOLINE: A first-generation antihistamine with anticholinergic properties.
DICLOXACILLIN: A narrow-spectrum beta-lactam antibiotic of the penicillin class.
RIFAPENTINE: An antibiotic used in the treatment of tuberculosis.
FLUVOXAMINE: A selective serotonin reuptake inhibitor (SSRI) used as an antidepressant.
VITAMIN A: A group of unsaturated nutritional organic compounds that includes retinol, retinal, and retinoic acid.
CETYLPYRIDINIUM BROMIDE: A quaternary ammonium antiseptic.
BUMETANIDE: A loop diuretic used to treat fluid retention and high blood pressure.
TRANILAST: An anti-allergic drug.
REGADENOSON ANHYDROUS: The anhydrous form of regadenoson, an adenosine A2A receptor agonist.
MOTESANIB: An experimental multi-kinase inhibitor targeting VEGFR, PDGFR, and Kit.
SULFAMETHAZINE: A sulfonamide antibiotic used in veterinary medicine.
BETAINE: A modified amino acid consisting of glycine with three methyl groups.
RILONACEPT: A dimeric fusion protein that blocks interleukin-1, used for cryopyrin-associated periodic syndromes.
FLAVANONE: A class of flavonoids.
ASUNAPREVIR: An antiviral drug for the treatment of hepatitis C.
RIVASTIGMINE: A cholinesterase inhibitor used for the treatment of dementia in Alzheimer's and Parkinson's disease.
BMS-754807: An experimental dual inhibitor of the IGF-1R and insulin receptor kinases.
DESMOSTEROL: An intermediate in the biosynthesis of cholesterol.
CYCLOBENZAPRINE: A centrally acting muscle relaxant.
TALAZOPARIB: A PARP inhibitor used to treat BRCA-mutated, HER2-negative breast cancer.
CLAVULANIC ACID: A beta-lactamase inhibitor, often combined with penicillin-group antibiotics.
ALEMTUZUMAB: A monoclonal antibody that targets CD52, used to treat multiple sclerosis and leukemia.
CLORGYLINE HYDROCHLORIDE: An irreversible and selective inhibitor of monoamine oxidase A (MAO-A).
METITEPINE: A potent antagonist of multiple serotonin and dopamine receptors.
ENFLURANE: An inhaled general anesthetic.
SULFADOXINE: A sulfonamide antibiotic, often used with pyrimethamine for malaria.
PYRAZOPHOS: An organophosphate fungicide and insecticide.
RUCAPARIB PHOSPHATE: The phosphate salt of rucaparib, a PARP inhibitor.
CANERTINIB: An experimental irreversible pan-ErbB tyrosine kinase inhibitor.
GENISTEIN: An isoflavone phytoestrogen with various biological activities.
4SC-202: An experimental inhibitor of the histone deacetylases HDAC1, HDAC2, and HDAC3.
SENREBOTASE: A research chemical or compound identifier.
ZALEPLON: A non-benzodiazepine hypnotic agent used for the short-term treatment of insomnia.
1-PHENETHYLPIPERIDINE: A chemical compound, a derivative of piperidine.
NISOLDIPINE: A calcium channel blocker used to treat hypertension.
CARBIDOPA ANHYDROUS: The anhydrous form of carbidopa, a medication given to people with Parkinson's disease in combination with levodopa.
DONEPEZIL: A centrally acting reversible acetylcholinesterase inhibitor used to treat Alzheimer's disease.
LEUCOVORIN CALCIUM: A form of folic acid used to counteract the toxic effects of methotrexate.
RIVIPANSEL: An experimental selectin antagonist studied for sickle cell disease.
GRANISETRON: A 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting.
GW827102X: A research chemical or compound identifier.
GW501516: An experimental PPAR-delta agonist, also known as cardarine.
LIRANAFTATE: A topical antifungal agent.
DENUFOSOL: An experimental P2Y2 receptor agonist that was studied for cystic fibrosis.
PEPEROMIN E: A natural product with biological activity.
INTERFERON BETA-1B: A manufactured form of the cytokine interferon beta, used to treat multiple sclerosis.
CLONAZEPAM: A benzodiazepine used to prevent and treat seizures, panic disorder, and the movement disorder akathisia.
3,5-DIPHENYLISOXAZOLE: A chemical compound, a derivative of isoxazole.
DELCASERTIB: An experimental protein kinase C (PKC) inhibitor.
IDALOPIRDINE: An experimental 5-HT6 receptor antagonist that was studied for Alzheimer's disease.
ENOBOSARM: An experimental selective androgen receptor modulator (SARM), also known as ostarine.
IDETREXED: An experimental antifolate drug.
2-METHOXYESTRADIOL: An endogenous metabolite of estradiol with anti-angiogenic and anticancer properties.
PRX-07034: An experimental 5-HT6 receptor antagonist.
LEVOCARNITINE PROPIONATE: A formulation of carnitine used to treat peripheral artery disease.
3,5-DIIODO-L-TYROSINE: An intermediate in the synthesis of thyroid hormones.
LANATOSIDE C: A cardiac glycoside found in the foxglove plant.
PTC299: An experimental agent that inhibits the production of vascular endothelial growth factor (VEGF).
SDZ 205557: A research chemical, a dopamine receptor agonist.
PALOVAROTENE: An experimental selective retinoic acid receptor gamma agonist.
CITRONELLYL ACETATE: An ester of citronellol, used in perfumes and flavorings.
EZOGABINE: An anticonvulsant that acts as a neuronal potassium channel opener.
PALIFERMIN: A recombinant form of human keratinocyte growth factor, used to treat oral mucositis.
ARISTOLOCHIC ACID: A carcinogenic, mutagenic, and nephrotoxic compound found in the plant family Aristolochiaceae.
SIBUTRAMINE: An oral anorexiant that was withdrawn from the market due to cardiovascular concerns.
BRENTUXIMAB VEDOTIN: An antibody-drug conjugate that targets the CD30 protein, used for lymphoma.
PINAFIDE: An experimental anticancer agent that intercalates into DNA.
ALPHA-TERTHIENYL: A natural thiophene compound with phototoxic and biocidal properties.
LISDEXAMFETAMINE DIMESYLATE: A prodrug of dextroamphetamine, a central nervous system stimulant.
XL999: An experimental multi-kinase inhibitor.
NS 2028: A research chemical that stimulates soluble guanylate cyclase.
XL765: An experimental dual PI3K/mTOR inhibitor.
METHYLBENZETHONIUM CHLORIDE: A quaternary ammonium antiseptic.
ACEBUTOLOL: A selective beta-1 blocker used to treat hypertension and angina.
TRIBUTYLTIN-OXIDE: An organotin compound used as a biocide.
ATRACURIUM: A non-depolarizing neuromuscular-blocking drug.
OCTOTROPINE METHYLBROMIDE: An antimuscarinic agent.
CLENBUTEROL: A sympathomimetic amine used as a decongestant and bronchodilator.
CINACALCET: A calcimimetic used to treat secondary hyperparathyroidism.
CILOSTAZOL: A phosphodiesterase inhibitor used to treat intermittent claudication.
CHORIOGONADOTROPIN ALFA: A recombinant form of human chorionic gonadotropin (hCG).
BROMPHENIRAMINE: A first-generation antihistamine.
DIPHENIDOL: An antiemetic and anti-vertigo agent.
NODAKENIN: A natural coumarin compound.
PRAZOSIN: An alpha-1 blocker used to treat high blood pressure.
IPRATROPIUM CATION: The active cation of ipratropium, an anticholinergic bronchodilator.
CVT-6883: An experimental adenosine A2B receptor antagonist.
CARPROFEN: A non-steroidal anti-inflammatory drug (NSAID) used in veterinary medicine.
ORPHENADRINE: A muscarinic antagonist and H1 histamine antagonist used as a skeletal muscle relaxant.
NALIDIXIC ACID: A quinolone antibiotic.
DESFLURANE: An inhaled general anesthetic.
PROMETHAZINE HYDROCHLORIDE: A first-generation antihistamine with antiemetic and sedative properties.
SILVESTROL: A natural product with potent anticancer activity.
DRONEDARONE: An antiarrhythmic medication used for atrial fibrillation.
CHENODEOXYCHOLIC ACID: A primary bile acid.
PYRROLIDINE DITHIOCARBAMATE: A potent inhibitor of the NF-kappaB signaling pathway.
LEVORPHANOL: An opioid medication used to treat moderate to severe pain.
MEPERIDINE HYDROCHLORIDE: An opioid pain medication, also known as pethidine.
MEPHENTERMINE: A sympathomimetic stimulant.
ADAPALENE: A third-generation topical retinoid used to treat acne.
FINGOLIMOD: A sphingosine-1-phosphate receptor modulator used for multiple sclerosis.
PENBUTOLOL: A non-selective beta-blocker.
FOSPROPOFOL: A water-soluble prodrug of the anesthetic propofol.
LANREOTIDE ACETATE: A long-acting somatostatin analogue used to treat acromegaly and neuroendocrine tumors.
TALBUTAL: A short- to intermediate-acting barbiturate.
RACEMENTHOL: A racemic mixture of menthol isomers.
TIMOLOL: A non-selective beta-blocker used in eye drops to treat glaucoma.
TREPROSTINIL: A prostacyclin vasodilator used to treat pulmonary arterial hypertension.
CHRYSOERIOL: A natural O-methylated flavone.
TROSPIUM: An antimuscarinic drug used to treat overactive bladder.
TRIFLUPROMAZINE: A typical antipsychotic of the phenothiazine class.
NYLIDRIN HYDROCHLORIDE: A peripheral vasodilator.
BOTULINUM TOXIN TYPE B: A neurotoxin used to treat cervical dystonia and other conditions.
OPIGOLIX: An experimental gonadotropin-releasing hormone (GnRH) antagonist.
4-METHOXYDALBERGIONE: A natural neoflavonoid compound.
NANOPARTICLE ALBUMIN-BOUND THIOCOLCHICINE DIMER NAB-5404: An experimental microtubule inhibitor formulation.
5,7-DIHYDROXYISOFLAVONE: A type of isoflavone.
SUTIMLIMAB: A monoclonal antibody that targets complement component C1s, used for cold agglutinin disease.
DUVORTUXIZUMAB: An experimental bispecific antibody.
PHOSMET: An organophosphate insecticide.
ROLUPERIDONE HYDROCHLORIDE: An experimental antipsychotic agent.
2,3,4-TRIHYDROXY-4'-ETHOXYBENZOPHENONE: A chemical compound, likely a UV absorber.
MK-8719: An experimental CETP inhibitor.
RONOMILAST: An experimental phosphodiesterase-4 (PDE4) inhibitor.
FLOXURIDINE: A chemotherapy agent, an antimetabolite.
VGX-100: An experimental immunomodulatory agent.
REMETINOSTAT: An experimental histone deacetylase (HDAC) inhibitor.
BRONTICTUZUMAB: An experimental monoclonal antibody that targets the Notch1 receptor.
IOPAMIDOL: A non-ionic, low-osmolality iodinated contrast agent used in medical imaging.
SELICICLIB: An experimental multi-cyclin-dependent kinase (CDK) inhibitor.
GARCINONE E: A natural xanthone compound from the mangosteen fruit.
TOTAROL: A natural phenol with antimicrobial properties.
OMEPRAZOLE: A proton pump inhibitor (PPI) used to treat GERD and peptic ulcers.
LEVDOBUTAMINE: The L-enantiomer of dobutamine, a sympathomimetic amine.
RAMATROBAN: A thromboxane A2 receptor antagonist.
GS-9256: An experimental antiviral drug for hepatitis C.
LEUKOTRIENE D4: A potent lipid mediator of inflammation.
L-765,314: A research chemical or compound identifier.
FUKINOLIC ACID: A natural phenolic compound.
GDC-0623: An experimental AKT inhibitor.
DICHLORVOS: An organophosphate insecticide.
ALVOCIDIB HYDROCHLORIDE: The hydrochloride salt of alvocidib, a CDK inhibitor.
CEP-11981: A research chemical or compound identifier.
NAN 190: A 5-HT1A receptor antagonist.
HARMAN-3-CARBOXYLIC ACID: A derivative of the beta-carboline alkaloid harman.
FENBUTATIN OXIDE: An acaricide (mite killer).
AL-78898A: A research chemical or compound identifier.
TLR-DIRECTED CATIONIC LIPID-DNA COMPLEX JVRS-100: An experimental immunotherapy agent.
ITRIGLUMIDE: A cholecystokinin receptor antagonist.
CHAETOCIN: A fungal metabolite with cytotoxic and antimicrobial properties.
MINOCYCLINE: A broad-spectrum tetracycline antibiotic.
HEPTANE: A straight-chain alkane hydrocarbon.
SAR100842: An experimental LPA1 receptor antagonist.
SOMATROGON: A long-acting recombinant human growth hormone.
CYCLOPIAZONIC ACID: A mycotoxin produced by fungi.
NIGULDIPINE: A calcium channel blocker.
1,2-NAPHTHOQUINONE: A chemical compound, a derivative of naphthalene.
AMINOGLUTETHIMIDE: An aromatase inhibitor that was used to treat Cushing's syndrome and breast cancer.
ZOTEPINE: An atypical antipsychotic.
DISULFOTON: An organophosphate insecticide.
PHENYLBUTYRYLHYDROXAMIC ACID: A research chemical or compound identifier.
XANTHINE: A purine base found in most human body tissues and fluids.
[3H]NGD941: A radiolabeled compound, likely a receptor ligand.
LERIDISTIM: An experimental agent that stimulates neutrophil production.
LOMEFLOXACIN: A fluoroquinolone antibiotic.
METHACYCLINE HYDROCHLORIDE: A tetracycline antibiotic.
SGN-30: An experimental monoclonal antibody that targets CD30.
HUPERZINE A: A natural alkaloid that acts as an acetylcholinesterase inhibitor.
FR-79620: A research chemical or compound identifier.
BENZOIC ACID: A simple aromatic carboxylic acid, used as a preservative.
EPHEDRINE: A sympathomimetic amine used as a stimulant and decongestant.
NEMONAPRIDE: An atypical antipsychotic that acts as a dopamine D2/D3 antagonist.
ATOSIBAN: An inhibitor of the hormones oxytocin and vasopressin, used to halt premature labor.
DIFLOMOTECAN: An experimental topoisomerase I inhibitor.
CAMOSTAT: A serine protease inhibitor used for pancreatitis.
MOTEXAFIN GADOLINIUM: An experimental photosensitizer and radiosensitizer.
DOLASETRON: A 5-HT3 receptor antagonist used as an antiemetic.
VICRIVIROC: An experimental CCR5 entry inhibitor for HIV.
NITRIC OXIDE: A gaseous signaling molecule involved in many physiological and pathological processes.
BERBAMINE: A natural bis-benzylisoquinoline alkaloid with various biological activities.
RILIMOGENE GALVACIREPVEC: An experimental cancer vaccine.
S-ETOMIDATE: The S-enantiomer of the anesthetic etomidate.
N-[2-(2-IODO-5-METHOXY-1H-INDOL-3-YL)ETHYL]ACETAMIDE: A chemical compound, likely a melatonin receptor ligand.
ABAGOVOMAB: An experimental anti-idiotype antibody vaccine for ovarian cancer.
PIXATIMOD: An experimental immunomodulatory agent that acts as a TLR9 agonist.
SITRAVATINIB: An experimental multi-kinase inhibitor targeting TAM and split-family kinases.
VITAMIN K3: Also known as menadione, a synthetic form of vitamin K.
ESTRADIOL VALERATE/DIENOGEST: A combination product used in hormonal contraception and hormone replacement therapy.
EUGENOL: A natural phenol found in clove oil, with antiseptic and analgesic properties.
CLANFENUR: A research chemical or compound identifier.
AMSACRINE HYDROCHLORIDE: The hydrochloride salt of amsacrine, a topoisomerase II inhibitor.
DULOXETINE HYDROCHLORIDE: A serotonin-norepinephrine reuptake inhibitor (SNRI) used as an antidepressant.
LOBEGLITAZONE: A thiazolidinedione (TZD) antidiabetic drug.
FASITIBANT CHLORIDE: An experimental bradykinin B2 receptor antagonist.
FUNAPIDE: An experimental Nav1.7 sodium channel blocker studied for pain.
N6022: An experimental inhibitor of the enzyme transglutaminase 2.
CONBERCEPT: A recombinant fusion protein that acts as a VEGF inhibitor, used for neovascular age-related macular degeneration.
IMD-1041: An experimental IKK-beta inhibitor.
ULOCUPLUMAB: An experimental monoclonal antibody that targets the CXCR4 receptor.
NESVACUMAB: An experimental monoclonal antibody that targets the angiopoietin-2 protein.
E-2212: A research chemical or compound identifier.
ELGEMTUMAB: An experimental monoclonal antibody.
NELIPEPIMUT-S: An experimental cancer vaccine.
ALCLOMETASONE: A topical corticosteroid.
QAX-576: An experimental monoclonal antibody that targets interleukin-13.
GEFAPIXANT: A P2X3 receptor antagonist used for the treatment of chronic cough.
IGN523: An experimental monoclonal antibody that targets the CD98 protein.
LIRILUMAB: An experimental monoclonal antibody that targets KIR receptors.
SAR-125844: An experimental bispecific antibody targeting MET and a vessel-specific antigen.
RISUTEGANIB: An experimental anti-integrin oligonucleotide studied for diabetic macular edema.
CIXUTUMUMAB: An experimental monoclonal antibody that targets the insulin-like growth factor 1 receptor (IGF-1R).
MAVATREP: A research chemical or compound identifier.
BIS(PIPERIDINYLTHIOCARBONYL)DISULFIDE: A chemical compound, also known as dipentamethylenethiuram tetrasulfide.
APTO-253: An experimental agent that induces the expression of the KLF4 tumor suppressor gene.
ORAL AZACITIDINE: An oral formulation of the chemotherapy agent azacitidine.
AZOXYSTROBIN: A broad-spectrum systemic fungicide.
NAKIJIQUINONES G: A marine natural product with biological activity.
IVABRADINE: A medication that lowers the heart rate, used for angina and heart failure.
3,4-DIMETHOXYBENZALDEHYDE: An organic compound, also known as veratraldehyde.
VITAMIN K3H2: A reduced form of vitamin K3.
TRIFLOXYSTROBIN: A strobilurin fungicide.
(+)-ALPHA-TOCOPHERYL SUCCINATE: A succinate ester of vitamin E.
LENVATINIB: A multi-kinase inhibitor used to treat various types of cancer.
ADP: Adenosine diphosphate, a key molecule in energy metabolism.
LEVOTHYROXINE: A manufactured form of the thyroid hormone thyroxine (T4).
ADIPHENINE: An antimuscarinic agent.
ANISODAMINE: An anticholinergic and antimuscarinic drug.
L-CYSTEINE SULPHINIC ACID: An intermediate in cysteine metabolism.
PIPERINE: The alkaloid responsible for the pungency of black pepper.
SCOPOLAMINE: An antimuscarinic drug used to treat motion sickness and postoperative nausea.
LEVOMEQUITAZINE: A second-generation antihistamine.
CHLORFENAPYR: An insecticide and acaricide.
RHODAMINE: A family of fluorescent dyes.
RILAPLADIB: An experimental inhibitor of the enzyme lipoprotein-associated phospholipase A2.
METARAMINOL: A sympathomimetic amine used to treat hypotension.
PHOSALONE: An organophosphate insecticide.
LIPOSOMAL MUC1/PET-LIPID A VACCINE ONT-10: An experimental therapeutic cancer vaccine.
TLC-388: A research chemical or compound identifier.
GSK-466317A: A research chemical or compound identifier.
OSU-03012: An experimental agent that inhibits PDK1 and induces apoptosis.
IPRIFLAVONE: A synthetic isoflavone used to inhibit bone resorption.
ISTRADEFYLLINE: An adenosine A2A receptor antagonist used as an add-on therapy for Parkinson's disease.
RAZUPROTAFIB: An experimental Tie2 receptor agonist.
FARLETUZUMAB: An experimental monoclonal antibody that targets the folate receptor alpha.
CEFUROXIME SODIUM: The sodium salt of the antibiotic cefuroxime.
MIRIDESAP: An experimental drug designed to remove serum amyloid P component.
M-1095: A research chemical or compound identifier.
FANGCHINOLINE: A natural bis-benzylisoquinoline alkaloid.
SULFAPHENAZOLE: An inhibitor of the CYP2C9 enzyme, used in research.
ONONIN: An isoflavone glycoside.
OXIDOPAMINE HYDROCHLORIDE: A neurotoxin used in research to selectively destroy dopaminergic and noradrenergic neurons.
PYRAZINOIC ACID: The active metabolite of the anti-tuberculosis drug pyrazinamide.
ZOMEPIRAC SODIUM: A non-steroidal anti-inflammatory drug (NSAID) that was withdrawn from the market.
BRYOSTATIN: A class of macrolide lactones with potent biological activities, including PKC modulation.
PH-797804: An experimental inhibitor of the p38 MAP kinase.
L-741,626: A selective dopamine D2 receptor antagonist.
DOBUTAMINE: A sympathomimetic amine used in the treatment of cardiogenic shock and severe heart failure.
HYDROXYFLUTAMIDE: The active metabolite of the antiandrogen drug flutamide.
PEGAPTANIB: A VEGF inhibitor used to treat neovascular age-related macular degeneration.
PROPYLHEXEDRINE: A sympathomimetic amine used as a nasal decongestant.
SOTIGALIMAB: An experimental monoclonal antibody that targets the CD40 receptor.
LIOTHYRONINE SODIUM: The sodium salt of liothyronine, a synthetic thyroid hormone T3.
VABICASERIN: An experimental 5-HT2C receptor agonist that was studied for obesity and schizophrenia.
VOLINANSERIN: A selective 5-HT2A receptor inverse agonist.
SOTAGLIFLOZIN: A dual inhibitor of SGLT1 and SGLT2, studied for diabetes.
REPARIXIN: An experimental inhibitor of the CXCR1/CXCR2 chemokine receptors.
CILOSTAMIDE: A potent inhibitor of the phosphodiesterase 3 (PDE3) enzyme.
CPP-115: An experimental GABA aminotransferase inactivator.
UTOMILUMAB: An experimental monoclonal antibody that targets the 4-1BB (CD137) receptor.
LP-211: A potent and selective 5-HT7 receptor agonist.
REPINOTAN: An experimental 5-HT1A receptor agonist.
[3H]GR 125,743: A radiolabeled selective 5-HT1D receptor antagonist.
5-BODMT: A research chemical or compound identifier.
MK-212: A 5-HT2C receptor agonist.
RS-127445: A selective 5-HT2B receptor antagonist.
DIPROPYL-5-CT: A research chemical, a 5-HT receptor agonist.
COMPOUND 2E [PMID: 31900320]: An experimental compound described in the specified publication.
PHT-427: An experimental dual inhibitor of AKT and PDK1.
SILODOSIN: A selective alpha-1A adrenergic receptor antagonist used to treat benign prostatic hyperplasia.
BENAZEPRIL: An ACE inhibitor used to treat high blood pressure.
AZELAPRAG: An experimental prostacyclin receptor agonist.
CYCLOUREA APELIN-12 (1-7): A research chemical or compound identifier.
ASC06-IGG1: An experimental monoclonal antibody.
2(S)-AMINO-6-BORONOHEXANOIC ACID: An inhibitor of the enzyme arginase.
BRADANICLINE: An experimental neuronal nicotinic acetylcholine receptor partial agonist.
A-317567: A research chemical, an A1 adenosine receptor antagonist.
JNJ-799760: A research chemical or compound identifier.
COMPOUND 10 [PMID: 31306001]: An experimental compound described in the specified publication.
MRS1086: A research chemical or compound identifier.
CPX: An abbreviation, possibly for a research compound like 8-Cyclopentyl-1,3-dipropylxanthine.
ATL802: A research chemical or compound identifier.
COMPOUND 6C [PMID: 34435786]: An experimental compound described in the specified publication.
PD-169316: A potent inhibitor of the p38 MAP kinase.
DPCPX: A potent and selective adenosine A1 receptor antagonist.
ZILEUTON: An inhibitor of 5-lipoxygenase, used for the maintenance treatment of asthma.
DUBERMATINIB: An experimental multi-kinase inhibitor.
INDACATEROL: An ultra-long-acting beta-2 adrenergic agonist (ultra-LABA) used for COPD.
TERBUTALINE: A short-acting beta-2 adrenergic receptor agonist used as a bronchodilator.
OLODATEROL: An ultra-long-acting beta-2 adrenergic agonist (ultra-LABA) used for COPD.
SULMAZOLE: An experimental cardiotonic agent.
12-HYDROXYHEPTADECATRIENOIC ACID: A lipid molecule involved in inflammatory processes.
TERTATOLOL: A beta-adrenergic receptor antagonist (beta-blocker).
COMPOUND 6 [PMID: 34333981]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
BAY-069: A research chemical or compound identifier.
SB290157: A potent and selective antagonist of the C3a receptor.
PROPACHLOR: An herbicide.
COMPOUND 4 [PMID: 12408711]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
RONACALERET: An experimental calcium-sensing receptor antagonist.
ZAMIFENACIN: A selective M3 muscarinic receptor antagonist.
ICATCXPZ-01: A research chemical or compound identifier.
COMPOUND 3 [PMID: 8410973]: An experimental compound described in a 1993 publication.
OPICAPONE: A COMT inhibitor used as an add-on therapy for Parkinson's disease.
GAT211: A research chemical, a positive allosteric modulator of the alpha-7 nicotinic receptor.
JD5037: An experimental peripherally restricted cannabinoid CB1 receptor inverse agonist.
N-OLEOYLDOPAMINE: An endogenous lipid that acts on TRPV1 and cannabinoid receptors.
SINCALIDE: A synthetic C-terminal fragment of cholecystokinin, used as a diagnostic aid.
CCK-33: Cholecystokinin-33, a peptide hormone.
CCL7: A small cytokine belonging to the CC chemokine family, also known as MCP-3.
UCB35625: A research chemical or compound identifier.
PF-07054894: A research chemical or compound identifier.
BMS-753426: A research chemical or compound identifier.
LILOTOMAB: An experimental monoclonal antibody that targets CD37.
OSAJIN: A natural isoflavone compound.
INOTUZUMAB OZOGAMICIN: An antibody-drug conjugate that targets CD22, used for acute lymphoblastic leukemia.
ACETAMINOPHEN: A widely used over-the-counter analgesic and antipyretic, also known as paracetamol.
JNJ-10311795: A research chemical or compound identifier.
TELAPREVIR: An antiviral drug used for the treatment of hepatitis C.
SGC2085: A research chemical or compound identifier.
CABIRALIZUMAB: An experimental monoclonal antibody that targets CSF1R.
JNJ-28312141: A research chemical or compound identifier.
(R)-ARN2508: A research chemical or compound identifier.
FENOPROFEN: A non-steroidal anti-inflammatory drug (NSAID).
TANSHINONE I: A natural compound from Salvia miltiorrhiza with various biological activities.
ETODOLAC: A non-steroidal anti-inflammatory drug (NSAID).
ASTRESSIN 2B: A potent and selective antagonist of the CRF2 receptor.
2-({6-[(3-CHLOROPHENYL)AMINO]-9-ISOPROPYL-9H-PURIN-2-YL}AMINO)ETHANOL: A chemical compound, likely a specific kinase inhibitor.
COMPOUND 4 [PMID: 26191369]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
(S)-DRF-1042: A research chemical or compound identifier.
LY3154885: A research chemical or compound identifier.
SKF-83566: A selective dopamine D1 receptor antagonist.
AG 9: A research chemical, a tyrosine kinase inhibitor.
AZ5104: An experimental EGFR kinase inhibitor.
EXAMPLE 10 [CN110740999A]: A specific chemical compound described in a Chinese patent application.
DUAL SEH/FAAH INHIBITOR 11: An experimental compound that inhibits both sEH and FAAH enzymes.
STREPTONIGRIN: An antibiotic with potent anticancer activity.
CARBACYCLIN: A stable analogue of prostacyclin.
TGF&ALPHA;: Transforming growth factor alpha, a protein that stimulates cell proliferation.
CLOPROSTENOL: A synthetic analogue of prostaglandin F2-alpha, used in veterinary medicine.
BMS-345541: A highly selective inhibitor of the IKK kinase.
MUBRITINIB: An experimental tyrosine kinase inhibitor that targets HER2.
PIROTINIB: A research chemical or compound identifier.
BETACELLULIN: A protein that is a ligand for the EGFR family of receptors.
FENOFIBRATE MICRONIZED: A formulation of the fibrate drug fenofibrate with smaller particle size.
CLAZOSENTAN: An experimental endothelin receptor antagonist.
APROCITENTAN: An experimental dual endothelin receptor antagonist.
CILOFEXOR: An experimental non-steroidal FXR agonist.
22R-HYDROXYCHOLESTEROL: An oxysterol, a metabolite of cholesterol.
ASPARTIC ACID: An amino acid that is used by the body to make proteins.
[3H]D-ASPARTIC ACID: A radiolabeled form of D-aspartic acid.
LB42908: A research chemical or compound identifier.
MINODRONIC ACID: A potent bisphosphonate drug used to treat osteoporosis.
[3H]GABAZINE: A radiolabeled form of gabazine, a GABAA receptor antagonist.
TPA023: An experimental compound that acts as a partial agonist at the benzodiazepine site of the GABAA receptor.
RY024: A research chemical or compound identifier.
&ALPHA;3IA: A research chemical or compound identifier.
[3H]CGS8216: A radiolabeled benzodiazepine receptor antagonist.
ANISINDIONE: An anticoagulant that functions as a vitamin K antagonist.
SOMATORELIN: A synthetic form of growth hormone-releasing hormone.
BIM28011: A research chemical or compound identifier.
FLUORO-WILLARDIINE: A selective AMPA receptor agonist.
FOSDAGROCORAT: An experimental selective glucocorticoid receptor agonist.
[3H]DIZOCILPINE: A radiolabeled form of dizocilpine (MK-801), a non-competitive NMDA receptor antagonist.
[3H]CGS19755: A radiolabeled competitive NMDA receptor antagonist.
[125I][TYR5,DALA6,NMELEU7,PRO9-NET]GNRH: A complex, radiolabeled peptide analogue of GnRH.
D-PHENYLALANINE: An enantiomer of the amino acid phenylalanine.
(R)-N-OLEOYLTYROSINOL: A research chemical or compound identifier.
LYSOPHOSPHATIDYLINOSITOL: A class of signaling lipid molecules.
2-ARACHIDONOYLGLYCEROLPHOSPHOINOSITOL: A research chemical or compound identifier.
SPHINGOSINE 1-PHOSPHATE: A bioactive signaling lipid molecule.
CARTPT (76-96): A peptide fragment of the CART (cocaine- and amphetamine-regulated transcript) peptide.
DIM: Diindolylmethane, a compound derived from the digestion of indole-3-carbinol.
KI16425: A potent antagonist of the LPA1 and LPA3 receptors.
EUPAFOLIN: A natural flavone with anti-inflammatory and other properties.
ZABEDOSERTIB: An experimental dual inhibitor of PI3K delta and PI3K gamma.
GLPG2534: A research chemical or compound identifier.
ANIFROLUMAB: A monoclonal antibody that targets the type I interferon receptor, used for lupus.
DACLIZUMAB: A monoclonal antibody that targets the CD25 receptor, used for multiple sclerosis.
NARINGENIN: A flavonoid found in grapefruit and other citrus fruits.
3-METHYLHEXANAL: A chemical compound, a type of aldehyde.
ALLOIN: A natural compound found in the aloe plant.
BRIVARACETAM: An anticonvulsant medication used to treat epilepsy.
DEURUXOLITINIB: An experimental JAK inhibitor.
S6821: A research chemical or compound identifier.
AZ960: An experimental Janus kinase (JAK) inhibitor.
XL019: A research chemical or compound identifier.
PF-06263276: A research chemical or compound identifier.
SOLCITINIB: An experimental Janus kinase (JAK) inhibitor.
SAR-20347: A research chemical or compound identifier.
IVARMACITINIB: An experimental Janus kinase (JAK) inhibitor.
JAK INHIBITOR 17B: A specific chemical inhibitor of Janus kinases used in research.
COMPOUND 3 [PMID: 23849879]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
PIRETANIDE: A loop diuretic used to treat hypertension and edema.
AZD4625: An experimental inhibitor of the BCL-2 and BCL-XL proteins.
CHLOROFORM: An organic compound, historically used as an anesthetic.
P05: A research chemical or compound identifier.
&GAMMA;-KTX1.7: A peptide toxin that blocks potassium channels.
RY796: A research chemical or compound identifier.
DPO-1: A potent and selective blocker of the Kv1.5 potassium channel.
FARNESYL MONOPHOSPHATE: An intermediate in the biosynthesis of isoprenoids.
PP-242: A potent and selective inhibitor of the mTOR kinase.
DENFIVONTINIB: An experimental FGFR inhibitor.
COMPOUND 14 [PMID: 23634668]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 22A [PMID: 21688779]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
VU0361737: A positive allosteric modulator of the mGluR4 receptor.
CHPG: A selective agonist for the group I metabotropic glutamate receptors.
TEZACAFTOR: A CFTR protein corrector used in combination for cystic fibrosis.
(S)-3,4-DCPG: A potent and selective agonist for the group I metabotropic glutamate receptors.
COMPOUND 14 [PMID: 34333981]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
PCC0208017: A research chemical or compound identifier.
MPPG: A selective antagonist of the group II metabotropic glutamate receptors.
CORTICOSTERONE: A corticosteroid hormone produced by the adrenal cortex.
LONIDAMINE: An experimental anticancer agent that inhibits glycolysis in tumor cells.
ETEPLIRSEN: An antisense oligonucleotide used to treat Duchenne muscular dystrophy with specific mutations.
JNK INHIBITOR V: A specific chemical inhibitor of the JNK kinase used in research.
ULIXERTINIB: An experimental ERK1/2 kinase inhibitor.
GNE-8505: A research chemical or compound identifier.
CM-352: A research chemical or compound identifier.
AZD6605: A research chemical or compound identifier.
SR-0813: A research chemical or compound identifier.
COMPOUND 15 [PMID: 22017539]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE: A complex chemical name, likely a specific receptor ligand or enzyme inhibitor.
VU0255035: A positive allosteric modulator of the mGluR4 receptor.
UCM 454: A research chemical or compound identifier.
GR 128107: A research chemical or compound identifier.
S26131: A research chemical or compound identifier.
ICOA-13: A research chemical or compound identifier.
LY 156735: A selective estrogen receptor modulator (SERM).
BMS-986124: An experimental LPA1 receptor antagonist.
NALTRINDOLE: A potent and selective delta-opioid receptor antagonist.
VENLAFAXINE: A serotonin-norepinephrine reuptake inhibitor (SNRI) used as an antidepressant.
GW-2580: A selective inhibitor of the CSF1R kinase.
[3H]CYTISINE: A radiolabeled form of cytisine, a nicotinic acetylcholine receptor partial agonist.
R396: A research chemical or compound identifier.
NEPADUTANT: An experimental neurokinin-2 (NK2) receptor antagonist.
R-486: A research chemical or compound identifier.
NEUROPEPTIDE S: A neuropeptide that regulates arousal and anxiety.
SR142948A: An experimental neurotensin receptor antagonist.
VONLEROLIZUMAB: An experimental monoclonal antibody that targets the CD40 receptor.
COMPOUND 3 [PMID: 26191365]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
FRAX486: An experimental inhibitor of the PAK1 kinase.
SB-334867: A selective orexin-1 receptor antagonist.
BZATP: A potent agonist for the P2X7 purinergic receptor.
2MESATP: A stable analogue of ATP, used as a P2Y receptor agonist.
BX 667: A research chemical or compound identifier.
DIQUAFOSOL: A P2Y2 receptor agonist used in eye drops to treat dry eye disease.
MRS2693: A potent and selective agonist of the P2Y6 purinergic receptor.
[125I][AC-HIS1]PACAP-27: A radioiodinated form of the peptide PACAP.
8S-HETE: A lipid mediator involved in inflammation.
[3H]-LKP: A radiolabeled compound, likely a receptor ligand.
EGANELISIB: An experimental PI3K delta inhibitor.
PF-07038124: A research chemical or compound identifier.
APREMILAST: A phosphodiesterase-4 (PDE4) inhibitor used to treat psoriasis and psoriatic arthritis.
TRANEXAMIC ACID: An antifibrinolytic agent used to treat or prevent excessive blood loss.
IACS-9439: An experimental agent that inhibits the mitochondrial electron transport chain complex I.
PDGF RTK INHIBITOR: A class of drugs that inhibit platelet-derived growth factor receptor tyrosine kinases.
AG14361: A research chemical or compound identifier.
ETC-1922159: An experimental inhibitor of the Wnt signaling pathway.
CHORIOMAMMOTROPIN: A hormone produced by the placenta, also known as human placental lactogen.
PEPTIDE 18 [PMID: 24350995]: A specific peptide ligand for a receptor, as described in the publication.
DS-437: A research chemical or compound identifier.
TILFRINIB: An experimental multi-kinase inhibitor.
TEGEPROTAFIB: An experimental Tie2 receptor agonist.
COMPOUND 8A [PMID: 23713581]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
RIPK2 INHIBITOR 5: A specific chemical inhibitor of the RIPK2 kinase used in research.
FOLIC ACID: A form of Vitamin B9, an essential nutrient.
(5Z)-1-(2-FLUOROPHENYL)-2-SULFANYLIDENE-5-(THIOPHEN-2-YLMETHYLIDENE)-1,3-DIAZINANE-4,6-DIONE: A complex chemical name, likely a specific enzyme inhibitor.
RGS4 INHIBITOR 11B: A specific chemical inhibitor of the RGS4 protein.
CD666: A research chemical or compound identifier.
CCG-50014: An inhibitor of Rho/MKL/SRF-mediated gene transcription.
SR8278: An antagonist of the nuclear receptor Rev-ErbA.
EUROPIUM-LABELLED RELAXIN-3-B/INSL5 A CHIMERA: A labeled peptide used in binding assays.
JK1: A research chemical or compound identifier.
GLUTAMINE: An amino acid that is a building block of protein.
PURMORPHAMINE: A potent agonist of the Smoothened receptor in the Hedgehog signaling pathway.
MARALIXIBAT: An ileal bile acid transporter (IBAT) inhibitor used to treat cholestatic pruritus.
MRT-92: A research chemical or compound identifier.
TAK-020: An experimental CCR5 antagonist.
FLIBANSERIN: A medication used for the treatment of pre-menopausal women with hypoactive sexual desire disorder.
BIM 23068: A research chemical, a somatostatin receptor ligand.
[125I]LTT-SRIF-28: A radioiodinated form of the peptide somatostatin-28.
CORTISTATIN-14: An endogenous neuropeptide with various physiological roles.
SRIF-14: Somatostatin-14, a peptide hormone that regulates the endocrine system.
AZ6102: An experimental inhibitor of the kinase Plk1.
RO5166017: A research chemical or compound identifier.
ROMIPLOSTIM: A thrombopoietin receptor agonist used to treat thrombocytopenia.
RALTEGRAVIR POTASSIUM: The potassium salt of raltegravir, an integrase inhibitor for HIV.
FLUPROSTENOL: A synthetic analogue of prostaglandin F2-alpha, used in veterinary medicine.
ICI 192605: A potent and selective antagonist of the thromboxane receptor.
A-967079: A potent and selective blocker of the TRPA1 ion channel.
SKF96365: A non-specific inhibitor of store-operated calcium entry.
BTD: An abbreviation, possibly for a research compound.
S-RHTX: A research chemical or compound identifier.
GABEXATE: A serine protease inhibitor used for pancreatitis.
[BZ-PHE6]U-II (HUMAN): A synthetic analogue of the peptide urotensin-II.
ZK159222: A research chemical or compound identifier.
F180: A research chemical or compound identifier.
SSR126768A: An experimental neurotensin receptor 1 antagonist.
D[VAL4,DARG8]VP: A synthetic analogue of vasopressin.
[3H]DDAVP: A radiolabeled form of desmopressin, a vasopressin analogue.
OH-LVA: A research chemical or compound identifier.
ENOXACIN: A broad-spectrum fluoroquinolone antibiotic.
NPY-(13-36) (PIG): A peptide fragment of Neuropeptide Y.
ALK INHIBITOR TAE684: A potent and selective inhibitor of the ALK kinase.
PAN-RAF INHIBITOR LY3009120: A broad-spectrum inhibitor of RAF kinases.
WARFARIN: An anticoagulant that functions as a vitamin K antagonist.
OICR-9429: An experimental inhibitor of the WDR5 protein.
AEE788: An experimental dual inhibitor of the EGFR and HER2 tyrosine kinases.
ENZASTAURIN: An experimental inhibitor of protein kinase C beta.
QUERCETIN: A flavonoid found in many plants, with antioxidant and anti-inflammatory properties.
OSUGACESTAT: An experimental gamma-secretase inhibitor that was studied for Alzheimer's disease.
BUTHIONINE SULFOXIMINE: An inhibitor of glutathione synthesis.
EPRENETAPOPT: An experimental agent that reactivates mutant p53 protein.
RAF INHIBITOR BDTX-4933: An experimental inhibitor of the RAF kinase.
FICERAFUSP ALFA: An experimental fusion protein.
ANTI-PD-L1/CD27 BISPECIFIC ANTIBODY CDX-527: An experimental bispecific antibody for cancer immunotherapy.
TORIPALIMAB-TPZI: A monoclonal antibody that targets the PD-1 immune checkpoint receptor.
TALETRECTINIB: A next-generation tyrosine kinase inhibitor that targets ROS1 and NTRK.
MOGAMULIZUMAB: A monoclonal antibody that targets the CCR4 receptor, used for certain types of lymphoma.
KADCYLA: A brand name for ado-trastuzumab emtansine, an antibody-drug conjugate.
APG-2575: An experimental BCL-2 inhibitor.
RAMUCIRUMAB: A monoclonal antibody that targets the VEGFR2 receptor, used for various cancers.
RIGOSERTIB: An experimental inhibitor of the Polo-like kinase 1 (Plk1).
ENOTICUMAB: An experimental monoclonal antibody that targets the DLL4 protein.
NOTCH SIGNALING PATHWAY INHIBITOR MK0752: An experimental inhibitor of the Notch signaling pathway.
2-TERT-BUTYL-9-FLUORO-1,6-DIHYDROBENZO[H]IMIDAZO[4,5-F]ISOQUINOLIN-7-ONE: A complex chemical name, likely a specific kinase inhibitor.
P53-HDM2 INTERACTION INHIBITOR MI-773: An experimental agent that disrupts the p53-MDM2 interaction.
TRILACICLIB: A CDK4/6 inhibitor used to decrease chemotherapy-induced myelosuppression.
ZIDESAMTINIB: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
AZD1390: An experimental inhibitor of the ATM kinase.
TRIFLURIDINE: A nucleoside analog used in combination with tipiracil for colorectal cancer.
M8891: A research chemical or compound identifier.
NIFURALDEZONE: An antibacterial agent.
EXAMPLE 373 [WO2012093101]: A specific chemical compound described in a patent application.
IGURATIMOD: A disease-modifying antirheumatic drug (DMARD) used in Japan and China.
DICLOFENAC EPOLAMINE: A topical formulation of the NSAID diclofenac.
BEMPEGALDESLEUKIN: An experimental immunotherapy agent, a pegylated form of interleukin-2.
PI-HEXATOXIN-HI1A: A peptide toxin from spider venom.
NARAZACICLIB: An experimental cyclin-dependent kinase (CDK) inhibitor.
TISLELIZUMAB: A monoclonal antibody that targets the PD-1 immune checkpoint receptor.
OFLOXACIN: A broad-spectrum fluoroquinolone antibiotic.
VORAPAXAR: An antiplatelet agent that acts as a PAR-1 antagonist.
ABEDITEROL: An experimental long-acting beta-2 adrenergic agonist.
IMMEPIP: A potent and selective histamine H3 receptor antagonist.
PEXIDARTINIB: A CSF1R kinase inhibitor used for the treatment of tenosynovial giant cell tumor.
[125I]TYR3 SMS 201-995: A radioiodinated form of octreotide, a somatostatin analog.
MILNACIPRAN: A serotonin-norepinephrine reuptake inhibitor (SNRI) used for fibromyalgia.
LURASIDONE HYDROCHLORIDE: An atypical antipsychotic used to treat schizophrenia and bipolar depression.
CHLOROQUINE: A medication used to prevent and treat malaria.
OXYTETRACYCLINE HYDROCHLORIDE: The hydrochloride salt of the antibiotic oxytetracycline.
RASBURICASE: An enzyme used to lower uric acid levels in patients receiving chemotherapy.
RS-504393: A potent and selective antagonist of the CCR2 chemokine receptor.
LEVOMETHADONE: The L-enantiomer of methadone, an opioid analgesic.
TENIPOSIDE: A topoisomerase II inhibitor used in chemotherapy.
URIDINE: A nucleoside that is a component of RNA.
EFLORNITHINE: A medication used to treat sleeping sickness and to reduce unwanted facial hair.
GENZ-644282: An experimental topoisomerase I inhibitor.
NP118809: A research chemical or compound identifier.
RO19-4603: A research chemical or compound identifier.
LOMITAPIDE MESYLATE: A medication used to treat homozygous familial hypercholesterolemia.
ETELCALCETIDE: A calcimimetic used to treat secondary hyperparathyroidism.
AN0128: A research chemical or compound identifier.
NEUROTENSIN: A neuropeptide involved in the regulation of dopamine pathways.
PRT-2607: A research chemical or compound identifier.
PF-05212377: An experimental monoclonal antibody that targets the PCSK9 protein.
K185: A research chemical or compound identifier.
AMATUXIMAB: An experimental monoclonal antibody that targets the 5T4 antigen.
ABBV-318: A research chemical or compound identifier.
JFD00064: A research chemical or compound identifier.
SJB2-043: A research chemical or compound identifier.
CAPTOPRIL: An ACE inhibitor used to treat high blood pressure and congestive heart failure.
BAMBUTEROL: A long-acting beta-2 adrenergic agonist (LABA) used for asthma.
FLURBIPROFEN: A non-steroidal anti-inflammatory drug (NSAID).
ONCOLYSIN M: A research chemical or compound identifier.
SB 203186: A research chemical or compound identifier.
NIROGACESTAT: An experimental gamma-secretase inhibitor.
OXALIPLATIN: A platinum-based chemotherapy drug used to treat colorectal cancer.
POLIDOCANOL: A sclerosing agent used to treat varicose veins.
W146: An antagonist of the sphingosine-1-phosphate receptor 1 (S1P1).
AF353: A research chemical or compound identifier.
MORPHANTHRIDINE: A chemical compound forming the core of some drugs.
CAMRELIZUMAB: A monoclonal antibody that targets the PD-1 immune checkpoint receptor.
LADOSTIGIL: An experimental drug that was studied for Alzheimer's disease.
ENDRIN: An organochlorine insecticide that has been banned globally.
DIPROTIN A: An inhibitor of the enzyme dipeptidyl peptidase-4 (DPP-4).
THERAPEUTIC ANDROGEN: A general class of androgen hormones used for medical treatment.
ZELASUDIL: A research chemical or compound identifier.
BETRIXABAN: An anticoagulant that acts as a direct factor Xa inhibitor.
COMPOUND 33 [TODA ET AL., 2013]: A specific chemical compound described in a 2013 publication by Toda et al.
GB110: A research chemical or compound identifier.
DANTROLENE: A postsynaptic muscle relaxant used to treat malignant hyperthermia and spasticity.
CJ13610: A research chemical or compound identifier.
COMPOUND 21 [PMID: 19191557]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
BIM 23313: A research chemical or compound identifier.
ICT-121 DENDRITIC CELL VACCINE: An experimental cancer vaccine.
AG 112: A research chemical or compound identifier.
TAMRLX: A research chemical or compound identifier.
IMETELSTAT: An experimental telomerase inhibitor.
MECHLORETHAMINE: A nitrogen mustard alkylating agent used in chemotherapy.
DIZOCILPINE: A non-competitive NMDA receptor antagonist, also known as MK-801.
NELOTANSERIN: An experimental 5-HT2A receptor inverse agonist.
ZEARALANONE: A synthetic non-steroidal estrogen.
VITAMIN K: A group of fat-soluble vitamins that play a role in blood clotting.
LIGELIZUMAB: An experimental monoclonal antibody that targets IgE.
PERAKIZUMAB: An experimental monoclonal antibody that targets interleukin-13.
URSODIOL: A bile acid used to treat gallstones and primary biliary cholangitis.
EXENATIDE: A GLP-1 receptor agonist used to treat type 2 diabetes.
ACALISIB: An experimental PI3K delta inhibitor.
DOLASTATIN 10: A potent natural antimitotic peptide.
(12E,20Z,18S)-8-HYDROXYVARIABILIN: A marine natural product with biological activity.
AUTOLOGOUS ANTI-CD19CAR-4-1BB-CD3ZETA-EGFRT-EXPRESSING T LYMPHOCYTES: A specific formulation of CAR-T cell therapy.
NU-7441: A potent and selective inhibitor of the DNA-dependent protein kinase (DNA-PK).
NF546: A research chemical, an antagonist of the P2Y11 receptor.
[111IN]DOTA-NOC: A radiolabeled somatostatin analog used in medical imaging.
[3H]WIN55212-2: A radiolabeled form of the cannabinoid receptor agonist WIN55212-2.
TENELIXIMAB: An experimental monoclonal antibody that targets the CD40 receptor.
PRX-03140: An experimental 5-HT4 receptor agonist that was studied for Alzheimer's disease.
FLECAINIDE ACETATE: An antiarrhythmic medication.
L-363,301: A research chemical or compound identifier.
ELIMUSERTIB: An experimental ATR kinase inhibitor.
EMATE: A research chemical or compound identifier.
LYSOZYME: An enzyme that damages bacterial cell walls, found in tears, saliva, and mucus.
PENICILLIN V: A narrow-spectrum beta-lactam antibiotic.
TERLIPRESSIN: A vasopressin analogue used to treat esophageal variceal bleeding.
RUBITECAN: An experimental topoisomerase I inhibitor.
SLX-4090: An experimental inhibitor of the MTP protein, studied for hyperlipidemia.
SIRTRATUMAB VEDOTIN: An experimental antibody-drug conjugate.
NORETHINDRONE: A progestin used in hormonal contraceptives and hormone replacement therapy.
BISOPROLOL: A selective beta-1 blocker used to treat hypertension and heart disease.
PAROMOMYCIN SULFATE: An aminoglycoside antibiotic used to treat intestinal infections.
RECOMBINANT RANTES: A manufactured form of the chemokine CCL5 (RANTES).
ACETYLDIGOXIN: A cardiac glycoside, a derivative of digoxin.
EXARAFENIB: An experimental RAF kinase inhibitor.
AMIODARONE HYDROCHLORIDE: A potent antiarrhythmic medication.
SAVIRIN: A research chemical or compound identifier.
PIMOZIDE: A typical antipsychotic of the diphenylbutylpiperidine class.
CEAROIN: A research chemical or compound identifier.
SIMTUZUMAB: An experimental monoclonal antibody that targets the LOXL2 enzyme.
TAK-070: A research chemical or compound identifier.
THIORPHAN: The active metabolite of the enkephalinase inhibitor racecadotril.
DEMECARIUM BROMIDE: A long-acting cholinesterase inhibitor used in eye drops for glaucoma.
AFASEVIKUMAB: An experimental monoclonal antibody.
ORTERONEL: An experimental inhibitor of the enzyme CYP17A1, studied for prostate cancer.
L-694,247: A potent and selective 5-HT1D receptor agonist.
FLX475: An experimental CCR4 antagonist for cancer immunotherapy.
RUSERONTINIB: An experimental JAK inhibitor.
BARASERTIB: An experimental Aurora kinase B inhibitor.
PHENYLPROPANOLAMINE POLISTIREX: An extended-release formulation of phenylpropanolamine, a decongestant and anorectic.
BRAF(V600E) KINASE INHIBITOR ABM-1310: An experimental inhibitor of the BRAF V600E mutated kinase.
IMIPENEM ANHYDROUS: The anhydrous form of imipenem, a broad-spectrum carbapenem antibiotic.
CORDYCEPIN: A derivative of the nucleoside adenosine, with various biological activities.
PF-04634817: A research chemical or compound identifier.
GÃ– 6976: A potent inhibitor of several protein kinases, including PKC.
GLUTAMIC ACID: An amino acid that functions as a major excitatory neurotransmitter.
COLTUXIMAB RAVTANSINE: An experimental antibody-drug conjugate targeting CD19.
GAMMA-INTERFERON: A cytokine that is critical for innate and adaptive immunity.
SPARSENTAN: A dual endothelin and angiotensin receptor antagonist.
OZARELIX: An experimental gonadotropin-releasing hormone (GnRH) antagonist.
RECOMBINANT CHEMOKINE: A general class of manufactured chemokine proteins.
PONATINIB: A multi-target tyrosine kinase inhibitor used to treat leukemia, particularly with the T315I mutation.
PERGOLIDE: A dopamine receptor agonist that was used to treat Parkinson's disease.
YM-543: A research chemical or compound identifier.
RIVOCERANIB: A potent VEGFR2 tyrosine kinase inhibitor, also known as apatinib.
RG-2833: An experimental histone deacetylase (HDAC) inhibitor.
RU 24969: A potent 5-HT1A/1B receptor agonist.
FX06: An experimental peptide that was studied for its anti-inflammatory effects.
BEVACIZUMAB-AWWB: A biosimilar of bevacizumab, a monoclonal antibody that targets VEGF.
TIDEGLUSIB: An experimental inhibitor of the enzyme GSK-3.
NEUROMEDIN U-8: A neuropeptide with various physiological roles.
POSDINEMAB: An experimental monoclonal antibody.
MYRCLUDEX B: A medication that blocks the entry of hepatitis B and D viruses into liver cells.
FIRSOCOSTAT: An experimental ACC inhibitor.
QUIN-C7: A research chemical or compound identifier.
COMPOUND 11J [PMID: 23021994]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
TRULI: A research chemical or compound identifier.
SARUPARIB: An experimental PARP inhibitor.
NEOSTIGMINE BROMIDE: A reversible cholinesterase inhibitor used to treat myasthenia gravis.
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN: A radiopharmaceutical targeting the PSMA protein.
PS020990: A research chemical or compound identifier.
R121919: An experimental corticotropin-releasing factor receptor 1 antagonist.
4',7-DIMETHOXY-5-HYDROXYGENISTEIN: A natural isoflavone compound.
HSP90 INHIBITOR LAM-003A: An experimental inhibitor of the Hsp90 protein.
SOLITOMAB: An experimental bispecific T-cell engager (BiTE) antibody targeting EpCAM and CD3.
1'-ACETOXYCHAVICOL ACETATE: A natural compound with anticancer properties.
AGANIRSEN: An experimental antisense oligonucleotide that targets the insulin receptor substrate-1.
RO4929097: An experimental gamma-secretase inhibitor.
PEMETREXED DISODIUM: The disodium salt of pemetrexed, a chemotherapy agent.
JAK2 INHIBITOR AZD1480: An experimental inhibitor of the Janus kinase 2.
LY-2780301: A research chemical or compound identifier.
1-STEAROYL-LYSOPHOSPHATIDYLCHOLINE: A type of lysophospholipid.
ABNORMAL CANNABIDIOL: A synthetic regioisomer of cannabidiol.
HYDROXYPROGESTERONE: A steroid hormone.
PRACTOLOL: A selective beta-1 blocker that was withdrawn from the market.
N-OLEOYLETHANOLAMIDE: An endogenous lipid that acts as a signaling molecule.
AZD-4547: A potent and selective inhibitor of the FGFR tyrosine kinase.
DNPA: A research chemical, a selective NMDA receptor antagonist.
LOVASTATIN: A statin drug used to lower cholesterol.
URAPIDIL: An antihypertensive agent that acts as an alpha-1 antagonist and 5-HT1A agonist.
OLARATUMAB: An experimental monoclonal antibody that targets the PDGFR-alpha receptor.
TRICHLORMETHIAZIDE: A thiazide diuretic used to treat hypertension and edema.
TEBENTAFUSP: A bispecific fusion protein used to treat uveal melanoma.
MOMETASONE: A synthetic corticosteroid used topically and as an inhaler.
OXYPHENCYCLIMINE HYDROCHLORIDE: An antimuscarinic agent.
ARGATROBAN: A direct thrombin inhibitor used as an anticoagulant.
QUINAPRIL HYDROCHLORIDE: An ACE inhibitor used to treat high blood pressure.
BIPERIDEN HYDROCHLORIDE: An anticholinergic agent used to treat Parkinson's disease.
NERVE GROWTH FACTOR: A neurotrophic factor that regulates the growth and survival of neurons.
RIZATRIPTAN BENZOATE: A triptan drug used for the acute treatment of migraine.
METHANTHELINE BROMIDE: An antimuscarinic agent.
INSULIN LISPRO PROTAMINE RECOMBINANT: An intermediate-acting insulin formulation.
PHENTERMINE RESIN: An extended-release formulation of phentermine, an appetite suppressant.
ATOMOXETINE HYDROCHLORIDE: A norepinephrine reuptake inhibitor used to treat ADHD.
TAPENTADOL HYDROCHLORIDE: An opioid pain medication.
ETONOGESTREL: A progestin used in hormonal contraceptives.
CODEINE PHOSPHATE: The phosphate salt of codeine, an opioid medication.
TP3 IMMUNOTOXIN: An experimental immunotoxin.
EFLORNITHINE HYDROCHLORIDE: The hydrochloride salt of eflornithine, used for sleeping sickness.
ENALAPRIL MALEATE: An ACE inhibitor used to treat high blood pressure and heart failure.
DIRITHROMYCIN: A macrolide antibiotic.
RIFAMPIN: An antibiotic used to treat several types of bacterial infections, including tuberculosis.
DEFEROXAMINE: A chelating agent used to treat iron overload.
UBENIMEX: An immunomodulatory agent that inhibits aminopeptidases.
EVOLOCUMAB: A monoclonal antibody that targets PCSK9, used to lower LDL cholesterol.
RAVOXERTINIB: An experimental ERK1/2 kinase inhibitor.
TYROSINE KINASE INHIBITOR: A general class of drugs that block the action of tyrosine kinases.
GSK-2636771: An experimental PI3K beta inhibitor.
ENSARTINIB: A second-generation ALK inhibitor used for non-small cell lung cancer.
MSX-122: An experimental CXCR4 antagonist.
GSK2798745: An experimental IRAK4 kinase inhibitor.
BURAPITANT: An experimental neurokinin-1 (NK1) receptor antagonist.
TOREFORANT: An experimental histamine H3 receptor antagonist/inverse agonist.
SUFUGOLIX: An experimental gonadotropin-releasing hormone (GnRH) antagonist.
AFACIFENACIN: A research chemical or compound identifier.
AMELUBANT: An experimental neurokinin-1 (NK1) receptor antagonist.
SELENIUM: A chemical element and an essential trace mineral.
NONABINE: A research chemical or compound identifier.
AZD1386: An experimental drug that was studied for neuropathic pain.
AMINOGLYCOSIDE ANTIBIOTIC: A class of antibiotics that inhibit bacterial protein synthesis.
ISPRONICLINE: An experimental neuronal nicotinic acetylcholine receptor partial agonist.
POZANICLINE: An experimental neuronal nicotinic acetylcholine receptor partial agonist.
RADIPRODIL: An experimental NMDA receptor antagonist.
SILICON PHTHALOCYANINE 4: A photosensitizer used in photodynamic therapy.
CA19-9 ANTIGEN: A tumor marker used primarily in the management of pancreatic cancer.
GONADOTROPIN, CHORIONIC: A hormone produced during pregnancy, also known as hCG.
MK-8777: An experimental pan-RAF inhibitor.
GP100 ANTIGEN: A protein that is a marker for melanoma cells.
ALEGLITAZAR: An experimental dual PPAR alpha/gamma agonist.
LATANOPROSTENE BUNOD: A medication used to lower intraocular pressure in glaucoma.
BEVENOPRAN: An experimental peripherally acting mu-opioid receptor antagonist.
BRODALUMAB: A monoclonal antibody that targets the interleukin-17 receptor, used for psoriasis.
BENRALIZUMAB: A monoclonal antibody that targets the interleukin-5 receptor, used for severe asthma.
ZALUTUMUMAB: An experimental monoclonal antibody that targets the epidermal growth factor receptor (EGFR).
ULIPRISTAL ACETATE: A selective progesterone receptor modulator used as an emergency contraceptive and for uterine fibroids.
TEGLARINAD CHLORIDE: A research chemical or compound identifier.
FONTOLIZUMAB: An experimental monoclonal antibody that targets interferon-gamma.
ADECATUMUMAB: An experimental monoclonal antibody that targets the EpCAM antigen.
ONCOLYSIN B: A research chemical or compound identifier.
TB-402: An experimental monoclonal antibody that targets Factor VIII.
ABX-IL8: An experimental monoclonal antibody that targets interleukin-8.
ELENBECESTAT: An experimental BACE1 inhibitor that was studied for Alzheimer's disease.
TOLRESTAT: An experimental aldose reductase inhibitor that was studied for diabetic complications.
AMG-811: An experimental monoclonal antibody that targets interleukin-17 receptor A.
PHOSPHODIESTERASE INHIBITOR: A class of drugs that block the action of phosphodiesterase enzymes.
MEDI-565: An experimental bispecific T-cell engager (BiTE) antibody targeting CEA and CD3.
DAPAGLIFLOZIN PROPANEDIOL: A formulation of dapagliflozin, an SGLT2 inhibitor.
LOFEXIDINE HYDROCHLORIDE: An alpha-2 adrenergic receptor agonist used to manage opioid withdrawal symptoms.
ANAGLIPTIN: A DPP-4 inhibitor used to treat type 2 diabetes.
TETRADECANOYLPHORBOL ACETATE: A potent tumor promoter and protein kinase C activator, also known as TPA or PMA.
CELGOSIVIR: An experimental antiviral drug that inhibits alpha-glucosidase.
CIMICOXIB: A non-steroidal anti-inflammatory drug (NSAID) used in veterinary medicine.
BREPOCITINIB: An experimental dual inhibitor of TYK2 and JAK1.
MK-0767: A research chemical or compound identifier.
AVDORALIMAB: An experimental monoclonal antibody.
PF-00610355: An experimental phosphodiesterase-10A (PDE10A) inhibitor.
BAY-1093884: An experimental soluble guanylate cyclase (sGC) activator.
ZIDOVUDINE: A nucleoside reverse transcriptase inhibitor (NRTI) used to treat HIV/AIDS.
DAZODALIBEP: An experimental CD40 ligand antagonist.
ROSIPTOR: A research chemical or compound identifier.
SNX 5422: An experimental Hsp90 inhibitor.
VOCLOSPORIN: An immunosuppressant drug, a calcineurin inhibitor, used for lupus nephritis.
4-PHENYLENEDIAMINE: An organic compound used in the production of polymers and dyes.
GALLIUM NITRATE: A medication used to treat cancer-related hypercalcemia.
DAVANAT: An experimental galectin-1 inhibitor.
PF-06823859: A research chemical or compound identifier.
FLYSYN: A research chemical or compound identifier.
LYMPHOKINE-ACTIVATED KILLER CELLS: A type of immune cell therapy.
ADL-5747: An experimental delta-opioid receptor agonist.
SPESOLIMAB: A monoclonal antibody that targets the interleukin-36 receptor.
TEREVALEFIM: An experimental immunomodulatory agent.
PARNAPARIN SODIUM: A low molecular weight heparin (LMWH) used as an anticoagulant.
AR-67: A research chemical or compound identifier.
ABELACIMAB: An experimental anticoagulant that targets Factor XI.
ONO-5334: An experimental cathepsin K inhibitor.
IRSENONTRINE: A research chemical or compound identifier.
LAZERTINIB: A third-generation EGFR tyrosine kinase inhibitor.
CAFFEINE: A central nervous system stimulant of the methylxanthine class.
TECARFARIN: An experimental anticoagulant that functions as a vitamin K antagonist.
RELENOPRIDE: An experimental 5-HT4 receptor agonist.
SETANAXIB: An experimental NOX1/NOX4 inhibitor.
BREQUINAR: An experimental immunosuppressive and anticancer drug that inhibits dihydroorotate dehydrogenase.
FONADELPAR: An experimental selective PPAR-delta agonist.
THERAPEUTIC ANDROSTANOLONE: A general class of androstane-based drugs.
MARGETUXIMAB-CMKB: A monoclonal antibody that targets the HER2 receptor.
ADOZELESIN: An experimental DNA-binding anticancer agent.
CARBOFENOTION: An organophosphate insecticide.
ISOQUINE: A research chemical or compound identifier.
PHENAMIL METHANESULFONATE: A blocker of the epithelial sodium channel (ENaC).
ANTI-ULCER AGENT: A general class of drugs used to treat ulcers.
FLAVANOMAREIN: A natural flavonoid glycoside.
TOPOISOMERASE-I INHIBITOR: A class of chemotherapy drugs that inhibit topoisomerase I.
TRISMETHOXYRESVERATROL: A derivative of resveratrol.
NEOCUPROINE: A heterocyclic organic compound used as a chelating agent.
ISOCHLOROGENIC ACID B: A natural phenolic compound.
SESAMIN: A lignan isolated from sesame oil.
NARASIN: An ionophore antibiotic used in veterinary medicine.
IRETOL: A research chemical or compound identifier.
12A-HYDROXY-5-DEOXYDEHYDROMUNDUSERONE: A complex natural product.
UMBELLIFERONE: A natural coumarin with various biological activities.
TROVAFLOXACIN MESYLATE: A fluoroquinolone antibiotic that was withdrawn from the market.
ANCITABINE: An experimental chemotherapy agent.
RO-3201195: A research chemical or compound identifier.
MONATEPIL: An alpha-1 blocker and calcium channel blocker.
PIMPINELLIN: A natural furanocoumarin.
SIB-1893: A selective group I metabotropic glutamate receptor antagonist.
COUMARIN: An aromatic organic chemical compound.
CYSTAMINE DIHYDROCHLORIDE: The dihydrochloride salt of cystamine.
EVANS BLUE: A diazo dye used in diagnostics to estimate blood plasma volume.
SERGEOLIDE: A natural product with biological activity.
SULINDAC: A non-steroidal anti-inflammatory drug (NSAID).
CEPHARANTHINE: A natural bis-benzylisoquinoline alkaloid.
RIMSULFURON: An herbicide of the sulfonylurea class.
ISO-IANTHERAN A: A research chemical or compound identifier.
WARFARIN POTASSIUM: The potassium salt of warfarin, an anticoagulant.
GW612286X: A research chemical or compound identifier.
GSK-718429A: A research chemical or compound identifier.
RS67506: A research chemical or compound identifier.
RILMENIDINE: An antihypertensive agent that acts on imidazoline receptors.
BISPHENOL A: An organic synthetic compound used to make certain plastics and resins.
XANTHOPTERIN: A pteridine compound found in the wings of butterflies.
FURAMIDINE: An antiprotozoal agent.
GW856804X: A research chemical or compound identifier.
PADIMATE-O: An organic compound used as an ingredient in some sunscreens.
NIFLUMIC ACID: A non-steroidal anti-inflammatory drug (NSAID).
NEOCYCLOCITRINOL C: A natural product with biological activity.
LAVENDUSTIN A: A potent tyrosine kinase inhibitor.
SALMETEROL: A long-acting beta-2 adrenergic agonist (LABA) used to treat asthma and COPD.
ANISALDEHYDE: An organic compound used in fragrances and flavorings.
PROTEIN KINASE C INHIBITOR: A class of drugs that inhibit protein kinase C enzymes.
(Z)-PIPLARTINE: An isomer of a natural product with biological activity.
BOVINE CARTILAGE: A preparation from cow cartilage, used as a supplement.
QUINOLINIC ACID: A neurotoxin that acts as an NMDA receptor agonist.
ALTHIAZIDE: A thiazide diuretic.
NIHYDRAZONE: An antibacterial agent.
KAINIC ACID: A potent neurotoxin that acts as a specific agonist for the kainate receptor.
IODINE I-131: A radioactive isotope of iodine used in nuclear medicine.
CHLORPYRIFOS-METHYL: An organophosphate insecticide.
DECYLUBIQUINONE: An analogue of coenzyme Q10.
CYCLOHEXANONE OXIME: A chemical intermediate.
CASEARINONE A: A natural product with biological activity.
FLUORODIFEN: An herbicide.
IL-7: Interleukin-7, a cytokine that is important for lymphocyte development.
Y-27632: A selective inhibitor of the ROCK (Rho-associated coiled-coil forming protein kinase) signaling pathway.
RECOMBINANT FIBROBLAST GROWTH FACTOR 2: A manufactured form of the FGF2 protein.
NIZATIDINE: An H2 receptor antagonist that decreases stomach acid production.
GW679410X: A research chemical or compound identifier.
MEXILETINE: An antiarrhythmic medication of the local anesthetic type.
ACIFRAN: A research chemical or compound identifier.
MEK1/2 INHIBITOR: A class of drugs that inhibit the MEK1 and MEK2 kinases.
PENDIMETHALIN: An herbicide.
NOMIFENSINE MALEATE: An antidepressant that acts as a norepinephrine-dopamine reuptake inhibitor.
ISOBAVACHALCONE: A natural chalconoid with various biological activities.
AICA RIBONUCLEOTIDE: An intermediate in the generation of inosine monophosphate.
SINENSETIN: A natural polymethoxylated flavone found in citrus peels.
MECLOFENOXATE: A nootropic drug that was studied for dementia and Alzheimer's disease.
STREPTOZOCIN: A naturally occurring chemotherapy agent that is particularly toxic to pancreatic beta cells.
NIRIDAZOLE: An antischistosomal agent.
PAC-1: An experimental agent that induces apoptosis by activating procaspase-3.
GM-CSF: Granulocyte-macrophage colony-stimulating factor, a cytokine that stimulates stem cells.
TETROQUINONE: A chemical compound.
DOXYLAMINE: A first-generation antihistamine used to treat insomnia.
GOSSYPOL: A natural polyphenol from the cotton plant with antifertility and other effects.
AMG-208: An experimental c-Met kinase inhibitor.
PHENOTHIAZINE: A class of antipsychotic drugs.
TECTORIGENIN: A natural isoflavone.
SOYBEAN SEED OIL: Oil extracted from the seeds of the soybean.
NORETHINDRONE ACETATE: A progestin used in hormonal contraceptives and hormone replacement therapy.
NYSTATIN: A polyene antifungal medication.
TNP-470: An angiogenesis inhibitor, a synthetic analogue of the natural product fumagillin.
RECOMBINANT VASCULAR ENDOTHELIAL GROWTH FACTOR: A manufactured form of VEGF, a key protein that stimulates the formation of blood vessels.
ECULIZUMAB: A monoclonal antibody that targets the complement component C5, used to treat paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
MILTEFOSINE: An oral medication used to treat leishmaniasis and certain free-living ameba infections.
PERFOSFAMIDE: An active metabolite of the chemotherapy drug cyclophosphamide.
CETIRIZINE HYDROCHLORIDE: A second-generation antihistamine used to treat allergies, hay fever, and hives.
ISOPROPYL ALCOHOL: A common solvent, antiseptic, and disinfectant.
INTERFERON BETA-1A: A manufactured form of the cytokine interferon beta, used to treat multiple sclerosis.
SACITUZUMAB GOVITECAN: An antibody-drug conjugate that targets the TROP-2 protein, used for triple-negative breast cancer.
ISPAGHULA HUSK: A bulk-forming laxative derived from the seeds of the Plantago ovata plant.
THYROGLOBULIN: A protein produced by the thyroid gland, which is a precursor to thyroid hormones.
MISTLETOE EXTRACT: A preparation from the mistletoe plant, used in complementary and alternative cancer therapy.
HEPARIN CALCIUM: The calcium salt of heparin, an anticoagulant.
ACTH: Adrenocorticotropic hormone, a pituitary hormone that stimulates the production of cortisol.
RECOMBINANT EOTAXIN: A manufactured form of the chemokine CCL11 (eotaxin), involved in allergic responses.
RECOMBINANT INTERFERON ALFA: A general class of manufactured interferon alfa proteins, used as antiviral and anticancer agents.
IFOSFAMIDE: A nitrogen mustard alkylating agent used in chemotherapy.
SUNSCREEN: A general term for topical products that absorb or reflect some of the sun's ultraviolet (UV) radiation.
NAFCILLIN: A narrow-spectrum beta-lactam antibiotic of the penicillin class.
LUMIRACOXIB: A selective COX-2 inhibitor (NSAID) that was withdrawn from the market.
THROMBOLYTIC AGENT: A class of drugs used to dissolve blood clots.
TERBINAFINE: An allylamine antifungal medication used to treat fungal infections of the skin and nails.
BENZNIDAZOLE: An antiparasitic medication used to treat Chagas disease.
EMODIN: A natural anthraquinone compound with laxative, anti-inflammatory, and other biological effects.
PROMEGAPOIETIN: An experimental agent designed to stimulate platelet production.
METHYLCELLULOSE: A chemical compound used as a thickener, emulsifier, and bulk-forming laxative.
LAROTRECTINIB: A potent and selective inhibitor of TRK kinases, used for TRK fusion-positive cancers.
TK216: An experimental agent that targets the EWS-FLI1 fusion protein in Ewing sarcoma.
SELPERCATINIB: A kinase inhibitor that targets RET alterations, used for certain types of thyroid and lung cancer.
PLX8394: An experimental next-generation BRAF inhibitor designed to avoid paradoxical activation.
PYRILAMINE: A first-generation antihistamine.
RHODAMINE123: A fluorescent dye used in cell biology to stain mitochondria.
NATEGLINIDE: A meglitinide antidiabetic drug that stimulates insulin secretion.
ISEPAMICIN: An aminoglycoside antibiotic.
ADALIMUMAB-ADBM: A biosimilar of adalimumab, a TNF inhibitor used for autoimmune diseases.
CARGLUMIC ACID: A medication used to treat hyperammonemia.
LENALIDOMIDE: An immunomodulatory drug used to treat multiple myeloma and myelodysplastic syndromes.
PYRIDOXAL PHOSPHATE ANHYDROUS: The active form of vitamin B6.
KETOROLAC TROMETHAMINE: A non-steroidal anti-inflammatory drug (NSAID) used for short-term management of moderate to severe pain.
CARIPRAZINE: An atypical antipsychotic used to treat schizophrenia and bipolar disorder.
ACETAMINOPHEN / CODEINE: A combination analgesic medication containing paracetamol and codeine.
AMOXAPINE: A tetracyclic antidepressant.
DAPSONE: An antibacterial sulfonamide used to treat leprosy and dermatitis herpetiformis.
LIDOCAINE: A common local anesthetic of the amide type and an antiarrhythmic drug.
RISDIPLAM: A survival of motor neuron 2 (SMN2) splicing modifier used to treat spinal muscular atrophy.
BUPRENORPHINE: An opioid medication used to treat opioid use disorder and pain.
DABIGATRAN: A direct thrombin inhibitor used as an anticoagulant.
VALBENAZINE: A vesicular monoamine transporter 2 (VMAT2) inhibitor used to treat tardive dyskinesia.
SELEGILINE: A selective monoamine oxidase B (MAO-B) inhibitor used to treat Parkinson's disease.
ARTICAINE / EPINEPHRINE: A combination product used for local dental anesthesia.
SN-38: The active metabolite of the chemotherapy drug irinotecan, which inhibits topoisomerase I.
VILDAGLIPTIN: A DPP-4 inhibitor used to treat type 2 diabetes.
TETANUS ANTITOXIN: A preparation of antibodies used to provide passive immunity against tetanus.
CYCLOPHOSPHAMIDE ANHYDROUS: The anhydrous form of the chemotherapy drug cyclophosphamide.
CERTOLIZUMAB PEGOL: A pegylated Fab' fragment of a monoclonal antibody that targets TNF-alpha.
ALTEPLASE: A recombinant tissue plasminogen activator (tPA) used as a thrombolytic drug.
CLOMIPHENE: A selective estrogen receptor modulator (SERM) used to treat infertility in women.
ANTI-CD3 MONOCLONAL ANTIBODY: A class of monoclonal antibodies that target the CD3 protein on T cells.
RG-7795: A research chemical or compound identifier.
ARTEMOTIL: A derivative of artemisinin used as an antimalarial drug.
VEROSUDIL: An experimental Rho-kinase inhibitor.
APALUTAMIDE: A non-steroidal antiandrogen used to treat prostate cancer.
VARLITINIB: An experimental pan-HER tyrosine kinase inhibitor.
SILDENAFIL: A PDE5 inhibitor used to treat erectile dysfunction and pulmonary arterial hypertension.
PROGUANIL: An antimalarial drug, often used in combination with atovaquone.
PHOSPHORODIAMIDATE MORPHOLINO OLIGOMER AVI-4126: An experimental antisense oligonucleotide.
ATL1102: An experimental antisense oligonucleotide targeting the VLA-4 receptor.
AV-412: An experimental inhibitor of the enzyme kynurenine monooxygenase.
PICROPODOPHYLLIN: An experimental inhibitor of the insulin-like growth factor-1 receptor (IGF-1R).
ADUCANUMAB: A monoclonal antibody that targets amyloid-beta, used for Alzheimer's disease.
TRALOKINUMAB: A monoclonal antibody that targets interleukin-13, used for atopic dermatitis.
CERE-110: An experimental gene therapy delivering nerve growth factor for Alzheimer's disease.
PHENPROCOUMON: An anticoagulant that functions as a vitamin K antagonist.
GESTODENE: A progestin used in hormonal contraceptives.
ABATACEPT: A fusion protein that modulates T-cell activation, used for autoimmune diseases.
GS9667: A research chemical or compound identifier.
FIPAMEZOLE: An alpha-2 adrenergic receptor antagonist that was studied to reverse the effects of medetomidine.
ICATIBANT: A bradykinin B2 receptor antagonist used to treat hereditary angioedema.
SALMON CALCITONIN: A form of the hormone calcitonin derived from salmon, used to treat osteoporosis.
LACOSAMIDE: An anticonvulsant medication used to treat epilepsy.
KETOTIFEN FUMARATE: A mast cell stabilizer and H1-histamine antagonist used for asthma and allergies.
LERCANIDIPINE: A calcium channel blocker used to treat hypertension.
VORTIOXETINE HYDROBROMIDE: An atypical antidepressant with multimodal activity.
BARICITINIB: A Janus kinase (JAK) inhibitor used to treat rheumatoid arthritis and alopecia areata.
PEVONEDISTAT: An experimental inhibitor of the NEDD8-activating enzyme.
MIV-701: An experimental cathepsin K inhibitor.
ETIRINOTECAN PEGOL: A long-acting formulation of irinotecan, a topoisomerase I inhibitor.
OPC-14523: A research chemical or compound identifier.
BAMOSIRAN: An experimental small interfering RNA (siRNA) therapeutic.
TESAMORELIN: A synthetic analogue of growth hormone-releasing hormone, used to treat lipodystrophy in HIV patients.
EDROPHONIUM CATION: The active cation of edrophonium, a short-acting cholinesterase inhibitor.
FLUPENTHIXOL: A typical antipsychotic of the thioxanthene class.
MEFENAMIC ACID: A non-steroidal anti-inflammatory drug (NSAID).
MEPENZOLATE: An antimuscarinic agent.
NAFARELIN: A gonadotropin-releasing hormone (GnRH) agonist.
OXPRENOLOL: A non-selective beta-blocker with partial beta-adrenergic agonist activity.
NITISINONE: A medication used to treat hereditary tyrosinemia type 1.
THIAMYLAL: An ultra-short-acting barbiturate anesthetic.
HYDROCORTAMATE: A topical corticosteroid.
PROPOXYPHENE: An opioid pain medication that was withdrawn from the market in many countries.
TADALAFIL: A PDE5 inhibitor used to treat erectile dysfunction and pulmonary arterial hypertension.
GDC-0425: An experimental inhibitor of the TEAD protein.
XALIPRODEN: An experimental neurotrophic agent that was studied for amyotrophic lateral sclerosis (ALS).
CA-170: An experimental oral immune checkpoint inhibitor targeting VISTA and PD-L1.
NANOPARTICLE SN-38-ENCAPSULATED MICELLE FORMULATION IT-141: An experimental formulation of the chemotherapy drug SN-38.
TINOSTAMUSTINE: An experimental alkylating agent and HDAC inhibitor.
ANDROGEN RECEPTOR ANTAGONIST TAS3681: An experimental antiandrogen drug.
CXCR4 ANTAGONIST USL311: An experimental antagonist of the CXCR4 chemokine receptor.
LORUKAFUSP ALFA: An experimental fusion protein.
MOTIXAFORTIDE: A CXCR4 antagonist used to mobilize hematopoietic stem cells.
AFLIBERCEPT: A recombinant fusion protein that acts as a VEGF inhibitor, used for various eye diseases and cancer.
KX2-361: An experimental Src kinase inhibitor.
OBINUTUZUMAB: A monoclonal antibody that targets the CD20 protein, used for chronic lymphocytic leukemia.
RUTHENIUM-BASED TRANSFERRIN TARGETING AGENT NKP-1339: An experimental ruthenium-based anticancer compound.
VAROGLUTAMSTAT: An experimental inhibitor of the glutaminyl cyclase enzyme.
MYCOPHENOLATE MOFETIL: A prodrug of mycophenolic acid, an immunosuppressant.
DIANEXIN: An experimental recombinant form of human annexin A5.
TETRAHYDROFOLIC ACID: The active form of folate (Vitamin B9).
DAS-431 IV: An experimental enzyme therapy.
GALLAMINE TRIETHIODIDE: A non-depolarizing neuromuscular-blocking drug.
BUCLIZINE: A first-generation antihistamine used as an antiemetic.
TERIFLUNOMIDE: A disease-modifying drug used to treat multiple sclerosis.
LERISETRON: An experimental 5-HT3 receptor antagonist.
BUSPIRONE: An anxiolytic drug of the azapirone class.
CHOLIC ACID: A primary bile acid.
CYCLOSERINE: An antibiotic used to treat tuberculosis.
NM-702: A research chemical or compound identifier.
IBUDILAST: A non-selective phosphodiesterase inhibitor with anti-inflammatory and neuroprotective effects.
PRETOMANID: An antibiotic used in combination for the treatment of multidrug-resistant tuberculosis.
DAPORINAD: An experimental NAMPT inhibitor.
PIPECURONIUM: A long-acting non-depolarizing neuromuscular-blocking drug.
SODIUM BICARBONATE: A salt used as an antacid and in various medical applications.
CYCLOPENTOLATE: An antimuscarinic drug used as an eye drop to dilate the pupil.
NELIVAPTAN: An experimental vasopressin V1b receptor antagonist.
UK-396,082: A research chemical or compound identifier.
MIRVETUXIMAB SORAVTANSINE: An antibody-drug conjugate that targets the folate receptor alpha.
LEVOMILNACIPRAN: A serotonin-norepinephrine reuptake inhibitor (SNRI) used as an antidepressant.
OPROZOMIB: An experimental proteasome inhibitor.
HUA33: A research chemical or compound identifier.
CERLAPIRDINE: An experimental 5-HT6 receptor antagonist that was studied for Alzheimer's disease.
FMH: An abbreviation, possibly for a research compound.
BI-836826: An experimental monoclonal antibody that targets the CD37 antigen.
ANTI-GITR MONOCLONAL ANTIBODY MK-4166: An experimental immunotherapy agent that targets the GITR receptor.
EMAPTICAP PEGOL: An experimental selectin antagonist.
TESTOSTERONE BUCYCLATE: A long-acting ester of testosterone.
INOTERSEN: An antisense oligonucleotide used to treat hereditary transthyretin-mediated amyloidosis.
LEUPROLIDE ACETATE: A gonadotropin-releasing hormone (GnRH) agonist used to treat prostate cancer and endometriosis.
ASP-8477: A research chemical or compound identifier.
ANTI-CD33 CAR T-CELLS: A type of CAR-T cell therapy targeting the CD33 protein.
RIVAROXABAN: An anticoagulant that acts as a direct factor Xa inhibitor.
BECAPLERMIN: A recombinant form of human platelet-derived growth factor, used topically to treat diabetic ulcers.
CARDIOTROPHIN-1: A cytokine of the interleukin-6 family.
ELACESTRANT: A selective estrogen receptor degrader (SERD) used to treat ER-positive breast cancer.
PEGAPAMODUTIDE: An experimental peptide.
TUCIDINOSTAT: A histone deacetylase (HDAC) inhibitor used to treat lymphoma in China.
SLV-334: A research chemical or compound identifier.
HYDROXYAMPHETAMINE HYDROBROMIDE: A sympathomimetic amine used in eye drops to dilate the pupil.
LITOXETINE: An experimental antidepressant.
ACECLOFENAC: A non-steroidal anti-inflammatory drug (NSAID).
SYNTHETIC CONJUGATED ESTROGENS, A: A mixture of synthetic estrogen hormones.
TINZAPARIN SODIUM: A low molecular weight heparin (LMWH) used as an anticoagulant.
TORSEMIDE: A loop diuretic used to treat fluid retention and high blood pressure.
TETRAHYDROZOLINE: A vasoconstrictor and decongestant used in eye drops.
IGMESINE: A sigma-1 receptor agonist.
IBROLIPIM: An experimental PPAR-alpha agonist.
Z-360: A research chemical or compound identifier.
LY320954: A research chemical or compound identifier.
AMESERGIDE: A potent antagonist of multiple serotonin receptors.
AC-90179: A research chemical or compound identifier.
[11C]GSK215083: A radiolabeled selective 5-HT6 receptor antagonist for PET imaging.
TH5487: An experimental inhibitor of the MTH1 enzyme.
SIAIS178: A research chemical or compound identifier.
CP-640186: An experimental ACC inhibitor.
UNECRITINIB: An experimental JAK2 inhibitor.
LIDORESTAT ANHYDROUS: The anhydrous form of lidorestat, an aldose reductase inhibitor.
UPIDOSIN: An experimental alpha-1A adrenergic receptor antagonist.
PHENOXYBENZAMINE: A non-selective, irreversible alpha-adrenergic antagonist.
BRIMONIDINE: A selective alpha-2 adrenergic agonist used in eye drops to treat glaucoma.
ETHYLISOPROPYLAMILORIDE: A potent inhibitor of the Na+/H+ exchanger.
APRACLONIDINE: An alpha-2 adrenergic agonist used in eye drops to treat glaucoma.
KF 17837S: A research chemical, a selective adenosine A1 receptor antagonist.
MRS1042: A research chemical or compound identifier.
MRS1486: A research chemical or compound identifier.
AZD5582: An experimental SMAC mimetic that antagonizes IAP proteins.
BCL6 PROTAC 15: A specific PROTAC molecule designed to degrade the BCL6 protein.
COMPOUND 9G [PMID: 24412111]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
[D-PHE6,&BETA;-ALA11,PHE13,NLE14]BOMBESIN-(6-14): A complex peptide analogue of bombesin.
NEMTABRUTINIB: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
MZ1: An experimental PROTAC that degrades the BRD4 protein.
NHWD-870: An experimental inhibitor of the STING protein.
SPEBRUTINIB: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
TIRABRUTINIB: A second-generation Bruton's tyrosine kinase (BTK) inhibitor.
EVOBRUTINIB: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
CGI1746: A potent and selective inhibitor of Bruton's tyrosine kinase (BTK).
COMPOUND 11 [PMID: 12812482]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
[DES-ARG9]BRADYKININ: A metabolite of bradykinin that is a B1 receptor agonist.
C3A RECEPTOR AGONIST: A class of compounds that activate the C3a complement receptor.
WIN 64338: An experimental bradykinin B2 receptor antagonist.
SQ007-5: A research chemical or compound identifier.
IC261: An inhibitor of the casein kinase 1 (CK1) delta/epsilon isoforms.
COMPOUND 14 [PMID: 24900428]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
NPS 2143: A negative allosteric modulator of the calcium-sensing receptor.
PB2+: The divalent lead cation, a toxic heavy metal ion.
DEXTROMETHORPHAN POLISTIREX: An extended-release formulation of the cough suppressant dextromethorphan.
ML218: A selective inhibitor of the potassium channel Kir2.1.
GC-376: An experimental broad-spectrum 3CL protease inhibitor for coronaviruses.
COMPOUND 2B-1 [PMID: 12614873]: An experimental compound described in the specified publication.
CCL3: A small cytokine belonging to the CC chemokine family, also known as MIP-1-alpha.
INCB8761: An experimental CXCR2 chemokine receptor antagonist.
CCL13: A small cytokine belonging to the CC chemokine family, also known as MCP-4.
CXCL12&GAMMA;: An isoform of the chemokine CXCL12.
SDF-1, 1-9[P2G] DIMER: A modified form of the chemokine SDF-1 (CXCL12).
MAVORIXAFOR: An experimental CXCR4 antagonist.
T140: A peptide antagonist of the CXCR4 chemokine receptor.
CX3CL1: A large cytokine, also known as fractalkine.
COMPOUND 9B [PMID: 18986805]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
CP-10: A research chemical or compound identifier.
5H78PF: A research chemical or compound identifier.
HAMI3379: A potent and selective antagonist of the GPR55 receptor.
DADLE: A synthetic opioid peptide with high affinity for the delta-opioid receptor.
PRALATREXATE: An antifolate chemotherapy drug used to treat T-cell lymphoma.
COMPOUND 5B [PMID: 25349648]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
[3H]7-OH-DPAT: A radiolabeled full agonist for the dopamine D3 receptor.
BAY-678: A research chemical or compound identifier.
OL135: A research chemical or compound identifier.
MYRISTIC ACID: A common saturated fatty acid.
GW9508: A potent agonist for the free fatty acid receptor 1 (GPR40).
(S)-4-CMTB: A research chemical or compound identifier.
PEMIGATINIB: An FGFR kinase inhibitor used to treat cholangiocarcinoma.
LIRAFUGRATINIB: An experimental pan-RAF inhibitor.
TAFETINIB: An experimental JAK3 inhibitor.
AG-14: A research chemical or compound identifier.
[125I]CHIPS: A radioiodinated compound, likely a receptor ligand.
AG-26: A research chemical or compound identifier.
SEPETAPROST: A research chemical or compound identifier.
FPRL1-INHIBITOR PROTEIN: A protein that inhibits the formyl peptide receptor-like 1.
GALANIN(1-16) (RAT/MOUSE/PIG): A fragment of the neuropeptide galanin.
SNAP 398299: A research chemical or compound identifier.
GALANIN(3-29) (PIG): A fragment of the neuropeptide galanin.
M1153: A research chemical or compound identifier.
GALANIN: A neuropeptide widely expressed in the brain and gut.
COMPOUND 1 [OVERHAND ET AL., 1997]: A specific chemical compound described in a 1997 publication by Overhand et al.
GSK866: A research chemical or compound identifier.
SYM2081: A potent agonist for kainate receptors that also causes desensitization.
[3H]KAINATE: A radiolabeled form of kainic acid, a glutamate receptor agonist.
LY466195: A research chemical, an AMPA receptor positive allosteric modulator.
[TYR8]GNRH: A synthetic analogue of gonadotropin-releasing hormone.
PEPTIDE P19 [PMID: 15652659]: A specific peptide ligand for a receptor, as described in the publication.
3-PYRIDINE-ACETIC ACID: A chemical compound, a derivative of pyridine.
SCRIPTAID: A research chemical that acts as a histone deacetylase (HDAC) inhibitor.
BAVAROSTAT: A research chemical or compound identifier.
UR-PG146: A research chemical or compound identifier.
THIOTHIXENE: A typical antipsychotic of the thioxanthene class.
MOLINDONE: A typical antipsychotic of the dihydroindolone class.
LEVOCETIRIZINE: A third-generation antihistamine.
COMPOUND 11JJ [PMID: 1656041]: An experimental compound described in a 1991 publication (PMID is for 1991).
OLVANIL: A synthetic analogue of capsaicin that acts on the TRPV1 receptor.
NE 52-QQ57: A research chemical or compound identifier.
MANSC (415-431): A peptide fragment.
QUINOLINE 2: A research chemical or compound identifier.
METOPROLOL: A selective beta-1 blocker used to treat hypertension and angina.
NORMORPHINE: A metabolite of morphine, which also has opioid activity.
NALBUPHINE HYDROCHLORIDE: An opioid medication with mixed agonist-antagonist activity.
DUAL VEGFR/PARP INHIBITOR 14B: An experimental compound that inhibits both VEGFR and PARP.
BARZOLVOLIMAB: An experimental monoclonal antibody.
LEI-DAB7: A research chemical or compound identifier.
APAMIN: A peptide neurotoxin from bee venom that blocks SK channels.
EBIO: A research chemical that activates calcium-activated potassium channels.
AZD2927: A research chemical or compound identifier.
A-935142: A research chemical or compound identifier.
KETOCONAZOLE: An azole antifungal medication.
(S)-N-[1-(3-MORPHOLIN-4-YL-PHENYL)-ETHYL]-3-PHENYL-ACRYLAMIDE: A chemical compound, likely a specific receptor ligand.
LINOPIRDINE: An experimental drug that was studied for Alzheimer's disease.
RO 48-8071: A research chemical, an inhibitor of the enzyme squalene epoxidase.
LRRK2-IN-1: A potent and selective inhibitor of the LRRK2 kinase.
JH-XII-03-02: A research chemical or compound identifier.
XL01126: A research chemical or compound identifier.
GSK2033: A research chemical or compound identifier.
MULTIKINASE INHIBITOR AEE788: An experimental compound that inhibits multiple tyrosine kinases.
AM966: A research chemical, a cannabinoid receptor agonist.
OLEOYL-THIOPHOSPHATE: A research chemical or compound identifier.
ZAVONDEMSTAT: An experimental IRAK4 kinase inhibitor.
ORY-1001: An experimental LSD1 inhibitor.
GSK2879552: An experimental LSD1 inhibitor.
A-196: A research chemical or compound identifier.
SETMELANOTIDE: A melanocortin-4 receptor agonist used to treat genetic obesity disorders.
ACTH-(11-24): A peptide fragment of the adrenocorticotropic hormone.
S36539: A research chemical or compound identifier.
TPI 1361-17: A research chemical or compound identifier.
PHCCC: A negative allosteric modulator of the mGluR4 receptor.
COMPOUND 23H [PMID: 17929793]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 9N [PMID: 23084894]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 34 [PMID: 20409708]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 48 [PMID: 22364337]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
FURTRETHONIUM IODIDE: A parasympathomimetic miotic agent.
UCSF7447: A research chemical or compound identifier.
[3H]AZ11637326: A radiolabeled compound, likely a receptor ligand.
TALNETANT: An experimental neurokinin-3 (NK3) receptor antagonist.
SCH 206272: A research chemical or compound identifier.
PAVINETANT: An experimental neurokinin-3 (NK3) receptor antagonist.
N',2-DIPHENYLQUINOLINE-4-CARBOHYDRAZIDE 8M: A chemical compound, likely a specific receptor ligand.
MCC950: A potent and selective inhibitor of the NLRP3 inflammasome.
CY-09: A research chemical or compound identifier.
CPN-267: A research chemical or compound identifier.
NM4-C16: A research chemical or compound identifier.
HTH-01-015: A research chemical or compound identifier.
ESTROPIPATE: A form of estrogen used in hormone replacement therapy.
HTH-02-006: A research chemical or compound identifier.
GSK-7975A: A research chemical or compound identifier.
L-366,948: A research chemical or compound identifier.
L-369,020: A research chemical or compound identifier.
D(CH2)5[TYR(ME)2]AVP: A synthetic analogue of vasopressin.
MRS4174: A research chemical or compound identifier.
[3H]MRS2279: A radiolabeled antagonist of the P2Y1 receptor.
[3H]HATRAP: A radiolabeled compound, likely a receptor ligand.
4-AMBA: A research chemical or compound identifier.
LY-518674: A research chemical or compound identifier.
AZD7648: An experimental PI3K delta inhibitor.
SELETALISIB: An experimental PI3K delta inhibitor.
ZANDELISIB: An experimental PI3K delta inhibitor.
AZD3458: An experimental PI3K delta inhibitor.
COMPOUND 5D [PMID: 31335136]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
BAY-297: A research chemical or compound identifier.
TUNODAFIL: An experimental PDE5 inhibitor.
COMPOUND 3M [PMID: 32603117]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
S20: A research chemical or compound identifier.
PROGESTERONE: A steroid hormone involved in the menstrual cycle, pregnancy, and embryogenesis.
ETHINYL ESTRADIOL: A synthetic estrogen used in many formulations of combined oral contraceptive pills.
PTHRP: Parathyroid hormone-related protein, a protein with roles in development and physiology.
ETAVOPIVAT: An experimental agent designed to increase red blood cell health.
DASA-58: A research chemical or compound identifier.
COMPOUND 21 [PMID: 24900635]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 8 [PMID: 17480064]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
CYM5520: A research chemical, an agonist for the S1P3 receptor.
FICLATUZUMAB: An experimental monoclonal antibody that targets the HGF/MET pathway.
INCLACUMAB: An experimental monoclonal antibody that targets P-selectin.
RP-101075: A research chemical or compound identifier.
COMPOUND 1 [PMID: 21742770]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 7 [PMID: 34333981]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
NORZOTEPINE: A metabolite of the antipsychotic drug zotepine.
EMD638683: A research chemical or compound identifier.
GSA-10: A research chemical, a GPR40 receptor agonist.
AZD8542: A research chemical or compound identifier.
SPHINGOMYELIN SYNTHASE 2 INHIBITOR 15W: A specific chemical inhibitor of the SMS2 enzyme.
COMPOUND D24 [PMID: 24374347]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 4Q [PMID: 7650673]: An experimental compound described in a 1995 publication.
SOVLEPLENIB: An experimental spleen tyrosine kinase (Syk) inhibitor.
SRA880: A research chemical or compound identifier.
DOTA-BASS: A research chemical or compound identifier.
BIM 23056: A research chemical, a somatostatin receptor ligand.
TBK1 PROTAC 3I: A specific PROTAC molecule designed to degrade the TBK1 protein.
BROMOACETONE: A chemical compound used as a reagent.
ML2-SA1: A research chemical or compound identifier.
ACAA: An abbreviation, possibly for a research compound.
COMBRETASTATIN A4: A natural product that acts as a vascular disrupting agent.
FIGITUMUMAB: An experimental monoclonal antibody that targets the insulin-like growth factor 1 receptor (IGF-1R).
VANIN-1 INHIBITOR [PMID: 33196323]: A specific chemical inhibitor of the Vanin-1 enzyme, as described in the publication.
[125I]PP (HUMAN): A radioiodinated form of pancreatic polypeptide.
[D-TRP32]NPY: A synthetic analogue of Neuropeptide Y.
JQ1: A potent and selective inhibitor of the BET family of bromodomains.
FILANESIB: An experimental inhibitor of the mitotic kinesin Eg5.
VOCIPROTAFIB: An experimental dual PPAR alpha/gamma agonist.
BUPARLISIB: An experimental pan-PI3K inhibitor.
TESEVATINIB: An experimental multi-kinase inhibitor.
FUTIBATINIB: An irreversible FGFR kinase inhibitor.
ASTUPROTIMUT-R: An experimental cancer vaccine.
AMSACRINE: A topoisomerase II inhibitor used in chemotherapy.
MULTI-NEO-EPITOPE VACCINE OSE 2101: An experimental therapeutic cancer vaccine.
NAB-PACLITAXEL: A nanoparticle albumin-bound formulation of the chemotherapy drug paclitaxel.
TIZATERKIB: An experimental ERK1/2 kinase inhibitor.
CFT1946: An experimental PROTAC that degrades the BRAF V600E protein.
SAPITINIB: An experimental tyrosine kinase inhibitor.
APG-2449: An experimental multi-kinase inhibitor.
CETRELIMAB: An experimental monoclonal antibody.
IDRX-42: An experimental tyrosine kinase inhibitor.
RO-5045337: A research chemical or compound identifier.
IDASANUTLIN: An experimental MDM2 inhibitor.
ANTI-CD19 CAR T CELLS PREPARATION: A general term for CAR-T cell therapies targeting the CD19 protein.
PI3K ALPHA/BETA INHIBITOR BAY1082439: An experimental inhibitor of the PI3K alpha and beta isoforms.
ONATASERTIB: An experimental AKT inhibitor.
PI3K-ALPHA INHIBITOR TOS-358: An experimental selective inhibitor of the PI3K alpha isoform.
PKI-179: A research chemical or compound identifier.
RIDAFOROLIMUS: An experimental mTOR inhibitor.
TELATINIB: An experimental multi-kinase inhibitor targeting VEGFR, PDGFR, and Kit.
C-RAF ANTISENSE OLIGONUCLEOTIDE ISIS 5132: An experimental antisense drug targeting the c-Raf kinase.
SKF-86002: An experimental anti-inflammatory agent.
LATANOPROST: A prostaglandin analogue used in eye drops to treat glaucoma.
PF-03882845: A research chemical or compound identifier.
LORLATINIB: A third-generation ALK inhibitor used for non-small cell lung cancer.
SAROGLITAZAR: A dual PPAR alpha/gamma agonist used to treat diabetic dyslipidemia.
IODINE I 131 MONOCLONAL ANTIBODY 81C6: A radioimmunotherapy agent.
MARIZOMIB: An experimental proteasome inhibitor.
PEPTIDE YY: A peptide hormone released in the gut that reduces appetite.
ACARBOSE: An alpha-glucosidase inhibitor used to treat type 2 diabetes.
CXCL10: A small cytokine belonging to the CXC chemokine family, also known as IP-10.
DALANTERCEPT: An experimental fusion protein that acts as a ligand trap for ALK1.
K-80003: A research chemical or compound identifier.
3-DEAZAADENOSINE: An adenosine analog with antiviral and other biological activities.
MUC1-TARGETED PEPTIDE GO-203-2C: An experimental peptide targeting the MUC1 oncoprotein.
CYCLIRAMINE MALEATE: A first-generation antihistamine.
SRI22141: A research chemical or compound identifier.
SAM68 MODULATOR CWP232291: An experimental agent that modulates the Sam68 protein.
BUPIVACAINE: A long-acting local anesthetic of the amide type.
ACLIDINIUM: An antimuscarinic agent used as a bronchodilator for COPD.
ODITRASERTIB: An experimental ERK1/2 kinase inhibitor.
COMPOUND 34 [PMID: 25974391]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
9-ANTHROIC ACID: A chemical compound, a derivative of anthracene.
VALDECOXIB: A selective COX-2 inhibitor (NSAID) that was withdrawn from the market.
AVN-944: An experimental inhibitor of the enzyme IMPDH.
ESMOLOL HYDROCHLORIDE: An ultra-short-acting beta-1 blocker.
AZILSARTAN MEDOXOMIL: A prodrug of azilsartan, an angiotensin II receptor antagonist.
FR173657: A research chemical, a tachykinin NK1 receptor antagonist.
DACOMITINIB ANHYDROUS: The anhydrous form of dacomitinib, a pan-HER kinase inhibitor.
HMPL-453: An experimental FGFR inhibitor.
TADEKINIG ALFA: A recombinant form of interleukin-18.
BIFEPRUNOX: An experimental atypical antipsychotic.
E163: A research chemical or compound identifier.
COMPOUND 30 [PMID: 22902653]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
MURAMYL DIPEPTIDE: A component of bacterial cell walls that is a potent activator of the immune system.
SEMORINEMAB: An experimental monoclonal antibody that targets the Tau protein.
THEONELLASTEROL F: A marine-derived sterol.
SILYMARIN: An extract from milk thistle seeds, containing silibinin and other flavonolignans.
PLX51107: An experimental BET inhibitor.
IRAK-1/4 INHIBITOR: A class of drugs that inhibit the IRAK-1 and IRAK-4 kinases.
NICARDIPINE HYDROCHLORIDE: The hydrochloride salt of nicardipine, a calcium channel blocker.
[SAR,D-PHE8,DES-ARG9]BRADYKININ: A synthetic peptide that is a B1 receptor agonist.
BREMELANOTIDE: A melanocortin receptor agonist used to treat hypoactive sexual desire disorder in women.
ADAGRASIB: A covalent inhibitor of the KRAS G12C mutant protein, used for non-small cell lung cancer.
INCYCLINIDE: A research chemical or compound identifier.
RPR260243: A research chemical or compound identifier.
LEROCICLIB: An experimental cyclin-dependent kinase (CDK) inhibitor.
VELDOREOTIDE: An experimental somatostatin analog.
INDOTECAN: An experimental topoisomerase I inhibitor.
CROTOXIN: A neurotoxin from rattlesnake venom.
PENTAMIDINE ISETHIONATE: An antimicrobial medication used to treat various protozoal and fungal infections.
DEXPRAMIPEXOLE: An experimental drug that was studied for amyotrophic lateral sclerosis (ALS).
PROPYLTHIOURACIL: An anti-thyroid drug used to treat hyperthyroidism.
BRIGATINIB: A potent ALK and EGFR inhibitor used to treat non-small cell lung cancer.
COMPOUND A34 [PMID: 35635004]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
ACYLINE: An experimental gonadotropin-releasing hormone (GnRH) antagonist.
DISULFIRAM: A medication used to support the treatment of chronic alcoholism.
TDE: Tetrachlorodiphenylethane, an insecticide related to DDT.
LEXATUMUMAB: An experimental monoclonal antibody that targets the death receptor 5 (DR5).
DIMETHYLENASTRON: An inhibitor of the mitotic kinesin Eg5.
I-BET151: An experimental inhibitor of the BET family of bromodomains.
OXYMETHOLONE: A potent androgen and anabolic steroid.
LINRODOSTAT: An experimental inhibitor of the enzyme indoleamine 2,3-dioxygenase 1 (IDO1).
(S)-LIQUIRITIGENIN: The S-enantiomer of liquiritigenin, a flavonoid with estrogenic activity.
TBO-FILGRASTIM: A biosimilar of filgrastim, a recombinant form of G-CSF.
GALSULFASE: An enzyme replacement therapy used for mucopolysaccharidosis VI.
RO-6870810: A research chemical or compound identifier.
GFT14: A research chemical or compound identifier.
ALIZAPRIDE: A dopamine D2 receptor antagonist used as an antiemetic.
GLYBURIDE: A second-generation sulfonylurea drug used to treat type 2 diabetes, also known as glibenclamide.
METHAMPHETAMINE: A potent central nervous system stimulant.
BUDESONIDE: A glucocorticoid used to treat asthma, COPD, and inflammatory bowel disease.
MLN-4760: An experimental inhibitor of angiotensin-converting enzyme 2 (ACE2).
GSK-3&BETA; INHIBITOR 3 [PMID: 25845281]: A specific chemical inhibitor of the GSK-3 beta kinase, as described in the publication.
THYROTROPIN ALFA: A recombinant form of human thyroid-stimulating hormone (TSH).
GLIMEPIRIDE: A third-generation sulfonylurea drug used to treat type 2 diabetes.
AC262970: A research chemical or compound identifier.
INCB7839: An experimental ADAM10 inhibitor.
PIDILIZUMAB: An experimental immunotherapy agent that targets the PD-1 protein.
TRABODENOSON: An experimental adenosine A1 receptor agonist.
SB590885: A potent and selective inhibitor of the BRAF kinase.
GSK1482160: A research chemical or compound identifier.
ROPINIROLE: A dopamine agonist used to treat Parkinson's disease and restless legs syndrome.
&BETA;-CGRP: Beta-Calcitonin gene-related peptide, a neuropeptide involved in pain and migraine.
[3H]-ALMOREXANT: A radiolabeled form of almorexant, a dual orexin receptor antagonist.
PF3845: A potent and selective inhibitor of the FAAH enzyme.
LICARBAZEPINE: An active metabolite of the anticonvulsant oxcarbazepine.
LIPOTECAN: An experimental topoisomerase I inhibitor.
TIAPROFENIC ACID: A non-steroidal anti-inflammatory drug (NSAID).
CUSTIRSEN SODIUM: An experimental antisense oligonucleotide that targets clusterin.
BENZOFURAN: A heterocyclic organic compound.
OCRELIZUMAB: A monoclonal antibody that targets CD20, used to treat multiple sclerosis.
PEGILODECAKIN: An experimental immunotherapy agent, a pegylated form of interleukin-10.
OTELIXIZUMAB: An experimental monoclonal antibody that targets CD3.
GLCC14C18: A research chemical or compound identifier.
ACOTIAMIDE HYDROCHLORIDE: A medication used to treat functional dyspepsia.
P505-15: A research chemical or compound identifier.
ADENOVIRAL TRANSDUCED HIL-12-EXPRESSING AUTOLOGOUS DENDRITIC CELLS INXN-3001 PLUS ACTIVATOR LIGAND INXN-1001: A complex cancer vaccine formulation.
GSK-2245035: A research chemical or compound identifier.
RAPALINK-1: An experimental PROTAC that degrades the mTOR protein.
PEPTIDE YY (3-36): A major circulating form of Peptide YY, which reduces appetite.
AMINOPYRIDINE 2: A research chemical or compound identifier.
AFURESERTIB: An experimental AKT inhibitor.
PX-478: An experimental inhibitor of HIF-1-alpha.
CASP 4 INHIB: A specific chemical inhibitor of the caspase-4 enzyme.
JNJ-42165279: An experimental fatty acid amide hydrolase (FAAH) inhibitor.
BIX02188: An experimental inhibitor of the MEK5 kinase.
ANDECALIXIMAB: An experimental monoclonal antibody.
5-LOX INHIBITOR 2M [PMID: 30199704]: A specific chemical inhibitor of the 5-lipoxygenase enzyme, as described in the publication.
SNX-5422: An experimental Hsp90 inhibitor.
BRIOBACEPT: An experimental fusion protein.
SOLIFENACIN: An antimuscarinic drug used to treat overactive bladder.
MK-4721: A research chemical or compound identifier.
DIETHYLPROPION HYDROCHLORIDE: A sympathomimetic stimulant used as an appetite suppressant.
AME-133V: An experimental monoclonal antibody.
TICAGRELOR: An antiplatelet drug, a P2Y12 inhibitor.
TRAVOPROST: A prostaglandin analogue used in eye drops to treat glaucoma and ocular hypertension.
PRANLUKAST: A leukotriene receptor antagonist used for the treatment of asthma.
METHIONINE BENZIMIDAZOLE 6: A research chemical or compound identifier.
JB 98064: A research chemical or compound identifier.
ACETYLDIGITOXIN: A cardiac glycoside, a derivative of digitoxin.
GSK 256471: A research chemical or compound identifier.
COMPOUND 3 [PMID: 27347366]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
MW150: An experimental agent that inhibits overproduction of pro-inflammatory cytokines.
BENZYLPENICILLOYL POLYLYSINE: A substance used for penicillin allergy skin testing.
TRIFLUPERIDOL: A typical antipsychotic of the butyrophenone class.
POMAGLUMETAD METHIONIL: An experimental prodrug of a metabotropic glutamate receptor 2/3 agonist.
CHLORPROPAMIDE: A first-generation sulfonylurea drug used to treat type 2 diabetes.
ADENOSINE TRIPHOSPHATE: A complex organic chemical that provides energy to drive many processes in living cells, also known as ATP.
BRUCEANTIN: A natural quassinoid with potent antimalarial and anticancer activity.
LESTAURTINIB: An experimental multi-kinase inhibitor that targets FLT3, JAK2, and TRK.
DIPHENYLPYRALINE: A first-generation antihistamine with anticholinergic properties.
DAROTROPIUM BROMIDE: An antimuscarinic agent.
ETHYNODIOL DIACETATE: A progestin used in hormonal contraceptives.
OSPA PROTEIN: Outer surface protein A, a major antigen of the Borrelia burgdorferi bacterium.
TRPM8 AGONIST D-3263: A specific chemical agonist of the TRPM8 ion channel.
ISTIRATUMAB: An experimental monoclonal antibody that targets the IGF-1R.
BENOXINATE: A local anesthetic used as eye drops for ophthalmic procedures.
L745870: A potent and selective dopamine D4 receptor antagonist.
PROCYCLIDINE: An anticholinergic drug used to treat parkinsonism and drug-induced extrapyramidal symptoms.
PROMAZINE: A typical antipsychotic of the phenothiazine class.
5-METHOXYCANTHINONE: A research chemical or compound identifier.
PROPANTHELINE: An antimuscarinic agent used to treat excessive sweating and gastrointestinal spasms.
NAMILUMAB: An experimental monoclonal antibody that targets the GM-CSF ligand.
MEPROBAMATE: A carbamate derivative used as an anxiolytic drug.
SEIMATOPOLIDE A: A natural product with biological activity.
BAY1125976: An experimental PI3K alpha/beta inhibitor.
BENGALENSOL: A research chemical or compound identifier.
BETHANIDINE: An antihypertensive drug that acts as an adrenergic neuron blocking agent.
ALISERTIB SODIUM: The sodium salt of alisertib, an Aurora kinase A inhibitor.
COMPOUND 20 [PMID: 23489211]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
TASQUINIMOD: An experimental immunomodulatory agent that targets the S100A9 protein.
AZ628: An experimental inhibitor of the RAF kinases.
ALFUZOSIN: An alpha-1 blocker used to treat benign prostatic hyperplasia.
L-748337: A research chemical or compound identifier.
NF-56-EJ40: A research chemical or compound identifier.
LUBIPROSTONE: A medication used to treat chronic constipation and irritable bowel syndrome.
PLAZOMICIN: An aminoglycoside antibiotic used to treat complicated urinary tract infections.
2-MERCAPTONICOTINIC ACID: A chemical compound with various biological effects.
CI-218872: A research chemical or compound identifier.
CALCITRIOL: The active form of vitamin D3, which regulates calcium and phosphate levels.
SARGRAMOSTIM: A recombinant form of granulocyte-macrophage colony-stimulating factor (GM-CSF).
ASENAPINE: An atypical antipsychotic used to treat schizophrenia and bipolar disorder.
APD668: An experimental agonist for the GPR119 receptor.
LICOAGRODIN: A research chemical or compound identifier.
ROSIGLITAZONE MALEATE: The maleate salt of rosiglitazone, a PPAR-gamma agonist.
IVACAFTOR: A CFTR protein potentiator used for the treatment of cystic fibrosis with specific mutations.
AFD(R): An abbreviation, possibly for a research compound.
ORLISTAT: A medication used to treat obesity by inhibiting pancreatic and gastric lipases.
BECLOMETHASONE: A synthetic glucocorticoid used as an inhaler for asthma and as a nasal spray.
ALK INHIBITOR ASP3026: An experimental inhibitor of the ALK kinase.
SUBSTANCE P-(6-11): A peptide fragment of the neuropeptide Substance P.
BETHANECHOL CHLORIDE: The chloride salt of bethanechol, a muscarinic receptor agonist.
ANTI-TIM-3 MONOCLONAL ANTIBODY: A class of immunotherapy agents that target the TIM-3 immune checkpoint.
IODINE-131-TOSITUMOMAB: A radioimmunotherapy agent, a monoclonal antibody targeting CD20.
ELDELUMAB: An experimental monoclonal antibody that targets the chemokine CXCL10.
VESNARINONE: An experimental inotropic agent that was studied for heart failure.
CANDIDIN: An antifungal antibiotic.
TRIMETHADIONE: An anticonvulsant used to treat absence seizures.
ETRASIMOD: A sphingosine-1-phosphate (S1P) receptor modulator used for ulcerative colitis.
ROMILKIMAB: An experimental monoclonal antibody that targets interleukin-4 and interleukin-13.
ALOXISTATIN: An inhibitor of the cysteine protease cathepsin B.
TENECTEPLASE: A recombinant tissue plasminogen activator (tPA) used as a thrombolytic drug.
AZD7325: An experimental positive allosteric modulator of the GABAA receptor.
PURVALANOLA: A potent and selective inhibitor of cyclin-dependent kinases (CDKs).
ML354: A research chemical or compound identifier.
COMPOUND 33 [PMID: 26230603]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
[125I]MOTILIN (HUMAN): A radioiodinated form of the peptide hormone motilin.
ADINAZOLAM: A benzodiazepine derivative with antidepressant properties.
PICLOZOTAN: An experimental 5-HT1A receptor agonist that was studied for Parkinson's disease.
ONVANSERTIB: An experimental inhibitor of the Polo-like kinase 1 (Plk1).
NS-398: A selective inhibitor of the COX-2 enzyme.
EPLERENONE: A potassium-sparing diuretic, an aldosterone antagonist.
LP-403812: A research chemical or compound identifier.
NIPRADILOL: A non-selective beta-blocker with alpha-blocking and nitric oxide-donating properties.
AZ12216052: A research chemical or compound identifier.
ALCAFTADINE: An H1 histamine receptor antagonist used in eye drops for allergic conjunctivitis.
BROMOPRIDE: A dopamine D2 receptor antagonist used as an antiemetic.
PENTOSAN POLYSULFATE SODIUM: A semi-synthetic polysulfated xylan used to treat interstitial cystitis.
VOXELOTOR: A medication used to treat sickle cell disease by inhibiting hemoglobin S polymerization.
COMPOUND 12P [LARSON ET AL., 2017]: A specific chemical compound described in a 2017 publication by Larson et al.
PAN-AKT INHIBITOR ARQ751: An experimental inhibitor of all three AKT kinase isoforms.
FLUPHENAZINE HYDROCHLORIDE: A typical antipsychotic medication of the phenothiazine class.
EMEDASTINE DIFUMARATE: A second-generation antihistamine used in eye drops.
GEMTUZUMAB OZOGAMICIN: An antibody-drug conjugate that targets the CD33 protein, used for acute myeloid leukemia.
EPROSARTAN MESYLATE: An angiotensin II receptor antagonist used to treat high blood pressure.
GONADORELIN HYDROCHLORIDE: A synthetic form of gonadotropin-releasing hormone (GnRH).
TROGLITAZONE: A thiazolidinedione (TZD) antidiabetic drug that was withdrawn from the market due to hepatotoxicity.
CALCIFEDIOL ANHYDROUS: The anhydrous form of calcifediol, a form of vitamin D.
DOFETILIDE: An antiarrhythmic medication that blocks potassium channels.
ALISKIREN FUMARATE: A direct renin inhibitor used to treat hypertension.
DIFENOXIN HYDROCHLORIDE: An opioid used in combination with atropine to treat diarrhea.
DIFLUPREDNATE: A potent topical corticosteroid used for eye inflammation.
MEDRYSONE: A topical corticosteroid that was used for eye inflammation.
ACEPROMETAZINE: A phenothiazine antipsychotic used in veterinary medicine as a sedative and antiemetic.
QUINESTROL: A long-acting synthetic estrogen.
DIETHYLSTILBESTROL DIPHOSPHATE: A prodrug of diethylstilbestrol, a synthetic non-steroidal estrogen.
TOCILIZUMAB: A monoclonal antibody that targets the interleukin-6 receptor, used for autoimmune diseases.
DICLOFENAC POTASSIUM: The potassium salt of the NSAID diclofenac.
BELIMUMAB: A monoclonal antibody that targets the B-lymphocyte stimulator (BLyS) protein, used for lupus.
HYDROXYZINE: A first-generation antihistamine with sedative and anxiolytic properties.
CLOPIDOGREL BISULFATE: The bisulfate salt of clopidogrel, an antiplatelet drug.
ISOPROTERENOL: A non-selective beta-adrenergic agonist, also known as isoprenaline.
ESOMEPRAZOLE STRONTIUM: A strontium salt of esomeprazole, a proton pump inhibitor.
AFATINIB DIMALEATE: The dimaleate salt of afatinib, a tyrosine kinase inhibitor.
OLODATEROL HYDROCHLORIDE: The hydrochloride salt of olodaterol, an ultra-LABA for COPD.
LEVETIRACETAM: An anticonvulsant medication used to treat epilepsy.
MEMANTINE HYDROCHLORIDE: An NMDA receptor antagonist used to treat moderate-to-severe Alzheimer's disease.
RG-7167: A research chemical or compound identifier.
CORT 108297: An experimental glucocorticoid receptor antagonist.
AVL-3288: An experimental alpha-7 nicotinic receptor positive allosteric modulator.
MR-1817: A research chemical or compound identifier.
AUS-131: A research chemical or compound identifier.
ORG-34517: A research chemical or compound identifier.
IDOXIFENE: A selective estrogen receptor modulator (SERM).
BECOCALCIDIOL: An experimental vitamin D analog.
MILCICLIB: An experimental multi-cyclin-dependent kinase (CDK) inhibitor.
R-343: A research chemical or compound identifier.
BAY1067197: A research chemical or compound identifier.
KRP203: An experimental sphingosine-1-phosphate receptor 1 (S1P1) modulator.
BVT.115959: An experimental DPP-4 inhibitor.
PRS-211375: A research chemical or compound identifier.
AMILORIDE: A potassium-sparing diuretic.
ACOLBIFENE: An experimental selective estrogen receptor modulator (SERM).
ALBINTERFERON ALFA-2B: An experimental long-acting form of interferon alfa-2b.
GOSOGLIPTIN: A DPP-4 inhibitor used to treat type 2 diabetes.
TAFAMIDIS: A transthyretin stabilizer used to treat transthyretin amyloidosis.
REPAGLINIDE: A meglitinide antidiabetic drug that stimulates insulin secretion.
TALAROZOLE: An experimental aromatase inhibitor.
ERITORAN TETRASODIUM: An experimental TLR4 antagonist that was studied for severe sepsis.
PRABOTULINUMTOXIN A: A form of botulinum toxin type A, used for cosmetic and medical purposes.
DUTOGLIPTIN: An experimental DPP-4 inhibitor.
PAZUFLOXACIN: A fluoroquinolone antibiotic.
CALCIUM OXYBATE: The calcium salt of gamma-hydroxybutyrate (GHB).
SOMAPACITAN: A long-acting recombinant human growth hormone.
TRIMETHAPHAN: A ganglionic blocker that was used for hypertensive emergencies.
BINTRAFUSP ALFA: An experimental bifunctional fusion protein targeting TGF-beta and PD-L1.
LEFITOLIMOD: An experimental Toll-like receptor 9 (TLR9) agonist.
MAVELERTINIB: An experimental ERK1/2 kinase inhibitor.
CYTISINE: A plant alkaloid that acts as a nicotinic acetylcholine receptor partial agonist, used for smoking cessation.
BMS-817399: An experimental ATP-competitive inhibitor of the focal adhesion kinase (FAK).
FEZOLINETANT: A neurokinin-3 (NK3) receptor antagonist used to treat vasomotor symptoms of menopause.
TILAVONEMAB: An experimental monoclonal antibody that targets the Tau protein.
BEMARITUZUMAB: An experimental monoclonal antibody that targets the FGFR2b receptor.
AMELPARIB DIHYDROCHLORIDE DIHYDRATE: A formulation of an experimental PARP inhibitor.
CIBINETIDE: An experimental peptide that mimics erythropoietin's non-hematopoietic effects.
PAT-1251: A research chemical or compound identifier.
EDOTECARIN: An experimental topoisomerase I inhibitor.
AVX-470: An experimental oral antibody therapy targeting TNF-alpha for inflammatory bowel disease.
NEIHULIZUMAB: An experimental monoclonal antibody that targets the PSGL-1 protein.
PSOROMIC ACID: A lichen acid with biological activities.
PEFCALCITOL: An experimental vitamin D analog.
DOLCANATIDE: An experimental guanylate cyclase-C agonist studied for gastrointestinal disorders.
SM-122: A research chemical or compound identifier.
1,3-DITOLYLGUANIDINE: A selective sigma-1 receptor agonist.
BETULINIC ACID: A natural pentacyclic triterpenoid with various biological activities, including anticancer effects.
PILAVAPADIN: An experimental beta-3 adrenergic agonist.
WISTIN: A research chemical or compound identifier.
MTORC1/2 KINASE INHIBITOR BI 860585: An experimental dual inhibitor of mTORC1 and mTORC2.
ROVALPITUZUMAB TESIRINE: An antibody-drug conjugate that targets the DLL3 protein.
GONIOTHALAMIN: A natural styryl-lactone with cytotoxic and other biological activities.
EUCALYPTIN A: A natural product with a specific chemical structure.
TRIDECAN-1-OL: A fatty alcohol.
TRELANSERIN: An experimental 5-HT2A receptor antagonist.
SELECTIVE ESTROGEN RECEPTOR MODULATOR TAS-108: An experimental SERM.
OXYMETAZOLINE HYDROCHLORIDE: An alpha-1/alpha-2 adrenergic agonist used as a topical decongestant.
MELANOMA VACCINE: A general class of vaccines designed to treat or prevent melanoma.
AMP-224: An experimental fusion protein that targets the PD-1 pathway.
AMODIAQUINE HYDROCHLORIDE: An antimalarial drug.
WR-159412: A research chemical or compound identifier.
ELTROMBOPAG: A thrombopoietin receptor agonist used to treat thrombocytopenia.
TROLEANDOMYCIN: A macrolide antibiotic.
MINOCYCLINE HYDROCHLORIDE: The hydrochloride salt of the antibiotic minocycline.
(S)-ONDANSETRON: The S-enantiomer of ondansetron, a 5-HT3 receptor antagonist.
AMITIFADINE: An experimental triple reuptake inhibitor (serotonin, norepinephrine, dopamine).
DYDROGESTERONE: A progestin used for a variety of gynecological conditions.
ORTHOTOLIDINE: A chemical compound used in analytical chemistry.
SULFATINIB: An experimental multi-kinase inhibitor targeting VEGFR, FGFR, and CSF1R.
LICOGLIFLOZIN: An experimental dual SGLT1/SGLT2 inhibitor.
PHENYLARSINE OXIDE: A chemical compound that inhibits protein tyrosine phosphatases.
PHENCYCLIDINE HYDROCHLORIDE: The hydrochloride salt of phencyclidine (PCP), a dissociative anesthetic.
OGLEMILAST: An experimental phosphodiesterase-4 (PDE4) inhibitor.
ALOIN: A natural compound found in the aloe plant.
TLR AGONIST CADI-05: An experimental Toll-like receptor agonist for cancer immunotherapy.
LY-377604: A research chemical or compound identifier.
CEFQUINOME: A fourth-generation cephalosporin antibiotic used in veterinary medicine.
(+)-TAXIFOLIN: A flavonoid with antioxidant and other biological properties.
GINSENOSIDE RG3: A specific saponin from ginseng with anticancer properties.
METHYSTICIN: A kavalactone found in the kava plant.
MACROCARPAL B: A natural product with biological activity.
RAZOXANE: An agent that inhibits topoisomerase II.
NORLEUCINE: An isomer of the amino acid leucine.
KURARINONE: A natural lavandulyl flavanone with various biological activities.
PRALMORELIN: A growth hormone secretagogue.
AZOSEMIDE: A loop diuretic.
ATRASENTAN: An experimental endothelin receptor antagonist.
DEXAMETHASONE PALMITATE: A lipophilic prodrug of dexamethasone.
CARFENTANIL: An extremely potent synthetic opioid analgesic.
AM-630: A potent and selective antagonist/inverse agonist for the cannabinoid CB2 receptor.
PRE-084: A potent and selective sigma-1 receptor agonist.
SURATADENOTUREV: An experimental gene therapy.
GW780056X: A research chemical or compound identifier.
RINFABATE: A research chemical or compound identifier.
THIOCTIC ACID: Also known as alpha-lipoic acid, an antioxidant.
IODINE I 131 TM-601: A radiolabeled synthetic chlorotoxin peptide studied for glioma.
ZOTIRACICLIB: An experimental cyclin-dependent kinase (CDK) inhibitor.
ETHAVERINE: A papaverine analog that acts as a phosphodiesterase inhibitor.
DIDODECANOYLPHLOROGLUCINOL: A chemical compound.
T-226296: A research chemical or compound identifier.
CHOLINE CHLORIDE: A salt of choline, an essential nutrient.
TOLNAFTATE: A topical antifungal agent.
CAPSAICIN: The active component of chili peppers, which acts as a TRPV1 receptor agonist.
NBI-34041: A research chemical or compound identifier.
AMIFAMPRIDINE PHOSPHATE: The phosphate salt of amifampridine, a potassium channel blocker.
AMIFAMPRIDINE: A potassium channel blocker used to treat Lambert-Eaton myasthenic syndrome.
CLOPIDOGREL: An antiplatelet drug that acts as a P2Y12 inhibitor.
ABT-510: An experimental anti-angiogenic peptide.
RECOMBINANT INTERFERON BETA: A general class of manufactured interferon beta proteins.
ANTI-ANDROGEN: A class of drugs that inhibit the biological effects of androgens.
BROXURIDINE: A halogenated derivative of deoxyuridine, used in research.
RECOMBINANT INHIBIN: A manufactured form of the inhibin protein.
CAPROMAB: A monoclonal antibody used in medical imaging for prostate cancer.
FRAMYCETIN: An aminoglycoside antibiotic.
STALLIMYCIN: An antibiotic compound.
CETRORELIX: A gonadotropin-releasing hormone (GnRH) antagonist used in assisted reproduction.
RECOMBINANT PROTHYMOSIN ALPHA: A manufactured form of the prothymosin alpha protein.
CDK INHIBITOR AT7519: An experimental inhibitor of multiple cyclin-dependent kinases.
3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE: A chemical compound, a potent kinase inhibitor also known as SU5416.
C1 ESTERASE INHIBITOR: A protein that regulates the complement and contact systems.
RECOMBINANT INTERLEUKIN-1-BETA: A manufactured form of the IL-1 beta cytokine.
DROLOXIFENE: An experimental selective estrogen receptor modulator (SERM).
AUTOANTIGEN: An endogenous antigen that is recognized by the immune system.
INTERLEUKIN-2 GENE: The gene that encodes the cytokine interleukin-2.
DEOXYSPERGUALIN: An immunosuppressive agent.
TRIFLUOPERAZINE: A typical antipsychotic of the phenothiazine class.
TARAFENACIN: An experimental M3 muscarinic receptor antagonist.
RECOMBINANT TRANSFORMING GROWTH FACTOR-BETA-2: A manufactured form of the TGF-beta2 cytokine.
CARCINOEMBRYONIC ANTIGEN-EXPRESSING MEASLES VIRUS: An experimental oncolytic virus therapy.
INCOMPLETE FREUND'S ADJUVANT: An adjuvant used to boost the immune response in animal research.
PRASUGREL: An antiplatelet drug that acts as a P2Y12 inhibitor.
MANNOMUSTINE: An alkylating agent used in chemotherapy.
VINBLASTINE: A vinca alkaloid chemotherapy agent that inhibits microtubule formation.
PARABEN: A class of preservatives used in cosmetics and pharmaceuticals.
TLR7 AGONIST 852A: An experimental Toll-like receptor 7 agonist.
BINDARIT: An experimental anti-inflammatory agent that inhibits the synthesis of MCP chemokines.
BERBERINE: A natural alkaloid with a wide range of pharmacological effects.
BLOSOZUMAB: An experimental monoclonal antibody that targets the sclerostin protein.
DELANZOMIB: An experimental proteasome inhibitor.
HCBE-11: A research chemical or compound identifier.
LOTAMILAST: An experimental phosphodiesterase-4 (PDE4) inhibitor.
PSI-697: A research chemical or compound identifier.
OXAZINE 89: A research chemical or compound identifier.
GI-4000: An experimental cancer vaccine targeting mutant Ras proteins.
ECALLANTIDE: An inhibitor of the plasma kallikrein enzyme, used to treat hereditary angioedema.
TABERMINOGENE VADENOVEC: An experimental gene therapy for glioblastoma.
MK-3697: A research chemical or compound identifier.
BOCOCIZUMAB: An experimental monoclonal antibody that targets the PCSK9 protein.
CALASPARGASE PEGOL: A pegylated form of the enzyme asparaginase, used for leukemia.
CG-200745: An experimental histone deacetylase (HDAC) inhibitor.
VUDALIMAB: An experimental bispecific antibody targeting PD-1 and VISTA.
FREMANEZUMAB: A monoclonal antibody that targets CGRP, used to prevent migraine.
TEZACAFTOR AND IVACAFTOR: A combination drug for the treatment of cystic fibrosis.
TAGRAXOFUSP-ERZS: A fusion protein targeting CD123, used for blastic plasmacytoid dendritic cell neoplasm.
NOV-002: An experimental agent that was studied as an adjunct to chemotherapy.
FLAVOXATE: An antimuscarinic drug used to treat urinary bladder spasms.
AZD4877: An experimental antibody-drug conjugate targeting the CD70 protein.
MET TYROSINE KINASE INHIBITOR SGX523: An experimental selective inhibitor of the MET kinase.
ALTROPANE: A radiopharmaceutical used in SPECT imaging of the dopamine transporter.
MIGLITOL: An alpha-glucosidase inhibitor used to treat type 2 diabetes.
LBY-135: A research chemical or compound identifier.
XEVINAPANT: An experimental IAP inhibitor studied for cancer.
BERAPROST: A prostacyclin analogue used to treat pulmonary hypertension.
ULODESINE: An inhibitor of purine nucleoside phosphorylase (PNP).
CENDERITIDE: An experimental dual natriuretic peptide receptor agonist.
TALIMOGENE LAHERPAREPVEC: An oncolytic virus therapy used to treat melanoma.
DENINTUZUMAB MAFODOTIN: An experimental antibody-drug conjugate targeting CD19.
ANTI-NY-ESO-1 IMMUNOTHERAPEUTIC GSK-2241658A: An experimental cancer vaccine.
ANTI-CD22 CAR T CELLS PREPARATION: A type of CAR-T cell therapy targeting the CD22 protein.
RECOMBINANT NEMATODE ANTICOAGULANT PROTEIN C2: A manufactured anticoagulant protein from hookworms.
RIMCAZOLE: An experimental antipsychotic agent.
LIFITEGRAST: A medication used in eye drops to treat dry eye disease.
AUTOLOGOUS CD19CAR-CD28-CD137/CD27/CD3ZETA-ICASP9-EXPRESSING T-LYMPHOCYTES: A specific formulation of CAR-T cell therapy.
HUMAN CALCITONIN: A hormone produced by the thyroid gland that regulates calcium levels.
VORSETUZUMAB MAFODOTIN: An experimental antibody-drug conjugate targeting CD70.
CARBOPROST TROMETHAMINE: A synthetic prostaglandin analogue used to induce labor and control postpartum bleeding.
FUMAGILLIN-DERIVED POLYMER CONJUGATE XMT-1107: An experimental anticancer agent.
SMAC MIMETIC GDC-0917: An experimental agent that antagonizes IAP proteins.
AMBENONIUM: A reversible cholinesterase inhibitor used to treat myasthenia gravis.
ANILERIDINE: An opioid analgesic.
DESOXIMETASONE: A potent topical corticosteroid.
GI-6301: A research chemical or compound identifier.
VALBENAZINE TOSYLATE: The tosylate salt of valbenazine, a VMAT2 inhibitor.
HALOTHANE: An inhaled general anesthetic.
BI-853520: An experimental BET inhibitor.
MINOXIDIL: A vasodilator used to treat high blood pressure and topically for hair loss.
FLUNARIZINE: A calcium channel blocker used to prevent migraine.
GLYCOPYRRONIUM: An antimuscarinic agent used to reduce secretions and for COPD.
MEPINDOLOL: A non-selective beta-blocker.
PALIPERIDONE: An atypical antipsychotic, the active metabolite of risperidone.
PILSICAINIDE: An antiarrhythmic medication.
SARPOGRELATE: An antiplatelet drug that acts as a 5-HT2A receptor antagonist.
OXYPHENCYCLIMINE: An antimuscarinic agent.
SUCCINIC ACID: A dicarboxylic acid that is an intermediate in the citric acid cycle.
TOLPERISONE: A centrally acting muscle relaxant.
COAGULATION FACTOR X, HUMAN: A preparation of the human Factor X protein, used for bleeding disorders.
TENAPANOR: An NHE3 inhibitor used to treat irritable bowel syndrome with constipation.
CVX-241: An experimental anti-angiogenic agent.
AVADOMIDE: An experimental immunomodulatory drug of the cereblon E3 ligase modulator class.
WP-1066: An experimental agent that inhibits the STAT3 signaling pathway.
IMO-2055: An experimental Toll-like receptor 9 (TLR9) agonist.
LIRIMILAST: An experimental phosphodiesterase-4 (PDE4) inhibitor.
AUTOLOGOUS PROSTATE CANCER ANTIGEN-EXPRESSING DENDRITIC CELL VACCINE BPX-101: An experimental cancer vaccine.
ALPHA-1-PROTEINASE INHIBITOR HUMAN: A protein used to treat alpha-1 antitrypsin deficiency.
NAPHAZOLINE: A decongestant that acts as an alpha-adrenergic agonist.
HYDRONIDONE: A research chemical or compound identifier.
AMLINTIDE: A synthetic analogue of the hormone amylin.
FLUOROQUINOLONE ANTIBiotic: A class of broad-spectrum antibiotics.
UE2343: A research chemical or compound identifier.
SIPLIZUMAB: An experimental monoclonal antibody that targets the CD2 receptor.
TEBIPENEM: A carbapenem antibiotic.
SNAP-7941: An experimental antagonist of the melanin-concentrating hormone receptor 1.
BETAMETHASONE: A potent synthetic glucocorticoid with anti-inflammatory and immunosuppressant effects.
CP-122721: A potent and selective 5-HT1D receptor agonist.
SAPROPTERIN: A synthetic form of tetrahydrobiopterin (BH4), used to treat phenylketonuria.
TROPISETRON: A 5-HT3 receptor antagonist used as an antiemetic.
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA: A long-acting erythropoiesis-stimulating agent.
REMIFENTANIL HYDROCHLORIDE: An ultra-short-acting synthetic opioid analgesic.
CRYPTENAMINE ACETATES: A mixture of alkaloids that was used as an antihypertensive.
DEXTROTHYROXINE SODIUM: The sodium salt of dextrothyroxine, which was used to lower cholesterol.
ESTRADIOL CYPIONATE: A long-acting ester of the estrogen estradiol.
PLECANATIDE: A guanylate cyclase-C agonist used to treat chronic constipation.
IMC-CS4: A research chemical or compound identifier.
ADEMETIONINE: A naturally occurring compound, also known as S-adenosyl methionine (SAMe).
ELAFIBRANOR: An experimental dual PPAR alpha/delta agonist.
VERUBULIN: An experimental vascular disrupting agent and microtubule inhibitor.
FROVATRIPTAN: A triptan drug used for the acute treatment of migraine.
ENOXAPARIN SODIUM: A low molecular weight heparin (LMWH) used as an anticoagulant.
CILOBRADINE: An experimental agent that inhibits the If current in the sinoatrial node.
AURORA B/C KINASE INHIBITOR GSK1070916A: An experimental inhibitor of the Aurora B and C kinases.
APABETALONE: An experimental agent that inhibits the BET family of bromodomains.
TAK-448: A research chemical or compound identifier.
PRADIGASTAT: An experimental DGAT1 inhibitor.
COMPOUND 1 [PMID: 20005102]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
NARATRIPTAN: A triptan drug used for the acute treatment of migraine.
3-ISOBUTYL-1-METHYL-7H-XANTHINE: A phosphodiesterase inhibitor, also known as IBMX.
CP 93129: A selective 5-HT1B receptor agonist.
OCAPERIDONE: An experimental antipsychotic agent.
MRS923: A research chemical or compound identifier.
[3H]HEMADO: A radiolabeled compound, likely a receptor ligand.
RHODEI-LITORIN: A research chemical or compound identifier.
AZ-4217: A research chemical or compound identifier.
COMPOUND 2 [PMID: 26061392]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
&ALPHA;-METHYL-5-HT: A selective agonist for the 5-HT2 receptor.
Z-DQMD-FMK: A specific, irreversible inhibitor of caspase-3.
BENIDIPINE: A calcium channel blocker used to treat hypertension.
EXAMPLE 166 [WO2014154727]: A specific chemical compound described in a patent application.
AM10257: A research chemical or compound identifier.
LENABASUM: An experimental cannabinoid receptor type 2 (CB2) agonist.
DESULFATED GASTRIN-71: A form of the peptide hormone gastrin.
PIPOTHIAZINE: A typical antipsychotic of the phenothiazine class.
FENOLDOPAM MESYLATE: The mesylate salt of fenoldopam, a dopamine D1 receptor partial agonist.
QUEMLICLUSTAT: An experimental METAP2 inhibitor.
PSB-6426: A research chemical or compound identifier.
COMPOUND 18J [PMID: 35446588]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
AG1478: A potent and selective inhibitor of the EGFR tyrosine kinase.
AUMOLERTINIB: A third-generation EGFR inhibitor used to treat non-small cell lung cancer.
ALLITINIB: An experimental irreversible pan-HER tyrosine kinase inhibitor.
HB-EGF: Heparin-binding EGF-like growth factor, a ligand for the EGFR.
SMTP-7: An experimental agent that was studied for ischemic stroke.
TG8-260: A research chemical or compound identifier.
NEUREGULIN-3: A protein that is a ligand for the ErbB4 receptor tyrosine kinase.
TERGURIDE: A dopamine agonist with partial agonist activity at serotonin receptors.
CYANOPINDOLOL: A beta-blocker that also acts as a 5-HT1A/1B receptor antagonist.
R,R-THC: An enantiomer of tetrahydrocannabinol (THC).
PD164333: A research chemical or compound identifier.
BIOCHANIN A: An isoflavone phytoestrogen found in red clover.
PKR INHIBITOR: A class of drugs that inhibit the protein kinase R.
COMPOUND 34 [PMID: 20189382]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
NBI-59159: A research chemical or compound identifier.
BIA 10-2639: An experimental fatty acid amide hydrolase (FAAH) inhibitor.
BASMISANIL: An experimental vasopressin V1b receptor antagonist.
AZA-THIP: A research chemical or compound identifier.
GSK1614343: A research chemical or compound identifier.
YIL781: An experimental LPA1 receptor antagonist.
MESULERGINE: A dopamine and serotonin receptor agonist.
COMPOUND 17 [PMID: 29741897]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
VELSECORAT: An experimental glucocorticoid receptor modulator.
NVP-AAM077: A selective NMDA receptor antagonist that targets the NR2A subunit.
COMPOUND 4G [PMID: 2680437]: An experimental compound described in a 1993 publication (PMID is for 1993).
SB-415286: A potent and selective inhibitor of the enzyme GSK-3.
COMPOUND 5 [PMID: 19338355]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 9N [PMID: 18752940]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
[125I]STA: A radiolabeled compound, likely a receptor ligand.
LIGHT: A cytokine that is a member of the tumor necrosis factor (TNF) superfamily.
[125I]CCL16 (HUMAN): A radioiodinated form of the chemokine CCL16.
COMPOUND 1 [PMID: 21939274]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
CLUL1 (52-77): A peptide fragment.
MS48107: A research chemical or compound identifier.
R-SPONDIN-2: A protein that is a ligand for LGR receptors and potentiates Wnt/beta-catenin signaling.
ML 10302: A research chemical or compound identifier.
CGEN-856: A research chemical or compound identifier.
R-SPONDIN-4: A protein that is a ligand for LGR receptors and potentiates Wnt/beta-catenin signaling.
MIANSERIN: A tetracyclic antidepressant.
CANDOXATRILAT: The active metabolite of the neutral endopeptidase inhibitor candoxatril.
FASIDOTRILAT: The active metabolite of the dual vasopeptidase inhibitor fasidotril.
COMPOUND 1A [PMID: 25692029]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
SB 699551: A selective 5-HT5A receptor antagonist.
SB 414240: A research chemical or compound identifier.
NEUROPEPTIDE B-23: The endogenous 23-amino acid form of neuropeptide B.
1DME: A research chemical or compound identifier.
[125I]1DME: A radiolabeled research chemical.
KH28: A research chemical or compound identifier.
RFRP-3: A neuropeptide that is the endogenous ligand for the GPR147 receptor.
JMV431: A research chemical, a growth hormone secretagogue receptor agonist.
ALMOREXANT: An experimental dual orexin receptor antagonist that was studied for insomnia.
CVN45502: A research chemical or compound identifier.
SB-649868: An experimental dual orexin receptor antagonist.
DATP: A research chemical or compound identifier.
GSK1370319A: A research chemical or compound identifier.
CANGRELOR: An antiplatelet drug, a P2Y12 inhibitor.
MRS2782: A research chemical or compound identifier.
MRS2768: A research chemical or compound identifier.
PLATELET ACTIVATING FACTOR: A potent phospholipid activator and mediator of many leukocyte functions.
EUROPIUM-LABELLED INSL5: A labeled form of the peptide hormone insulin-like peptide 5.
JNJ-18038683: A potent and selective 5-HT7 receptor antagonist.
VALSPODAR: An experimental P-glycoprotein inhibitor designed to overcome multidrug resistance.
[125I]RELAXIN-3 (HUMAN): A radioiodinated form of the peptide hormone relaxin-3.
SD-91: A research chemical or compound identifier.
HISTIDINE: An essential amino acid.
SLC4101431: A research chemical or compound identifier.
DES-AA1,5-[TYR2,D-TRP8,IAMP9]SRIF: A complex synthetic peptide analogue of somatostatin.
ANALOG 32 [PMID:18543899]: A specific chemical analog described in a 2008 publication.
MK-4256: An experimental CETP inhibitor.
ADU-S100: An experimental STING pathway activator for cancer immunotherapy.
LAROPIPRANT: An experimental prostaglandin D2 receptor 1 (DP1) antagonist.
U46609: A stable synthetic analogue of the prostaglandin thromboxane A2.
OTAMIXABAN: An experimental direct factor Xa inhibitor.
ILOMASTAT: A broad-spectrum matrix metalloproteinase (MMP) inhibitor.
AM237: A research chemical or compound identifier.
ML9: A research chemical that inhibits myosin light-chain kinase.
GSMTX-4: A peptide toxin from spider venom that blocks mechanosensitive ion channels.
BTDM: An abbreviation, possibly for a research compound.
SPHINGOSINE: An amino alcohol that is a fundamental component of sphingolipids.
PHENYLACETYLRINVANIL: A synthetic cannabinoid that acts as a potent agonist for the TRPV1 receptor.
[125I]N-BIOTIN-[AHX0, BPA3]U-II (HUMAN): A complex, radiolabeled peptide analogue of urotensin-II.
MOZAVAPTAN: A vasopressin V2 receptor antagonist.
CIRAZOLINE: A selective alpha-1 adrenergic receptor agonist.
ABZ-SER-PRO-TYR(NO2)-OH: A research chemical or compound identifier.
3H[MET(0)11]-APELIN-13: A radiolabeled form of the peptide apelin-13.
COMPOUND 5B [PMID: 25974655]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
UGR 9-1: A research chemical or compound identifier.
FLT3 INHIBITOR FF-10101 SUCCINATE: An experimental inhibitor of the FLT3 kinase.
ROLOFYLLINE: An experimental adenosine A1 receptor antagonist that was studied for heart failure.
APADENOSON: A selective adenosine A2A receptor agonist.
TRABECTEDIN: A chemotherapy agent used to treat soft tissue sarcoma and ovarian cancer.
MRS1132: A research chemical or compound identifier.
LOMUSTINE: A nitrosourea alkylating agent used in chemotherapy, particularly for brain tumors.
MRS1754: A potent and selective antagonist of the adenosine A2B receptor.
PATRITUMAB DERUXTECAN: An experimental antibody-drug conjugate targeting the HER3 protein.
PREXASERTIB: An experimental inhibitor of the Chk1 kinase.
TONAPOFYLLINE: An experimental adenosine A1/A2 receptor antagonist.
TCPA: A research chemical or compound identifier.
PYRVINIUM: An anthelmintic medication with potential anticancer activity.
ICG-001: An experimental agent that inhibits the Wnt/beta-catenin signaling pathway.
LUF6000: A research chemical or compound identifier.
GVAX: A type of cancer vaccine composed of tumor cells modified to secrete GM-CSF.
COMPOUND 1 [PMID: 28379944]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
AT-9283: An experimental multi-kinase inhibitor targeting Aurora kinases and JAK.
IBCASERTIB: An experimental AKT inhibitor.
SM-337: A research chemical or compound identifier.
COMPOUND 17C [PMID: 25497965]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
ABT-737: An experimental agent that inhibits the BCL-2 family of proteins.
CGP 12177: A classic beta-adrenergic receptor partial agonist/antagonist.
CHF-6366: A research chemical or compound identifier.
MIRABEGRON: A beta-3 adrenergic receptor agonist used to treat overactive bladder.
L742791: A research chemical or compound identifier.
COMPOUND 5B [PMID: 31287314]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
Z-IETD-FMK: A specific, irreversible inhibitor of caspase-8.
7,3'-DIMETHOXYFLAVONE: A natural flavone compound.
CALHEX 231: A negative allosteric modulator of the calcium-sensing receptor.
REGRELOR: An experimental antiplatelet agent.
ARI-3099: A research chemical or compound identifier.
UPACICALCET: An experimental calcimimetic.
TELOTRISTAT ETHYL: An inhibitor of the enzyme tryptophan hydroxylase, used to treat carcinoid syndrome diarrhea.
COMPOUND 8A [PMID: 22861813]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 3D [PMID: 3941405]: An experimental compound described in a 1985 publication.
SEMULOPARIN SODIUM: An experimental ultra-low-molecular-weight heparin.
ABT-639: An experimental TRPV1 antagonist.
EVACETRAPIB: An experimental CETP inhibitor that was studied to raise HDL cholesterol.
GW842166: An experimental TRPV1 antagonist.
TRYPTOPHAN: An essential amino acid, a precursor to serotonin and melatonin.
LEO 29102: A research chemical or compound identifier.
RELAXIN: A peptide hormone with various physiological roles, including vasodilation.
CCK-39: Cholecystokinin-39, a peptide hormone.
AV-203: A research chemical or compound identifier.
GASTRIN-71: A long form of the peptide hormone gastrin.
BODILISANT: An experimental histamine H3 receptor antagonist/inverse agonist.
[3H]DEVAZEPIDE: A radiolabeled form of devazepide, a cholecystokinin receptor antagonist.
GASTRIN-34: A long form of the peptide hormone gastrin.
SR146131: A research chemical or compound identifier.
[125I]CCL5 (HUMAN): A radioiodinated form of the chemokine CCL5 (RANTES).
CCL25: A small cytokine belonging to the CC chemokine family, also known as TECK.
TREGALIZUMAB: An experimental monoclonal antibody that targets the CD4 receptor.
LEVAMISOLE: An anthelmintic and immunomodulatory agent.
UBLITUXIMAB: A monoclonal antibody that targets the CD20 protein, used for multiple sclerosis.
VOSAROXIN: An experimental topoisomerase II inhibitor studied for acute myeloid leukemia.
OTILIMAB: An experimental monoclonal antibody that targets the GM-CSF protein.
DIPHENIDOL HYDROCHLORIDE: An antiemetic and anti-vertigo agent.
LOMERIZINE: A calcium channel blocker used to prevent migraine.
COMPOUND 50 [PMID: 24313754]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
RKI-1447: A potent and selective inhibitor of the ROCK kinase.
OCEDURENONE: An experimental non-steroidal mineralocorticoid receptor antagonist.
NEOMYCIN SULFATE: An aminoglycoside antibiotic used topically and orally.
GLPG1837: An experimental CFTR protein corrector.
TALMAPIMOD: An experimental p38 MAP kinase inhibitor.
NS5818: A research chemical that potentiates GABAA receptors.
COMPOUND 2 [PMID: 22911925]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
PTBE: An abbreviation, possibly for a research compound.
CP-673451: An experimental inhibitor of the PDGFR tyrosine kinase.
NK3201: A research chemical or compound identifier.
PROTON PUMP INHIBITOR: A class of drugs that decrease stomach acid production, used for GERD and ulcers.
ERGOCALCIFEROL: Also known as Vitamin D2, used to treat vitamin D deficiency.
GLYCINE: An amino acid that functions as an inhibitory neurotransmitter.
TECHNETIUM TC 99M TROFOLASTAT: A radiopharmaceutical used in SPECT imaging to detect prostate cancer.
INCB086550: A research chemical or compound identifier.
ANTINEOPLASTIC ANTIBIOTIC: A class of antibiotics that have anticancer activity.
N-METHYLHISTAMINE DIHYDROCHLORIDE: A metabolite of histamine.
TOPICAL CORTICOSTEROID: A class of steroid medications applied to the skin.
UROCORTIN 1: A peptide related to corticotropin-releasing factor that acts on CRF receptors.
[3H]TIOTROPIUM: A radiolabeled form of tiotropium, a long-acting antimuscarinic bronchodilator.
AMYLIN: A peptide hormone that is co-secreted with insulin from pancreatic beta-cells.
AC187: A peptide antagonist of the amylin receptor.
LITIFILIMAB: An experimental monoclonal antibody that targets the BDCA2 protein.
PBF-509: An experimental adenosine A2A receptor antagonist.
ERYTHROMYCIN ACISTRATE: A prodrug of the antibiotic erythromycin.
KBP-066: A research chemical or compound identifier.
GNE-9605: An experimental inhibitor of the SHP2 phosphatase.
TEPODITAMAB: An experimental bispecific antibody targeting CD19 and CD3.
VB-201: An experimental anti-inflammatory agent.
LOXOPROFEN: A non-steroidal anti-inflammatory drug (NSAID).
KU-55933: A potent and selective inhibitor of the ATM kinase.
CXCL16: A small cytokine belonging to the CXC chemokine family.
SY-5609: An experimental cyclin-dependent kinase 7 (CDK7) inhibitor.
ST-1535: A research chemical or compound identifier.
TRIPLE MODULATOR 10 [PMID: 29878767]: A specific CFTR modulator compound described in the publication.
TERPESTACIN: A natural product that inhibits the syncytium formation induced by HIV.
CHLORPHENIRAMINE MALEATE: A first-generation antihistamine used to treat allergies.
FUREGRELATE SODIUM: An inhibitor of the enzyme thromboxane A2 synthase.
SDZ 64-412: A research chemical or compound identifier.
MABP1: A research chemical or compound identifier.
MOXIDECTIN: An anthelmintic drug used in veterinary medicine.
PTEROSTILBENE: A stilbenoid compound, chemically related to resveratrol.
1G244: A research chemical or compound identifier.
ARRY-502: An experimental inhibitor of the kinase IRAK4.
PGD2: Prostaglandin D2, a lipid mediator involved in inflammation and sleep.
ANISOCOUMARIN H: A natural product with biological activity.
COMPOUND 6641: A research chemical or compound identifier.
NORADRENALINE: A catecholamine that functions as a hormone and neurotransmitter, also known as norepinephrine.
ENASIDENIB: An inhibitor of mutant isocitrate dehydrogenase 2 (IDH2), used for acute myeloid leukemia.
QAV680: An experimental monoclonal antibody that targets the IgE receptor.
BEMPEDOIC ACID: A medication used to lower LDL cholesterol by inhibiting the enzyme ATP citrate lyase.
Y-KE88: A research chemical or compound identifier.
VOFATAMAB: An experimental monoclonal antibody that targets the FGFR3 receptor.
MORACIN M: A natural product with biological activity.
ISOPROPAMIDE IODIDE: A long-acting anticholinergic drug.
TIP39-(7-39) (HUMAN/BOVINE): A peptide fragment of tuberoinfundibular peptide of 39 residues.
COMPOUND 53 [PMID: 19631533]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
DDO-3055: A research chemical or compound identifier.
[125I]OH-LVA: A radiolabeled compound, likely a receptor ligand.
KC-12615: A research chemical or compound identifier.
CURCUMIN: A bright yellow chemical produced by Curcuma longa plants, with various biological activities.
HAS-NMU: A research chemical or compound identifier.
METHIXENE HYDROCHLORIDE: An anticholinergic drug.
EGF: Epidermal Growth Factor, a protein that stimulates cell growth and differentiation.
CLOFARABINE: A purine nucleoside antimetabolite used in chemotherapy for leukemia.
ILOPROST: A prostacyclin analogue used to treat pulmonary arterial hypertension.
QUINELORANE: A potent and selective dopamine D2/D3 receptor agonist.
ONO-8713: A research chemical, a prostaglandin EP1 receptor antagonist.
T532: A research chemical or compound identifier.
TAPRENEPAG: An experimental prostaglandin EP2 receptor agonist.
OXENDOLONE: An experimental agent that was studied for its effects on steroid hormones.
BUTAPROST (FREE ACID FORM): The active acid form of butaprost, a prostaglandin EP2 receptor agonist.
RUPATADINE: A second-generation antihistamine with PAF-antagonizing activity.
TIGATUZUMAB: An experimental monoclonal antibody that targets the death receptor 5 (DR5).
SYN-BRP-LPA: A research chemical or compound identifier.
DTS-201: An experimental agent, a prodrug of a matrix metalloproteinase inhibitor.
COMPOUND 47 [PMID: 35640059]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
LEO-15520: A research chemical or compound identifier.
BAY1316957: A research chemical or compound identifier.
FALNIDAMOL: A research chemical or compound identifier.
TAS-119: A research chemical or compound identifier.
NORENDOXIFEN: A metabolite of the drug tamoxifen.
TIAGABINE HYDROCHLORIDE: An anticonvulsant that acts as a GABA reuptake inhibitor.
FERB 033: A research chemical or compound identifier.
LTK-14: A research chemical or compound identifier.
[125I]PD164333: A radiolabeled compound, likely a receptor ligand.
[125I]INSL3 (HUMAN): A radioiodinated form of the peptide hormone insulin-like peptide 3.
[3H]S0139: A radiolabeled compound, likely a receptor ligand.
[ALA1,3,11,15]ET-1: A synthetic analogue of the peptide endothelin-1.
K-8794: A research chemical or compound identifier.
ALFAXALONE: A neuroactive steroid used as an intravenous anesthetic agent.
PRUCALOPRIDE: A 5-HT4 receptor agonist used to treat chronic constipation.
MACITENTAN: A dual endothelin receptor antagonist used to treat pulmonary arterial hypertension.
CDK1/5 INHIBITOR: A class of drugs that inhibit cyclin-dependent kinases 1 and 5.
UNC0638: A potent and selective inhibitor of the histone methyltransferases G9a and GLP.
CORALYNE: An intercalating agent that binds to DNA.
UCPH-101: A selective inhibitor of the glutamate transporter EAAT1.
NE97220: A research chemical or compound identifier.
AXELOPRAN: An experimental peripherally acting mu-opioid receptor antagonist.
LJ-4517: A research chemical or compound identifier.
OLEUROPEIN: A phenolic compound found in olive leaf with antioxidant and other properties.
JZL195: An experimental enzyme inhibitor that blocks both FAAH and MAGL.
MAB92: A research chemical or compound identifier.
GR 89696: A potent and selective kappa-opioid receptor agonist.
ZAGOTENEMAB: An experimental monoclonal antibody that targets the Tau protein.
[18F]FLUOROETHYLFLUMAZENIL: A radiopharmaceutical used in PET imaging of benzodiazepine receptors.
NDD-713: A research chemical or compound identifier.
AZ13102909: A research chemical or compound identifier.
RESVERATROL 4'-METHYL ETHER: A methylated derivative of resveratrol.
LGD-2941: A research chemical or compound identifier.
QUILIZUMAB: An experimental monoclonal antibody that targets IgE.
OCINAPLON: An experimental non-benzodiazepine anxiolytic.
CGS-27023A: A broad-spectrum matrix metalloproteinase (MMP) inhibitor.
GW795486X: A research chemical or compound identifier.
PUCOTENLIMAB: An experimental monoclonal antibody.
LICOFELONE: An experimental anti-inflammatory drug that inhibits COX and 5-LOX enzymes.
A-123189: A research chemical or compound identifier.
ISOGUVACINE: A GABAA receptor agonist.
DAPITANT: An experimental neurokinin-1 (NK1) receptor antagonist.
FIBOFLAPON SODIUM: A research chemical or compound identifier.
LETAXABAN: An experimental direct factor Xa inhibitor.
GAL-B2-MPEG4: A research chemical or compound identifier.
OGERIN: A positive allosteric modulator of the GPR55 receptor.
RP-8-CPT-CGMPS: A specific activator of protein kinase G.
RO15-4513: A partial inverse agonist for the benzodiazepine site of the GABAA receptor.
GW801372X: A research chemical or compound identifier.
2',BETA-DIHYDROXYCHALCONE: A chemical compound, a type of chalcone.
ABBV-3373: An experimental antibody-drug conjugate targeting TNF-alpha.
CHROMOCARB: An anti-hemorrhagic drug.
FLETIKUMAB: An experimental monoclonal antibody that targets interleukin-1 beta.
LISOCABTAGENE MARALEUCEL: A CAR-T cell therapy targeting CD19, used for lymphoma.
TRICIRIBINE: An experimental anticancer agent that inhibits the AKT kinase.
COMPOUND 8 [PMID: 15482908]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
KYNURENIC ACID: An endogenous antagonist of excitatory amino acid receptors.
SULFASALAZINE: A medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease.
TRANS-3-ACPBPA: A research chemical or compound identifier.
HYDROQUINONE: A chemical compound used topically for skin depigmentation.
ADENOSINE A2B RECEPTOR ANTAGONIST PBF-1129: An experimental antagonist of the A2B adenosine receptor.
TPMPA: A selective antagonist of the GABAC receptor.
5-OXO-ODE: A research chemical or compound identifier.
[3H]MUSCIMOL: A radiolabeled form of muscimol, a GABAA receptor agonist.
M242: A research chemical or compound identifier.
DESOXYCORDIFOLINE: A natural alkaloid with biological activity.
LESOGABERAN: An experimental GABAB receptor agonist that was studied for GERD.
GAL-B2-C12: A research chemical or compound identifier.
CILANSETRON: An experimental 5-HT3 receptor antagonist studied for irritable bowel syndrome.
ISO-FLUDELONE: A research chemical or compound identifier.
HUMAN GIP(5-30)NH2: A peptide fragment of the hormone GIP.
ETHISTERONE: A progestin hormone.
LSN3318839: A research chemical or compound identifier.
INSULIN ASPART PROTAMINE, HUMAN: An intermediate-acting insulin formulation.
CX516: An ampakine compound that acts as a positive allosteric modulator of the AMPA receptor.
COMPOUND 1 [PATEL ET AL., 1991]: A specific chemical compound described in a 1991 publication by Patel et al.
DARGLITAZONE: An experimental thiazolidinedione (TZD) antidiabetic drug.
LY392098: A research chemical or compound identifier.
F19 131I: A radiolabeled compound, likely a diagnostic or therapeutic agent.
GYKI53784: A non-competitive antagonist of the AMPA receptor.
H-151: A research chemical, an inhibitor of the ROCK kinase.
TL6: A research chemical or compound identifier.
COMPOUND 2 [MAURER ET AL., 2012]: A specific chemical compound described in a 2012 publication by Maurer et al.
852A: An experimental Toll-like receptor 7 (TLR7) agonist.
NMDA: N-methyl-D-aspartate, an amino acid derivative that acts as a specific agonist at the NMDA receptor.
D-CCPENE: A potent and selective antagonist of the glycine site of the NMDA receptor.
BETA-TOXICAROL: A natural rotenoid compound.
UBP141: A research chemical, an antagonist of the kainate receptor.
DUTPASE/DPD INHIBITOR TAS-114: An experimental agent that inhibits two enzymes involved in fluoropyrimidine metabolism.
RO-0505124: A research chemical or compound identifier.
METHYLFURMETHIDE: A muscarinic receptor agonist.
DL-TRYPTOPHAN: A racemic mixture of the essential amino acid tryptophan.
NATALIZUMAB: A monoclonal antibody that targets the alpha-4 integrin, used for multiple sclerosis.
CISAPRIDE: A prokinetic agent that was used to treat gastroesophageal reflux disease.
D-AP5: A selective NMDA receptor antagonist.
EVT-101: An experimental NMDA receptor antagonist that targets the NR2B subunit.
GSK2606414: An experimental inhibitor of the PERK kinase.
TREMELIMUMAB: An immune checkpoint inhibitor (anti-CTLA-4 antibody) used for cancer therapy.
5-MEO-DMT: A psychedelic tryptamine.
GV196771A: An experimental neurokinin-1 (NK1) receptor antagonist.
DIBUTYLPHTHALATE: A common plasticizer.
EFMOROCTOCOG ALFA: A recombinant Factor VIII fusion protein used to treat hemophilia A.
GINKGOLIDE B: A major bioactive terpenoid from the Ginkgo biloba tree.
MRI-1867: An experimental peripherally restricted cannabinoid CB1 receptor inverse agonist.
HS014: A selective antagonist for the melanocortin-4 receptor.
CH7057288: A research chemical or compound identifier.
NEUROPEPTIDE-Y: A peptide neurotransmitter found in the brain and autonomic nervous system.
EDROPHONIUM CHLORIDE: A short-acting cholinesterase inhibitor used to diagnose myasthenia gravis.
6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE: A chemical compound, likely a specific enzyme inhibitor or receptor ligand.
7-HYDROXYSTAUROSPORINE: A metabolite of staurosporine, also a kinase inhibitor.
GSK256073: A research chemical or compound identifier.
METYRAPONE: A medication used in the diagnosis of adrenal insufficiency, which inhibits steroid synthesis.
&BETA;-CYANO-L-ALANINE: A neurotoxic amino acid found in some plants.
CAY10441: A research chemical, a prostaglandin E2 receptor antagonist.
PALMIDROL: Also known as palmitoylethanolamide (PEA), an endogenous fatty acid amide.
UDP-GALACTOSE: An intermediate in the production of polysaccharides.
AM6538: A research chemical or compound identifier.
DERIVATIVE 17 [NAKAHATA ET AL., 2018]: A specific chemical derivative described in a 2018 publication by Nakahata et al.
ZQ-16: A research chemical or compound identifier.
GNE-4997: A research chemical or compound identifier.
TEPRASIRAN: An experimental siRNA therapeutic.
R-SPONDIN-1: A protein that is a ligand for LGR receptors and potentiates Wnt/beta-catenin signaling.
AC264613: A research chemical or compound identifier.
PEGDINETANIB: A pegylated form of an experimental anti-angiogenic agent.
2-AMINO-4-METHYLPYRIDINE: A chemical compound.
MIPOMERSEN: An antisense oligonucleotide that targets apolipoprotein B, used for homozygous familial hypercholesterolemia.
ARN726: A research chemical or compound identifier.
TIFLUADOM: An experimental opioid analgesic that acts as a kappa-opioid receptor agonist.
COMPOUND 7 [PMID: 31381331]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
GW780159X: A research chemical or compound identifier.
ANTI-CD40/ANTI-MESOTHELIN BISPECIFIC ANTIBODY ABBV-428: An experimental bispecific antibody for cancer therapy.
PREDNISOLONE ACETATE: The acetate ester of prednisolone, a synthetic glucocorticoid.
DYCLONINE: A local anesthetic used in throat lozenges.
COMPOUND 37 [PMID: 24418773]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
BIPERIDEN: An anticholinergic agent used to treat Parkinson's disease.
ITASETRON: An experimental 5-HT3 receptor antagonist.
GANETESPIB: An experimental Hsp90 inhibitor.
POMALIDOMIDE: An immunomodulatory drug used to treat multiple myeloma.
TRIPROLIDINE HYDROCHLORIDE: A first-generation antihistamine.
DIPHENHYDRAMINE CITRATE: The citrate salt of the antihistamine diphenhydramine.
OMALIZUMAB: A monoclonal antibody that targets IgE, used to treat allergic asthma.
AZILSARTAN KAMEDOXOMIL: A prodrug of azilsartan, an angiotensin II receptor antagonist.
DAPIPRAZOLE HYDROCHLORIDE: An alpha-1 blocker used in ophthalmology to reverse pupil dilation.
DIVALPROEX SODIUM: A medication used to treat epilepsy, bipolar disorder, and to prevent migraines.
CLOFIBRATE: A fibrate drug that was used to lower cholesterol.
FAMOTIDINE: An H2 receptor antagonist that decreases stomach acid production.
OXYCODONE TEREPHTHALATE: A salt of the opioid pain medication oxycodone.
RIMEXOLONE: A topical corticosteroid used for eye inflammation.
FLUPREDNISOLONE: A synthetic glucocorticoid.
SYNTHETIC CONJUGATED ESTROGENS, B: A mixture of synthetic estrogen hormones.
ZOMIRADOMIDE: A research chemical or compound identifier.
TOLBUTAMIDE SODIUM, STERILE: A sterile formulation of the sulfonylurea drug tolbutamide.
EBLASAKIMAB: An experimental monoclonal antibody.
DEXTROTHYROXINE: The D-isomer of thyroxine, which was used to lower cholesterol.
LEVALLORPHAN TARTRATE: An opioid antagonist that was used to reverse opioid overdose.
NEBIVOLOL HYDROCHLORIDE: A highly selective beta-1 blocker used to treat hypertension.
ANIDULAFUNGIN: An echinocandin antifungal medication.
QUINUPRISTIN: A streptogramin antibiotic, used in combination with dalfopristin.
TAPROSTENE: A prostacyclin analogue.
MUROMONAB-CD3: A monoclonal antibody that targets the CD3 receptor, used to prevent organ transplant rejection.
LUTEOLIN: A flavonoid found in many plants, with antioxidant and anti-inflammatory properties.
ACESULFAME: An artificial sweetener.
GATIFLOXACIN ANHYDROUS: The anhydrous form of gatifloxacin, a fluoroquinolone antibiotic.
SIMEPREVIR SODIUM: The sodium salt of simeprevir, an antiviral drug for hepatitis C.
TASIMELTEON: A melatonin receptor agonist used for non-24-hour sleep-wake disorder.
VEDOLIZUMAB: A monoclonal antibody that targets the alpha-4 beta-7 integrin, used for inflammatory bowel disease.
GSK2881078: An experimental selective androgen receptor modulator (SARM).
BMS-794833: An experimental multi-kinase inhibitor targeting MET and VEGFR.
HYODEOXYCHOLIC_ACID: A secondary bile acid.
AC-430: A research chemical or compound identifier.
AZD-8055: A potent and selective dual mTORC1/mTORC2 inhibitor.
SC-80036: A research chemical or compound identifier.
LY2623091: A research chemical or compound identifier.
ELOCALCITOL: An experimental vitamin D analog that was studied for benign prostatic hyperplasia.
PIMASERTIB: An experimental MEK inhibitor.
CAMICINAL: An experimental motilin receptor agonist.
LY545694: A research chemical or compound identifier.
AZD4818: A research chemical or compound identifier.
NETAZEPIDE: An experimental cholecystokinin receptor antagonist.
RESLIZUMAB: A monoclonal antibody that targets interleukin-5, used for severe eosinophilic asthma.
IXEKIZUMAB: A monoclonal antibody that targets interleukin-17A, used for psoriasis.
NIVOCASAN: An experimental caspase inhibitor.
CITRONELLAL: A monoterpenoid aldehyde, the main component in citronella oil.
GIV3727: An experimental antagonist of the TRPM8 ion channel.
JAK3 INHIBITOR IV: A specific chemical inhibitor of the Janus kinase 3.
IBUTAMOREN MESYLATE: The mesylate salt of ibutamoren, a growth hormone secretagogue.
TEPROTUMUMAB-TRBW: A monoclonal antibody that targets the IGF-1R, used for thyroid eye disease.
TUCOTUZUMAB CELMOLEUKIN: An experimental immunotherapy agent.
CINPANEMAB: An experimental monoclonal antibody that targets the alpha-synuclein protein.
HUMAX-IL15: An experimental immunotherapy agent, a form of interleukin-15.
LEVOSIMENDAN: A calcium sensitizer used to manage acute decompensated heart failure.
ANTI-TAC 90 Y-HAT: A research chemical or compound identifier.
LUMRETUZUMAB: An experimental bispecific antibody targeting HER3 and EpCAM.
MU-BC-1: A research chemical or compound identifier.
HG-10-102-01: A research chemical or compound identifier.
PF-03446879: A research chemical or compound identifier.
FEDRATINIB HYDROCHLORIDE: The hydrochloride salt of fedratinib, a JAK inhibitor.
GEMIGLIPTIN: A DPP-4 inhibitor used to treat type 2 diabetes.
LASOFOXIFENE: An experimental selective estrogen receptor modulator (SERM).
AR-M1000390: A research chemical or compound identifier.
OMIDENEPAG: A selective prostaglandin EP2 receptor agonist used to treat glaucoma.
SITAFLOXACIN: A broad-spectrum fluoroquinolone antibiotic.
LAFUTIDINE: An H2 receptor antagonist that also has gastroprotective effects.
PEPTIDE KLK2B(C1): A research chemical or compound identifier.
FAZPILODEMAB: An experimental monoclonal antibody.
IDH305: An experimental inhibitor of mutant IDH1.
IBREXAFUNGERP CITRATE: An antifungal medication.
VILAPRISAN: An experimental selective progesterone receptor modulator.
ZILUCOPLAN: An experimental complement component C5 inhibitor.
RODATRISTAT ETHYL: An experimental inhibitor of the enzyme tryptophan hydroxylase.
PF-04937319: A research chemical or compound identifier.
LERIGLITAZONE: An experimental PPAR-gamma agonist.
RUNCACIGUAT: An experimental soluble guanylate cyclase (sGC) activator.
ENCEQUIDAR: An experimental P-glycoprotein inhibitor.
HK2P01 DERIVATIVE KLK2 INHIBITOR: A specific chemical inhibitor of the KLK2 enzyme.
PF-04217903: An experimental c-Met kinase inhibitor.
DIOA: A blocker of the K-Cl cotransporter.
RA839: An experimental agent that activates the Nrf2 pathway.
PHILANTHOTOXIN 343: A toxin from a wasp that blocks ionotropic glutamate receptors.
PLX-4720: An experimental, potent, and selective inhibitor of the BRAF V600E mutated kinase.
SPIPERONE: A typical antipsychotic and research chemical that is a potent dopamine D2 antagonist.
SU-14813: An experimental multi-kinase inhibitor targeting VEGFR, PDGFR, and Kit.
AMBROXOL: A mucolytic agent used in the treatment of respiratory diseases.
E1501: A research chemical or compound identifier.
HERBIMYCIN: A natural product that inhibits the Hsp90 protein.
LOFEPRAMINE: A tricyclic antidepressant.
DIMETHYL SUCCINATE: An ester of succinic acid.
ROXITHROMYCIN: A macrolide antibiotic.
ACRYLAMIDE: A chemical compound used in industry, also found in some cooked foods.
ONONETIN: A natural isoflavone compound.
BENFLUOREX HYDROCHLORIDE: A withdrawn anorectic and hypolipidemic agent.
ESTRADIOL PHOSPHATE: An ester of the estrogen estradiol.
SU-11652: An experimental multi-kinase inhibitor.
BEZUCLASTINIB: An experimental KIT kinase inhibitor.
ELENESTINIB: An experimental multi-kinase inhibitor.
ETHYL NITRITE [SPIRIT]: A chemical compound that acts as a vasodilator.
TAMAPIN: A peptide toxin from bee venom that blocks SK2 channels.
NS309: An activator of small- and intermediate-conductance calcium-activated potassium channels.
OSELTAMIVIR PHOSPHATE: The phosphate salt of oseltamivir, an antiviral neuraminidase inhibitor.
TENIDAP: An experimental anti-inflammatory drug.
H+: The hydrogen ion, or proton.
URANTIDE: A peptide antagonist of the urotensin-II receptor.
CLOFILIUM: An experimental antiarrhythmic drug that blocks potassium channels.
TRIAZOPHOS: An organophosphate insecticide.
3-CHLOROTYROSINE: A marker of inflammation and oxidative stress.
NECROSTATIN-1: A potent and selective inhibitor of the RIPK1 kinase, which blocks necroptosis.
SEROTONIN HYDROCHLORIDE: The hydrochloride salt of the neurotransmitter serotonin.
COMPOUND 66 [PMID: 36126387]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
ETHYLISOTHIOUREA: A chemical compound.
TRICIFEROL: A research chemical or compound identifier.
BENZANTHRONE: A fluorescent dye.
6-FLUOROTRYPTOPHAN: A synthetic analogue of the amino acid tryptophan.
FENCLONINE: An irreversible inhibitor of the enzyme tryptophan hydroxylase.
CANTHIN-6-ONE: A natural alkaloid with various biological activities.
COMPOUND 21B [PMID: 31430136]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
TRIPHENYLBISMUTHINE: An organobismuth compound.
KU-0063794: A potent dual inhibitor of the mTORC1 and mTORC2 kinases.
PIRENPERONE: A serotonin 5-HT2A receptor antagonist.
LOTEPREDNOL: A topical corticosteroid used for eye inflammation.
CZ415: A research chemical or compound identifier.
DEXKETOPROFEN: A non-steroidal anti-inflammatory drug (NSAID).
STM2457: An experimental inhibitor of the METTL3 enzyme.
1,2-DIHYDROXYNAPHTHALENE: A chemical compound.
ELZOVANTINIB: An experimental c-Met kinase inhibitor.
CBIPES: A research chemical or compound identifier.
[3H]PENTAZOCINE: A radiolabeled form of the opioid analgesic pentazocine.
SILYBIN B: An isomer of silibinin, a component of silymarin.
HYPERFORIN: A major active constituent of the plant St. John's wort.
OLOMOUCINE: An inhibitor of cyclin-dependent kinases (CDKs).
MOSAPRAMINE: An atypical antipsychotic.
EXISULIND: An experimental agent that induces apoptosis in cancer cells.
N6-BENZYLADENOSINE: A synthetic cytokinin, a type of plant hormone.
PENFLURIDOL: A long-acting typical antipsychotic of the diphenylbutylpiperidine class.
BENOMYL: A systemic fungicide.
NEOCHAMAEJASMIN A: A natural biflavonoid.
CITALOPRAM HYDROBROMIDE: The hydrobromide salt of the antidepressant citalopram.
DIPROPYLDOPAMINE HYDROBROMIDE: A research chemical or compound identifier.
AKT INHIBITOR VIII: A specific chemical inhibitor of the AKT kinase, also known as isozyme-selective Akt-1/2 inhibitor.
MILBEMYCIN A4: A component of the milbemycin class of veterinary antiparasitics.
FENOVERINE: An antispasmodic agent.
6-AMINONICOTINAMIDE: An antagonist of the vitamin niacin.
TURBINATINE: A research chemical or compound identifier.
ESTRADIOL PROPIONATE: An ester of the estrogen estradiol.
CEFOTAXIME SODIUM: The sodium salt of the third-generation cephalosporin antibiotic cefotaxime.
(2-NITROVINYL)BENZENE: A chemical compound, also known as beta-nitrostyrene.
GERANIOL: A monoterpenoid and an alcohol, a primary component of rose oil and citronella oil.
GSK-300014A: A research chemical or compound identifier.
NALIDIXATE SODIUM: The sodium salt of nalidixic acid, a quinolone antibiotic.
ORPHENADRINE CITRATE: The citrate salt of the muscle relaxant orphenadrine.
ETHYLNOREPINEPHRINE HYDROCHLORIDE: A sympathomimetic amine used as a bronchodilator.
SYRINGARESINOL: A natural lignan compound.
AZORUBINE: A synthetic red food dye.
DOCUSATE SODIUM: The sodium salt of docusate, a stool softener.
MALTOTRIOSE: A trisaccharide consisting of three glucose molecules.
DEUTETRABENAZINE: A deuterated form of tetrabenazine, a VMAT2 inhibitor.
NUSINERSEN: An antisense oligonucleotide used to treat spinal muscular atrophy.
PITOLISANT: A histamine H3 receptor antagonist/inverse agonist used to treat narcolepsy.
SIMEPREVIR: An antiviral drug used for the treatment of hepatitis C.
XL281: An experimental inhibitor of the RAF kinases.
ENCORAFENIB: A potent inhibitor of the BRAF V600E mutated kinase, used to treat melanoma.
MM-151: An experimental mixture of three monoclonal antibodies targeting EGFR.
NAFOXIDINE: An experimental selective estrogen receptor modulator (SERM).
INTERLEUKIN-12 GENE: The gene that encodes the cytokine interleukin-12.
OXYGEN THERAPY: The administration of oxygen as a medical intervention.
GRN-529: An experimental negative allosteric modulator of the mGluR5 receptor.
COMPOUND 16A [PMID: 14697765]: An experimental compound described in the specified publication.
COMPOUND 29B [PMID: 20809633]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
KLEBSIELLA PNEUMONIAE GLYCOPROTEIN: A preparation from the bacterium Klebsiella pneumoniae, used as an immunomodulator.
IMIPENEM-CILASTATIN SODIUM: A combination antibiotic product.
LSN2814617: A research chemical or compound identifier.
VU0360172: A positive allosteric modulator of the mGluR5 receptor.
LOBAPLATIN: A platinum-based chemotherapy drug.
FENOBAM ANHYDROUS: The anhydrous form of fenobam, an experimental anxiolytic.
INDOLE-3-CARBINOL: A compound found in cruciferous vegetables, a precursor to DIM.
PENTOSTATIN: A chemotherapy agent that inhibits the enzyme adenosine deaminase.
(+)-MCPG: A non-selective antagonist of metabotropic glutamate receptors.
ANTIESTROGEN: A class of drugs that prevent estrogens from mediating their biological effects.
TANZISERTIB: An experimental inhibitor of the IRAK4 kinase.
PF-03715455: An experimental phosphodiesterase-4 (PDE4) inhibitor.
COMPOUND 10 [PMID: 23147077]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
ANTIEMETIC AGENT: A class of drugs that are effective against vomiting and nausea.
APITOLISIB: An experimental dual PI3K/mTOR inhibitor.
GANGLIOSIDE GM2: A type of ganglioside, a molecule composed of a glycosphingolipid with one or more sialic acids.
MOBOCERTINIB: A tyrosine kinase inhibitor that targets EGFR with exon 20 insertion mutations.
PF-152: A research chemical or compound identifier.
BMS-963272: A research chemical or compound identifier.
KML29: A potent and selective inhibitor of the monoacylglycerol lipase (MAGL).
TELITHROMYCIN: A ketolide antibiotic.
MOTILIN-(1-13) (HUMAN): A peptide fragment of the hormone motilin.
ELAGOLIX: A gonadotropin-releasing hormone (GnRH) antagonist used to treat endometriosis.
MA-2029: A research chemical or compound identifier.
MOTILIN-(1-11) (HUMAN): A peptide fragment of the hormone motilin.
SODIUM ASCORBATE: The sodium salt of ascorbic acid (Vitamin C).
DULAGLUTIDE: A GLP-1 receptor agonist used to treat type 2 diabetes.
BUPRENORPHINE/NALOXONE: A combination medication used to treat opioid use disorder.
IPEROXO: An experimental peroxisome proliferator-activated receptor (PPAR) agonist.
AZD8330: An experimental MEK inhibitor.
NNC 11-1314: A research chemical or compound identifier.
APRINOCARSEN: An experimental antisense oligonucleotide that targets protein kinase C-alpha.
UMECLIDINIUM BROMIDE: A long-acting antimuscarinic agent used as a bronchodilator for COPD.
KT 5823: A potent and selective inhibitor of protein kinase G.
ACOTIAMIDE: A medication used to treat functional dyspepsia.
ELINOGREL: An experimental antiplatelet drug that acts as a P2Y12 inhibitor.
ELIGLUSTAT: An inhibitor of the enzyme glucosylceramide synthase, used to treat Gaucher disease.
ERITORAN: An experimental TLR4 antagonist that was studied for severe sepsis.
TASIDOTIN: An experimental anticancer agent, a dolastatin 15 analog.
INSULIN GLULISINE, HUMAN: A rapid-acting insulin analog.
AFEGOSTAT: An experimental glucosylceramide synthase inhibitor.
JB991: A research chemical or compound identifier.
RGFP109: An experimental histone deacetylase (HDAC) inhibitor.
RESVERATROL: A stilbenoid natural phenol with antioxidant and other biological properties.
S26284: A research chemical or compound identifier.
OTLERTUZUMAB: An experimental monoclonal antibody that targets the ROR1 protein.
DIPRENORPHINE: A non-selective opioid receptor antagonist.
XL844: An experimental multi-kinase inhibitor.
BETAZOLE: A histamine H2 receptor agonist that was used in a diagnostic test for gastric acid secretion.
PROFENAMINE: An anticholinergic drug.
PHENYLPROPANOLAMINE: A sympathomimetic amine used as a decongestant and anorectic.
RITODRINE: A tocolytic agent used to stop premature labor.
BMS-986123: An experimental LPA1 receptor antagonist.
AMBRISENTAN: An endothelin receptor antagonist used to treat pulmonary arterial hypertension.
LEVALLORPHAN: An opioid antagonist that was used to reverse opioid overdose.
GONADORELIN: A synthetic form of gonadotropin-releasing hormone (GnRH).
MOEXIPRIL: An ACE inhibitor used to treat high blood pressure.
ROTIGOTINE: A dopamine agonist used to treat Parkinson's disease and restless legs syndrome.
REMIKIREN: An experimental direct renin inhibitor.
TAMIBAROTENE: A synthetic retinoid used to treat acute promyelocytic leukemia.
TRIMIPRAMINE: A tricyclic antidepressant.
AZD1678: A research chemical or compound identifier.
IMARIKIREN HYDROCHLORIDE: An experimental direct renin inhibitor.
SAVOLITINIB: An experimental c-Met kinase inhibitor.
ENOBLITUZUMAB: An experimental bispecific antibody targeting PSMA and CD3.
DEPATUXIZUMAB: An experimental antibody-drug conjugate targeting EGFR.
GEPTANOLIMAB: An experimental monoclonal antibody that targets the PD-1 receptor.
ODRONEXTAMAB: An experimental bispecific antibody targeting CD20 and CD3.
ANTI-EGFR MONOCLONAL ANTIBODY SYN004: An experimental monoclonal antibody targeting EGFR.
BTRX-246040: An experimental agent that was studied for depression.
GOSURANEMAB: An experimental monoclonal antibody that targets nerve growth factor (NGF).
AZD1332: A research chemical or compound identifier.
PIMAGEDINE: An experimental agent that was studied for diabetic nephropathy.
FLANVOTUMAB: An experimental bispecific antibody targeting MUC1 and CD3.
PARIDIPRUBART: An experimental monoclonal antibody.
BGC-20-1531: A research chemical or compound identifier.
PARECOXIB: A selective COX-2 inhibitor (NSAID) for intravenous use.
TBC-3711: An experimental endothelin receptor antagonist.
ANIRACETAM: A nootropic drug of the racetam family.
ENDOSTATIN: An endogenous protein that inhibits angiogenesis.
NEUROTROPHIN-3: A neurotrophic factor that supports the survival and differentiation of neurons.
TILARGININE ACETATE: An experimental nitric oxide synthase inhibitor.
SUMANIROLE: A potent and selective dopamine D2 receptor agonist.
SARALASIN: A peptide antagonist of the angiotensin II receptor.
CCT-018159: An experimental Hsp90 inhibitor.
DERENOFYLLINE: A research chemical or compound identifier.
[3H]&ALPHA;-BUNGAROTOXIN: A radiolabeled form of alpha-bungarotoxin, a nicotinic acetylcholine receptor antagonist.
FLURPIRIDAZ F-18: A radiopharmaceutical used in PET imaging of myocardial perfusion.
[125I]EPIBATIDINE: A radioiodinated form of epibatidine, a potent nicotinic acetylcholine receptor agonist.
ANTROQUINONOL: A natural compound from Antrodia cinnamomea with various biological activities.
ELOSULFASE ALFA: An enzyme replacement therapy used for mucopolysaccharidosis IVA.
PEGUNIGALSIDASE ALFA: An enzyme replacement therapy used for Fabry disease.
MECAMYLAMINE: A non-selective nicotinic acetylcholine receptor antagonist.
VOBARILIZUMAB: An experimental monoclonal antibody.
SASANLIMAB: An experimental monoclonal antibody that targets the PD-1 receptor.
CY-1503: A research chemical or compound identifier.
LEUKOCYTE INTERLEUKIN: An older term for a type of cytokine, now known as interleukin.
MELOXICAM: A non-steroidal anti-inflammatory drug (NSAID).
TAK-285: An experimental dual inhibitor of EGFR and HER2.
NMS-1286937: An experimental inhibitor of the kinase Mps1.
LY-2624587: A research chemical or compound identifier.
ANTI-GPC3-CAR AUTOLOGOUS T LYMPHOCYTES: A type of CAR-T cell therapy targeting the GPC3 protein.
ETIDRONATE DISODIUM: A bisphosphonate used to treat Paget's disease of bone and prevent heterotopic ossification.
ECHOTHIOPHATE IODIDE: An irreversible cholinesterase inhibitor used in eye drops to treat glaucoma.
ISOETHARINE: A short-acting beta-2 adrenergic receptor agonist used as a bronchodilator.
PINACIDIL: A potassium channel opener that causes vasodilation, studied as an antihypertensive agent.
TERIPARATIDE: A recombinant form of parathyroid hormone used to treat osteoporosis.
DELAPRIL: An ACE inhibitor used to treat hypertension.
DEXIBUPROFEN: The S-(+)-enantiomer of ibuprofen, a non-steroidal anti-inflammatory drug (NSAID).
PIMAVANSERIN: An atypical antipsychotic that acts as an inverse agonist of the 5-HT2A receptor, used for Parkinson's disease psychosis.
DSP-2230: An experimental agent that was studied for its effects on the central nervous system.
UPROSERTIB: An experimental pan-Akt inhibitor.
ENSACULIN HYDROCHLORIDE: An experimental anticancer agent.
ISRAPAFANT: An experimental platelet-activating factor (PAF) receptor antagonist.
SIRUKUMAB: An experimental monoclonal antibody that targets interleukin-6 (IL-6).
4-1BB LIGAND: A protein that binds to the 4-1BB (CD137) receptor, providing a co-stimulatory signal to T-cells.
CP-122288: A research chemical or compound identifier.
ML 10375: A research chemical or compound identifier.
TEGASEROD: A 5-HT4 agonist used for irritable bowel syndrome with constipation.
WAY-181187: An experimental, potent, and selective 5-HT6 receptor agonist.
KV-37: A research chemical or compound identifier.
PHOSPHATIDYLSERINE: A phospholipid and a component of the cell membrane, also sold as a dietary supplement.
RS-100329: A potent and selective 5-HT4 receptor antagonist.
PCMBS: p-Chloromercuribenzenesulfonic acid, a chemical that inhibits aquaporins.
AUPHEN: A research chemical or compound identifier.
AG+: The silver cation, which has antimicrobial properties.
[125I](PYR1)APELIN-13: A radioiodinated form of the peptide apelin-13.
DIMINAZENE: An antiprotozoal drug used in veterinary medicine.
AS99: A research chemical or compound identifier.
UK-432,097: An experimental adenosine A2A receptor antagonist.
MRS1084: A research chemical or compound identifier.
[3H]ZM 241385: A radiolabeled selective adenosine A2A receptor antagonist.
DAX: An abbreviation, possibly for a research compound.
L-163,101: A research chemical or compound identifier.
TRV026: A research chemical or compound identifier.
PD 168368: An experimental irreversible inhibitor of the EGFR kinase.
PHENYLACETYL-ALA,DTRP-PHENTHYLAMIDE: A complex synthetic peptide.
COMPOUND 15 [PMID: 25699151]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
[3H](-)CGP 12177: A radiolabeled beta-adrenergic receptor partial agonist/antagonist.
COMPOUND 42 [PMID: 26938474]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
Z-DEVD-FMK: A specific, irreversible inhibitor of caspase-3.
AC265347: A research chemical or compound identifier.
Z-VEID-FMK: A specific, irreversible inhibitor of caspase-6.
COMPOUND (R)-26 [PMID: 22686657]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
TM38837: An experimental GPR40 receptor agonist.
AM1241: A potent and selective agonist for the cannabinoid CB2 receptor.
DEXLOXIGLUMIDE: The R-isomer of loxiglumide, a cholecystokinin receptor antagonist.
CCX354: An experimental CCR1 chemokine receptor antagonist.
E913: A research chemical or compound identifier.
COMPOUND 24 [PMID: 26987013 ]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
CCL20: A small cytokine belonging to the CC chemokine family, also known as MIP-3-alpha.
NARATUXIMAB EMTANSINE: An experimental antibody-drug conjugate.
LULIZUMAB PEGOL: An experimental monoclonal antibody.
MK-0159: A research chemical or compound identifier.
PEPTIDE 5A: A research chemical or compound identifier.
CFZ533: An experimental monoclonal antibody that targets the CD40 receptor.
COMPOUND 14F [PMID: 35063894]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 7F [PMID: 29283260]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
BIVALIRUDIN: A direct thrombin inhibitor used as an anticoagulant.
L-(CIS)-DILTIAZEM: An isomer of the calcium channel blocker diltiazem.
AZ12971554: A research chemical or compound identifier.
OSOCIMAB: An experimental monoclonal antibody.
COMPOUND 57 [PMID: 16610804]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
CXCL12&DELTA;: An isoform of the chemokine CXCL12.
ACT-660602: A research chemical or compound identifier.
[125I]CXCL16 (HUMAN): A radioiodinated form of the chemokine CXCL16.
IRALUKAST: An experimental leukotriene D4 receptor antagonist.
TP0472993: A research chemical or compound identifier.
COMPOUND 24DD [PMID: 20684603]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
NAPORAFENIB: An experimental pan-RAF inhibitor.
15(R)-15-METHYL-PGD2: A synthetic analogue of prostaglandin D2.
PRAMIPEXOLE: A dopamine agonist used to treat Parkinson's disease and restless legs syndrome.
SKF-38393: A potent and selective dopamine D1 receptor agonist.
(+)-ADTN: A research chemical, a dopamine receptor agonist.
VALEMETOSTAT: An experimental dual inhibitor of EZH1 and EZH2.
COMPOUND 52 [PMID: 36749735]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
MPPA: A research chemical or compound identifier.
AH23848: A potent and selective antagonist of the prostaglandin EP4 receptor.
WAY200070: A selective estrogen receptor beta (ER-beta) agonist.
[125I]ET-2 (HUMAN): A radioiodinated form of the peptide endothelin-2.
BQ788: A selective endothelin receptor type B (ETB) antagonist.
GALANIN(10-29) (PIG): A peptide fragment of the neuropeptide galanin.
GAL-R2-DPEG24: A research chemical or compound identifier.
COMPOUND 16 [PMID: 18800762]: An experimental compound, likely a kinase inhibitor, described in the publication.
[125I]TYR-ALA-HEXARELIN: A radiolabeled synthetic growth hormone secretagogue.
GLUCAGON (RDNA): A recombinant form of the hormone glucagon, used to treat severe hypoglycemia.
[3H]CNQX: A radiolabeled form of CNQX, a competitive AMPA/kainate receptor antagonist.
NS1738: A positive allosteric modulator of alpha-7 nicotinic acetylcholine receptors.
EZLOPITANT: An experimental neurokinin-1 (NK1) receptor antagonist.
FK-888: An experimental neurokinin-1 (NK1) receptor antagonist.
TAREXTUMAB: An experimental monoclonal antibody that targets the Notch signaling pathway.
GSK-3BETA INHIBITOR II: A specific chemical inhibitor of the GSK-3 beta kinase.
[125I][DES-GLY10,D-ALA6]GNRH N-ETHYLAMIDE: A radiolabeled analogue of gonadotropin-releasing hormone.
COMPOUND 2G [PMID: 19309152]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
GUANYLIN: A peptide hormone that regulates electrolyte and water transport in the intestine.
JNJ-10191584: A research chemical, a histamine H3 receptor antagonist.
[125I]NPW-23 (HUMAN): A radioiodinated form of the neuropeptide W-23.
7&BETA;, 27-DIHYDROXYCHOLESTEROL: A metabolite of cholesterol.
EXAMPLE 31 [WO2018183145]: A specific chemical compound described in a patent application.
GLPG1205: An experimental GPR84 receptor antagonist.
PANCREATIC POLYPEPTIDE: A peptide hormone secreted by the pancreas that regulates pancreatic and gastric secretions.
LINSITINIB: An experimental dual inhibitor of the IGF-1R and insulin receptor kinases.
ND-2158: A research chemical or compound identifier.
[CY5-LYS19]NPS: A fluorescently labeled form of the neuropeptide S.
PROCYANIDIN C2: A type of proanthocyanidin flavonoid.
ABSINTHIN: The main bitter compound in the wormwood plant.
RETOSIBAN: An experimental oxytocin receptor antagonist studied to prevent preterm labor.
COMPOUND 5E [PMID: 28580438]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 5 {PMID: 24900446]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
NALFURAFINE: A kappa-opioid receptor agonist used to treat uremic pruritus.
COMPOUND 74 [PMID: 24793884]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
E2078: A research chemical or compound identifier.
JDTIC: A potent and selective kappa-opioid receptor antagonist.
LY3522348: A research chemical or compound identifier.
VU0240551: A positive allosteric modulator of the mGluR1 receptor.
TCS 1102: A potent and selective antagonist of the orexin-2 receptor.
OSI-930: An experimental multi-kinase inhibitor targeting Kit, KDR, and CSF-1R.
MRTX1133: An experimental covalent inhibitor of the KRAS G12D mutant protein.
DARIDOREXANT: A dual orexin receptor antagonist used for the treatment of insomnia.
AZD3778: A research chemical or compound identifier.
VM24: A research chemical or compound identifier.
S9947: A research chemical or compound identifier.
COMPOUND 4 [PMID: 24432870]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
VPC32179: A research chemical or compound identifier.
COMPOUND 65 [PMID: 36126387]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
H3-COA-20: A research chemical or compound identifier.
GAMCEMETINIB: An experimental multi-kinase inhibitor.
7-FLUOROCHROMONE-2-CARBOXAMIDE: A chemical compound.
SGX-523: An experimental, potent, and selective inhibitor of the MET tyrosine kinase.
DOLICHOL PHOSPHATE: A lipid carrier involved in the synthesis of glycoproteins.
ISOSPAGLUMIC ACID: A research chemical, a metabotropic glutamate receptor ligand.
COMPOUND 41 [PMID: 23434029]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 11A [PMID: 14697765]: An experimental compound described in the specified publication.
MTEP: A potent, selective, and non-competitive antagonist of the mGluR5 receptor.
PCC0105003: A research chemical or compound identifier.
IVERMECTIN: A broad-spectrum antiparasitic medication.
COMPOUND 27 [PMID: 29775310]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 35 [PMID: 23916259]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
BRILLIANT BLUE G: A synthetic dye used as a food colorant and as a P2X7 receptor antagonist.
COMPOUND 26 [PMID: 31710475]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
AZ11657312 (SALT FREE): The salt-free form of an experimental P2X7 receptor antagonist.
WAY170523: A selective estrogen receptor beta (ER-beta) agonist.
TANOMASTAT: An experimental matrix metalloproteinase (MMP) inhibitor.
UDP-GLUCURONIC ACID: A sugar nucleotide, an intermediate in the biosynthesis of polysaccharides.
ABD-1970: A research chemical or compound identifier.
BIFEMELANE: An antidepressant and nootropic drug.
COMPOUND 30 [PMID: 16455256]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
CLOPIDOGREL (ACTIVE METABOLITE): The active form of the antiplatelet drug clopidogrel.
[11C]XANOMELINE: A radiolabeled form of the muscarinic receptor agonist xanomeline for PET imaging.
5-METHOXY-LUZINDOLE: A melatonin receptor antagonist.
NALOXONE BENZOYLHYDRAZONE: A derivative of the opioid antagonist naloxone.
BMS-986122: An experimental LPA1 receptor antagonist.
MRS4183: A research chemical or compound identifier.
NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3 LIGAND 1: A ligand for the NKp30 immune receptor.
AR-C67085: A potent and selective antagonist of the P2Y12 purinergic receptor.
OSTEOCRIN: A protein that regulates bone growth.
PONAZURIL: An antiprotozoal drug used in veterinary medicine.
ANIZATRECTINIB: An experimental pan-TRK inhibitor.
[3H]NISOXETINE: A radiolabeled form of nisoxetine, a norepinephrine reuptake inhibitor.
EMZELTRECTINIB: An experimental pan-TRK inhibitor.
PPADS: A non-selective antagonist of P2 purinergic receptors.
ITP: Inosine triphosphate, a purine nucleotide.
MEN 10376: A potent and selective antagonist of the neurokinin-2 (NK2) receptor.
AC-RYYRIK-NH2: A peptide antagonist of the CXCR4 chemokine receptor.
PI1: A research chemical or compound identifier.
QA1: A research chemical or compound identifier.
APAFANT: A platelet-activating factor (PAF) receptor antagonist.
5S-HETE: A lipid mediator involved in inflammation.
5S-HPETE: A precursor to the lipid mediator 5S-HETE.
CETILISTAT: An inhibitor of pancreatic lipase, studied for obesity.
SCH-79797: A potent PAR1 antagonist and antimicrobial agent.
AZ3451: An experimental ghrelin receptor antagonist.
[3H]MIROGABALIN: A radiolabeled form of mirogabalin, a gabapentinoid drug.
6-HYDROXY-5,7-DIMETHOXYFLAVONE: A natural polymethoxylated flavone.
NERANDOMILAST: An experimental phosphodiesterase-4 (PDE4) inhibitor.
CHIGLITAZAR: A dual PPAR alpha/gamma agonist used to treat type 2 diabetes.
AKT INHIBITOR X: A specific chemical inhibitor of the AKT kinase.
SERALUTINIB: An experimental multi-kinase inhibitor.
ADP-RIBOSYLATION FACTOR 1: A small GTPase involved in vesicular trafficking.
COMPOUND 6 [PMID: 30125504]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND (S)-29 [PMID: 37606563]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
PAMIPARIB: An experimental PARP inhibitor.
PUQUITINIB: An experimental multi-kinase inhibitor.
OCIFISERTIB: An experimental Polo-like kinase 1 (Plk1) inhibitor.
ONAMETOSTAT: An experimental inhibitor of the enzyme fatty acid synthase.
PICLAMILAST: An experimental phosphodiesterase-4 (PDE4) inhibitor.
C21: An experimental angiotensin II type 2 receptor agonist.
DARAPLADIB: An experimental inhibitor of the enzyme lipoprotein-associated phospholipase A2.
DAROVASERTIB: An experimental inhibitor of protein kinase C (PKC).
CCG-203920: An experimental inhibitor of the Rho/MKL/SRF signaling pathway.
COMPOUND 1 [PMID: 34917254]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
TRIAZINE COMPOUND PC7: A specific chemical compound from the triazine class.
UVI3003: A research chemical or compound identifier.
RELAXIN-3: A neuropeptide hormone.
COMPOUND 86 [PMID: 26982234]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
SIRT1 ACTIVATOR 3: A specific chemical activator of the SIRT1 enzyme.
BD-1047: An antagonist of the sigma-1 receptor.
CHORIONIC SOMATOMAMMOTROPIN HORMONE-LIKE 1: A protein related to human placental lactogen.
KE 108: A research chemical or compound identifier.
BIM 23050: A research chemical, a somatostatin receptor ligand.
GA-NODAGA-LM3: A radiolabeled compound for medical imaging.
BEXMARILIMAB: An experimental monoclonal antibody that targets the CLEC12A protein.
TPC2-A1-N: A research chemical or compound identifier.
COMPOUND 11 [PMID: 37449845]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 15B [PMID: 16539403]: An experimental compound described in the specified publication.
PYR3: An inhibitor of the TRPC3 ion channel.
GSK2332255B: A research chemical or compound identifier.
I-C11: A research chemical or compound identifier.
[3H]RESINIFERATOXIN: A radiolabeled form of resiniferatoxin, an ultra-potent capsaicin analog.
JAK INHIBITOR 20A: A specific chemical inhibitor of Janus kinases.
[123I]IODOBENZOVESAMICOL: A radiopharmaceutical for SPECT imaging of the vesicular acetylcholine transporter.
SZM594: A research chemical or compound identifier.
SB-611812: A research chemical or compound identifier.
HELODERMIN: A peptide hormone with structural similarity to VIP and secretin.
[3H]D(CH2)5[TYR(ME)2]AVP: A radiolabeled analogue of vasopressin.
BEXAROTENE: A retinoid X receptor (RXR) selective agonist used to treat cutaneous T-cell lymphoma.
[125I]PYY (PIG): A radioiodinated form of porcine Peptide YY.
SAR407899: An experimental Rho-kinase inhibitor.
U0126: A potent and selective non-competitive inhibitor of the kinases MEK1 and MEK2.
INSL5 ANALOGUE 13: A synthetic analogue of the peptide hormone insulin-like peptide 5.
ERLOTINIB HYDROCHLORIDE: The hydrochloride salt of erlotinib, an EGFR tyrosine kinase inhibitor.
SPLITOMICIN: An inhibitor of the Sir2 family of histone deacetylases.
ALANINE: A non-essential amino acid.
TYROSINE KINASE INHIBITOR SU5402: An experimental inhibitor of the VEGFR and FGFR kinases.
ENAVOGLIFLOZIN: An SGLT2 inhibitor used to treat type 2 diabetes.
VACTOSERTIB: An experimental TGF-beta receptor I kinase inhibitor.
NOFAZINLIMAB: An experimental monoclonal antibody.
ENGINEERED TOXIN BODY TARGETING PD-L1 MT-6402: An experimental immunotherapy agent.
MRK-003: An experimental gamma-secretase inhibitor.
ZOTATIFIN: An experimental agent that inhibits the eIF4A protein.
TAMATINIB: An experimental multi-kinase inhibitor.
ALTIRATINIB: An experimental multi-kinase inhibitor targeting TRK, ROS1, and ALK.
YM-254890: A potent inhibitor of the Gq/11 protein alpha subunit.
FORITINIB SUCCINATE: A research chemical or compound identifier.
CHIR-124: An experimental inhibitor of the Chk1 kinase.
(S)-NITRENDIPINE: The S-enantiomer of the calcium channel blocker nitrendipine.
LB80380: An experimental antiviral drug for hepatitis B.
NOVAFERON: A recombinant form of interferon alfa.
(D-ALA11]BOMBESIN: A synthetic analogue of the peptide bombesin.
APARARENONE: An experimental non-steroidal mineralocorticoid receptor antagonist.
FZ7-21: A research chemical or compound identifier.
LY063518: A research chemical or compound identifier.
CYANIDIN: A type of anthocyanidin, a natural pigment.
RILZABRUTINIB: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
SKF-105494: A research chemical or compound identifier.
EPZ004777: A potent and selective inhibitor of the DOT1L histone methyltransferase.
BATIRAXCEPT: An experimental fusion protein that targets the AXL receptor.
COMPOUND 49 [PMID: 30889352]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
BETA-LAPACHONE PRODRUG ARQ 761: An experimental formulation of beta-lapachone, an NQO1-bioactivatable agent.
HEXYLCAINE: A local anesthetic.
BUCELIPASE ALFA: An enzyme replacement therapy for lysosomal acid lipase deficiency.
AVOSENTAN: An experimental endothelin receptor antagonist.
BINODENOSON: An experimental adenosine A1 receptor partial agonist.
ISATUXIMAB: A monoclonal antibody that targets the CD38 protein, used for multiple myeloma.
GDC-0134: An experimental PI3K delta inhibitor.
OLEOCANTHAL: A natural phenolic compound found in extra-virgin olive oil with anti-inflammatory properties.
FIGOPITANT: An experimental neurokinin-1 (NK1) receptor antagonist.
NNC1702: A research chemical or compound identifier.
ALFERMINOGENE TADENOVEC: An experimental gene therapy delivering fibroblast growth factor 4.
TUG-1375: A research chemical or compound identifier.
CENERIMOD: An experimental sphingosine-1-phosphate receptor 1 (S1P1) modulator.
A-971432: A research chemical or compound identifier.
AC262620: A research chemical or compound identifier.
AMINEPTIN: An atypical tricyclic antidepressant that was withdrawn from the market.
BUSERELIN: A gonadotropin-releasing hormone (GnRH) agonist.
BUTAMBEN: A local anesthetic of the ester type.
DR-4004: A research chemical or compound identifier.
[D-PRO4,D-TRP7,9,10]SUBSTANCE P (4-11): A complex peptide analogue of Substance P.
BIM 23052: A research chemical, a somatostatin receptor ligand.
BIM 23454: A research chemical, a somatostatin receptor ligand.
[125I]TYR10-CST14: A radioiodinated form of the peptide cortistatin-14.
5-HYDROXYTRYPTOPHAN: An amino acid that is a precursor to the neurotransmitter serotonin.
PHOTOSENSITIZING AGENT: A class of drugs that become toxic upon exposure to light.
L-803,087: A research chemical or compound identifier.
RILVEGOSTOMIG: An experimental monoclonal antibody.
MALEIC ACID: An organic compound, a dicarboxylic acid.
INHIBITOR 1 [COLOMBO ET AL., 2012]: A specific chemical inhibitor described in a 2012 publication by Colombo et al.
PSB-0788: A research chemical or compound identifier.
2'3'-CGAMP: Cyclic GMP-AMP, an endogenous second messenger that activates the STING pathway.
PLIXORAFENIB: An experimental pan-RAF inhibitor.
RO 63-0563: A selective 5-HT6 receptor antagonist.
CIS-3-ACPBPA: A research chemical or compound identifier.
CAPREOMYCIN SULFATE: An antibiotic used to treat tuberculosis.
DIDEOXYADENOSINE: A nucleoside analog, a precursor to the antiviral drug didanosine.
S5A1: A research chemical or compound identifier.
COMPOUND 27 [WO2019226977A1]: A specific chemical compound described in a patent application.
RORC2 INVERSE AGONIST 66 [PMID: 30130103]: A specific chemical inverse agonist of the ROR-gamma-t receptor, as described in the publication.
ULINASTATIN: A protease inhibitor used for pancreatitis and other inflammatory conditions.
AMEDIPLASE: An experimental thrombolytic agent.
[125I]PTA-OH: A radiolabeled compound, likely a receptor ligand.
H. POLYGYRUS TGF-&BETA; MIMIC: A protein from a parasitic worm that mimics the cytokine TGF-beta.
CYCRIMINE: An anticholinergic drug that was used for Parkinson's disease.
TEMELIMAB: An experimental monoclonal antibody that targets the HERV-W envelope protein.
NA+: The sodium cation, an essential electrolyte.
MK6-83: A research chemical or compound identifier.
ONO-1301: An experimental prostacyclin receptor agonist.
FLT3 TYROSINE KINASE INHIBITOR TTT-3002: An experimental inhibitor of the FLT3 kinase.
DIPHENYLBORONIC ANHYDRIDE: A chemical compound.
TEZACITABINE: An experimental nucleoside analog chemotherapy agent.
COMPOUND 60 [PMID: 30889352]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
NMS-P715: An experimental inhibitor of the kinase Mps1.
GPX4 INHIBITOR C18: A specific chemical inhibitor of the GPX4 enzyme.
LARGE NEUROTENSIN: A precursor form of the neuropeptide neurotensin.
XENTUZUMAB: An experimental monoclonal antibody that targets the IGF-1 and IGF-2 ligands.
COMPOUND 31 [PMID: 24915291]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 30 [PMID: 17280833]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
PNU-120596: A positive allosteric modulator of the alpha-7 nicotinic acetylcholine receptor.
COMPOUND 13 [PMID: 19456099]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
AMINOBENZOVESAMICOL: A research chemical that binds to the vesicular acetylcholine transporter.
HYDROCORTISONE SODIUM SUCCINATE: A salt of the corticosteroid hydrocortisone.
MELK-TI: A research chemical or compound identifier.
EPPTB: A negative allosteric modulator of the mGluR5 receptor.
PIBOSEROD: An experimental 5-HT4 receptor antagonist.
SR101099: A research chemical or compound identifier.
[125I]IODOVINYL-TBZ: A radiolabeled compound for imaging the vesicular monoamine transporter.
COMPOUND 20 [PMID: 23692593]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
[125I]VIP (HUMAN, MOUSE, RAT): A radioiodinated form of vasoactive intestinal peptide.
Z-LEHD-FMK: A specific, irreversible inhibitor of caspase-9.
ICOTINIB: An EGFR tyrosine kinase inhibitor used to treat non-small cell lung cancer.
ESTRADIOL DIPROPIONATE: An ester of the estrogen estradiol.
CH7233163: A research chemical or compound identifier.
YM 218: A research chemical or compound identifier.
IMEGLIMIN: A medication used to treat type 2 diabetes.
UNDECANOIC ACID: A saturated fatty acid.
[PHAA1,D-TYR2,VAL4,ARG6,ARG-NH29]AVP: A complex synthetic peptide analogue of vasopressin.
H87/07: A research chemical or compound identifier.
TRIPROLIDINE: A first-generation antihistamine.
DINITROPHENYLENE: A chemical group used in immunological research.
YM 471: A research chemical or compound identifier.
COMPOUND 1K [PMID: 35912476]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
EXALAMIDE: A research chemical or compound identifier.
MS40: A research chemical or compound identifier.
FEXOFENADINE HYDROCHLORIDE: A third-generation antihistamine used to treat allergies.
NEUROPEPTIDE Y: A peptide neurotransmitter found in the brain and autonomic nervous system.
4-[3-(1,4-DIAZEPAN-1-YLCARBONYL)-4-FLUOROBENZYL]PHTHALAZIN-1(2H)-ONE: A chemical compound, a potent PARP inhibitor.
CELL SURFACE ANTIGEN: A general term for an antigen located on the surface of a cell.
[125I]PYY-(3-36) (HUMAN): A radioiodinated form of the peptide PYY (3-36).
D(CH2)5[TYR(ME)2,ARG8]VP: A synthetic analogue of vasopressin, a V2 receptor agonist.
ALISKIREN: A direct renin inhibitor used to treat hypertension.
COMPOUND 7D [PMID: 19111466]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
CLOBETASOL: A very high-potency topical corticosteroid.
ALGENPANTUCEL-L: An experimental cancer vaccine.
EPZ005687: A potent and selective inhibitor of the DOT1L histone methyltransferase.
ALPHA 1-ANTITRYPSIN: A protein that protects tissues from enzymes of inflammatory cells.
CHLOROACETOXYQUINOLINE: A chemical compound.
TONANTZITLOLONE: A natural product with biological activity.
6-CHLORONICOTINIC ACID: A chemical compound, a derivative of nicotinic acid.
MB-07803: An experimental agent that was studied for its effects on cholesterol.
APINOCALTAMIDE: A research chemical or compound identifier.
REVUMENIB: An experimental inhibitor of the menin-KMT2A interaction for leukemia.
B-RAF/VEGFR-2 INHIBITOR RAF265: An experimental dual inhibitor of the BRAF kinase and VEGFR2.
DMP696: An experimental corticotropin-releasing factor receptor 1 antagonist.
RP-6685: A research chemical or compound identifier.
HYDROCORTISONE ACETATE: The acetate ester of the corticosteroid hydrocortisone.
TESTOSTERONE CYPIONATE: A long-acting ester of testosterone.
SAR247799: An experimental agent that was studied for dyslipidemia.
ATALUREN: A medication used to treat Duchenne muscular dystrophy with a nonsense mutation.
NODAGA-[TYR3]-OCTREOTIDE: A chelator-peptide conjugate used in nuclear medicine.
ACROLEIN: A highly reactive and toxic aldehyde.
INSULIN TREGOPIL: An experimental oral insulin formulation.
CT-011: An experimental immunotherapy agent.
RANITIDINE BISMUTH CITRATE: A combination drug that was used for peptic ulcers.
INSULIN ZINC SUSP EXTENDED BEEF: A long-acting insulin preparation from beef sources.
INSULIN ZINC SUSP PROMPT BEEF: A rapid-acting insulin preparation from beef sources.
SUCRALFATE: A medication used to treat stomach ulcers.
NORGESTREL: A progestin used in hormonal contraceptives.
TAZEMETOSTAT: An EZH2 inhibitor used to treat epithelioid sarcoma and follicular lymphoma.
CERALASERTIB: An experimental ATR kinase inhibitor.
PJ34: A potent inhibitor of the PARP enzyme.
TEMSIROLIMUS: An mTOR inhibitor used to treat renal cell carcinoma.
YTTRIUM Y 90 IBRITUMOMAB TIUXETAN: A radioimmunotherapy agent targeting CD20.
POLO-LIKE KINASE 1 INHIBITOR GSK461364: An experimental inhibitor of the Plk1 kinase.
GUNAGRATINIB: An experimental FGFR inhibitor.
SUVOREXANT: A dual orexin receptor antagonist used for the treatment of insomnia.
GMI-1359: An experimental dual E-selectin and CXCR4 antagonist.
SAR-260301: An experimental PI3K beta inhibitor.
RO-4987655: An experimental inhibitor of the BRAF kinase.
ALFENTANIL HYDROCHLORIDE: An ultra-short-acting synthetic opioid analgesic.
TAK-632: An experimental pan-RAF inhibitor.
MEK 1/2 INHIBITOR FCN-159: An experimental inhibitor of the MEK1 and MEK2 kinases.
LY2881835: A research chemical or compound identifier.
LAS190792: A research chemical or compound identifier.
SILMITASERTIB: An experimental inhibitor of the casein kinase 2 (CK2).
M-2698: A research chemical or compound identifier.
RAFABEGRON: An experimental alpha-4 integrin agonist.
DAVALINTIDE: An experimental amylin analog that was studied for obesity.
CE-224535: An experimental agent that was studied for its effects on cholesterol.
BEMCENTINIB: An experimental AXL kinase inhibitor.
MUTANT-SELECTIVE PI3K-ALPHA H1047R INHIBITOR LOXO-783: An experimental selective inhibitor of the PI3K alpha H1047R mutant.
BECTUMOMAB: An experimental monoclonal antibody that targets the CD22 antigen.
ALK/C-MET INHIBITOR TQ-B3139: An experimental dual inhibitor of the ALK and c-Met kinases.
ROLEDUMAB: An experimental monoclonal antibody.
ANATUMOMAB MAFENATOX: An experimental targeted cancer therapy.
PIRPROFEN: A non-steroidal anti-inflammatory drug (NSAID).
AMG-820: An experimental monoclonal antibody that targets the angiopoietin-2 protein.
ABX-MA1: An experimental monoclonal antibody.
PITAVASTATIN SODIUM: The sodium salt of the statin drug pitavastatin.
OCARATUZUMAB: An experimental monoclonal antibody that targets the CD20 protein.
AS-1403: A research chemical or compound identifier.
MIROCOCEPT: An experimental complement receptor 1-based therapeutic.
IDECABTAGENE VICLEUCEL: A CAR-T cell therapy targeting BCMA, used for multiple myeloma.
ELRAGLUSIB: An experimental GSK-3 inhibitor.
NEMONOXACIN: A non-fluorinated quinolone antibiotic.
BATOPROTAFIB: An experimental Tie2 receptor agonist.
ONO-2952: A research chemical or compound identifier.
AURORA KINASE INHIBITOR AMG 900: A potent and selective inhibitor of Aurora kinases.
BLZ945: A potent and selective inhibitor of the CSF1R kinase.
VIBOSTOLIMAB: An experimental monoclonal antibody that targets the TIGIT immune checkpoint.
TEBUFENPYRAD: An acaricide (mite killer).
VU0001171: A research chemical or compound identifier.
ZINLIRVIMAB: An experimental monoclonal antibody.
TRASTUZUMAB DUOCARMAZINE: An experimental antibody-drug conjugate targeting the HER2 protein.
GILORALIMAB: An experimental monoclonal antibody that targets the CD40 receptor.
MASUPIRDINE: An experimental 5-HT6 receptor antagonist.
MILVEXIAN: An experimental direct factor XIa inhibitor.
ROVATIRELIN: An experimental thyrotropin-releasing hormone (TRH) analog.
EMB-01: A research chemical or compound identifier.
ABACAVIR: A nucleoside reverse transcriptase inhibitor (NRTI) used to treat HIV.
NOMEGESTROL ACETATE: A progestin used in hormonal contraceptives.
FEXUPRAZAN: A potassium-competitive acid blocker used to treat acid-related disorders.
RO 04-6790: A research chemical or compound identifier.
GW279320X: A research chemical or compound identifier.
PROTOCATECHUIC ACID: A natural phenolic acid with antioxidant properties.
CARBENDAZIM: A broad-spectrum systemic fungicide.
ISOBOnduCELLIN: A research chemical or compound identifier.
CARNITINE: A quaternary ammonium compound involved in metabolism.
LEVOMETHADYL ACETATE HYDROCHLORIDE: A synthetic opioid analgesic.
BROQUINALDOL: An antiseptic agent.
8,2'-DIMETHOXYFLAVONE: A chemical compound, a type of flavonoid.
CXCL9: A small cytokine belonging to the CXC chemokine family, also known as Mig.
RS 39604: A research chemical or compound identifier.
GW827396X: A research chemical or compound identifier.
ADX88178: A positive allosteric modulator of the mGluR4 receptor.
DAMGO: A potent and selective mu-opioid receptor agonist.
ACETOSIDE: A natural phenylethanoid glycoside.
PREGNANT MARE SERUM GONADOTROPIN: A hormone preparation used in veterinary medicine to induce ovulation.
ALPHA-TOCOPHEROL: The most biologically active form of Vitamin E.
SULCONAZOLE NITRATE: A topical azole antifungal agent.
BIFENOX: An herbicide.
MANSONONE F: A natural naphthoquinone compound.
PREDNICARBATE: A topical corticosteroid.
METRIBUZIN: An herbicide.
MEDI6012: An experimental monoclonal antibody.
AESCULIOSIDE IIC: A saponin compound found in some plants.
GANGLEOIDIN ACETATE: A research chemical or compound identifier.
DESMEDIPHAM: An herbicide.
HYDROCORTISONE VALERATE: An ester of the corticosteroid hydrocortisone.
RANOLAZINE: A medication used to treat chronic angina.
GLABRIDIN: A major isoflavan in licorice root extract.
SHINJULACTONE B: A natural product with biological activity.
BISSALICYL FUMARATE: A research chemical or compound identifier.
DIFENPIRAMIDE: An experimental anti-inflammatory drug.
RITODRINE HYDROCHLORIDE: The hydrochloride salt of ritodrine, a tocolytic agent.
DIETHANOLAMINE: An organic compound used in various industrial applications.
VU0010010: A positive allosteric modulator of the mGluR4 receptor.
DEFLAZACORT: A glucocorticoid used for its anti-inflammatory and immunosuppressant effects.
SB 218078: A research chemical or compound identifier.
ALVESPIMYCIN: An Hsp90 inhibitor.
NONYL 4-HYDROXYBENZOATE: A type of paraben preservative.
GLYCITEIN: An isoflavone phytoestrogen found in soy.
MELAGATRAN: An experimental direct thrombin inhibitor.
R-348: A research chemical or compound identifier.
DIHYDRALAZINE: A vasodilator used to treat hypertension.
CLOCAPRAMINE: A typical antipsychotic of the iminodibenzyl class.
BUNAMIDINE HYDROCHLORIDE: An anthelmintic used in veterinary medicine.
BENZOXIQUINE: An antiseptic and disinfectant.
ROPINIROLE HYDROCHLORIDE: The hydrochloride salt of ropinirole, a dopamine agonist.
VITEXIN: A natural apigenin flavone glucoside.
CYCLOCITRINOL: A natural product with biological activity.
MINOPAFANT: An experimental platelet-activating factor (PAF) receptor antagonist.
PHENIDONE: A chemical used in photographic developers.
AESCULIOSIDE IVA: A saponin compound found in some plants.
SPERMINE TETRAHYDROCHLORIDE: The hydrochloride salt of spermine, a polyamine.
MOXISYLYTE: An alpha-1 blocker used to treat Raynaud's syndrome.
NALOXONE HYDROCHLORIDE: An opioid antagonist used to reverse opioid overdose.
GALLINAMIDE A: A natural cyclic peptide.
SECRAMINE B: A research chemical or compound identifier.
GW833373X: A research chemical or compound identifier.
XANTHOANGELOL F: A natural chalcone compound.
DAPHNORETIN: A natural bicoumarin.
GR 113808: A potent and selective 5-HT4 receptor antagonist.
ACETAMIDE: A simple organic compound, the amide derived from acetic acid.
GW621431X: A research chemical or compound identifier.
TIPLASININ: A research chemical or compound identifier.
PHENTOLAMINE: A non-selective alpha-adrenergic antagonist.
LUPEOL: A natural pentacyclic triterpenoid.
GAVESTINEL SODIUM: An experimental antagonist of the glycine site of the NMDA receptor.
NIMETAZEPAM: A long-acting benzodiazepine.
RESCINNAMINE: An antihypertensive drug, a rauwolfia alkaloid.
PHYTANIC ACID: A branched-chain fatty acid that accumulates in Refsum's disease.
FENHEXAMID: A fungicide.
RECOMBINANT INTERFERON: A general class of manufactured interferon proteins.
BIOFLAVONOID: A class of plant-derived compounds with antioxidant properties.
ATU-027: An experimental siRNA therapeutic targeting PKN3.
INFIGRATINIB PHOSPHATE: The phosphate salt of infigratinib, an FGFR inhibitor.
ANTHRAQUINONE: An aromatic organic compound, the parent structure of many dyes.
VACCINE ADJUVANT: A substance that enhances the body's immune response to an antigen.
TAS-106: An experimental topoisomerase I inhibitor.
PRN694: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
DEMECOLCINE: An alkaloid that inhibits mitosis by depolymerizing microtubules.
EXATECAN MESYLATE: The mesylate salt of exatecan, a topoisomerase I inhibitor.
INTERLEUKIN-3: A cytokine that stimulates the differentiation of hematopoietic stem cells.
TOSITUMOMAB: A monoclonal antibody that targets the CD20 protein, used in radioimmunotherapy for lymphoma.
DEXRAZOXANE: A cardioprotective agent used to prevent heart problems caused by doxorubicin chemotherapy.
ANTIHYPERTENSIVE AGENT: A general class of drugs used to treat hypertension (high blood pressure).
MONOCLONAL ANTIBODY ICR62: An experimental monoclonal antibody that targets the EGFR.
RECOMBINANT INTERFERON GAMMA: A manufactured form of the cytokine interferon-gamma, used for chronic granulomatous disease.
GELDANAMYCIN: A natural product that inhibits the Hsp90 protein, used in research.
OXANDROLONE: An androgen and anabolic steroid used to promote weight gain and treat bone pain.
KEYHOLE LIMPET HEMOCYANIN: An immunogenic protein from a marine mollusk, used as a vaccine carrier and immune stimulant.
CETYLPYRIDINIUM CHLORIDE: A quaternary ammonium antiseptic found in many mouthwashes and personal care products.
TENIVASTATIN: A research chemical or compound identifier.
BOC-ATE: A research chemical or compound identifier.
GIVOSIRAN: An RNAi therapeutic that targets ALAS1, used to treat acute hepatic porphyria.
GENTAMICIN: An aminoglycoside antibiotic used to treat many types of bacterial infections.
WAY-100135: A selective 5-HT1A receptor antagonist.
2-(PHENOXYMETHYL)BENZOTHIAZOLE: A chemical compound.
COMPOUND 3 [PMID: 32636746]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
FEXARAMINE: An experimental farnesoid X receptor (FXR) agonist.
[3H]SNAP-7941: A radiolabeled antagonist of the melanin-concentrating hormone receptor 1.
SB 225002: A potent and selective antagonist of the CXCR2 chemokine receptor.
CAPLACIZUMAB-YHDP: A nanobody that targets von Willebrand factor, used to treat acquired thrombotic thrombocytopenic purpura.
APC-100: A research chemical or compound identifier.
PLACULUMAB: An experimental monoclonal antibody.
BELAGENPUMATUCEL-L: An experimental therapeutic cancer vaccine for non-small cell lung cancer.
CGS8216: A benzodiazepine receptor antagonist.
EFATUTAZONE DIHYDROCHLORIDE: An experimental PPAR-gamma agonist.
EW-A-401: A research chemical or compound identifier.
FLUOCINONIDE: A high-potency topical corticosteroid used to treat skin conditions.
DEXMETHYLPHENIDATE: The dextrorotary enantiomer of methylphenidate, a CNS stimulant used for ADHD.
M0002: A research chemical or compound identifier.
MDX-1342: An experimental monoclonal antibody.
TAFASITAMAB: A monoclonal antibody that targets CD19, used in combination for diffuse large B-cell lymphoma.
TALNIFLUMATE: A non-steroidal anti-inflammatory drug (NSAID).
PONEZUMAB: An experimental monoclonal antibody that targets amyloid-beta, studied for Alzheimer's disease.
SB-559448: A potent and selective 5-HT1B receptor antagonist.
TELMISARTAN: An angiotensin II receptor antagonist used to treat high blood pressure.
TORCETRAPIB: An experimental CETP inhibitor that was studied to raise HDL cholesterol.
V24343: A research chemical or compound identifier.
VEGLIN: A research chemical or compound identifier.
VESTIPITANT: An experimental neurokinin-1 (NK1) receptor antagonist.
PACRITINIB CITRATE: The citrate salt of pacritinib, a JAK inhibitor.
ZOXAMIDE: A fungicide used in agriculture.
TIVOZANIB HYDROCHLORIDE: The hydrochloride salt of tivozanib, a VEGFR tyrosine kinase inhibitor.
GSK-466314A: A research chemical or compound identifier.
VIMSELTINIB: An experimental CSF1R kinase inhibitor.
TELRATOLIMOD: An experimental Toll-like receptor 7 (TLR7) agonist.
LIXUMISTAT ACETATE: An experimental GCS inhibitor.
ANTI-TIM3 MONOCLONAL ANTIBODY LY3321367: An experimental immunotherapy agent targeting the TIM-3 checkpoint.
PU-H71: An experimental Hsp90 inhibitor.
MK-8353: An experimental ERK1/2 kinase inhibitor.
LISAVANBULIN: An experimental microtubule inhibitor.
VECABRUTINIB: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
BIMEKIZUMAB: A monoclonal antibody that targets IL-17A and IL-17F, used for psoriasis.
L 755507: A selective beta-3 adrenergic receptor agonist.
GSK2831781: A research chemical or compound identifier.
DIFELIKEFALIN: A peripherally acting kappa-opioid receptor agonist used for pruritus.
COTADUTIDE: An experimental dual GLP-1 and glucagon receptor agonist.
COBICISTAT: A pharmacokinetic enhancer used to increase the levels of other HIV medications.
LESINURAD: A uricosuric agent that was used to treat gout.
SITAGLIPTIN: A DPP-4 inhibitor used to treat type 2 diabetes.
AGT-182: An experimental enzyme replacement therapy.
RECOMBINANT HUMAN KALLIKREIN-1: A manufactured form of the KLK1 protein.
LONODELESTAT: An experimental neutrophil elastase inhibitor.
RANIRESTAT: An experimental aldose reductase inhibitor.
SAR-113945: A research chemical or compound identifier.
FEZAKINUMAB: An experimental monoclonal antibody that targets interleukin-1 beta.
VERINURAD: An experimental uricosuric agent.
HYDROXOCOBALAMIN: A form of Vitamin B12 used to treat vitamin B12 deficiency and cyanide poisoning.
SAPRISARTAN: An experimental angiotensin II receptor antagonist.
LMB-2: An experimental immunotoxin targeting the CD25 receptor.
ALBUSOMATROPIN: A research chemical or compound identifier.
NEUROKININ A: A peptide neurotransmitter of the tachykinin family.
PRAZIQUANTEL: An anthelmintic medication used to treat a number of parasitic worm infections.
TROMETHAMINE: An organic amine used as a buffering agent in biochemical and medical applications.
MIBEFRADIL: A calcium channel blocker that was withdrawn from the market.
ARCITUMOMAB: An experimental monoclonal antibody fragment targeting CEA for imaging.
ZOTAROLIMUS: An mTOR inhibitor, a derivative of sirolimus, used on drug-eluting stents.
HSP90 INHIBITOR BIIB021: An experimental inhibitor of the Hsp90 protein.
MEBENDAZOLE: An anthelmintic medication used to treat a variety of parasitic worm infestations.
MALATHION: An organophosphate insecticide and parasympathicide.
SIVELESTAT: A neutrophil elastase inhibitor used for acute lung injury.
MDX-1411: An experimental bispecific antibody.
TASPOGLUTIDE: An experimental GLP-1 receptor agonist.
MK-0354: An experimental agent that was studied for obesity.
CH-4051: A research chemical or compound identifier.
264W94: An experimental antiviral drug.
AZD-8848: A research chemical or compound identifier.
CYP17/CYP11B2 INHIBITOR LAE001: An experimental dual inhibitor of the enzymes CYP17 and CYP11B2.
LINERIXIBAT: An experimental IBAT inhibitor.
VESATOLIMOD: An experimental Toll-like receptor 7 (TLR7) agonist.
THIOPENTAL: An ultra-short-acting barbiturate used for general anesthesia.
BETIFISOLIMAB: An experimental monoclonal antibody.
CH 275: A research chemical or compound identifier.
PF-06291874: A research chemical or compound identifier.
OMIDENEPAG ISOPROPYL: A prodrug of omidenepag, a prostaglandin EP2 receptor agonist for glaucoma.
AUTOLOGOUS CD30CAR-CD28-CD3ZETA-EXPRESSING T-LYMPHOCYTES: A specific formulation of CAR-T cell therapy targeting CD30.
AXICABTAGENE CILOLEUCEL: A CAR-T cell therapy targeting CD19, used for large B-cell lymphoma.
AUTOLOGOUS NKG2D CAR-CD3ZETA-DAP10-EXPRESSING T-LYMPHOCYTES CYAD-01: An experimental CAR-T cell therapy based on the NKG2D receptor.
ALEFACEPT: A fusion protein used to treat psoriasis.
FELZARTAMAB: An experimental monoclonal antibody that targets CD38.
DOXORUBICIN-MAGNETIC TARGETED CARRIER COMPLEX: An experimental drug delivery system for doxorubicin.
SURVIVIN MRNA ANTAGONIST EZN-3042: An experimental antisense drug targeting survivin.
FASINUMAB: An experimental monoclonal antibody that targets nerve growth factor (NGF).
ETIPREDNOL DICLOACETATE: A soft corticosteroid.
ACRIVASTINE: A second-generation antihistamine.
AMPIROXICAM: A prodrug of the NSAID piroxicam.
COSYNTROPIN: A synthetic peptide that mimics the effects of ACTH.
LIVE ATTENUATED INFLUENZA VACCINE: A type of vaccine that uses a weakened form of the influenza virus.
NICORANDIL: A medication that acts as a potassium channel opener and nitrate, used for angina.
NICERGOLINE: A derivative of ergot used to treat dementia and other vascular disorders.
SIFALIMUMAB: An experimental monoclonal antibody that targets interferon-alpha.
TRIMAZOSIN: An alpha-1 blocker that was used as an antihypertensive agent.
VOLAGIDEMAB: An experimental monoclonal antibody.
IVUXOLIMAB: An experimental monoclonal antibody.
SAR-405838: An experimental inhibitor of the enzyme fatty acid synthase.
APLINDORE FUMARATE: An experimental dopamine D2 receptor partial agonist.
LUCATUMUMAB: An experimental monoclonal antibody that targets the CD40 receptor.
SELODENOSON: An experimental adenosine A1 receptor partial agonist.
RIMACALIB: An experimental inhibitor of the ROCK kinase.
LYSERGOL: An alkaloid of the ergoline family.
BLONANSERIN: An atypical antipsychotic used to treat schizophrenia.
WWL123: A research chemical or compound identifier.
AH 11110: A research chemical or compound identifier.
(+)-ADRENALINE: The naturally occurring form of epinephrine, a hormone and neurotransmitter.
TERAZOSIN: An alpha-1 antagonist used to treat symptoms of an enlarged prostate and high blood pressure.
VUF8507: A research chemical or compound identifier.
NEUROMEDIN B (1-30) (HUMAN): A peptide hormone related to bombesin.
OBRINDATAMAB: An experimental monoclonal antibody.
CPI-203: An experimental BET inhibitor.
ARV-771: An experimental PROTAC that degrades the BRD4 protein.
MS436: A research chemical or compound identifier.
INHIBITOR E4: A research chemical or compound identifier.
[TYR8]BRADYKININ: A synthetic analogue of the peptide bradykinin.
ACT-1014-6470: A research chemical or compound identifier.
P59 [PMID: 27108698]: A specific peptide ligand described in the publication.
WWGKKYRASKLGLAR: A peptide sequence.
JR14A: A research chemical or compound identifier.
AC-DEVD-CHO: A specific, reversible inhibitor of caspase-3.
COMPOUND 1E [PMID: 27285276]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
CCL11: A small cytokine belonging to the CC chemokine family, also known as eotaxin.
BMS-741672: A research chemical or compound identifier.
AZD2098: An experimental CCR1 chemokine receptor antagonist.
MG-277: A research chemical or compound identifier.
SC-560: A selective inhibitor of the COX-1 enzyme.
SC-58125: A selective inhibitor of the COX-2 enzyme.
CXCL7: A small cytokine belonging to the CXC chemokine family, also known as NAP-2.
CXCL12&PHI;: An isoform of the chemokine CXCL12.
BS-181: A potent and selective inhibitor of the kinase CDK7.
TIBREMCICLIB: An experimental cyclin-dependent kinase (CDK) inhibitor.
TL1A: A cytokine that is a member of the tumor necrosis factor (TNF) superfamily.
SNC80: A potent and selective delta-opioid receptor agonist.
ERVOGASTAT: An experimental DGAT2 inhibitor.
S416: A research chemical or compound identifier.
COMPOUND 10F [PMID: 24556381]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
OLMUTINIB: A third-generation EGFR inhibitor that was studied for non-small cell lung cancer.
GPI-1046: An experimental neurotrophic compound.
AG-11/03: A research chemical or compound identifier.
T-BOC-FLFLF: A peptide antagonist of formyl peptide receptors.
AS604872: An experimental JNK kinase inhibitor.
AL12180: A research chemical or compound identifier.
FZM1: A research chemical or compound identifier.
WNT-4: A protein that is a ligand in the Wnt signaling pathway.
2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE: A complex chemical name, likely a synthetic intermediate.
LY3463251: A research chemical or compound identifier.
ALX 1393: A potent inhibitor of the glycine transporter GlyT1.
FERTIRELIN: A synthetic analogue of gonadotropin-releasing hormone (GnRH).
[3H](R)-NPTS: A radiolabeled compound, likely a receptor ligand.
[TRP8]GNRH: A synthetic analogue of gonadotropin-releasing hormone.
BAY1214784: An experimental Factor XIa inhibitor.
DEOXYCHOLIC ACID: A secondary bile acid.
C-TYPE NATRIURETIC PEPTIDE: A peptide hormone with vasodilatory effects.
G36: A research chemical or compound identifier.
A-71915: A research chemical, a neurotensin receptor antagonist.
CITRULLINE: An amino acid that is an intermediate in the urea cycle.
COMPOUND 1 [PMID: 16821802]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
IBC 293: A research chemical or compound identifier.
MARBOSTAT-100: An experimental histone deacetylase (HDAC) inhibitor.
UR-PG153: A research chemical or compound identifier.
A-349821: A research chemical or compound identifier.
VUF 5207: A research chemical or compound identifier.
GSK334429: A research chemical or compound identifier.
COMPOUND 33 [PMID: 17574412]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 42 [PMID: 17574411]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
NEBOGLAMINE: An experimental NMDA receptor antagonist.
COMPOUND 47 [PMID: 28737909]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
IKK-BETA INHIBITOR R-28: A specific chemical inhibitor of the IKK-beta kinase.
AM3: A research chemical or compound identifier.
BAY-73-1449: A research chemical or compound identifier.
BARDOXOLONE: An experimental antioxidant inflammation modulator.
KISSPEPTIN-14: A peptide hormone that stimulates the release of GnRH.
OPNURASIB: An experimental SOS1 inhibitor.
EXAMPLE 320 [WO2018198077A2]: A specific chemical compound described in a patent application.
IBUTILIDE: An antiarrhythmic medication that blocks potassium channels.
INHIBITOR 19 [PMID: 21476495]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
RO3306: A potent and selective inhibitor of the kinase CDK1.
COMPOUND 12 [PMID: 31990537]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
UCM-14216: A research chemical or compound identifier.
AS2717638: A research chemical or compound identifier.
VINTAFOLIDE: An experimental targeted chemotherapy agent for folate receptor-positive tumors.
OG-L002: An experimental agent that was studied for its effects on cholesterol.
MCH (SALMON): Melanin-concentrating hormone from salmon.
CC-401: A research chemical or compound identifier.
MK2A INHIBITOR: A class of drugs that inhibit the MK2a kinase.
CORTICOTROPIN-ZINC HYDROXIDE: A long-acting formulation of ACTH.
[125I]ACTH-(1-24): A radioiodinated fragment of the adrenocorticotropic hormone.
MBP10: A research chemical or compound identifier.
MNI-137: A research chemical or compound identifier.
ZALOGLANSTAT: An experimental microsomal prostaglandin E synthase-1 inhibitor.
GW805758X: A research chemical or compound identifier.
[3H]DIHYDROALPRENOLOL: A radiolabeled non-selective beta-blocker.
JINGZHAOTOXIN-III: A peptide toxin from scorpion venom that blocks potassium channels.
ELECLAZINE: An experimental agent that was studied for angina and heart failure.
XMD8-92: A potent and selective inhibitor of the BRSK and MARK kinases.
NEUROTROPHIN-4: A neurotrophic factor that supports the survival of neurons, also known as NT-4.
&ALPHA;-CONOTOXIN MII [H9A, L15A]: A synthetic analogue of a peptide neurotoxin.
CHLORMADINONE: A steroidal progestin.
CASOPITANT: An experimental neurokinin-1 (NK1) receptor antagonist.
FOSAPREPITANT: A prodrug of aprepitant, an NK1 receptor antagonist.
SENKTIDE: A potent and selective neurokinin-3 (NK3) receptor agonist.
GR138676: A research chemical or compound identifier.
NOCICEPTIN/ORPHANIN FQ: An endogenous opioid peptide that is the ligand for the NOP receptor.
NY0116: A research chemical or compound identifier.
[3H]ESTRADIOL-17&BETA;-GLUCURONIDE: A radiolabeled metabolite of estradiol.
MRS4625: A research chemical or compound identifier.
2,2'-PYRIDYLISATOGEN TOSYLATE: A chemical compound.
MRS2578: A potent and selective antagonist of the P2Y6 purinergic receptor.
P4PAL-10: A research chemical or compound identifier.
BMS-986120: An experimental LPA1 receptor antagonist.
SLIGKV-NH2: A peptide agonist of the PAR-2 receptor.
MRL20: A research chemical or compound identifier.
TIROTUNDIN: An experimental prostaglandin D2 receptor 2 (DP2) antagonist.
QUINOSTATIN: A research chemical or compound identifier.
TIP39: Tuberoinfundibular peptide of 39 residues, an endogenous ligand for the PTH2 receptor.
CHOLESTEROL: A sterol that is an essential structural component of animal cell membranes.
ECLITASERTIB: An experimental RAC1 kinase inhibitor.
S1P D20:1: A species of the signaling lipid sphingosine-1-phosphate.
[(CH2NH)4,5]SECRETIN: A synthetic analogue of the hormone secretin.
XMU-MP-1: A potent and selective inhibitor of the Mps1 kinase.
COMPOUND 48 [PMID: 25815140]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 3A [PMID: 12238936]: An experimental compound described in the specified publication.
SLB1122168: A research chemical or compound identifier.
H-C[CYS-PHE-LAGL(N&BETA;ME,BENZOYL)-DTRP-LYS-THR-PHE-CYS]-OH: A complex synthetic peptide.
EXAMPLE 203 [WO2017058503A1]: A specific chemical compound described in a patent application.
COMPOUND 130 [PMID: 29157600]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
PEPTIDE 4 [PMID: 18294843]: A specific peptide ligand for a receptor, as described in the publication.
THYMOL: A natural monoterpenoid phenol with antiseptic properties.
AM12: A research chemical or compound identifier.
AM-0883: A research chemical or compound identifier.
SF-51: A research chemical or compound identifier.
ML1-SA1: A research chemical or compound identifier.
KPR-5714: A research chemical or compound identifier.
SBI-0206965: An inhibitor of the ULK1 kinase, involved in autophagy.
CHECKPOINT KINASE INHIBITOR AZD7762: An experimental inhibitor of the Chk1 and Chk2 kinases.
OBATOCLAX: An experimental BCL-2 family inhibitor.
UMI-77: An experimental agent that disrupts the Mcl-1/Bim interaction.
MEK INHIBITOR RO4987655: An experimental inhibitor of the MEK kinase.
6BETA-HYDROXYTESTOSTERONE: A metabolite of testosterone.
PSORALEN: A natural compound that forms covalent adducts to DNA upon photoactivation.
KD3010: An experimental PPAR-delta agonist.
LARGE NEUROMEDIN N: A precursor form of the neuropeptide neuromedin N.
PWT2-N/OFQ: A research chemical or compound identifier.
[111IN,90Y]DOTA-TOC: A radiolabeled somatostatin analog used in nuclear medicine.
FLUPIRTINE: A centrally acting non-opioid analgesic.
OXIDOPAMINE: A neurotoxin used in research to selectively destroy dopaminergic and noradrenergic neurons.
CLARITHROMYCIN: A macrolide antibiotic used to treat a variety of bacterial infections.
CHINOMETHIONAT: An acaricide and fungicide.
MM-121: An experimental monoclonal antibody that targets the ErbB3 receptor.
BPH-608: A research chemical or compound identifier.
[3H]LTB4: A radiolabeled form of leukotriene B4, a lipid mediator of inflammation.
RIPK3 INHIBITOR 18: A specific chemical inhibitor of the RIPK3 kinase.
QUAVONLIMAB: An experimental monoclonal antibody that targets the CTLA-4 immune checkpoint.
COMPOUND 23C [PMID: 17929793]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
EMICERFONT: An experimental corticotropin-releasing factor receptor 1 antagonist.
NELARABINE: A chemotherapy agent used to treat T-cell acute lymphoblastic leukemia and lymphoma.
DS88790512: A research chemical or compound identifier.
GSK-1070806: A research chemical or compound identifier.
ARDEPARIN SODIUM: A low molecular weight heparin (LMWH) used as an anticoagulant.
CIFORADENANT: An experimental adenosine A2A receptor antagonist.
FIRTECAN PEGOL: A long-acting formulation of the topoisomerase I inhibitor irinotecan.
METHYLINOSITOL: A derivative of inositol.
DIAZOXIDE CHOLINE: A formulation of the potassium channel activator diazoxide.
HYOSCYAMINE: An antimuscarinic agent used to treat various gastrointestinal disorders.
IMAGABALIN: An experimental gabapentinoid drug.
ROLIPRAM: A selective phosphodiesterase-4 (PDE4) inhibitor.
SODIUM NITRITE: An inorganic salt used as a preservative and as a medication for cyanide poisoning.
COAGULATION FACTOR VIIA (RECOMBINANT)-JNCW: A recombinant form of Factor VIIa.
VINDESINE SULFATE: A vinca alkaloid chemotherapy agent.
THIOUREIDOBUTYRONITRILE: A research chemical or compound identifier.
GR94800: A research chemical or compound identifier.
D-SERINE: An amino acid that acts as a co-agonist at the NMDA receptor.
CHLOROTRIANISENE: A synthetic non-steroidal estrogen.
RM-2 GA-68: A radiolabeled compound for medical imaging.
METAPROTERENOL: A short-acting beta-2 adrenergic receptor agonist used as a bronchodilator.
MLN8054: An experimental Aurora kinase A inhibitor.
ANANDAMIDE: An endocannabinoid, an endogenous agonist of the cannabinoid receptors.
AZD9898: A research chemical or compound identifier.
POLYESTRADIOL PHOSPHATE: A long-acting estrogen medication.
PLASMIN: An important enzyme present in blood that degrades many blood plasma proteins, including fibrin clots.
COMPOUND 72 [WO2013026806]: A specific chemical compound described in a patent application.
OZANIMOD HYDROCHLORIDE: The hydrochloride salt of ozanimod, an S1P receptor modulator for multiple sclerosis.
LORNEIC ACID A: A research chemical or compound identifier.
SETRUSUMAB: An experimental monoclonal antibody that targets the sclerostin protein.
12-EPI LTB4: An isomer of the lipid mediator leukotriene B4.
I-CBP112: An experimental CB2 cannabinoid receptor agonist.
ETIGILIMAB: An experimental monoclonal antibody that targets the TIGIT immune checkpoint.
MEPREDNISONE: A synthetic glucocorticoid.
RITONAVIR: A protease inhibitor and pharmacokinetic enhancer used to treat HIV.
PIMECROLIMUS: A calcineurin inhibitor used topically to treat atopic dermatitis.
SEMAGLUTIDE: A GLP-1 receptor agonist used to treat type 2 diabetes and obesity.
NOMEGESTROL: A progestin hormone.
SOS1 PROTAC 9D: A specific PROTAC molecule designed to degrade the SOS1 protein.
[125I]PSALMOTOXIN 1: A radioiodinated peptide toxin from spider venom that blocks acid-sensing ion channels.
DEFERITAZOLE: A research chemical or compound identifier.
AM841: A research chemical, a cannabinoid receptor agonist.
ND-2110: A research chemical or compound identifier.
COMPOUND 6 [PMID: 7629799]: An experimental compound described in a 1995 publication.
AZD0156: An experimental ATM kinase inhibitor.
VODOBATINIB: An experimental multi-kinase inhibitor.
FLT-3 INHIBITOR II: A specific chemical inhibitor of the FLT3 kinase.
MIVACURIUM: A short-acting non-depolarizing neuromuscular-blocking drug.
EXATECAN: An experimental topoisomerase I inhibitor.
TM30339: A research chemical or compound identifier.
COAGULATION FACTOR IX: A key protein in the blood coagulation cascade.
QUISQUALIC ACID: A potent agonist for AMPA and some metabotropic glutamate receptors.
JATRORRHIZINE: A protoberberine alkaloid with various biological activities.
AZD7762: An experimental inhibitor of the Chk1 and Chk2 kinases.
VONICOG ALFA: A recombinant form of human von Willebrand factor.
CXCL17: A small cytokine belonging to the CXC chemokine family.
D(CH2)5[D-ILE2,VAL4,TYR-NH29]AVP: A complex synthetic peptide analogue of vasopressin.
COMPOUND 29E [PMID: 23631440]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
OXYCODEGOL: A research chemical or compound identifier.
[3H]CGS 21680: A radiolabeled selective adenosine A2A receptor agonist.
ASTRESSIN: A non-selective antagonist of corticotropin-releasing factor receptors.
LINEZOLID: An oxazolidinone antibiotic used to treat serious bacterial infections.
BMS-986158: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
RICOLINOSTAT: An experimental histone deacetylase 6 (HDAC6) inhibitor.
VIPOGLANSTAT: An experimental prostaglandin D2 synthase inhibitor.
ASP-4058: A research chemical or compound identifier.
TIMAPIPRANT: An experimental prostaglandin D2 receptor 2 (DP2) antagonist.
ETIOCHOLANOLONE: An endogenous steroid metabolite.
IPRAGLIFLOZIN: An SGLT2 inhibitor used to treat type 2 diabetes.
LIRENTELIMAB: An experimental monoclonal antibody that targets the Siglec-8 protein.
SALIRASIB: An experimental Ras inhibitor.
SOLIFENACIN SUCCINATE: The succinate salt of solifenacin, an antimuscarinic drug.
EXAMPLE 2 [WO2013004676]: A specific chemical compound described in a patent application.
CINSEBRUTINIB: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
INOTUZUMAB: An antibody-drug conjugate that targets CD22.
GLUCAGON-LIKE PEPTIDE 1-(7-36) AMIDE: A major active form of the GLP-1 hormone.
RTA 744: An experimental anticancer agent.
FENOTEROL: A short-acting beta-2 adrenergic receptor agonist used as a bronchodilator.
T863: A research chemical or compound identifier.
VELAGLUCERASE ALFA: An enzyme replacement therapy used for Gaucher disease.
GW680191X: A research chemical or compound identifier.
&DELTA;12-PGJ2: A type of prostaglandin that acts as a PPAR-gamma agonist.
S-14671: A research chemical or compound identifier.
METHOCTRAMINE HYDROCHLORIDE: A selective M2 muscarinic receptor antagonist.
TUMOUR NECROSIS FACTOR MEMBRANE FORM: The membrane-bound precursor of the cytokine TNF.
ABROCITINIB: A Janus kinase (JAK) inhibitor used to treat atopic dermatitis.
[125I]CXCL7 (HUMAN): A radioiodinated form of the chemokine CXCL7.
BMS-986318: An experimental monoclonal antibody.
EPTACOG ALFA PEGOL (ACTIVATED): A long-acting recombinant Factor VIIa.
EC 5-21: A research chemical or compound identifier.
FGFR INHIBITOR CPL304110: An experimental inhibitor of the FGFR kinase.
COMPOUND 29 [PMID: 36356320]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
ULOTARONT: An experimental antipsychotic that acts as a TAAR1 and 5-HT1A agonist.
CUPRESSUFLAVONE: A natural biflavonoid compound.
AG 1295: A research chemical, an inhibitor of the PDGFR kinase.
GLPG0974: An experimental GPR43 receptor antagonist.
SIVOPIXANT: An experimental neurokinin-1 (NK1) receptor antagonist.
GLUCAGON HYDROCHLORIDE: The hydrochloride salt of the hormone glucagon.
DSTBULET: A research chemical or compound identifier.
PRODIGIOSIN: A family of natural red pigments with antimicrobial and other biological activities.
BMS-770767: A potent and selective inhibitor of the MET tyrosine kinase.
COMPOUND (S)-3H [PMID: 15686947]: An experimental compound described in the specified publication.
CARLUMAB: An experimental monoclonal antibody that targets the CCL2 chemokine.
VOSORITIDE: An analog of C-type natriuretic peptide, used to treat achondroplasia.
BMS-955176: A research chemical or compound identifier.
ETAMICASTAT: An inhibitor of the enzyme dopamine beta-hydroxylase.
SUZETRIGINE: An experimental anticonvulsant.
CX-6258: An experimental inhibitor of the PI3K/mTOR pathway.
TRYPTANTHRIN 5I: A research chemical or compound identifier.
NEXINHIB20: An experimental agent that inhibits the release of exosomes.
KANZONOL X: A natural product with biological activity.
IS1: A research chemical or compound identifier.
CHLOROPYRAMINE: A first-generation antihistamine.
MCL-1 INHIBITOR MIK665: An experimental inhibitor of the Mcl-1 anti-apoptotic protein.
VIXTIMOTAMAB: An experimental bispecific antibody.
NTP42: A research chemical or compound identifier.
NETARSUDIL: A Rho-kinase inhibitor used in eye drops to treat glaucoma.
DORAMAPIMOD: An experimental p38 MAP kinase inhibitor.
[L-BPA5,ILE13]MOTILIN (HUMAN): A synthetic analogue of the peptide hormone motilin.
ADOMEGLIVANT: An experimental dual GLP-1 and glucagon receptor agonist.
PF-03654746: An experimental phosphodiesterase-4 (PDE4) inhibitor.
TEDIZOLID: An oxazolidinone antibiotic.
ILORASERTIB: An experimental Aurora kinase inhibitor.
PHENIRAMINE MALEATE: A first-generation antihistamine.
HYDROXYZINE HYDROCHLORIDE: The hydrochloride salt of the antihistamine hydroxyzine.
PREDNISOLONE SODIUM PHOSPHATE: A salt of the corticosteroid prednisolone.
FLUOROMETHOLONE ACETATE: The acetate ester of the corticosteroid fluorometholone.
TRIAMCINOLONE DIACETATE: An ester of the corticosteroid triamcinolone.
METHYLPREDNISOLONE ACETATE: The acetate ester of the corticosteroid methylprednisolone.
CLONIDINE HYDROCHLORIDE: An alpha-2 adrenergic agonist used to treat high blood pressure and ADHD.
FENOPROFEN CALCIUM: The calcium salt of the NSAID fenoprofen.
GLPG0492: An experimental GPR84 receptor antagonist.
TELISOTUZUMAB: An experimental bispecific antibody targeting MET and EGFR.
AZD-4769: A research chemical or compound identifier.
NMS-1116354: A research chemical or compound identifier.
SB-85635: A research chemical or compound identifier.
WHI-P131: An experimental inhibitor of the JAK3 kinase.
TAK-960: An experimental Polo-like kinase 1 (Plk1) inhibitor.
XL550: A research chemical or compound identifier.
ZYH7: A research chemical or compound identifier.
AZD-1480: An experimental Janus kinase (JAK) inhibitor.
DES-BR-NEUROPEPTIDE B-29: A peptide fragment of neuropeptide B.
BGT-226: An experimental dual PI3K/mTOR inhibitor.
INCB-40093: An experimental PI3K delta inhibitor.
VERUCERFONT: An experimental corticotropin-releasing factor receptor 1 antagonist.
AZD2423: A research chemical or compound identifier.
TRADIPITANT: An experimental neurokinin-1 (NK1) receptor antagonist.
DIPRAGLURANT: An experimental negative allosteric modulator of the mGluR5 receptor.
MAPRACORAT: An experimental selective glucocorticoid receptor agonist.
ERYTHRITYL TETRANITRATE: A vasodilator of the nitrate class.
ETORICOXIB: A selective COX-2 inhibitor (NSAID).
BENZYDAMINE: A locally acting non-steroidal anti-inflammatory drug (NSAID).
LIPEGFILGRASTIM: A long-acting recombinant form of G-CSF.
EPLIVANSERIN: An experimental selective 5-HT2A receptor inverse agonist.
EMIXUSTAT: An inhibitor of the RPE65 enzyme, studied for Stargardt disease.
PEGPLERANIB SODIUM: An experimental anti-PDGF agent studied for age-related macular degeneration.
TILDRAKIZUMAB: A monoclonal antibody that targets interleukin-23, used for psoriasis.
[3H]4-DAMP: A radiolabeled selective M3 muscarinic receptor antagonist.
ENLIMOMAB PEGOL: A pegylated form of an experimental monoclonal antibody targeting ICAM-1.
AZARIBINE: An antimetabolite drug that was used for psoriasis.
TESMILIFENE: An experimental agent that was studied to enhance chemotherapy.
ZATUXIMAB: An experimental monoclonal antibody.
NAADP: Nicotinic acid adenine dinucleotide phosphate, a second messenger that mobilizes calcium.
NARNATUMAB: An experimental monoclonal antibody that targets the ROR1 protein.
BICTEGRAVIR: An integrase inhibitor used in combination for the treatment of HIV.
HUJ591 111IN: A radiolabeled antibody targeting PSMA for imaging.
BICTEGRAVIR SODIUM: The sodium salt of the antiviral drug bictegravir.
ALISPORIVIR: An experimental antiviral drug that inhibits cyclophilin.
ESTRIOL: A weak estrogen hormone, primarily produced during pregnancy.
EPOETIN DELTA: A form of erythropoietin.
NAFTOPIDIL: An alpha-1 blocker used to treat benign prostatic hyperplasia.
IMIDAPRIL: An ACE inhibitor used to treat hypertension.
IOBENGUANE I-131: A radiopharmaceutical used for the treatment of pheochromocytoma and neuroblastoma.
MITIGLINIDE CALCIUM DIHYDRATE: A meglitinide antidiabetic drug.
VOLIXIBAT: An experimental IBAT inhibitor.
PASCOLIZUMAB: An experimental monoclonal antibody that targets interleukin-4.
PEGBELFERMIN: An experimental long-acting analogue of fibroblast growth factor 21.
DKN-01: An experimental monoclonal antibody that targets the DKK1 protein.
OLECLUMAB: An experimental monoclonal antibody that targets the CD73 protein.
BILR 355: A research chemical or compound identifier.
TNP-2092: A research chemical or compound identifier.
RELAMORELIN: An experimental ghrelin receptor agonist.
LENOGRASTIM: A recombinant form of granulocyte colony-stimulating factor (G-CSF).
OLODANRIGAN: An experimental EP4 receptor antagonist.
ZOLIFLODACIN: An experimental antibiotic.
SISOMICIN: An aminoglycoside antibiotic.
NIPOCALIMAB: An experimental monoclonal antibody that targets the neonatal Fc receptor (FcRn).
PIRTOBRUTINIB: A non-covalent Bruton's tyrosine kinase (BTK) inhibitor.
ORN-0829 HYDRATE: A research chemical or compound identifier.
INSULIN, PROTAMINE ZINC: A long-acting insulin preparation.
INCB-086550: A research chemical or compound identifier.
TRENONACOG ALFA: A recombinant form of human coagulation factor IX.
TRIMEGESTONE: A progestin hormone.
DEPEMOKIMAB: An experimental monoclonal antibody that targets interleukin-5.
REGRAMOSTIM: A recombinant form of granulocyte-macrophage colony-stimulating factor (GM-CSF).
APELIN: A peptide hormone that is the endogenous ligand for the APJ receptor.
MOTOLIMOD: An experimental Toll-like receptor 8 (TLR8) agonist.
AMDINOCILLIN: A beta-lactam antibiotic used for urinary tract infections.
HARPAGOSIDE: A natural compound from the devil's claw plant with anti-inflammatory properties.
RO 8-4304: A research chemical or compound identifier.
LUFENURON: An insect development inhibitor used in veterinary medicine to control fleas.
IMIDOCARB DIPROPIONATE: An antiprotozoal drug used in veterinary medicine.
ANECORTAVE ACETATE: An experimental angiogenesis inhibitor.
OXYPHENONIUM BROMIDE: An antimuscarinic agent.
PYRIDOSTIGMINE BROMIDE: A reversible cholinesterase inhibitor used to treat myasthenia gravis.
FENTHION: An organophosphate insecticide.
METOLAZONE: A thiazide-like diuretic.
GARENOXACIN: A fluoroquinolone antibiotic.
4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE: An irreversible serine protease inhibitor, also known as AEBSF.
FURATHIOCARB: A carbamate insecticide.
RESORCINOL MONOACETATE: An antiseptic and disinfectant.
DIFLUCORTOLONE 21-VALERATE: A topical corticosteroid.
TAK-779: A potent and selective antagonist of the CCR5 chemokine receptor.
METHYLNITROSOUREA: A potent carcinogen and mutagen used in research.
ADJUVANT: A substance that enhances the body's immune response to an antigen.
CORTICOTROPIN: A hormone produced by the pituitary gland, also known as ACTH.
RESVERATROL HEXANOIC ACID: An ester derivative of resveratrol.
TETRAHYDROCANNABIVARIN: A cannabinoid compound found in cannabis.
PALMATINE CHLORIDE: The chloride salt of the protoberberine alkaloid palmatine.
AMINOPHYLLINE: A bronchodilator, a combination of theophylline and ethylenediamine.
CHLORPHRIFOS OXON: The toxic active metabolite of the insecticide chlorpyrifos.
PYRIDALYL: An insecticide.
DIFLOXACIN HYDROCHLORIDE: A fluoroquinolone antibiotic used in veterinary medicine.
METRONIDAZOLE: An antibiotic and antiprotozoal medication.
TUBERCIDIN: An adenosine analog with cytotoxic properties.
PURVALANOL B: A potent and selective inhibitor of cyclin-dependent kinases (CDKs).
COUMERMYCIN: An aminocoumarin antibiotic that inhibits bacterial DNA gyrase.
CANNABIDIOL: A non-psychoactive cannabinoid found in the cannabis plant, known as CBD.
GW300657X: A research chemical or compound identifier.
CAMPHOR OIL: An essential oil extracted from the wood of the camphor tree, used topically as a skin coolant and mild analgesic.
BMS309403: An experimental agent that inhibits fatty acid-binding proteins.
MANZAMINE A: A complex marine alkaloid with a wide range of biological activities, including antimicrobial and anticancer effects.
NAKIJIQUINONE I: A natural product with biological activity.
LICARIN A: A natural neolignan compound with antioxidant and other biological properties.
2-CHLOROADENOSINE-5-TRIPHOSPHATE: An analogue of adenosine triphosphate (ATP).
APAZONE: A non-steroidal anti-inflammatory drug (NSAID) that was used for inflammatory joint diseases.
OCTOCRYLENE: An organic compound used as an ingredient in sunscreens and cosmetics.
L-161,982 (EP4A): A research chemical or compound identifier.
ADENINE: One of the four nucleobases in the nucleic acid of DNA, also a component of ATP.
ALAPROCLATE: A selective serotonin reuptake inhibitor (SSRI) that was studied as an antidepressant.
ESCULIN: A coumarin glucoside found in the horse chestnut, with vasoprotective properties.
ENOXAMAST: An experimental anti-inflammatory drug.
TERBUTALINE SULFATE: The sulfate salt of terbutaline, a short-acting beta-2 adrenergic receptor agonist.
BOCEPREVIR: A protease inhibitor used for the treatment of hepatitis C.
APATINIB: A tyrosine kinase inhibitor that selectively targets VEGFR2, also known as rivoceranib.
MRS-1477: A research chemical or compound identifier.
ANTI-FLT3/CD3 BISPECIFIC ANTIBODY CLN-049: An experimental bispecific antibody for cancer therapy.
SAQUINAVIR MESYLATE: A protease inhibitor used to treat HIV/AIDS.
PROPANIDID: An ultra-short-acting intravenous anesthetic agent.
PENTETIC ACID: Also known as DTPA, a chelating agent used to bind and remove heavy metals.
NALTREXONE: An opioid receptor antagonist used to manage alcohol and opioid dependence.
GOSSYPOL ACETIC ACID: The acetic acid salt of gossypol, a compound studied for its antifertility and anticancer effects.
BUTYLATED HYDROXYTOLUENE: A common antioxidant used as a food additive and in cosmetics.
CHOLECALCIFEROL: Also known as Vitamin D3, a fat-soluble vitamin that helps the body absorb calcium.
METHAPYRILENE: A first-generation antihistamine that was withdrawn from the market due to carcinogenicity.
PROCARBAZINE HYDROCHLORIDE: An alkylating agent used in chemotherapy, particularly for Hodgkin's lymphoma.
IODOPHENPROPIT: A potent and selective histamine H3 receptor antagonist.
RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR: A manufactured form of the cytokine GM-CSF.
IMMUNOADJUVANT: A substance that enhances the body's immune response to an antigen.
FLURAZEPAM HYDROCHLORIDE: A long-acting benzodiazepine used for the treatment of insomnia.
ALUMINUM HYDROXIDE: A compound used as an antacid and as a vaccine adjuvant.
IMMUNOTHERAPEUTIC AGENT: A class of drugs that stimulate or suppress the immune system to fight disease.
BACITRACIN: A polypeptide antibiotic used topically to treat skin infections.
LIPID ENCAPSULATED ANTI-PLK1 SIRNA TKM-PLK1: An experimental RNAi therapeutic targeting the Plk1 kinase.
G207: An oncolytic herpes simplex virus engineered for cancer therapy.
THIOGUANINE: A purine analogue used in chemotherapy to treat leukemias.
C-1311: An experimental anticancer agent that targets topoisomerase II.
NEUROPROTECTIVE AGENT: A class of drugs that protect nerve cells against damage or degeneration.
SIGNAL TRANSDUCTION INHIBITOR: A class of drugs that interfere with cell signaling pathways.
ANTIMETABOLITE: A class of chemotherapy drugs that interfere with DNA and RNA synthesis.
9-AMINOCAMPTOTHECIN: A derivative of camptothecin that inhibits topoisomerase I.
FLUINDIONE: An anticoagulant that functions as a vitamin K antagonist.
SULFADIAZINE: A sulfonamide antibiotic.
FENCAMFAMIN: A central nervous system stimulant.
INEBILIZUMAB-CDON: A monoclonal antibody that targets CD19, used to treat neuromyelitis optica spectrum disorder.
BELZUTIFAN: An inhibitor of HIF-2-alpha, used to treat certain cancers associated with von Hippel-Lindau disease.
K-00546: A research chemical or compound identifier.
DALOTUZUMAB: An experimental monoclonal antibody that targets the insulin-like growth factor 1 receptor (IGF-1R).
HEXYLRESORCINOL: An organic compound with antiseptic, anesthetic, and anthelmintic properties.
NOBERASTINE: An experimental antihistamine.
C-MET INHIBITOR AMG 208: An experimental inhibitor of the c-Met kinase.
JZL184: A potent and selective inhibitor of the enzyme monoacylglycerol lipase (MAGL).
COMPOUND 37 [PMID: 16250654]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
GSK-923295: An experimental inhibitor of the mitotic kinesin Cenp-E.
R3(B&DELTA;23-27)R/I5 CHIMERIC PEPTIDE: A complex synthetic peptide.
AFAMELANOTIDE: A synthetic analogue of alpha-melanocyte-stimulating hormone, used to treat erythropoietic protoporphyria.
PARATHYROID HORMONE: A hormone secreted by the parathyroid glands that regulates serum calcium concentration.
BMS-863233: An experimental pan-RAF inhibitor.
CH-1504: A research chemical or compound identifier.
DARUSENTAN: An experimental endothelin receptor antagonist.
DACETUZUMAB: An experimental monoclonal antibody that targets the CD40 receptor.
CYT006-ANGQB: An experimental immunotherapy agent.
DAPOXETINE: A short-acting selective serotonin reuptake inhibitor (SSRI) used for the treatment of premature ejaculation.
PRIMAQUINE: An antimalarial drug used to treat and prevent relapse of malaria caused by P. vivax and P. ovale.
VATIQUINONE: An experimental agent that was studied for Friedreich's ataxia.
EPROTIROME: An experimental thyroid hormone receptor agonist that was studied for dyslipidemia.
GEPIRONE: An experimental antidepressant and anxiolytic of the azapirone class.
GTS-21: An experimental alpha-7 nicotinic receptor partial agonist that was studied for schizophrenia and Alzheimer's disease.
LOBELINE: An alkaloid from the Indian tobacco plant with mixed nicotinic agonist-antagonist effects.
OREGOVOMAB: An experimental monoclonal antibody that targets the CA-125 antigen, studied as a cancer vaccine.
RESINIFERATOXIN: An ultra-potent capsaicin analog that acts as a TRPV1 receptor agonist.
RELACATIB: An experimental cathepsin K inhibitor.
ANTI-CA6-DM4 IMMUNOCONJUGATE SAR566658: An experimental antibody-drug conjugate targeting the CA6 antigen.
PENECA: A research chemical or compound identifier.
EFAVIRENZ: A non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV/AIDS.
SELECTIVE CYTOKINE INHIBITORY DRUG CC-1088: A specific type of experimental anti-inflammatory agent.
PIVAMPICILLIN: A prodrug of the antibiotic ampicillin.
VTP-27999: An experimental renin inhibitor.
REMACEMIDE HYDROCHLORIDE: An experimental NMDA receptor antagonist that was studied for epilepsy.
DIPIVEFRIN: A prodrug of epinephrine, used as eye drops to treat glaucoma.
FLUNITRAZEPAM: A potent benzodiazepine, also known by the trade name Rohypnol.
RANK LIGAND: A protein that is a key factor for osteoclast differentiation and activation, also known as RANKL.
KS0365: A research chemical or compound identifier.
BIBP3226: A potent and selective antagonist of the Neuropeptide Y Y1 receptor.
BENZOCAINE: A local anesthetic of the ester type, commonly used as a topical pain reliever.
BENZONATATE: A non-narcotic cough suppressant.
PENTAGASTRIN: A synthetic peptide that stimulates gastric acid secretion, used as a diagnostic aid.
NAVTEMADLIN: An experimental MDM2 inhibitor that reactivates the p53 pathway.
NORSTICTIC ACID: A lichen acid with biological activities.
VANOXERINE: A dopamine reuptake inhibitor that was studied for cocaine dependence.
GEDUNIN: A natural limonoid with antimalarial and anticancer properties.
DIPHENHYDRAMINE: A first-generation antihistamine with sedative and anticholinergic effects.
TILUDRONIC ACID: A bisphosphonate drug used to treat Paget's disease of bone.
MANNOSE-BINDING LECTIN: A protein involved in the innate immune system.
TRIPELENNAMINE: A first-generation antihistamine.
AMG-191: An experimental monoclonal antibody that targets the IL-23 receptor.
FENEBRUTINIB: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
TESNATILIMAB: An experimental monoclonal antibody.
BI-836880: An experimental monoclonal antibody that targets the JAK2 pseudokinase domain.
PF-06840003: An experimental agent that was studied for its effects on cholesterol.
IODINE I 131 APAMISTAMAB: A radioimmunoconjugate targeting the YB-1 protein.
PI3K-DELTA INHIBITOR AMG 319: An experimental selective inhibitor of the PI3K delta isoform.
GNKG-168: An experimental agent that activates the STING pathway.
BFH-772: An experimental monoclonal antibody.
TOVETUMAB: An experimental monoclonal antibody that targets the PDGFR-alpha receptor.
EMFILERMIN: A recombinant form of fibroblast growth factor 1.
OSILODROSTAT: An inhibitor of the enzyme 11-beta-hydroxylase, used to treat Cushing's disease.
RECOMBINANT HUMAN ALBUMIN-HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR: A long-acting formulation of G-CSF.
BISMUTH: A chemical element whose compounds are used in various medications, particularly for gastrointestinal issues.
POLYTHIAZIDE: A thiazide diuretic used to treat hypertension and edema.
A-85380: A potent agonist for the alpha-4 beta-2 nicotinic acetylcholine receptor.
TACRINE: A centrally acting cholinesterase inhibitor that was used to treat Alzheimer's disease.
METHYLDOPATE HYDROCHLORIDE: The hydrochloride salt of methyldopate, a prodrug of methyldopa.
CAPMATINIB HYDROCHLORIDE: The hydrochloride salt of capmatinib, a MET kinase inhibitor.
SEMAPIMOD: An experimental anti-inflammatory agent that inhibits cytokine production.
ILODECAKIN: An experimental agent, a form of interleukin-10.
QR-333: A research chemical or compound identifier.
PRELADENANT: An experimental adenosine A2A receptor antagonist that was studied for Parkinson's disease.
SODIUM TETRADECYL SULFATE: A sclerosing agent used to treat varicose and spider veins.
TALACTOFERRIN ALFA: A recombinant form of human lactoferrin, studied as an immunotherapy agent.
MITIGLINIDE: A meglitinide antidiabetic drug.
ZOLMITRIPTAN: A triptan drug used for the acute treatment of migraine.
NOX-6-18: A research chemical or compound identifier.
CP-724714: A potent and selective inhibitor of the HER2/ErbB2 tyrosine kinase.
DEFERASIROX: An oral iron chelating agent used to treat chronic iron overload.
PARDOPRUNOX: An experimental agent that was studied for Parkinson's disease and depression.
YM-355179: A research chemical or compound identifier.
METHANTHELINE: An antimuscarinic agent.
STREPTOKINASE: A thrombolytic (clot-busting) drug, an enzyme.
GLIQUIDONE: A sulfonylurea drug used to treat type 2 diabetes.
SONOLISIB: An experimental PI3K delta inhibitor.
BROMODIPHENHYDRAMINE: A first-generation antihistamine with anticholinergic properties.
E-7820: An experimental agent that inhibits the synthesis of E-selectin.
LERONLIMAB: An experimental monoclonal antibody that targets the CCR5 receptor.
SCYLLITOL: A naturally occurring inositol stereoisomer studied for Alzheimer's disease.
ANGIOTENSIN-(1-7): A peptide hormone with vasodilatory and anti-proliferative effects.
MK-8033: An experimental CGRP receptor antagonist.
DANICOPAN: An experimental complement Factor D inhibitor.
ITOLIZUMAB: A monoclonal antibody that targets the CD6 receptor, used for psoriasis.
GDC-0349: An experimental mTOR inhibitor.
GTX-758: An experimental agent that was studied for prostate cancer.
SACUBITRIL/VALSARTAN: A combination drug used for heart failure, containing a neprilysin inhibitor and an angiotensin receptor blocker.
PEGINTERFERON BETA-1A: A pegylated form of interferon beta-1a, a long-acting formulation for multiple sclerosis.
BRILANESTRANT: An experimental selective estrogen receptor degrader (SERD).
ILACIRNON: A research chemical or compound identifier.
SPARTALIZUMAB: An experimental monoclonal antibody that targets the PD-1 immune checkpoint receptor.
PEGVALIASE: An enzyme replacement therapy used to treat phenylketonuria.
AZETUKALNER: A research chemical or compound identifier.
DOCIPARSTAT SODIUM: A modified heparin that inhibits heparanase.
THYMOSIN BETA-4: A naturally occurring peptide with roles in wound healing and tissue regeneration.
TC-6987: A research chemical or compound identifier.
CERLIPONASE ALFA: An enzyme replacement therapy used for a form of Batten disease.
EPIRUBICIN: An anthracycline chemotherapy drug used to treat various cancers.
METHARBITAL: A barbiturate used as an anticonvulsant.
NIRAPARIB TOSYLATE: The tosylate salt of niraparib, a PARP inhibitor.
MEBUTAMATE: An anxiolytic and antihypertensive drug.
PARP-1/2 INHIBITOR ABT-767: An experimental inhibitor of the PARP-1 and PARP-2 enzymes.
PELITINIB: An experimental irreversible EGFR and HER2 kinase inhibitor.
CARPHENAZINE: A typical antipsychotic of the phenothiazine class.
DIHYDROTACHYSTEROL: A synthetic analog of vitamin D.
STIRIPENTOL: An anticonvulsant used for seizures associated with Dravet syndrome.
BPN14770: An experimental phosphodiesterase-4D (PDE4D) inhibitor.
TG100-115: A research chemical, an inhibitor of PI3K delta and gamma.
BIW-8962: An experimental monoclonal antibody.
INO-1001: An experimental PARP inhibitor.
LANABECESTAT: An experimental BACE1 inhibitor that was studied for Alzheimer's disease.
SEMULOPARIN: An experimental ultra-low-molecular-weight heparin.
SSR-126517E: A research chemical or compound identifier.
(+)-WAY 100135: An enantiomer of WAY 100135, a 5-HT1A receptor antagonist.
[11C]SB207145: A radiolabeled selective 5-HT4 receptor antagonist for PET imaging.
ESTRADIOL DISULFATE: A metabolite of estradiol.
DO264: A research chemical, a biased agonist of the mu-opioid receptor.
&RHO;-DA1A: A research chemical or compound identifier.
COMPOUND 21B [PMID: 31136173]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 14A [PMID: 34795866]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
PSALMOTOXIN 1: A peptide toxin from spider venom that blocks acid-sensing ion channels.
MAMBALGIN-1: A peptide toxin from black mamba venom that inhibits acid-sensing ion channels.
VPC171: A research chemical or compound identifier.
ANGIOTENSIN IV: A peptide fragment of angiotensin II with various effects in the central nervous system.
AZ20: A research chemical or compound identifier.
ZIRITAXESTAT: An experimental autotaxin inhibitor.
PF-06684511: A research chemical or compound identifier.
XAMOTEROL: A beta-1 adrenergic receptor partial agonist.
ALBUTEROL SULFATE: The sulfate salt of albuterol (salbutamol), a short-acting beta-2 adrenergic agonist.
BUTOXAMINE: A selective beta-2 adrenergic receptor antagonist.
BRINZOLAMIDE: A carbonic anhydrase inhibitor used in eye drops to treat glaucoma.
AZ10417808: An experimental 5-HT1B receptor antagonist.
ENTACAPONE: A COMT inhibitor used in combination with levodopa for Parkinson's disease.
CP-481,715: A research chemical or compound identifier.
ONTORPACEPT: An experimental fusion protein.
TETHERED CHEMERIN 9: A modified form of the chemerin peptide.
GLPG4716: A research chemical or compound identifier.
AR-H067637: A research chemical or compound identifier.
ALPHA-KETOTHIAZOLE ANALOGUE 36: A specific chemical compound.
PD123319: A selective antagonist of the angiotensin II type 2 receptor.
COMPOUND 2 [PMID: 28621538]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 51 [PMID: 19743866]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
ANTALARMIN: An experimental corticotropin-releasing factor receptor 1 antagonist.
ISCHEMIN: A research chemical or compound identifier.
K41498: A research chemical or compound identifier.
X4-HIV-1 GP120: The gp120 envelope protein from an X4-tropic strain of HIV-1.
HET0016: An inhibitor of the enzyme CYP4A.
NECITUMUMAB: A monoclonal antibody that targets the epidermal growth factor receptor (EGFR).
SDX-101: An experimental agent that induces apoptosis in cancer cells.
MIFANERTINIB: An experimental multi-kinase inhibitor.
LANEPITANT: An experimental neurokinin-1 (NK1) receptor antagonist.
ONO-AE3-208: A potent and selective prostaglandin EP4 receptor agonist.
ZARAGOZIC ACID A: A natural product that inhibits the enzyme squalene synthase.
MARGETUXIMAB: A monoclonal antibody that targets the HER2 receptor.
TX1-85-1: A research chemical or compound identifier.
METENKEFALIN: An endogenous opioid peptide.
ALVERINE CITRATE: An antispasmodic drug.
PD-156707: A potent and selective endothelin ET-A receptor antagonist.
ENDOTHELIN-3: A peptide of the endothelin family, involved in vasoconstriction.
WAY-213613: A research chemical or compound identifier.
NE58018: A research chemical or compound identifier.
ONO-8590580: A research chemical or compound identifier.
LAURYL ALCOHOL DIPHOSPHONIC ACID: A chemical compound.
SM-130,686: An experimental agent that was studied for its effects on cholesterol.
TELAGLENASTAT: An experimental inhibitor of the enzyme glutaminase.
4-HYDROXYBUTYRIC ACID: Also known as gamma-hydroxybutyrate (GHB), a neurotransmitter and recreational drug.
N,N-DIMETHYLHISTAMINE: A derivative of histamine.
SPAG11B (61-103): A peptide fragment of the SPAG11B protein.
IRAK3 PROTAC 23: A specific PROTAC molecule designed to degrade the IRAK3 protein.
COMPOUND 10 [PMID: 31411465]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
KISSPEPTIN-15: A peptide hormone that stimulates the release of GnRH.
ERAS-5024: A research chemical or compound identifier.
SENICAPOC: An experimental agent that blocks the Gardos channel in red blood cells.
NS6180: A potent blocker of calcium-activated potassium channels.
L6H21: A research chemical or compound identifier.
PECAZINE: A typical antipsychotic of the phenothiazine class.
SAFIMALTIB: An experimental multi-kinase inhibitor.
AGOUTI-RELATED PROTEIN: An endogenous neuropeptide that is an inverse agonist of melanocortin receptors.
GSK1331258: A research chemical or compound identifier.
[3H]JNJ-40068782: A radiolabeled compound, likely a receptor ligand.
BOMA: An abbreviation, possibly for a research compound.
GRAZOPREVIR: An antiviral drug used for the treatment of hepatitis C.
DROSPIRENONE: A progestin used in hormonal contraceptives.
HALICIN: An antibiotic compound identified through a deep learning model.
COMPOUND 25 [PMID: 28038940]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
RXP470.1: An experimental C5a receptor antagonist.
COMPOUND 20 [PMID: 22153340]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
CIPEMASTAT: An experimental matrix metalloproteinase (MMP) inhibitor.
UK-356618: A research chemical or compound identifier.
BMS-986172: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
VU0090157: A research chemical or compound identifier.
UCM 793: An experimental inhibitor of the monoacylglycerol lipase (MAGL).
PYRIMETHAMINE: An antiparasitic medication used to treat toxoplasmosis and other infections.
EFPPEA: A research chemical or compound identifier.
AP811: A research chemical or compound identifier.
UTATRECTINIB: An experimental pan-TRK inhibitor.
&ALPHA;-CONOTOXIN MI: A peptide neurotoxin from cone snail venom that blocks nicotinic acetylcholine receptors.
ENCENICLINE: An experimental alpha-7 nicotinic receptor partial agonist that was studied for schizophrenia.
[NPHE1]N/OFQ-(1-13)-NH2: A synthetic peptide analogue of nociceptin/orphanin FQ.
UFP-112: A potent and selective antagonist of the nociceptin/orphanin FQ (NOP) receptor.
DES-BR-NEUROPEPTIDE B-23: A peptide fragment of neuropeptide B.
[125I]Y-RFRP-3: A radioiodinated form of the peptide RFRP-3.
NF770: A research chemical, a P2X1 receptor antagonist.
NF279: A potent and selective antagonist of the P2X1 purinergic receptor.
GW791343: An experimental neurokinin-3 (NK3) receptor antagonist.
A438079: A potent and selective antagonist of the P2X7 purinergic receptor.
NF340: A research chemical or compound identifier.
BX 048: A research chemical or compound identifier.
RWJ-56110: An experimental agent that was studied for its anti-inflammatory effects.
GSK-461364A: An experimental inhibitor of the Polo-like kinase 1 (Plk1).
AUNP-12: An experimental peptide targeting the uPARAP receptor.
PF-06939999: A research chemical or compound identifier.
COMPOUND 13C [PMID: 20684591]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
YHJ1039: A research chemical or compound identifier.
IRIGENOL: A natural product with biological activity.
SIR1-365: A research chemical or compound identifier.
AC55649: A research chemical, a biased agonist of the 5-HT2A receptor.
HX 531: A synthetic retinoid that acts as an antagonist for the RXR receptor.
WF-47-JS03: A research chemical or compound identifier.
[G(B24)S]R3/I5: A complex synthetic peptide.
RELAXIN-3 B CHAIN DIMER: A form of the neuropeptide hormone relaxin-3.
COMPOUND 28 [PMID: 35439002]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
ENTOSPLETINIB: An experimental spleen tyrosine kinase (Syk) inhibitor.
COMPOUND 66 [PMID: 21802293]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
BN-81,674: A research chemical or compound identifier.
CBP-501: An experimental agent that modulates calmodulin.
PEPTIDE 22D: A research chemical or compound identifier.
PEPTIDOGLYCAN: A major component of bacterial cell walls.
STA2: A research chemical or compound identifier.
TGF-BETA RI INHIBITOR III: A specific chemical inhibitor of the TGF-beta receptor I kinase.
DOMITROBAN: An experimental thromboxane A2 receptor antagonist.
AM-1473: A research chemical or compound identifier.
ML3-SA1: A research chemical or compound identifier.
SN-1: A research chemical or compound identifier.
NSC151066: A research chemical or compound identifier.
RN-9893: A research chemical or compound identifier.
NPY-(2-36): A peptide fragment of Neuropeptide Y.
WZ4002: A potent and selective inhibitor of mutant EGFR kinases.
PRALSETINIB: A kinase inhibitor that targets RET alterations, used for thyroid and lung cancer.
TETMYB DNA VACCINE: An experimental DNA vaccine.
CAMONSERTIB: An experimental multi-kinase inhibitor.
TAS0612: An experimental CDK inhibitor.
RET INHIBITOR EP0031: An experimental inhibitor of the RET kinase.
VEPAFESTINIB: An experimental BET inhibitor.
ELTANEXOR: An experimental selective inhibitor of nuclear export (SINE).
LB-100: An experimental inhibitor of the protein phosphatase 2A.
SERDEMETAN: An experimental MDM2 inhibitor.
FURAPREVIR: An experimental antiviral drug for hepatitis C.
PHENSERINE: An experimental cholinesterase inhibitor that was studied for Alzheimer's disease.
[3H]HEMICHOLINIUM-3: A radiolabeled form of hemicholinium-3, a choline transporter inhibitor.
(+)-AJ76: A research chemical, a dopamine D2 receptor partial agonist.
MOSUNETUZUMAB: A bispecific antibody that targets CD20 and CD3, used for follicular lymphoma.
T-0632: A research chemical, a selective 5-HT2A receptor antagonist.
GLP-1: Glucagon-like peptide-1, a hormone that stimulates insulin secretion.
PUUPEHENONE: A natural product with various biological activities.
LANDIOLOL: An ultra-short-acting beta-1 blocker.
VIPIVOTIDE TETRAXETAN: A radiopharmaceutical targeting the PSMA protein.
XEN-D0501: An experimental beta-cell tropin.
SODIUM DODECYL SULFATE: A common surfactant used in cleaning and hygiene products.
TERBOGREL: An experimental thromboxane A2 receptor antagonist.
ORLUDODSTAT: An experimental DGAT1 inhibitor.
DAPANSUTRILE: An experimental inhibitor of the NLRP3 inflammasome.
AZATHIOPRINE SODIUM: The sodium salt of the immunosuppressant drug azathioprine.
A-1155463: A potent and selective inhibitor of the BCL-XL protein.
RO0094889: A research chemical or compound identifier.
REFANEZUMAB: An experimental monoclonal antibody that targets the repulsive guidance molecule A.
ARRY-382: An experimental inhibitor of the HER2 kinase.
RELMACABTAGENE AUTOLEUCEL: A type of CAR-T cell therapy.
SUGEMALIMAB: An experimental monoclonal antibody that targets the PD-L1 receptor.
ZIBOTENTAN: An experimental endothelin receptor antagonist.
PF-04418948: An experimental phosphodiesterase-2A (PDE2A) inhibitor.
NNC0114-0006: A research chemical or compound identifier.
COMPOUND 21N [PMID: 17656086]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
SALICYLIC ACID: A beta hydroxy acid used in many skincare products and as a precursor to aspirin.
[3H]NPVF: A radiolabeled compound, likely a receptor ligand.
BELORANIB: An experimental agent that was studied for obesity.
ARACHIDONYLCYCLOPROPYLAMIDE: A synthetic cannabinoid that acts as a CB1 receptor agonist.
URIDINE MONOPHOSPHATE: A nucleotide that is a component of RNA.
PF-4708671: A potent and selective inhibitor of the S6K1 kinase.
MEZAGITAMAB: An experimental monoclonal antibody.
AM-211: A research chemical or compound identifier.
RESMETIROM: A thyroid hormone receptor-beta selective agonist used for non-alcoholic steatohepatitis.
AURAPTENE: A natural coumarin with various biological activities.
RHTX: A research chemical or compound identifier.
TIOCONAZOLE: A topical azole antifungal agent.
BMS-509744: An experimental inhibitor of the LFA-1 integrin.
NAFITHROMYCIN: An experimental antibiotic of the macrolide class.
TRIMETHYL-TETRADECYL-AMMONIUM CHLORIDE: A quaternary ammonium antiseptic.
LIAROZOLE: An aromatase and retinoic acid metabolism blocking agent.
APILIMOD: An experimental inhibitor of the PIKfyve kinase.
BAYCYSLT2: A research chemical or compound identifier.
TATM2NX: A research chemical or compound identifier.
MIZOLASTINE: A second-generation antihistamine.
GW572401X: A research chemical or compound identifier.
L-796,778: A research chemical or compound identifier.
GADOFOSVESET TRISODIUM: An MRI contrast agent.
ARCAINE: An inhibitor of nitric oxide synthase.
PBT-3: A research chemical or compound identifier.
GW680975X: A research chemical or compound identifier.
CNV-2197944: A research chemical or compound identifier.
BPH-830: A research chemical or compound identifier.
COMPOUND 24D [PMID: 23357634]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
[PRO34]NPY: A synthetic analogue of Neuropeptide Y.
MLN-120B: An experimental monoclonal antibody that targets the CCR2 chemokine receptor.
PUROMYCIN HYDROCHLORIDE: The hydrochloride salt of the antibiotic puromycin.
AMONAFIDE: An experimental anticancer agent that intercalates into DNA.
YH18968: A research chemical or compound identifier.
PENTAZOCINE LACTATE: The lactate salt of the opioid analgesic pentazocine.
TRIAPINE: An inhibitor of the enzyme ribonucleotide reductase.
ADX71743: An experimental GABAB receptor positive allosteric modulator.
VANILLYLMANDELIC ACID: A metabolite of the catecholamines epinephrine and norepinephrine.
TFLLR-NH2: A peptide agonist of the PAR-1 receptor.
2,3',4,5'-TETRAMETHOXYSTILBENE: A synthetic derivative of resveratrol.
BRP-LPA: A research chemical or compound identifier.
BREMELANOTIDE ACETATE: The acetate salt of bremelanotide, a melanocortin receptor agonist.
METHYL DEOXYCHOLATE: An ester derivative of deoxycholic acid.
TRX-518: An experimental monoclonal antibody that targets the GITR receptor.
ALRIZOMADLIN: An experimental MDM2 inhibitor.
2-AMINO-3-(3-HYDROXY-7,8-DIHYDRO-6H-CYCLOHEPTA[D]-4-ISOXAZOLYL)PROPIONIC ACID: A chemical compound, a glutamate receptor ligand.
COMPOUND 10 [O'MAHONY ET AL., 2022]: A specific chemical compound described in a 2022 publication by O'Mahony et al.
LABRADIMIL: An experimental agent that enhances the efficacy of radiation therapy.
BET BROMODOMAIN INHIBITOR ZEN-3694: An experimental inhibitor of the BET family of bromodomains.
ABBV-3221: A research chemical or compound identifier.
COMPOUND 23 [PMID: 17125252]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
TANEZUMAB: An experimental monoclonal antibody that targets nerve growth factor (NGF).
DOXORUBICIN-HPMA CONJUGATE: A polymer-drug conjugate of the chemotherapy drug doxorubicin.
THIOTHIXENE HYDROCHLORIDE: The hydrochloride salt of the antipsychotic thiothixene.
AV608: A research chemical or compound identifier.
PREDNISOLONE TEBUTATE: An ester of the corticosteroid prednisolone.
LUF5962: A research chemical or compound identifier.
HEXACONAZOLE: A broad-spectrum systemic fungicide.
ANTI-HGF MONOCLONAL ANTIBODY TAK-701: An experimental monoclonal antibody that targets HGF.
L19TNFA: An experimental immunocytokine combining an antibody targeting fibronectin with TNF-alpha.
MIK-BETA-1: An experimental monoclonal antibody.
EPITUMOMAB CITUXETAN: An experimental radioimmunoconjugate targeting the EpCAM antigen.
TECADENOSON: An experimental adenosine A1 receptor agonist.
COMPOUND 4FF [PMID: 1656041]: An experimental compound described in a 1991 publication (PMID is for 1991).
ST074946: A research chemical or compound identifier.
GALLOCATECHIN GALLATE: A type of catechin found in green tea.
RILPIVIRINE: A non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV/AIDS.
FAXELADOL: An experimental opioid analgesic.
ATEVIRDINE MESYLATE: An experimental non-nucleoside reverse transcriptase inhibitor.
GT 389-255: A research chemical or compound identifier.
MOLGRAMOSTIM: A recombinant form of granulocyte-macrophage colony-stimulating factor (GM-CSF).
POLYGLUTAMATE CAMPTOTHECIN: A polymer-drug conjugate of camptothecin.
TIQ-15: A research chemical or compound identifier.
LANADELUMAB-FLYO: A monoclonal antibody that inhibits plasma kallikrein, used for hereditary angioedema.
PIMURUTAMAB: An experimental monoclonal antibody.
PROTOXIN II: A peptide toxin from spider venom.
ROBUSTONE: A research chemical or compound identifier.
GD3+: The trivalent gadolinium cation, used in MRI contrast agents.
EGFR INHIBITOR: A class of drugs that block the action of the epidermal growth factor receptor.
LY2874455: An experimental pan-FGFR kinase inhibitor.
CV-1674: A research chemical or compound identifier.
UNC0006: A research chemical or compound identifier.
TYR3-OCTREOTIDE: A synthetic analogue of the peptide somatostatin.
ACLIMOSTAT: An experimental inhibitor of the acetyl-CoA carboxylase enzyme.
RECOMBINANT BETA CHEMOKINE: A general class of manufactured beta-chemokine proteins.
MAGROLIMAB: An experimental monoclonal antibody that targets the CD47 protein.
ISOSAKURANETIN: A natural flavanone with various biological activities.
TECHTOCHRYSIN: A natural flavone compound.
D-LYS0-[DES-ARG10]KALLIDIN: A synthetic peptide that is a B1 receptor antagonist.
LY2275796: A research chemical or compound identifier.
SUVN-911: An experimental alpha-4 beta-2 nicotinic receptor antagonist.
DIFAMILAST: An experimental phosphodiesterase-4 (PDE4) inhibitor.
ANTHRACYCLINE ANTINEOPLASTIC ANTIBIOTIC: A class of chemotherapy drugs derived from Streptomyces bacteria.
CXCL1: A small cytokine belonging to the CXC chemokine family, also known as GRO-alpha.
TROPICAMIDE: An antimuscarinic drug used as an eye drop to dilate the pupil.
TIOTROPIUM BROMIDE: A long-acting antimuscarinic agent used as a bronchodilator for COPD.
SPIRAPRIL HYDROCHLORIDE: An ACE inhibitor.
BELVARAFENIB: An experimental pan-RAF inhibitor.
PROPIOMAZINE HYDROCHLORIDE: A phenothiazine antihistamine used for insomnia.
PROCYCLIDINE HYDROCHLORIDE: The hydrochloride salt of the anticholinergic drug procyclidine.
HIMBACINE: A natural alkaloid that acts as a muscarinic receptor antagonist.
HYDROCHLOROTHIAZIDE: A thiazide diuretic used to treat high blood pressure and edema.
CLOMIPRAMINE HYDROCHLORIDE: The hydrochloride salt of the tricyclic antidepressant clomipramine.
CIMETIDINE HYDROCHLORIDE: The hydrochloride salt of the H2 receptor antagonist cimetidine.
INSULIN ZINC SUSP PURIFIED BEEF/PORK: An intermediate-acting insulin preparation from animal sources.
PSEUDOEPHEDRINE POLISTIREX: An extended-release formulation of the decongestant pseudoephedrine.
HYDROXYPROGESTERONE CAPROATE (USP): A synthetic progestin used to reduce the risk of preterm birth.
TETRAIDOFLUORESCEIN: A research chemical or compound identifier.
ABAMECTIN: A broad-spectrum antiparasitic and insecticidal agent.
TREPROSTINIL DIOLAMINE: A salt of treprostinil, a prostacyclin vasodilator.
[ILE5]PTHRP-(1-36): A synthetic peptide analogue of parathyroid hormone-related protein.
EMD-1204831: A research chemical or compound identifier.
IDH1/IDH2 DUAL INHIBITOR HMPL-306: An experimental agent that inhibits both IDH1 and IDH2 enzymes.
THELIATINIB: An experimental pan-HER kinase inhibitor.
RG-7376: A research chemical or compound identifier.
SCH-900776: An experimental agent that was studied for its effects on cholesterol.
RG-7741: A research chemical or compound identifier.
SR2640: A research chemical or compound identifier.
PALOSURAN: An experimental urokinase plasminogen activator receptor antagonist.
VELNEPERIT: An experimental neurokinin-1 (NK1) receptor antagonist.
PEPINEMAB: An experimental monoclonal antibody that targets the SEMA4D protein.
HONOKIOL: A lignan isolated from the bark of Magnolia trees, with various biological activities.
GRC-17536: An experimental Nav1.7 sodium channel blocker.
CYCLOSTREPTIN: A natural product with biological activity.
RIVOCERANIB MESYLATE: The mesylate salt of rivoceranib (apatinib), a VEGFR2 inhibitor.
OTENABANT: An experimental cannabinoid receptor type 1 (CB1) antagonist.
APLAVIROC HYDROCHLORIDE: An experimental CCR5 entry inhibitor for HIV.
ETROLIZUMAB: An experimental monoclonal antibody that targets the beta-7 integrin.
ODULIMOMAB: An experimental monoclonal antibody.
ROMOSOZUMAB: A monoclonal antibody that targets sclerostin, used to treat osteoporosis.
LYM-1: An experimental monoclonal antibody that targets the HLA-DR10 antigen.
REMOGLIFLOZIN ETABONATE: A prodrug of remogliflozin, an SGLT2 inhibitor.
ALCLOFENAC: A non-steroidal anti-inflammatory drug (NSAID).
THENALIDINE: A first-generation antihistamine.
ALFACALCIDOL: A synthetic analog of vitamin D.
VORSETZUMAB MAFODOTIN: An experimental antibody-drug conjugate targeting CD70.
CALCITONIN: A hormone produced by the thyroid gland that regulates calcium levels.
SS1(DSFV)-PE38: An experimental immunotoxin targeting the mesothelin protein.
ZIRALIMUMAB: An experimental monoclonal antibody.
TELIMOMAB ARITOX: An experimental immunotoxin.
NARLAPREVIR: An antiviral drug for the treatment of hepatitis C.
WNT-974: An experimental inhibitor of the Wnt signaling pathway.
PF-04447943: An experimental phosphodiesterase-9A (PDE9A) inhibitor.
COBOLIMAB: An experimental monoclonal antibody that targets the TIM-3 immune checkpoint.
TILSOTOLIMOD: An experimental Toll-like receptor 9 (TLR9) agonist.
JNJ-41443532: A research chemical or compound identifier.
DEUCRAVACITINIB: A selective tyrosine kinase 2 (TYK2) inhibitor used for psoriasis.
PF-00489791: An experimental phosphodiesterase-10A (PDE10A) inhibitor.
AT-1501: An experimental monoclonal antibody that targets the CD40 ligand.
MK-7622: An experimental agent that was studied for its effects on cholesterol.
BOMEDEMSTAT: An experimental LSD1 inhibitor.
ASTEGOLIMAB: An experimental monoclonal antibody that targets the ST2 receptor.
ZANSECIMAB: An experimental monoclonal antibody.
PEPTIDE YY HUMAN (3-36): A major circulating form of Peptide YY, which reduces appetite.
PSILOCYBINE: A naturally occurring psychedelic prodrug compound produced by more than 200 species of fungi.
LY-2608204: A research chemical or compound identifier.
NITIDINE CHLORIDE: The chloride salt of nitidine, a natural benzophenanthridine alkaloid.
BINOSPIRONE: An experimental anxiolytic and antipsychotic of the azapirone class.
SECAUBRYOLIDE: A research chemical or compound identifier.
S-METHYL-D-THIOCITRULLINE: A research chemical or compound identifier.
TRIFLUOROMETHANESULFONAMIDE: A chemical compound.
PIPERILATE ETHOBROMIDE: An antimuscarinic agent.
HERNANDEZINE: A natural bis-benzylisoquinoline alkaloid.
LOFEPRAMINE HYDROCHLORIDE: The hydrochloride salt of the tricyclic antidepressant lofepramine.
CGP 55845: A potent and selective GABAB receptor antagonist.
GW621970X: A research chemical or compound identifier.
2-MERCAPTOETHANESULFONIC ACID: Also known as Mesna, a medication used to decrease the risk of bleeding from the bladder during chemotherapy.
PIRIBEDIL: A dopamine agonist used to treat Parkinson's disease.
STEARIC ACID: A common saturated fatty acid.
MK-912: A research chemical or compound identifier.
QUINALPHOS: An organophosphate insecticide.
MRS3558: A potent and selective antagonist of the P2Y6 purinergic receptor.
ICI-164384: An early, pure estrogen receptor antagonist, a precursor to fulvestrant.
VALERENIC ACID: A major active compound in the valerian plant, which modulates GABAA receptors.
THUNBERGINOL E: A natural product with biological activity.
KOBOPHENOL A: A natural stilbenoid compound.
L741742: A research chemical or compound identifier.
GW580509X: A research chemical or compound identifier.
CARBOXYLATED GLUCOSAMINE: A derivative of glucosamine.
AMOPYROQUINE: An antimalarial drug.
TRIACETIN: A triglyceride used as a food additive and pharmaceutical excipient.
ETRETINATE: A second-generation retinoid that was used for severe psoriasis.
FLOCTAFENINE: A non-steroidal anti-inflammatory drug (NSAID).
AZELASTINE: A second-generation antihistamine used as a nasal spray and eye drops.
METHAZOLAMIDE: A carbonic anhydrase inhibitor used to treat glaucoma.
HEXOCYCLIUM METHYLSULFATE: An antimuscarinic agent that was used to treat peptic ulcers.
EPOTHILONE D: A natural product of the epothilone class, which stabilizes microtubules.
PASIREOTIDE DIASPARTATE: The diaspartate salt of pasireotide, a somatostatin analog.
GUANABENZ: An alpha-2 adrenergic agonist used as an antihypertensive agent.
DORZOLAMIDE HYDROCHLORIDE: The hydrochloride salt of dorzolamide, a carbonic anhydrase inhibitor.
EPINASTINE HYDROCHLORIDE: A second-generation antihistamine used in eye drops.
DEMETON-S-METHYL: An organophosphate insecticide.
APTIGANEL HYDROCHLORIDE: The hydrochloride salt of aptiganel, an NMDA receptor antagonist.
BENZYL CAFFEATE: An ester of benzyl alcohol and caffeic acid.
SOFOSBUVIR: A direct-acting antiviral medication used to treat hepatitis C.
TOFACITINIB: A Janus kinase (JAK) inhibitor used to treat rheumatoid arthritis and ulcerative colitis.
ATAZANAVIR: A protease inhibitor used to treat HIV/AIDS.
RECOMBINANT GROWTH FACTOR: A general class of manufactured growth factor proteins.
POMEGRANATE JUICE: Juice from the pomegranate fruit, containing various polyphenols.
TIRAPAZAMINE: An experimental anticancer agent that is selectively toxic to hypoxic tumor cells.
PENTAZOCINE HYDROCHLORIDE: The hydrochloride salt of the opioid analgesic pentazocine.
AZIRIDINE: A reactive heterocyclic organic compound.
WARFARIN SODIUM: The sodium salt of warfarin, an anticoagulant.
MONOCLONAL ANTIBODY 1F5: An experimental monoclonal antibody.
ANTISENSE OLIGONUCLEOTIDES: A class of therapeutic molecules that bind to specific mRNA sequences to modulate gene expression.
NORETHYNODREL: A progestin that was used in early oral contraceptives.
GRAPEFRUIT JUICE: Juice from the grapefruit, known to interact with many drugs by inhibiting CYP3A4.
CODEINE SULFATE: The sulfate salt of the opioid medication codeine.
ASUNERCEPT: An experimental TNF receptor fusion protein.
APLINDORE: An experimental dopamine D2 receptor partial agonist.
ADH-1: An experimental peptide that targets N-cadherin, studied as an anti-angiogenic agent.
LFB-R603: A research chemical or compound identifier.
LX1031: An experimental agent that was studied for irritable bowel syndrome.
MBX-2044: An experimental PPAR-delta agonist.
MBX-2982: An experimental GPR119 receptor agonist studied for type 2 diabetes.
PPI-2458: An experimental inhibitor of the methionine aminopeptidase 2.
TRABEDERSEN: An experimental antisense oligonucleotide targeting TGF-beta2.
APRACLONIDINE HYDROCHLORIDE: An alpha-2 adrenergic agonist used in eye drops to treat glaucoma.
VOGLIBOSE: An alpha-glucosidase inhibitor used to treat type 2 diabetes.
CHLOPHEDIANOL: A cough suppressant.
CLOCORTOLONE: A topical corticosteroid.
CYPROTERONE: A steroidal antiandrogen.
GOSERELIN ACETATE: A gonadotropin-releasing hormone (GnRH) agonist used to treat prostate and breast cancer.
TESTOLACTONE: An aromatase inhibitor that was used to treat breast cancer.
CAFFEINE CITRATE: A formulation of caffeine used to treat apnea of prematurity.
OXAPROZIN POTASSIUM: The potassium salt of the NSAID oxaprozin.
INDOMETHACIN SODIUM: The sodium salt of the NSAID indomethacin.
DESIRUDIN: A direct thrombin inhibitor used as an anticoagulant.
ANTI-HBEGF MONOCLONAL ANTIBODY U3-1565: An experimental monoclonal antibody that targets HB-EGF.
PRALICIGUAT: An experimental soluble guanylate cyclase (sGC) stimulator.
ALDH2 ACTIVATOR FP-045: An experimental agent that activates the aldehyde dehydrogenase 2 enzyme.
SALMETEROL XINAFOATE: The xinafoate salt of salmeterol, a long-acting beta-2 adrenergic agonist.
ASN007: An experimental ERK1/2 kinase inhibitor.
FT-1101: An experimental agent that was studied for its effects on sickle cell disease.
TROTABRESIB: An experimental BET inhibitor.
TGFBETA INHIBITOR LY3200882: An experimental inhibitor of the TGF-beta receptor I kinase.
NP-G2-044: A research chemical or compound identifier.
MEVOCICLIB: An experimental cyclin-dependent kinase (CDK) inhibitor.
EPICATECHIN: A flavonoid found in foods like dark chocolate and tea, with antioxidant properties.
EVINACUMAB: A monoclonal antibody that targets ANGPTL3, used to treat homozygous familial hypercholesterolemia.
BMS-908662: A research chemical or compound identifier.
ANTI-HER3 MONOCLONAL ANTIBODY GSK2849330: An experimental monoclonal antibody that targets the HER3 receptor.
AFIMOXIFENE: The active metabolite of tamoxifen, also known as 4-hydroxytamoxifen.
ZOPTARELIN DOXORUBICIN: An experimental targeted chemotherapy agent.
NCX-4016: A nitric oxide-donating derivative of aspirin.
MOTILIN: A peptide hormone that stimulates gastrointestinal motility.
TIANEPTINE: An atypical antidepressant with anxiolytic properties.
ISATORIBINE: An experimental Toll-like receptor 7 (TLR7) agonist.
ANDOLAST: An experimental anti-asthmatic agent.
ELISIDEPSIN: An experimental anticancer agent, a synthetic cyclic peptide.
METHYL AMINOLEVULINATE: A prodrug of aminolevulinic acid, used in photodynamic therapy.
PRX-321: A research chemical or compound identifier.
ZINPENTRAXIN ALFA: An experimental fusion protein.
PEGINTERFERON LAMBDA-1A: An experimental pegylated form of interferon lambda.
VU0364739: A positive allosteric modulator of the mGluR5 receptor.
MILATUZUMAB: An experimental monoclonal antibody that targets the CD74 antigen.
PROCYSTEINE: A prodrug of the amino acid cysteine.
RIOCIGUAT: A soluble guanylate cyclase (sGC) stimulator used to treat pulmonary hypertension.
NELADENOSON: An experimental adenosine A1 receptor partial agonist.
ABALOPARATIDE: A synthetic analog of parathyroid hormone-related protein, used to treat osteoporosis.
RTI-336: A research chemical, a serotonin-norepinephrine-dopamine reuptake inhibitor.
ALBIGLUTIDE: A GLP-1 receptor agonist that was used to treat type 2 diabetes.
BLARCAMESINE: An experimental agent that targets the sigma-1 and muscarinic receptors, studied for Alzheimer's disease.
LIPOSOMAL SN-38: A liposomal formulation of SN-38, the active metabolite of irinotecan.
ATABECESTAT: An experimental BACE1 inhibitor that was studied for Alzheimer's disease.
BMS 181,101: A research chemical or compound identifier.
DIHYDROERGOCRYPTINE: An ergot alkaloid.
LY334362: A research chemical or compound identifier.
BIMU 8: A potent 5-HT4 receptor agonist.
GLYCOCHENODEOXYCHOLIC ACID: A conjugated bile acid.
BRL 44408: A potent and selective alpha-2A adrenergic receptor antagonist.
BTB07018: A research chemical or compound identifier.
STANOLONE: An androgen and anabolic steroid, also known as dihydrotestosterone (DHT).
MRE 3010F20: A research chemical, an adenosine A3 receptor antagonist.
AM-37: A research chemical or compound identifier.
[125I]HPP-DESARG10HOE140: A complex, radiolabeled peptide antagonist of the bradykinin B2 receptor.
[3H]NPC17731: A radiolabeled compound, likely a receptor ligand.
ORYZATENSIN: A peptide derived from rice protein.
INS(3,4,5,6)P4: A specific inositol polyphosphate signaling molecule.
BENZOLAMIDE: A carbonic anhydrase inhibitor.
COMPOUND 15B [PMID: 18334293]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
Z-VDVAD-FMK: A specific, irreversible inhibitor of caspase-2.
ONC201: An experimental agent with anticancer activity that targets dopamine receptor D2 and ClpP.
YM-022: A potent and selective antagonist of the cholecystokinin B receptor.
UCCF-853: A research chemical or compound identifier.
SAUVAGINE: A peptide related to corticotropin-releasing factor.
BOHEMINE: A research chemical or compound identifier.
COMPOUND 9 [PMID: 11606127]: An experimental compound described in the specified publication.
ICI198615: A potent leukotriene B4 receptor antagonist.
DSM705: An experimental antimalarial drug that inhibits dihydroorotate dehydrogenase.
ALVELESTAT: An experimental neutrophil elastase inhibitor.
EBI-2511: A research chemical or compound identifier.
TIGOZERTINIB: An experimental MET kinase inhibitor.
COMPOUND 2 [PMID: 18295483]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
GSK2194069: An experimental agent that was studied for its effects on inflammation.
CATPB: An abbreviation, possibly for a research compound.
PROPIONIC ACID: A short-chain fatty acid.
AKN-028: An experimental multi-kinase inhibitor.
PYRAZOLONE, 1: A research chemical or compound identifier.
MMK-1: A research chemical or compound identifier.
COMPOUND 1754-31 [PMID: 23788657]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
[125I]FSH (HUMAN): A radioiodinated form of human follicle-stimulating hormone.
[125I]GDNF (RAT): A radioiodinated form of rat glial cell line-derived neurotrophic factor.
HEXYLCAINE HYDROCHLORIDE: A local anesthetic.
ALX 1405: A research chemical or compound identifier.
T-98475: A potent and selective antagonist of the Neuropeptide Y Y5 receptor.
WAY-207024: A research chemical or compound identifier.
CYCLORELIX: An experimental gonadotropin-releasing hormone (GnRH) antagonist.
BILASTINE: A second-generation antihistamine used to treat allergies.
(&PLUSMN;)-CIS-H2-PAT: A research chemical or compound identifier.
BI-3231: A research chemical or compound identifier.
COMPOUND 41 [PMID: 17574411]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
2-HYDROXY CAPRIC ACID: A type of alpha-hydroxy acid.
LOXAPINE SUCCINATE: The succinate salt of the antipsychotic drug loxapine.
COUMESTROL: A natural organic compound in the class of phytoestrogens.
&BETA;-NEOENDORPHIN: An endogenous opioid peptide.
5'-GUANIDINONALTRINDOLE: A potent and selective kappa-opioid receptor antagonist.
[125I]TYR45-KISSPEPTIN-15: A radioiodinated form of the peptide kisspeptin.
LABUXTINIB: An experimental JAK2 inhibitor.
NIP-142: A research chemical or compound identifier.
VORAPAXAR SULFATE: The sulfate salt of vorapaxar, a PAR-1 antagonist.
&KAPPA;M-CONOTOXIN RIIIK: A peptide neurotoxin from cone snail venom.
HSTX1[R14A]: A synthetic analogue of a toxin from spider venom.
GNE-7915: An experimental dual inhibitor of the LRRK2 and MAP4K4 kinases.
EXAMPLE 36 [WO2016177845]: A specific chemical compound described in a patent application.
CP-459632: A research chemical or compound identifier.
COMPOUND 41 [PMID: 15026062]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
GLPG-0555: An experimental drug that was studied for its effects on inflammation.
NCL-1: A research chemical or compound identifier.
ML324: A selective inhibitor of the USP1-UAF1 deubiquitinase complex.
COMPOUND 11S [PMID: 19433355]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 9A [PMID: 22266036]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
4-MPPTS: A research chemical or compound identifier.
3F-MT-45: A research chemical or compound identifier.
NGF: Nerve Growth Factor, a neurotrophic factor that regulates the growth and survival of neurons.
PHTX-11: A research chemical or compound identifier.
SUBSTANCE P-OME: An ester derivative of the neuropeptide Substance P.
CP-424,174: A research chemical or compound identifier.
N&#8242;,2-DIPHENYLQUINOLINE-4-CARBOHYDRAZIDE: A chemical compound, a potent vasopressin V1b receptor antagonist.
NEUROMEDIN U-23: A neuropeptide with various physiological roles.
CPN-116: A research chemical or compound identifier.
CRAC CHANNEL INHIBITOR 1 [PMID: 26256403]: A specific chemical inhibitor of the CRAC channel, as described in the publication.
LY3372689: An experimental O-GlcNAcase inhibitor.
[32P]MRS2500: A radiolabeled antagonist of the P2Y1 receptor.
ISOX-CHA-CHG-ARK(SULFO-CY5)-NH2: A complex, fluorescently labeled peptide.
AYPGKF-NH2: A peptide agonist of the PAR-4 receptor.
NS-220: A research chemical or compound identifier.
TAGITININ A: A natural sesquiterpene lactone.
MDG 548: A research chemical or compound identifier.
POSELTINIB: An experimental Janus kinase (JAK) inhibitor.
LGX-806: An experimental RAF kinase inhibitor.
GISADENAFIL: An experimental PDE5 inhibitor.
TPN171: An experimental phosphodiesterase inhibitor.
VEGF RECEPTOR TYROSINE KINASE INHIBITOR III: A specific chemical inhibitor of the VEGFR kinase.
WAY-255348: A research chemical or compound identifier.
(S)-RP-6306: A research chemical or compound identifier.
PRRP-20: A research chemical or compound identifier.
TAK-828F: A research chemical or compound identifier.
SR2211: A synthetic ligand that acts as an inverse agonist for the nuclear receptor ROR-gamma.
7-HYDROXYCHOLESTEROL: A metabolite of cholesterol, an oxysterol.
COMPOUND 1 [PMID: 21882820]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
B-R13/17K H2 RELAXIN: A synthetic analogue of the hormone relaxin.
SA10SC-RLX: A research chemical or compound identifier.
SELECTIN P LIGAND: A molecule that binds to P-selectin, a cell adhesion molecule.
SR-13668: An experimental agent that inhibits the JNK signaling pathway.
Y-39983: An experimental Rho-kinase inhibitor used in eye drops for glaucoma.
COMPOUND 15 [PMID: 19456099]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 35 [PMID: 19191557]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
[GA-DOTA,TYR3,THR8]OCTREOTIDE: A radiolabeled somatostatin analog for PET imaging.
STING AGONIST 3: A specific chemical activator of the STING pathway.
TC-2216: A research chemical or compound identifier.
APV207095A: A research chemical or compound identifier.
QUINAZOLIN-4(3H) DERIVATIVE 36: A specific chemical compound from the quinazoline class.
5'-IODORESINIFERATOXIN: A potent analogue of resiniferatoxin, which acts on the TRPV1 receptor.
UROTENSIN-II: A potent vasoconstrictor peptide.
LDN-91946: A research chemical or compound identifier.
BMS-911543: An experimental inhibitor of the TYK2 kinase.
[125I][LEU31,PRO34]NPY: A radioiodinated analogue of Neuropeptide Y.
ASPARAGINASE: An enzyme used as a chemotherapy agent, particularly for acute lymphoblastic leukemia.
PIXANTRONE: An aza-anthracenedione agent used for non-Hodgkin lymphoma.
THERAPEUTIC GLUCOCORTICOID: A class of corticosteroid hormones used for medical treatment.
PI3K-ALPHA INHIBITOR HS-10352: An experimental selective inhibitor of the PI3K alpha isoform.
ENAVATUZUMAB: An experimental monoclonal antibody that targets the TWEAK receptor.
PEGSUNERCEPT: A pegylated form of a soluble TNF receptor.
STAMULUMAB: An experimental monoclonal antibody that targets the GM-CSF protein.
VATELIZUMAB: An experimental monoclonal antibody that targets the VLA-2 integrin.
GSK933776: A research chemical or compound identifier.
CARBARIL: A carbamate insecticide.
MIRVETUXIMAB: An antibody-drug conjugate that targets the folate receptor alpha.
AVE-9633: An experimental antibody-drug conjugate.
EPRATUZUMAB 90Y: A radioimmunoconjugate, an antibody targeting CD22 linked to Yttrium-90.
TGN-1412: An experimental immunomodulatory antibody that targets CD28.
TREVOGRUMAB: An experimental monoclonal antibody that targets the GDF-8 protein.
CMB-401: An experimental antibody-drug conjugate.
KRN-330: An experimental monoclonal antibody that targets the A33 antigen.
ELSUBRUTINIB: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
UPROLESELAN: A selectin antagonist studied for acute myeloid leukemia.
DORZAGLIATIN: A glucokinase activator used to treat type 2 diabetes.
NEMIRALISIB: An experimental PI3K delta inhibitor.
SUVN-G3031: An experimental histamine H3 receptor antagonist.
IBI-939: A research chemical or compound identifier.
BI-187004: A research chemical or compound identifier.
GLENZOCIMAB: An experimental antiplatelet agent targeting glycoprotein VI.
DOMVANALIMAB: An experimental monoclonal antibody that targets the TIGIT immune checkpoint.
DEXBROMPHENIRAMINE MALEATE: A first-generation antihistamine.
BETUNOLIC ACID: A research chemical or compound identifier.
DRINABANT: An experimental cannabinoid receptor type 1 (CB1) antagonist.
RIVENPROST: An experimental prostaglandin EP4 receptor agonist.
[3H]WAY100635: A radiolabeled selective 5-HT1A receptor antagonist.
APIMOSTINEL: An experimental NMDA receptor modulator.
DIGERANYL BISPHOSPHONATE: A research chemical or compound identifier.
AESCULIOSIDE IIK: A saponin compound found in some plants.
TIZANIDINE HYDROCHLORIDE: A centrally acting alpha-2 adrenergic agonist used as a muscle relaxant.
SALICYLAMIDE: A non-prescription drug with analgesic and antipyretic properties.
RG3487: A research chemical or compound identifier.
HYPOTAURINE: An intermediate in the biosynthesis of taurine.
SIMPINICLINE: An experimental alpha-7 nicotinic receptor partial agonist.
CARBENICILLIN INDANYL: A prodrug of the antibiotic carbenicillin.
GLUTACONATE: A research chemical or compound identifier.
GUANABENZ ACETATE: The acetate salt of guanabenz, an alpha-2 adrenergic agonist.
GW301888X: A research chemical or compound identifier.
METHAPYRILENE HYDROCHLORIDE: The hydrochloride salt of the antihistamine methapyrilene.
PEFLOXACIN MESYLATE: The mesylate salt of pefloxacin, a fluoroquinolone antibiotic.
BUTACAINE: A local anesthetic of the ester type.
DITIOCARB SODIUM: The sodium salt of ditiocarb, an immunomodulatory agent.
BETAXOLOL: A selective beta-1 blocker used to treat hypertension and glaucoma.
BATILOL: A research chemical or compound identifier.
BRIVANIB ALANINATE: A prodrug of the multi-kinase inhibitor brivanib.
AC-55541: A selective estrogen receptor beta (ER-beta) agonist.
PROTRIPTYLINE: A tricyclic antidepressant.
ROZROLIMUPAB: An experimental monoclonal antibody.
TIRBANIBULIN: A microtubule inhibitor used topically to treat actinic keratosis.
OFATUMUMAB: A monoclonal antibody that targets the CD20 protein, used for multiple sclerosis and leukemia.
SATRALIZUMAB: A monoclonal antibody that targets the interleukin-6 receptor, used for neuromyelitis optica spectrum disorder.
RECOMBINANT HUMAN 6CKINE: A manufactured form of the chemokine CCL21.
CLENOLIXIMAB: An experimental monoclonal antibody that targets the CD4 receptor.
O-CHLOROACETYLCARBAMOYLFUMAGILLOL: A chemical compound, an angiogenesis inhibitor.
SOTATERCEPT: A fusion protein that acts as a ligand trap for activins, used for pulmonary arterial hypertension.
ROQUINIMEX: An experimental immunomodulatory agent.
TUMOR ANTIGEN: A general term for an antigenic substance produced in tumor cells.
IROPLACT: An experimental thrombopoietin receptor agonist.
IDOXURIDINE: An antiviral medication used topically for herpes simplex keratitis.
BI-505: An experimental monoclonal antibody that targets ICAM-1.
LYSOSOMAL ALPHA-GLUCOSIDASE: An enzyme used in replacement therapy for Pompe disease.
GLAFENINE: A non-steroidal anti-inflammatory drug (NSAID) that was withdrawn from the market.
NIALAMIDE: A monoamine oxidase inhibitor (MAOI) that was used as an antidepressant.
CEPHRADINE: A first-generation cephalosporin antibiotic.
CEFADROXIL ANHYDROUS: The anhydrous form of cefadroxil, a first-generation cephalosporin antibiotic.
PHENOXYPROPAZINE: A monoamine oxidase inhibitor (MAOI) that was used as an antidepressant.
REMOXIPRIDE HYDROCHLORIDE: The hydrochloride salt of the antipsychotic remoxipride.
ELEXACAFTOR: A CFTR protein corrector used in triple combination therapy for cystic fibrosis.
ALVERINE: An antispasmodic drug used for irritable bowel syndrome.
DEXTROMORAMIDE: A potent opioid analgesic.
FURAZOLIDONE: An antimicrobial agent.
COPANLISIB HYDROCHLORIDE: The hydrochloride salt of copanlisib, a PI3K inhibitor.
VESENCUMAB: An experimental monoclonal antibody.
PG-110: A research chemical or compound identifier.
FBT-A05: A research chemical or compound identifier.
NEMIFITIDE: An experimental antidepressant peptide.
ALICAFORSEN: An experimental antisense oligonucleotide targeting ICAM-1.
ISIS 104838: An experimental antisense oligonucleotide targeting TNF-alpha.
KARENITECIN: An experimental topoisomerase I inhibitor.
PERINDOPRIL: An ACE inhibitor used to treat high blood pressure and heart failure.
SOTALOL: A beta-blocker that also has antiarrhythmic properties.
MRA 003 US: A research chemical or compound identifier.
NEVANIMIBE HYDROCHLORIDE: An experimental ACAT-1 inhibitor.
VENGLUSTAT: An experimental glucosylceramide synthase inhibitor.
BMS-986104: An experimental BTK inhibitor.
TELISOTUZUMAB VEDOTIN: An experimental antibody-drug conjugate targeting the MET protein.
SELTOREXANT: An experimental dual orexin receptor antagonist.
SIMUFILAM: An experimental agent that was studied for Alzheimer's disease.
DOMAGROZUMAB: An experimental monoclonal antibody that targets myostatin.
EZETIMIBE: A medication used to lower cholesterol levels by inhibiting cholesterol absorption.
BIO-11006: An experimental agent that targets the VLA-4 integrin.
AGG-523: A research chemical or compound identifier.
DENOSUMAB: A monoclonal antibody that targets RANKL, used to treat osteoporosis and bone metastases.
RELDESEMTIV: An experimental fast skeletal muscle troponin activator.
MK-0731: A research chemical or compound identifier.
ELPAMOTIDE: An experimental cancer vaccine.
LY-2382770: A research chemical or compound identifier.
ACLERASTIDE: An experimental peptide that was studied for scleroderma.
LEXAPTEPID PEGOL: An experimental agent that was studied for its effects on inflammation.
LAS101057: A research chemical or compound identifier.
DP-B99: An experimental agent that was studied for stroke.
VS-4718: An experimental focal adhesion kinase (FAK) inhibitor.
RAMOSETRON: A 5-HT3 receptor antagonist used for irritable bowel syndrome.
ISOCARBOXAZID: A monoamine oxidase inhibitor (MAOI) used as an antidepressant.
FGI-101-1A6: A research chemical or compound identifier.
CD19CAR-CD3ZETA-4-1BB-EXPRESSING ALLOGENEIC T-LYMPHOCYTE CELLS: A specific formulation of allogeneic CAR-T cell therapy.
ROR1 CAR-SPECIFIC AUTOLOGOUS T-LYMPHOCYTES: A type of CAR-T cell therapy targeting the ROR1 protein.
EMD-386088: A research chemical or compound identifier.
OLEAMIDE: An endogenous fatty acid amide with sleep-inducing properties.
BW284C51: A selective inhibitor of the enzyme acetylcholinesterase.
[PYR1]APELIN-13: A synthetic analogue of the peptide apelin-13.
AUDIEN: A research chemical or compound identifier.
E339-3D6: A research chemical or compound identifier.
CCK-4: A peptide fragment of cholecystokinin, used in research to induce panic attacks.
PECAVAPTAN: An experimental vasopressin V1a receptor antagonist.
ZK 756326: A research chemical or compound identifier.
GOLCADOMIDE: An experimental cereblon E3 ligase modulator (CELMoD).
CITCO: A research chemical that activates the CAR nuclear receptor.
[125I]CRF (OVINE): A radioiodinated form of ovine corticotropin-releasing factor.
HYPOGLAUCIN A: A toxic amino acid found in the ackee fruit.
CXCL12-(1-9) DIMER: A modified form of the chemokine CXCL12.
SULUKAST: An experimental leukotriene D4 receptor antagonist.
3 ALPHA-AMINOCHOLESTANE: A chemical compound, a derivative of cholesterol.
EPICATECHIN GALLATE: A type of catechin found in tea.
S7958: A research chemical or compound identifier.
POVORCITINIB: An experimental JAK1 inhibitor.
ROVADICITINIB: An experimental JAK inhibitor.
EXAMPLE 131 [WO2009133348]: A specific chemical compound described in a patent application.
PZ-128: A research chemical or compound identifier.
SKA-20: A research chemical or compound identifier.
TERTIAPIN-Q: A peptide toxin that blocks Kir channels.
SKA-121: A research chemical that activates small-conductance calcium-activated potassium channels.
TORIPALIMAB: A monoclonal antibody that targets the PD-1 immune checkpoint receptor.
LP533401: An experimental tryptophan hydroxylase inhibitor.
COMPOUND 9 [DOI:10.26434/CHEMRXIV.7072592.V1]: An experimental compound described in a ChemRxiv preprint.
AZD8055: A potent and selective dual mTORC1/mTORC2 inhibitor.
XMT-1191: An experimental antibody-drug conjugate.
MTEB: A potent, selective, and non-competitive antagonist of the mGluR5 receptor.
MOTILIN-(1-12) (HUMAN): A peptide fragment of the hormone motilin.
AZD6088: A research chemical or compound identifier.
DIMETHYL-W84: A research chemical or compound identifier.
BMS-986141: An experimental TYK2 kinase inhibitor.
MK-0873: A research chemical or compound identifier.
PROGRAMMED CELL DEATH 1 LIGAND 1: A protein that binds to the PD-1 receptor, also known as PD-L1.
ABIVERTINIB: An experimental multi-kinase inhibitor targeting EGFR and BTK.
COMPOUND 11 [PMID: 29442501]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
HT1042: A research chemical or compound identifier.
EPZ015666: A potent and selective inhibitor of the PRMT5 enzyme.
COMPOUND 3B [PMID: 24946214]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
COMPOUND 1 [PMID: 22795084]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
ALLOSTERIC MODULATOR 33 [PMID: 35878399]: A specific allosteric modulator described in the publication.
KCL-286: A research chemical or compound identifier.
ZETELETINIB: An experimental EGFR inhibitor.
BMS-936559: An early investigational immune checkpoint inhibitor targeting PD-L1, also known as MDX-1105.
PENPULIMAB: A monoclonal antibody that targets the PD-1 receptor.
PHI-101: An experimental Bcl-xL inhibitor.
FLT3/CDK4/6 INHIBITOR FLX925: An experimental agent that inhibits FLT3, CDK4, and CDK6.
SR9009: A synthetic Rev-ErbA agonist.
BALICATIB: An experimental cathepsin K inhibitor.
TILARGININE: An experimental nitric oxide synthase inhibitor.
FGFR INHIBITOR DEBIO 1347: An experimental inhibitor of the FGFR kinase.
AMY-101: An experimental complement C3 inhibitor.
MERIMEPODIB: An experimental inhibitor of the enzyme IMPDH.
SIMLUKAFUSP ALFA: An experimental fusion protein.
FOSMANOGEPIX: An experimental antifungal agent.
INSULIN [INJECTION], BIPHASIC: A formulation of insulin containing both rapid-acting and intermediate-acting insulin.
INSULIN, ISOPHANE: An intermediate-acting insulin preparation.
PLONMARLIMAB: An experimental monoclonal antibody.
ORILANOLIMAB: An experimental monoclonal antibody.
INSULIN HUMAN, ISOPHANE: An intermediate-acting insulin preparation derived from human sources.
LINCOMYCIN: A lincosamide antibiotic.
JOSAMYCIN: A macrolide antibiotic.
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE: A complex chemical name, likely a specific receptor ligand or enzyme inhibitor.
DESMETHOXYYANGONIN: A kavalactone found in the kava plant.
DEMETHYLENCECALIN: A natural product with biological activity.
STROPHANTHIDIN ACETATE: An ester of the cardiac glycoside strophanthidin.
CEFAMANDOLE: A second-generation cephalosporin antibiotic.
MEDRONIC ACID: A bisphosphonate used in bone scans.
FLUMEQUINE: A quinolone antibiotic used in veterinary medicine.
PRULIFLOXACIN: A fluoroquinolone antibiotic.
BROMETHALIN: A rodenticide that uncouples oxidative phosphorylation.
ELEMICIN: A natural phenylpropene compound found in essential oils.
AM251: A potent and selective antagonist/inverse agonist for the cannabinoid CB1 receptor.
ROCURONIUM BROMIDE: The bromide salt of rocuronium, a neuromuscular-blocking drug.
PLA D: A research chemical or compound identifier.
ETOFENAMATE: A non-steroidal anti-inflammatory drug (NSAID) used topically.
(S)-ROSCOVITINE: The S-enantiomer of roscovitine, a potent inhibitor of cyclin-dependent kinases.
ZIRAM: A dithiocarbamate fungicide.
BUTACLAMOL: A typical antipsychotic that is a potent dopamine D2 antagonist.
BROMODICHLOROACETIC ACID: A chemical compound.
EUPAROTIN ACETATE: A natural product with biological activity.
DICOFOL: An organochlorine miticide related to DDT.
SOLOMONSTEROL A: A marine natural product.
2-METHYL GRAMINE: A derivative of the alkaloid gramine.
ETHAMSYLATE: An anti-hemorrhagic agent.
BISACODYL: A stimulant laxative.
GLABRANIN: A natural isoflavene compound.
1R,9S-HYDRASTINE: An isomer of the alkaloid hydrastine.
AR-AO-14418: An experimental glycogen phosphorylase inhibitor.
BENZOXATHIAN: A research chemical or compound identifier.
OCTAVERINE: A papaverine-like antispasmodic agent.
HYDROGEN PEROXIDE: A chemical compound used as an oxidizer, bleaching agent, and antiseptic.
BUFURALOL: A non-selective beta-blocker.
BENZO[E]PYRENE: A polycyclic aromatic hydrocarbon (PAH).
FAGARONINE: A natural benzophenanthridine alkaloid with anticancer activity.
DEOXIEPINEPHRINE: A research chemical or compound identifier.
SB 204070: A research chemical, a 5-HT2B receptor antagonist.
BAY 11-7082: An inhibitor of the IKK kinase, which blocks NF-kappaB activation.
IMAZODAN: An experimental cardiotonic agent.
3,6-DIMETHOXYFLAVONE: A natural polymethoxylated flavone.
OXYQUINOLINE: A heterocyclic organic compound with antiseptic properties.
2-HYDROXYESTRADIOL: A major metabolite of the hormone estradiol.
RETINYL ACETATE: An ester of retinol (Vitamin A).
2,4-DIACETYLPHLOROGLUCINOL: A natural antibiotic compound produced by Pseudomonas bacteria.
GW459057A: A research chemical or compound identifier.
RESMETHRIN: A synthetic pyrethroid insecticide.
GW300660X: A research chemical or compound identifier.
4-METHYLDAPHNETIN: A derivative of the coumarin daphnetin.
LYCOBETAINE: A research chemical or compound identifier.
FLAVONE: The parent compound of a class of flavonoids.
MURABUTIDE: A synthetic analogue of muramyl dipeptide.
FLUTOLANIL: A systemic fungicide.
L-NOREPINEPHRINE: The L-enantiomer of norepinephrine, a hormone and neurotransmitter.
TRICHLOROMONOFLUOROMETHANE: A chlorofluorocarbon (CFC), also known as Freon-11.
DOCONEXENT: An omega-3 fatty acid, also known as docosahexaenoic acid (DHA).
MEPANIPYRIM: A fungicide.
RONNEL: An organophosphate insecticide.
FERBAM: A dithiocarbamate fungicide.
FAMPROFAZONE: A non-steroidal anti-inflammatory drug (NSAID).
SANGUINARIUM CHLORIDE: A research chemical or compound identifier.
DIMPYLATE: An organophosphate insecticide, also known as diazinon.
TINORIDINE: An anti-inflammatory agent.
HYDRAMETHYLNON: An insecticide used in bait formulations.
BERKELEYAMIDE B: A marine natural product.
PEPSTATIN: A potent inhibitor of aspartyl proteases.
CLORINDIONE: An anticoagulant of the indandione class.
ISOLIQUIRITIGENIN: A natural chalconoid with various biological activities.
DORLIMOMAB ARITOX: An experimental immunotoxin.
UMBRALISIB TOSYLATE: The tosylate salt of umbralisib, a PI3K delta and CK1 epsilon inhibitor.
AG 490: A potent inhibitor of the JAK2 tyrosine kinase.
N-HISTIDYL-2-AMINONAPHTHALENE (BETANA): A research chemical or compound identifier.
M-CSF: Macrophage colony-stimulating factor, a cytokine that stimulates hematopoietic stem cells.
COMPOUND 7D [PMID: 25703523]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
BLISIBIMOD: An experimental agent that inhibits B-cell activating factor (BAFF).
MIRDAMETINIB: An experimental MEK1/2 inhibitor.
DALFAMPRIDINE: A potassium channel blocker used to improve walking in patients with multiple sclerosis.
JNJ-67569762: A research chemical or compound identifier.
VEGFC: Vascular endothelial growth factor C, a protein involved in lymphangiogenesis.
[3H]5-HT: A radiolabeled form of the neurotransmitter serotonin.
CLOFOCTOL: An antibacterial agent.
AZD5438: An experimental multi-cyclin-dependent kinase (CDK) inhibitor.
DOI: A psychedelic drug that acts as a 5-HT2A/2B/2C receptor agonist.
XL-228: An experimental multi-kinase inhibitor targeting IGF-1R, Src, Abl, and Aurora kinases.
ATAGABALIN: An experimental gabapentinoid drug.
ARX-788: An experimental antibody-drug conjugate targeting the HER2 protein.
TAXIFOLIN: A flavonoid with antioxidant and other biological properties.
SAQUINAVIR: A protease inhibitor used to treat HIV/AIDS.
ETOXAZOLE: A mite growth inhibitor used as an acaricide.
LHVS: A research chemical or compound identifier.
MESOTRIONE: An herbicide.
QWF: A research chemical or compound identifier.
COMPOUND 38 [PMID: 22123324]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
RECOMBINANT TRANSFORMING GROWTH FACTOR: A general class of manufactured TGF proteins.
GINKGOLIDE X: A research chemical or compound identifier.
TISOTUMAB VEDOTIN-TFTV: An antibody-drug conjugate that targets Tissue Factor, used for cervical cancer.
(+)-EPITAXIFOLIN: An isomer of taxifolin.
Z-WEHD-FMK: A specific, irreversible inhibitor of caspase-1 and caspase-5.
AC-186: A research chemical or compound identifier.
4-CHLOROMERCURIBENZOIC ACID: A chemical reagent that reacts with sulfhydryl groups.
RASDEGAFUSP ALFA: An experimental fusion protein.
POLYETHYLENE GLYCOL 4000: A polymer used as a laxative and in various medical applications.
ORG 24598: A partial agonist of the AMPA receptor.
2-METHOXY-5 (6)EPOXY-TETRAHYDROCARYOPHYLLENE: A chemical compound.
DAZOXIBEN HYDROCHLORIDE: An experimental inhibitor of thromboxane synthase.
DAUNORUBICIN HYDROCHLORIDE: The hydrochloride salt of daunorubicin, an anthracycline chemotherapy drug.
LAUROGUADINE: An antiseptic agent.
ENTINOSTAT: A histone deacetylase (HDAC) inhibitor studied for various cancers.
GOSSYPETIN: A natural flavonoid with antioxidant properties.
NVP-TAE684: A potent and selective inhibitor of the ALK kinase, also known as TAE684.
2-CHLORO-5-NITRO-N-PHENYLBENZAMIDE: A chemical compound, an anthelmintic agent.
&BETA;-FNA: Beta-Funaltrexamine, an irreversible mu-opioid receptor antagonist.
TOLPERISONE HYDROCHLORIDE: The hydrochloride salt of the muscle relaxant tolperisone.
ESLICARBAZEPINE: An anticonvulsant used to treat epilepsy.
AUROTHIOGLUCOSE: A gold-containing compound that was used to treat rheumatoid arthritis.
IRL 2500: An experimental endothelin ETB receptor antagonist.
BILIRUBIN: A yellow compound that occurs in the normal catabolic pathway that breaks down heme.
BIMATOPROST: A prostaglandin analogue used in eye drops to treat glaucoma and to enhance eyelash growth.
TEDATIOXETINE: An experimental multimodal antidepressant.
LUMEFANTRINE: An antimalarial agent used in combination with artemether to treat malaria.
2-[125I]MELATONIN: A radioiodinated form of melatonin used for autoradiographic localization of melatonin receptors.
STREPTOMYCIN SULFATE: The sulfate salt of streptomycin, an aminoglycoside antibiotic used to treat tuberculosis.
(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE: A chemical compound, a potent inhibitor of the VEGFR-2 kinase, also known as Sunitinib.
FLURANDRENOLIDE: A topical corticosteroid used to treat various skin conditions.
PENTAERYTHRITOL TETRANITRATE: A vasodilator of the nitrate class that was used to treat angina.
XILIERTINIB: An experimental EGFR tyrosine kinase inhibitor.
DAPHNETIN: A natural coumarin with various biological activities, including anti-inflammatory and antioxidant effects.
SIBUTRAMINE HYDROCHLORIDE: An oral anorexiant that was withdrawn from the market due to cardiovascular concerns.
ANTISERUM: Blood serum containing polyclonal antibodies, used to provide passive immunity.
REMIMAZOLAM: An ultra-short-acting benzodiazepine used for procedural sedation.
OXOTREMORINE-M: A potent muscarinic acetylcholine receptor agonist.
BIVATUZUMAB MERTANSINE: An experimental antibody-drug conjugate targeting the CD44v6 antigen.
COMPOUND 32 [PMID: 31638797]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
SN-1,2-DIDECANOYLGLYCEROL: A type of diacylglycerol, a signaling lipid.
TUXOBERTINIB: An experimental IRAK4 kinase inhibitor.
MEASLES VACCINE: A vaccine to prevent measles, a highly contagious infectious disease.
ACETAMINOPHEN/TRAMADOL: A combination analgesic medication containing paracetamol and tramadol.
LY379268: A potent and selective group II metabotropic glutamate receptor agonist.
[PHE3]OT: A research chemical or compound identifier.
SB220025: A potent and selective inhibitor of the p38 MAP kinase.
BERGAMOTTIN: A natural furanocoumarin found in grapefruit juice that inhibits CYP3A4.
ALSTERPAULLONE: An inhibitor of several cyclin-dependent kinases (CDKs) and GSK-3.
ORAL CONTRACEPTIVE: A class of medications taken by mouth to prevent pregnancy.
TETRAHYDRODEOXYCORTICOSTERONE: A neuroactive steroid.
PROROXAN HYDROCHLORIDE: An alpha-1 adrenergic receptor antagonist.
NALUZOTAN: An experimental 5-HT1A receptor agonist that was studied for anxiety.
ESMOLOL: An ultra-short-acting beta-1 blocker used to control heart rate.
ENTOLIMOD: An experimental agent that acts as a Toll-like receptor 5 (TLR5) agonist.
VARGATEF: A brand name for nintedanib, a multi-target tyrosine kinase inhibitor.
AZATHIOPRINE: An immunosuppressive drug used in organ transplantation and for autoimmune diseases.
DATISCETIN: A natural flavonol with antioxidant properties.
CLIOQUINOL: An antifungal and antiprotozoal drug that was used topically and orally.
LANSOPRAZOLE SULFIDE: A metabolite of the proton pump inhibitor lansoprazole.
DIMETHYL FUMARATE: A medication used to treat multiple sclerosis and psoriasis.
BENZETHONIUM CHLORIDE: A quaternary ammonium antiseptic and surfactant.
LARCAVIXIMAB: An experimental monoclonal antibody.
SNDX-5613: An experimental inhibitor of the menin-KMT2A interaction for leukemia.
PHOSPHONOACETIC ACID: An antiviral agent that inhibits viral DNA polymerase.
SOTULETINIB: An experimental spleen tyrosine kinase (Syk) inhibitor.
COMPOUND 38 [PMID: 20817473]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
CARNOSIC ACID: A natural benzenediol abietane diterpene found in rosemary and sage.
(-)-ENGLERIN A: A natural product with potent and selective cytotoxic activity against renal cancer cells.
GSK-269962A: A selective ROCK2 kinase inhibitor.
PF-04852946: A research chemical or compound identifier.
BA2+: The divalent barium cation.
ALOE-EMODIN: A natural anthraquinone compound with laxative and other biological effects.
FRENTIZOLE: An immunosuppressive agent.
GUTHION: An organophosphate insecticide, also known as azinphos-methyl.
LITHOGLYCOCHOLATE: A conjugated bile acid.
ZAMPANOLIDE: A marine natural product that stabilizes microtubules.
ACP-001: A research chemical or compound identifier.
PRASINEZUMAB: An experimental monoclonal antibody that targets the alpha-synuclein protein.
&BETA;3-TETRAPEPTIDE: A research chemical or compound identifier.
LIDOCAINE HYDROCHLORIDE: The hydrochloride salt of the local anesthetic lidocaine.
DDR1/2 INHIBITOR 5N: A specific chemical inhibitor of the DDR1 and DDR2 kinases.
FMET-MET-TRP-LEU-LEU: A peptide sequence.
SARILUMAB: A monoclonal antibody that targets the interleukin-6 receptor, used for rheumatoid arthritis.
AZD6482: An experimental PI3K beta inhibitor.
WEDELOLACTONE: A natural coumarin that inhibits the IKK kinase.
BETA-SITOSTEROL: A phytosterol with a chemical structure similar to that of cholesterol.
MIVAVOTINIB: An experimental spleen tyrosine kinase (Syk) inhibitor.
BIAPENEM: A broad-spectrum carbapenem antibiotic.
COMPOUND 82 [PMID: 21332118]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
APSTATIN: A research chemical or compound identifier.
GUANIDINE HYDROCHLORIDE: A chemical compound used to denature proteins.
PROPIONYLPROMAZINE HYDROCHLORIDE: A phenothiazine sedative used in veterinary medicine.
TX2-121-1: An experimental agent that inhibits the STAT3 signaling pathway.
HEXAHYDROSILADIFENIDOL: A selective M3 muscarinic receptor antagonist.
DECYNIUM 22: A research chemical that blocks organic cation transporters.
SB 216763: A potent and selective inhibitor of the enzyme GSK-3.
OXETHAZAINE: A topical anesthetic used for gastrointestinal pain.
REVEFENACIN: A long-acting antimuscarinic agent used as a bronchodilator for COPD.
3-HYDROXY-3',4'-DIMETHOXYFLAVONE: A natural polymethoxylated flavone.
VS-5584: An experimental dual PI3K/mTOR inhibitor.
DEPHOSTATIN: An inhibitor of protein tyrosine phosphatases.
HER2-TARGETED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE MM-302: An experimental formulation of doxorubicin.
VORUCICLIB: An experimental cyclin-dependent kinase (CDK) inhibitor.
TPX-0131: An experimental kinase inhibitor targeting ALK and ROS1.
SULFOBROMOPHTHALEIN: A compound used in a liver function test.
BICALUTAMIDE: A non-steroidal antiandrogen used to treat prostate cancer.
T-900607: A research chemical or compound identifier.
THIOPHANATE METHYL: A systemic fungicide.
EDIFOLIGIDE SODIUM: The sodium salt of edifoligide, an experimental transcription factor decoy.
SP-600125: A potent and selective inhibitor of the JNK kinase.
ATHRAQUINONES A: A research chemical or compound identifier.
INTERFERON ALFA-N3: A form of interferon alfa, a cytokine used in immunotherapy.
PP2: A potent and selective inhibitor of Src family tyrosine kinases.
GRAMICIDIN S: A cyclic peptide antibiotic.
URELUMAB: An experimental monoclonal antibody that targets the 4-1BB (CD137) receptor.
PARAROSANILINE: A triphenylmethane dye.
ABL127: A research chemical or compound identifier.
HYDROFLUMETHIAZIDE: A thiazide diuretic used to treat hypertension and edema.
NALMEFENE: An opioid receptor antagonist used to manage alcohol dependence.
GLEMBATUMUMAB VEDOTIN: An antibody-drug conjugate that targets GPNMB, studied for breast cancer and melanoma.
WZ4003: A research chemical or compound identifier.
IRAMPANEL: An experimental AMPA receptor antagonist.
FLUROGESTONE ACETATE: A progestin hormone used in veterinary medicine.
BAVITUXIMAB: An experimental monoclonal antibody that targets phosphatidylserine.
GALIXIMAB: An experimental monoclonal antibody that targets the CD80 protein.
EDICOTINIB: An experimental CSF1R kinase inhibitor.
MW01: A research chemical or compound identifier.
CICAPROST: A stable analogue of prostacyclin.
LY320135: A research chemical or compound identifier.
IPTACOPAN: An experimental complement Factor B inhibitor.
HYDROXYCAMPTOTHECIN: A derivative of camptothecin that inhibits topoisomerase I.
METHIOTHEPIN MESYLATE: A potent antagonist of multiple serotonin and dopamine receptors.
SILIDIANIN: A flavonolignan, a component of silymarin from milk thistle.
RAMELTEON: A melatonin receptor agonist used for the treatment of insomnia.
COMPOUND 9 [PMID: 1992149]: An experimental compound described in a 1990 publication (PMID is for 1990).
1-METHYL-L-TRYPTOPHAN: An inhibitor of the enzyme indoleamine 2,3-dioxygenase (IDO).
CAPTAN: A general use pesticide (GUP) that belongs to the phthalimide class of fungicides.
JWH015: A synthetic cannabinoid that is a selective agonist for the CB2 receptor.
SLAZINIC ACID: A research chemical or compound identifier.
BTI-410: A research chemical or compound identifier.
PROTHIOFOS: An organophosphate insecticide.
CALCIUM CHANNEL BLOCKER: A class of drugs that disrupt the movement of calcium through calcium channels.
QUAZINONE: An experimental cardiotonic agent.
PRIMIDONE: An anticonvulsant of the barbiturate class used to treat seizures.
CDPPB: A positive allosteric modulator of the mGluR5 receptor.
TIPRANAVIR: A protease inhibitor used to treat HIV/AIDS.
LXH254: An experimental pan-RAF inhibitor.
THERAPEUTIC CORTICOSTEROID: A class of steroid hormones used for medical treatment.
EBASTINE: A second-generation antihistamine.
PF-06263507: A research chemical or compound identifier.
GALP(3-32) (HUMAN): A peptide fragment of galanin-like peptide.
GNF-5837: An experimental pan-TRK inhibitor.
PRRP-(24-31) (HUMAN): A peptide fragment of prolactin-releasing peptide.
ICILIN: A synthetic compound that is a potent agonist of the TRPM8 and TRPA1 ion channels.
PYRONIN Y: A fluorescent dye used to stain RNA in histology.
THERAPEUTIC TUMOR INFILTRATING LYMPHOCYTES: A type of immunotherapy using a patient's own T-cells.
CAPSAZEPINE: A competitive antagonist of the TRPV1 receptor.
5-HYDROXYTRYPTAMINE: The chemical name for the neurotransmitter serotonin.
COMPOUND 7 [PMID: 22464456]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
TRIDIHEXETHYL CHLORIDE: An antimuscarinic agent.
ANTI-CD70 ANTIBODY-DRUG CONJUGATE MDX-1203: An experimental antibody-drug conjugate.
BETA-CCM: Beta-Carboline-3-carboxylic acid methyl ester, a benzodiazepine receptor inverse agonist.
ARTEMETHER: An antimalarial medication used in combination with lumefantrine.
BROMOXYNIL: An herbicide.
BRADYKININ: A peptide that causes blood vessels to dilate and therefore causes blood pressure to lower.
INTEGRIN RECEPTOR ANTAGONIST GLPG0187: An experimental antagonist of integrin receptors.
CEPHAPIRIN SODIUM: A first-generation cephalosporin antibiotic.
MESTRANOL: A synthetic estrogen, a component of some early oral contraceptives.
PAMP-20: A peptide derived from the proadrenomedullin protein.
NNC 11-1585: A research chemical or compound identifier.
CATECHOL: An organic compound, a common substructure in many natural products and pharmaceuticals.
GAMMA-FAGARINE: An alkaloid with various biological activities.
CIGLITAZONE: An experimental thiazolidinedione (TZD) antidiabetic drug.
CCL2: A small cytokine belonging to the CC chemokine family, also known as MCP-1.
J20 (GALANIN ANALOGUE): A synthetic analogue of the neuropeptide galanin.
CDK/CRK INHIBITOR: A class of drugs that inhibit cyclin-dependent kinases and CRK proteins.
COMPOUND 31 [PMID: 22902653]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
FLUFENACET: An herbicide.
ANTI-CD47 MONOCLONAL ANTIBODY CC-90002: An experimental monoclonal antibody that targets the CD47 protein.
ENADOLINE: A potent and selective kappa-opioid receptor agonist.
[ILE5]PTHRP-(1-36) (HUMAN): A synthetic peptide analogue of parathyroid hormone-related protein.
RHEIN: An anthraquinone compound found in rhubarb, with laxative and other effects.
BRILLIANT GREEN OXALATE: A triphenylmethane dye with antiseptic properties.
TEGOPRAZAN: A potassium-competitive acid blocker used to treat acid-related disorders.
TERIPARATIDE ACETATE: The acetate salt of teriparatide, a recombinant form of parathyroid hormone.
ISOKAEMPFERIDE: A natural O-methylated flavonol.
PROPYLENE GLYCOL MONOSTEARATE: An ester of propylene glycol and stearic acid, used as an emulsifier.
[D-TYR6,&BETA;-ALA11,N-ME-ALA13,NLE14]BOMBESIN-(6-14): A complex peptide analogue of bombesin.
SKI II: An inhibitor of sphingosine kinase.
AGN193109: A research chemical or compound identifier.
OXIGLUTATIONE: A research chemical or compound identifier.
TEPOTINIB HYDROCHLORIDE: The hydrochloride salt of tepotinib, a MET kinase inhibitor.
PF-04995274: A research chemical or compound identifier.
DS21360717: A research chemical or compound identifier.
[GLN8]GNRH: A synthetic analogue of gonadotropin-releasing hormone.
COMPOUND 19A [PMID: 30503936]: An experimental compound, likely a specific enzyme inhibitor, described in the publication.
BIM 23060: A research chemical, a somatostatin receptor ligand.
SARACATINIB: An experimental dual inhibitor of the Src and Abl kinases.
LY-2787106: A research chemical or compound identifier.
PYRIDABEN: An acaricide and insecticide.
RO5508887: A research chemical or compound identifier.
PORGAVIXIMAB: An experimental monoclonal antibody.
DEBRISOQUIN: An antihypertensive drug that acts as an adrenergic neuron blocking agent.
CINALUKAST: An experimental leukotriene D4 receptor antagonist.
RETEPLASE: A recombinant tissue plasminogen activator (tPA) used as a thrombolytic drug.
OXPRENOLOL HYDROCHLORIDE: The hydrochloride salt of the beta-blocker oxprenolol.
FLUVOXAMINE MALEATE: The maleate salt of the antidepressant fluvoxamine.
CHOLINE FENOFIBRATE: A formulation of the fibrate drug fenofibrate.
PHENMETRAZINE HYDROCHLORIDE: A stimulant drug that was used as an appetite suppressant.
DOXYCYCLINE CALCIUM: The calcium salt of the antibiotic doxycycline.
LEVONORDEFRIN: A vasoconstrictor used in combination with local anesthetics in dentistry.
TUBOCURARINE CHLORIDE: A toxic alkaloid, historically used as a muscle relaxant in anesthesia.
DESLANOSIDE: A cardiac glycoside.
TRICLOFOS SODIUM: A sedative and hypnotic drug.
BEPRIDIL HYDROCHLORIDE: The hydrochloride salt of the calcium channel blocker bepridil.
QUINIDINE GLUCONATE: A salt of the antiarrhythmic drug quinidine.
MERETHOXYLLINE PROCAINE: A combination diuretic and local anesthetic.
OLANZAPINE PAMOATE: A long-acting injectable formulation of the antipsychotic olanzapine.
LOXAPINE HYDROCHLORIDE: The hydrochloride salt of the antipsychotic drug loxapine.
CARIPRAZINE HYDROCHLORIDE: The hydrochloride salt of the antipsychotic cariprazine.
PASIREOTIDE PAMOATE: A long-acting release formulation of the somatostatin analog pasireotide.
BMS-698769: A research chemical or compound identifier.
SELONSERTIB: An experimental inhibitor of the ASK1 kinase.
GSK1070916: An experimental inhibitor of the Aurora B and C kinases.
DS-3078A: A research chemical or compound identifier.
GSK-1059615: An experimental dual PI3K/mTOR inhibitor.
RECILISIB: An experimental agent that was studied for its effects on inflammation.
TTP-607: A research chemical or compound identifier.
WX-037: A research chemical or compound identifier.
XL-844: An experimental multi-kinase inhibitor.
SAD448: A research chemical or compound identifier.
ORDOPIDINE: A research chemical or compound identifier.
MK-7246: An experimental CGRP receptor antagonist.
DECERNOTINIB: An experimental Janus kinase (JAK) inhibitor.
AZD2066: A research chemical or compound identifier.
ANATIBANT: An experimental bradykinin B2 receptor antagonist.
BARUSIBAN: An experimental oxytocin receptor antagonist.
S-237648: A research chemical or compound identifier.
ENRASENTAN: An experimental dual endothelin and angiotensin receptor antagonist.
SB-705498: A potent and selective 5-HT4 receptor antagonist.
AZD7009: An experimental potassium channel blocker that was studied for atrial fibrillation.
IDREVLORIDE: A research chemical or compound identifier.
TEBANICLINE TOSYLATE: A research chemical or compound identifier.
VISILIZUMAB: An experimental monoclonal antibody that targets the CD3 receptor.
AFELIMOMAB: An experimental monoclonal antibody that targets TNF-alpha.
TEDISAMIL: An experimental antiarrhythmic drug that blocks multiple potassium channels.
TELBERMIN: A recombinant form of human fibroblast growth factor 2.
SAGOPILONE: An experimental microtubule inhibitor of the epothilone class.
VARESPLADIB METHYL: A prodrug of varespladib, an inhibitor of phospholipase A2.
ZONAMPANEL: An experimental AMPA receptor antagonist.
ENOKIZUMAB: An experimental monoclonal antibody that targets interleukin-9.
BAMINERCEPT ALFA: An experimental fusion protein that acts as a ligand trap for lymphotoxin.
TADOCIZUMAB: An experimental monoclonal antibody that targets the C5a complement component.
PRO-542: An experimental immunotherapy agent, a CD4-IgG2 fusion protein.
DAPIROLIZUMAB PEGOL: A pegylated form of an experimental monoclonal antibody targeting CD40L.
BUTAMBEN PICRATE: A formulation of the local anesthetic butamben.
PROGLUMIDE: A cholecystokinin receptor antagonist that was used to treat peptic ulcers.
PYROVALERONE HYDROCHLORIDE: A stimulant drug that acts as a norepinephrine-dopamine reuptake inhibitor.
TETRAZEPAM: A benzodiazepine with muscle relaxant properties.
HOKT3: A research chemical or compound identifier.
MINAPRINE HYDROCHLORIDE: The hydrochloride salt of the antidepressant minaprine.
AVP-21D9: A research chemical or compound identifier.
NACOLOMAB TAFENATOX: An experimental radioimmunotherapy agent.
DELAFLOXACIN MEGLUMINE: The meglumine salt of delafloxacin, a fluoroquinolone antibiotic.
CENEGERMIN-BKBJ: A recombinant form of human nerve growth factor, used for neurotrophic keratitis.
DROTAVERIN: An antispasmodic drug.
ROCACETRAPIB: An experimental CETP inhibitor.
LERCANIDIPINE HYDROCHLORIDE: The hydrochloride salt of the calcium channel blocker lercanidipine.
CP-866087: A research chemical or compound identifier.
CAPRAVIRINE: An experimental non-nucleoside reverse transcriptase inhibitor.
CAMIDANLUMAB TESIRINE: An experimental antibody-drug conjugate targeting the ROR1 protein.
VERICIGUAT: A soluble guanylate cyclase (sGC) stimulator used to treat heart failure.
TRANIMILAST: A research chemical or compound identifier.
TOFIMILAST: An experimental phosphodiesterase-4 (PDE4) inhibitor.
DONANEMAB: An experimental monoclonal antibody that targets amyloid-beta, studied for Alzheimer's disease.
DOLASTATIN-10: A potent natural antimitotic peptide.
S-1360: A research chemical or compound identifier.
CAPROMORELIN: An experimental growth hormone secretagogue.
GUSACITINIB: An experimental dual inhibitor of JAK and Syk kinases.
FOLIGLURAX: An experimental mGluR4 positive allosteric modulator.
BRENSOCATIB: An experimental inhibitor of the DPP-1 enzyme.
S-777469: A research chemical or compound identifier.
ISPINESIB: An experimental inhibitor of the mitotic kinesin Eg5.
AGS-16C3F: An experimental antibody-drug conjugate.
BELNACASAN: An experimental caspase inhibitor.
BEMIPARIN: A low molecular weight heparin (LMWH) used as an anticoagulant.
IZOKIBEP: An experimental bispecific antibody targeting interleukin-17A.
LEUPROLIDE MESYLATE: The mesylate salt of leuprolide, a GnRH agonist.
EPHEDRINE HYDROCHLORIDE: The hydrochloride salt of the stimulant ephedrine.
LORVOTUZUMAB MERTANSINE: An experimental antibody-drug conjugate targeting the CD56 antigen.
CANTUZUMAB MERTANSINE: An experimental antibody-drug conjugate targeting the MUC1 antigen.
K-134: A research chemical or compound identifier.
ENOXIMONE: A phosphodiesterase 3 inhibitor used for congestive heart failure.
ONZIGOLIDE: A research chemical or compound identifier.
ZABOFLOXACIN: A fluoroquinolone antibiotic.
EZUTROMID: An experimental agent that was studied for Duchenne muscular dystrophy.
CS-1003: A research chemical or compound identifier.
UNASNEMAB: An experimental monoclonal antibody.
EFTILAGIMOD ALPHA: An experimental immunotherapy agent, a soluble LAG-3 fusion protein.
QUISOVALIMAB: An experimental monoclonal antibody.
LERODALCIBEP: An experimental agent designed to lower LDL cholesterol.
PEMETREXED TROMETHAMINE: A formulation of the chemotherapy drug pemetrexed.
CHLOROTHALONIL: A broad-spectrum fungicide.
GLUTAMIC ACID HYDROCHLORIDE: The hydrochloride salt of the amino acid glutamic acid.
METHYLDOPA (RACEMIC): A racemic mixture of the antihypertensive drug methyldopa.
PI-CLONIDINE: A research chemical or compound identifier.
CHLOROXINE: An antiseptic and disinfectant.
FR-122047: A selective prostaglandin E2 receptor antagonist.
NAFRONYL OXALATE: The oxalate salt of nafronyl, a vasodilator.
CETRIMONIUM BROMIDE: A quaternary ammonium antiseptic and surfactant.
TYRPHOSTIN 47: A research chemical that inhibits the EGFR tyrosine kinase.
(R)-FLECAINIDE: The R-enantiomer of the antiarrhythmic drug flecainide.
GR 127935: A potent antagonist of the 5-HT1B and 5-HT1D receptors.
ISOTHYMONIN: A research chemical or compound identifier.
PAPAVERINE: An opium alkaloid used to treat spasms and vasospasms.
APOMORPHINE HYDROCHLORIDE HEMIHYDRATE: A formulation of the dopamine agonist apomorphine.
ENOXOLONE: Also known as glycyrrhetinic acid, a compound from licorice root.
CARBONYL CYANIDE M-CHLOROPHENYLHYDRAZONE: A chemical uncoupler of oxidative phosphorylation, known as CCCP.
NSC-663284: An experimental anticancer agent that inhibits the Cdc25 phosphatase.
TICRYNAFEN: A diuretic and uricosuric agent that was withdrawn from the market due to hepatotoxicity.
DIPHENHYDRAMINE HYDROCHLORIDE: The hydrochloride salt of the antihistamine diphenhydramine.
PHANQUONE: An antiprotozoal agent.
EPIGALLOCATECHIN-3-GALLATE: The most abundant catechin in tea, with various biological activities.
BW723C86: A potent and selective 5-HT2B receptor agonist.
CALMIDAZOLIUM CHLORIDE: A potent inhibitor of calmodulin.
LEUCETTAMINE B: A marine natural product with biological activity.
GISENOSIDE RK1: A specific saponin from ginseng.
GRISEOFULVIN: An antifungal medication used to treat a number of types of dermatophytoses.
METHOXYCHLOR: An organochlorine insecticide.
PD-168393: An experimental irreversible inhibitor of the EGFR kinase.
BUTYLPARABEN: A preservative commonly used in cosmetics.
DIGITOXIGENIN: The aglycone of digitoxin, a cardiac glycoside.
TRICLOCARBAN: An antibacterial agent used in soaps and personal care products.
(S)-MEXILETINE: The S-enantiomer of the antiarrhythmic drug mexiletine.
TROPOLONE: An organic compound with antifungal properties.
FLUSILAZOLE: A fungicide.
PROADIFEN HYDROCHLORIDE: An inhibitor of cytochrome P450 enzymes.
GW782612X: A research chemical or compound identifier.
SELEGILINE HYDROCHLORIDE: The hydrochloride salt of the MAO-B inhibitor selegiline.
SPICLOMAZINE: An experimental antipsychotic agent.
PHENYLMERCURIC ACETATE: An organomercury compound that was used as a preservative and antiseptic.
FLUFENOXURON: An insect growth regulator.
PIPOBROMAN: An alkylating agent that was used as an anticancer drug.
BP 897: A potent and selective dopamine D3 receptor partial agonist.
FENDILINE HYDROCHLORIDE: A calcium channel blocker that was used for angina.
PLADIENOLIDE B: A natural product that inhibits the splicing factor SF3B.
PURPUROGALLIN: A natural phenolic compound with antioxidant properties.
XCT790: An inverse agonist for the orphan nuclear receptor ERR-alpha.
YANGONIN: A kavalactone found in the kava plant.
ANCITABINE HYDROCHLORIDE: The hydrochloride salt of the experimental chemotherapy agent ancitabine.
RO-281675: A research chemical or compound identifier.
FANDOSENTAN POTASSIUM: The potassium salt of fandosentan, an endothelin receptor antagonist.
MLN-8054: An experimental Aurora kinase A inhibitor.
AILANTHINONE: A natural quassinoid with various biological activities.
CINNAMTANNIN B1: A type of proanthocyanidin found in cinnamon.
CLIOXANIDE: An anthelmintic used in veterinary medicine.
3,4-DIHYDROXYPHENYLACETIC ACID: A major metabolite of the neurotransmitter dopamine.
SARCOLYSIN: An alkylating agent, also known as melphalan.
MK-886: An inhibitor of the 5-lipoxygenase-activating protein (FLAP).
THIOACETAZONE: An antibiotic that was used to treat tuberculosis.
MERCURIC CHLORIDE: A highly toxic inorganic compound of mercury and chlorine.
QUERCETAGETIN: A natural flavonol with antioxidant properties.
CEFIXIME ANHYDROUS: The anhydrous form of cefixime, a third-generation cephalosporin antibiotic.
THONZONIUM BROMIDE: An antiseptic and surfactant.
ARTEANNUIN B: A natural product related to artemisinin.
CARINATIN G: A research chemical or compound identifier.
PIPERONYL BUTOXIDE: A synergist used to enhance the potency of pesticides.
EHNA: An inhibitor of the enzyme adenosine deaminase.
DIPYRITHIONE: An antimicrobial agent.
CANRENONE: The active metabolite of the diuretic spironolactone.
PYRACLOSTROBIN: A strobilurin fungicide.
OUABAIN: A cardiac glycoside that inhibits the Na+/K+-ATPase pump.
HYMECROMONE: A medication used as a choleretic and antispasmodic agent.
GERALDOL: A research chemical or compound identifier.
2-(1-PHENYLETHYLIDENE)HYDRAZINECARBOXIMIDAMIDE: A chemical compound.
HYDRALAZINE: A vasodilator used to treat high blood pressure.
N-[6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-YL]-4,4,4-TRIFLUORO-3-HYDROXYBUTANAMIDE (DIASTEREOMERIC MIX): A complex chemical name, likely a specific receptor ligand or enzyme inhibitor.
TRIFLUSAL: An antiplatelet drug similar to aspirin.
WORTMANNIN: A potent and selective inhibitor of phosphoinositide 3-kinases (PI3Ks).
ESTRAMUSTINE: A chemotherapy agent used to treat prostate cancer.
ENNIATIN B: A cyclic peptide with antibiotic and ionophoric properties.
ACACETIN: A natural flavone with various biological activities.
ERGONOVINE: An ergot alkaloid used to cause contractions of the uterus.
MIANSERIN HYDROCHLORIDE: The hydrochloride salt of the antidepressant mianserin.
DIHYDROXANTHOHUMOL: A natural prenylflavonoid compound.
(RS)-ROSCOVITINE: A racemic mixture of roscovitine, a potent inhibitor of cyclin-dependent kinases.
BIOTINYLATED GAMBOGIC ACID: A labeled form of gambogic acid used in research.
AMAUROMINE: A fungal alkaloid with biological activity.
PHENMEDIPHAM: An herbicide.
ELLIPTECINE: An anticancer agent that intercalates into DNA.
BENOXACOR: An herbicide safener.
CEFDINIR: A third-generation cephalosporin antibiotic.
LAURYL ISOQUINOLINIUM: A research chemical or compound identifier.
BENSERAZIDE: A peripherally acting DOPA decarboxylase inhibitor, used with levodopa for Parkinson's disease.
CAPTAMINE: A research chemical or compound identifier.
METAPHIT METHANESULFONATE: The methanesulfonate salt of metaphit, an irreversible NMDA receptor antagonist.
SODIUM MOLYBDATE: A source of the essential trace element molybdenum.
BW373U86: A potent and selective delta-opioid receptor agonist.
BERBERINE CHLORIDE: The chloride salt of the alkaloid berberine.
PHLORETIN: A natural dihydrochalcone with various biological activities.
PYRIDOSTIGMINE: A reversible cholinesterase inhibitor used to treat myasthenia gravis.
TPCK: A chemical reagent that irreversibly inhibits chymotrypsin-like serine proteases.
CANAVANINE: A non-proteinogenic amino acid found in some legumes.
VANITIOLIDE: A choleretic agent.
LOPINAVIR: A protease inhibitor used to treat HIV/AIDS.
DEMECLOCYCLINE HYDROCHLORIDE: The hydrochloride salt of the antibiotic demeclocycline.
LACTOFEN: An herbicide.
SALINAZID: An antibacterial drug that was used for tuberculosis.
CHLORQUINALDOL: A topical antiseptic and disinfectant.
THIMEROSAL: An organomercury compound that was used as an antiseptic and preservative.
UNOPROSTONE ISOPROPYL: A prostaglandin analogue used in eye drops to treat glaucoma.
DESACETYLBUFOTALIN: A cardiotonic steroid, a component of Chan Su.
DITHIAZANINE IODIDE: An anthelmintic dye.
BROMOENOL LACTONE: An irreversible inhibitor of calcium-independent phospholipase A2.
LIPOIC ACID, ALPHA: An antioxidant, also known as thioctic acid.
4,4'-METHYLENEDIANILINE: An organic compound used in the production of polymers.
SR9011: A synthetic Rev-ErbA agonist.
AMARANTH: A synthetic red food dye.
CAMBINOL: An inhibitor of the SIRT1 and SIRT2 enzymes.
SKIMMIANINE: A furoquinoline alkaloid with various biological activities.
CRYPTOLEPINE HYDROCHLORIDE: The hydrochloride salt of the alkaloid cryptolepine.
ISOXSUPRINE: A vasodilator used to treat symptoms of cerebrovascular and peripheral vascular disease.
REL-CISAPRIDE: A research chemical or compound identifier.
CLOSANTEL: An anthelmintic used in veterinary medicine.
4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE: A chemical compound, a potent histamine H3 receptor antagonist.
IPRONIAZID: A monoamine oxidase inhibitor (MAOI) that was used as an antidepressant.
PROSTAGLANDIN A2: A type of prostaglandin.
ARCTIGENIN: A natural lignan with various biological activities.
TBBT: A research chemical or compound identifier.
TERPYRIDINE: A heterocyclic organic compound used as a ligand in coordination chemistry.
URSOLIC ACID: A natural pentacyclic triterpenoid with various biological activities.
4'-METHOXYFLAVONE: A synthetic flavonoid derivative.
DILAZEP: A coronary vasodilator.
AMBAZONE: An oral antiseptic.
GS-461203: A research chemical or compound identifier.
XANTHINE AMINE CONGENER: A class of chemical compounds.
QUINACRINE DIHYDROCHLORIDE: The dihydrochloride salt of quinacrine, an antimalarial and antiprotozoal drug.
HYPEROSIDE: A flavonoid glycoside, also known as quercetin-3-O-galactoside.
HOMIDIUM BROMIDE: An antiprotozoal agent used in veterinary medicine.
4'-O-ACETYLPATENTIFLORIN B: A derivative of a natural product.
MONTELUKAST SODIUM: The sodium salt of montelukast, a leukotriene receptor antagonist.
CLOFENOXYDE: A research chemical or compound identifier.
MEVASTATIN: A statin drug, also known as compactin, which inhibits HMG-CoA reductase.
THIETHYLPERAZINE MALATE: The malate salt of thiethylperazine, an antiemetic.
HESPERIDIN: A flavanone glycoside found in citrus fruits.
DISOPYRAMIDE: An antiarrhythmic medication.
ACETOCHLOR: An herbicide.
ERUCIC ACID: A monounsaturated omega-9 fatty acid.
CAPENSIN: A research chemical or compound identifier.
DNQX: A potent competitive AMPA/kainate receptor antagonist.
SODIUM AZIDE: A toxic inorganic compound used as a preservative and in airbags.
5-(N-METHYL-N-ISOBUTYL)AMILORIDE: A potent inhibitor of the Na+/H+ exchanger.
DACTHAL: An herbicide, also known as chlorthal-dimethyl.
TRANSPLATIN: An isomer of the chemotherapy drug cisplatin, which is largely inactive.
GUAIAZULENE: A natural azulene derivative with anti-inflammatory properties.
EPIRUBICIN HYDROCHLORIDE: The hydrochloride salt of epirubicin, an anthracycline chemotherapy drug.
IOFETAMINE HYDROCHLORIDE: A radiopharmaceutical that was used for SPECT imaging of the brain.
TYRPHOSTIN AG 835: A research chemical that inhibits tyrosine kinases.
DIHYDRO-12-HYDROXY-2,2-DIMETHYL-2H,6H-PYRANO[3,2-B]XANTHEN-6-ONE: A complex chemical name for a natural product derivative.
TETRANITROMETHANE: A chemical compound, a powerful oxidizer.
CETRIMIDE: An antiseptic agent consisting of a mixture of quaternary ammonium salts.
GERONTOXANTHONE H: A natural xanthone compound.
CROMOGLYCATE: A mast cell stabilizer used to treat asthma and allergic rhinitis.
OSI-027: An experimental dual mTORC1/mTORC2 inhibitor.
COBALT: A chemical element, an essential trace mineral.
ALANOSINE: An antibiotic with antitumor activity.
JNJ 7777120: A potent and selective histamine H4 receptor antagonist.
THERAPEUTIC HORMONE: A general class of hormones used for medical treatment.
DAUNORUBICIN LIPOSOMAL: A liposomal formulation of the chemotherapy drug daunorubicin.
PROTEASE INHIBITOR: A class of drugs that inhibit the action of proteases.
PARATHION: A highly toxic organophosphate insecticide.
NONSTEROIDAL ANTIINFLAMMATORY DRUG: A class of analgesic medication that reduces pain, fever, and inflammation (NSAIDs).
IL-12: Interleukin-12, a cytokine that is important for the differentiation of T helper 1 cells.
TRAIL: Tumor necrosis factor-related apoptosis-inducing ligand, a protein that induces apoptosis.
IROFULVEN: An experimental anticancer agent.
PHYTOESTROGEN: A plant-derived compound with estrogenic activity.
PICEATANNOL: A stilbenoid compound, a metabolite of resveratrol.
PENTACHLORONITROBENZENE: A fungicide.
IL-3: Interleukin-3, a cytokine that stimulates the differentiation of hematopoietic stem cells.
DEXTRAN SULFATE: A polyanionic derivative of dextran.
RECOMBINANT FLT3 LIGAND: A manufactured form of the FLT3 ligand protein, which stimulates hematopoietic cells.
ANTIVIRAL AGENT: A class of drugs used to treat viral infections.
TICARCILLIN: A carboxypenicillin antibiotic.
CHRYSANTHEMUM MORIFOLIUM/GANODERMA LUCIDUM/GLYCYRRHIZA GLABRA/ISATIS INDIGOTICA/PANAX PSEUDOGINSENG/RABDOSIA RUBESCENS/SCUTELLARIA BAICALENSIS/SERONA REPENS SUPPLEMENT: A complex herbal supplement.
COLESTIPOL HYDROCHLORIDE: A bile acid sequestrant used to lower cholesterol.
DOXIFLURIDINE: A prodrug of 5-fluorouracil (5-FU), a chemotherapy agent.
1,4-BENZOQUINONE: An organic compound, the oxidized derivative of hydroquinone.
RECOMBINANT TRANSFORMING GROWTH FACTOR-BETA 1: A manufactured form of the TGF-beta1 cytokine.
IL-9: Interleukin-9, a cytokine that supports the growth of T-cells and mast cells.
IV FLUID: A general term for intravenous solutions used for fluid replacement.
OPIATE: A class of drugs derived from or similar to opium.
ALDESLEUKIN: A recombinant form of interleukin-2, used as an immunotherapy for cancer.
GP-120 ANTIGEN: The gp120 envelope glycoprotein of the HIV virus.
FGF-1: Fibroblast growth factor 1, a protein that is a potent mitogen and angiogenic factor.
PICIBANIL: A preparation of killed Streptococcus pyogenes, used as an immunomodulator.
DIPHTHERIA TOXIN: A toxic protein produced by the bacterium Corynebacterium diphtheriae.
ADENOSINE DEAMINASE INHIBITOR: A class of drugs that inhibit the enzyme adenosine deaminase.
SOY PROTEIN ISOLATE: A highly refined or purified form of soy protein.
DALBERGIONE, 4-METHOXY-4'-HYDROXY-: A specific neoflavonoid compound.
THROMBIN: A serine protease that converts fibrinogen into fibrin in blood coagulation.
PENICILLAMINE: A chelating agent used to treat Wilson's disease and rheumatoid arthritis.
AMIFOSTINE ANHYDROUS: The anhydrous form of amifostine, a cytoprotective agent.
INDIMITECAN: An experimental topoisomerase I inhibitor.
ESTRONE SULFATE: A major circulating estrogen in postmenopausal women.
ENPIROLINE: An experimental antimalarial drug.
IODINE I 131-6-BETA-IODOMETHYL-19-NORCHOLESTEROL: A radiopharmaceutical that was used for adrenal imaging.
FMET-LEU-PHE: A synthetic peptide that is a potent chemoattractant for neutrophils.
GRAMINE: An indole alkaloid found in certain plants.
IPRONIAZID SULFATE: The sulfate salt of the antidepressant iproniazid.
BACAMPICILLIN: A prodrug of the antibiotic ampicillin.
DAPTOMYCIN: A lipopeptide antibiotic used to treat serious bacterial infections.
ELACRIDAR: An experimental P-glycoprotein inhibitor designed to overcome multidrug resistance.
MENTHOFURAN: A toxic organic compound found in some essential oils.
NORFLOXACIN: A fluoroquinolone antibiotic.
BROMAZEPAM: A benzodiazepine with anxiolytic properties.
VILOXAZINE: A selective norepinephrine reuptake inhibitor used to treat ADHD.
METACETAMOL: An isomer of paracetamol (acetaminophen).
LENPERONE: A typical antipsychotic of the butyrophenone class.
3,7-DIMETHOXYFLAVONE: A natural polymethoxylated flavone.
DAPH: An abbreviation, possibly for a research compound.
3,4-METHYLENEDIOXYMETHAMPHETAMINE: A psychoactive drug, commonly known as MDMA or ecstasy.
EDOXABAN: An anticoagulant that acts as a direct factor Xa inhibitor.
CAPIVASERTIB: An experimental pan-Akt inhibitor.
EZETIMIBE / SIMVASTATIN: A combination drug used to lower cholesterol.
CICHORIC ACID: A natural phenolic compound found in echinacea and other plants.
BETA-CARBOLINE: A class of indole alkaloids with a wide range of psychoactive effects.
GLUCARPIDASE: An enzyme used to lower toxic methotrexate levels in patients.
TOFISOPAM: An anxiolytic drug of the benzodiazepine class, acting atypically.
VADIMEZAN: An experimental vascular-disrupting agent and immune modulator.
D-TRYPTOPHAN: An enantiomer of the essential amino acid tryptophan, used in research.
(20S,21R)-FLUOROCAMPTOTHECIN: A derivative of camptothecin, investigated as an anticancer agent.
ESKETAMINE HYDROCHLORIDE: The hydrochloride salt of esketamine, an NMDA receptor antagonist used for depression.
ARRY-300: An investigational drug targeting the p38 MAPK pathway for inflammatory diseases.
EGAPTIVON PEGOL: A pegylated aptamer that neutralizes C5, investigated for eye diseases.
DERRUBONE: A natural isoflavonoid compound with potential anti-inflammatory properties.
ANTI-CD19 CAR T CELLS AT101: An investigational CAR T-cell therapy targeting the CD19 protein on cancer cells.
BGC201531: An investigational compound developed for research purposes.
BEPOTASTINE BESILATE: An antihistamine used to treat allergic conjunctivitis.
CAPROSPINOL: A synthetic neurosteroid analogue investigated for neurological disorders.
GW559768X: An experimental compound developed by GlaxoSmithKline for research.
COLFORSIN: A derivative of forskolin, an activator of adenylyl cyclase.
LGD-1550: An investigational selective androgen receptor modulator (SARM).
TABALUMAB: A monoclonal antibody that targets B-cell activating factor (BAFF).
MELOGLIPTIN: A dipeptidyl peptidase-4 (DPP-4) inhibitor investigated for type 2 diabetes.
UPAMOSTAT: An experimental serine protease inhibitor.
MKC-1: An investigational anticancer agent that inhibits tubulin polymerization.
IODINE: A chemical element essential for thyroid hormone production.
MX-DNG1: A research compound, likely an experimental drug candidate.
FORALUMAB: An immunosuppressive monoclonal antibody that targets the CD3 epsilon chain.
OXYMORPHONE: An opioid analgesic used for the relief of moderate to severe pain.
XANTHOANGELOL B: A natural chalcone compound found in the plant Angelica keiskei.
SELETRACETAM: An antiepileptic drug, a structural analog of levetiracetam.
OPORTUZUMAB MONATOX: An immunotoxin consisting of an anti-EpCAM antibody linked to a bacterial toxin.
FLUTICASONE FUROATE: A synthetic corticosteroid used to treat allergic rhinitis and asthma.
VOLOCIXIMAB: An experimental monoclonal antibody that targets Î±5Î²1 integrin for cancer therapy.
COCAINE: A potent central nervous system stimulant and local anesthetic.
LISURIDE: A dopamine agonist of the ergoline class, used to treat Parkinson's disease.
LEVOMETHADYL: A synthetic opioid analgesic used for opioid maintenance therapy.
METOCURINE IODIDE: A neuromuscular blocking agent.
PENTOLINIUM: A ganglionic blocker formerly used as an antihypertensive agent.
PARAMETHASONE: A synthetic glucocorticoid with anti-inflammatory properties.
TRIDIHEXETHYL: An anticholinergic drug used to treat peptic ulcers.
ENPROFYLLINE: A xanthine derivative with bronchodilator effects, used for asthma.
EPOPROSTENOL: A synthetic form of prostacyclin (PGI 2), used to treat pulmonary hypertension.
INTERFERON ALFACON-1: A recombinant type-I interferon used to treat chronic hepatitis C.
OXAZEPAM: A short-to-intermediate-acting benzodiazepine used for anxiety and insomnia.
SECOBARBITAL: A short-acting barbiturate derivative used as a sedative and hypnotic.
U73122: A research chemical that inhibits phospholipase C.
XMAB-2513: An investigational monoclonal antibody.
ANTI-TIGIT MONOCLONAL ANTIBODY ASP8374: An investigational cancer immunotherapy agent targeting the TIGIT immune checkpoint.
ROEMERINE: A natural aporphine alkaloid found in certain plants.
ANTI-HER2 ANTIBODY-DRUG CONJUGATE MEDI4276: An experimental cancer therapy targeting HER2-positive tumors.
PEPOSERTIB: An investigational inhibitor of DNA-dependent protein kinase (DNA-PK).
INDOXIMOD PRODRUG NLG802: A prodrug of indoximod, an inhibitor of the IDO pathway for cancer immunotherapy.
UZANSERTIB: An investigational ATR kinase inhibitor for cancer treatment.
ANNAMYCIN LIPOSOMAL: A liposomal formulation of an anthracycline antibiotic for cancer therapy.
ZOLIGRATINIB: An investigational selective fibroblast growth factor receptor (FGFR) inhibitor.
NENDRATAREOTIDE UZATANSINE: An antibody-drug conjugate targeting somatostatin receptor 2.
DIMERCAPROL: A chelating agent used to treat heavy metal poisoning.
TELAZORLIMAB: An investigational monoclonal antibody targeting the NKG2D receptor.
CERDULATINIB: An investigational dual SYK/JAK kinase inhibitor for cancer.
2- (2,6-DIMETHOXYPHENOXYETHYL)AMINOMETHYL-1,4-BENZODIOXANE HYDROCHLORIDE (WB 4101): A selective alpha-1A adrenergic receptor antagonist used in research.
FINERENONE: A non-steroidal, selective mineralocorticoid receptor antagonist for kidney and cardiovascular disease.
GSK126: An investigational selective inhibitor of the EZH2 methyltransferase.
PL37: An investigational drug targeting enkephalinase for pain management.
OBP-801: An experimental STAT3 inhibitor for cancer therapy.
BRENTUXIMAB: An antibody-drug conjugate targeting CD30 for lymphoma treatment.
ASCRINVACUMAB: An investigational monoclonal antibody.
FP-1039: A fusion protein designed to trap fibroblast growth factors (FGFs), an experimental cancer therapy.
AZD-6088: An investigational compound from AstraZeneca, for research.
ANTIFUNGAL AGENT: A general term for a drug that treats fungal infections.
ST. JOHN'S WORT: An herbal supplement commonly used for depression.
ANALGESIC AGENT: A general term for a drug that relieves pain.
VALNIVUDINE HYDROCHLORIDE: The hydrochloride salt of an investigational antiviral drug.
TRIBUTYRIN: A triglyceride and prodrug of butyric acid, with potential anticancer effects.
DELPHINIDIN: A natural anthocyanidin pigment found in flowers and fruits with antioxidant properties.
METOPRINE: An inhibitor of dihydrofolate reductase, investigated as an anticancer agent.
AZASETRON: A 5-HT3 receptor antagonist used as an antiemetic.
THIOCOLCHICOSIDE: A muscle relaxant with anti-inflammatory and analgesic properties.
TRAFERMIN: Recombinant human basic fibroblast growth factor (bFGF).
HERBIMYCIN A: A benzoquinone ansamycin antibiotic that inhibits tyrosine kinases.
IMD-0354: An experimental inhibitor of IKKÎ², with anti-inflammatory effects.
LY404039: An experimental agonist for the mGlu2/3 receptors, investigated for schizophrenia.
HE3235: An investigational synthetic steroid with anti-inflammatory properties.
BMS-986202: An investigational oral lysophosphatidic acid receptor 1(LPA1) antagonist.
HEPARAN SULFATE: A linear polysaccharide found on cell surfaces and in the extracellular matrix.
TUROCTOCOG ALFA PEGOL: A long-acting, pegylated recombinant human coagulation factor VIII.
PREP-001: An investigational agent designed to stimulate the innate immune system.
METHDILAZINE: A first-generation antihistamine with anticholinergic properties.
BIMU 1: A selective agonist for the 5-HT4 receptor used in research.
ETHINYLESTRADIOL/DROSPIRENONE/PRASTERONE: A combination oral contraceptive pill.
ANTI-DIABETIC AGENT: A general term for a drug used to treat diabetes mellitus.
D-157495: An experimental research compound.
CEPHALOSTATIN: A potent natural anticancer agent isolated from a marine worm.
AUTOLOGOUS ANTI-CD20 CAR TRANSDUCED CD4/CD8 ENRICHED T-CELLS MB-CART20.1: An investigational CAR T-cell therapy targeting CD20.
RICIN: A highly toxic protein obtained from castor beans.
RECOMBINANT TUMOR NECROSIS FACTOR-BETA: A genetically engineered cytokine, also known as lymphotoxin-alpha.
MASILUKAST: An experimental leukotriene receptor antagonist for asthma.
GARLIC: A plant species used as a food seasoning and in herbal medicine.
SYNTHETIC HUMAN PAPILLOMAVIRUS 16 E6 PEPTIDE: A synthetic peptide fragment from an HPV protein, used in vaccine research.
PERILLYL ALCOHOL: A natural monoterpene with potential anticancer properties.
GPI-0100: A saponin-based adjuvant used to enhance immune responses to vaccines.
BETA-ADRENERGIC ANTAGONIST: A class of drugs that block beta-adrenergic receptors, also known as beta-blockers.
ESTRADIOL 3-BENZOATE: An ester of estradiol, a form of estrogen.
OMAPATRILAT: An experimental antihypertensive agent that inhibits both ACE and neprilysin.
CREMOPHOR: A brand name for polyethoxylated castor oil, used as a solubilizer in drug formulations.
HYPOXANTHINE: A naturally occurring purine derivative.
SIALYL TN ANTIGEN: A carbohydrate antigen associated with various cancers.
CLADRIBINE: A purine analog used in the treatment of hairy cell leukemia and multiple sclerosis.
ANISTREPLASE: A thrombolytic drug used to dissolve blood clots.
BITOLTEROL: A short-acting beta-2 adrenergic receptor agonist used as a bronchodilator.
CELIPROLOL HYDROCHLORIDE: A beta-blocker with vasodilating properties, used for hypertension.
BIRABRESIB: An investigational inhibitor of the BET family of proteins for cancer treatment.
NIRAVOLINE: An experimental research compound.
MANOALIDE: A natural product from marine sponges that inhibits phospholipase A2.
BUCINDOLOL HYDROCHLORIDE: A non-selective beta-blocker with mild vasodilating activity.
1-NAPHTHYLPIPERAZINE: A chemical compound that acts as a ligand for various serotonin and adrenergic receptors.
VER-3323: An experimental Hsp70 inhibitor.
METERGOLINE: A serotonin and dopamine receptor antagonist of the ergoline class.
SB 216641: A research chemical that acts as a 5-HT1B/1D receptor antagonist.
RS-102221: A selective antagonist of the 5-HT2C receptor, used in research.
TD-8954: An experimental, selective 5-HT4 receptor agonist.
EMDT: A research chemical and agonist at the MT1 and MT2 melatonin receptors.
WAY-208466: A research chemical and selective estrogen receptor beta (ERÎ²) agonist.
SB399885: A research chemical that acts as a selective 5-HT6 receptor antagonist.
PFKFB3 KINASE INHIBITOR 69: A research chemical that inhibits the PFKFB3 enzyme.
COMPOUND 25 [PMID: 18068976]: A research compound described in the specified scientific publication.
TOFA: An inhibitor of acetyl-CoA carboxylase, used in metabolic research.
ACETALDEHYDE: An organic chemical compound, a primary metabolite of ethanol.
GI254023X: An experimental inhibitor of ADAM10 metalloprotease.
ZOTIZALKIB: An investigational PI3K delta inhibitor.
AK198: An experimental research compound.
COMPOUND 5G [PMID: 20483621]: A research compound described in the specified scientific publication.
ZENARESTAT: An aldose reductase inhibitor investigated for diabetic complications.
RS-17053: A research chemical that is a selective alpha-1A adrenergic receptor antagonist.
INDORAMIN: An alpha-1 adrenergic receptor antagonist used as an antihypertensive agent.
TOLAZOLINE: A non-selective alpha-adrenergic antagonist used as a vasodilator.
ANDARINE: An investigational selective androgen receptor modulator (SARM), also known as S-4.
COMPOUND 9 [PMID: 1738140]: A research compound described in the specified scientific publication.
ETRUMADENANT: An investigational dual A2a/A2b adenosine receptor antagonist for cancer immunotherapy.
[SAR1,ILE8]ANG-II: A synthetic analog of Angiotensin II used in research.
LY301875: An experimental research compound.
CDK2 INHIBITOR IV: A research chemical that selectively inhibits cyclin-dependent kinase 2.
PHYLLOLITORIN: A neuropeptide related to bombesin, found in amphibian skin.
BOMBESIN: A peptide found in amphibian skin that stimulates gastrin release and gut motility.
CCG258747: An experimental inhibitor of the Rho/MRTF/SRF signaling pathway.
AM-6494: An experimental research compound.
LEVOSALBUTAMOL: The (R)-enantiomer of salbutamol, a short-acting Î²2-adrenergic receptor agonist.
[125I]ICYP: A radiolabeled version of cyanopindolol used to study beta-adrenergic receptors.
CHIR-265: An investigational multi-kinase inhibitor targeting VEGFR, PDGFR, and FGFR.
COMPOUND 4D [PMID: 21851057]: A research compound described in the specified scientific publication.
COMPOUND 38 [PMID: 24000170]: A research compound described in the specified scientific publication.
XY-06-007: An experimental research compound.
BI-9564: An experimental inhibitor of the BET family of proteins.
REMIBRUTINIB: An investigational oral Bruton's tyrosine kinase (BTK) inhibitor.
LYS-KALLIDIN: A bioactive peptide, also known as lysyl-bradykinin.
FR191413: An experimental research compound.
B-9958: An experimental neuroprotective agent that acts as an NMDA receptor antagonist.
[125I]HPP-HOE140: A radiolabeled antagonist of the bradykinin B2 receptor.
COMPOUND 2-3-2 [PMID: 24900824]: A research compound described in the specified scientific publication.
COMPOUND 2-1-1 [PMID: 24900824]: A research compound described in the specified scientific publication.
COMPOUND 2-3-1 [PMID: 24900824]: A research compound described in the specified scientific publication.
NPC-567: An analog of the neuropeptide substance P.
PMX205: An experimental cyclic peptide that acts as a C5a receptor agonist.
EU-DTPA-[SER27, NLE70]HC5A: A labeled peptide analog for research.
CACCINH-A01: A research chemical that acts as an inhibitor of calcium-activated chloride channels (CaCCs).
ISATIN SULFONAMIDE 34 [PMID: 11384246]: A research compound described in the specified publication, likely a caspase inhibitor.
CALCISEPTINE: A peptide toxin from black mamba venom that blocks L-type calcium channels.
TTA-A2: A research chemical that selectively inhibits T-type calcium channels.
GSK COMPOUND 34: An experimental research compound from GlaxoSmithKline.
MET-CK&BETA;7: A research peptide.
VMIP-III: A viral chemokine-like protein used in research.
[125I]CCL3 (HUMAN): A radiolabeled version of the human chemokine CCL3 for research.
LORNOXICAM: A non-steroidal anti-inflammatory drug (NSAID).
COMPOUND 2 [PMID: 22560567]: A research compound described in the specified scientific publication.
IBERDOMIDE: An investigational cereblon E3 ligase modulator (CELMoD) for hematological cancers.
UCCF-339: A research chemical that acts as a CCR8 chemokine receptor antagonist.
NS004: A small molecule activator of large-conductance calcium-activated potassium (BK) channels.
DTAG-13: A degrader molecule used in targeted protein degradation research.
PURVALANOL A: A research chemical that inhibits cyclin-dependent kinases (CDKs).
BMS-265246: An experimental inhibitor of cyclin-dependent kinases (CDKs).
SU9516: An experimental inhibitor of cyclin-dependent kinase 2 (CDK2).
THAL-SNS-032: A PROTAC degrader targeting CDK9.
(2R)-2-({9-(1-METHYLETHYL)-6-[(4-PYRIDIN-2-YLBENZYL)AMINO]-9H-PURIN-2-YL}AMINO)BUTAN-1-OL: A specific CDK inhibitor research compound.
BS-194: An experimental inhibitor of cyclin-dependent kinase 2 (CDK2).
(7S)-2-(2-AMINOPYRIMIDIN-4-YL)-7-(2-FLUOROETHYL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE: A specific kinase inhibitor research compound.
RIVICICLIB: An investigational inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6).
COMPOUND 39A [PMID: 15634016]: A research compound described in the specified scientific publication.
[3H]LTC4: A radiolabeled version of leukotriene C4, used in research.
NOMIFENSINE: A norepinephrine-dopamine reuptake inhibitor, withdrawn from the market.
SCH221510: An experimental dual antagonist of histamine H1 and serotonin 5-HT2A receptors.
CTAP: A peptide that acts as a selective mu-opioid receptor antagonist.
FARUDODSTAT: An investigational inhibitor of purine nucleoside phosphorylase (PNP).
RHC80267: A research chemical that acts as a selective inhibitor of diacylglycerol lipase.
IOX1: An inhibitor of histone demethylases, used in epigenetic research.
MAK683: An investigational inhibitor of EED, a component of the PRC2 complex.
COMPOUND 66 [PMID: 19788238]: A research compound described in the specified scientific publication.
RALIMETINIB: An investigational p38 MAP kinase inhibitor.
JBJ-04-125-02: A research chemical designed to target the LSD1 demethylase.
PP-121: A research chemical that dually inhibits mTOR and VEGFR kinases.
(S)-ARN2508: A research compound, likely an experimental drug candidate.
ASP8477: An investigational research compound from Astellas Pharma.
HM50316: An experimental research compound.
ACETATE: The salt or ester of acetic acid.
BLU-9931: An investigational selective inhibitor of fibroblast growth factor receptor 4 (FGFR4).
BMS-690514: An experimental pan-HER (EGFR, HER2, HER4) and VEGFR kinase inhibitor.
FLT-3 INHIBITOR III: A research chemical that inhibits the FLT3 kinase.
CHMFL-KIT-64: An experimental inhibitor of the KIT kinase.
RIPK1 INHIBITOR 22B: A research chemical that inhibits receptor-interacting protein kinase 1 (RIPK1).
T20(DP178): An HIV fusion inhibitor peptide, also known as enfuvirtide.
ANNEXIN I-(2-26): A peptide fragment of Annexin I with anti-inflammatory properties.
MRK016: An investigational research compound from Merck.
[3H]SYM2081: A radiolabeled kainate receptor agonist used in research.
TEVERELIX: A GnRH antagonist investigated for hormone-related conditions.
5-(N,N-HEXAMETHYLENE)-AMILORIDE: A derivative of amiloride that inhibits the Na+/H+ exchanger.
DENDROASPIS NATRIURETIC PEPTIDE: A peptide toxin from mamba venom with natriuretic properties.
COMPOUND 6O [PMID: 19524438]: A research compound described in the specified scientific publication.
GIVINOSTAT: An experimental histone deacetylase (HDAC) inhibitor.
KA1010: An experimental research compound.
PRACINOSTAT: An experimental histone deacetylase (HDAC) inhibitor.
TMP269: An experimental selective inhibitor of class IIa histone deacetylases (HDACs).
MARTINOSTAT: An investigational histone deacetylase 6 (HDAC6) inhibitor.
RGFP966: An experimental selective inhibitor of histone deacetylase 3 (HDAC3).
9-OH-RISPERIDONE: The active metabolite of the antipsychotic drug risperidone, also known as paliperidone.
CIPROXIFAN: A potent histamine H3 receptor antagonist/inverse agonist.
CYCLIZINE: A first-generation antihistamine used to treat nausea, vomiting, and dizziness.
AMTHAMINE: A selective histamine H2 receptor agonist.
CELIPROLOL: A beta-blocker with vasodilating properties, used for hypertension.
2-(3-BROMOPHENYL)HISTAMINE: A research chemical related to histamine.
RVD1-ME: A methyl ester derivative of Resolvin D1, a specialized pro-resolving mediator.
PROSAPTIDE: A neurotrophic peptide derived from prosaposin.
DIPHENYLENEIODONIUM CHLORIDE: An inhibitor of NADPH oxidase and nitric oxide synthase.
LAURIC ACID: A saturated fatty acid found in coconut oil and palm kernel oil.
O-1602: An abnormal cannabidiol analog that is an agonist of the GPR55 receptor.
COMPOUND 3A [BADOLATO ET AL., 2019]: A research compound described in the specified scientific publication.
NIL: A placeholder, not representing a specific chemical substance.
ARN19702: An experimental inhibitor of fatty acid amide hydrolase (FAAH).
L-TRP-TRP-TRP: A tripeptide consisting of three tryptophan residues.
N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE: A chemical compound used in quorum sensing research.
SANTONIN: A natural organic compound historically used as an anthelmintic.
NOBILETIN: A polymethoxylated flavone found in citrus peels with various biological activities.
SJ988497: An experimental research compound.
LASW1393: An experimental research compound.
CEP-33779: An investigational dual inhibitor of JAK2 and FLT3 kinases.
COMPOUND 1D [PMID: 21493067]: A research compound described in the specified scientific publication.
SPARFLOXACIN: A fluoroquinolone antibiotic.
PROBE 1.1 [PMID: 24187130]: A research chemical probe described in the specified scientific publication.
SR16835: An experimental research compound.
DYNORPHIN B: An endogenous opioid peptide that acts on the kappa-opioid receptor.
NALTRIBEN: A selective delta-opioid receptor antagonist.
NORCLOBAZAM: The active metabolite of the benzodiazepine drug clobazam.
RA-2: An experimental research compound.
HALOFANTRINE: An antimalarial drug.
NC00075159: An identifier for a chemical compound used in research databases.
RETIGABINE DERIVATIVE 10G: A chemical derivative of the anticonvulsant drug retigabine.
COMPOUND 1 [PMID: 22533316]: A research compound described in the specified scientific publication.
RELATLIMAB: A monoclonal antibody that blocks the LAG-3 immune checkpoint for cancer therapy.
LIVMONIPLIMAB: An investigational monoclonal antibody targeting the ICOS receptor for cancer immunotherapy.
COMPOUND 35 [PMID: 22902653]: A research compound described in the specified scientific publication.
DG-051: An experimental inhibitor of leukotriene A4 hydrolase.
COMPOUND 17L [PMID: 26288691]: A research compound described in the specified scientific publication.
BMS-986278: An investigational TYK2 kinase inhibitor.
RN-1: An experimental inhibitor of the PAD4 enzyme.
ANACARDIC ACID: A natural phenolic lipid found in cashew nut shells with various biological activities.
KDM5 INHIBITOR N71: A research chemical that inhibits the KDM5 family of histone demethylases.
MQ1: A research chemical that acts as an activator of the Mcl-1 protein.
THIIC: An experimental research compound.
COMPOUND 25C [PMID: 36649216]: A research compound described in the specified scientific publication.
BOS172722: An investigational inhibitor of the MPS1 kinase for cancer treatment.
G&OUML; 7874: A research chemical that inhibits protein kinase C.
CARBAMOYLCHOLINE: A parasympathomimetic agent that acts as a cholinergic receptor agonist.
TRIPITRAMINE: A selective antagonist of the M2 muscarinic acetylcholine receptor.
VU0467154: A research chemical that is a positive allosteric modulator of the M5 muscarinic receptor.
THIOCHROME: An oxidation product of thiamine (vitamin B1).
AAE-M-PBP-AMINE: A research chemical or probe.
ELUXADOLINE: A mixed mu-opioid receptor agonist and delta-opioid receptor antagonist for irritable bowel syndrome.
UFP-505: An experimental antagonist for the P2X3 receptor.
AZD5904: An experimental myeloperoxidase (MPO) inhibitor.
COMPOUND 17 [PMID: 36111834]: A research compound described in the specified scientific publication.
COMPOUND 25 [PMID: 17935989]: A research compound described in the specified scientific publication.
NSC 780521: An experimental compound from the National Cancer Institute library.
HUWENTOXIN IV: A peptide toxin from spider venom that inhibits sodium channels.
SAXITOXIN: A potent neurotoxin that blocks sodium channels, produced by certain marine organisms.
ATX-II: A sea anemone toxin that modulates sodium channels.
A-867744: An experimental nicotinic acetylcholine receptor agonist.
SAREDUTANT: An experimental neurokinin 2 (NK2) receptor antagonist.
SB 218795: A research chemical that acts as a 5-HT1B receptor antagonist.
RO64-6198: A research chemical that acts as an opioid receptor-like 1 (ORL-1) receptor agonist.
KML110: An experimental research compound.
COMPOUND 15A [PMID: 36642961]: A research compound described in the specified scientific publication.
THIAMET-G: An inhibitor of O-GlcNAcase, used in neurological research.
[125I]THYROXINE: A radiolabeled version of the thyroid hormone thyroxine.
L-368,930: A research chemical that acts as a selective oxytocin receptor antagonist.
PFIZER COMPOUND 11 [PMID:18445527]: A research compound from Pfizer described in the specified publication.
PCA 4248: An experimental inhibitor of platelet-activating factor (PAF).
PERTUSSIS VACCINE: A vaccine for preventing whooping cough.
PACAP-38: A 38-amino acid neuropeptide with widespread effects in the body.
LYS[Z(NO2)]-LYS[Z(NO2)]: A chemically modified dipeptide used in peptide synthesis or research.
AC-[13C,15N]PGP: An isotopically labeled form of the peptide Ac-Pro-Gly-Pro for research.
GW409544: An experimental agonist for the farnesoid X receptor (FXR).
L-764406: A research chemical that acts as a PPAR delta/beta agonist.
AS-252424: An experimental inhibitor of the PI3K gamma isoform.
LENIOLISIB: An inhibitor of phosphoinositide 3-kinase delta (PI3KÎ´) for immunodeficiencies.
DUVELISIB: A dual inhibitor of PI3K-delta and PI3K-gamma used to treat certain cancers.
COMPOUND 52 [PMID: 28541707]: A research compound described in the specified scientific publication.
RV1729: An experimental research compound.
TGX-221: A selective inhibitor of the PI3K beta isoform.
MAVACAMTEN: An inhibitor of cardiac myosin used to treat hypertrophic cardiomyopathy.
LENRISPODUN: An investigational serotonin 5-HT2A receptor inverse agonist.
AZD1208: An investigational inhibitor of the PIM kinase family.
GNF-1331: An experimental research compound.
FURIN INHIBITOR PEPTIDE: A peptide that inhibits furin, a proprotein convertase.
PTHRP-(1-20)/TIP-(23-39) (HUMAN): A hybrid peptide combining parts of two different human peptides.
[ILE5,TRP23]PTHRP-(3-36) (HUMAN): A synthetic analog of parathyroid hormone-related protein.
MITAPIVAT: A pyruvate kinase activator used to treat hemolytic anemia.
7-BIA: A research chemical that is an allosteric modulator of the A1 adenosine receptor.
VPC44116: An experimental antagonist of the S1P1 receptor.
SEW2871: An experimental agonist for the sphingosine-1-phosphate receptor 1 (S1P1).
COMPOUND 43 [PMID: 26751273]: A research compound described in the specified scientific publication.
TGN4: An investigational research compound.
GSK650394: An experimental inhibitor of serum/glucocorticoid-regulated kinase (SGK).
EMPAGLIFLOZIN: An SGLT2 inhibitor used to treat type 2 diabetes.
COMPOUND 4G [PMID: 17709461]: A research compound described in the specified scientific publication.
BIM 23627: A somatostatin receptor agonist analog.
[111IN,90Y]DOTA-LAN: A radiolabeled lanreotide analog for imaging and therapy.
OCTOPAMINE: A biogenic amine structurally related to norepinephrine.
[3H]TYRAMINE: A radiolabeled version of tyramine, a monoamine compound.
VK-2809: An experimental agonist for the thyroid hormone receptor beta.
GSK1795091: An experimental transient receptor potential vanilloid 4 (TRPV4) channel antagonist.
PF-4840154: An experimental inhibitor of stearoyl-CoA desaturase-1 (SCD1).
GSK2833503A: An experimental research compound from GlaxoSmithKline.
OXOGLAUCINE: An aporphine alkaloid with various biological activities.
LYMPHOTOXIN-&ALPHA;: A cytokine involved in the inflammatory response, also known as tumor necrosis factor-beta.
INECALCITOL: An analog of vitamin D investigated for cancer treatment.
N-STEARYL-[NLE17]VIP: A modified form of vasoactive intestinal peptide (VIP).
[125I]PACAP-27: A radiolabeled form of the 27-amino acid PACAP neuropeptide.
PACAP-27: A 27-amino acid neuropeptide with widespread effects in the body.
COMPOUND 20 [PMID: 34432979]: A research compound described in the specified scientific publication.
[LEU31,PRO34]NPY: A modified analog of Neuropeptide Y (NPY).
ONARTUZUMAB: An experimental monoclonal antibody that targets the MET receptor.
FLT3/ABL/AURORA KINASE INHIBITOR KW-2449: An experimental multi-kinase inhibitor.
PI3K/BET INHIBITOR LY294002: A well-known PI3K pathway inhibitor used in research.
QUARFLOXIN: An experimental G-quadruplex-interactive compound for cancer therapy.
PLATINUM COMPOUND: A general term for a class of chemotherapy drugs containing platinum.
NVP-AEW541: An experimental inhibitor of the insulin-like growth factor 1 receptor (IGF-1R).
MDM2 ANTAGONIST RO6839921: An investigational MDM2 inhibitor designed to reactivate p53.
CASPOFUNGIN: An echinocandin antifungal drug.
RIGOSERTIB SODIUM: An experimental multi-kinase inhibitor for cancer therapy.
GDC-0152: An experimental IAP inhibitor designed to induce apoptosis in cancer cells.
GSK2256098: An experimental focal adhesion kinase (FAK) inhibitor.
LY3295668: An experimental research compound from Eli Lilly.
MYELOID CELL LEUKEMIA 1 INHIBITOR PRT1419: An experimental inhibitor of the Mcl-1 anti-apoptotic protein.
ALFATRADIOL: A mild estrogen and 5-alpha-reductase inhibitor used topically for hair loss.
DNA VACCINE: A type of vaccine that uses engineered DNA to induce an immunologic response.
PROCAINAMIDE HYDROCHLORIDE: A class Ia antiarrhythmic agent.
AZD-4877: An experimental inhibitor of polo-like kinase 1 (PLK1).
CICLESONIDE: A corticosteroid used to treat asthma and allergic rhinitis.
ASNUCICLIB: An investigational CDK inhibitor.
CYTOSPORONE B: A natural compound that inhibits the ASK1 signaling pathway.
SCH-23390: A research chemical that acts as a selective dopamine D1 receptor antagonist.
2MESAMP: A research chemical that is an antagonist at glutamate receptors.
[3H]IPEROXO: A radiolabeled antagonist for the M2 muscarinic acetylcholine receptor.
S-15535: A research chemical with partial agonist activity at 5-HT1A receptors.
C2-NPY (PIG): A modified fragment of porcine neuropeptide Y.
TACRINE HYDROCHLORIDE: The salt of tacrine, an acetylcholinesterase inhibitor formerly used for Alzheimer's disease.
SURAMIN HEXASODIUM: An antiparasitic drug also investigated for cancer and other conditions.
SR8185: An experimental research compound.
AZD9056: An experimental P2X7 receptor antagonist.
KHELLIN: A natural compound with vasodilatory and antispasmodic properties.
VU0119498: A research chemical that is a positive allosteric modulator of the D2 dopamine receptor.
UCB-1184197: An experimental research compound from UCB Pharma.
ARFOLITIXORIN: An active metabolite of folinic acid, used in combination with chemotherapy.
PF-3758309: An experimental inhibitor of p21-activated kinase 4 (PAK4).
YM-244769: An experimental research compound.
IMMUNOTHERAPY REGIMEN MKC-1106-MT: An experimental peptide-based cancer vaccine.
NS-49: A research chemical that is a positive allosteric modulator of Î±7 nicotinic receptors.
CDP840: An experimental research compound.
TIPP&PSI;: A peptide that acts as a selective delta-opioid receptor antagonist.
ERLIZUMAB: A monoclonal antibody targeting the CD18 antigen, also known as rhuMAb CD18.
LANIQUIDAR: An experimental P-glycoprotein inhibitor to reverse multidrug resistance.
MAPK13-IN-1: A research chemical that acts as an inhibitor of the p38 delta MAP kinase (MAPK13).
SONEDENOSON: An experimental partial agonist of the A1 adenosine receptor.
IODINE I 124 GIRENTUXIMAB: A radiolabeled antibody targeting carbonic anhydrase IX for PET imaging.
SEOCALCITOL: A vitamin D analog with antiproliferative properties.
MONOMETHYL FUMARATE: The active metabolite of dimethyl fumarate, used to treat multiple sclerosis.
ALDOSTERONE: A steroid hormone that regulates salt and water balance.
CT-1578: An experimental research compound.
BASIMGLURANT: An experimental negative allosteric modulator of the mGlu5 receptor.
DANICAMTIV: An experimental cardiac myosin activator.
2,4-DIHYDROXYBENZOPHENONE: A chemical compound used as a UV absorber in sunscreens.
METIPRANOLOL HYDROCHLORIDE: A non-selective beta-blocker used in eye drops for glaucoma.
ETHYLENEDIAMINE: An organic compound used as a building block in chemical synthesis.
COMPOUND 7F [PMID: 29191554]: A research compound described in the specified scientific publication.
U46619: A synthetic thromboxane A2 receptor agonist used in research.
[LEU31,PRO34]PYY (HUMAN): A modified analog of human Peptide YY (PYY).
ALEXA-488-TELENZEPINE: A fluorescently labeled antagonist of the M1 muscarinic receptor.
COBITOLIMOD: An investigational Toll-like receptor 9 (TLR9) agonist for immunotherapy.
ALPHA-NAPHTHOFLAVONE: A synthetic flavone that acts as an aryl hydrocarbon receptor antagonist.
PI-103: A research chemical that inhibits multiple isoforms of PI3K and mTOR.
SIPOGLITAZAR: An experimental dual PPAR alpha/gamma agonist.
DERSALAZINE: An experimental 5-aminosalicylic acid derivative for inflammatory bowel disease.
4-HYDROXYCYCLOPHOSPHAMIDE: An active metabolite of the chemotherapy drug cyclophosphamide.
SALICYLANILIDE: A class of chemical compounds with various biological activities, including antifungal.
ELBASVIR: An antiviral drug used to treat hepatitis C.
BAZEDOXIFENE ACETATE: The acetate salt of a selective estrogen receptor modulator (SERM).
PEGYLATED RECOMBINANT HUMAN ARGINASE I BCT-100: An experimental enzyme therapy for arginine-dependent cancers.
DEPUDECIN: A natural product that acts as a histone deacetylase (HDAC) inhibitor.
DIETHYLDITHIOCARBAMATE: A metabolite of disulfiram with various biological activities.
I-BRD9: An experimental inhibitor of the bromodomain-containing protein 9 (BRD9).
CIRTUVIVINT: An experimental Wnt pathway inhibitor.
CS+: A research compound, possibly an abbreviation.
JNJ-46281222: An experimental research compound from Johnson & Johnson.
DEXAMETHASONE VALARATE: An ester of the corticosteroid dexamethasone.
IZENCITINIB: An investigational JAK1 inhibitor.
COMPOUND 3 [PMID: 23134120]: A research compound described in the specified scientific publication.
TABIMORELIN: An experimental growth hormone secretagogue.
INSULIN SUSP PROTAMINE ZINC PURIFIED PORK: An intermediate-acting insulin preparation derived from pork.
ANTI-CD19 CAR T-CELLS XLCART001: An investigational CAR T-cell therapy targeting the CD19 protein.
ABBV-744: An experimental inhibitor of the BET family of proteins.
FR190997: An experimental research compound.
DYCLONINE HYDROCHLORIDE: A local anesthetic used in lozenges and sprays.
INCB-047986: An experimental research compound from Incyte Corporation.
EP-217609: An experimental research compound.
BRIMAPITIDE: An experimental melanocortin receptor agonist.
ANG1005: An experimental drug conjugate designed to cross the blood-brain barrier.
TUBULIN INHIBITOR ALB 109564 DIHYDROCHLORIDE: The salt of a research chemical that inhibits tubulin polymerization.
IBIPINABANT: An experimental cannabinoid receptor 1 (CB1) antagonist.
M871: An experimental research compound.
CD2+: A designation for cells expressing the CD2 surface protein, often T cells.
BPR1R024: An experimental research compound.
ANTI-ILT7 ANTIBODY: An antibody targeting the immunoglobulin-like transcript 7 (ILT7) receptor.
ARRY-371797: An investigational p38 MAP kinase inhibitor.
PROPAZINE: A triazine herbicide.
[3H]CGP39653: A radiolabeled antagonist of the NMDA receptor glutamate binding site.
GSK-3BETA INHIBITOR I: A research chemical that inhibits the GSK-3 beta enzyme.
2-AMINOANTHRACENE: A chemical compound classified as a polycyclic aromatic amine.
MULTIVITAMIN: A preparation intended to supplement a diet with vitamins.
PF-4800567: An experimental research compound from Pfizer.
FARNESYL DIPHOSPHATE: An intermediate in the mevalonate pathway, a precursor to sterols.
AMUVATINIB: An experimental multi-kinase inhibitor targeting ABL, c-KIT, and PDGFR.
SONTUZUMAB: An experimental monoclonal antibody targeting an epitope on epithelial cells.
UAMC00039: An experimental research compound.
ANTITHROMBIN ALFA: A recombinant form of human antithrombin used to treat its hereditary deficiency.
VARLILUMAB: An investigational monoclonal antibody that is an agonist for the CD27 receptor.
MINIMISED INSL5 ANALOGUE 7: A synthetic analog of the peptide hormone Insulin-like peptide 5.
QUINAPRIL: An ACE inhibitor used to treat high blood pressure and heart failure.
OLEIC ACID: A monounsaturated omega-9 fatty acid.
BROMPHENIRAMINE MALEATE: A first-generation antihistamine.
BENZPHETAMINE HYDROCHLORIDE: A sympathomimetic amine used as a short-term appetite suppressant.
DAPIPRAZOLE: An alpha-1 adrenergic antagonist used to reverse pupil dilation.
A2P5P: A research chemical, likely a nucleotide analog.
CHF-5074: An experimental gamma-secretase modulator for Alzheimer's disease.
CORIFOLLITROPIN ALFA: A long-acting follicle-stimulating hormone (FSH) analog.
GOLVATINIB: An investigational multi-kinase inhibitor.
CP-609,754: An experimental research compound.
HU7691: An experimental research compound.
COCAINE HYDROCHLORIDE: The salt form of cocaine, a potent CNS stimulant and local anesthetic.
GW810372X: An experimental research compound from GlaxoSmithKline.
DESONIDE: A low-potency topical corticosteroid.
PF-670462: A selective inhibitor of casein kinase 1, used in circadian rhythm research.
COMPOUND NRA 4 [PMID: 25262941]: A research compound described in the specified scientific publication.
TEROXIRONE: An experimental anticancer agent.
SB269970: A selective 5-HT7 receptor antagonist used in research.
PROTEIN KINASE A INHIBITOR: A general term for a substance that blocks the action of protein kinase A.
FG-2216: An experimental hypoxia-inducible factor (HIF) prolyl-hydroxylase inhibitor.
PSEUDOEPHEDRINE: A sympathomimetic drug used as a nasal decongestant.
PXS-4681A: An experimental inhibitor of the lysyl oxidase (LOX) enzyme.
ALSTERPAULLONE 2-CYANOETHYL: A derivative of alsterpaullone, a CDK inhibitor.
FLUCYTOSINE: An antifungal medication.
GARENOXACIN MESYLATE: A quinolone antibiotic.
ARZOXIFENE: An experimental selective estrogen receptor modulator (SERM).
SULFINPYRAZONE: A uricosuric drug used to treat gout.
ETHAMBUTOL HYDROCHLORIDE: An antibiotic used to treat tuberculosis.
NADIFLOXACIN: A topical fluoroquinolone antibiotic.
PEPCAN-12: A research peptide.
A331440: An experimental research compound.
BPKDI: An experimental research compound.
SB-408124: A research chemical that acts as a selective orexin-1 receptor antagonist.
CYNARIN: A phenolic compound found in artichoke with lipid-lowering effects.
NEOSTIGMINE: A cholinesterase inhibitor used to treat myasthenia gravis and reverse neuromuscular blockade.
PYRANTEL PAMOATE: An anthelmintic drug used to treat parasitic worm infections.
PEFICITINIB: An oral Janus kinase (JAK) inhibitor for rheumatoid arthritis.
NGD-8243: An experimental mGluR5 negative allosteric modulator.
PHENETHYL ISOCYANATE: A compound in cruciferous vegetables with potential anticancer properties.
OMEGA-CHLOROACETOPHENONE: A chemical compound used as a tear gas agent.
NF-KAPPAB DECOY: A synthetic oligonucleotide designed to inhibit NF-ÎºB activity.
FMET-ILE-PHE-LEU: A synthetic peptide related to fMLP, a bacterial chemoattractant.
PSB-0739: A selective antagonist of the A2B adenosine receptor.
SCH 58261: A selective A2A adenosine receptor antagonist.
NAPROXCINOD: An experimental cyclooxygenase-inhibiting nitric oxide-donating anti-inflammatory drug.
SALAGEN: The brand name for pilocarpine, used to treat dry mouth and glaucoma.
KISSPEPTIN-10: The C-terminal decapeptide of kisspeptin, a key regulator of reproduction.
BATOCLIMAB: An investigational monoclonal antibody targeting the neonatal Fc receptor (FcRn).
X-165: An experimental research compound.
COMPOUND 33 [PMID: 19364658]: A research compound described in the specified scientific publication.
[3H]2-DEOXYGLUCOSE: A radiolabeled glucose analog used in metabolic and imaging studies.
PHYSOSTIGMINE: A cholinesterase inhibitor used to treat glaucoma and anticholinergic toxicity.
PANOBINOSTAT LACTATE: The salt of panobinostat, a histone deacetylase (HDAC) inhibitor for multiple myeloma.
EZATIOSTAT: An experimental glutathione S-transferase P1-1 inhibitor.
NPS(1-4)NH2: A fragment of the neuropeptide S.
FORODESINE: An inhibitor of purine nucleoside phosphorylase (PNP) for T-cell malignancies.
SPERMINE: A polyamine involved in cellular metabolism.
ANTI-CD30 CAR T CELLS PREPARATION: A type of CAR T-cell therapy targeting the CD30 protein.
OLOCROLIMUS: An experimental immunosuppressant of the macrolide class.
EMETINE HYDROCHLORIDE: The salt of an alkaloid formerly used as an emetic and to treat amebiasis.
CENDAKIMAB: An investigational monoclonal antibody that targets interleukin-13 (IL-13).
TRANYLCYPROMINE: A monoamine oxidase inhibitor (MAOI) used as an antidepressant.
2-O, 3-O DESULFATED HEPARIN: A modified form of heparin with reduced anticoagulant activity.
SEMZUVOLIMAB: An investigational monoclonal antibody targeting the CD27 immune receptor.
KEPONE: An organochlorine compound, also known as chlordecone, formerly used as a pesticide.
ESTETROL: A natural estrogen produced by the human fetal liver.
METHYLHOMATROPINE: An anticholinergic agent, a derivative of homatropine.
SS-208: An experimental research compound.
COMPOUND 108 [PMID: 37918435]: A research compound described in the specified scientific publication.
HYPERICIN: A natural napthodianthrone found in St. John's wort with photosensitizing properties.
THERAPEUTIC GONADOTROPIN: A class of hormones used in fertility treatments to stimulate the gonads.
RG-7602: An investigational compound developed for research purposes.
POSIPHEN: An experimental stereoisomer of phenserine investigated for Alzheimer's disease.
IOX2: An inhibitor of hypoxia-inducible factor (HIF) prolyl-hydroxylases used in research.
BI-3406: An experimental inhibitor of the KRAS-SOS1 protein-protein interaction for cancer therapy.
ACET: An abbreviation for a research compound or chemical group.
135PAM1: An experimental positive allosteric modulator research compound.
GALLIC ACID METHYL ESTER: The methyl ester of gallic acid, a phenolic compound.
CYCLOPENTYL PALMITATE: An ester of cyclopentanol and palmitic acid, used in cosmetics.
BUDIODARONE: An investigational amiodarone analog with antiarrhythmic properties.
COMPOUND 13B [PMID: 19101153]: A research compound described in the specified scientific publication.
SAPROPTERIN DIHYDROCHLORIDE: A synthetic form of tetrahydrobiopterin(BH4) used to treat phenylketonuria (PKU).
FLUPAROXAN: A research chemical that acts as a selective alpha-2 adrenergic receptor antagonist.
ALCURONIUM: A non-depolarizing neuromuscular blocking agent.
STRONTIUM RANELATE: A drug used to treat osteoporosis by promoting bone formation and reducing resorption.
BETAINE HYDROCHLORIDE: The hydrochloride salt of betaine, used as a digestive aid.
COMPOUND 12D [PMID: 33821636]: A research compound described in the specified scientific publication.
TUNLAMETINIB: An investigational dual MEK/RAF kinase inhibitor.
COMPOUND 40 [PMID: 34982553]: A research compound described in the specified scientific publication.
PHYTOSTEROL: A group of steroid alcohols naturally occurring in plants.
MSC-2364447: An experimental research compound.
AMPKINONE: A class of compounds that activate AMP-activated protein kinase (AMPK).
DOMIPHEN BROMIDE: An antiseptic and disinfectant agent.
TETRODOTOXIN: A potent neurotoxin found in pufferfish that blocks voltage-gated sodium channels.
DIPYRIDYL: A class of bidentate chelating ligands, such as 2,2'-bipyridine.
PANCURONIUM: A long-acting non-depolarizing neuromuscular blocking agent.
FAMITINIB: An investigational multi-kinase inhibitor targeting VEGFR2, c-Kit, and PDGFR.
MIBEFRADIL DIHYDROCHLORIDE: The salt of mibefradil, a T-type calcium channel blocker withdrawn from the market.
ARANIDIPINE: A dihydropyridine calcium channel blocker used as an antihypertensive.
CEE321: An experimental research compound.
ELEZANUMAB: An investigational monoclonal antibody that targets repulsive guidance molecule A (RGMa).
REVEGLUCOSIDASE ALFA: An enzyme replacement therapy for Pompe disease.
BROMFENAC SODIUM: The salt of bromfenac, a non-steroidal anti-inflammatory drug (NSAID) used as an eye drop.
PP1: A research chemical that is a selective inhibitor of Src family kinases.
AZD8108: An investigational compound from AstraZeneca for research purposes.
RUSALATIDE: An experimental peptide designed to promote bone fracture healing.
AZD1283: An experimental P2Y12 receptor antagonist.
ML323: A research chemical that inhibits the deubiquitinating enzyme USP1.
[11C]GLYSAR: A radiolabeled tracer used for PET imaging of the glycine transporter 1 (GlyT1).
DEOXYCYTIDINE: A deoxyribonucleoside, a component of DNA.
TRIMEPRAZINE TARTRATE: The salt of trimeprazine, a first-generation antihistamine with sedative properties.
TRIPELENNAMINE CITRATE: The salt of tripelennamine, a first-generation antihistamine.
TRIMIPRAMINE MALEATE: The salt of trimipramine, a tricyclic antidepressant.
SECRETIN SYNTHETIC PORCINE: A synthetic version of porcine secretin, a hormone that stimulates pancreatic secretion.
INSULIN ZINC SUSP EXTENDED PURIFIED BEEF: A long-acting insulin preparation derived from beef.
INSULIN SUSP ISOPHANE BEEF/PORK: An intermediate-acting NPH insulin derived from a beef/pork mixture.
INSULIN ZINC SUSP PURIFIED BEEF: An insulin preparation of mixed-acting duration derived from beef.
DESOXYCORTICOSTERONE PIVALATE: A long-acting mineralocorticoid used in veterinary medicine.
AMBENONIUM CHLORIDE: A cholinesterase inhibitor used to treat myasthenia gravis.
PARAMETHASONE ACETATE: The acetate ester of paramethasone, a synthetic glucocorticoid.
ABCIXIMAB: A monoclonal antibody fragment that inhibits platelet aggregation by blocking the GPIIb/IIIa receptor.
ESTROGENS, ESTERIFIED (USP): A mixture of esterified estrogens, primarily estrone sulfate.
RAUWOLFIA SERPENTINA (USP): A powdered whole root from the plant Rauwolfia serpentina, containing reserpine.
PARGYLINE HYDROCHLORIDE: The salt of pargyline, a MAO-B inhibitor formerly used as an antihypertensive.
PHENELZINE SULFATE: The salt of phenelzine, a monoamine oxidase inhibitor (MAOI) used as an antidepressant.
IDURSULFASE: An enzyme replacement therapy for Hunter syndrome (MPS II).
DILTIAZEM MALATE: The malate salt of diltiazem, a calcium channel blocker.
RIVASTIGMINE TARTRATE: The salt of rivastigmine, a cholinesterase inhibitor for Alzheimer's and Parkinson's dementia.
BITOLTEROL MESYLATE: The salt of bitolterol, a short-acting beta-2 adrenergic agonist.
TESTOSTERONE ENANTHATE: A long-acting injectable ester of testosterone.
FOSAMPRENAVIR: A prodrug of amprenavir, an HIV protease inhibitor.
RAPACURONIUM BROMIDE: A rapid-onset, short-acting neuromuscular blocker, withdrawn from the market.
ATRACURIUM BESYLATE: An intermediate-acting non-depolarizing neuromuscular blocking agent.
CLORAZEPATE DIPOTASSIUM: The salt of clorazepate, a benzodiazepine prodrug used for anxiety and seizures.
METHYPRYLON: A sedative and hypnotic drug of the piperidinedione class.
ENFUVIRTIDE: An HIV fusion inhibitor used in combination antiretroviral therapy.
DIETHYLPROPION: A sympathomimetic amine used as a short-term appetite suppressant.
FINGOLIMOD HYDROCHLORIDE: The salt of fingolimod, a sphingosine-1-phosphate receptor modulator for multiple sclerosis.
GEMIFLOXACIN MESYLATE: The salt of gemifloxacin, a fluoroquinolone antibiotic.
ENMD-981693: An experimental multi-kinase inhibitor.
4SC-203: An experimental dual inhibitor of LSD1 and HDACs.
AZD-1208: An investigational inhibitor of the PIM kinase family.
CE-245677: An experimental corticotropin-releasing factor 1 (CRF1) receptor antagonist.
MK-6592: An experimental research compound from Merck.
INDEGLITAZAR: An experimental dual PPAR alpha/gamma agonist.
DRF-10945: An experimental research compound.
AEE-788: An experimental dual inhibitor of EGFR and VEGFR tyrosine kinases.
EPINASTINE: An antihistamine and mast cell stabilizer, used as an eye drop.
JI-101: An experimental multi-kinase inhibitor targeting IGF-1R, IR, and VEGFR.
R-112: An experimental research compound.
PG-760564: An experimental research compound.
ENCAINIDE: A class Ic antiarrhythmic agent, withdrawn from the market.
XL-281: An experimental RAF kinase inhibitor.
VABICASERIN HYDROCHLORIDE: The salt of vabicaserin, an experimental 5-HT2C receptor agonist.
LY377604: An experimental research compound from Eli Lilly.
DECOGLURANT: An experimental mGlu2/3 receptor antagonist.
CENICRIVIROC: An investigational dual CCR2/CCR5 antagonist for liver fibrosis and HIV.
LY2624803: An experimental monoclonal antibody.
IMIGLITAZAR: An experimental PPAR gamma agonist.
ASOPRISNIL: An experimental selective progesterone receptor modulator.
CANERTINIB DIHYDROCHLORIDE: The salt of canertinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor.
BEVACIZUMAB 111IN: An indium-111 radiolabeled form of bevacizumab for imaging.
BERUBICIN HYDROCHLORIDE: The salt of berubicin, an experimental anthracycline that may cross the blood-brain barrier.
EZATIOSTAT HYDROCHLORIDE: The salt of ezatiostat, an experimental glutathione S-transferase P1-1 inhibitor.
NAPROXEN ETEMESIL: An experimental prodrug of naproxen.
MIFAMURTIDE: An immunomodulator used as an adjuvant therapy for osteosarcoma.
MOXONIDINE: A centrally acting antihypertensive agent that is an imidazoline receptor agonist.
HUHMFG1: An investigational monoclonal antibody.
ANRUKINZUMAB: An investigational monoclonal antibody that targets interleukin-13 (IL-13).
ASELIZUMAB: An investigational monoclonal antibody targeting the LFA-1 integrin.
BHQ-880: An experimental antibody that targets DKK1 for cancer therapy.
OXELUMAB: An investigational monoclonal antibody.
BRAZIKUMAB: An investigational monoclonal antibody targeting the IL-23 p19 subunit.
ATINUMAB: An investigational monoclonal antibody targeting RANKL.
BISMUTH SUBGALLATE: A bismuth compound used as an internal deodorant and astringent.
DICHLOROBENZYL ALCOHOL: An antiseptic agent used in throat lozenges.
NETARSUDIL DIMESYLATE: The salt of netarsudil, a Rho kinase inhibitor used to treat glaucoma.
VILOBELIMAB: An investigational monoclonal antibody that targets the C5a complement component.
HEFI-1: An experimental research compound.
PROPIOMAZINE: A first-generation antihistamine with sedative properties.
AFAMELANOTIDE ACETATE: The salt of afamelanotide, a synthetic analog of alpha-melanocyte-stimulating hormone.
MICROPARTICLE MDP/BACTERIAL DNA-CONTAINING MIS416: An experimental microparticle-based vaccine adjuvant.
RAMOSETRON HYDROCHLORIDE: The salt of ramosetron, a 5-HT3 receptor antagonist for irritable bowel syndrome.
PEMAFIBRATE: A selective PPAR alpha modulator for treating dyslipidemia.
FADROZOLE HYDROCHLORIDE: The salt of fadrozole, a non-steroidal aromatase inhibitor.
EPOETIN THETA: A recombinant form of human erythropoietin.
LIPROTAMASE: A non-porcine pancreatic enzyme replacement therapy.
DOTINURAD: A selective uric acid reabsorption inhibitor for gout.
SINTILIMAB: A monoclonal antibody that targets the PD-1 immune checkpoint for cancer therapy.
CE-326597: An experimental research compound.
NOMACOPAN: An investigational protein that inhibits both C5 and leukotriene B4.
TAK-653: An investigational AMPA receptor positive allosteric modulator.
SELGANTOLIMOD: An investigational Toll-like receptor 8 (TLR8) agonist.
IANALUMAB: An investigational monoclonal antibody that targets the BAFF receptor.
TAVAPADON: An investigational partial agonist of the dopamine D1 and D5 receptors.
PARSACLISIB: An investigational PI3K delta inhibitor.
CDX-301: Recombinant human Flt3 ligand, an agent to mobilize hematopoietic stem cells.
TRILACICLIB DIHYDROCHLORIDE: The salt of trilaciclib, a transient CDK4/6 inhibitor to protect bone marrow during chemotherapy.
DS-1001B: An investigational compound for treating brain tumors.
RENZAPRIDE: An experimental 5-HT4 agonist and 5-HT3 antagonist for gastrointestinal disorders.
EFPEGLENATIDE: An investigational long-acting GLP-1 receptor agonist.
EFEPOETIN ALFA: A long-acting erythropoiesis-stimulating agent.
TIBULIZUMAB: An investigational monoclonal antibody.
TARLOXOTINIB: An experimental prodrug of a pan-ErbB inhibitor.
RIPASUDIL HYDROCHLORIDE DIHYDRATE: The hydrated salt of ripasudil, a Rho kinase inhibitor for glaucoma.
BRIMAPITIDE, C-TERMINAL ACID: A variant of the experimental drug brimapitide.
AL-12182: An experimental research compound.
NS-2359: A research chemical that acts as a triple reuptake inhibitor.
OBEXELIMAB: An investigational monoclonal antibody targeting CD19.
EFLAPEGRASTIM: A long-acting granulocyte colony-stimulating factor (G-CSF).
KN-026: An investigational bispecific antibody targeting HER2.
MESDOPETAM: An investigational dopamine D3 receptor antagonist for Parkinson's disease.
MITAPIVAT SULFATE: The sulfate salt of mitapivat, a pyruvate kinase activator.
COSFROVIXIMAB: An investigational monoclonal antibody.
CLESACOSTAT: An experimental acetyl-CoA carboxylase inhibitor.
DIMETHYLCURCUMIN: A synthetic analog of curcumin with improved stability.
OMBRABULIN: An experimental vascular-disrupting agent for cancer therapy.
MOBOCERTINIB SUCCINATE: The salt of mobocertinib, an EGFR kinase inhibitor for non-small cell lung cancer.
ANTI-ERBB3 MONOCLONAL ANTIBODY REGN1400: An experimental monoclonal antibody targeting the HER3/ErbB3 receptor.
CMX-2043: An experimental neuroprotective agent.
MITIPERSTAT: An investigational myeloperoxidase inhibitor.
FUSARIC ACID: A natural mycotoxin that inhibits dopamine beta-hydroxylase.
DINOTERB: A dinitrophenol herbicide.
URB597: A research chemical that acts as a selective inhibitor of fatty acid amide hydrolase (FAAH).
CAVROTOLIMOD: An investigational Toll-like receptor 9 (TLR9) agonist.
DICHLOROTRIPHENYLBISMUTHANE: An organobismuth compound.
BTK INHIBITOR DTRMWXHS-12: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
COTI-2: An experimental agent that targets p53 for cancer therapy.
MOFEBUTAZONE: A non-steroidal anti-inflammatory drug (NSAID).
3,4-DIDESMETHYL-5-DESHYDROXY-3'-ETHOXYSCLEROIN: A complex organic research chemical.
3',4'-DIMETHOXYFLAVONE: A natural polymethoxylated flavone.
HALAZONE: A chlorine-releasing compound used for water disinfection.
DIOSMETIN: A natural O-methylated flavone found in citrus fruits.
ROGARATINIB: An investigational pan-fibroblast growth factor receptor (FGFR) inhibitor.
LOMETREXOL: An antifolate agent that inhibits glycinamide ribonucleotide formyltransferase.
EUFLAVINE: An antiseptic agent, a component of acriflavine.
CETUXIMAB SAROTALOCAN SODIUM: An antibody-photosensitizer conjugate for photodynamic therapy.
TRIMETHYL-[3-(TETRADECANE-1-SULFONYLAMINO)-PROPYL]-AMMONIUM IODIDE: A complex organic research chemical.
CURCUMIN/DOXORUBICIN-ENCAPSULATING NANOPARTICLE IMX-110: An experimental cancer therapy delivering two agents in a nanoparticle.
PHOMOPSIN A: A potent mycotoxin that inhibits microtubule assembly.
TEBUCONAZOLE: A triazole fungicide.
XANTHOXYLIN: A natural lignan with various biological activities.
VEGF/HGF-TARGETING DARPIN MP0250: An experimental protein targeting VEGF and HGF for cancer therapy.
GW642138X: An experimental research compound from GlaxoSmithKline.
SIROLIMUS ALBUMIN-BOUND NANOPARTICLES: An albumin-bound nanoparticle formulation of sirolimus (rapamycin).
CALCIMYCIN: An ionophore antibiotic also known as A23187.
SEP-363856: An experimental antipsychotic agent that acts on TAAR1 and 5-HT1A receptors.
CONICASTEROL E: A sterol isolated from a marine sponge.
BUTACLAMOL HYDROCHloride: The salt of butaclamol, a research antipsychotic that acts as a dopamine antagonist.
EFINOPEGDUTIDE: An investigational dual GLP-1/glucagon receptor agonist.
NORDEFRIN: A sympathomimetic amine used as a vasoconstrictor in local anesthetics.
3,3'-DIFLUOROBENZALDAZINE: A chemical intermediate.
MAHANINE: A natural carbazole alkaloid with potential anticancer activity.
BLESELUMAB: An investigational monoclonal antibody that targets CADM1.
TRIADIMENOL: A triazole fungicide.
GW561436X: An experimental research compound from GlaxoSmithKline.
METHOCARBAMOL: A centrally acting skeletal muscle relaxant.
NEOPETROFORMYNE A: A natural product isolated from a marine sponge.
FIDUXOSIN HYDROCHloride: The salt of fiduxosin, an experimental alpha-1a/d adrenergic receptor antagonist.
PEGMUSIRUDIN: A pegylated form of musirudin, a direct thrombin inhibitor.
ZOXAZOLAMINE: A muscle relaxant and uricosuric agent, withdrawn due to hepatotoxicity.
ERYTHROSINE: A red food dye.
JNJ16259685: An experimental mGlu1 receptor negative allosteric modulator.
TRICLABENDAZOLE: An anthelmintic drug used to treat fascioliasis.
3,4-DICHLOROBENZAMIL: A derivative of amiloride that blocks the Na+/Ca2+ exchanger.
TRIPHENYLSTANNANOL: An organotin compound with fungicidal properties.
PIROMELATINE: An investigational agonist for melatonin and serotonin receptors.
INDINAVIR: An HIV protease inhibitor.
BUTYRYLHYDROXAMIC ACID: A short-chain fatty acid derivative.
QUINALIZARIN: A dye and inhibitor of protein kinase CK2.
BETAINE ALDEHYDE CHLORIDE: The chloride salt of betaine aldehyde, a metabolic intermediate.
ASARININ: A lignan found in various plants.
PF-00337210: An experimental research compound from Pfizer.
SCHISANHENOL: A lignan isolated from Schisandra sphenanthera.
TIPLIMOTIDE: An investigational Toll-like receptor 1/2 agonist.
PECTOLINARIGENIN: A natural O-methylated flavone.
GSK-1030061A: An experimental research compound from GlaxoSmithKline.
4-CHLORO-BENZOIC ACID: A chlorinated derivative of benzoic acid.
PROTRIPTYLINE HYDROCHLORIDE: The salt of protriptyline, a tricyclic antidepressant.
HARMOL: A fluorescent beta-carboline alkaloid.
DIFLUFENICAN: A pyridinecarboxamide herbicide.
CUCURBITACIN B: A toxic triterpenoid found in plants of the gourd family.
OXYFLUORFEN: A diphenyl ether herbicide.
DESACETOXYMATRICARIN: A natural sesquiterpene lactone.
DITHIOLETHIONE: A class of organosulfur compounds with chemopreventive properties.
6BIO: A research chemical that is an inhibitor of GSK-3.
BITERTANOL: A triazole fungicide.
TERLAKIREN: An experimental renin inhibitor.
TALAROFLAVONE: An experimental research compound.
TAK-220: An experimental CCR5 antagonist.
2,4-HEXADIENAL: A volatile organic compound and food flavorant.
LEVOMEPROMAZINE MALEATE: The salt of levomepromazine, a typical antipsychotic of the phenothiazine class.
RACEPINEPHRINE HYDROCHLORIDE: The salt of a racemic mixture of epinephrine isomers, used as a bronchodilator.
FIPRONIL: A broad-spectrum phenylpyrazole insecticide.
DIETHYLCARBAMAZINE CITRATE: The salt of diethylcarbamazine, an anthelmintic for filarial infections.
TIOPRONIN: A thiol drug used to prevent kidney stones.
CALCIUM PANTOTHENATE: The calcium salt of pantothenic acid (Vitamin B5).
TETRADIFON: An organochlorine acaricide (miticide).
UMESPIRONE: An anxiolytic agent of the azapirone class.
AMINOQUINOL: An experimental research compound.
PAC1: An activator of procaspase-3, investigated for cancer therapy.
RETUSIN 7-METHYL ETHER: A polymethoxylated flavone.
AMI-1: A research chemical that inhibits protein arginine methyltransferases.
CLOROPHENE: An antiseptic and disinfectant.
PROPICONAZOLE: A triazole fungicide.
HAPLAMINE: A natural alkaloid.
2-MERCAPTOBENZIMIDAZOLE: An antioxidant and rubber chemical.
SALERMIDE: A research chemical that is an antagonist of sirtuin enzymes.
QUINOXYFEN: A quinoline fungicide.
ETOCRYLENE: A UV absorber used in sunscreens and plastics.
LAWSONE: A red-orange dye molecule present in the leaves of the henna plant.
DICHLORISONE ACETATE: The acetate ester of dichlorisone, a topical corticosteroid.
OLEANDEROLIDE: A cardiac glycoside found in the oleander plant.
PORFIROMYCIN: An antibiotic and alkylating agent, an analog of mitomycin C.
ARECOLINE HYDROBROMIDE: The salt of arecoline, a nicotinic acetylcholine receptor agonist found in the areca nut.
DICHLORODIMETHYLSTANNANE: An organotin compound.
NITROSCANATE: An anthelmintic drug used in veterinary medicine.
TRIPHENYLSTANNYL ACETATE: An organotin compound formerly used as a fungicide and molluscicide.
DINOSEB: A dinitrophenol herbicide, now banned in many countries.
THIOGUANOSINE: A thio-analog of the nucleoside guanosine.
ISATIN: An indole derivative with a wide range of biological activities.
CGP53353: A research chemical that acts as a GABA-B receptor antagonist.
TRIOXSALEN: A psoralen derivative used in PUVA therapy for vitiligo and psoriasis.
PYRROLNITRIN: An antifungal antibiotic produced by some bacteria.
BERBERRUBINE: A protoberberine alkaloid, a derivative of berberine.
KOLAVENIC ACID: A natural diterpene.
TRICYCLAZOLE: A systemic fungicide used for rice blast disease.
EPIANDROSTERONE: A steroid prohormone, an isomer of androsterone.
CYTARABINE HYDROCHLORIDE: The salt of cytarabine, a chemotherapy agent used mainly for hematological cancers.
OCTADECYLAMINE: An 18-carbon primary alkyl amine.
DYRENE: A triazine fungicide.
NALED: An organophosphate insecticide and acaricide.
PHENOL: An aromatic organic compound, also known as carbolic acid.
DIFENOCONAZOLE: A broad-spectrum triazole fungicide.
NORARMEPAVINE: A benzylisoquinoline alkaloid.
BEXLOSTERIDE: An experimental 5-alpha-reductase inhibitor.
LAS38096: An experimental research compound.
TETRAHYDROGAMBOGIC ACID: A derivative of gambogic acid.
BENSERAZIDE HYDROCHLORIDE: The salt of benserazide, a DOPA decarboxylase inhibitor used with L-DOPA for Parkinson's disease.
DIELDRIN: An organochloride insecticide, now banned in most of the world.
GEOPYXIN A: A natural product with antifungal activity.
LXR-623: An experimental liver X receptor (LXR) agonist.
METHYL PARATHIONE: A highly toxic organophosphate insecticide.
AMIDATE: An investigational anesthetic agent.
BOLDINE: The main alkaloid of the boldo tree, with antioxidant and anti-inflammatory properties.
CARISOPRODOL: A centrally acting skeletal muscle relaxant.
DINUTUXIMAB: A monoclonal antibody that targets GD2, used to treat neuroblastoma.
DULANERMIN: Recombinant human Apo2L/TRAIL, an experimental agent to induce apoptosis in cancer cells.
ANTI-ERBB3 MONOCLONAL ANTIBODY AV-203: An experimental monoclonal antibody targeting the HER3/ErbB3 receptor.
GANCICLOVIR: An antiviral medication used to treat cytomegalovirus infections.
GSK269962A: An experimental Rho-associated kinase (ROCK) inhibitor.
ENVIRONMENTAL ESTROGEN: A general term for synthetic chemicals that mimic estrogen in the body.
RADIOSENSITIZING AGENT: A class of drugs that make tumor cells more sensitive to radiation therapy.
POLY ICLC: A synthetic complex of polyriboinosinic-polyribocytidylic acid, an immune modulator.
ENZYME INHIBITOR: A general term for a molecule that binds to an enzyme and decreases its activity.
CEPHALOSPORIN ANTIBIOTIC: A class of beta-lactam antibiotics.
CIZOLIRTINE: An experimental analgesic.
OXITROPIUM BROMIDE: An anticholinergic bronchodilator.
RECOMBINANT INTERLEUKIN: A genetically engineered version of an interleukin cytokine.
RECOMBINANT LYMPHOTOXIN BETA: A genetically engineered form of the lymphotoxin-beta cytokine.
BENZODIAZEPINE: A class of psychoactive drugs used as sedatives, anxiolytics, and anticonvulsants.
SQUALAMINE: An aminosterol antibiotic with broad-spectrum activity.
TRAPIDIL: A vasodilator and antiplatelet agent.
RECOMBINANT TYROSINASE-RELATED PROTEIN-2: A genetically engineered melanoma-associated antigen for vaccine research.
MART-1 ANTIGEN: A protein found on melanocytes, used as a target in melanoma immunotherapy.
IL-13: Interleukin-13, a cytokine involved in allergic inflammation.
NALFURAFINE HYDROCHLORIDE: The salt of nalfurafine, a selective kappa-opioid receptor agonist for uremic pruritus.
NABILONE: A synthetic cannabinoid used as an antiemetic and neuropathic pain analgesic.
PSMA PEPTIDE: A peptide that binds to prostate-specific membrane antigen (PSMA), used for imaging and therapy.
TOPOISOMERASE INHIBITOR: A class of chemotherapy drugs that interfere with topoisomerase enzymes.
PI3K INHIBITOR BGT226: An experimental dual pan-PI3K and mTOR inhibitor.
PF-03463275: An experimental research compound from Pfizer.
VITAMIN D: A group of fat-soluble secosteroids essential for calcium homeostasis.
CL 246738: An experimental research compound.
ANTI-HIV-1 LENTIVIRAL VECTOR-EXPRESSING SH5/C46 CAL-1: An experimental gene therapy approach for HIV.
MLN-591RL: An experimental radio-labeled antibody.
HMG-COA REDUCTASE INHIBITOR: A class of lipid-lowering drugs, commonly known as statins.
EMICIZUMAB: A bispecific monoclonal antibody for treating hemophilia A.
RECOMBINANT VACCINIA-B7.1 VACCINE: An experimental cancer vaccine using a modified vaccinia virus.
TEPOXALIN: An NSAID with dual COX/LOX inhibitory activity.
DB959: An experimental research compound.
TOPOISOMERASE-II INHIBITOR: A class of chemotherapy drugs that target topoisomerase II.
BIOMED 101: An experimental research compound.
AVALGLUCOSIDASE ALFA: A second-generation enzyme replacement therapy for Pompe disease.
ESTRAMUSTINE PHOSPHATE: A combination of nitrogen mustard and estradiol used in prostate cancer therapy.
HER2 ECD+TM VIRUS-LIKE REPLICON PARTICLES VACCINE AVX901: An experimental cancer vaccine targeting HER2.
MITOMYCIN C ANALOG KW-2149: An experimental analog of the anticancer drug mitomycin C.
ALKAVERVIR: A mixture of veratrum alkaloids formerly used as an antihypertensive.
LIATERMIN: Recombinant human neurotrophin-3.
INCLISIRAN: A small interfering RNA (siRNA) that lowers LDL cholesterol.
OXICONAZOLE: An azole antifungal medication.
PRUVANSERIN: An experimental selective 5-HT2A receptor inverse agonist.
SURONACRINE MALEATE: The salt of suronacrine, an experimental cholinesterase inhibitor.
VOXILAPREVIR: A protease inhibitor used to treat hepatitis C.
APIXABAN: An anticoagulant that acts as a direct factor Xa inhibitor.
AS03-ADJUVANTED H1N1 PANDEMIC INFLUENZA VACCINE: An influenza vaccine containing the AS03 adjuvant system.
SOLITHROMYCIN: An investigational macrolide antibiotic.
EPROSARTAN: An angiotensin II receptor blocker (ARB) used to treat high blood pressure.
PRIFINIUM: An anticholinergic drug used to treat gastrointestinal spasms.
NITROPRUSSIDE: A potent vasodilator used to treat hypertensive crises.
CERGUTUZUMAB AMUNALEUKIN: An immunocytokine combining an anti-CEA antibody with interleukin-2.
APRATASTAT: An experimental inhibitor of leukotriene A4 hydrolase.
PIVALOYLOXYMETHYLBUTYRATE: A prodrug of butyrate.
MANNOSE 6-PHOSPHATE: A phosphorylated mannose sugar involved in protein targeting.
SEPANTRONIUM BROMIDE: An experimental selective survivin suppressant.
B27PD: A research compound.
BF-1: An experimental research compound.
CER-001: An experimental therapy designed to mimic pre-beta HDL.
DG041: An experimental EP3 receptor antagonist for thrombosis.
DIMIRACETAM: An experimental nootropic agent of the racetam class.
LATREPIRDINE: An experimental antihistamine investigated for neurodegenerative diseases.
PEGINESATIDE: A pegylated peptide-based erythropoiesis-stimulating agent.
ILEPATRIL: An experimental vasopeptidase inhibitor.
SAMPATRILAT: The active metabolite of an experimental vasopeptidase inhibitor.
CILNIDIPINE: A dual L-type and N-type calcium channel blocker used as an antihypertensive.
DECTREKUMAB: An investigational monoclonal antibody that targets semaphorin 4D.
VORSETUZUMAB: An experimental monoclonal antibody targeting CD70.
ORG 12962: The active metabolite of the antidepressant mirtazapine.
STANNSOPORFIN: An experimental inhibitor of heme oxygenase.
BRL-15572: A research chemical that is a selective 5-HT1D receptor antagonist.
LY215840: An experimental research compound from Eli Lilly.
GLEMANSERIN: An experimental 5-HT2A receptor antagonist.
TIOTROPIUM: A long-acting muscarinic antagonist used as a bronchodilator for COPD.
ANTI-HUMAN GITR MONOCLONAL ANTIBODY TRX518: An experimental agonist antibody targeting the GITR immune checkpoint.
[125I]DOI: A radiolabeled version of DOI, a 5-HT2A/2C receptor agonist.
[3H]8-OH-DPAT: A radiolabeled 5-HT1A receptor agonist used in research.
LORCASERIN: A serotonin 5-HT2C receptor agonist formerly used for weight loss.
BENTIROMIDE: A diagnostic agent used for testing pancreatic function.
CAPESEROD: An experimental 5-HT4 receptor partial agonist.
PHENMETRAZINE: A stimulant drug of the morpholine class, formerly used as an appetite suppressant.
COMPOUND 14 [PMID: 30925062]: A research compound described in the specified scientific publication.
ZOSUQUIDAR: An experimental P-glycoprotein inhibitor to reverse multidrug resistance.
ZILURGISERTIB: An investigational LRRK2 kinase inhibitor.
FIDRISERTIB: An investigational PLK4 kinase inhibitor.
RANIBIZUMAB: A monoclonal antibody fragment that inhibits VEGF-A, used for wet age-related macular degeneration.
IRUPLINALKIB: An investigational ALK/ROS1 kinase inhibitor.
ABX-1431: An experimental cannabinoid CB2 receptor agonist.
[125I]HEAT (BE2254): A radiolabeled alpha-1 adrenergic receptor antagonist.
DWP05195: An experimental research compound.
SEVITERONEL: An investigational inhibitor of CYP17A1 and androgen receptor antagonist.
NAVICIXIZUMAB: An investigational bispecific antibody targeting DLL4 and VEGF.
JP1302: An experimental research compound.
VILOXAZINE HYDROCHLORIDE: The salt of viloxazine, a norepinephrine reuptake inhibitor for ADHD.
RX821002: A research chemical that is a selective alpha-2 adrenergic receptor antagonist.
GNE-0877: An experimental brain-penetrant LRRK2 inhibitor.
INARIGIVIR SOPROXIL: An investigational RIG-I agonist prodrug for viral infections.
HLA-A*0201 RESTRICTED TERT(572Y)/TERT(572) PEPTIDES VACCINE VX-001: An experimental peptide vaccine for cancer.
PMX53: A research chemical that is a C5a receptor antagonist.
DULIGOTUZUMAB: An experimental bispecific antibody targeting EGFR and HER3.
AUTOLOGOUS BONE MARROW-DERIVED CD34/CXCR4-POSITIVE STEM CELLS AMR-001: An investigational autologous stem cell therapy.
N,N`-BIS-ALKYL BUTYLIMMIDAZOLE 12B: A complex organic research chemical.
CRETOSTIMOGENE GRENADENOREPVEC: An investigational oncolytic immunotherapy.
GSK-2647544: An experimental research compound from GlaxoSmithKline.
NUCLEOLIN ANTAGONIST IPP-204106N: An experimental aptamer that targets nucleolin.
GROWTH ARREST SPECIFIC PROTEIN 6: A vitamin K-dependent protein that is a ligand for Tyro3, Axl, and Mer receptors.
LITORIN: A peptide related to bombesin, found in amphibian skin.
[D-TYR6,APA-4CL11,PHE13,NLE14]BOMBESIN-(6-14): A modified bombesin receptor antagonist.
COMPOUND 12 [PMID:28626832]: A research compound described in the specified scientific publication.
DELPARANTAG: An experimental protease-activated receptor 1 (PAR-1) antagonist.
CEQ508: An experimental therapy using engineered bacteria to deliver siRNA.
LAPRITUXIMAB EMTANSINE: An antibody-drug conjugate targeting the FOLR1 receptor.
UMIBECESTAT: An experimental BACE1 inhibitor for Alzheimer's disease.
15S-HETE: 15-Hydroxyeicosatetraenoic acid, a lipid mediator.
MS363: An experimental research compound.
YTTRIUM Y 90 ANTI-CEA MONOCLONAL ANTIBODY CT84.66: A radioimmunotherapy agent targeting CEA.
ONO-AE1-437: An experimental EP4 receptor partial agonist.
CINROMIDE: An experimental anticonvulsant.
P54: A research compound or protein designation.
C5A HEXAPEPTIDE ANALOGUE: A synthetic peptide based on the C5a complement component.
COMPOUND 26 [PMID: 34543009]: A research compound described in the specified scientific publication.
STO609: A research chemical that inhibits CaMKK.
AMIBEGRON: An experimental beta-3 adrenergic receptor agonist.
OZ277: An experimental antimalarial agent.
URACIL 20: An experimental research compound.
DIFLORASONE DIACETATE: A high-potency topical corticosteroid.
(-)-(S)-BAYK8644: An L-type calcium channel agonist used in research.
COMPOUND 1 [PMID: 10498202]: A research compound described in the specified scientific publication.
MAFENIDE: A topical sulfonamide antibiotic for burns.
GLUCOSAMINE: An amino sugar and a popular dietary supplement for osteoarthritis.
PGF1&ALPHA;: Prostaglandin F1 alpha, a metabolite of arachidonic acid.
COMPOUND 70 [PMID: 26161824]: A research compound described in the specified scientific publication.
BI-6901: An experimental research compound.
UK-432097: An experimental A2A adenosine receptor antagonist.
RS-102895: A research chemical that acts as a 5-HT2C receptor antagonist.
CCL14: A chemokine also known as HCC-1.
CH-5132799: An experimental PI3K inhibitor.
SB328437: An experimental research compound.
JNJ-26070109: An experimental research compound from Johnson & Johnson.
MD-222: An experimental research compound.
EPELSIBAN: An experimental oxytocin receptor antagonist.
SCH-900271: An experimental research compound.
AQW051: An experimental alpha-7 nicotinic acetylcholine receptor partial agonist.
SC-236: A research chemical that is a selective COX-2 inhibitor.
CRS-207: An experimental cancer vaccine using a live-attenuated Listeria monocytogenes strain.
MINI-TYRRS: A fragment of an enzyme with anti-angiogenic properties.
VCXCL1: A viral chemokine.
AFM-13: An investigational bispecific antibody targeting CD30 and CD16A.
CXCL122 (DIMER): A dimeric form of the chemokine CXCL12.
TAGTOCICLIB: An investigational CDK4/6 inhibitor.
CDK4 INHIBITOR: A class of drugs that block cyclin-dependent kinase 4.
HEXAFLUORENIUM: A drug that prolongs the action of succinylcholine.
CCT251545: An experimental Wnt pathway inhibitor.
LEVOKETOCONAZOLE: The (2S,4R)-enantiomer of ketoconazole, used to treat Cushing's syndrome.
CEBSULFASE ALFA: An enzyme replacement therapy.
NVP-2: An experimental research compound.
AUTOLOGOUS PROSTATE STEM CELL ANTIGEN-SPECIFIC CAR T CELLS BPX-601: An investigational CAR T-cell therapy targeting PSCA.
ANTI-CD20 CAR T CELLS PREPARATION: A type of CAR T-cell therapy targeting the CD20 protein.
INSULIN SUSP ISOPHANE RECOMBINANT HUMAN: NPH insulin produced by recombinant DNA technology.
PIPERACETAZINE: A typical antipsychotic of the phenothiazine class.
SARALASIN ACETATE: The salt of saralasin, an angiotensin II receptor antagonist used for diagnosis.
PROBUCOL: A lipid-lowering agent with antioxidant properties.
PAROXETINE HYDROCHLORIDE: The salt of paroxetine, a selective serotonin reuptake inhibitor (SSRI) antidepressant.
DANIQUIDONE: An experimental research compound.
YXG-158: An experimental research compound.
COMPOUND 4 [PMID: 16495056]: A research compound described in the specified scientific publication.
VERLUKAST: An experimental leukotriene receptor antagonist.
SC-67655: An experimental research compound.
COMPOUND 13 [PMID: 37465299]: A research compound described in the specified scientific publication.
ADL5747: An experimental mu-opioid receptor agonist.
NFP: An abbreviation, possibly for a research compound.
ICLAPRIM: An experimental antibiotic, a dihydrofolate reductase inhibitor.
DO34: An experimental research compound.
COMPOUND 6EE [PMID: 22364528]: A research compound described in the specified scientific publication.
S136492: An experimental research compound.
EAI045: An experimental allosteric inhibitor of EGFR.
PD 158780: An experimental research compound.
CAY10499: A research chemical that is an EP4 receptor antagonist.
COMPOUND 13 [PMID: 17502136]: A research compound described in the specified scientific publication.
TRANS-2-METHYLCROTONIC ACID: A metabolite found in some metabolic disorders.
FONDAPARINUX: A synthetic anticoagulant that inhibits Factor Xa.
SERMORELIN: A synthetic analog of growth hormone-releasing hormone (GHRH).
ARC-19499: An experimental research compound.
ANTI-IL17A MONOCLONAL ANTIBODY CJM112: An experimental monoclonal antibody targeting interleukin-17A.
CRYPTOPHYCIN 52: A potent tubulin inhibitor isolated from cyanobacteria.
ALOFANIB: An experimental inhibitor of the fibroblast growth factor receptor 2 (FGFR2).
MIROGABALIN: A gabapentinoid used for neuropathic pain.
CUTAMESINE: An experimental sigma-1 receptor agonist.
ML355: A research chemical that inhibits the METTL3-METTL14 complex.
[3H]NLX-112: A radiolabeled 5-HT1A receptor agonist.
FLESINOXAN: An experimental 5-HT1A receptor full agonist.
LY344864: An experimental 5-HT1F receptor agonist.
FG-5893: An experimental research compound.
PRN1371: An irreversible inhibitor of fibroblast growth factor receptor (FGFR).
SB 649915: An experimental orexin-1 receptor antagonist.
2-METHYL-5-HT: A selective agonist for the 5-HT3 receptor.
DORSOMORPHIN: A research chemical that inhibits AMP-activated protein kinase (AMPK).
TUSPETINIB: An investigational kinase inhibitor.
BRL-54443: A research chemical with agonist activity at 5-HT1A and 5-HT1D receptors.
M-CHLOROPHENYLPIPERAZINE: A psychoactive compound that is a metabolite of some antidepressants.
CGS-12066: A research chemical that is a 5-HT1B receptor agonist.
QUINPIROLE: A research chemical that is a selective D2/D3 dopamine receptor agonist.
COMPOUND 38K [PMID: 34351741]: A research compound described in the specified scientific publication.
PAK-104P: An experimental research compound.
ACHE REACTIVATOR 2: A research compound designed to reactivate acetylcholinesterase.
CXCL12&ALPHA;: The alpha isoform of the chemokine CXCL12.
COMPOUND E22 [PMID: 31298542]: A research compound described in the specified scientific publication.
COMPOUND 39 [PMID: 34982553]: A research compound described in the specified scientific publication.
PD81723: A research chemical that is a positive allosteric modulator of the A1 adenosine receptor.
BAY 60-6583: A research chemical that is a selective A2B adenosine receptor agonist.
HEMADO: An experimental research compound.
[3H]FMET-LEU-PHE: A radiolabeled version of the chemotactic peptide fMLP.
(R)-PIA: The (R)-enantiomer of N6-phenylisopropyladenosine, a potent A1 adenosine receptor agonist.
MRS1523: A research chemical that acts as a selective A3 adenosine receptor antagonist.
KF26777: An experimental A1 adenosine receptor antagonist.
COMPOUND 23 [PMID: 31398032]: A research compound described in the specified scientific publication.
AZ13824374: An experimental research compound from AstraZeneca.
TUVUSERTIB: An investigational ATR kinase inhibitor for cancer treatment.
GROUP E 1682-2106 [PMID:16118363]: A peptide group described in the specified scientific publication.
SERUM AMYLOID A: An acute-phase reactant protein associated with inflammation.
EXAMPLE 1.11 [WO2014139978]: A chemical compound described in the specified patent application.
NINGETINIB: An investigational multi-kinase inhibitor targeting FGFR, VEGFR, and PDGFR.
XMD-12: An experimental research compound.
BANTAG-1: An experimental research compound.
AMYLOID &BETA;: A peptide that is the main component of amyloid plaques in Alzheimer's disease.
D-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-NAL-NH2: A synthetic cyclic peptide analog of somatostatin.
LY3202626: An experimental inhibitor of beta-secretase 1 (BACE1).
COMPOUND 9 [PMID: 26937601]: A research compound described in the specified scientific publication.
EXAMPLE 41 [WO2012028563]: A chemical compound described in the specified patent application.
ANNEXIN I: A calcium-dependent phospholipid-binding protein involved in anti-inflammation.
CIMATEROL: A beta-adrenergic agonist used as a repartitioning agent in livestock.
ACT-389949: An experimental research compound.
LY3009120: An experimental pan-RAF kinase inhibitor.
COMPOUND 7 [PMID: 25719566]: A research compound described in the specified scientific publication.
LIFIRAFENIB: An investigational pan-RAF kinase inhibitor.
TAFLUPROST ACID: The active metabolite of the prostaglandin analog tafluprost.
INDISULAM: An experimental anticancer agent that acts as a molecular glue degrader.
2-METHYL-3-PHENETHYL-3H-PYRIMIDIN-4-ONE: A chemical name for a specific research compound.
ACT-709478: An experimental T-type calcium channel blocker.
&BETA;-SECRETASE INHIBITOR IV: A research chemical that inhibits the beta-secretase (BACE1) enzyme.
BAY-593074: An experimental research compound from Bayer.
NNC55-0396: A research chemical that acts as a T-type calcium channel blocker.
JWH-018: A synthetic cannabinoid that is a potent agonist of CB1 and CB2 receptors.
GW-5823: An experimental research compound from GlaxoSmithKline.
DESULFATED GASTRIN-34: A form of the gastrin hormone lacking a sulfate group.
LORGLUMIDE: A research chemical that acts as a cholecystokinin receptor antagonist.
DEVAZEPIDE: A research chemical that is a potent and selective CCK1 receptor antagonist.
[125I]-BDZ2: A radiolabeled peptide for research purposes.
BX 471: An experimental antagonist of the CCR1 chemokine receptor.
GSK2239633A: An experimental research compound from GlaxoSmithKline.
M1152: An experimental research compound.
GALANIN(7-29) (PIG): A fragment of porcine galanin neuropeptide.
[3H]ANCRIVIROC: A radiolabeled CCR5 antagonist used in research.
[125I]CCL19 (HUMAN): A radiolabeled form of the human chemokine CCL19 for research.
MOXETUMOMAB PASUDOTOX: An anti-CD22 immunotoxin for treating hairy cell leukemia.
COMPOUND 1 [PMID: 24793884]: A research compound described in the specified scientific publication.
SPEXIN-1: A neuropeptide involved in metabolism and reproductive functions.
C7: An abbreviation for a research compound.
NVS-1: An experimental research compound from Novartis.
[3H]AMPA: A radiolabeled version of AMPA, a selective agonist for the AMPA receptor.
DIPHENYLAMINE-2-CARBOXYLIC ACID: A chemical intermediate, also known as N-phenylanthranilic acid.
MK-8262: An experimental research compound from Merck.
DUP-714: An experimental research compound.
MS023: A research chemical that is an inhibitor of type I protein arginine methyltransferases.
COMPOUND 57 [PMID: 20121197]: A research compound described in the specified scientific publication.
COMPOUND 28 [PMID: 16460935]: A research compound described in the specified scientific publication.
[125I]ASTRESSIN: A radiolabeled antagonist of corticotropin-releasing factor (CRF) receptors.
COMPOUND 27 [PMID: 36449304]: A research compound described in the specified scientific publication.
KINASE INHIBITOR 2 [PMID: 30199702]: A research compound described as a kinase inhibitor in the specified publication.
BEGELOMAB: An investigational monoclonal antibody that targets CD126 (IL-6 receptor).
OMARIGLIPTIN: A long-acting dipeptidyl peptidase-4 (DPP-4) inhibitor for type 2 diabetes.
DCLK1-IN-1: A research chemical that inhibits the DCLK1 kinase.
L-888,291: An experimental research compound.
BWA868C: An experimental adenosine A1 receptor agonist.
15(S)-15-METHYL-PGD2: A synthetic analog of prostaglandin D2.
L-644,698: An experimental research compound.
HS665: An experimental research compound.
7-TRANS-OH-PIPAT: A metabolite of the D3 dopamine receptor agonist 7-OH-DPAT.
[3H]PD128907: A radiolabeled dopamine D3 receptor agonist.
[3H]CGP61594: A radiolabeled research compound.
(+)-SCH-23390: The active enantiomer of SCH-23390, a selective D1 dopamine receptor antagonist.
NAFADOTRIDE: A research chemical that is a D3 dopamine receptor antagonist.
EGIS-11150: An experimental 5-HT7 receptor antagonist.
PF-592379: An experimental D3 dopamine receptor partial agonist.
PLUMBAGIN: A natural naphthoquinone found in Plumbago plants with anticancer properties.
[3H]UBP310: A radiolabeled antagonist of kainate receptors.
EPIGEN: A ligand for the epidermal growth factor receptor (EGFR).
SC-19220: A research chemical that is an EP1 receptor antagonist.
NEUREGULIN-2: A member of the epidermal growth factor (EGF) family of proteins.
DESLORELIN: A synthetic GnRH superagonist used in veterinary medicine.
STANOZOLOL: An anabolic steroid derived from dihydrotestosterone.
GSK5182: An experimental estrogen-related receptor gamma (ERRÎ³) inverse agonist.
CMPD-1: An experimental research compound.
[125I][ALA1,3,11,15]ET-1: A radiolabeled analog of endothelin-1.
GSK2656157: An experimental inhibitor of the PERK kinase.
COMPOUND 25 [PMID: 32687365]: A research compound described in the specified scientific publication.
NE58043: An experimental research compound.
COMPOUND 20 [PMID: 35584373]: A research compound described in the specified scientific publication.
PIPERIDINE-4-SULPHONIC ACID: A research chemical that is a GABA receptor partial agonist.
BICUCULLINE: A light-sensitive competitive antagonist of GABA-A receptors.
ARGININE: An amino acid involved in the urea cycle and protein synthesis.
DS2: A research chemical that acts as a positive allosteric modulator of GABA-A receptors.
(&PLUSMN;)-CIS-2-CAMP: A research chemical that is an agonist at metabotropic glutamate receptors.
[125I][TYR26]GALANIN (PIG): A radiolabeled version of porcine galanin.
[N-ME,DES-SAR]GAL-B2: A modified galanin analog.
SCH 202596: An experimental galanin receptor antagonist.
COMPOUND 19 [PMID: 18800762]: A research compound described in the specified scientific publication.
PF-6870961: An experimental GLP-1 receptor agonist.
IDRA-21: An experimental nootropic drug that acts as an AMPA receptor positive allosteric modulator.
COMPOUND 30 [PMID: 22468970]: A research compound described in the specified scientific publication.
ZK216348: An experimental progesterone receptor antagonist.
TCN-201: A research chemical that is a negative allosteric modulator of the NMDA receptor.
PREGNENOLONE SULPHATE: A sulfated neurosteroid that modulates several neurotransmitter receptors.
ZATEBRADINE: An experimental bradycardic agent that inhibits the If current in the sinoatrial node.
LITHIUM CARBONATE: A chemical salt used as a mood stabilizer, primarily for bipolar disorder.
[SER8]GNRH: A synthetic analog of gonadotropin-releasing hormone.
5-METHYL-5-(5-METHYLTHIOPHEN-3-YL)-4-OXO-4,5-DIHYDROFURAN-2-CARBOXYLIC ACID: A complex organic research chemical.
GUANYLYL CYCLASE-ACTIVATING PROTEIN 1: A calcium-binding protein involved in phototransduction.
ACY-738: An experimental selective inhibitor of histone deacetylase 6 (HDAC6).
CCL16: A chemokine also known as liver-expressed chemokine (LEC).
COMPOUND 4I [PMID: 2296036]: A research compound described in the specified scientific publication.
7&BETA;-HYDROXYCHOLESTEROL: An oxysterol, an oxidized derivative of cholesterol.
7&ALPHA;-HYDROXYCHOLESTEROL: An oxysterol, an intermediate in bile acid synthesis.
SUPRASTAT: An experimental research compound.
NCRW0105-E06: An experimental research compound.
COMPOUND 1 [PMID: 37741852]: A research compound described in the specified scientific publication.
3-HYDROXY CAPRIC ACID: A medium-chain hydroxy fatty acid.
AR234960: An experimental research compound.
GSK-1838705A: An experimental dual inhibitor of IGF-1R and ALK kinases.
SVEP1: A large extracellular matrix protein.
IRAK4 INHIBITOR RAC-45 [PMID: 18501603]: A research compound described as an IRAK4 inhibitor in the specified publication.
AFP-07: An experimental research compound.
OSE-127: An investigational monoclonal antibody that antagonizes the IL-7 receptor.
VANILLIN: The primary component of vanilla bean extract, used as a flavoring agent.
GROSHEIMIN: A natural sesquiterpene lactone.
COMPOUND 4D [PMID: 25489658]: A research compound described in the specified scientific publication.
PAMUFETINIB: An investigational kinase inhibitor.
BI-0474: An experimental research compound.
FULZERASIB: An investigational KRAS G12C inhibitor.
ASP-0819: An experimental research compound from Astellas Pharma.
RODATRISTAT: An inhibitor of tryptophan hydroxylase, investigated for pulmonary hypertension.
MERESTINIB: An investigational multi-kinase inhibitor targeting AXL, MER, and FLT3.
GSK-J4: A research chemical that inhibits the JMJD3 and UTX histone demethylases.
CCT365623: An experimental kinase inhibitor.
CDK4 INHIBITOR III: A research chemical that selectively inhibits cyclin-dependent kinase 4.
COMPOUND 16 [PMID: 18945615]: A research compound described in the specified scientific publication.
MACROPHAGE STIMULATING PROTEIN 1: A protein that is a ligand for the RON receptor tyrosine kinase.
[125I]MCH (HUMAN, MOUSE, RAT): A radiolabeled version of melanin-concentrating hormone.
MT-II: Melanotan II, a synthetic analog of alpha-melanocyte-stimulating hormone.
AC-C[CYS-GLU-HIS-D-PHE-ARG-TRP-D-CYS]-PRO-PRO-LYS-ASP-NH2: A synthetic cyclic peptide analog of Î±-MSH.
NEOLYMPHOSTIN A: A research chemical that inhibits the STAT3 signaling pathway.
STC-15: An experimental research compound.
A-841720: An experimental nicotinic acetylcholine receptor agonist.
A-794278: An experimental research compound.
GSK2210875: An experimental research compound from GlaxoSmithKline.
LSN2463359: An experimental mGlu5 receptor negative allosteric modulator.
L-CCG-I: A research chemical that is an agonist for group II metabotropic glutamate receptors.
CPPZ: An experimental research compound.
VU0404251: An experimental research compound.
VU6012962: An experimental research compound.
&ALPHA;-METHYLSERINE-O-PHOSPHATE: An agonist for group III metabotropic glutamate receptors.
AZD-9977: An experimental MPO inhibitor.
JNK-IN-8: A research chemical that is a covalent inhibitor of JNK kinases.
ACUMAPIMOD: An investigational p38 MAP kinase inhibitor.
JNK INHIBITOR 9L: A research chemical that inhibits JNK kinases.
AX15836: An experimental research compound.
5Z-7-OXOZEAENOL: A natural product that is a potent inhibitor of the TAK1 kinase.
COMPOUND 5I [PMID: 36542759]: A research compound described in the specified scientific publication.
MOTILIN-(2-22) (HUMAN): A fragment of the human motilin hormone.
BAY-8002: An experimental PI3K inhibitor.
RASAGILINE: A selective, irreversible monoamine oxidase-B inhibitor for Parkinson's disease.
5-HEAT: An experimental research compound.
ETONITAZENE: A potent synthetic opioid analgesic.
M372049: An experimental research compound.
KELATORPHAN: A dual inhibitor of enkephalin-degrading enzymes.
L760735: An experimental neurokinin 1 (NK1) receptor antagonist.
ZD6021: An experimental endothelin-A receptor antagonist.
[&BETA;ALA8]NEUROKININ A-(4-10): A selective agonist for the neurokinin 2 (NK2) receptor.
5-(6-CHLORO-2-HEXYL-1H-INDOL-1-YL)-5-OXO-VALERIC ACID: A chemical name for a specific research compound.
FIRAZOREXTON: An investigational orexin-2 receptor agonist.
T-516: An experimental research compound.
[3H]CP-1: A radiolabeled research compound.
L-&BETA;&GAMMA;-MEATP: An ATP analog that is a P2X receptor antagonist.
BAY-1797: An experimental research compound from Bayer.
MRS2690: A research chemical that is a P2Y6 receptor agonist.
PSB-416: An experimental research compound.
COMPOUND 14B [PMID: 25742366]: A research compound described in the specified scientific publication.
IC-87114: A selective inhibitor of the PI3K delta isoform.
COMPOUND 1A [PMID: 24900749]: A research compound described in the specified scientific publication.
PIM447: An investigational pan-PIM kinase inhibitor.
PROKINETICIN-1: A regulatory peptide, also known as endocrine gland-derived VEGF.
COMPOUND 8I [PMID: 22765894]: A research compound described in the specified scientific publication.
PDGF RECEPTOR TYROSINE KINASE INHIBITOR III: A research chemical that inhibits the PDGFR tyrosine kinase.
LERZEPARIB: An investigational PARP1/2 inhibitor.
AZAPRO-3: An experimental research compound.
BISINDOLYLMALEIMIDE IV: A research chemical that inhibits protein kinase C.
CRT 0066101: A research chemical that is an inhibitor of protein kinase D.
ALOISINE: A research chemical that is an inhibitor of cyclin-dependent kinases (CDKs).
COMPOUND 32 [PMID: 20471253]: A research compound described in the specified scientific publication.
COMPOUND 182 [PMID: 37500611]: A research compound described in the specified scientific publication.
AGN194204: An experimental research compound.
PA451: An experimental research compound.
PA452: An experimental research compound.
NANOLUC-INSL3: A bioluminescent fusion protein of insulin-like peptide 3.
MINIMISED RELAXIN-3 ANALOGUE 2: A synthetic, shortened analog of the peptide hormone relaxin-3.
COMPOUND 4 [PMID: 30824200]: A research compound described in the specified scientific publication.
CLOBENPROPIT: A research chemical that is a potent antagonist at the histamine H3 receptor.
R3 B1-22R: A peptide antagonist of the relaxin-3 receptor RXFP1.
COMPOUND 7A [PMID: 33730669]: A research compound described in the specified scientific publication.
RELAXIN-3 (B CHAIN): The B chain component of the peptide hormone relaxin-3.
HINSL5: A8-21 (T15K): A modified fragment of insulin-like peptide 5.
NE-100: A research chemical that is a sigma-1 receptor antagonist.
AGK2: A research chemical that is an inhibitor of the sirtuin 2 (SIRT2) enzyme.
COMPOUND 12E [PMID: 18605714]: A research compound described in the specified scientific publication.
CYCLO(7-12) DES-AA1,2,5-[GLU7,D-TRP8,IAMP9,M-I-TYR11,HHLYS12]SRIF: A complex synthetic analog of somatostatin.
BIM 23027: A somatostatin receptor subtype 2 antagonist.
[125I]CGP 23996: A radiolabeled somatostatin analog.
BIM 23295: An experimental somatostatin analog.
PRL-2915: An experimental research compound.
LEVAMFETAMINE: The levorotatory stereoisomer of amphetamine.
VUF 8328: An experimental research compound.
HETROMBOPAG: An investigational thrombopoietin receptor agonist.
ENERISANT: An experimental histamine H3 receptor antagonist/inverse agonist.
SUCUNAMOSTAT: An experimental research compound.
COMPOUND 13D [PMID: 23639540]: A research compound described in the specified scientific publication.
CLEMIZOLE: A first-generation antihistamine.
GDC-6599: An experimental research compound from Genentech.
GLYCYRRHETINIC ACID: A triterpenoid from licorice root with anti-inflammatory properties.
20-HETE: 20-Hydroxyeicosatetraenoic acid, a lipid signaling molecule.
2-APB: A research chemical that modulates IP3 receptors and TRP channels.
COMPOUND 39 [PMID: 36402081]: A research compound described in the specified scientific publication.
COMPOUND 2T [PMID: 2296036]: A research compound described in the specified scientific publication.
TACALCITOL: A synthetic vitamin D3 analog used topically for psoriasis.
[ALA11,22,28]VIP: A synthetic analog of vasoactive intestinal peptide (VIP).
ARGIPRESTOCIN: An analog of vasopressin found in non-mammalian vertebrates.
N-STEARYL-[NLE17] NEUROTENSIN-(6-11)/VIP-(7-28): A hybrid peptide combining parts of neurotensin and VIP.
[3H]AVP (HUMAN, MOUSE, RAT): A radiolabeled version of arginine vasopressin.
OPC-51803: An experimental vasopressin V1A receptor antagonist.
D[D-PAL2]AVP: A synthetic analog of arginine vasopressin.
BOVINE ADRENAL MEDULLA PEPTIDE 8-22: A fragment of a peptide from bovine adrenal medulla.
JTE-013: A research chemical that is an antagonist of the S1P2 receptor.
IP3: Inositol trisphosphate, a second messenger molecule in signal transduction.
CTLA-4-TARGETING AGENT: A class of immunotherapy drugs that block the CTLA-4 immune checkpoint.
NE21650: An experimental research compound.
DELGOCITINIB: A topical Janus kinase (JAK) inhibitor for atopic dermatitis.
BELIZATINIB: An investigational aurora kinase inhibitor.
EG5 KINESIN-RELATED MOTOR PROTEIN INHIBITOR 4SC-205: An experimental inhibitor of the KIF11/Eg5 motor protein.
(-)-BREMAZOCINE: A potent kappa-opioid receptor agonist with some mu-antagonist activity.
ACRIZANIB: An investigational kinase inhibitor.
UNC1999: A research chemical that is a dual inhibitor of EZH2 and EZH1.
GTP-14564: An experimental research compound.
PIMIVALIMAB: An investigational monoclonal antibody targeting PD-1.
ASP2453: An experimental research compound from Astellas Pharma.
MTI-31: An experimental research compound.
LUMINESPIB: An experimental Hsp90 inhibitor.
FLT-3 INHIBITOR: A class of drugs that block the FLT3 kinase.
OMACETAXINE MEPESUCCINATE: A protein synthesis inhibitor used to treat chronic myeloid leukemia.
LY3410738: An experimental research compound from Eli Lilly.
CHELIDONINE: A benzylisoquinoline alkaloid found in the greater celandine plant.
RET INHIBITOR TY-1091: An experimental inhibitor of the RET kinase.
NS8593: A research chemical that activates small-conductance calcium-activated potassium (SK) channels.
BRIGIMADLIN: An investigational MDM2 inhibitor.
GSK-711701A: An experimental research compound from GlaxoSmithKline.
HELATX1: A peptide toxin from a spider.
GZ-389988: An experimental research compound.
RY785: An experimental research compound.
&ALPHA;&BETA;-METHYLENEADP: A non-hydrolyzable analog of adenosine diphosphate (ADP).
ONO-AE1-329: An experimental EP4 receptor agonist.
ICA-27243: A research chemical that is a potent KCNQ2/3 potassium channel opener.
A-674563: An experimental Akt kinase inhibitor.
VMIP-I: A viral chemokine-like protein used in research.
COMPOUND 27 [PMID: 24900635]: A research compound described in the specified scientific publication.
K-252A: A natural product that is a broad-spectrum protein kinase inhibitor.
COMPOUND 9 [PMID: 22533316]: A research compound described in the specified scientific publication.
RWJ-67657: An experimental p38 MAP kinase inhibitor.
EPALRESTAT: An aldose reductase inhibitor used for diabetic neuropathy.
RADOTINIB: A second-generation BCR-ABL tyrosine kinase inhibitor.
AIDA: A research chemical that is a group I metabotropic glutamate receptor antagonist.
CC-90006: An investigational DDX3 inhibitor.
STX-107: An experimental research compound.
ANTI-HIF-1ALPHA LNA ANTISENSE OLIGONUCLEOTIDE EZN-2968: An experimental antisense therapy targeting HIF-1 alpha.
CRA1000: An experimental research compound.
COMPOUND 14 [PMID: 19831390]: A research compound described in the specified scientific publication.
MITOFLAXONE: A research compound targeting mitochondria.
SL422: An experimental research compound.
PHENACYLAMINE HYDROCHLORIDE: The salt of a chemical intermediate.
LYS006: An experimental research compound.
CLAUSINE E: A natural carbazole alkaloid.
DIOCTANOYLGLYCEROL PYROPHOSPHATE: A synthetic lipid molecule.
IGN-101: An experimental monoclonal antibody.
LPA: Lysophosphatidic acid, a signaling phospholipid.
RAS PEPTIDE CANCER VACCINE: A type of cancer vaccine using peptides from the Ras protein.
DUSIGITUMAB: An investigational monoclonal antibody targeting RON receptor tyrosine kinase.
TIAZOFURIN: An inhibitor of IMP dehydrogenase with antiviral and anticancer activity.
DODECYLPHOSPHATE: A 12-carbon alkyl phosphate.
COMPOUND 5B [PMID: 24900464]: A research compound described in the specified scientific publication.
PRU-10: An experimental research compound.
DAMINOZIDE: A plant growth regulator.
CLEMASTINE: A first-generation antihistamine with anticholinergic effects.
DALBAVANCIN: A long-acting lipoglycopeptide antibiotic.
RECOMBINANT NEUROTROPHIC FACTOR: A genetically engineered protein that supports neuron survival.
SKF 105854: An experimental research compound.
FEDOVAPAGON: An experimental vasopressin V2 receptor agonist.
COMPOUND III [PMID: 24080463]: A research compound described in the specified scientific publication.
TALABOSTAT: An experimental inhibitor of dipeptidyl peptidases, including FAP.
PD-170292: An experimental research compound.
RIFABUTIN: An antibiotic used to treat tuberculosis and MAC.
MG149: An experimental research compound.
NPC 17731: An experimental research compound.
KIN-3248: An experimental research compound.
P53/HDM2 INTERACTION INHIBITOR CGM097: An investigational MDM2 inhibitor.
CEVIMELINE HYDROCHLORIDE: The salt of cevimeline, a muscarinic receptor agonist for dry mouth.
CLODRONATE DISODIUM: The salt of clodronate, a first-generation bisphosphonate.
ATC0175: An experimental research compound.
AMG-1: An experimental research compound from Amgen.
S38151: An experimental research compound.
GANGALEOIDIN: A natural lichen metabolite.
PTD10: An experimental research compound.
[D-TRP8]&GAMMA;-MSH: A synthetic analog of gamma-melanocyte-stimulating hormone.
RET INHIBITOR HS-10365: An experimental inhibitor of the RET kinase.
2-BENZOYL-5-METHOXYBENZOQUINONE: A chemical name for a specific research compound.
COMPOUND R-16 [PMID: 21967808]: A research compound described in the specified scientific publication.
IPAFRICEPT: An experimental fusion protein that acts as a Wnt pathway inhibitor.
FTIDC: A research chemical that is a positive allosteric modulator of the MT1 melatonin receptor.
BMS493: An experimental inverse agonist of the retinoic acid receptor.
CAPADENOSON: An experimental partial agonist of the A1 adenosine receptor.
CORTISTATIN A: A natural steroidal alkaloid that is a potent anti-angiogenic agent.
[SAR1,GLY4,GLY8]ANG-II: A synthetic analog of Angiotensin II.
POSTSTATIN: An inhibitor of prolyl endopeptidase.
COMPOUND 31 [PMID: 24809814]: A research compound described in the specified scientific publication.
TAS-103: An experimental topoisomerase I inhibitor.
FLUNARIZINE HYDROCHLORIDE: The salt of flunarizine, a calcium channel blocker used for migraine prophylaxis.
3-MPPTS: An experimental research compound.
JNJ-42153605: An experimental inhibitor of fatty acid amide hydrolase (FAAH).
AXOMADOL: An experimental analgesic with opioid and norepinephrine reuptake inhibitory actions.
SELEXIPAG: A prostacyclin receptor agonist for pulmonary arterial hypertension.
LY395756: An experimental AMPA receptor positive allosteric modulator.
YL5084: An experimental research compound.
COMPOUND 11 [PMID: 26431428]: A research compound described in the specified scientific publication.
BERZOSERTIB: An investigational ATR kinase inhibitor.
VINCAMINE: A monoterpenoid indole alkaloid with vasodilating properties.
ENALAPRILAT ANHYDROUS: The active metabolite of the ACE inhibitor enalapril.
KHK-4083: An investigational monoclonal antibody targeting OX40.
(R)-STU104: An experimental research compound.
YUANHUADINE: A natural daphnane-type diterpenoid.
NAFARELIN ACETATE: The salt of nafarelin, a gonadotropin-releasing hormone (GnRH) agonist.
ANTAZOLINE HYDROCHLORIDE: The salt of antazoline, a first-generation antihistamine.
MEK INHIBITOR II: A research chemical that inhibits MAP kinase kinase (MEK).
CITRIC ACID: A weak organic acid used as a preservative and flavoring.
TESETAXEL: An investigational oral taxane chemotherapy agent.
GALANIN(2-29) (PIG): A fragment of porcine galanin neuropeptide.
VU0422288: An experimental research compound.
COMPOUND 44 [PMID: 19748780]: A research compound described in the specified scientific publication.
KANAMYCIN SULFATE: The salt of kanamycin, an aminoglycoside antibiotic.
AZD7624: An experimental p38 MAP kinase inhibitor.
TAK-637: An experimental pan-RAF kinase inhibitor.
ZIMBERELIMAB: An investigational monoclonal antibody targeting PD-1.
ISOQUERCETIN: A flavonoid, the 3-O-glucoside of quercetin.
INK-1117: An experimental PI3K alpha inhibitor.
UR-63325: An experimental research compound.
PEGCANTRATINIB: An experimental pegylated kinase inhibitor.
[3H]OXOTREMORINE-M: A radiolabeled muscarinic acetylcholine receptor agonist.
DESOXYCORTICOSTERONE ACETATE: The acetate ester of a mineralocorticoid hormone.
DSLET: A synthetic opioid peptide that is a selective delta-opioid receptor agonist.
ENILURACIL: An inhibitor of dihydropyrimidine dehydrogenase.
W-84: An experimental research compound.
SYMPLOSTATIN 5: A natural product with anticancer properties.
WDUO3: An experimental research compound.
COMPOUND 33 [PMID: 19908842]: A research compound described in the specified scientific publication.
VOLANESORSEN: An antisense oligonucleotide that lowers triglyceride levels.
ACTINIUM AC 225 LINTUZUMAB: A radioimmunoconjugate combining an anti-CD33 antibody with actinium-225.
PARAMETHADIONE: An anticonvulsant drug of the oxazolidinedione class.
MILAMELINE: An experimental muscarinic acetylcholine receptor agonist.
AS16: An experimental research compound.
SB 272183: A research chemical that is a 5-HT6 receptor antagonist.
FEVIPIPRANT: An experimental antagonist of the prostaglandin D2 receptor 2.
LAPACHONE: A naphthoquinone with potential anticancer activity.
SEMUSTINE: A nitrosourea compound used as a chemotherapy agent.
ALL-TRANS-RETINAL: A form of vitamin A involved in the visual cycle.
RINETERKIB: An investigational ERK1/2 kinase inhibitor.
S33084: An experimental research compound.
ASP5878: An experimental FGF receptor inhibitor.
PHTHALAZINONE: A heterocyclic chemical scaffold used in drug design.
LEXIPAFANT: An experimental antagonist of platelet-activating factor (PAF).
BIBH 1: An experimental research compound.
PYRONARIDINE: An antimalarial drug.
L-162,313: An experimental PPAR beta/delta agonist.
CALYCOSIN: A natural O-methylated isoflavone.
CHLORHEXIDINE HYDROCHLORIDE: The salt of chlorhexidine, a broad-spectrum antiseptic.
AH6809: A research chemical that acts as an antagonist for several prostanoid receptors.
COMPOUND A127 [WO2013110309]: A chemical compound described in the specified patent application.
[125I]RELAXIN-3-B/INSL5 A CHIMERA: A radiolabeled chimeric peptide for research.
D-ALANINE: The D-stereoisomer of the amino acid alanine.
DIALLYLDISULFIDE: An organosulfur compound found in garlic.
MUSCARINIC TOXIN 3: A peptide toxin from mamba venom that targets M1/M4 muscarinic receptors.
[125I][TYR4]BOMBESIN: A radiolabeled version of the peptide bombesin.
MI-1148: An experimental research compound.
BITOPERTIN: An experimental glycine reuptake inhibitor for schizophrenia.
KT 5720: A research chemical that is a selective inhibitor of protein kinase A.
N-DESMETHYLTAMOXIFEN: A major active metabolite of tamoxifen.
UCM 724: An experimental research compound.
L-739,750: An experimental research compound.
CPY: An abbreviation, possibly for a research compound.
2F-MT-45: A designer opioid of the piperazine class.
GUANOSINE-5'-TRIPHOSPHATE: A purine nucleoside triphosphate involved in energy transfer and signal transduction.
OD36: An experimental research compound.
LY-510929: An experimental research compound from Eli Lilly.
ICI-199441: An experimental benzodiazepine receptor inverse agonist.
IDO-1 INHIBITOR LY3381916: An experimental inhibitor of the IDO1 enzyme for cancer immunotherapy.
GSK1521498: An experimental melanocortin-4 receptor antagonist.
ATIPAMEZOLE: A selective alpha-2 adrenergic receptor antagonist used in veterinary medicine.
BRADYZIDE: An experimental research compound.
2-O-ETHYL-PAF C-16: A modified form of platelet-activating factor.
S 16924: An experimental research compound.
VIXOTRIGINE: An investigational voltage-gated sodium channel blocker.
XEN907: An investigational selective sodium channel Nav1.6 inhibitor.
FIPEXIDE HYDROCHLORIDE: The salt of fipexide, a nootropic agent.
CIS/TRANS-ISOEUGENOL: A mixture of isomers of eugenol, used in fragrances.
TILIQUINOL: An intestinal antiseptic.
JNJ-5207852: An experimental histamine H3 receptor antagonist.
RETINOID X RECEPTOR AGONIST IRX4204: An experimental RXR agonist.
LARGE PROLINE-RICH PROTEIN BAG6: A multifunctional protein involved in protein quality control.
AZD0328: An experimental alpha-7 nicotinic acetylcholine receptor agonist.
ACETYLCHOLINE CHLORIDE: The salt of acetylcholine, a major neurotransmitter.
ELETRIPTAN: A selective 5-HT1B/1D receptor agonist used to treat migraines.
TRIHEXYPHENIDYL HYDROCHLORIDE: The salt of trihexyphenidyl, an anticholinergic agent for Parkinson's disease.
TIMOLOL MALEATE: The salt of timolol, a non-selective beta-blocker used for glaucoma and hypertension.
METOPROLOL TARTRATE: The salt of metoprolol, a selective beta-1 blocker for cardiovascular conditions.
COMPOUND 31 [PMID: 20936789]: A research compound described in the specified scientific publication.
DOLASETRON MESYLATE: The salt of dolasetron, a 5-HT3 receptor antagonist used as an antiemetic.
ALOGLIPTIN BENZOATE: The salt of alogliptin, a DPP-4 inhibitor for type 2 diabetes.
FROVATRIPTAN SUCCINATE: The salt of frovatriptan, a 5-HT1B/1D receptor agonist for migraines.
ERGOTAMINE TARTRATE: The salt of ergotamine, an ergot alkaloid used to treat migraines.
FK 224: An experimental research compound.
ELVITEGRAVIR: An HIV integrase inhibitor.
R-PSOP: An experimental research compound.
RUXOLITINIB PHOSPHATE: The salt of ruxolitinib, a Janus kinase (JAK) inhibitor.
ACETAZOLAMIDE SODIUM: The salt of acetazolamide, a carbonic anhydrase inhibitor.
RIFAMYCIN SV: A rifamycin class antibiotic.
GUANFACINE HYDROCHLORIDE: The salt of guanfacine, a selective alpha-2A adrenergic receptor agonist.
D(CH2)5[TYR(ME)2,THR4,PHE(3125I,4N3)-NH29]OVT: A complex radiolabeled oxytocin analog.
PENBUTOLOL SULFATE: The salt of penbutolol, a non-selective beta-blocker.
METAPROTERENOL SULFATE: The salt of metaproterenol, a non-selective beta-adrenergic agonist.
DESGLYNH2-D(CH2)5[TYR(ME)2,THR4,ORN8]OT: A synthetic oxytocin analog and antagonist.
LIT-001: An experimental research compound.
ADENOSINE-3'-5'-BISPHOSPHATE: A derivative of adenosine involved in sulfur metabolism.
URIDINE 5'-TRIPHOSPHATE: A pyrimidine nucleoside triphosphate.
ERYTHROMYCIN LACTOBIONATE: An intravenous formulation of the macrolide antibiotic erythromycin.
FOROPAFANT: An experimental antagonist of platelet-activating factor (PAF).
I-287: An experimental research compound.
PERINDOPRIL ARGININE: The arginine salt of the ACE inhibitor perindopril.
LGH-447: An experimental research compound.
MLN-0415: An experimental IKK-beta inhibitor.
RG-7603: An experimental research compound from Roche.
LY2969822: An experimental research compound from Eli Lilly.
EVT401: An experimental P2X7 receptor antagonist.
ABT-107: An experimental research compound from Abbott.
CAFUSERTIB: An investigational ATR kinase inhibitor.
SOFINICLINE: An experimental alpha-4-beta-2 nicotinic receptor partial agonist.
CG250 111IN: An indium-111 radiolabeled antibody.
KELIXIMAB: A chimeric monoclonal antibody that targets CD4.
MDX-070: An experimental monoclonal antibody.
F16IL2: An immunocytokine combining an antibody fragment with interleukin-2.
SITAXENTAN SODIUM: The salt of sitaxentan, an endothelin-A receptor antagonist.
T-DM1: Trastuzumab emtansine, an antibody-drug conjugate for HER2-positive breast cancer.
ALOXIPRIN: A polymeric condensation product of aluminium oxide and aspirin.
KD-247: An experimental research compound.
IMGN-388: An experimental antibody-drug conjugate.
RINUCUMAB: An investigational monoclonal antibody that targets interleukin-6.
MOROLIMUMAB: An investigational monoclonal antibody that targets the rhesus D antigen.
APOLIZUMAB: An investigational humanized monoclonal antibody that targets HLA-DR.
BRECANAVIR: An experimental HIV protease inhibitor.
FAM-TRASTUZUMAB DERUXTECAN-NXKI: An antibody-drug conjugate targeting HER2 for cancer.
PIRINIXIC ACID: A PPAR alpha agonist, also known as Wy-14643.
GW9578: An experimental research compound from GlaxoSmithKline.
P6949: An experimental research compound.
BEVASIRANIB: An experimental siRNA designed to inhibit VEGF production.
7-ETHYL-10-HYDROXYCAMPTOTHECIN: SN-38, the active metabolite of the chemotherapy drug irinotecan.
BICIFADINE: An experimental serotonin-norepinephrine reuptake inhibitor.
TAPRENEPAG ISOPROPYL: The prodrug of taprenepag, an EP2 receptor agonist.
DEPELESTAT: An experimental neutrophil elastase inhibitor.
AZD-1236: An experimental dual antagonist of CXCR2 and CCR2.
APG115: An investigational MDM2-p53 inhibitor.
SETMELANOTIDE ACETATE: The salt of setmelanotide, a melanocortin-4 receptor agonist for genetic obesity.
MARDEPODECT: An experimental research compound.
RIPASUDIL: A Rho kinase inhibitor used to treat glaucoma.
BAY-091: An experimental research compound from Bayer.
OMBIPEPIMUT-S: An experimental therapeutic cancer vaccine.
DICLOFENAC ETALHYALURONATE SODIUM: An experimental formulation of diclofenac.
ROSMANTUZUMAB: An investigational monoclonal antibody targeting the PTK7 receptor.
AZ1366: An experimental research compound from AstraZeneca.
TILPISERTIB: An investigational non-hormonal oral contraceptive.
COAGULATION FACTOR IX RECOMBINANT IMMUNOGLOBULIN G1 FUSION PROTEIN: A long-acting recombinant Factor IX fused to IgG1 Fc.
COMPOUND 16 [PMID: 31653597]: A research compound described in the specified scientific publication.
&ALPHA;-METHYL-D,L-TRYPTOPHAN: A racemic mixture of an analog of tryptophan.
PTHRP-(1-21)/PTH-(22-34) (HUMAN): A hybrid peptide combining parts of two human hormones.
CHAULMOSULFONE: A sulfone drug formerly used to treat leprosy.
MANEB: A manganese-containing dithiocarbamate fungicide.
[ALA1,12,AIB3,GLN10,HARG11,TRP14,ARG19]PTH-(1-21)-NH2 (HUMAN): A complex synthetic analog of parathyroid hormone.
PRRP-31: A 31-amino acid prolactin-releasing peptide.
CETALKONIUM CHLORIDE: A quaternary ammonium compound used as an antiseptic.
LECANORIC ACID: A natural depside found in lichens.
TIP39-(3-39) (HUMAN/BOVINE): A fragment of tuberoinfundibular peptide of 39 residues.
[TYR34]PTH-(1-34) (HUMAN): A synthetic fragment of human parathyroid hormone.
IBUFENAC: A non-steroidal anti-inflammatory drug (NSAID), withdrawn due to hepatotoxicity.
{4-[3-(4-ACETYL-3-HYDROXY-2-PROPYLPHENOXY)PROPOXY]PHENOXY}ACETIC ACID: A leukotriene B4 receptor antagonist.
ENILCONAZOLE: An imidazole fungicide.
[ILE5,TRP23]PTHRP-(2-36) (HUMAN): A synthetic analog of parathyroid hormone-related protein.
COMPOUND 16 [PMID: 31977207]: A research compound described in the specified scientific publication.
PIMARIC ACID: A resin acid, an organic compound found in pine oleoresin.
COMPOUND 3 [PMID: 17942791]: A research compound described in the specified scientific publication.
CADMIUM ACETATE: The acetate salt of cadmium, a toxic heavy metal.
XANTHOANGELOL: A natural chalcone compound found in the plant Angelica keiskei.
TRIBUTYLCHLOROSTANNANE: An organotin compound used as a chemical reagent.
N-METHYLCALOTHRIXIN B: A synthetic derivative of a cyanobacterial natural product.
GSK2981278: An experimental RIPK1 kinase inhibitor.
3,5-DINITROCATECHOL (OR-486): An inhibitor of catechol-O-methyltransferase (COMT).
ALL-TRANS-4-OXO-RETINOIC ACID: A metabolite of all-trans retinoic acid.
GIPARMEN: An investigational PARP1 inhibitor.
CI-966: A research chemical that is a GABA reuptake inhibitor.
CGP74514A: A research chemical that inhibits cyclin-dependent kinases (CDKs).
MILTIRONE: A tanshinone compound isolated from Salvia miltiorrhiza.
(S)-AMPA: The active enantiomer of AMPA, an agonist for the AMPA-type glutamate receptor.
MAKALUVAMINE A: A marine alkaloid with topoisomerase II inhibitory activity.
FENOTEROL HBR: The hydrobromide salt of fenoterol, a short-acting beta-2 adrenergic agonist.
MALTOL: A naturally occurring organic compound used as a flavor enhancer.
METHYL ROBUSTONE: A natural product with potential anti-inflammatory effects.
SOVESUDIL: An investigational Rho-kinase inhibitor.
AMITRAZ: An acaricide and insecticide.
[33P]RELAXIN (HUMAN): A radiolabeled version of human relaxin for research.
VIALININ A: A natural diaryl ether dimer with anti-allergic properties.
DRB: 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole, an inhibitor of protein kinase CK2.
INSL3 B CHAIN DIMER ANALOGUE 8: A synthetic analog based on insulin-like peptide 3.
CEFOTIAM HYDROCHLORIDE: The salt of cefotiam, a second-generation cephalosporin antibiotic.
SULFAQUINOXALINE: A sulfonamide antibiotic used in veterinary medicine.
OZANIMOD: A sphingosine-1-phosphate (S1P) receptor modulator for multiple sclerosis and ulcerative colitis.
IFENPRODIL: A research chemical that is an NMDA receptor antagonist.
THUNBERGINOL A: A natural isocoumarin found in hydrangea leaves.
HG-9-91-01: A research chemical that is a selective inhibitor of the ERK5 kinase.
NADA: N-arachidonoyl dopamine, an endogenous cannabinoid.
MYRIOCIN: A potent inhibitor of serine palmitoyltransferase, an enzyme in sphingolipid synthesis.
OCTYLONIUM: An anticholinergic and antispasmodic agent.
1-PHENYLBIGUANIDE: A research chemical that acts as a 5-HT3 receptor agonist.
GLABROL: A natural prenylated isoflavonoid.
FOLPET: A phthalimide fungicide.
OXADIAZON: A pre-emergent herbicide.
2',4'-DIHYDROXYCHALCONE: A chalcone compound with various biological activities.
SIDURON: An herbicide used to control crabgrass.
COMPOUND 14N [PMID: 25589934]: A research compound described in the specified scientific publication.
CASTANOSPERMINE: A natural indolizidine alkaloid that is a potent glycosidase inhibitor.
DROFENINE HYDROCHLORIDE: The salt of drofenine, an antispasmodic agent.
(R)-NITRENDIPINE: The R-enantiomer of nitrendipine, a dihydropyridine calcium channel blocker.
SB-633825: An experimental research compound.
GLYASPERIN D: A natural product isolated from Glycyrrhiza aspera.
BROMOETHANE: An organobromine compound, also known as ethyl bromide.
HEMOPRESSIN: An endogenous peptide that acts as an inverse agonist at the CB1 cannabinoid receptor.
BX-795: A research chemical that inhibits the PDK1 and TBK1/IKKÎµ kinases.
MELEVODOPA: A methyl ester prodrug of levodopa.
DIMETHISOQUIN HYDROCHLORIDE: The salt of dimethisoquin, a topical anesthetic.
(-)-N-PORPHYNORAPOMORPHINE: An experimental research chemical.
PALINURIN: A natural product isolated from a marine sponge.
CASEARINONE B: A natural product isolated from the plant Casearia sylvestris.
OCHROMYCINONE: An angucyclinone antibiotic.
DIFFRACTAIC ACID: A natural depside found in lichens.
2,3,4,4'-TETRAMETHOXYBIPHENYL: A methoxy-substituted biphenyl compound.
LISINOPRIL HYDRATE: The hydrated form of lisinopril, an ACE inhibitor.
CGS 21680: A research chemical that is a selective A2A adenosine receptor agonist.
CYMOXANIL: A cyanoacetamide fungicide.
HYMECROMONE METHYL ETHER: The methyl ether of hymecromone.
(S)-VERAPAMIL: The S-enantiomer of verapamil, a calcium channel blocker.
AMITRIPTYLINOXIDE: A metabolite of the antidepressant amitriptyline.
COCLAURINE: A benzylisoquinoline alkaloid.
METHYLENE BLUE: A dye with various medical uses, including as a treatment for methemoglobinemia.
THAPSIGARGIN: A natural sesquiterpene lactone that inhibits SERCA pumps.
ONTERNABEZ: An experimental gamma-secretase modulator for Alzheimer's disease.
CYCLOASPEPTIDE A: A natural cyclic peptide with anti-inflammatory activity.
BUNITROLOL: A non-selective beta-blocker.
CLOSTEBOL: A synthetic anabolic-androgenic steroid.
INGLIFORIB: An investigational PI3K delta inhibitor.
QUININE ETHYLCARBONATE: A tasteless ester of the antimalarial drug quinine.
DIBUTYLDICHLOROSTANNANE: An organotin compound.
IPRONIAZID PHOSPHATE: The salt of iproniazid, a monoamine oxidase inhibitor (MAOI).
CLOFIBRIC ACID: The active metabolite of several fibrate drugs used to lower lipids.
FLUORANTHENE: A polycyclic aromatic hydrocarbon (PAH).
METHYL ANTHRANILATE: An ester of anthranilic acid used as a flavoring and fragrance.
LUCIDUMOL A: A natural product isolated from a mushroom.
ECHINATIN: A natural chalcone with anti-inflammatory properties.
TALIPEXOLE: A dopamine agonist used to treat Parkinson's disease.
MERSALYL: An organomercury compound formerly used as a diuretic.
(S)-ALAPROCLATE: An experimental selective serotonin reuptake inhibitor (SSRI).
VINBURNINE: A vinca alkaloid derivative with cerebrovascular effects.
DEXEFAROXAN: The active dextrorotatory enantiomer of efaroxan, an alpha-2 adrenoceptor antagonist.
BENZOPHENONE: An organic compound used in sunscreens and as a photoinitiator.
O-F-AMIDINE: An experimental research compound.
VEGFRECINE: An experimental research compound.
MIZAGLIFLOZIN: An investigational SGLT1 inhibitor.
COMPOUND 3 [PMID: 19191557]: A research compound described in the specified scientific publication.
E5700: An experimental research compound.
1-ALLYL-2-[3-(ISOPROPYLAMINO)PROPOXY]-9H-XANTHEN-9-ONE: A chemical name for a specific research compound.
DC 23-60: An experimental research compound.
[111IN]DOTA-BOC-ATE: A radiolabeled octreotate analog for imaging.
NVPâ€TNKS656: An experimental inhibitor of tankyrase enzymes.
DITIOCARB: A chelating agent, also known as diethyldithiocarbamate.
ISOFLAVONE: A class of flavonoid phenolic compounds.
NIMUSTINE: A nitrosourea alkylating agent used in chemotherapy.
SOBETIROME: An experimental selective thyroid hormone receptor-beta agonist.
GSK2245035: An experimental research compound from GlaxoSmithKline.
AMPRENAVIR: An HIV protease inhibitor.
DTRIM24: An experimental research compound.
JT010: An experimental research compound.
AURANOFIN: A gold-containing compound used as a disease-modifying antirheumatic drug (DMARD).
OPTOBI-1: An experimental research compound.
PICO145: A research chemical that is a potent inhibitor of PI3K delta and PI3K gamma.
SCUTELLAREIN: A flavone found in plants of the genus Scutellaria.
CEFEPIME: A fourth-generation cephalosporin antibiotic.
ESTRADIOL 3-METHYL ETHER: A methylated derivative of estradiol.
ISOPENTENYL PYROPHOSPHATE: An intermediate in the mevalonate pathway for isoprenoid synthesis.
ASPIRIN-TRIGGERED RESOLVIN D1: A specialized pro-resolving lipid mediator.
BUTEIN: A chalcone with antioxidant and anti-inflammatory properties.
ANTIANXIETY AGENT: A general term for a drug that alleviates anxiety.
COMPOUND 27F [PMID: 25625617]: A research compound described in the specified scientific publication.
[PEN5]U-(4-11) (HUMAN): A modified peptide fragment of urotensin.
VESAMICOL: A research chemical that inhibits the vesicular acetylcholine transporter.
IL-4: Interleukin-4, a cytokine that induces differentiation of helper T cells.
[LYS15,ARG16,LEU27]VIP-(1-7)/GRF-(8-27)-NH2: A hybrid peptide combining parts of VIP and GRF.
NPY-(22-36) (PIG): A C-terminal fragment of porcine Neuropeptide Y.
[ALA31,AIB32]NPY (PIG): A modified analog of porcine Neuropeptide Y.
NPY-(3-36) (PIG): A fragment of porcine Neuropeptide Y that is a Y2 receptor agonist.
RECOMBINANT THYROID-STIMULATING HORMONE: A genetically engineered form of TSH, also known as thyrotropin alfa.
ALPHA-ADRENERGIC ANTAGONIST: A class of drugs that block alpha-adrenergic receptors, also known as alpha-blockers.
SORBITOL: A sugar alcohol used as a sugar substitute and laxative.
OTERACIL POTASSIUM: The potassium salt of oteracil, an inhibitor of orotate phosphoribosyltransferase.
H3B-8800: An investigational modulator of the SF3b splicing factor complex.
SITAMAQUINE: An 8-aminoquinoline drug candidate for leishmaniasis.
JAK3 INHIBITOR II: A research chemical that selectively inhibits Janus kinase 3.
GLYCEROL PHENYLBUTYRATE: A nitrogen-binding agent for urea cycle disorders.
ROPEGINTERFERON ALFA-2B: A long-acting, mono-pegylated interferon alfa-2b.
LUMASIRAN: An siRNA therapy for primary hyperoxaluria type 1.
OMACETAXINE: A protein synthesis inhibitor used to treat chronic myeloid leukemia.
MK0731: An experimental research compound from Merck.
ALMOTRIPTAN: A 5-HT1B/1D receptor agonist used to treat migraines.
ATAMESTANE: An experimental steroidal aromatase inhibitor.
ENFORTUMAB VEDOTIN: An antibody-drug conjugate targeting Nectin-4 for urothelial cancer.
ANTI-PKN3 SIRNA ATU027: An experimental siRNA therapy targeting Protein Kinase N3.
AVE-1625: An experimental cannabinoid CB1 receptor antagonist.
CROFELEMER: A botanical drug that inhibits chloride ion channels, used for diarrhea.
CTA018: An experimental research compound.
KB002: An investigational monoclonal antibody.
MEM 1414: An experimental phosphodiesterase 4 inhibitor.
DILMAPIMOD: An investigational p38 MAP kinase inhibitor.
TOZADENANT: An experimental A2A adenosine receptor antagonist for Parkinson's disease.
MTOR KINASE INHIBITOR AZD8055: An experimental ATP-competitive inhibitor of mTOR kinase.
DIAZEPINOMICIN: A natural product with antibacterial and anticancer activity.
VIPADENANT: An experimental A2A adenosine receptor antagonist.
CERULETIDE: A peptide analog of cholecystokinin used as a diagnostic agent.
OXYPHENONIUM: An anticholinergic drug.
ZUCLOPENTHIXOL: A typical antipsychotic of the thioxanthene class.
CISATRACURIUM BESYLATE: An intermediate-acting non-depolarizing neuromuscular blocking agent.
DEGARELIX: A gonadotropin-releasing hormone (GnRH) receptor antagonist for prostate cancer.
METHOHEXITAL: A short-acting barbiturate anesthetic.
YSIL6: An experimental research compound.
VUPANORSEN: An investigational antisense oligonucleotide targeting ANGPTL3.
BLZ-945: An experimental CSF1R kinase inhibitor.
PALUPIPRANT: An experimental EP4 receptor antagonist.
ATM INHIBITOR M 3541: An experimental inhibitor of the ATM kinase.
EVEXOMOSTAT: An investigational dipeptidyl peptidase inhibitor.
FF-10501-01: An experimental guanine analog for cancer therapy.
SABATOLIMAB: An investigational monoclonal antibody targeting TIM-3.
BIMAGRUMAB: An investigational monoclonal antibody that blocks activin type II receptors.
SETIPIPRANT: An experimental antagonist of the prostaglandin D2 receptor 2.
SAR425899: An experimental research compound from Sanofi.
SHP2 INHIBITOR PF-07284892: An experimental inhibitor of the SHP2 phosphatase.
SAMALIZUMAB: An investigational monoclonal antibody that targets CD200.
INSULIN, REGULAR, PORK: A short-acting insulin preparation derived from pork.
TRIMEPRAZINE: A first-generation antihistamine with sedative properties.
TEMUTERKIB: An investigational ERK1/2 kinase inhibitor.
AROFYLLINE: An experimental phosphodiesterase 4 inhibitor.
NICARAVEN: A free radical scavenger used to treat brain damage.
MPI-0479605: An experimental kinase inhibitor.
AMITIFADINE HYDROCHLORIDE: The salt of amitifadine, a triple reuptake inhibitor.
SB-743921: An experimental inhibitor of the kinesin spindle protein (KSP).
CINACIGUAT: An experimental soluble guanylate cyclase activator.
FENBUFEN: A non-steroidal anti-inflammatory drug (NSAID).
ODM-203: An experimental TRK kinase inhibitor.
LATIGLUTENASE: An experimental enzyme therapy for celiac disease.
GW 597599: An experimental research compound from GlaxoSmithKline.
MK-0773: An experimental selective androgen receptor modulator (SARM).
MALTOSE: A disaccharide sugar made of two glucose units.
POLMACOXIB: A selective COX-2 inhibitor for osteoarthritis.
LIDOFLAZINE: A coronary vasodilator and calcium channel blocker.
CYCLOPENTENYL CYTOSINE: An experimental anticancer agent.
NXN-188: An experimental dual NOS inhibitor and 5-HT1B/1D receptor agonist.
LY2828360: An experimental BACE1 inhibitor.
MITEMCINAL FUMARATE: The salt of mitemcinal, an experimental motilin receptor agonist.
AUTOLOGOUS ANTI-BCMA-CAR-4-1BB-CD3ZETA-EXPRESSING T-CELLS C-CAR088: An investigational CAR T-cell therapy targeting BCMA.
ANDROGEN RECEPTOR ANTISENSE OLIGONUCLEOTIDE AZD5312: An experimental antisense therapy targeting the androgen receptor.
PYRUVATE KINASE INHIBITOR TLN-232: An experimental peptide that inhibits pyruvate kinase M2.
IPAMORELIN: A peptide that is a selective growth hormone secretagogue.
DEGLYCOSYLATED RICIN A CHAIN-CONJUGATED ANTI-CD19/ANTI-CD22 IMMUNOTOXINS: An experimental dual-targeting immunotoxin therapy.
FF-10101: An experimental antimetabolite drug.
MOTESANIB DIPHOSPHATE: The salt of motesanib, an experimental multi-kinase inhibitor.
MAZINDOL: A sympathomimetic amine used as a short-term appetite suppressant.
TAK-071: An investigational M1 muscarinic receptor positive allosteric modulator.
2-HYDROXYOLEIC ACID: A synthetic fatty acid analog with anticancer properties.
RHODACYANINE ANALOG MKT-077: An experimental cationic dye that accumulates in mitochondria of cancer cells.
BIMOSIAMOSE: An experimental pan-selectin antagonist.
LECOZOTAN HYDROCHLORIDE: The salt of lecozotan, an experimental 5-HT1A receptor antagonist.
BROLAMFETAMINE: A psychedelic drug of the phenethylamine class.
SDZ SER-082: An experimental research compound.
RS 100235: An experimental research compound.
GR 125487: A research chemical that is a selective 5-HT1D receptor antagonist.
FICONALKIB: An investigational ALK/IGF-1R kinase inhibitor.
(+)-CYCLAZOSIN: An experimental alpha-1b adrenergic receptor antagonist.
[3H]MK-912: A radiolabeled alpha-1b adrenergic receptor antagonist.
RACEPINEPHRINE: A racemic mixture of epinephrine isomers, used as a bronchodilator.
GALETERONE: An investigational antiandrogen for prostate cancer.
IMIDAPRILAT: The active metabolite of the ACE inhibitor imidapril.
(R,S)-PHPNECA: A research chemical that is an A1 adenosine receptor agonist.
CGP42112: A peptide that is a selective angiotensin II AT2 receptor agonist.
N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE: A chemical name for an ABL kinase inhibitor.
BV-6: A research chemical that is a bivalent IAP antagonist.
[D-TYR6,(R)-APA11,PHE13,NLE14]BOMBESIN-(6-14): A modified bombesin receptor antagonist.
AZD4320: An investigational dual inhibitor of BCL2 and BCLxL.
SIM1: An experimental research compound.
COMPOUND 9 [PMID: 23517011]: A research compound described in the specified scientific publication.
N-METHYL-2-PYRROLIDONE: An organic solvent.
CNX-774: A research chemical that is a covalent inhibitor of Bruton's tyrosine kinase (BTK).
RN486: An experimental IRAK4 kinase inhibitor.
MET-LYS-BRADYKININ: A naturally occurring kinin peptide.
B-10356: An experimental research compound.
SSR240612: An experimental bradykinin B1 receptor antagonist.
NG291: An experimental research compound.
COMPOUND 4 [PMID: 25259874]: A research compound described in the specified scientific publication.
COMPOUND 2C [PMID: 22115617]: A research compound described in the specified scientific publication.
TECALCET: A calcium-sensing receptor agonist for secondary hyperparathyroidism.
CCL18: A chemokine also known as PARC.
KALLSTROEMIN D: A natural product from a marine sponge.
JH-VIII-49: An experimental research compound.
BSJ-03-123: An experimental covalent CDK12 inhibitor.
(S)-CR8: A research chemical that inhibits cyclin-dependent kinases (CDKs).
URMC-099: An experimental kinase inhibitor with neuroprotective properties.
YT47R: An experimental research compound.
[3H]DPDPE: A radiolabeled selective delta-opioid receptor agonist.
DSM421: An experimental antimalarial agent that inhibits dihydroorotate dehydrogenase.
ML321: A research chemical that is a selective inhibitor of the deubiquitinase USP2.
R-VK4-40: An experimental research compound.
[125I]L750667: A radiolabeled dopamine D4 receptor antagonist.
N-PROPYLNORAPOMORPHINE: A potent D2/D3 dopamine receptor agonist.
EPZ011989: An experimental EZH2 methyltransferase inhibitor.
NAZARTINIB: An investigational mutant-selective EGFR inhibitor.
PD166285: A research chemical that is a potent inhibitor of FGFR and VEGFR kinases.
MS39: An experimental research compound.
PKI166: An experimental dual inhibitor of EGFR and HER2/neu kinases.
GRIFOLIC ACID METHYL ETHER: A methylated derivative of a natural product.
ISOBUTYRIC ACID: A carboxylic acid found in some foods and esters.
COMPOUND 19B [PMID: 37058391]: A research compound described in the specified scientific publication.
AC710: An experimental research compound.
GSK2334470: An experimental Akt kinase inhibitor.
BVT173187: An experimental research compound.
MET-MET-TRP-LEU-LEU: A synthetic peptide.
PRP106-126: A peptide fragment.
F7H: An experimental research compound.
&ALPHA;5IA: An experimental inverse agonist at the Î±5 subunit of GABA-A receptors.
GALANIN(1-15): An N-terminal fragment of the neuropeptide galanin.
GAL-B2-C18: A modified galanin analog.
DITHIIPIN-1,1,4,4-TETROXIDE ANALOGUE 7: A complex organic research chemical.
OPIRANSERIN: An investigational 5-HT2A receptor inverse agonist.
HISTERELIN: A gonadotropin-releasing hormone (GnRH) agonist.
[125I]GNRH I (HUMAN, MOUSE, RAT): A radiolabeled version of gonadotropin-releasing hormone.
[125I]CETRORELIX: A radiolabeled GnRH antagonist.
COMPOUND 77A [PMID: 37639383]: A research compound described in the specified scientific publication.
MK 6892: An experimental research compound from Merck.
EC18: An experimental research compound.
B AND T LYMPHOCYTE ATTENUATOR: BTLA, an inhibitory receptor expressed on lymphocytes.
TUBACIN: A research chemical that is a selective inhibitor of histone deacetylase 6 (HDAC6).
COMPOUND 16 [PMID: 20947351]: A research compound described in the specified scientific publication.
SANTACRUZAMATE A: A research chemical that inhibits histone deacetylase (HDAC) activity.
METHYLHISTAPRODIFEN: A research chemical that is a histamine H3 receptor ligand.
TIOTIDINE: A potent histamine H2 receptor antagonist used in research.
2-METHYLHISTAMINE: A selective histamine H1 receptor agonist.
METHIMEPIP: A research chemical that is a potent histamine H3 and H4 receptor agonist.
2-HYDROXYLAURIC ACID: A hydroxylated fatty acid.
BETA-ALANINE: A non-essential amino acid that is a precursor to carnosine.
COMPOUND 8U [PMID: 31999451]: A research compound described in the specified scientific publication.
PIP2: Phosphatidylinositol 4,5-bisphosphate, a key signaling lipid in cell membranes.
COMPOUND 8L [PMID: 36053746]: A research compound described in the specified scientific publication.
INDIUM-111: A radioactive isotope of indium used in medical imaging.
LINTOPRIDE: An experimental 5-HT4 receptor agonist.
ERGTX-1: A peptide toxin that blocks HERG potassium channels.
APX-3330: An investigational agent that targets the APE1/Ref-1 protein.
3S,4R-293B: An experimental research compound.
COMPOUND 3 [PMID: 22533316]: A research compound described in the specified scientific publication.
AUTOLOGOUS ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T-CELLS C-CAR011: An investigational CAR T-cell therapy targeting CD19.
COMPOUND 39 [PMID: 23623673]: A research compound described in the specified scientific publication.
ZAK INHIBITOR 6P: A research chemical that inhibits ZAK (MLTK) kinase.
COMPOUND 6N [PMID: 31419141]: A research compound described in the specified scientific publication.
27-HYDROXYCHOLESTEROL: An oxysterol that acts as an endogenous selective estrogen receptor modulator.
NADIDE: The oxidized form of nicotinamide adenine dinucleotide (NAD+).
COMPOUND 6A [PMID: 18942826]: A research compound described in the specified scientific publication.
[PHE13,TYR19]MCH: A modified analog of melanin-concentrating hormone.
GALAPAGOS MAPKAPK5 INHIBITOR D: An experimental inhibitor of the MAPKAPK5 kinase.
AZD5991: An investigational Mcl-1 protein inhibitor.
[AVA9,10,AVA14,15]-AC-HMCH6-16-NH2: A modified peptide fragment of melanin-concentrating hormone.
COMPOUND 2F [PMID: 17532216]: A research compound described in the specified scientific publication.
COMPOUND 23E [PMID: 17929793]: A research compound described in the specified scientific publication.
MEK INHIBITOR I: A research chemical that inhibits MAP kinase kinase (MEK).
4-DAMP: A research chemical that is a selective antagonist of the M3 muscarinic receptor.
DUO3: An experimental research compound.
LEVETIMIDE: An experimental anticonvulsant.
HEXOCYCLIUM: An anticholinergic drug.
N-BENZYL BRUCINE: A derivative of the alkaloid brucine.
COMPOUND 28 [PMID: 28671460]: A research compound described in the specified scientific publication.
PF-06282999: An experimental diacylglycerol O-acyltransferase 2 (DGAT2) inhibitor.
PF?6526290: An experimental research compound from Pfizer.
COMPOUND 7 [PMID: 37428122]: A research compound described in the specified scientific publication.
PHYSALAEMIN: A tachykinin peptide found in amphibian skin.
L-703,606: A research chemical that is a neurokinin 1 (NK1) receptor antagonist.
MEN10627: An experimental neurokinin 2 (NK2) receptor antagonist.
NT-0796: An experimental research compound.
AT-403: An experimental research compound.
MCOPPB: An experimental mGlu5 receptor negative allosteric modulator.
N/OFQ-(1-13)-NH2: A fragment of the neuropeptide nociceptin/orphanin FQ.
PEG40-NMU: A pegylated form of neuromedin U.
BMS-813160: An investigational chemokine receptor D6 (CCR D6) modulator.
(3,5)-[19F]2-PHE-&PSI;-ALA: A modified peptide for research.
LYS[Z(NO2)]-PRO: A chemically protected dipeptide.
[3H]-IPP: A radiolabeled research compound.
GW0742X: An experimental selective PPAR beta/delta agonist.
BADGE: Bisphenol A diglycidyl ether, a component of epoxy resins with PPAR gamma antagonist activity.
PAT5A: An experimental research compound.
MK-0359: An experimental research compound from Merck.
ME0328: An experimental research compound.
MICROCYSTIN-LR: A potent hepatotoxin produced by cyanobacteria.
OKADAIC ACID: A marine toxin that is a potent inhibitor of protein phosphatases.
[3H]N5-METHYLFOLATE: A radiolabeled form of the active B vitamin folate.
QRFP43: A 43-amino acid pyroglutamylated RF-amide peptide.
NANOLUC R3/I5 CHIMERA: A bioluminescent chimeric peptide of relaxin-3 and INSL5.
B1-27: A peptide antagonist of the relaxin family peptide receptor 1 (RXFP1).
PHYTOSPHINGOSINE 1-PHOSPHATE: A phosphorylated sphingoid base.
BAY-293: An experimental research compound from Bayer.
DEMOTATE 2: An experimental research compound.
L-054,522: An experimental research compound.
CST-17: An experimental research compound.
A947: An experimental research compound.
COMPOUND 21 [PMID: 34141085]: A research compound described in the specified scientific publication.
METHYLMALONIC ACID: An organic acid whose levels are elevated in vitamin B12 deficiency.
I-432: An experimental research compound.
INDIPLON: An experimental non-benzodiazepine sedative-hypnotic.
EXAMPLE 8 [WO1999033801A1]: A chemical compound described in the specified patent application.
GSK1702934A: An experimental transient receptor potential vanilloid 4 (TRPV4) channel activator.
PHOSPHATIDYL (3,5) INOSITOL BISPHOSPHATE: A phosphoinositide signaling lipid.
SB452533: An experimental research compound.
AC-7954: An experimental research compound.
FL104: An experimental research compound.
JNJ-39319202: An experimental histamine H4 receptor antagonist.
[LEU31,PRO34]NPY (PIG): A modified analog of porcine Neuropeptide Y that is a selective Y1 receptor agonist.
TERT-BUTYLPHENOXYCYCLOHEXANOL: A chemical intermediate.
DUP-697: A research chemical that is a selective COX-2 inhibitor.
CEFMETAZOLE SODIUM: The salt of cefmetazole, a second-generation cephalosporin antibiotic.
DUAL IGF-1R/INSR INHIBITOR BMS-754807: An experimental dual inhibitor of the IGF-1 and insulin receptors.
BEDORADRINE SULFATE: The salt of bedoradrine, an experimental beta-2 adrenergic agonist.
SERIBANTUMAB: An investigational monoclonal antibody targeting HER3/ErbB3.
TOMINOSTAT: An investigational histone deacetylase (HDAC) inhibitor.
AGI-5198: An experimental inhibitor of the mutant IDH1 enzyme.
ERK INHIBITOR CC-90003: An experimental inhibitor of the ERK kinase.
SCH772984: A research chemical that is a selective inhibitor of ERK1/2 kinases.
MS417: An experimental research compound.
BORUSSERTIB: An investigational PLK4 kinase inhibitor.
PF-04191834: An experimental research compound from Pfizer.
DYSIHERBAINE: A natural kainoid amino acid with neuroexcitatory properties.
SZUH280: An experimental research compound.
BEKM-1: An experimental research compound.
AE9C90CB: An experimental research compound.
[14C]GLYSAR: A radiolabeled tracer for imaging the glycine transporter 1 (GlyT1).
PATISIRAN: An RNA interference (RNAi) therapeutic for hereditary transthyretin-mediated amyloidosis.
TYRPHOSTIN A25: A research chemical that inhibits the EGFR tyrosine kinase.
(R)-INDOPROFEN: An experimental cyclooxygenase inhibitor.
MIPSAGARGIN: An experimental prodrug of a thapsigargin analog for prostate cancer.
SIVIFENE: An experimental research compound.
TOMELUKAST: An experimental leukotriene receptor antagonist.
BMS-986142: An experimental lysophosphatidic acid receptor 1 (LPA1) antagonist.
SARAFOTOXIN S6C: A peptide toxin from snake venom that is an endothelin receptor agonist.
GHRP-6: A synthetic peptide that is a growth hormone secretagogue.
[ILE5,TRP23]PTHRP-(4-36) (HUMAN): A synthetic analog of parathyroid hormone-related protein.
ROBALZOTAN: An experimental 5-HT1A receptor antagonist.
COMPOUND 10A [PMID: 31283223]: A research compound described in the specified scientific publication.
CITARINOSTAT: An experimental histone deacetylase 6 (HDAC6) inhibitor.
INSULIN ZINC SUSP SEMISYNTHETIC PURIFIED HUMAN: An intermediate-acting (Lente) human insulin preparation.
PRITUMUMAB: An investigational monoclonal antibody for brain tumors.
COMPOUND 11H [PMID: 29808961]: A research compound described in the specified scientific publication.
VASCULAR DISRUPTING AGENT BNC105: An experimental tubulin inhibitor that disrupts tumor vasculature.
PROCAINE: A local anesthetic of the ester type.
SGN-CD70A: An antibody-drug conjugate targeting the CD70 protein.
LONCASTUXIMAB TESIRINE: An antibody-drug conjugate targeting CD19.
MECAMYLAMINE HYDROCHLORIDE: The salt of mecamylamine, a nicotinic acetylcholine receptor antagonist.
CX157: An experimental research compound.
SJ995973: An experimental research compound.
VU0155094: A research chemical that is a positive allosteric modulator of the mGlu4 receptor.
ESTRAMUSTINE PHOSPHATE SODIUM: The salt of estramustine phosphate, a chemotherapy agent for prostate cancer.
ALUM, POTASSIUM: Potassium aluminum sulfate, used as an adjuvant in vaccines.
F215: An experimental research compound.
SA-57: An experimental research compound.
BESIFLOXACIN HYDROCHLORIDE: The salt of besifloxacin, a topical fluoroquinolone antibiotic.
PF-4191834: An experimental ALK5 kinase inhibitor.
FLOTETUZUMAB: An investigational bispecific antibody targeting CD123 and CD3.
COMPOUND 15B [PMID: 31811124]: A research compound described in the specified scientific publication.
OHM-11526: An experimental research compound.
HYDROXYCHLOROQUINE SULFATE: The salt of hydroxychloroquine, a drug for malaria, lupus, and rheumatoid arthritis.
TETRYDAMINE: An experimental anti-inflammatory and analgesic agent.
NARSOPLIMAB: An investigational monoclonal antibody that targets MASP-2 in the lectin complement pathway.
COMPOUND 3 [PMID: 21105727]: A research compound described in the specified scientific publication.
FD6: An experimental research compound.
TEIJIN-LEAD_CMP_5: An experimental research compound.
CANTHARIDIN: A toxic blistering agent produced by blister beetles.
COMPOUND 15A [PMID: 22464687]: A research compound described in the specified scientific publication.
IMPLITAPIDE: An experimental inhibitor of microsomal triglyceride transfer protein (MTP).
HOOKEROSIDE A: A natural product.
INCB13739: An experimental research compound from Incyte Corporation.
METHSCOPOLAMINE BROMIDE: The salt of methscopolamine, an anticholinergic agent.
HYDROCORTISONE PROBUTATE: A topical corticosteroid ester.
GSK-356278: An experimental selective androgen receptor modulator (SARM).
NALOXONE METHIODIDE: A peripherally acting opioid antagonist.
ATG002: An experimental research compound.
LAVENDUSTIN B: A research chemical that inhibits tyrosine kinases.
GREPAFLOXACIN: A fluoroquinolone antibiotic, withdrawn from the market.
DUSQUETIDE: An experimental peptide that modulates immune responses.
ONO-8711: An experimental EP1 receptor antagonist.
VU0409551: A research chemical that is a positive allosteric modulator of the mGlu4 receptor.
8-DEOXY-NEODYSIHERBAINE: A natural kainoid amino acid.
AMINACRINE: A topical antiseptic and fluorescent dye.
BUROSUMAB-TWZA: A monoclonal antibody that targets FGF23, used to treat X-linked hypophosphatemia.
SERINE/THREONINE KINASE INHIBITOR CBP501: An experimental kinase inhibitor.
AZD-7762: An experimental CHK1 kinase inhibitor.
ROPSACITINIB: An investigational TYK2/JAK1 inhibitor.
COBITOLIMOD SODIUM: The salt of cobitolimod, an investigational Toll-like receptor 9 (TLR9) agonist.
LOVASTATIN ACID: The active hydroxy acid form of the statin drug lovastatin.
12-HYDROXY-4,4-BISNOR-4,8,11,13-PODOCARPATETRAEN-3-ONE: A chemical name for a specific research compound.
COBIMETINIB FUMARATE: The salt of cobimetinib, a MEK inhibitor for melanoma.
ULEVOSTINAG: An experimental research compound.
COMPOUND 3B [PMID: 23454515]: A research compound described in the specified scientific publication.
AVE-9940: An experimental research compound.
BECATECARIN: An experimental topoisomerase I and II inhibitor.
[125I]BANTAG-1: A radiolabeled research compound.
CDK1 INHIBITOR: A class of drugs that block cyclin-dependent kinase 1.
(+)-HA966: A research chemical that is an antagonist at the glycine site of the NMDA receptor.
ANANTIN: A cyclic peptide that is a bradykinin B2 receptor antagonist.
CTCE-9908: An experimental antagonist of the CXCR4 chemokine receptor.
SSR-103800: An experimental glycine reuptake inhibitor.
DASIGLUCAGON HYDROCHLORIDE: The salt of dasiglucagon, a glucagon analog for severe hypoglycemia.
RISEDRONIC ACID: A bisphosphonate used to treat osteoporosis.
ZELNECIRNON: An investigational TLR7/8 antagonist.
LCL161: An experimental IAP antagonist that promotes apoptosis in cancer cells.
VAMOROLONE: A dissociative steroid with anti-inflammatory but reduced side effects.
SU11274: A research chemical that is a selective inhibitor of the c-Met kinase.
RACECADOTRIL: An enkephalinase inhibitor used as an antidiarrheal drug.
(-)-U-50488 METHANE SULFONATE: The salt of U-50488, a selective kappa-opioid receptor agonist.
SPIPERONE HYDROCHLORIDE: The salt of spiperone, a typical antipsychotic and research tool.
MRE 2029F20: An experimental A3 adenosine receptor antagonist.
MRS8054: An experimental research compound.
BSJ-03-204: An experimental research compound.
RONOPTERIN: A dihydropteridine reductase inhibitor.
ETRAVIRINE: A non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV.
DAROLUTAMIDE: A non-steroidal androgen receptor antagonist for prostate cancer.
RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST: A genetically engineered version of IL-1Ra, also known as anakinra.
DARIZMETINIB: An investigational EZH2 methyltransferase inhibitor.
ZASOCITINIB: An investigational JAK inhibitor.
SB 243213: A research chemical that is a selective 5-HT2C receptor inverse agonist.
MIRICORILANT: An investigational glucocorticoid receptor antagonist.
RELAXIN-1: A peptide hormone involved in reproduction and cardiovascular regulation.
MONGERSEN: An experimental antisense oligonucleotide targeting SMAD7.
TANAPROGET: An experimental non-steroidal progesterone receptor agonist.
AVA5: An experimental research compound.
ARTESUNATE: An antimalarial drug derived from artemisinin.
BETA-DEFENSIN 4A: An antimicrobial peptide involved in innate immunity.
N-PHENYLTHIOUREA: A chemical compound that tastes bitter to individuals with a certain genotype.
OLOKIZUMAB: An investigational monoclonal antibody that targets interleukin-6.
EFAPROXIRAL: An experimental allosteric modifier of hemoglobin that enhances oxygen release.
BAY-1125976: An experimental P2X4 receptor antagonist.
COMPOUND 60 [PMID: 26155854]: A research compound described in the specified scientific publication.
CVN424: An investigational GPR6 inverse agonist for Parkinson's disease.
MITOGUAZONE: An inhibitor of S-adenosylmethionine decarboxylase with anticancer activity.
JMV3008: An experimental research compound.
ATACICEPT: A fusion protein that inhibits B-lymphocyte stimulator (BLyS) and APRIL.
DIPHENYLSULFANE: An organosulfur compound, also known as diphenyl sulfide.
BALSALAZIDE: A prodrug of mesalazine, used to treat inflammatory bowel disease.
TOBRAMYCIN: An aminoglycoside antibiotic.
BMS-817378: An experimental ALK inhibitor.
DX-9065A: An experimental direct factor Xa inhibitor.
TRIADIMEFON: A triazole fungicide.
ELDECALCITOL: An active vitamin D3 analog for osteoporosis.
[3H]ELETRIPTAN: A radiolabeled version of the migraine drug eletriptan.
CCR5 MAB: A monoclonal antibody that targets the CCR5 chemokine receptor.
UDM-001651: An experimental research compound.
BJP-06-005-3: An experimental research compound.
PENCONAZOLE: A triazole fungicide.
AZD-3043: An experimental glucagon receptor antagonist.
BENZYL SALICYLATE: An ester used as a fragrance and UV light absorber.
NETILMICIN SULFATE: The salt of netilmicin, an aminoglycoside antibiotic.
[125I]CXCL5 (HUMAN): A radiolabeled version of the human chemokine CXCL5.
CAMOTESKIMAB: An investigational monoclonal antibody.
XCC: An experimental research compound.
EFWSLAAPQRF-NH2: The peptide sequence for QRFP-26.
CID1792197: An identifier for a chemical compound used in research databases.
BUFOGENIN: A cardiotoxic steroid found in the venom of some toads.
AUY922: An experimental Hsp90 inhibitor.
UCM 765: An experimental research compound.
L-796449: An experimental research compound.
(R/S) EF-1500: An experimental research compound.
OLPRINONE: A phosphodiesterase 3 inhibitor with positive inotropic and vasodilatory effects.
XL-820: An experimental multi-kinase inhibitor.
LH (MENOTROPINS): Luteinizing hormone, a gonadotropin extracted from urine.
OLMESARTAN MEDOXOMIL: A prodrug of olmesartan, an angiotensin II receptor blocker for hypertension.
SODIUM VALPROATE: The sodium salt of valproic acid, an anticonvulsant and mood stabilizer.
NARATRIPTAN HYDROCHLORIDE: The salt of naratriptan, a 5-HT1B/1D receptor agonist for migraines.
LORCASERIN HYDROCHLORIDE: The salt of lorcaserin, a 5-HT2C receptor agonist formerly for weight loss.
FENTANYL HYDROCHLORIDE: The salt of fentanyl, a potent synthetic opioid analgesic.
HYDROCORTAMATE HYDROCHLORIDE: The salt of hydrocortamate, a topical corticosteroid.
BETAMETHASONE SODIUM PHOSPHATE: A water-soluble salt of betamethasone, a potent glucocorticoid.
DEXAMETHASONE SODIUM PHOSPHATE: A water-soluble salt of dexamethasone, a potent glucocorticoid.
METHOXAMINE HYDROCHLORIDE: The salt of methoxamine, a selective alpha-1 adrenergic receptor agonist.
TRIMETHAPHAN CAMSYLATE: The salt of trimethaphan, a short-acting ganglionic blocker.
INAMRINONE LACTATE: The lactate salt of inamrinone, a phosphodiesterase 3 inhibitor for congestive heart failure.
GSK2849466: An experimental research compound from GlaxoSmithKline.
JTE-151: An experimental research compound.
SERABELISIB: An investigational PI3K alpha/delta inhibitor.
RG7893: An experimental research compound from Roche.
DAGROCORAT: An investigational glucocorticoid receptor modulator.
EFATUTAZONE HYDROCHLORIDE: The salt of efatutazone, an experimental PPAR gamma agonist.
CP-778875: An experimental research compound.
AMG-337: An experimental c-Met kinase inhibitor.
R-333: An experimental research compound.
DNK333: An experimental gamma-secretase inhibitor.
PF-03654764: An experimental histamine H3 receptor antagonist.
JNJ-17216498: An experimental histamine H3 receptor antagonist.
AZD2207: An experimental research compound from AstraZeneca.
N6-PHENYLADENOSINE: An adenosine analog.
PEGNIVACOGIN: A pegylated aptamer that binds to von Willebrand factor.
DARUNAVIR: An HIV protease inhibitor.
MAFTIVIMAB: An investigational monoclonal antibody.
HARMINE HYDROCHLORIDE: The salt of harmine, a fluorescent beta-carboline alkaloid.
MONTEPLASE: A recombinant tissue-type plasminogen activator.
BALSTILIMAB: An investigational monoclonal antibody targeting PD-1.
FULACIMSTAT: An investigational methionine aminopeptidase 2 inhibitor.
ABT-384: An experimental 5-lipoxygenase activating protein (FLAP) inhibitor.
OSI-7904: An experimental thymidylate synthase inhibitor.
AZD-5423: An experimental inhaled non-steroidal glucocorticoid receptor agonist.
MK-0557: An experimental research compound from Merck.
BIROPEPIMUT-S: An experimental therapeutic cancer vaccine.
PELITREXOL: An antifolate agent that inhibits glycinamide ribonucleotide formyltransferase.
T-62: An experimental research compound.
BNC-210: An investigational negative allosteric modulator of the alpha-7 nicotinic acetylcholine receptor.
ONGERICIMAB: An investigational monoclonal antibody.
SAXAGLIPTIN ANHYDROUS: The anhydrous form of saxagliptin, a DPP-4 inhibitor.
QUINOCIDE: An 8-aminoquinoline antimalarial drug.
HALOPEMIDE: An experimental antipsychotic agent.
BUNAMIDINE: An anthelmintic drug used in veterinary medicine.
LY367385: A research chemical that is a selective mGlu5 receptor antagonist.
CEFONICID SODIUM: The salt of cefonicid, a second-generation cephalosporin antibiotic.
GR-55562: A research chemical that is a 5-HT1D receptor antagonist.
DIMETHENAMID: A chloroacetamide herbicide.
BUPIRIMATE: A pyrimidine fungicide.
BROTIZOLAM: A short-acting thienodiazepine drug used as a hypnotic.
DIGALLIC ACID: A polyphenol composed of two gallic acid units.
METHYL AMINOLEVULINATE HYDROCHLORIDE: The salt of a prodrug used in photodynamic therapy.
ETOCARLIDE: An experimental antitubercular agent.
ARISTOLACTONE: A natural product from the plant family Aristolochiaceae.
2-ARACHIDONYL GLYCERYL ETHER: A stable analog of the endocannabinoid 2-AG.
TCS 5861528: An experimental research compound.
CARBOSULFAN: A carbamate insecticide.
SOTALOL HYDROCHLORIDE: The salt of sotalol, a non-selective beta-blocker and class III antiarrhythmic.
GSK-312948A: An experimental research compound from GlaxoSmithKline.
BETAMETHASONE VALERATE: An ester of betamethasone, a medium-potency topical corticosteroid.
CHARTREUSIN: An antibiotic natural product with anticancer properties.
3-PHENYL-CPP: A research chemical that is an NMDA receptor antagonist.
TRIFLUMIZOLE: A broad-spectrum imidazole fungicide.
ANDALUSOL: A natural diterpenoid.
CINACALCET HYDROCHLORIDE: The salt of cinacalcet, a calcimimetic agent for hyperparathyroidism.
ACACETIN DIACETATE: An acetylated derivative of the flavonoid acacetin.
CUMINGIANOSIDE A: A natural steroidal glycoside.
XYLOMETAZOLINE HYDROCHLORIDE: The salt of xylometazoline, a topical nasal decongestant.
IRISOLIDONE: A natural isoflavone.
PIRENZEPINE HYDROCHLORIDE: The salt of pirenzepine, a selective M1 muscarinic receptor antagonist.
TRICHLORFON: An organophosphate insecticide and anthelmintic.
ASCORBYL PALMITATE: An ester of ascorbic acid and palmitic acid, used as an antioxidant food additive.
5-BENZYLOXYTRYPTAMINE: A derivative of serotonin used in research.
L690330: An experimental research compound.
ETHACRIDINE: A topical antiseptic and abortifacient.
CHELIDONINE (+): The dextrorotatory isomer of chelidonine, a benzylisoquinoline alkaloid.
DEBRISOQUIN SULFATE: The salt of debrisoquin, an antihypertensive agent.
DIHYDROCAPSAICIN: A capsaicinoid found in chili peppers, an analog of capsaicin.
NEOVASTAT: An experimental anti-angiogenic agent derived from shark cartilage.
HEXAMETHYLENEBISACETAMIDE: A chemical compound that can induce cell differentiation.
BRAIN-DERIVED NEUROTROPHIC FACTOR: A protein that supports neuron survival and growth.
CEFACLOR ANHYDROUS: The anhydrous form of cefaclor, a second-generation cephalosporin antibiotic.
REVEXEPRIDE: An experimental 5-HT4 receptor antagonist.
BIZELESIN: An experimental DNA alkylating agent for cancer therapy.
BASIC FIBROBLAST GROWTH FACTOR: A signaling protein involved in angiogenesis and wound healing, also known as FGF2.
PHYTOSTEROLS: A group of steroid alcohols naturally occurring in plants.
DROTRECOGIN ALFA: Recombinant human activated protein C, formerly used for severe sepsis.
HEROIN: An illicit opioid, also known as diacetylmorphine.
OBLIMERSEN: An antisense oligonucleotide designed to inhibit the production of the Bcl-2 protein.
PAMAPIMOD: An investigational p38 MAP kinase inhibitor.
SHARK CARTILAGE EXTRACT AE-941: An experimental anti-angiogenic agent derived from shark cartilage.
JNJ-40411813: An experimental mGlu2 receptor positive allosteric modulator.
OMIGAPIL: An experimental inhibitor of apoptosis for neurodegenerative diseases.
OSI-7904L: A liposomal formulation of the experimental drug OSI-7904.
EFALIZUMAB: A monoclonal antibody targeting CD11a, formerly used for psoriasis.
PELAREOREP: An oncolytic virus (reovirus) for cancer therapy.
REV131: An experimental research compound.
[D-TPI6, LEU13 &PSI;(CH2NH)-LEU14]BOMBESIN-(6-14): A modified bombesin receptor antagonist.
GLEPAGLUTIDE: An investigational long-acting GLP-2 analog.
DROPERIDOL: A butyrophenone antipsychotic used as an antiemetic and sedative.
MDX-018: An experimental monoclonal antibody.
ORVEPITANT: An experimental neurokinin 1 (NK1) receptor antagonist.
IR502: An experimental research compound.
MEDI0680: An investigational monoclonal antibody targeting PD-1.
PF-01247324: An experimental research compound from Pfizer.
EICOSAPENTAENOIC ACID: An omega-3 fatty acid found in fish oil.
TRYPTAMINE: A monoamine alkaloid found in plants and animals.
BIMAKALIM: A potassium channel opener.
FADOLMIDINE: An experimental alpha-2 adrenergic receptor agonist.
UK-356202: An experimental research compound.
LIDORESTAT: An experimental aldose reductase inhibitor.
SPIRAPRIL: An ACE inhibitor.
NM-3: An experimental anti-angiogenic agent.
TERAMEPROCOL: An experimental agent that inhibits cyclin-dependent kinases and survivin.
MONOBENZONE: A depigmenting agent used to treat vitiligo.
[125I]CCL21 (HUMAN): A radiolabeled version of the human chemokine CCL21.
OFRANERGENE OBADENOVEC: An investigational gene therapy for cancer.
COVA322: An experimental bispecific antibody-like molecule.
GW1100: An experimental research compound from GlaxoSmithKline.
CYCLOFENIL: A selective estrogen receptor modulator (SERM) used as a fertility drug.
FOSFESTROL: A synthetic, non-steroidal estrogen used in prostate cancer therapy.
QUINOLONYL-OXAZOLIDINONE ANTIBIOTIC DNV3837: An experimental antibiotic.
VX-148: An experimental research compound.
LY-2334737: An experimental research compound from Eli Lilly.
GS-9901: An experimental spleen tyrosine kinase (Syk) inhibitor.
RITOBEGRON: A beta-3 adrenergic receptor agonist for overactive bladder.
DEZAMIZUMAB: An investigational monoclonal antibody.
TUSAMITAMAB RAVTANSINE: An antibody-drug conjugate targeting CEACAM5.
GW274150: An experimental selective inhibitor of inducible nitric oxide synthase (iNOS).
LANRAPLENIB: An investigational spleen tyrosine kinase (Syk) inhibitor.
TELCAGEPANT: An experimental CGRP receptor antagonist for migraine.
BT7480: An experimental bicyclic peptide conjugate for cancer therapy.
I3MT-3: An experimental research compound.
7-METHOXY-1-NAPHTHYLPIPERAZINE: A chemical intermediate.
PSB-11: An experimental A1 adenosine receptor antagonist.
2-HEXYNYL-NECA: A modified adenosine analog.
AS74: An experimental research compound.
OSIP339391: An experimental research compound.
HESPERADIN: A research chemical that is an inhibitor of Aurora B kinase.
5-OXO-ETE: 5-oxo-eicosatetraenoic acid, a potent chemoattractant for eosinophils.
PD 176252: An experimental CGRP receptor antagonist.
NEUROMEDIN C: A decapeptide fragment of gastrin-releasing peptide.
[(3-PH-PR6), HIS7,D-ALA11,D-PRO13,&PSI;13-14),PHE14]BOMBESIN-(6-14): A modified bombesin receptor antagonist.
COMPOUND 1B [PMID: 18078750]: A research compound described in the specified scientific publication.
SR-4133: An experimental research compound.
GRASSYSTATIN A: A natural product that inhibits cholesterol trafficking.
COMPOUND 2 [PMID: 8410973]: A research compound described in the specified scientific publication.
KASSININ: A tachykinin peptide found in the skin of some frogs.
JWH-133: A synthetic cannabinoid that is a potent selective CB2 receptor agonist.
[125I]DTYR-GLY-[(NLE28,31)CCK-26-33: A radiolabeled analog of cholecystokinin.
PG01037: An experimental chemokine CXCR4 antagonist.
SONEPIPRAZOLE: An experimental partial agonist of the D2 and D3 dopamine receptors.
MUPADOLIMAB: An investigational monoclonal antibody targeting the ICOS receptor.
EC5026: An experimental folate receptor-targeted agent.
AH13205: A research chemical that is a prostaglandin EP2 receptor antagonist.
TG11-77: An experimental research compound.
DG-041: An experimental EP3 receptor antagonist for thrombosis.
NEUREGULIN-4: A member of the epidermal growth factor (EGF) family of proteins involved in metabolism.
1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE: A chemical name for a specific research compound.
DEMECLOCYCLINE: A tetracycline antibiotic.
SARAFOTOXIN S6B: A peptide toxin from snake venom that is an endothelin receptor agonist.
UNC0642: A research chemical that inhibits the G9a and GLP histone methyltransferases.
BRD9539: An experimental research compound.
CPCCOET: A research chemical that is a non-competitive mGlu1 receptor antagonist.
BMS-986339: An investigational IL-23 receptor antagonist peptide.
DIPHOSPHORIC ACID: An inorganic acid, also known as pyrophosphoric acid.
CGP 47656: An experimental research compound.
ABBOTT 14C: An experimental research compound from Abbott.
BIM 28163: An experimental research compound.
LIVER ENRICHED ANTIMICROBIAL PEPTIDE 2: LEAP-2, a peptide hormone that antagonizes the ghrelin receptor.
TEZAMPANEL ANHYDROUS: The anhydrous form of tezampanel, an AMPA/kainate receptor antagonist.
GLUCAGON-LIKE PEPTIDE 2-(3-33): An antagonist of the GLP-2 receptor.
NVP-DKY709: An experimental p38 MAP kinase inhibitor.
AVEXITIDE: An experimental GLP-1 receptor antagonist.
4â€BCCA: An experimental research compound.
5-METHOXYPSORALEN: A psoralen derivative found in citrus fruits, used in PUVA therapy.
ATPO: A research chemical that is a competitive antagonist of the P2X1 receptor.
RU28362: A research chemical that is a glucocorticoid receptor agonist.
CALPEPTIN: A research chemical that is a calpain inhibitor.
COMPOUND 2F [JIANG ET AL., 2018]: A research compound described in the specified scientific publication.
[3H]GSK931145: A radiolabeled ghrelin receptor inverse agonist.
H4 ANTAGONIST 48: A research chemical that acts as a histamine H4 receptor antagonist.
PSN632408: A research chemical that is a GPR119 receptor agonist.
OLEOYL-LYSOPHOSPHATIDYLCHOLINE: A species of lysophosphatidylcholine, a signaling lipid.
LTC4: Leukotriene C4, an inflammatory lipid mediator.
ASN06917370: An experimental research compound.
COMPOUND 2 [PMID: 24793972]: A research compound described in the specified scientific publication.
N-DESALKYLQUETIAPINE: An active metabolite of the antipsychotic drug quetiapine, also known as norquetiapine.
UCM-1306: An experimental research compound.
RIVANICLINE: An experimental alpha-4-beta-2 nicotinic acetylcholine receptor partial agonist.
COMPOUND 2 [PMID: 21627121]: A research compound described in the specified scientific publication.
[PHE(ME)7]NEUROKININ B: A modified analog of the neuropeptide neurokinin B.
RP67580: A research chemical that is a non-peptide neurokinin 1 (NK1) receptor antagonist.
COMPOUND 6B [PMID: 24999562]: A research compound described in the specified scientific publication.
[F/G]N/OFQ-(1-13)-NH2: A modified fragment of nociceptin/orphanin FQ.
COMPOUND 46 [PMID: 25268943]: A research compound described in the specified scientific publication.
EMPA: An experimental mGlu1 receptor negative allosteric modulator.
MK-1064: An experimental orexin-2 receptor antagonist.
ACT-462206: An experimental dual orexin-1/2 receptor antagonist.
MRS 2219: A research chemical that is a P2Y1 receptor antagonist.
MRS2802: An experimental research compound.
AP4A: Diadenosine tetraphosphate, an endogenous signaling molecule.
COMPOUND 4 [PMID: 23083103]: A research compound described in the specified scientific publication.
R-138727: An experimental research compound.
MRS2957: An experimental research compound.
CYCLIC INSL3 B-CHAIN ANALOGUE 6: A synthetic analog based on insulin-like peptide 3.
&DELTA;R3/I5: A chimeric peptide of relaxin-3 and INSL5.
RP-001: An experimental research compound.
SUNVOZERTINIB: An investigational EGFR kinase inhibitor for non-small cell lung cancer.
IL-37: Interleukin-37, a cytokine with anti-inflammatory properties.
[3H]TAUROCHOLIC ACID: A radiolabeled form of a primary bile acid.
SC-435: An experimental research compound.
MP-A08: An experimental Sphingosine-1-phosphate receptor 1 (S1P1) antagonist.
PF-543: A research chemical that is a potent inhibitor of sphingosine kinase 1.
COMPOUND 41 [PMID: 31855425]: A research compound described in the specified scientific publication.
SEGLITIDE: A somatostatin analog.
[L-TYR8]CYN 154806: A modified somatostatin receptor antagonist.
CIS-1,2-CYCLOPROPANEDICARBOXYLIC ACID: A chemical intermediate.
COMPOUND 5 [PMID: 17618114]: A research compound described in the specified scientific publication.
NH-3: An experimental research compound.
SD-208: A research chemical that is a TGF-beta receptor 1 kinase inhibitor.
GSK2256294: An experimental research compound from GlaxoSmithKline.
HC067047: A research chemical that is a TRPV4 channel antagonist.
[125I]TSH (HUMAN): A radiolabeled version of human thyroid-stimulating hormone.
COMPOUND 61 [PMID: 36221183]: A research compound described in the specified scientific publication.
DOXERCALCIFEROL: A synthetic vitamin D analog used to treat secondary hyperparathyroidism.
PG 97-269: An experimental research compound.
[VAL4]AVP: A synthetic analog of arginine vasopressin.
LS-192629: An experimental research compound.
D[D-PHE2]AVP: A synthetic analog of arginine vasopressin.
[125I]3-N3-PHPA-LVA: A radiolabeled vasopressin analog.
D[LEU4]LVP: A synthetic analog of lysine vasopressin.
D(CH2)5[D-TYR(ET)2,VAL4,TYR-NH29]AVP: A potent vasopressin V1a/V2 receptor antagonist.
[3H]DESGLY-NH2[D-ILE2,ILE4]VP: A radiolabeled vasopressin analog.
TFC007: An experimental research compound.
PAN-AKT KINASE INHIBITOR GSK690693: An experimental inhibitor of all Akt kinase isoforms.
TYRPHOSTIN AG 1295: A research chemical that inhibits the PDGFR tyrosine kinase.
ATR INHIBITOR ART0380: An experimental inhibitor of the ATR kinase.
UFP-101: A peptide that is a selective antagonist of the nociceptin/orphanin FQ receptor.
PERINDOPRILAT: The active metabolite of the ACE inhibitor perindopril.
CYPPA: A research chemical that is a positive allosteric modulator of SK potassium channels.
DMPP: 1,1-Dimethyl-4-phenylpiperazinium, a nicotinic acetylcholine receptor agonist.
CHRYSIN DIMETHYL ETHER: A methylated derivative of the flavonoid chrysin.
TAFENOQUINE: An 8-aminoquinoline antimalarial drug.
4P-PDOT: A research chemical that is a selective antagonist of the MT2 melatonin receptor.
CILTACABTAGENE AUTOLEUCEL: A CAR T-cell therapy targeting BCMA for multiple myeloma.
PF-956980: An experimental research compound from Pfizer.
MEZIGDOMIDE: An investigational cereblon E3 ligase modulator (CELMoD).
THEONELLASTEROL B: A natural sterol isolated from a marine sponge.
RG-7160: An experimental research compound from Roche.
LY2940094: An experimental research compound from Eli Lilly.
COMPOUND 16 [PMID: 23412139]: A research compound described in the specified scientific publication.
MRS1191: A research chemical that is an A3 adenosine receptor antagonist.
BIMIRALISIB: An investigational dual PI3K/mTOR inhibitor.
MLS1547: A research chemical that activates the KCNQ2/3 potassium channel.
BDNF: Brain-derived neurotrophic factor, a protein that supports neuron survival and growth.
BUSERELIN ACETATE: The salt of buserelin, a gonadotropin-releasing hormone (GnRH) agonist.
TAPINAROF: An aryl hydrocarbon receptor agonist for plaque psoriasis.
ATRANORIN: A natural depside found in lichens.
CGP 20712A: A research chemical that is a selective beta-1 adrenergic receptor antagonist.
ALX40-4C: A peptide-based HIV entry inhibitor.
GARETOSMAB: An investigational monoclonal antibody that targets activin A.
GALANIN(1-10): An N-terminal fragment of the neuropeptide galanin.
VU0810464: An experimental research compound.
5-OXO-C20:3: An eicosanoid lipid mediator.
PALBINONE: A natural product.
IL-27 SUBUNIT &ALPHA;: The alpha subunit of the cytokine interleukin-27.
EPITINIB: An investigational EGFR kinase inhibitor.
PROSTAGLANDIN D2: A prostaglandin involved in inflammation and sleep regulation.
LINSIDOMINE: A nitric oxide donor and vasodilator.
PSB-1584: An experimental research compound.
PERHEXILINE: An anti-anginal agent that shifts cardiac metabolism.
VALECOBULIN: An experimental research compound.
BRAF(V600E) KINASE INHIBITOR RO5212054: An experimental inhibitor of the BRAF V600E mutant kinase.
BIVALENT BRD4 INHIBITOR AZD5153: An experimental bivalent inhibitor of the BRD4 protein.
COMPOUND 17 [PMID: 23916253]: A research compound described in the specified scientific publication.
IBREXAFUNGERP: A triterpenoid antifungal drug.
APETX-1: A peptide toxin from sea anemone that inhibits ASIC3 channels.
GALNON: A non-peptide agonist of the galanin receptor.
E. COLI HEAT-STABLE ENTEROTOXIN (STA): A bacterial toxin that causes diarrhea.
S-ADENOSYLMETHIONINE: A common cosubstrate involved in methyl group transfers.
VANUCIZUMAB: An investigational bispecific antibody targeting Ang-2 and VEGF-A.
ERTEBEREL: An experimental estrogen receptor beta agonist.
CB-5083: An experimental p97 ATPase inhibitor.
ANX-042: An experimental research compound.
MEVIDALEN: An investigational positive allosteric modulator of the D1 dopamine receptor.
ORYZALIN: A dinitroaniline herbicide that inhibits microtubule assembly.
BISPECIFIC ANTIBODY: An artificial protein that can simultaneously bind to two different types of antigen.
GALANGIN: A flavonol found in galangal rhizome.
PL017: A synthetic peptide analog of melanocortin.
METOCHALCONE: A chalcone derivative with vasodilating properties.
ACETYLCHOLINE: A major neurotransmitter in the central and peripheral nervous systems.
NF157: A research chemical that is a P2Y11 receptor antagonist.
QUINUPRISTIN/DALFOPRISTIN: A combination of streptogramin antibiotics.
AUTOLOGOUS ANTI-BCMA-CAR-MRNA-TRANSFECTED CD8+ T-LYMPHOCYTES: An experimental mRNA-based CAR T-cell therapy.
2-HYDROXYOCTANOIC ACID: A hydroxylated fatty acid.
LETERMOVIR: An antiviral drug for cytomegalovirus (CMV) prophylaxis.
1-NAPHTHOL: A fluorescent organic compound, a derivative of naphthalene.
COMPOUND C10 [PMID: 24297249]: A research compound described in the specified scientific publication.
AZELASTINE HYDROCHLORIDE: The salt of azelastine, an antihistamine used as a nasal spray and eye drops.
IPA-3: A research chemical that inhibits p21-activated kinase 1 (PAK1).
ADENOPHOSTIN A: A natural product that is a potent agonist of the IP3 receptor.
DIRLOTAPIDE: An MTP inhibitor used in veterinary medicine for canine obesity.
C5A: A potent pro-inflammatory protein of the complement system.
SAPPANONE A 7-METHYL ETHER: A methylated derivative of a natural homoisoflavonoid.
[125I]U-II (HUMAN): A radiolabeled version of human urotensin-II.
MLN-3897: An experimental CCR1 chemokine receptor antagonist.
GSK-264220A: An experimental research compound from GlaxoSmithKline.
6-PRENYLNARINGENIN: A prenylated flavonoid.
[3H]METHYLLYCACONITINE: A radiolabeled antagonist of alpha-7 nicotinic acetylcholine receptors.
EST64454: An experimental research compound.
EGFR/ERBB-2 INHIBITOR: A class of drugs that block the EGFR and ErbB2/HER2 kinases.
PELDESINE: An inhibitor of purine nucleoside phosphorylase (PNP).
AZ191: A research chemical that is an inhibitor of the MEK5 kinase.
NEDOCROMIL: A mast cell stabilizer used to treat asthma.
GONADOTROPIN-RELEASING HORMONE ANALOG: A class of drugs that mimic or block GnRH.
GR148672X: An experimental research compound.
VACCINIA VACCINE: A vaccine containing the live vaccinia virus, used to prevent smallpox.
COMPOUND 7K [PMID: 23521020]: A research compound described in the specified scientific publication.
4&ALPHA;-PDD: 4-alpha-phorbol 12,13-didecanoate, a phorbol ester that activates protein kinase C.
PD98059: A research chemical that is a non-competitive inhibitor of MEK1.
FR139317: An experimental bradykinin B2 receptor antagonist.
MK-1029: An experimental research compound from Merck.
MRE 3008F20: An experimental A3 adenosine receptor antagonist.
ADROPIN: A peptide hormone involved in energy homeostasis.
NEUROMEDIN U-25: A 25-amino acid form of the neuropeptide neuromedin U.
ENASIDENIB MESYLATE: The salt of enasidenib, an inhibitor of mutant IDH2 for acute myeloid leukemia.
CCG-63802: An experimental research compound.
ACETOMENAPHTHONE: A synthetic vitamin K analog.
METADOXINE: A compound used in the treatment of acute alcohol intoxication.
PHENAZINE-1-CARBOXYLIC ACID: A natural antibiotic produced by Pseudomonas bacteria.
COMPOUND 36 [PMID: 24000170]: A research compound described in the specified scientific publication.
[19F]-HALOPERIDOL: A fluorinated version of haloperidol for imaging studies.
ARTENIMOL: Dihydroartemisinin, the active metabolite of artemisinin-based antimalarial drugs.
AB-MECA: A research chemical that is an A3 adenosine receptor agonist.
ENSIFENTRINE: An investigational dual phosphodiesterase 3 and 4 inhibitor.
FXIA INHIBITOR 3F: A research chemical that inhibits coagulation Factor XIa.
AZENOSERTIB: An investigational WEE1 kinase inhibitor.
MBX-8025: An experimental PPAR delta agonist.
ILAPRAZOLE: A proton pump inhibitor.
MECLIZINE HYDROCHLORIDE: The salt of meclizine, a first-generation antihistamine for motion sickness.
AME-527: An experimental research compound.
MK 0354: An experimental research compound from Merck.
TGF&BETA;3: Transforming growth factor beta 3, a cytokine involved in cell growth and differentiation.
TAK-441: An experimental gonadotropin-releasing hormone (GnRH) antagonist.
COMPOUND 7A [PMID: 24884590]: A research compound described in the specified scientific publication.
ADEFOVIR: An antiviral drug used to treat hepatitis B.
BENDROFLUMETHIAZIDE: A thiazide diuretic used to treat hypertension.
BI-1935: An experimental research compound.
OXOTREMORINE: A research chemical that is a non-selective muscarinic acetylcholine receptor agonist.
METHYLTESTOSTERONE: A synthetic anabolic-androgenic steroid.
PLASMINOGEN: The inactive precursor of plasmin, an enzyme that degrades fibrin clots.
(R)-FELODIPINE: The R-enantiomer of felodipine, a calcium channel blocker.
INSULIN DETEMIR: A long-acting human insulin analog.
VINDESINE: A vinca alkaloid chemotherapy agent.
[125I]NDP-MSH: A radiolabeled analog of alpha-melanocyte-stimulating hormone.
ATOVAQUONE: An antimicrobial drug used to treat or prevent parasitic infections.
PG-102: An experimental research compound.
ALBUMIN HUMAN-KJDA: A proprietary formulation of human albumin.
N-AMINOHEXYL-5-CHLORO-1-NAPTHALENESULFONAMIDE HYDROCHLORIDE: W-7, a research chemical that is a calmodulin antagonist.
16,16-DIMETHYL-PGE2: A synthetic analog of prostaglandin E2.
FIPI: A research chemical that is a dual inhibitor of insulin receptor and IGF-1R.
HCL: Hydrochloric acid, a strong mineral acid.
TAUROLITHOCHOLIC ACID-3-SULPHATE: A sulfated metabolite of a secondary bile acid.
ENPROSTIL: A synthetic prostaglandin E2 analog.
THYMIDINE: A pyrimidine deoxynucleoside, a component of DNA.
DIACYLGLYCEROL KINASE INHIBITOR II: A research chemical that inhibits diacylglycerol kinase.
COMPOUND 27 [PMID: 20346665]: A research compound described in the specified scientific publication.
NOLASIBAN: An experimental oxytocin and vasopressin receptor antagonist.
ALATROFLOXACIN MESYLATE: The salt of alatrofloxacin, a prodrug of the antibiotic trovafloxacin.
AMG-548: An experimental p38 MAP kinase inhibitor.
DE-104: An experimental research compound.
PLOVAMER ACETATE: An experimental research compound.
JNJ-67869386: An experimental research compound from Johnson & Johnson.
SR7826: An experimental research compound.
CUSATUZUMAB: An investigational monoclonal antibody targeting CD70.
ISIS-2503: An antisense oligonucleotide designed to inhibit the production of c-Raf kinase.
PRONETALOL: A non-selective beta-blocker, one of the first to be developed.
CENTANAFADINE: An investigational serotonin-norepinephrine-dopamine reuptake inhibitor.
VARDENAFIL HYDROCHLORIDE TRIHYDRATE: The hydrated salt of vardenafil, a PDE5 inhibitor for erectile dysfunction.
AXT914: An experimental research compound.
CONIVAPTAN HYDROCHLORIDE: The salt of conivaptan, a vasopressin receptor antagonist.
INSULIN PURIFIED BEEF: A regular, short-acting insulin preparation derived from beef.
MEQUINOL: A phenol used in topical drugs for skin depigmentation.
ABACAVIR SULFATE: The salt of abacavir, a nucleoside reverse transcriptase inhibitor for HIV.
LEVALBUTEROL TARTRATE: The salt of levalbuterol, the (R)-enantiomer of salbutamol.
OXYTETRACYCLINE CALCIUM: The calcium salt of oxytetracycline, a tetracycline antibiotic.
TETRACYCLINE HYDROCHLORIDE: The salt of tetracycline, a broad-spectrum antibiotic.
SECUKINUMAB: A monoclonal antibody that targets interleukin-17A for autoimmune diseases.
AZD3514: An experimental androgen receptor downregulator.
AMG-319: An experimental PI3K delta inhibitor.
ARQ-736: An experimental ERK kinase inhibitor.
PWT-33579: An experimental research compound.
MIVAVOTINIB CITRATE: The salt of an investigational IRAK4 kinase inhibitor.
LY2245461: An experimental research compound from Eli Lilly.
ELUBRIXIN: An experimental CXCR2 antagonist.
LY2590443: An experimental research compound from Eli Lilly.
AZD5672: An experimental CXCR2 antagonist.
OLCEGEPANT: An experimental CGRP receptor antagonist for migraine.
K-877: An experimental selective PPAR alpha modulator, also known as pemafibrate.
LAPAQUISTAT ACETATE: The salt of lapaquistat, an experimental squalene synthase inhibitor.
ONERCEPT: A recombinant soluble tumor necrosis factor receptor p55.
ONCOLYSIN S: An oncolytic adenovirus.
TENATUMOMAB: An experimental monoclonal antibody that targets tenascin C.
BENDAZAC: A non-steroidal anti-inflammatory drug (NSAID).
EBROTIDINE: A histamine H2 receptor antagonist, withdrawn from the market.
GLECAPREVIR: An NS3/4A protease inhibitor used to treat hepatitis C.
MEDI-8968: An experimental monoclonal antibody targeting respiratory syncytial virus (RSV).
MONO-DGA-RFB4: A deglycosylated immunotoxin.
MCS-110: An experimental monoclonal antibody.
LIPIDYL PSEUDOPTERANE A: A lipidated form of a natural product.
GLASDEGIB MALEATE: The salt of glasdegib, a Hedgehog pathway inhibitor for acute myeloid leukemia.
FOSTAMATINIB DISODIUM: The salt of fostamatinib, a spleen tyrosine kinase (Syk) inhibitor.
PF-06459988: An experimental research compound from Pfizer.
PAMITEPLASE: A recombinant tissue plasminogen activator.
IMSIDOLIMAB: An investigational monoclonal antibody that targets the IL-36 receptor.
PCI-27483: An experimental Factor VIIa/tissue factor inhibitor.
JNJ-39220675: An experimental research compound from Johnson & Johnson.
FIANLIMAB: An investigational monoclonal antibody targeting the LAG-3 immune checkpoint.
PEGTEOGRASTIM: A pegylated form of granulocyte colony-stimulating factor (G-CSF).
ABICIPAR PEGOL: A pegylated DARPin therapeutic targeting VEGF-A.
ML221: A research chemical that is a GIRK potassium channel activator.
GC1118: An investigational monoclonal antibody targeting EGFR.
LONAPEGSOMATROPIN: A long-acting prodrug of human growth hormone.
CFI-400945: An experimental PLK4 kinase inhibitor.
PEGAPTANIB OCTASODIUM: The salt of pegaptanib, a pegylated aptamer that binds to VEGF.
VALTORCITABINE: An experimental L-nucleoside analog for cancer therapy.
TORUDOKIMAB: An investigational monoclonal antibody.
ASP-8374: An investigational monoclonal antibody targeting TIGIT.
GW-406381: An experimental research compound from GlaxoSmithKline.
PHENYLEPHRINE HYDROCHLORIDE: The salt of phenylephrine, a selective alpha-1 adrenergic receptor agonist.
BROMOCHLOROACETIC ACID: A haloacetic acid, a disinfection byproduct.
H-89: A research chemical that is a potent inhibitor of protein kinase A.
PROGLUMETACIN: A prodrug of indomethacin.
PALMATINE CHLORIDE HYDRATE: The hydrated salt of palmatine, a protoberberine alkaloid.
BENAZEPRIL HYDROCHLORIDE: The salt of benazepril, an ACE inhibitor.
PROPOXYCAINE: A local anesthetic of the ester type.
NICOTINE BITARTRATE: The bitartrate salt of nicotine.
BUFOTENINE: A tryptamine derivative found in some plants and toad venom with psychedelic properties.
DEOXYURIDINE MONOPHOSPHATE: A deoxynucleotide, a precursor for DNA synthesis.
KAVAIN: A kavalactone found in the kava plant with anxiolytic properties.
ISOPROPAMIDE: An anticholinergic drug.
SHINPTEROCARPIN: A natural pterocarpan.
HOLACANTHONE: A natural quassinoid with antimalarial activity.
WHILE OLIVETOL: A probable misspelling of olivetol, a natural organic compound.
CHLORBROMURON: An urea-based herbicide.
ETHOFUMESATE: A benzofuran herbicide.
METHYLBENZETHONIUM: A quaternary ammonium compound used as a disinfectant.
THIABENDAZOLE: A benzimidazole fungicide and parasiticide.
UNGEREMINE: A natural alkaloid.
METHOPRENE: An insect growth regulator.
GSK591: An experimental BET inhibitor.
SINEFUNGIN: A natural nucleoside analog antibiotic with antifungal and antiparasitic activity.
PIPERTRAMINE: An experimental research compound.
NISOXETINE HYDROCHLORIDE: The salt of nisoxetine, a selective norepinephrine reuptake inhibitor.
ALAPROCLATE HYDROCHLORIDE: The salt of alaproclate, an experimental SSRI.
MECYSTEINE HYDROCHLORIDE: The salt of mecysteine, a mucolytic agent.
CINTAZONE: A non-steroidal anti-inflammatory drug (NSAID).
CP-339818: An experimental Janus kinase (JAK) inhibitor.
FLUACIZINE: An antidepressant of the phenothiazine class.
PAPAVEROLINE: A metabolite of papaverine.
CROMOLYN SODIUM: The salt of cromolyn, a mast cell stabilizer.
BCR-ABL INHIBITOR GNF-2: An experimental allosteric inhibitor of the BCR-ABL kinase.
TRENBOLONE ACETATE: A potent anabolic-androgenic steroid used in veterinary medicine.
OXACILLIN: A penicillinase-resistant beta-lactam antibiotic.
BENZALKONIUM CHLORIDE: A quaternary ammonium compound used as an antiseptic and preservative.
BUPROFEZIN: An insect growth regulator.
CR002: An experimental research compound.
PENICILLIN G POTASSIUM: The potassium salt of penicillin G, a narrow-spectrum antibiotic.
5-METHOXYISATIN: A derivative of isatin.
PENICILLIN V BENZATHINE: A long-acting salt of penicillin V.
PYROCATECHOL VIOLET: A dye used as a metal indicator.
IONIS-FGFR4RX: An antisense oligonucleotide targeting fibroblast growth factor receptor 4.
IMIDACLOPRID: A neonicotinoid systemic insecticide.
DL-LACTIC ACID: A racemic mixture of lactic acid.
ALPHA-ENDOSULFAN: An isomer of the organochlorine insecticide endosulfan.
CHLORACYZINE: An anti-anginal drug of the phenothiazine class.
DITHIODIMORPHOLINE: A vulcanizing agent for rubber.
DIBEKACIN: An aminoglycoside antibiotic.
CCG-63808: An experimental research compound.
METHYCLOTHIAZIDE: A thiazide diuretic.
2,4,6-TRIHYDROXYACETOPHENONE: A phenolic compound.
ARGENTEOSIDE A: A natural product.
COMPOUND 27 [PMID: 21123062]: A research compound described in the specified scientific publication.
FASUDIL HYDROCHLORIDE: The salt of fasudil, a Rho-kinase inhibitor.
BOPINDOLOL: A non-selective beta-blocker.
ARTHONIOIC ACID: A natural lichen metabolite.
LISSOCLINIDINE B: A natural alkaloid.
PURGIN II: An experimental research compound.
BERKELEYAMIDE C: A natural product from a marine-derived fungus.
GSK0660: An experimental PPAR beta/delta antagonist.
DOFEQUIDAR FUMARATE: The salt of dofequidar, an experimental P-glycoprotein inhibitor.
ALKYLSULFONATE COMPOUND: A general class of organosulfur compounds.
MAGNESIUM CHLORIDE ANHYDROUS: The anhydrous salt of magnesium chloride.
CO-TRIMOXAZOLE: A combination antibiotic containing trimethoprim and sulfamethoxazole.
LUTEINIZING HORMONE: A gonadotropic hormone that triggers ovulation and testosterone production.
MACROLIDE ANTIBIOTIC: A class of antibiotics characterized by a macrocyclic lactone ring.
ECHINACEA PREPARATION: An herbal supplement derived from plants of the Echinacea genus.
CMF-019: An experimental research compound.
ANTICOAGULANT AGENT: A general term for a substance that prevents blood clotting.
DNA-PK INHIBITOR V: A research chemical that inhibits DNA-dependent protein kinase.
CYTOPROTECTIVE AGENT: A general term for a drug that protects cells from harmful agents.
IMMUNOSTIMULANT: A substance that stimulates the immune system.
TEGAFUR-GIMERACIL-OTERACIL POTASSIUM: A combination chemotherapy drug containing three components.
ESMETHADONE: The (S)-enantiomer of methadone, which acts as an NMDA receptor antagonist.
MEFLOQUINE: An antimalarial drug.
SARAKALIM: A potassium channel opener.
CILAZAPRIL: An ACE inhibitor used to treat hypertension and heart failure.
MEPOLIZUMAB: A monoclonal antibody that targets interleukin-5 (IL-5).
LOSIGAMONE: An experimental anticonvulsant.
NEDOSIRAN: An RNA interference (RNAi) therapeutic for primary hyperoxaluria.
TOFERSEN: An antisense oligonucleotide for treating amyotrophic lateral sclerosis (ALS) with SOD1 mutations.
SOFOSBUVIR / VELPATASVIR / VOXILAPREVIR: A combination antiviral drug for hepatitis C.
SONEPCIZUMAB: An investigational monoclonal antibody that targets sphingosine-1-phosphate (S1P).
ECABET: An anti-ulcer agent.
DP-VPA: A derivative of valproic acid.
CIMAGLERMIN ALFA: Recombinant human neuregulin-1, investigated for heart failure.
INSULIN GLARGINE-YFGN: A biosimilar of insulin glargine, a long-acting insulin analog.
AMG-131: An experimental monoclonal antibody from Amgen.
ISIS 113715: An antisense oligonucleotide targeting protein tyrosine phosphatase 1B.
PROGESTOGEN: A class of steroid hormones that includes progesterone.
STAT3 INHIBITOR OPB-51602: An experimental inhibitor of the STAT3 signaling pathway.
RECOMBINANT FACTOR VIIA: A genetically engineered form of coagulation factor VIIa.
STIBOGLUCONATE: An antimony-containing drug used to treat leishmaniasis.
ISOEUGENITOL: A natural phenylpropanoid.
ABITUZUMAB: An investigational monoclonal antibody that targets integrin Î±vÎ²3.
DIPHENOXYLATE: An opioid receptor agonist used for diarrhea.
RHODOMYRTOXIN B: A natural acylphloroglucinol compound with antibacterial activity.
SALSALATE: A non-steroidal anti-inflammatory drug (NSAID), a dimer of salicylic acid.
EXAMPLE 494 [WO2014028479] PARENT MOLECULE: A chemical compound described in the specified patent application.
MRS4162-BODIPY CONJUGATE: A fluorescently labeled research compound.
YM976: An experimental phosphodiesterase 4 inhibitor.
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES: An enzyme mixture used to treat Dupuytren's contracture.
COMPOUND 35 [PMID: 24157366]: A research compound described in the specified scientific publication.
AZINPHOS-ETHYL: An organophosphate insecticide.
DELAVIRDINE MESYLATE: The salt of delavirdine, a non-nucleoside reverse transcriptase inhibitor for HIV.
ST-1006: An experimental research compound.
D(CH2)5[TYR(ME)2,THR4]OVT: A synthetic oxytocin analog and antagonist.
DAVAMOTECAN PEGADEXAMER: An experimental polymer-drug conjugate of a camptothecin derivative.
ANTI-PD-L1 MONOCLONAL ANTIBODY FAZ053: An experimental monoclonal antibody targeting the PD-L1 immune checkpoint.
ANTI-CD123/CD3 BISPECIFIC ANTIBODY JNJ-63709178: An experimental bispecific antibody.
JNJ-54175446: An experimental purinergic P2X7 receptor antagonist.
TIGAPOTIDE: An experimental peptide that targets the ApoB-100 protein.
FOLATE RECEPTOR-TARGETED VINCA ALKALOID EC0489: An experimental cancer therapy linking a vinca alkaloid to a folate ligand.
EDASALONEXENT: An experimental NF-ÎºB inhibitor for Duchenne muscular dystrophy.
DABELOTINE: An investigational dopamine D1/D5 receptor partial agonist.
AZD-5122: An experimental research compound from AstraZeneca.
PF-05190457: An experimental melanocortin-4 receptor antagonist.
PLITIDEPSIN: A cyclic depsipeptide from a marine tunicate with antiviral and anticancer activity.
SR-123781A: An experimental research compound.
DELTIBANT: A bradykinin B2 receptor antagonist.
TANOGITRAN: An experimental direct thrombin inhibitor.
GUANOSINE: A purine nucleoside, a component of RNA.
LIPOSOMAL ALPHA GALACTOSYLCERAMIDE: A liposomal formulation of an immunostimulatory glycolipid.
ATF-936: An experimental research compound.
RODUCITABINE: An investigational ribonucleotide reductase inhibitor.
JNJ-49095397: An experimental research compound from Johnson & Johnson.
ELIGLUSTAT TARTRATE: The salt of eliglustat, a glucosylceramide synthase inhibitor for Gaucher disease.
ANTI-TF MONOCLONAL ANTIBODY ALT-836: An experimental antibody targeting tissue factor.
GALICAFTOR: An experimental potentiator of the CFTR protein.
PEFLOXACIN: A fluoroquinolone antibiotic.
PHENINDAMINE: A first-generation antihistamine.
TAUROCHOLIC ACID: A primary bile acid.
CILIARY NEUROTROPHIC FACTOR: A protein that promotes neurotransmitter synthesis and neuronal survival.
AQ-13: An experimental antimalarial agent.
SER-100: An experimental research compound.
AUTOLOGOUS ANTI-BCMA-CAR-TCRZ/4-1BB-EXPRESSING T-LYMPHOCYTES CART-BCMA: An investigational CAR T-cell therapy targeting BCMA.
INSULIN SUSP PROTAMINE ZINC BEEF/PORK: A long-acting insulin preparation derived from a beef/pork mixture.
ICARITIN: A prenylated flavonol glycoside, a constituent of horny goat weed.
SARIZOTAN: An experimental 5-HT1A receptor agonist and D2/D3 receptor partial agonist.
LY-2584702: An experimental p70S6K kinase inhibitor.
ANTI-GPA33/CD3 MONOCLONAL ANTIBODY MGD007: An experimental bispecific antibody.
ELUVIXTAMAB: An investigational bispecific antibody.
ANTI-EGFR/HER2/HER3 MONOCLONAL ANTIBODY MIXTURE SYM013: An experimental mixture of antibodies targeting the ErbB family.
TETRAHYDROURIDINE: An inhibitor of the enzyme cytidine deaminase.
RESATORVID: An experimental Toll-like receptor 4 (TLR4) antagonist.
PD-146176: An experimental research compound.
CARBOXYCINNAMIC ACID BISHYDROXAMIDE: A research chemical that is an ADAMTS-5 inhibitor.
BX-912: An experimental PDK1 kinase inhibitor.
NLX-101: An experimental research compound.
BMY-14802: A research chemical with sigma-1 and 5-HT1A receptor activity.
P-MPPI: A research chemical that is a selective 5-HT1A receptor antagonist.
(S)-FLUROCARAZOLOL: A fluorescent beta-adrenergic receptor antagonist.
AVITRIPTAN: An experimental 5-HT1B/1D receptor agonist.
[3H]MESULERGINE: A radiolabeled serotonin and dopamine receptor ligand.
RO 60-0175: A research chemical that is a selective 5-HT2C receptor agonist.
SB 215505: A research chemical that is a 5-HT2B receptor antagonist.
SB 271046: A research chemical that is a selective 5-HT6 receptor antagonist.
INCB3619: An experimental research compound from Incyte Corporation.
2-PHENYLETHYLYL-ADENOSINE DERIVATIVE: A class of modified adenosine compounds.
PSB603: A research chemical that is an A1 adenosine receptor antagonist.
ANGIOTENSIN A: A bioactive peptide of the renin-angiotensin system.
BIO-32546: An experimental research compound.
D-NAL,CYS,TYR,D-TRP,ORN,VAL,CYS,NAL-NH2: A synthetic cyclic peptide analog of somatostatin.
NEUROMEDIN B: A peptide of the bombesin family.
EVOCALCET: A calcium-sensing receptor agonist for secondary hyperparathyroidism.
Z-ARG-LEU-VAL-AGLY-ILE-VAL-OME: A peptide-based research chemical.
CITRUSININE II: A natural acridone alkaloid.
CANNABINOR: A synthetic cannabinoid that is a potent CB2 receptor agonist.
LY-288513: An experimental research compound from Eli Lilly.
DESULFATED CHOLECYSTOKININ-8: A form of the CCK-8 peptide lacking a sulfate group.
CCL5: A chemokine, also known as RANTES.
ALPIDEM: A non-benzodiazepine anxiolytic, withdrawn from the market.
RO320-2947/001: An experimental protein kinase C inhibitor.
DIMETHYL SULFOXIDE: An organosulfur compound used as a solvent and topical analgesic.
RABUSERTIB: An investigational PLK1 kinase inhibitor.
ISOGRANULATIMIDE: A natural product that inhibits cell cycle progression.
JTV-803: An experimental phosphodiesterase 7 inhibitor.
SOTEVTAMAB: An investigational monoclonal antibody.
AZD6495: An experimental research compound from AstraZeneca.
AMG820: An experimental monoclonal antibody from Amgen.
COMPOUND 9 [KUMAR ET AL., 2019]: A research compound described in the specified scientific publication.
UROTENSIN 1 (FISH): A peptide hormone from fish related to corticotropin-releasing hormone.
CXCL5: A chemokine also known as epithelial-neutrophil activating peptide-78 (ENA-78).
BALIXAFORTIDE: An investigational CXCR4 antagonist.
CEFDITORIN PIVOXIL: The prodrug of cefditorin, a third-generation cephalosporin antibiotic.
OZAGREL: A thromboxane A2 synthase inhibitor.
PICOTAMIDE: A dual antiplatelet and antithrombotic agent.
COMPOUND 9 [PMID: 20718420]: A research compound described in the specified scientific publication.
RS 93520: An experimental research compound.
BW 245C: A research chemical that is a prostacyclin analog and DP1 receptor agonist.
TTK21: An experimental research compound.
COMPOUND 15 [PMID: 32045236]: A research compound described in the specified scientific publication.
SC-51089: A research chemical that is a prostaglandin EP1 receptor antagonist.
ZONGERTINIB: An investigational MET kinase inhibitor.
LSZ102: An experimental selective estrogen receptor degrader (SERD).
[125I]ET-1 (HUMAN, MOUSE, RAT): A radiolabeled version of endothelin-1.
DY131: An experimental research compound.
[125I]SARAFOTOXIN S6B: A radiolabeled endothelin receptor agonist.
PHTPP: A research chemical that is a selective estrogen receptor beta (ERÎ²) antagonist.
BQ 3020: A selective endothelin ET-B receptor agonist.
EXAMPLE 13 [WO2009109743]: A chemical compound described in the specified patent application.
LAU463: An experimental research compound.
GAL-B2-C14: A modified galanin analog.
GALANIN(2-29) (RAT/MOUSE): A fragment of rodent galanin neuropeptide.
GALANIN(3-29) (RAT/MOUSE): A fragment of rodent galanin neuropeptide.
BPH-252: An experimental research compound.
EXENDIN-3: A peptide toxin from Gila monster venom, an analog of GLP-1.
LIXISENATIDE: A glucagon-like peptide-1 (GLP-1) receptor agonist for type 2 diabetes.
[D-ARG1,D-PHE5,D-TRP7,9,LEU11]SUBSTANCE P: A broad-spectrum tachykinin receptor antagonist.
GLP-2 ANALOGUE 10: An experimental analog of glucagon-like peptide-2.
S18986: A research chemical that is an AMPA receptor positive allosteric modulator.
2,4-EPI-NEODYSIHERBAINE: An isomer of a natural neuroexcitatory amino acid.
C1-27: An experimental research compound.
FLUPERLAPINE: An atypical antipsychotic agent.
GLUTATHIONE DISULFIDE: The oxidized form of glutathione.
CHIR-98014: A research chemical that is a potent inhibitor of GSK-3.
CYANOTRIPHENYLBORATE: An activator of large-conductance calcium-activated potassium (BK) channels.
AZD1080: An experimental GSK-3 inhibitor.
LSP4-2022: An experimental group III metabotropic glutamate receptor agonist.
GLYT1 INHIBITOR 51B: A research chemical that inhibits the glycine transporter 1.
COMPOUND 2 [PMID: 24486398]: A research compound described in the specified scientific publication.
ACIPIMOX: A lipid-lowering agent that inhibits lipolysis.
D-KYNURENINE: The D-isomer of kynurenine, an antagonist at the glycine site of the NMDA receptor.
IMPROGAN: A research chemical that is a potent histamine H3 receptor agonist.
JNJ-38431055: An experimental research compound from Johnson & Johnson.
COMPOUND 29A [PMID: 21444206]: A research compound described in the specified scientific publication.
COMPOUND 42 [PMID: 22545772]: A research compound described in the specified scientific publication.
7&ALPHA;,25-DIHYDROXYCHOLESTEROL: An oxysterol involved in immune regulation.
[3H]RESOLVIN D1: A radiolabeled version of the lipid mediator Resolvin D1.
PSB-17365: An experimental research compound.
POMC (141-162): A peptide fragment of pro-opiomelanocortin.
EPACADOSTAT: An experimental inhibitor of the IDO1 enzyme for cancer immunotherapy.
ROVELIZUMAB: An investigational monoclonal antibody that targets CD11a.
VALATEGRAST: An experimental alpha-4 integrin antagonist.
NEMOLIZUMAB: A monoclonal antibody that targets the IL-31 receptor A for atopic dermatitis.
COMPOUND 22 [PMID: 21823616]: A research compound described in the specified scientific publication.
GRANDININ: A natural ellagitannin.
AC430: An experimental research compound.
COMPOUND 32 [PMID: 31675166]: A research compound described in the specified scientific publication.
T-817 MALEATE: The salt of an experimental neuroprotective agent.
TPT-004: An experimental research compound.
CRIDANIMOD: An immunomodulatory agent.
GSK-J1: A research chemical that is a cell-permeable inhibitor of JMJD3/UTX histone demethylases.
AM7: An experimental research compound.
CYPPTS: An experimental research compound.
[3H]CTEP: A radiolabeled negative allosteric modulator of the mGlu5 receptor.
VU-1545: An experimental research compound.
MCCG: A research chemical that is a group II metabotropic glutamate receptor antagonist.
CTPI-2: An experimental research compound.
1,2,3-BENZENETRICARBOXYLIC ACID: A simple organic acid.
FPA144: An investigational monoclonal antibody targeting FGFR2b.
DESOXYCORTICOSTERONE: A mineralocorticoid steroid hormone.
COMPOUND 4E [PMID: 35546685]: A research compound described in the specified scientific publication.
J30-8: An experimental research compound.
JNK INHIBITOR VIII: A research chemical that inhibits c-Jun N-terminal kinases (JNK).
5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE: A chemical name for a specific JNK inhibitor.
TPL2 KINASE INHIBITOR: A class of drugs that block the TPL2 (COT) kinase.
COMPOUND 1A [PMID: 15055993]: A research compound described in the specified scientific publication.
MOTILIN-(1-19) (HUMAN): An N-terminal fragment of the human motilin hormone.
T440: An experimental research compound.
NNC 11-1607: An experimental research compound.
S24014: An experimental research compound.
ISOTONITAZENE: A potent synthetic opioid analgesic of the benzimidazole class.
ZURLETRECTINIB: An investigational pan-TRK kinase inhibitor.
GR 159897: A research chemical that is a neurokinin 2 (NK2) receptor antagonist.
[125I]NKA (HUMAN, MOUSE, RAT): A radiolabeled version of neurokinin A.
IMR-1: An experimental research compound.
NEUROPEPTIDE W-30: A 30-amino acid neuropeptide that binds to GPR7 and GPR8.
Sâ€Y048: An experimental research compound.
[3H]-TCS 1102: A radiolabeled antagonist of the orexin-2 receptor.
[125I]OREXIN A (HUMAN, MOUSE, RAT): A radiolabeled version of the neuropeptide orexin A.
NF023: A research chemical that is a P2X1 receptor antagonist.
PSB-10211: An experimental research compound.
ELIAPIXANT: An investigational P2X3 receptor antagonist.
A839977: An experimental P2X7 receptor antagonist.
A740003: A research chemical that is a potent P2X7 receptor antagonist.
ITH15004: An experimental research compound.
2',3'-DIDEOXYADENOSINE TRIPHOSPHATE: A chain-terminating analog of dATP.
2-FUROYL-LIGRLO-AMIDE: A peptide that is a protease-activated receptor 2 (PAR2) agonist.
COMPOUND 16 [PMID: 31525966]: A research compound described in the specified scientific publication.
CL-AMIDINE: A research chemical that inhibits protein arginine deiminases (PADs).
AG-122018: An experimental research compound.
MLN0905: An experimental Aurora kinase inhibitor.
CONTELTINIB: An investigational PI3K alpha inhibitor.
MIGOPROTAFIB: An experimental research compound.
COMPOUND V [PMID: 29351497]: A research compound described in the specified scientific publication.
(5Z)-5-[(5-BROMOTHIOPHEN-2-YL)METHYLIDENE]-1-METHYL-2-SULFANYLIDENE-1,3-DIAZINANE-4,6-DIONE: A chemical name for a specific research compound.
BMS641: An experimental research compound from Bristol-Myers Squibb.
COMPOUND 28 [HEITEL ET AL., 2019]: A research compound described in the specified scientific publication.
FLUOROBEXAROTENE: A fluorinated derivative of the retinoid X receptor (RXR) agonist bexarotene.
EUROPIUM-LABELLED R3(B1-22R): A fluorescently labeled peptide for research.
TTI-101: An investigational STAT3 inhibitor.
AKK(THIOAC)LM21: A modified peptide for research.
OPAGANIB: An investigational sphingosine kinase 2 inhibitor.
[111IN]DOTA-NOC-ATE: A radiolabeled peptide for imaging neuroendocrine tumors.
DOTA-JR11: A radiolabeled somatostatin receptor antagonist for imaging.
J-2156: A research chemical that is a somatostatin receptor subtype 4 antagonist.
RK-287107: A natural product that inhibits STAT3 signaling.
COMPOUND 8E [PMID: 23044371]: A research compound described in the specified scientific publication.
2-PHENYL-PROPYLAMINE: A chemical intermediate.
COMPOUND 10 [PMID: 34989568]: A research compound described in the specified scientific publication.
UM-9: An experimental research compound.
DALTROBAN: An experimental thromboxane A2 receptor antagonist.
COMPOUND 21K [PMID: 34985886]: A research compound described in the specified scientific publication.
LEPUNAFUSP ALFA: An investigational fusion protein.
COMPOUND 5 [PMID: 29579323]: A research compound described in the specified scientific publication.
ADENOSINE MONOPHOSPHATE: A nucleotide that is a monomer in RNA.
ML SA1: A research chemical that is an activator of the TRPML1 channel.
COMPOUND 34H [PMID: 27055065]: A research compound described in the specified scientific publication.
TYK2 INHIBITOR 14L: A research chemical that inhibits the TYK2 kinase.
[3H]SR 121463A: A radiolabeled vasopressin V2 receptor antagonist.
NPY-(26-36) (PIG): A C-terminal fragment of porcine Neuropeptide Y.
GRACILIN J: A natural product from a marine sponge.
PROLGOLIMAB: A monoclonal antibody targeting the PD-1 immune checkpoint.
SHP2 INHIBITOR ERAS-601: An experimental inhibitor of the SHP2 phosphatase.
AGL 2043: An experimental research compound.
NERVIANO: An experimental research compound.
GSK1059615: An experimental dual PI3K/mTOR inhibitor.
DOXORUBICIN LIPOSOME: A liposomal formulation of the chemotherapy drug doxorubicin.
OBICETRAPIB: An investigational CETP inhibitor for dyslipidemia.
INOLIMOMAB: A monoclonal antibody that targets the IL-2 receptor alpha chain.
ETHAVERINE HYDROCHLORIDE: The salt of ethaverine, a papaverine derivative with spasmolytic properties.
ICATIBANT ACETATE: The salt of icatibant, a bradykinin B2 receptor antagonist for hereditary angioedema.
FTI 276: A research chemical that is a farnesyltransferase inhibitor.
LIAFENSINE: An experimental serotonin-norepinephrine-dopamine reuptake inhibitor.
CHIPS: A protein from Staphylococcus aureus that inhibits chemotaxis.
SPIRAPRILAT: The active metabolite of the ACE inhibitor spirapril.
MIMOPEZIL: An experimental drug for Alzheimer's disease.
SB-3CT: A research chemical that is an inhibitor of gelatinase (MMP-2, MMP-9).
[125I]PYY: A radiolabeled version of Peptide YY.
BENZHYDROCODONE HYDROCHLORIDE: The salt of benzhydrocodone, an opioid prodrug.
COMPOUND 21 [PMID: 22802221]: A research compound described in the specified scientific publication.
L-888,607: An experimental research compound.
TOLMETIN: A non-steroidal anti-inflammatory drug (NSAID).
DIXANTHOGEN: A chemical compound used in mining, also a xanthate derivative.
COUMARIN-3-CARBOXYLIC ACID: A derivative of coumarin.
GW837331X: An experimental research compound from GlaxoSmithKline.
TRITIOZINE: An anti-ulcer agent.
N-[3H]METHYLHISTAMINE: A radiolabeled metabolite of histamine.
GURETOLIMOD: An investigational Toll-like receptor 8 (TLR8) agonist.
COMMENSAL BACTERIAL STRAIN FORMULATION VE800: An investigational live biotherapeutic product.
DOCARPAMINE: A prodrug of dopamine.
PRIDINOL: A centrally acting muscle relaxant.
ALDRIN: An organochlorine insecticide, now banned in many countries.
BUTACHLOR: A chloroacetamide herbicide.
XANTHURENATE: A metabolite of tryptophan.
NAMITECAN: An experimental topoisomerase I inhibitor.
SKLB-03220: An experimental research compound.
LANINAMIVIR OCTANOATE: A long-acting neuraminidase inhibitor for influenza.
LAUROCAPRAM: A penetration enhancer used in topical drug formulations.
ALPHA-CYPERMETHRIN: A synthetic pyrethroid insecticide.
DIHYDROSTREPTOMYCIN: A derivative of the antibiotic streptomycin.
[3H]TBZOH: A radiolabeled research compound.
SELECTIVE ESTROGEN RECEPTOR COVALENT ANTAGONIST H3B-6545: An experimental covalent antagonist of the estrogen receptor.
12-IMIDAZOLYL-1-DODECANOL: A thromboxane synthase inhibitor.
KOS1326: An experimental research compound.
HYDRASTININE: An alkaloid derived from hydrastine.
LINCOMYCIN HYDROCHLORIDE: The salt of lincomycin, a lincosamide antibiotic.
ZOFENOPRIL: An ACE inhibitor.
FGF401: An experimental FGFR4 kinase inhibitor.
ANTI-CD30 MONOCLONAL ANTIBODY MDX-1401: An experimental monoclonal antibody targeting CD30.
PPTN: An experimental research compound.
LY2979165: An experimental research compound from Eli Lilly.
7&ALPHA;,27-DIHYDROXYCHOLESTEROL: An oxysterol involved in cholesterol metabolism.
GI?30159: An experimental research compound.
SIPULEUCEL-T: An autologous cellular immunotherapy for prostate cancer.
AFURESERTIB HYDROCHLORIDE: The salt of afuresertib, an experimental Akt kinase inhibitor.
FOSCARNET: An antiviral medication for herpesvirus infections.
INTERLEUKIN-12: A cytokine that is a key inducer of Th1 cell differentiation.
SOPHORAFLAVANONE G: A natural prenylated flavanone with anti-inflammatory activity.
ALTROPANE I-123: A radiopharmaceutical used for imaging the dopamine transporter.
LENZILUMAB: An investigational monoclonal antibody that targets GM-CSF.
3-IODOBENZYLGUANIDINE: Iobenguane, a radiopharmaceutical used for imaging neuroendocrine tumors.
AROMOLINE: A natural bisbenzylisoquinoline alkaloid.
AVANAFIL: A PDE5 inhibitor used to treat erectile dysfunction.
COMPOUND 16D [PMID: 36573286]: A research compound described in the specified scientific publication.
CPUY192018: An experimental research compound.
IROSUSTAT: An experimental steroid sulfatase inhibitor.
EPTACOG ALFA (ACTIVATED): Recombinant activated coagulation factor VII.
DEUCRICTIBANT: An investigational bradykinin B2 receptor antagonist.
CEBRANOPADOL: An investigational nociceptin/opioid receptor agonist.
TIMBETASIN: An experimental research compound.
GSK-2269557: An experimental inhaled PI3K delta inhibitor.
SITOKIREN: An experimental renin inhibitor.
SKA-111: A research chemical that activates KCa2.x/KCa3.1 channels.
TTC-352: An experimental selective estrogen receptor partial agonist.
EPOPROSTENOL SODIUM: The salt of epoprostenol, a synthetic prostacyclin for pulmonary hypertension.
A68930: A research chemical that is a potent D1 dopamine receptor agonist.
SCH 37370: An experimental research compound.
CONTEZOLID ACEFOSAMIL: An investigational oxazolidinone antibiotic prodrug.
COMPOUND 22E [PMID: 20167483]: A research compound described in the specified scientific publication.
CCL21: A chemokine also known as secondary lymphoid-tissue chemokine (SLC).
RO330-0802/001: An experimental research compound from Roche.
BIHELICAL APOA-I MIMETIC PEPTIDE 5A: An experimental peptide designed to mimic Apolipoprotein A-I.
CHLOROPHACINONE: An anticoagulant rodenticide.
AMTOLMETIN GUACIL: A non-steroidal anti-inflammatory drug (NSAID).
COMPOUND 5E [PMID: 17975902]: A research compound described in the specified scientific publication.
RIFAXIMIN: A non-absorbable antibiotic for gastrointestinal conditions.
POSACONAZOLE: A triazole antifungal medication.
ISOETHARINE HYDROCHLORIDE: The salt of isoetharine, a short-acting beta-2 adrenergic agonist.
SECURININE: A GABA-A receptor antagonist alkaloid.
MRS4478: An experimental research compound.
SAF312: An experimental research compound.
KAI-1678: An experimental peptide inhibitor of protein kinase C epsilon.
DEXFENFLURAMINE: A serotonin releasing agent, withdrawn as an anorectic.
DINITRAMINE: A dinitroaniline herbicide.
VORETIGENE NEPARVOVEC: A gene therapy for an inherited retinal disease.
PX-12: An experimental inhibitor of thioredoxin-1.
ALT-2074: An experimental research compound.
ZORIFERTINIB: An investigational EGFR kinase inhibitor.
AMA: An experimental research compound.
2-FUROYL-LIGRL[N-(ALEXA FLUOR 594)-O]-NH2: A fluorescently labeled peptide agonist of PAR2.
DEXPROPRANOLOL HYDROCHLORIDE: The salt of dexpropranolol, the non-beta-blocking isomer of propranolol.
CHEMERIN C-TERMINAL PEPTIDE: A peptide fragment of the chemerin protein.
RECOMBINANT HUMAN THROMBOPOIETIN: A genetically engineered form of the hormone that stimulates platelet production.
SIVELESTAT SODIUM: The salt of sivelestat, a neutrophil elastase inhibitor.
BENDAMUSTINE: An alkylating agent used as a chemotherapy drug.
INSULIN SUSP ISOPHANE PURIFIED BEEF: NPH insulin derived from beef.
LEVOBUPIVACAINE HYDROCHLORIDE: The salt of levobupivacaine, a long-acting local anesthetic.
BETHANIDINE SULFATE: The salt of bethanidine, an adrenergic neuron blocking agent.
NESIRITIDE: Recombinant human B-type natriuretic peptide for acute decompensated heart failure.
RISEDRONATE SODIUM ANHYDROUS: The anhydrous form of risedronate sodium, a bisphosphonate.
DAPAGLIFLOZIN PROPYLENE GLYCOL: A co-crystal of dapagliflozin, an SGLT2 inhibitor.
CM-082: An investigational multi-kinase inhibitor.
AZD6280: An experimental pan-RAF kinase inhibitor.
INCB-9471: An experimental research compound from Incyte Corporation.
RUPLIZUMAB: An investigational monoclonal antibody that targets CD40L.
ANAMORELIN HYDROCHLORIDE: The salt of anamorelin, a ghrelin receptor agonist for cachexia.
IBODUTANT: An experimental neurokinin 2 (NK2) receptor antagonist.
FLAVOXATE HYDROCHLORIDE: The salt of flavoxate, a urinary antispasmodic.
MIROGABALIN BESYLATE: The salt of mirogabalin, a gabapentinoid for neuropathic pain.
BAPINEUZUMAB: An investigational monoclonal antibody targeting amyloid beta.
OBILTOXAXIMAB: A monoclonal antibody for the treatment of inhalational anthrax.
DEFIBROTIDE: An oligonucleotide mixture used to treat hepatic veno-occlusive disease.
INSULIN PEGLISPRO: A pegylated, long-acting insulin analog.
ESOMEPRAZOLE MAGNESIUM: The magnesium salt of esomeprazole, a proton pump inhibitor.
NALMEFENE HYDROCHLORIDE: The salt of nalmefene, an opioid receptor antagonist.
CLOMETACIN: A non-steroidal anti-inflammatory drug (NSAID).
ANSUVIMAB-ZYKL: A monoclonal antibody for the treatment of Ebola virus disease.
FAVIPIRAVIR: An antiviral drug that inhibits RNA-dependent RNA polymerase.
OLITIGALTIN: An experimental research compound.
NEBICAPONE: An experimental inhibitor of catechol-O-methyltransferase (COMT).
ETHYLESTRENOL: An anabolic steroid.
RAVAGALIMAB: An investigational monoclonal antibody.
DOVRAMILAST: An investigational phosphodiesterase 4 inhibitor.
FELADILIMAB: An investigational monoclonal antibody targeting ICOS.
LUTIKIZUMAB: An investigational monoclonal antibody targeting IL-1 alpha and IL-1 beta.
MILRINONE LACTATE: The salt of milrinone, a phosphodiesterase 3 inhibitor for heart failure.
LUCERASTAT: An experimental glucosylceramide synthase inhibitor.
FIMASARTAN: An angiotensin II receptor blocker (ARB).
BI-671800: An experimental research compound.
OLENDALIZUMAB: An investigational monoclonal antibody.
ORG-25935: An experimental research compound.
PIPECURONIUM BROMIDE: A long-acting non-depolarizing neuromuscular blocking agent.
TALAMPANEL: An experimental AMPA receptor antagonist.
FIDANACOGENE ELAPARVOVEC: An investigational gene therapy for hemophilia B.
REPROTEROL: A short-acting beta-2 adrenergic agonist.
PHA-665752: A research chemical that is a potent inhibitor of the c-Met kinase.
TETRADECANOYL PHORBOL ACETATE: Phorbol 12-myristate 13-acetate (PMA), a potent activator of protein kinase C.
BISMUTH SUBSALICYLATE: A bismuth compound used for indigestion and diarrhea.
GW784684X: An experimental research compound from GlaxoSmithKline.
5-AMINOISOQUINOLINE: A research chemical that is a PARP1 inhibitor.
DIAZIRINE: A class of photoreactive chemical cross-linking agents.
CYCLOHETERPHYLLIN: A natural isoprenylated chalcone.
FURAZABOL: An anabolic steroid.
6-CHLOROFLAVONE: A synthetic flavone.
HETEROCODEINE: A derivative of the opioid codeine.
KRESOXIM-METHYL: A strobilurin fungicide.
5-OH-DPAT: A research chemical that is a D2/D3 dopamine receptor agonist.
TECTOQUINONE: A naphthoquinone found in teak wood.
INDIGO: A natural dye, historically from the plant Indigofera tinctoria.
PROTUBOXEPIN A: A natural product with antibacterial activity.
INDOLE-3-ACETIC ACID: The most common naturally occurring plant hormone of the auxin class.
NAFTOPIDIL DIHYDROCHLORIDE: The salt of naftopidil, an alpha-1d/1a adrenergic receptor antagonist.
ORTHO-PHTHALALDEHYDE: An organic compound used as a high-level disinfectant.
CHLORPROPHAM: A plant growth regulator and herbicide.
METHYLSELENOCYSTEINE: A selenized amino acid with potential chemopreventive properties.
AHPN: A synthetic retinoid analog.
VINCLOZOLIN: A dicarboximide fungicide with antiandrogenic activity.
4-METHYLESCULETIN: A derivative of the coumarin esculetin.
IRINOTECAN HYDROCHLORIDE HYDRATE: The hydrated salt of irinotecan, a topoisomerase I inhibitor.
P-TOLUENESULFONAMIDE: An organic sulfonamide.
KINETIN: A type of cytokinin, a class of plant hormone.
METHYLTHIOURACIL: An antithyroid agent.
AESCULIOSIDE IIB: A natural triterpenoid saponin.
WOGONIN: A natural O-methylated flavone.
SPIRUCHOSTATIN C: A natural product that is a histone deacetylase (HDAC) inhibitor.
BMY-7378: A research chemical that is a 5-HT1A receptor antagonist and alpha-1d adrenergic antagonist.
FLAVIN ADENINE DINUCLEOTIDE: A redox-active coenzyme.
SPHAEROPSIDIN A: A fungal metabolite with phytotoxic activity.
ANTIAROL: A natural phenolic compound.
LEOIDIN: An experimental research compound.
DIBROMOACETIC ACID: A haloacetic acid, a disinfection byproduct.
PAMICOGREL: An experimental thromboxane A2 synthase inhibitor.
RP-67580: A research chemical that is a non-peptide neurokinin 1 (NK1) receptor antagonist.
DODINE: An agricultural fungicide.
E-64C: A research chemical that is an irreversible inhibitor of cysteine proteases.
CLADRIN: An experimental research compound.
GW785804X: An experimental research compound from GlaxoSmithKline.
BERKELEYTRIONE: A natural product from a marine-derived fungus.
BROMAMINIC ACID: A dye intermediate.
AESCULIOSIDE IID: A natural triterpenoid saponin.
QUINIZARIN: An anthraquinone dye.
4-TRIETHYLGERMYLPHENOL: An organogermanium compound.
NIFEKALANT: A class III antiarrhythmic agent.
PERAMIVIR ANHYDROUS: The anhydrous form of peramivir, a neuraminidase inhibitor for influenza.
ANTIPARASITIC AGENT: A general term for a drug used to treat parasitic diseases.
C-FOS ANTISENSE: An antisense oligonucleotide designed to inhibit the production of the c-Fos protein.
PROTEIN PHOSPHATASE INHIBITOR: A general term for a substance that blocks the action of protein phosphatases.
VERTEPORFIN: A photosensitizer used in photodynamic therapy for macular degeneration.
MONOAMINE OXIDASE INHIBITOR: A class of drugs that inhibit monoamine oxidase enzymes, used as antidepressants.
ATROPINE SULFATE: The salt of atropine, a muscarinic acetylcholine receptor antagonist.
RECOMBINANT TRANSFORMING GROWTH FACTOR-BETA: A genetically engineered form of the TGF-beta cytokine.
AT-13148: An experimental Aurora kinase inhibitor.
PINGYANGMYCIN: An antibiotic mixture of bleomycin A5 used as an antineoplastic agent.
AZD-0424: An experimental spleen tyrosine kinase (Syk) inhibitor.
VALINOMYCIN: A natural depsipeptide that acts as a potassium-selective ionophore.
SIPONIMOD: A sphingosine-1-phosphate (S1P) receptor modulator for multiple sclerosis.
METHACHOLINE: A synthetic choline ester that acts as a muscarinic receptor agonist.
CYCLOGUANIL: An antifolate agent, the active metabolite of proguanil.
BAY-1161909: An experimental research compound from Bayer.
INFLUENZA VACCINE: A vaccine that protects against infection by influenza viruses.
PEGLOTICASE: A pegylated recombinant uricase enzyme for treating chronic gout.
NITRIC OXIDE-RELEASING ACETYLSALICYLIC ACID DERIVATIVE: A class of experimental anti-inflammatory drugs.
PEGINTERFERON ALFACON-1: A pegylated form of interferon alfacon-1.
TELAPRISTONE: An experimental selective progesterone receptor modulator.
TAK-901: An experimental c-Met kinase inhibitor.
PAC-14028: An experimental transient receptor potential vanilloid 1 (TRPV1) antagonist.
CX1739: An experimental nootropic agent of the ampakine class.
RG6029: An experimental research compound from Roche.
AVE8134: An experimental soluble epoxide hydrolase inhibitor.
LONAPRISAN: An experimental selective progesterone receptor antagonist.
OMS405: An experimental research compound.
NRX195183: An experimental research compound.
P-P68 INHIBITOR RX-5902: An investigational agent that targets the p68 RNA helicase.
GLYCOOPTIMIZED TRASTUZUMAB-GEX: A glyco-engineered version of the monoclonal antibody trastuzumab.
TAPOTOCLAX: An investigational dual BCL-2/BCL-xL inhibitor.
CPG OLIGODEOXYNUCLEOTIDE TLR9 AGONIST DV281: An experimental Toll-like receptor 9 agonist.
CRENIGACESTAT: An experimental gamma-secretase inhibitor.
TAS-116: An experimental Hsp90 inhibitor.
PEN-866: An experimental small molecule-drug conjugate for cancer therapy.
MEDI-547: An experimental monoclonal antibody.
CRIDANIMOD SODIUM: The sodium salt of an immunomodulatory agent.
IT-139: An experimental GRP78 inhibitor for cancer therapy.
SELECTIVE ESTROGEN RECEPTOR MODULATOR CC-8490: An experimental SERM.
PIMAGEDINE HYDROCHLORIDE: The salt of pimagedine, an experimental inhibitor of advanced glycation end-products.
ORTATAXEL: An oral taxane chemotherapy agent.
ALVIMOPAN ANHYDROUS: The anhydrous form of alvimopan, a peripherally acting mu-opioid receptor antagonist.
SB-436811: An experimental research compound.
ORG-25435: An experimental research compound.
3K3A-ACTIVATED PROTEIN C: A genetically modified variant of activated protein C with neuroprotective effects.
VATREPTACOG ALFA (ACTIVATED): An experimental recombinant activated factor VII variant.
MK-0249: An experimental CGRP receptor antagonist.
ELAGOLIX SODIUM: The salt of elagolix, a gonadotropin-releasing hormone (GnRH) antagonist.
VESTIPITANT MESYLATE: The salt of vestipitant, an experimental neurokinin-1 (NK1) receptor antagonist.
EPIDERMAL GROWTH FACTOR: A protein that stimulates cell growth and differentiation by binding to its receptor, EGFR.
INDIBULIN: An experimental tubulin inhibitor for cancer therapy.
ZATOSETRON MALEATE: The salt of zatosetron, a 5-HT3 receptor antagonist.
DANIRIXIN: An experimental CXCR2 chemokine receptor antagonist.
BARBITAL: A barbiturate derivative, the first to be marketed.
TEMANOGREL: An experimental serotonin 5-HT2A and thromboxane receptor antagonist.
L-NAME: N(G)-Nitro-L-arginine methyl ester, a research chemical that inhibits nitric oxide synthase.
AZD8683: An experimental research compound from AstraZeneca.
XANOMELINE TARTRATE: The salt of xanomeline, an experimental muscarinic acetylcholine receptor agonist.
LY86057: An experimental research compound from Eli Lilly.
BURIXAFOR: An investigational CXCR4 antagonist.
WWL70: A research chemical that is an inhibitor of alpha/beta-hydrolase domain containing 6 (ABHD6).
RASEGLURANT: An experimental mGlu5 receptor negative allosteric modulator.
APELIN-17: A 17-amino acid isoform of the endogenous peptide apelin.
[3H]DPCPX: A radiolabeled selective A1 adenosine receptor antagonist.
UNC4203: An experimental research compound.
FX1: A research chemical that is an inhibitor of the STAT3 signaling pathway.
MF101: A botanical drug preparation containing a mixture of flavonoids.
COMPOUND 101 [PMID: 21596927]: A research compound described in the specified scientific publication.
[3H]CGS23131: A radiolabeled research compound.
LTB4: Leukotriene B4, a potent inflammatory lipid mediator.
ISOXAZOLE AZEPINE COMPOUND 3: A research chemical based on an isoxazole azepine scaffold.
[LEU9,DES-ARG10]KALLIDIN: An analog of the peptide kallidin that is a bradykinin B1 receptor agonist.
C5A DES-ARG: A metabolite of the C5a complement protein, also known as acylation-stimulating protein.
ACPHE-ORN-PRO-D-CHA-TRP-ARG: A synthetic peptide that is a bradykinin B1 receptor antagonist.
FLPLAR: A synthetic peptide.
AC-RHYPLWR: A synthetic peptide.
[125I]C5A (HUMAN): A radiolabeled version of the human C5a complement protein.
COMPOUND 21 [PMID: 25259874]: A research compound described in the specified scientific publication.
SITS: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid, an anion transport inhibitor.
SZ(+)-(S)-202-791: The S-enantiomer of an L-type calcium channel agonist.
TROX-1: A research chemical with neuroprotective properties.
COMPOUND 1B [PMID: 16290936]: A research compound described in the specified scientific publication.
AM6545: An experimental peripherally restricted CB1 cannabinoid receptor antagonist.
R5-HIV-1 GP120: The gp120 envelope glycoprotein from an R5-tropic strain of HIV-1.
[125I]CCL4 (HUMAN): A radiolabeled version of the human chemokine CCL4 (MIP-1Î²).
LORECIVIVINT: An investigational Wnt pathway inhibitor for osteoarthritis.
CFTRINH-172: A research chemical that inhibits the CFTR chloride channel.
GATX1: An experimental research compound.
COMPOUND 10 [PMID: 34279934]: A research compound described in the specified scientific publication.
CYTOKINE DOMAIN OF TYROSYL TRNA SYNTHETASE: The cytokine-like domain of an aminoacyl-tRNA synthetase.
NBI-74330: An experimental corticotropin-releasing factor 1 (CRF1) receptor antagonist.
JMS-17-2: An experimental agent that inhibits p97/VCP ATPase.
PF?6928215: An experimental research compound from Pfizer.
CTA091: An experimental research compound.
[3H]GBR12935: A radiolabeled dopamine reuptake inhibitor.
SOLRIAMFETOL: A dopamine-norepinephrine reuptake inhibitor for excessive daytime sleepiness.
[3H]WIN35428: A radiolabeled cocaine analog that binds to the dopamine transporter.
NGB 2904: A research chemical that is a kappa-opioid receptor antagonist.
REBOXETINE: A selective norepinephrine reuptake inhibitor used as an antidepressant.
NE11808: An experimental research compound.
FHQC: An experimental research compound.
COMPOUND A [PMID 24997608]: A research compound described in the specified scientific publication.
RESIGRATINIB: An investigational pan-fibroblast growth factor receptor (FGFR) inhibitor.
SAFIT2: An experimental research compound.
IRPAGRATINIB: An investigational FGFR inhibitor.
VEGFB: Vascular endothelial growth factor B, a protein involved in angiogenesis.
T21/DP107: An HIV fusion inhibitor peptide.
PSM&ALPHA;3: A phenol-soluble modulin peptide from Staphylococcus aureus.
WRWWWW: A synthetic hexapeptide with cell-penetrating properties.
WNT-3A: A protein of the Wnt signaling pathway family.
M35: An experimental galanin receptor ligand.
GALP(1-32) (HUMAN): A fragment of human galanin-like peptide.
GALANIN(10-29) (RAT/MOUSE): A fragment of rodent galanin neuropeptide.
QU-SPX: An experimental research compound.
M32: An experimental galanin receptor antagonist.
L-168,049: An experimental research compound.
COMPOUND 8 [PMID: 17562362]: A research compound described in the specified scientific publication.
SER11PBNP2-15: A chimeric natriuretic peptide.
ORNITHINE, (L)-ISOMER: The L-isomer of the amino acid ornithine.
PEGFILGRASTIM-JMDB: A biosimilar of pegfilgrastim, a long-acting granulocyte colony-stimulating factor.
GROWTH HORMONE 2: A variant of human growth hormone.
COMPOUND 8F [PMID: 20615702]: A research compound described in the specified scientific publication.
UR-PG55B: An experimental research compound.
(S)-3-HYDROXY-3-METHYLGLUTARYL-COA: An intermediate in the mevalonate pathway for cholesterol synthesis.
COMPOUND 2D [PMID: 2153213]: A research compound described in the specified scientific publication.
COMPOUND 3 [DREYER ET AL., 1991]: A research compound described in the specified scientific publication.
COMPOUND 24 [PMID: 31343176]: A research compound described in the specified scientific publication.
1-PALMITOYL-LYSOPHOSPHATIDYLCHOLINE: A species of lysophosphatidylcholine.
MSMB (91-114): A peptide fragment of microseminoprotein beta.
SODIUM DICHLOROACETATE: The salt of dichloroacetic acid, an experimental cancer drug.
JAK3 INHIBITOR 34: A research chemical that inhibits Janus kinase 3.
&ALPHA;-NEOENDORPHIN: An endogenous opioid peptide.
MP1104: An experimental research compound.
CANLITINIB: An investigational HER2 kinase inhibitor.
STEM CELL FACTOR: A cytokine that binds to the c-Kit receptor, involved in hematopoiesis.
UCL1848: A research chemical that inhibits the TREK-1 potassium channel.
VU0405601: An experimental research compound.
QO-58: A research chemical that is an activator of the KCNQ1 potassium channel.
COMPOUND 6 [PMID: 22533316]: A research compound described in the specified scientific publication.
GSK180: An experimental research compound from GlaxoSmithKline.
WH-4-023: An experimental Lck kinase inhibitor.
[125I]CHORIONIC GONADOTROPIN (HUMAN): A radiolabeled version of human chorionic gonadotropin (hCG).
ONO-7300243: An experimental IP receptor agonist.
ANTI-BRP-LPA: An antibody targeting lysophosphatidic acid.
VU0469650: An experimental research compound.
[3H]2,2,2-TEMPS: A radiolabeled spin probe for research.
C7/3-PHTH: An experimental research compound.
ML380: A research chemical that is an inhibitor of USP7.
N-CHLOROMETHYL-BRUCINE: A derivative of the alkaloid brucine.
[125I]S70254: A radiolabeled research compound.
PF-06761281: An experimental research compound from Pfizer.
NISOXETINE: A selective norepinephrine reuptake inhibitor used in research.
BNC375: An experimental research compound.
NEUROPEPTIDE-&GAMMA;: A peptide derived from the VGF protein.
ZM 253270: A research chemical that is a vasopressin V1A receptor antagonist.
ZM-274773: An experimental research compound.
COMPOUND 29 [VIETOR, ET AL., 2023]: A research compound described in the specified scientific publication.
NARINGIN: A flavonoid glycoside found in citrus fruits.
MRS2298: An experimental research compound.
PSB-16133: An experimental research compound.
RP-5-OME-UDP&ALPHA;B: A modified uridine nucleotide.
ABT-491: An experimental A1 adenosine receptor agonist.
M65: An experimental research compound.
ATOPAXAR: An experimental protease-activated receptor 1 (PAR-1) antagonist.
SLIGRL-NH2: A peptide agonist of the protease-activated receptor 2 (PAR2).
I-191: An experimental research compound.
AG-17724: An experimental research compound.
BAY-8400: An experimental research compound from Bayer.
STK16-IN-1: A research chemical that inhibits the STK16 kinase.
VINPOCETINE: A synthetic derivative of the vinca alkaloid vincamine, used as a nootropic.
ELND006: An experimental agent that inhibits myo-inositol transport.
[PHE23]PTH-(1-34) (HUMAN): A synthetic fragment of human parathyroid hormone.
[125I]QRFP43 (HUMAN): A radiolabeled version of the human QRFP43 peptide.
SR1001: A research chemical that is an inverse agonist of the RORÎ±/Î³t receptors.
PN10: An experimental research compound.
A(4-24)(B7-24)H2: A hybrid insulin peptide.
LY3540378: An experimental research compound from Eli Lilly.
BMS-986104 DERIVATIVE 24: A chemical derivative of an experimental drug from Bristol-Myers Squibb.
PO-322: An experimental research compound.
COMPOUND 3F [PMID: 12238936]: A research compound described in the specified scientific publication.
SYK INHIBITOR II: A research chemical that inhibits spleen tyrosine kinase (Syk).
COMPOUND 19 [PMID: 19191557]: A research compound described in the specified scientific publication.
O3: Ozone, an inorganic molecule.
ARTEPILLIN C: A prenylated cinnamic acid derivative found in propolis.
A-1165442: An experimental HCV NS5B polymerase inhibitor.
JNJ17203212: An experimental histamine H3 receptor antagonist.
RO3280: An experimental research compound from Roche.
81C6 131I: An iodine-131 radiolabeled monoclonal antibody targeting tenascin.
BAY-805: An experimental research compound from Bayer.
PHV: An experimental research compound.
DANTHRON: An anthraquinone derivative used as a stimulant laxative.
AMG-888: An experimental PARP inhibitor from Amgen.
BET INHIBITOR: A class of drugs that inhibit the bromodomain and extraterminal domain family of proteins.
TELOTRISTAT ETIPRATE: A prodrug of telotristat, an inhibitor of tryptophan hydroxylase.
HDAC INHIBITOR REC-2282: An experimental histone deacetylase (HDAC) inhibitor.
YTTRIUM Y 90 EPRATUZUMAB: A radioimmunoconjugate combining an anti-CD22 antibody with yttrium-90.
KRAS G12D INHIBITOR MRTX1133: An investigational covalent inhibitor of the KRAS G12D mutant.
MEDI-5117: An experimental bispecific antibody targeting IFN-Î± and the BAFF receptor.
TORIN 1: A research chemical that is a potent ATP-competitive inhibitor of mTOR kinase.
FOSNETUPITANT CHLORIDE HYDROCHLORIDE: The salt of fosnetupitant, a prodrug of the NK1 antagonist netupitant.
PRUCALOPRIDE SUCCINATE: The salt of prucalopride, a selective 5-HT4 receptor agonist for constipation.
VPS34-IN-1: A research chemical that inhibits the VPS34 lipid kinase.
OMADACYCLINE TOSYLATE: The salt of omadacycline, a tetracycline-class antibiotic.
BETULIN: A natural pentacyclic triterpenoid with various biological activities.
LEFAMULIN ACETATE: The salt of lefamulin, a pleuromutilin antibiotic.
TPC2-A1-P: A research chemical that acts as an antagonist of two-pore channels.
LASMIDITAN SUCCINATE: The salt of lasmiditan, a 5-HT1F receptor agonist for migraine.
AZD-4017: An experimental inhibitor of 11Î²-hydroxysteroid dehydrogenase type 1.
CRIZANLIZUMAB: A monoclonal antibody that targets P-selectin for sickle cell disease.
FACTOR XIII, HUMAN: A human plasma-derived form of the coagulation factor XIII.
MK-8776: An experimental CHK1 kinase inhibitor.
DEHYDROMUTACTIN: A natural product with antibacterial activity.
[14C]HISTIDINE: A radiolabeled version of the amino acid histidine.
TETRAETHYLAMMONIUM CHLORIDE: A quaternary ammonium compound that blocks potassium channels.
APILIMOD DIMESYLATE CAPSULE: A formulation of apilimod, an experimental PIKfyve kinase inhibitor.
HYRTIOERECTINE B: A natural indole alkaloid from a marine sponge.
AGN-211745: An experimental research compound.
DERSIMELAGON: An investigational melanocortin 1 receptor agonist.
PTEB: An experimental research compound.
BMS-816336: An experimental research compound from Bristol-Myers Squibb.
ANTI-C-FMS MONOCLONAL ANTIBODY AMG 820: An experimental antibody targeting the CSF1 receptor.
GLYCYL-[13C3]-SARCOSINE: An isotopically labeled form of the dipeptide glycylsarcosine.
LYOPHILIZED HUMAN RECOMBINANT INTERFERON-BETA 1A FP-1201: A formulation of recombinant interferon beta-1a.
COMPOUND 14J [PMID: 27050842]: A research compound described in the specified scientific publication.
AZD-8330: An experimental MEK1/2 kinase inhibitor.
GPR4 ANTAGONIST 3B: A research chemical that is an antagonist of the GPR4 receptor.
[125I]CX3CL1 (HUMAN): A radiolabeled version of the human chemokine CX3CL1 (fractalkine).
FRUCTOSE: A simple ketonic monosaccharide found in many plants.
OLOPATADINE: An antihistamine and mast cell stabilizer used in eye drops.
BEVANTOLOL HYDROCHLORIDE: The salt of bevantolol, a cardioselective beta-blocker.
DAU 6285: A research chemical that is a 5-HT3 antagonist and 5-HT4 agonist.
DBRD9-A: An experimental research compound.
SUFORAPHANE ISOSELENOCYANATE: A selenium-containing analog of sulforaphane.
TIGULIXOSTAT: An investigational non-purine xanthine oxidase inhibitor.
EVOGLIPTIN: A dipeptidyl peptidase-4 (DPP-4) inhibitor for type 2 diabetes.
SOBLIDOTIN: An experimental tubulin inhibitor of the dolastatin class.
EP4 ANTAGONIST ONO-4578: An experimental EP4 receptor antagonist.
ACADESINE: An adenosine-regulating agent investigated for various conditions.
JNJ-38877605: An experimental c-Met kinase inhibitor.
PSAB-OFP: A photolabile caged probe of a GABA-A receptor agonist.
TIFACOGIN: Recombinant human tissue factor pathway inhibitor.
MAXADILAN: A vasodilating peptide from the sand fly Lutzomyia longipalpis.
PYY-(13-36) (MOUSE, RAT, PIG): A fragment of Peptide YY.
TARIBAVIRIN HYDROCHLORIDE: The salt of taribavirin, a prodrug of ribavirin.
NGX-267: An experimental muscarinic M1 receptor agonist.
LAMPALIZUMAB: An investigational monoclonal antibody fragment targeting complement factor D.
T84.66: An experimental monoclonal antibody that targets carcinoembryonic antigen (CEA).
ANTI-ANGIOPOIETIN MONOCLONAL ANTIBODY AMG 780: An experimental antibody targeting angiopoietin.
JNJ-42226314: An experimental research compound from Johnson & Johnson.
BROMFENAC: A non-steroidal anti-inflammatory drug (NSAID) used as an eye drop.
PCO-371: An experimental vasopressin V2 receptor agonist.
TRICHLOROETHYLENE: A volatile halocarbon used as an industrial solvent.
BMS-986187: An investigational TYK2 kinase inhibitor.
SULFENTRAZONE: A phenyl-triazolinone herbicide.
MECLOCYCLINE SULFOSALICYLATE: The salt of meclocycline, a tetracycline antibiotic.
MIBOLERONE: A potent anabolic steroid used in veterinary medicine.
CORTODOXONE: A steroid, also known as 11-deoxycortisol.
PD-135158: A research chemical that is a CCK2 receptor antagonist.
COMPOUND IV [PMID: 29351497]: A research compound described in the specified scientific publication.
CIRSIMARITIN: A natural O-methylated flavone.
GSK-1030062A: An experimental research compound from GlaxoSmithKline.
GW-328267: An experimental research compound from GlaxoSmithKline.
IOBENGUANE I-123: A radiopharmaceutical used for imaging neuroendocrine tumors.
ENCLOMIPHENE: The (E)-stereoisomer of clomifene, a selective estrogen receptor modulator.
COMPOUND 77 [PMID: 24793884]: A research compound described in the specified scientific publication.
BETIBEGLOGENE AUTOTEMCEL: A gene therapy for beta-thalassemia.
COMPOUND 12 [PMID: 12723943]: A research compound described in the specified scientific publication.
DAPK INHIBITOR 13: A research chemical that inhibits death-associated protein kinase.
METRH: An experimental research compound.
LUSPATERCEPT-AAMT: An erythroid maturation agent for anemia in beta-thalassemia.
AMCASERTIB: An investigational Aurora kinase inhibitor.
BETAZOLE HYDROCHLORIDE: The salt of betazole, a histamine H2 receptor agonist.
COMPOUND 42 [PMID: 37721854]: A research compound described in the specified scientific publication.
&ALPHA;-CONOTOXIN PNIA: A peptide toxin from cone snail venom that blocks nicotinic acetylcholine receptors.
AC261066: A research chemical that is an RAR beta-2 receptor agonist.
LACTIMIDOMYCIN: A natural product that inhibits protein synthesis.
LEVOCABASTINE: A second-generation antihistamine used in eye drops and nasal sprays.
IFETROBAN SODIUM: The salt of ifetroban, an experimental thromboxane A2 receptor antagonist.
4BP-TQS: A research chemical that is an allosteric agonist of the free fatty acid receptor 1.
FLUROCHLORIDONE: A pyrrolidone herbicide.
AMOBARBITAL: A barbiturate derivative with sedative-hypnotic properties.
GSK-1030058A: An experimental research compound from GlaxoSmithKline.
CR-6086: An experimental research compound.
ICHORCUMAB: An investigational monoclonal antibody.
MRX-2843: An investigational dual MERTK/FLT3 kinase inhibitor.
N-METHYLANTHRANILIC ACID: A derivative of anthranilic acid.
COMPOUND 5N [PMID: 20483621]: A research compound described in the specified scientific publication.
PIMICOTINIB: An investigational CSF-1R inhibitor.
[3H]PAROXETINE: A radiolabeled version of the SSRI antidepressant paroxetine.
CYM5442: A research chemical that is a potent S1P1 receptor agonist.
BIA 10-2474: An experimental fatty acid amide hydrolase (FAAH) inhibitor.
SPINORPHIN: An endogenous peptide that inhibits enkephalin-degrading enzymes.
GIRIPLADIB: An experimental Lp-PLA2 inhibitor.
PHENYLALANINE: An essential amino acid.
GW809897X: An experimental research compound from GlaxoSmithKline.
TESIDOLUMAB: An investigational monoclonal antibody.
CLOROTEPINE: A typical antipsychotic of the dibenzothiepin class.
DELPAZOLID: An investigational oxazolidinone antibiotic.
BEKANAMYCIN: An aminoglycoside antibiotic.
PELUBIPROFEN: A non-steroidal anti-inflammatory drug (NSAID).
RADIX POLYGALAE EXTRACT PDC-1421: An herbal extract from Polygala tenuifolia.
AMFONELIC ACID: A research chemical that is a potent dopamine reuptake inhibitor.
LENTINAN: A polysaccharide from the shiitake mushroom used as an immunoadjuvant.
CERULENIN: A natural product that inhibits fatty acid and polyketide synthases.
QAV-680: An experimental monoclonal antibody.
COAGULATION FACTOR X HUMAN: A plasma-derived concentrate of coagulation Factor X.
XIMELAGATRAN: An oral direct thrombin inhibitor, withdrawn from the market.
GSK-270822A: An experimental research compound from GlaxoSmithKline.
BENOXAPROFEN: A non-steroidal anti-inflammatory drug (NSAID), withdrawn from the market.
SIMENEPAG ISOPROPYL: An experimental prostaglandin EP2 receptor agonist.
METHDILAZINE HYDROCHLORIDE: The salt of methdilazine, a first-generation antihistamine.
DEGARELIX ACETATE: The salt of degarelix, a GnRH receptor antagonist.
CORTISONE ACETATE: An ester of cortisone, a synthetic glucocorticoid.
OSIMERTINIB MESYLATE: The salt of osimertinib, an EGFR kinase inhibitor for non-small cell lung cancer.
CHF4227: An experimental research compound.
AZD6703: An experimental p38 MAP kinase inhibitor.
AMIVANTAMAB-VMJW: A bispecific antibody targeting EGFR and MET for lung cancer.
CC-115: An experimental dual DNA-PK and mTOR kinase inhibitor.
SPEBRUTINIB BESYLATE: The salt of an investigational Bruton's tyrosine kinase (BTK) inhibitor.
PF-00477736: An experimental CHK1 kinase inhibitor.
PLX-8394: An experimental pan-RAF kinase inhibitor.
TALQUETAMAB: An investigational bispecific antibody targeting GPRC5D and CD3.
KD7040: An experimental research compound.
ETILEVODOPA: An ethyl ester prodrug of levodopa.
COBIPROSTONE: An experimental activator of CIC-2 chloride channels.
BALOVAPTAN: An experimental vasopressin V1a receptor antagonist.
DENUFOSOL TETRASODIUM: The salt of denufosol, an experimental P2Y2 receptor agonist.
ROBATUMUMAB: An investigational monoclonal antibody that targets IGF-1R.
ANTRAFENINE: A non-steroidal anti-inflammatory drug (NSAID).
ANTI-SCLEROSTIN: A class of drugs that inhibit the protein sclerostin to increase bone formation.
RALPANCIZUMAB: An investigational monoclonal antibody.
AMG-729: An experimental monoclonal antibody from Amgen.
PF-03475952: An experimental research compound from Pfizer.
INDATUXIMAB RAVTANSINE: An antibody-drug conjugate targeting the CD138 protein.
TRC-093: An experimental research compound.
ABEQUOLIXRON: An experimental research compound.
TRIFAROTENE: A selective retinoic acid receptor-gamma agonist for acne.
PITOLISANT HYDROCHLORIDE: The salt of pitolisant, a histamine H3 receptor inverse agonist for narcolepsy.
IPRAGLIFLOZIN L-PROLINE: A co-crystal of ipragliflozin, an SGLT2 inhibitor.
DIROXIMEL FUMARATE: A prodrug of monomethyl fumarate for multiple sclerosis.
BREXUCABTAGENE AUTOLEUCEL: A CAR T-cell therapy targeting CD19 for mantle cell lymphoma.
AZD-1656: An experimental glucokinase activator.
ETOKIMAB: An investigational monoclonal antibody targeting interleukin-33.
PF-232798: An experimental research compound from Pfizer.
AMDOXOVIR: An experimental nucleoside reverse transcriptase inhibitor for HIV.
CAMIZESTRANT: An investigational selective estrogen receptor degrader (SERD).
EVATANEPAG: An experimental EP4 receptor antagonist.
OCIPERLIMAB: An investigational monoclonal antibody targeting TIGIT.
GIREDESTRANT: An investigational selective estrogen receptor degrader (SERD).
NLY-01: An experimental pegylated exendin-4 for neurodegenerative diseases.
ATECEGATRAN METOXIL: An experimental research compound.
ASCIMINIB HYDROCHLORIDE: The salt of asciminib, a BCR-ABL1 tyrosine kinase inhibitor.
OMFILOCTOCOG ALFA: A recombinant coagulation factor VIII.
NADROPARIN CALCIUM: A low molecular weight heparin.
GINSENOSIDE RH1: A saponin found in ginseng with various biological activities.
ALTISSIMACOUMARIN D: A natural coumarin.
THIOPROPERAZINE MESYLATE: The salt of thioproperazine, a typical antipsychotic.
[3H]GLYSAR: A radiolabeled tracer for imaging the glycine transporter 1 (GlyT1).
MORNIFLUMATE: A non-steroidal anti-inflammatory drug (NSAID).
COLUBRINIC ACID: A natural triterpenoid.
SILICRISTIN A: A flavonolignan from milk thistle.
SODIUM AMINOSALICYLATE: The sodium salt of aminosalicylic acid, used for inflammatory bowel disease.
PF750: An experimental research compound.
BUCLADESINE: Dibutyryl-cAMP, a cell-permeable analog of cyclic AMP.
TURNAGAINOLIDE B: A cyclic peptide from a marine sponge.
FLUORESCEIN DIPHOSPHATE: A fluorogenic substrate for phosphatases.
PHENOXYETHANOL: A glycol ether used as a preservative in cosmetics.
DIPHENADIONE: An anticoagulant rodenticide.
3,3',4',5-TETRACHLOROSALICYLANILIDE: An antibacterial agent.
LIDAMIDINE HYDROCHLORIDE: The salt of lidamidine, an antidiarrheal agent.
DIMETHISTERONE: A progestin.
AESCULIOSIDE IIIA: A natural triterpenoid saponin.
DENATONIUM BENZOATE: The most bitter chemical compound known, used as an aversive agent.
FLUDIOXONIL: A phenylpyrrole fungicide.
CHINIOFON: An anti-protozoal drug.
GW703087X: An experimental research compound from GlaxoSmithKline.
HYDROCOTARNINE: An alkaloid.
IDAZOXAN HYDROCHLORIDE: The salt of idazoxan, a selective alpha-2 adrenergic receptor antagonist.
METHYLROSANILINE: A dye with antibacterial and antifungal properties, also known as gentian violet.
E-64: A research chemical that is an irreversible inhibitor of cysteine proteases.
VIDARABINE: An antiviral drug.
ZD-7155: An experimental angiotensin II AT1 receptor antagonist.
NEROLIDOL: A naturally occurring sesquiterpene alcohol found in many essential oils.
PREDNISOLONE HEMISUCCINATE: A water-soluble ester of prednisolone.
GW828525X: An experimental research compound from GlaxoSmithKline.
GW280670X: An experimental research compound from GlaxoSmithKline.
O,O'-DIMETHYLCAFFEIC ACID: A methylated derivative of caffeic acid.
TERAZOSIN HYDROCHLORIDE HYDRATE: The hydrated salt of terazosin, an alpha-1 adrenergic blocker.
DODECYL GALLATE: The ester of dodecanol and gallic acid, used as an antioxidant.
GW513184X: An experimental research compound from GlaxoSmithKline.
PHTHALIC ACID: An aromatic dicarboxylic acid.
ALTISSIMACOUMARIN C: A natural coumarin.
METILDIGOXIN: A methyl derivative of the cardiac glycoside digoxin.
TERCONAZOLE: An azole antifungal medication.
BISABOLOL: A natural sesquiterpene alcohol derived from chamomile.
VINCA ALKALOID COMPOUND: A class of antimitotic chemotherapy drugs derived from the periwinkle plant.
RECOMBINANT ALPHA CHEMOKINE: A genetically engineered chemokine of the alpha (CXC) subfamily.
RECOMBINANT INTERLEUKIN-16: A genetically engineered form of the cytokine IL-16.
RETRO-INVERSO PEPTIDE: A synthetic peptide with reversed sequence and chiral centers, for increased stability.
PNU-37883: An experimental research compound.
BACCHARIN: A macrocyclic trichothecene mycotoxin.
PYRIPROXYFEN: An insect growth regulator.
AMINOCAMPTOTHECIN: A derivative of the topoisomerase inhibitor camptothecin.
LUZINDOLE: A research chemical that is a competitive antagonist of melatonin receptors.
CEPHALOTHIN SODIUM: The salt of cephalothin, a first-generation cephalosporin antibiotic.
OMEGA-3 FATTY ACIDS: A class of polyunsaturated fatty acids.
DITHIAZANINE: An anthelmintic dye.
GW711782X: An experimental research compound from GlaxoSmithKline.
ARQ-621: An experimental Eg5 kinesin inhibitor.
AVACOPAN: An orally active C5a receptor antagonist for ANCA-associated vasculitis.
DESMOTEPLASE: A recombinant plasminogen activator derived from bat saliva.
QUERCETIN-3'-O-PHOSPHATE: A phosphorylated derivative of quercetin.
RECOMBINANT HUMAN CHORIONIC GONADOTROPIN: A genetically engineered form of hCG.
SNS01-T: An experimental gene therapy for multiple myeloma.
TRODUSQUEMINE: An experimental aminosterol that inhibits PTP1B.
VX-765: An experimental inhibitor of the caspase-1 enzyme.
ZANOLIMUMAB: An investigational monoclonal antibody that targets CD4.
YKP-1358: An experimental atypical antipsychotic agent.
THYMALFASIN: A synthetic peptide corresponding to thymosin alpha 1, an immune modulator.
QUINETHAZONE: A thiazide-like diuretic.
BMS-919373: An experimental research compound from Bristol-Myers Squibb.
ABRILUMAB: An investigational monoclonal antibody that targets the IL-20 receptor.
PRAME-TARGETING T-CELL RECEPTOR/INDUCIBLE CASPASE 9 BPX-701: An experimental T-cell therapy targeting the PRAME antigen.
PACANALOTAMAB: An investigational monoclonal antibody.
PLAMOTAMAB: An investigational bispecific antibody.
BPS-804: An investigational monoclonal antibody targeting sclerostin.
ONFEKAFUSP ALFA: An investigational fusion protein.
ME-344: An experimental isoflavone analog that disrupts mitochondrial metabolism.
MARZEPTACOG ALFA (ACTIVATED): An experimental recombinant activated factor VII.
GSK-1614235: An experimental research compound from GlaxoSmithKline.
VIAGENPUMATUCEL-L: An experimental allogeneic cancer vaccine for lung cancer.
ELPETRIGINE: An experimental research compound.
TLR9 AGONIST SD-101: An experimental Toll-like receptor 9 agonist.
LY-2881835: An experimental research compound from Eli Lilly.
BATABULIN: An experimental vascular-disrupting agent that binds to tubulin.
ETHINAMATE: A sedative and hypnotic drug of the carbamate class.
XEN-2174: A synthetic peptide analog of a conotoxin.
LUCANTHONE: An antischistosomal agent that intercalates into DNA.
BUNTANETAP: An investigational muscarinic M1 receptor positive allosteric modulator.
ODIPARCIL: An investigational agent for mucopolysaccharidosis.
LAPULEUCEL-T: An experimental autologous cancer vaccine.
ATL-104: An experimental research compound.
MK-3207: An experimental glucagon receptor antagonist.
MK-8245: An experimental research compound from Merck.
GEMOGENOVATUCEL-T: An experimental cancer immunotherapy.
ZD7288: A research chemical that blocks the hyperpolarization-activated cyclic nucleotide-gated (HCN) channel.
DRL-17822: An experimental research compound.
LX-7101: An experimental Rho-kinase inhibitor.
INDECAINIDE: A class Ic antiarrhythmic agent.
SARUPLASE: A recombinant form of unglycosylated single-chain urokinase-type plasminogen activator.
BESIPIRDINE: An experimental cholinergic agent for Alzheimer's disease.
PUERARIN: A major isoflavonoid found in the kudzu root.
BENTAZEPAM: A benzodiazepine derivative with anxiolytic properties.
FORASARTAN: An experimental angiotensin II receptor antagonist.
AI-850: An experimental research compound.
AUTO3: An investigational CAR T-cell therapy.
ALAGEBRIUM CHLORIDE: The salt of alagebrium, an experimental advanced glycation end-product (AGE) breaker.
P-[18F]MPPF: A radiolabeled 5-HT1A receptor antagonist for PET imaging.
PIZOTYLINE: An antihistamine and serotonin antagonist used for migraine prophylaxis.
SB 258719: A research chemical that is a selective 5-HT7 receptor antagonist.
GNF-5: An experimental allosteric inhibitor of the BCR-ABL kinase.
[14C]ACETYLCOA: A radiolabeled version of acetyl-CoA.
DX600: A peptide inhibitor of plasma kallikrein.
MM07: An experimental research compound.
AGMATINE: An aminoguanidine metabolite of arginine with neuromodulatory effects.
DEPX: An experimental research compound.
[125I]ABOPX: A radiolabeled research compound.
APNEA: An abbreviation, possibly for a research compound.
CEPHALORIDINE: A first-generation cephalosporin antibiotic.
BI-3802: An experimental research compound.
AMG-8718: An experimental monoclonal antibody from Amgen.
COMPOUND 13 [PMID: 23412139]: A research compound described in the specified scientific publication.
RACTOPAMINE: A beta-adrenergic agonist used as a feed additive for livestock.
VIBEGRON: A beta-3 adrenergic receptor agonist for overactive bladder.
RO5101576: An experimental research compound from Roche.
COMPOUND 27 [PMID: 26938474]: A research compound described in the specified scientific publication.
COMPOUND 18C [PMID:19143533]: A research compound described in the specified scientific publication.
DIHYDROXYBERGAMOTTIN: A natural furanocoumarin in grapefruit that inhibits cytochrome P450 enzymes.
COMPOUND 33 [PMID: 32003991]: A research compound described in the specified scientific publication.
EFONIDIPINE: A dihydropyridine calcium channel blocker.
ORG27569: An experimental cannabinoid CB1 receptor agonist.
L-759,656: An experimental alpha-1b adrenergic receptor antagonist.
A-71378: An experimental research compound.
VMCC-I: A viral chemokine-like protein used in research.
CCT245737: An experimental CHK1 kinase inhibitor.
CCT241533: An experimental Pim kinase inhibitor.
COMPOUND 1 [PMID: 16650987]: A research compound described in the specified scientific publication.
COMPOUND 29 [PMID: 31934767]: A research compound described in the specified scientific publication.
[125I]TYR0-CRF (HUMAN, RAT, MOUSE): A radiolabeled version of corticotropin-releasing factor.
[125I]CT (HUMAN): A radiolabeled version of human calcitonin.
[125I]MINI-TYRRS: A radiolabeled fragment of an enzyme.
CXCL12&EPSILON;: The epsilon isoform of the chemokine CXCL12.
[125I]CXCL12&BETA; (HUMAN): A radiolabeled version of the human chemokine CXCL12 beta isoform.
COMPOUND 7 [PMID: 32302132]: A research compound described in the specified scientific publication.
CAMONAGREL: An experimental thromboxane A2 synthase inhibitor.
N-OXALYLGLYCINE: An inhibitor of 2-oxoglutarate-dependent oxygenases.
COMPOUND 10A [PMID: 1447738]: A research compound described in the specified scientific publication.
SQ-27986: An experimental research compound.
SODIUM SELENITE: An inorganic salt of selenium.
ECTODYSPLASIN A1: A protein of the tumor necrosis factor family, involved in ectodermal development.
COMPOUND 56 [PMID: 8568816]: A research compound described in the specified scientific publication.
C34 [ZHU ET AL., 2023]: A research peptide described in the specified scientific publication.
DIFLAPOLIN: An investigational research compound.
TG4-155: An experimental research compound.
GRAPIPRANT: A prostaglandin EP4 receptor antagonist used in veterinary medicine.
METHYL-PIPERIDINO-PYRAZOLE: A research chemical that inhibits nitric oxide synthase.
ERD-308: An experimental research compound.
[125I]PD151242: A radiolabeled endothelin ETA receptor antagonist.
(R)-AS-1: An experimental research compound.
DIHYDROKAINATE: A research chemical that inhibits excitatory amino acid transporters.
HUMAN GIP(3-30)NH2: A fragment of human gastric inhibitory polypeptide that acts as a receptor antagonist.
WB4-24: An experimental research compound.
LENOMORELIN: A growth hormone-releasing peptide.
JI-38: An experimental research compound.
AZD2858: An experimental research compound from AstraZeneca.
[HIS5,D-TYR6]GNRH: A synthetic analog of gonadotropin-releasing hormone.
UROGUANYLIN: An endogenous peptide hormone that regulates fluid and electrolyte transport in the intestine.
MEL57A: An experimental research compound.
NOX-6-7: An experimental research compound.
LP-471756: An experimental research compound.
ASN02563583: An experimental research compound.
RTI-122: An experimental research compound.
AR244555: An experimental research compound.
LW106: An experimental research compound.
PAEONOL: A phenolic compound from the Moutan Cortex with anti-inflammatory properties.
CAROTEGRAST METHYL: The methyl ester prodrug of carotegrast, an alpha-4 integrin antagonist.
IL-15: Interleukin-15, a cytokine that stimulates the proliferation of natural killer cells.
8-AZAGUANINE: A purine analog with antineoplastic activity.
SILYBIN: The major active constituent of silymarin, an extract from milk thistle seeds.
(&PLUSMN;)-EQUOL: A racemic mixture of equol, a non-steroidal estrogen produced by gut flora.
ITACNOSERTIB: An investigational FLT3/aurora kinase inhibitor.
VEGF RECEPTOR 2 KINASE INHIBITOR IV: A research chemical that inhibits VEGFR-2.
KISSPEPTIN-54: The 54-amino acid form of kisspeptin, a key regulator of reproduction.
NS11021: A research chemical that is an activator of BK and SK potassium channels.
CROMAKALIM: A potassium channel opener.
[1-BROMO-(3S)-HYDROX-4-(PALMITOYLOXY)BUTYL]PHOSPHATE: A chemical name for a specific research compound.
KDOAM25: An experimental research compound.
COMPOUND 2 [PMID: 11375253]: A research compound described in the specified scientific publication.
BIPHENYLINDANONE A: An experimental AMPA receptor positive allosteric modulator.
CPPHA: A research chemical that is a positive allosteric modulator of the mGlu5 receptor.
ADX-47273: An experimental mGlu5 receptor positive allosteric modulator.
PPG: An experimental research compound.
ERK INHIBITOR III: A research chemical that inhibits extracellular signal-regulated kinase (ERK).
NDPPC: An experimental research compound.
LOSMAPIMOD: An investigational p38 MAP kinase inhibitor.
SB202190: A research chemical that is a potent inhibitor of p38 MAP kinase.
COMPOUND 10 [PMID: 18790648]: A research compound described in the specified scientific publication.
COMPOUND 18N [PMID: 34382802]: A research compound described in the specified scientific publication.
DS-3801B FREE BASE: The free base form of an experimental research compound.
UCM 549: An experimental research compound.
EG00229: An experimental research compound.
&ALPHA;-CONOTOXIN PIA: A peptide toxin from cone snail venom that blocks nicotinic acetylcholine receptors.
N/OFQ-NH2: The amidated form of nociceptin/orphanin FQ.
PEPTIDE III-BTD: An experimental peptide.
AVA3: An experimental research compound.
ALPHA-KETOGLUTARIC ACID: A key intermediate in the Krebs cycle.
SB-674042: An experimental orexin-1 receptor antagonist.
TCS-OX2-29: A research chemical that is an antagonist of the orexin-2 receptor.
TNP-ATP: A fluorescent analog of ATP.
AF-906: An experimental research compound.
AZ11645373: An experimental P2X7 receptor antagonist.
POLYMYXIN B SULFATE: The sulfate salt of polymyxin B, a polypeptide antibiotic.
[33P]2MESADP: A radiolabeled analog of adenosine diphosphate, a P2Y12 receptor agonist.
GLAXOSMITHKLINE COMPOUND 6I [PMID:18926700]: A research compound from GlaxoSmithKline described in the specified publication.
AP5A: Diadenosine pentaphosphate, an endogenous signaling molecule.
UTP&GAMMA;S: A non-hydrolyzable analog of uridine triphosphate.
AZ2429: An experimental research compound from AstraZeneca.
P2PAL18S: A synthetic peptide that is a P2Y14 receptor antagonist.
COMPOUND 28 [PMID: 30624936]: A research compound described in the specified scientific publication.
COMPOUND 37 [PMID: 29193967]: A research compound described in the specified scientific publication.
APROTININ: A serine protease inhibitor used to reduce bleeding during surgery.
TRIAZINE COMPOUND PC1: An experimental research compound based on a triazine scaffold.
(5E)-1-(4-FLUOROPHENYL)-5-[(5-METHYLTHIOPHEN-2-YL)METHYLIDENE]-2-SULFANYLIDENE-1,3-DIAZINANE-4,6-DIONE: A chemical name for a specific research compound.
CELASTROL: A natural triterpenoid with anti-inflammatory and anti-obesity effects.
RLX-33: An experimental research compound.
DC591053: An experimental research compound.
[125I]INSL5 (HUMAN): A radiolabeled version of human insulin-like peptide 5.
ANALOGUE 13: B7-24: A synthetic peptide analog.
LLY-507: An experimental research compound from Eli Lilly.
(R)-PFI-2: A research chemical that is an inhibitor of the SETD7 methyltransferase.
SD-36: An experimental STAT3 protein degrader.
BULEVIRTIDE: An entry inhibitor for hepatitis D virus.
CGP-37157: A research chemical that inhibits the mitochondrial Na+/Ca2+ exchanger.
COMPOUND 55 [PMID: 30889352]: A research compound described in the specified scientific publication.
L-797,591: An experimental research compound.
SMD-3040: An experimental research compound.
CIS-EPOXYSUCCINIC ACID: An inhibitor of cysteine proteases.
ANGIOPOIETIN-1: A protein growth factor involved in angiogenesis.
AGATOLIMOD: An investigational Toll-like receptor 9 (TLR9) agonist.
ONO-3708: An experimental research compound.
MUCRONULATOL(+/-): A racemic mixture of a natural isoflavan.
METHYLGLYOXAL: A reactive dicarbonyl compound formed as a byproduct of metabolism.
M084: An experimental research compound.
HC030031: A research chemical that is a TRPA1 channel antagonist.
PYR10: A research chemical that is an inhibitor of the TRPC5 channel.
ML204: A research chemical that is a potent and selective TRPC4/5 channel inhibitor.
PYRAZOLO-PYRIMIDINE 14A [PMID: 29859875]: A research compound described in the specified scientific publication.
CIM0216: A research chemical that is an activator of the TRPA1 channel.
COMPOUND 8B [PMID: 22408719]: A research compound described in the specified scientific publication.
GSK3527497: An experimental research compound from GlaxoSmithKline.
UROTENSIN II-RELATED PEPTIDE: An endogenous peptide structurally related to urotensin-II.
ANTI-C-MET MONOCLONAL ANTIBODY SAIT301: An experimental monoclonal antibody targeting the c-Met receptor.
PROPENTOFYLLINE: A xanthine derivative with neuroprotective effects.
SALINOMYCIN: A polyether antibiotic with activity against cancer stem cells.
CLEMASTINE FUMARATE: The salt of clemastine, a first-generation antihistamine.
TETRAZOLIUM RED: A dye used in biochemical assays to measure cellular respiration.
PEGYLATED SN-38 CONJUGATE PLX038: An experimental pegylated form of the active metabolite of irinotecan.
PD-L1/IDO PEPTIDE VACCINE IO102-103: An experimental cancer vaccine targeting PD-L1 and IDO.
CHK1 INHIBITOR GDC-0575: An experimental inhibitor of the CHK1 kinase.
SB258585: A research chemical that is a selective 5-HT6 receptor antagonist.
TILSOTOLIMOD SODIUM: The salt of tilsotolimod, an investigational Toll-like receptor 9 (TLR9) agonist.
VE-821: A research chemical that is a potent inhibitor of the ATR kinase.
CINNAMIC ALDEHYDE: The organic compound that gives cinnamon its flavor and odor.
ANTI-THYMOCYTE GLOBULIN: An infusion of horse or rabbit-derived antibodies against human T-cells.
[125I]ANP (HUMAN): A radiolabeled version of human atrial natriuretic peptide.
CARICOTAMIDE/TRETAZICAR: An investigational combination therapy.
EXAMORELIN: A peptide that is a growth hormone secretagogue, also known as hexarelin.
BTRX-335140: An investigational kappa-opioid receptor antagonist.
MUNDULONE: A natural rotenoid.
EPIGALLOCATECHIN: A flavan-3-ol, a type of catechin.
GUTTIFERONE K: A natural polycyclic polyprenylated acylphloroglucinol.
ETHYL ANTHRANILATE: An ester used in fragrances and as a flavoring.
NAHUOIC ACID A: A natural product that inhibits protein farnesyltransferase.
ZANDATRIGINE: An investigational sodium channel blocker.
LONTUCIREV: An investigational oncolytic virus.
COBALAMIN: Vitamin B12, an essential nutrient.
GF109203X: A research chemical that is an inhibitor of protein kinase C.
MADOLIN A: A research chemical that inhibits the APC/C-Cdh1 E3 ubiquitin ligase.
DI-LEU16-IL2: An experimental variant of interleukin-2.
EDAXETERKIB: An investigational SRC/ABL kinase inhibitor.
PSEUDOCHELERYTHRINE: A natural benzophenanthridine alkaloid.
MAPATUMUMAB: An investigational monoclonal antibody that targets the TRAIL-R1 receptor.
MOXIFLOXACIN: A fourth-generation fluoroquinolone antibiotic.
TOTROMBOPAG: An investigational thrombopoietin receptor agonist.
DIPHENOXYLATE HYDROCHLORIDE: The salt of diphenoxylate, an opioid used for diarrhea.
CET KRAS ANTISENSE OLIGONUCLEOTIDE AZD4785: An experimental antisense therapy targeting the KRAS oncogene.
BERUBICIN: An experimental anthracycline that may cross the blood-brain barrier.
AZD-7624: An experimental p38 MAP kinase inhibitor.
BI-44370: An experimental research compound.
AZELIRAGON: An experimental RAGE inhibitor for Alzheimer's disease.
HENAGLIFLOZIN: An investigational SGLT2 inhibitor.
CROTEDUMAB: An investigational monoclonal antibody.
ISAVUCONAZONIUM SULFATE: The salt of a prodrug of isavuconazole, a triazole antifungal.
COMPOUND 15 [PMID: 35034442]: A research compound described in the specified scientific publication.
NIDUFEXOR: An experimental farnesoid X receptor (FXR) agonist.
AZD9574: An investigational brain-penetrant PARP1 inhibitor.
SELISISTAT: An experimental inhibitor of the sirtuin 1 (SIRT1) enzyme.
ITURELIX: A gonadotropin-releasing hormone (GnRH) antagonist.
CARPHENAZINE MALEATE: The salt of carphenazine, a typical antipsychotic of the phenothiazine class.
T-KININ: A kinin peptide found in rats.
JNJ40355003: An experimental research compound from Johnson & Johnson.
MENADIONE SODIUM BISULPHITE: A water-soluble form of menadione (Vitamin K3).
APELIN-13: A 13-amino acid isoform of the endogenous peptide apelin.
1-AMINOCYCLOPROPANE CARBOXYLIC ACID: A disubstituted cyclic amino acid and precursor to ethylene in plants.
PEXELIZUMAB: An investigational single-chain antibody fragment that inhibits complement component C5.
ARUNDINE: An experimental research compound.
DIACETYLRHEIN: Diacerein, a slow-acting drug for osteoarthritis.
CYC116: An experimental Aurora kinase inhibitor.
DEXPROPRANOLOL: The non-beta-blocking dextrorotatory isomer of propranolol.
ANTI-CD22 CAR-EXPRESSING T LYMPHOCYTES: A CAR T-cell therapy targeting the CD22 protein.
MERADIMATE: An organic compound used as an ingredient in sunscreens.
METHYLEPHEDRINE: A sympathomimetic amine, a derivative of ephedrine.
PINOSYLVIN METHYL ETHER: A methylated derivative of a natural stilbenoid.
BMS-833923: An experimental smoothened (SMO) receptor antagonist.
[125I]TYR7-SST3-ODN-8: A radiolabeled somatostatin analog.
TELAVANCIN: A lipoglycopeptide antibiotic.
EMAPUNIL: An experimental anxiolytic that binds to the translocator protein (TSPO).
GRC-15300: An experimental Nav1.7 sodium channel blocker for pain.
RNR INHIBITOR COH29: An experimental inhibitor of ribonucleotide reductase.
THEONELLASTEROL C: A natural sterol isolated from a marine sponge.
GW1929: A research chemical that is a potent PPAR gamma agonist.
THIPHENAMIL: An anticholinergic drug.
BMS COMPOUND 4C: An experimental research compound from Bristol-Myers Squibb.
DERRUSTONE: A natural rotenoid.
CYCLOCITRAL: A fragrance compound, a derivative of citral.
PFK15: An experimental inhibitor of the PFKFB3 enzyme.
[11C]BUTYLTHIO-TZTP: A radiolabeled tracer for PET imaging of muscarinic M2 receptors.
COMPOUND 13E [PMID: 16759857]: A research compound described in the specified scientific publication.
SQ-29548: A research chemical that is a potent thromboxane receptor antagonist.
PEMTUMOMAB: An experimental radio-labeled monoclonal antibody.
ACLIDINIUM BROMIDE: The salt of aclidinium, a long-acting muscarinic antagonist for COPD.
PILOCARPINE NITRATE: The salt of pilocarpine, a muscarinic receptor agonist.
GINGKOLIC ACID: A probable misspelling of ginkgolic acid from the Ginkgo biloba tree.
LEVALBUTEROL: The (R)-enantiomer of salbutamol, a short-acting beta-2 adrenergic agonist.
NELFINAVIR MESYLATE: The salt of nelfinavir, an HIV protease inhibitor.
HYDROXYZINE PAMOATE: The salt of hydroxyzine, a first-generation antihistamine with sedative properties.
PS-516895: An experimental research compound.
ZD-4190: An experimental VEGFR-2 kinase inhibitor.
SRX251: An experimental vasopressin V1a receptor antagonist.
TEDALINAB: An investigational cannabinoid CB2 receptor agonist.
RXDX-103: An experimental research compound.
RG7185: An experimental research compound from Roche.
OSEMOZOTAN: An experimental 5-HT1A receptor agonist.
SMC021: An experimental research compound.
GEVOKIZUMAB: An investigational monoclonal antibody that targets interleukin-1 beta.
MATUZUMAB: An investigational monoclonal antibody that targets the epidermal growth factor receptor (EGFR).
RG-1512: An experimental research compound from Roche.
BENZIODARONE: An antiarrhythmic agent and coronary vasodilator.
TNX-650: An investigational monoclonal antibody targeting IL-13.
BC8 131I: An iodine-131 radiolabeled anti-CD45 monoclonal antibody.
CANRENOATE POTASSIUM: The potassium salt of canrenoate, an aldosterone antagonist.
DIBENZEPIN: A tricyclic antidepressant.
AD-439: An experimental research compound.
GLEMBATUMUMAB: An investigational antibody-drug conjugate targeting GPNMB.
TELINAVIR: An experimental HIV protease inhibitor.
CILUPREVIR: An experimental hepatitis C virus NS3/4A protease inhibitor.
ALFLUTINIB: An investigational mutant-selective EGFR inhibitor.
ORP-101: An experimental research compound.
MURELETECAN: An experimental topoisomerase I inhibitor.
ELISMETREP: An investigational research compound.
DISTIGMINE: A long-acting cholinesterase inhibitor.
ITEPEKIMAB: An investigational monoclonal antibody targeting IL-33.
PACMILIMAB: An investigational monoclonal antibody.
IMALUMAB: An investigational monoclonal antibody targeting IFN-gamma.
PF-04991532: An experimental research compound from Pfizer.
ACOZIBOROLE: An investigational agent for sleeping sickness.
ANTIHEMOPHILIC FACTOR, PEGYLATED (MW 20000) HUMAN SEQUENCE RECOMBINANT: A pegylated recombinant Factor VIII.
RAFUTROMBOPAG: An investigational thrombopoietin receptor agonist.
TECHNETIUM TC 99M SUCCIMER: A radiopharmaceutical used for kidney imaging.
ORM-12741: An experimental alpha-2c adrenoceptor antagonist for Alzheimer's disease.
MULBERROFURAN H: A natural product from mulberry trees.
SULFORAPHANE: An organosulfur compound from cruciferous vegetables with potential anticancer effects.
2-NITROFLUORENE: A nitrated polycyclic aromatic hydrocarbon.
OXABOLONE CIPIONATE: An ester of oxabolone, an anabolic steroid.
VERMISTATIN: A natural product that is a farnesyltransferase inhibitor.
HYDRASTINE: A natural isoquinoline alkaloid from goldenseal.
GIGANTOL: A bibenzyl compound from several medicinal plants.
ISOXABEN: A pre-emergence herbicide.
GW589933X: An experimental research compound from GlaxoSmithKline.
OCTABENZONE: An organic compound used as a UV stabilizer in plastics.
LICOAGRONE: A natural product with anti-inflammatory properties.
EPIRIZOLE: A non-steroidal anti-inflammatory drug (NSAID).
TRANYLCYPROMINE HYDROCHLORIDE: The salt of tranylcypromine, a monoamine oxidase inhibitor (MAOI).
YOHIMBINE HYDROCHLORIDE: The salt of yohimbine, an alpha-2 adrenergic receptor antagonist.
GW874091X: An experimental research compound from GlaxoSmithKline.
CHLOROQUINE-PYROLIDINYL: A derivative of the antimalarial drug chloroquine.
TRETAZICAR: An experimental research compound.
BENZAMIL: A derivative of amiloride that blocks the epithelial sodium channel.
METOLACHOR: A chloroacetamide herbicide.
ENDOSULFAN SULFATE: The primary metabolite of the insecticide endosulfan.
SALUBRINAL: A research chemical that protects cells from endoplasmic reticulum stress.
METHIOCARB: A carbamate pesticide.
KAEMPFERITRIN: A natural flavonoid glycoside.
XAMOTEROL FUMARATE: The salt of xamoterol, a beta-1 adrenergic partial agonist.
GW581744X: An experimental research compound from GlaxoSmithKline.
LONCHOCARPIC ACID: A natural rotenoid.
HOMATROPINE HYDROBROMIDE: The salt of homatropine, an anticholinergic used as a cycloplegic eye drop.
GLABRONE: A natural isoflavone from licorice root.
LAGASCATRIOL: A natural product.
CLENBUTEROL HYDROCHLORIDE: The salt of clenbuterol, a beta-2 adrenergic agonist.
PROPYL GALLATE: The ester of propanol and gallic acid, used as an antioxidant.
GW831091X: An experimental research compound from GlaxoSmithKline.
CEFAZOLIN: A first-generation cephalosporin antibiotic.
FOMOCAINE: A topical anesthetic.
KLUGINE: A natural product.
PREGNENOLONE SULFATE SODIUM: The sodium salt of a sulfated neurosteroid.
OXAPIUM: A quaternary ammonium compound.
SOLYPERTINE TARTRATE: The salt of solypertine, an experimental antipsychotic.
BENZYL NICOTINATE: An ester used as a rubefacient.
GW643971X: An experimental research compound from GlaxoSmithKline.
NORDEFRIN HYDROCHLORIDE: The salt of nordefrin, a vasoconstrictor used in local anesthetics.
PHENETHYL PHENYLCARBAMATE: A chemical intermediate.
OLIVOMYCIN I: An experimental research compound.
HOECHST 33258: A fluorescent stain for DNA.
TOXYLOXANTHONE C: A natural xanthone.
RNA POLYMERASE INHIBITOR: A class of drugs that inhibit the enzyme RNA polymerase.
N-METHYLFORMAMIDE: An organic solvent.
ANTITUBERCULAR AGENT: A general term for a drug used to treat tuberculosis.
GARLIC EXTRACT: A supplement made from garlic, used for various health purposes.
ALTRETAMINE: An alkylating agent used as a chemotherapy drug.
INDIUM CHLORIDE: An inorganic salt of indium.
TRIPTORELIN: A gonadotropin-releasing hormone (GnRH) agonist.
ALVAC VACCINE: A type of vaccine using a canarypox virus vector.
BRL50481: A research chemical that is a phosphodiesterase 7 inhibitor.
SYMCLOSENE: A chlorine-releasing compound used as a disinfectant.
SACROSIDASE: An enzyme replacement therapy for congenital sucrase-isomaltase deficiency.
CHLORMIDAZOLE: An imidazole antifungal agent.
GRAMICIDIN: A polypeptide antibiotic mixture used in topical preparations.
BIS(2-ETHYLHEXYL) PHTHALATE: A common plasticizer, also known as DEHP.
FLUOXETINE / OLANZAPINE: A combination drug used for treatment-resistant depression.
NITROUS OXIDE: An inorganic gas used for its anesthetic and analgesic effects.
VERNAKALANT: An antiarrhythmic agent for atrial fibrillation.
HPTE: A metabolite of the insecticide methoxychlor with estrogenic activity.
VANCOMYCIN: A glycopeptide antibiotic.
BESTATIN METHYL ESTER: An ester derivative of bestatin, an aminopeptidase inhibitor.
ASIMADOLINE: An experimental selective kappa-opioid receptor agonist.
NARONAPRIDE: An experimental 5-HT4 receptor agonist for gastrointestinal disorders.
ETOPOSIDE TONIRIBATE: A prodrug of the chemotherapy agent etoposide.
CR665: An experimental peripherally acting kappa-opioid receptor agonist.
LIGANDROL: An investigational selective androgen receptor modulator (SARM).
LY-517717: An experimental direct factor Xa inhibitor.
MPI-674: An experimental research compound.
CONTEZOLID ACEFOSAMIL (PARENT): An oxazolidinone antibiotic prodrug.
CANFOSFAMIDE: An experimental bioreductive alkylating agent.
EMEDASTINE: A second-generation antihistamine used in eye drops.
DIPHEMANIL METHYLSULFATE: An anticholinergic drug.
KETAMINE HYDROCHLORIDE: The salt of ketamine, a dissociative anesthetic and antidepressant.
MIMOSINE: A toxic non-proteinogenic amino acid found in some legumes.
PRECLAMOL HYDROCHLORIDE: The salt of preclamol, an experimental dopamine autoreceptor agonist.
AXATILIMAB: An investigational monoclonal antibody.
AZD0284: An experimental research compound from AstraZeneca.
DICHLOFENTHION: An organophosphate nematicide.
2,6-DIDEHYDROPEPEROMIN B: A natural secolignan.
TAFIA INHIBITOR DS-1040B: An experimental inhibitor of thrombin-activatable fibrinolysis inhibitor.
TEZEPELUMAB: A monoclonal antibody that targets thymic stromal lymphopoietin (TSLP) for asthma.
INSULIN SENSITIZER S-707106: An experimental insulin-sensitizing agent.
GLYCERYLPHOSPHORYLCHOLINE: A natural choline compound, also known as alpha-GPC.
ICOFUNGIPEN: An experimental antifungal agent that inhibits isoleucyl-tRNA synthetase.
ING-1: An experimental research compound.
AMODIAQUINE: An antimalarial drug.
BMS-387032: An experimental CDK2 inhibitor.
RILOPIROX: A topical antifungal agent.
SIMOCYCLINONE D8: A natural product that inhibits bacterial DNA gyrase.
EFUNGUMAB: An investigational monoclonal antibody targeting fungal Hsp90.
VELIMOGENE ALIPLASMID: An experimental non-viral gene therapy.
PINOCEMBRIN: A flavanone found in honey and propolis.
RINTATOLIMOD: An experimental Toll-like receptor 3 (TLR3) agonist.
TOMARALIMAB: An investigational monoclonal antibody that is a CD40 agonist.
ANTI-PD-1 MONOCLONAL ANTIBODY SYM021: An experimental monoclonal antibody targeting the PD-1 immune checkpoint.
THYMOCTONAN: An experimental research compound.
FLORBETAPIR F-18: A radioactive diagnostic agent for amyloid PET imaging.
ANTI-ENPP3/MMAF ANTIBODY-DRUG CONJUGATE AGS-16M8F: An experimental antibody-drug conjugate.
ABAPERIDONE: An investigational antipsychotic agent.
AMEZINIUM: A sympathomimetic agent used as an antihypertensive.
CERTOPARIN SODIUM: The sodium salt of certoparin, a low molecular weight heparin.
RHUCIN: Recombinant human C1 esterase inhibitor.
REPIRINAST: An anti-allergic drug.
TEMOCAPRIL HYDROCHLORIDE: The salt of temocapril, an ACE inhibitor.
ROSABULIN: An experimental tubulin inhibitor.
TEPROTUMUMAB: A monoclonal antibody that targets IGF-1R, used for thyroid eye disease.
MECLINERTANT: An experimental neurokinin 1 (NK1) receptor antagonist.
CP94253: A research chemical that is a 5-HT1B receptor agonist.
(R)-FLUROCARAZOLOL: A fluorescent beta-adrenergic receptor antagonist.
N-1-ISOPROPYL-5-MEOT: A derivative of the tryptamine 5-MeO-T.
5-LOX ACTIVATING PROTEIN: FLAP, a protein required for leukotriene synthesis.
MRS1067: An experimental research compound.
[3H]PSB-11: A radiolabeled A1 adenosine receptor antagonist.
JNJ-65234637: An experimental research compound from Johnson & Johnson.
AZD3839: An experimental BACE1 inhibitor.
ORELABRUTINIB: An oral Bruton's tyrosine kinase (BTK) inhibitor.
B-9858: An experimental neuroprotective agent that is an NMDA receptor antagonist.
COMPOUND 2-13-1 [PMID: 24900824]: A research compound described in the specified scientific publication.
[125I][TYR8]BRADYKININ: A radiolabeled version of the peptide bradykinin.
DF2593A: An experimental dual 5-HT2A/2C receptor antagonist.
C089: An experimental research compound.
BM221: An experimental research compound.
CHIPS-(28-149): A fragment of the CHIPS protein from Staphylococcus aureus.
SULFONAMIDE-01: An experimental research compound.
CP-316,311: An experimental research compound.
NSC 157449: An experimental compound from the National Cancer Institute library.
[125I]CXCL1 (HUMAN): A radiolabeled version of the human chemokine CXCL1.
RBM2-1B: An experimental research compound.
SLR14: An experimental research compound.
COMPOUND 2-2C [PMID: 32003560]: A research compound described in the specified scientific publication.
ETHYL CAFFEATE: An ester of ethanol and caffeic acid.
MM-433593: An experimental research compound.
TTT-3002: An experimental peptide that is an antagonist of the sortilin receptor.
AG-09/1: An experimental research compound.
COMPOUND 8D [PMID: 15027864]: A research compound described in the specified scientific publication.
FMET-ILE-VAL-ILE-LEU: A synthetic chemoattractant peptide.
ASPIRIN TRIGGERED LIPOXIN A4: A specialized pro-resolving lipid mediator.
WNT-5A: A protein of the Wnt signaling pathway family.
BI 653048: An experimental research compound.
MSVIII-19: An experimental research compound.
[D-LYS6]GNRH-II: A synthetic analog of gonadotropin-releasing hormone II.
[3H]SB-733993: A radiolabeled research compound.
NBI-42902: An experimental gonadotropin-releasing hormone (GnRH) antagonist.
OLEANOLIC ACID: A natural pentacyclic triterpenoid with various biological activities.
[ASU7,23']&BETA;-ANP-(7-28): A synthetic analog of atrial natriuretic peptide.
BU-E 47: An experimental research compound.
2-(3-CHLOROPHENYL)HISTAMINE: A research chemical related to histamine.
PROXYFAN: A research chemical that is a histamine H3 receptor antagonist/inverse agonist.
GSK494581A: An experimental research compound from GlaxoSmithKline.
PSB-16434: An experimental research compound.
ERIODICTYOL CHALCONE: A natural chalcone, a precursor to the flavanone eriodictyol.
KISSPEPTIN-9: A nine-amino acid fragment of the peptide kisspeptin.
PD-307243: An experimental research compound.
HMR-1556: A research chemical that is a potent inhibitor of the IKs potassium channel.
GSK065: An experimental research compound from GlaxoSmithKline.
PF-06454589: An experimental research compound from Pfizer.
ONO-9780307: An experimental research compound.
TAK-418: An experimental research compound from Takeda.
(10R)-10-METHYL-3-(6-METHYLPYRIDIN-3-YL)-9,10,11,12-TETRAHYDRO-8H-[1,4]DIAZEPINO[5',6':4,5]THIENO[3,2-F]QUINOLIN-8-ONE: A chemical name for an M4 muscarinic receptor positive allosteric modulator.
[3H]MCH (HUMAN, MOUSE, RAT): A radiolabeled version of melanin-concentrating hormone.
4-ARYLPHTHALAZIN-1(2H)-3,4-DI-F: A chemical name for a specific PARP inhibitor.
[125I][PHE13,TYR19]MCH: A radiolabeled analog of melanin-concentrating hormone.
[125I]S36057: A radiolabeled MCH-1 receptor antagonist.
MNI-136: An experimental research compound.
COMPOUND 23I [PMID: 17929793]: A research compound described in the specified scientific publication.
(&PLUSMN;)YM796: A racemic mixture of an AMPA receptor positive allosteric modulator.
EG-1-230: An experimental research compound.
MT-45: A designer opioid of the 1,2-diphenylethylamine class.
JNJ1930942: An experimental research compound from Johnson & Johnson.
&ALPHA;-CONOTOXIN IMI: A peptide toxin from cone snail venom that blocks nicotinic acetylcholine receptors.
[PRO7]NEUROKININ B: A selective agonist of the neurokinin 3 (NK3) receptor.
ML385: A research chemical that is an inhibitor of NRF2.
COMPOUND 26 [PMID: 21733693]: A research compound described in the specified scientific publication.
[MPA1,D-TYR(ET)2,D-TIC7,AIB9]OT: A complex synthetic oxytocin analog.
L-365,209: A research chemical that is a CCK2 receptor antagonist.
BMS COMPOUND 16 [PMID:23368907]: An experimental research compound from Bristol-Myers Squibb.
(N)METHANOCARBA-UTP: A modified UTP analog that is a P2Y2 receptor agonist.
BN 50739: An experimental research compound.
COMPOUND 20 [PMID: 25091930]: A research compound described in the specified scientific publication.
GW2433: An experimental research compound from GlaxoSmithKline.
COMPOUND 5 [PMID: 34779204]: A research compound described in the specified scientific publication.
ISA-2011B: An experimental research compound.
WNT-C59: A research chemical that inhibits Wnt signaling by blocking porcupine O-acyltransferase.
5&BETA;-CHOLESTANE-3&ALPHA;,7&ALPHA;,12&ALPHA;-TRIOL: A metabolite of cholesterol and a precursor to bile acids.
AZ4800: An experimental research compound from AstraZeneca.
SCHISANDRIN A: A lignan from Schisandra chinensis with hepatoprotective effects.
MK-0616: An experimental research compound from Merck.
NARMAFOTINIB: An investigational kinase inhibitor.
COMPOUND 25 [ZHANG ET AL., 2020]: A research compound described in the specified scientific publication.
ILLUDALIC ACID: A natural product with antibacterial activity.
DOTA/EU RELAXIN-3: A europium-labeled relaxin-3 peptide for research.
CYM-5541: A research chemical that is an S1P3 receptor antagonist.
CYM-50308: A research chemical that is an S1P4 receptor agonist.
IHMT-MST1-58: An experimental research compound.
COMPOUND 37 [PMID: 36384290]: A research compound described in the specified scientific publication.
NB-598: A research chemical that is an inhibitor of squalene epoxidase.
COMPOUND 32 [PMID: 19191557]: A research compound described in the specified scientific publication.
GA-DOTA-NOC: A gallium-labeled peptide for imaging neuroendocrine tumors.
H-C[CYS-PHE-LAGL(N&BETA;ME,BENZOYL)-TRP-LYS-THR-PHE-CYS]-OH: A complex synthetic analog of somatostatin.
RALMITARONT: An investigational TAAR1 agonist for schizophrenia.
SB705498: A research chemical that is a 5-HT2B receptor antagonist.
EMPESERTIB: An investigational ULK1/2 kinase inhibitor.
TOLYACETYL-C[DCYS-APA-DTRP-ORN-VAL-CYS]-HIS-AMIDE: A complex synthetic analog of somatostatin.
[125I]7-AZIDO-8-IODOKETANSERINE: A radiolabeled photoaffinity ligand for 5-HT2A receptors.
PHM: Peptidylglycine alpha-hydroxylating monooxygenase, an enzyme in peptide amidation.
SR120819A: An experimental research compound.
FGFR INHIBITOR ASP5878: An experimental inhibitor of fibroblast growth factor receptor.
K 252A: A natural product that is a broad-spectrum protein kinase inhibitor.
BENZENE SELENOIC ACID: A probable misspelling of benzeneselenoic acid.
TW-37: A research chemical that is a small-molecule inhibitor of Bcl-2.
SSR128129E: An experimental FGF receptor antagonist.
DIGOXIGENIN: The aglycone of digoxin, used as a hapten in molecular biology.
TAFAMIDIS MEGLUMINE: The meglumine salt of tafamidis, a transthyretin stabilizer.
TRELAGLIPTIN SUCCINATE: The salt of trelagliptin, a long-acting DPP-4 inhibitor.
AMRUBICIN HYDROCHLORIDE: The salt of amrubicin, an anthracycline chemotherapy agent.
TORALIZUMAB: An investigational monoclonal antibody that targets CD40L.
LANDOGROZUMAB: An investigational monoclonal antibody targeting myostatin.
HUMAX-IL8: An investigational monoclonal antibody targeting interleukin-8.
CONICASTEROL D: A sterol isolated from a marine sponge.
BEMIPARIN SODIUM: The sodium salt of bemiparin, a low molecular weight heparin.
HGS-1025: An experimental research compound.
CDP-850: An experimental research compound.
ANETUMAB RAVTANSINE: An antibody-drug conjugate targeting mesothelin.
EMIVIRINE: An experimental non-nucleoside reverse transcriptase inhibitor.
NIPECOTIC ACID: A research chemical that is a GABA uptake inhibitor.
GW786460X: An experimental research compound from GlaxoSmithKline.
CEFONICID: A second-generation cephalosporin antibiotic.
ALLANTODAPSONE: An experimental research compound.
GSK-586581A: An experimental research compound from GlaxoSmithKline.
NAKIJIQUINONES H: A natural product from a marine sponge.
STREPTOMYCIN: An aminoglycoside antibiotic, the first discovered for tuberculosis.
FEBANTEL: A benzimidazole anthelmintic used in veterinary medicine.
3,4-DIHYDROXYXANTHONE: A xanthone compound.
MACROCARPAL A: A natural acylphloroglucinol-sesquiterpenoid adduct.
ALFADEX: A cyclic oligosaccharide, also known as alpha-cyclodextrin.
CIMIPRONIDINE: An experimental research compound.
PIPERONAL: An organic compound commonly found in fragrances.
5-(N,N-DIMETHYL)AMILORIDE HYDROCHLORIDE: The salt of a derivative of amiloride that inhibits the Na+/H+ exchanger.
FLAVONOL: A class of flavonoids that have a ketone group.
ATROPINE METHYLBROMIDE: A quaternary ammonium derivative of atropine.
NAFCILLIN SODIUM: The salt of nafcillin, a penicillinase-resistant penicillin.
ISOCEPHAELINE: An alkaloid related to emetine.
SIRTINOL: A research chemical that is an inhibitor of sirtuin enzymes.
MIRISTALKONIUM CHLORIDE: A quaternary ammonium compound used as an antiseptic.
GOLODIRSEN: An antisense oligonucleotide for Duchenne muscular dystrophy.
ANTI-IGF-1R RECOMBINANT MONOCLONAL ANTIBODY BIIB022: An experimental monoclonal antibody targeting IGF-1R.
GALACTITOL: A sugar alcohol, also known as dulcitol.
METOPROLOL SUCCINATE: An extended-release salt of metoprolol, a selective beta-1 blocker.
BEAUVERICIN: A cyclic depsipeptide mycotoxin.
FAMCICLOVIR: A prodrug of penciclovir, an antiviral medication.
SARCNU: An experimental nitrosourea chemotherapy agent.
PHENYL ISATIN: A derivative of isatin.
HYPOXIS HEMEROCALLIDEA ROOT EXTRACT: An herbal extract containing hypoxoside.
TALOTREXIN: An experimental antifolate agent.
CALCITONIN GENE-RELATED PEPTIDE: CGRP, a neuropeptide involved in vasodilation and pain transmission.
ERDOSTEINE: A mucolytic agent.
BENZODODECINIUM CHLORIDE: A quaternary ammonium antiseptic.
APAXIFYLLINE: An experimental phosphodiesterase 4 inhibitor.
GUADECITABINE: An experimental DNA hypomethylating agent.
CEVIDOPLENIB DIMESYLATE: The salt of an investigational spleen tyrosine kinase (Syk) inhibitor.
APVO-414: An experimental bispecific antibody-like molecule.
COFETUZUMAB PELIDOTIN: An investigational antibody-drug conjugate.
TOLEBRUTINIB: An investigational oral Bruton's tyrosine kinase (BTK) inhibitor.
PEGFILGRASTIM BIOSIMILAR LA-EP2006: A biosimilar of pegfilgrastim, a long-acting G-CSF.
TCD-717: An experimental research compound.
CONTUSUGENE LADENOVEC: An experimental gene therapy for retinoblastoma.
CTCE-0214: A peptide analog of the chemokine SDF-1 alpha (CXCL12).
IOWH-032: An experimental research compound.
PALIFOSFAMIDE: The active metabolite of the chemotherapy drug ifosfamide.
DEFERIPRONE: An oral iron chelator.
BIS-TRIAZOLE DERIVATIVE 10: A research compound based on a bis-triazole scaffold.
SPRIFERMIN: Recombinant human fibroblast growth factor 18 (FGF18).
ULARITIDE: A synthetic form of the peptide hormone urodilatin.
OLAPTESED PEGOL: A pegylated aptamer that neutralizes nucleolin.
PF-05089771: An experimental research compound from Pfizer.
ANTI-LAG-3/PD-L1 BISPECIFIC ANTIBODY FS118: An experimental bispecific antibody for cancer.
ELDACIMIBE: An experimental acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor.
CTS-21166: An experimental inhibitor of beta-secretase 1 (BACE1).
IPSAPIRONE: An anxiolytic agent of the azapirone class.
[18F]ALTANSERIN: A radiolabeled 5-HT2A receptor antagonist for PET imaging.
(-)-NORFENFLURAMINE: The active metabolite of the anorectic drug fenfluramine.
FR260010: An experimental research compound.
XNT [PMID: 18391097]: A research compound described in the specified scientific publication.
APELIN-36: A 36-amino acid isoform of the endogenous peptide apelin.
COMPOUND 1 [PMID: 25241924]: A research compound described in the specified scientific publication.
ELABELA/TODDLER-21: A 21-amino acid form of the peptide hormone Elabela.
PI-THERAPHOTOXIN-HM3A: A peptide toxin from a spider.
CCL21B: An isoform of the chemokine CCL21.
CHK2 INHIBITOR II: A research chemical that inhibits checkpoint kinase 2.
OSTN (81-102): A fragment of the peptide hormone osteocrin.
MIRIPIRIUM CHLORIDE: An antiseptic agent.
PHA-408: An experimental research compound.
SSR125543A: An experimental research compound.
UROCORTIN 3: An endogenous peptide of the corticotropin-releasing factor family.
CXCL3: A chemokine also known as GRO-gamma.
LINAGLIPTIN: A dipeptidyl peptidase-4 (DPP-4) inhibitor for type 2 diabetes.
ALOGLIPTIN: A dipeptidyl peptidase-4 (DPP-4) inhibitor for type 2 diabetes.
6-FLUOROMEVALONATE PYROPHOSPHATE: A fluorinated intermediate in the mevalonate pathway.
SKF-82958: A research chemical that is a selective D1 dopamine receptor full agonist.
(R)-ZINC-3573: An experimental research compound.
L-PHE-PHE-PHE: A tripeptide of phenylalanine.
PROCAINAMIDE: A class Ia antiarrhythmic agent.
BEROTRALSTAT: An oral plasma kallikrein inhibitor for hereditary angioedema.
COMPOUND 25 [PMID: 32023060]: A research compound described in the specified scientific publication.
SLOTOXIN: A peptide toxin that blocks SK potassium channels.
MK-8153: An experimental research compound from Merck.
KYT-0353: An experimental research compound.
N-(3-AMINOPROPYL)-2-NITROBENZENAMINE: A chemical intermediate.
JNJ-67856633: An experimental research compound from Johnson & Johnson.
&GAMMA;-MSH: Gamma-melanocyte-stimulating hormone, a peptide derived from POMC.
COMPOUND 10 [PMID: 15482908]: A research compound described in the specified scientific publication.
BONGKREK ACID: A respiratory toxin that inhibits the mitochondrial ADP/ATP translocase.
[18F]FMBP: A radiolabeled tracer for PET imaging of myelin.
COMPOUND 4F [PMID: 34328319]: A research compound described in the specified scientific publication.
ME67: An experimental research compound.
DH97: An experimental research compound.
RAG8: An experimental research compound.
GB88: An experimental research compound.
COMPOUND 22 [WO2019141694A1]: A chemical compound described in the specified patent application.
CX-5011: An experimental research compound.
(S)-23 [PMID: 27933945]: A research compound described in the specified scientific publication.
MRTX1719: An investigational PRMT5 inhibitor.
JMS-053: An experimental agent targeting the IRE1Î±/XBP1s pathway.
(4Z)-1-(3-FLUOROPHENYL)-4-(2-OXO-1H-INDOL-3-YLIDENE)PYRAZOLIDINE-3,5-DIONE: A chemical name for a specific research compound.
COMPOUND II [PMID: 29351497]: A research compound described in the specified scientific publication.
ONCOLYTIC TYPE 2 HERPES SIMPLEX VIRUS EXPRESSING GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR OH2: An investigational oncolytic virus.
FLT3 INHIBITOR BMF-500: An investigational covalent inhibitor of the FLT3 kinase.
MELK INHIBITOR OTS167: An experimental inhibitor of the MELK kinase.
IDH2 MUTANT INHIBITOR TQB3455: An investigational inhibitor of mutant IDH2.
VCN-01: An investigational oncolytic adenovirus.
P53 Y220C MUTANT REACTIVATOR PC14586: An investigational agent designed to reactivate mutant p53.
SP600125: A research chemical that is a broad-spectrum inhibitor of JNK kinases.
CGP 54626A: A research chemical that is a potent GABA-B receptor antagonist.
GABACULINE: A neurotoxin that is an irreversible inhibitor of GABA transaminase.
PROROXAN: An alpha-adrenergic receptor antagonist.
GW3965: A research chemical that is a potent LXR agonist.
DROMETRIZOLE: A UV absorber used in plastics and cosmetics.
IOBENGUANE: A radiopharmaceutical used for imaging and treating neuroendocrine tumors.
NONOXYNOL-9: A nonionic surfactant used as a spermicide.
CITICOLINE SODIUM: The sodium salt of citicoline, a nootropic used for cognitive impairment.
AZAMETHIPHOS: An organothiophosphate insecticide.
CETYLPYRIDINIUM: A quaternary ammonium compound used as an antiseptic.
INTERLEUKIN-8: A chemokine, also known as CXCL8, that is a major mediator of inflammation.
PYRAZOLE: A heterocyclic aromatic organic compound.
CORTISONE: A corticosteroid hormone.
SHO-SAIKO-TO: A traditional Japanese herbal medicine (Kampo).
CASPASE INHIBITOR: A class of drugs that block caspase enzymes to prevent apoptosis.
PROTECTIVE AGENT: A general term for a substance that shields cells or tissues from damage.
ORNITHINE DECARBOXYLASE INHIBITOR: A class of drugs that block the enzyme ornithine decarboxylase.
RECOMBINANT MACROPHAGE COLONY-STIMULATING FACTOR: A genetically engineered form of the M-CSF cytokine.
CEP-2563 DIHYDROCHLORIDE: The salt of an experimental focal adhesion kinase (FAK) inhibitor.
ERGOT ALKALOIDS: A class of compounds derived from the Claviceps fungus.
FLUTICASONE/SALMETEROL: A combination drug used to treat asthma and COPD.
PEGASPARGASE: A pegylated form of the enzyme asparaginase, used in chemotherapy.
LAROTAXEL: An experimental taxane chemotherapy agent.
RECOMBINANT CYTOKINE: A genetically engineered version of a cytokine protein.
MB-28767: An experimental research compound.
LINOLENIC ACID: An essential omega-3 or omega-6 polyunsaturated fatty acid.
[3H]BANYU (I): A radiolabeled research compound.
FSH DEGLYCOSYLATED &ALPHA;/&BETA;: A modified form of follicle-stimulating hormone.
TRACAZOLATE: An anxiolytic agent of the pyrazolopyridine class.
[11C]WAY100635: A radiolabeled 5-HT1A receptor antagonist for PET imaging.
GSK852: An experimental research compound from GlaxoSmithKline.
NPPB: A research chemical that blocks chloride channels.
VINFLUNINE: A vinca alkaloid chemotherapy agent.
2,4-DINITROPHENOL: A chemical compound used for uncoupling oxidative phosphorylation.
EXALUREN: An experimental research compound.
[3H]NEMONAPRIDE: A radiolabeled D2/D3 dopamine receptor antagonist.
DECAVANADATE: A polyoxometalate ion of vanadium.
SKF-83959: A research chemical that is a D1 dopamine receptor partial agonist.
SLM6071469: An experimental research compound.
ALDICARB: A carbamate insecticide.
MEDI-578: An experimental monoclonal antibody.
MRS928: An experimental research compound.
DIHYDROMORPHINE: An opioid analgesic, a semi-synthetic derivative of morphine.
PHYSCION: A natural anthraquinone derivative.
DEXFENFLURAMINE HYDROCHLORIDE: The salt of dexfenfluramine, a serotonin releasing agent.
CEFSULODIN SODIUM: The salt of cefsulodin, a third-generation cephalosporin antibiotic.
RECOMBINANT INTERLEUKIN-8: A genetically engineered form of the chemokine IL-8.
ARACHIDONIC ACID: A polyunsaturated omega-6 fatty acid.
ROPIVACAINE HYDROCHLORIDE: The salt of ropivacaine, a long-acting local anesthetic.
HUJ591 177LU: A lutetium-177 radiolabeled agent targeting PSMA.
[3H]AZIETOMIDATE: A radiolabeled photoaffinity ligand.
PHENAMIL: A derivative of amiloride that blocks the epithelial sodium channel.
SULFAMETHOXAZOLE / TRIMETHOPRIM: A combination antibiotic, also known as co-trimoxazole.
CARTEOLOL HYDROCHLORIDE: The salt of carteolol, a non-selective beta-blocker.
CHRYSIN: A natural flavone with various biological activities.
QUINIDINE POLYGALACTURONATE: A salt of quinidine, a class Ia antiarrhythmic agent.
COMPOUND 3 [PMID: 25408830]: A research compound described in the specified scientific publication.
DENATONIUM: The most bitter chemical compound known, used as an aversive agent.
PSILOCIN: A psychedelic tryptamine, the active metabolite of psilocybin.
LENERCEPT: A recombinant fusion protein that inhibits tumor necrosis factor (TNF).
NC 4-28B: An experimental research compound.
LYSINE: An essential amino acid.
SYL-1001: An experimental siRNA therapeutic for ocular pain.
SULFAMIDE: The simplest sulfuryl diamide, a chemical intermediate.
INSULIN DEGLUDEC: An ultra-long-acting human insulin analog.
(RS)-(TETRAZOL-5-YL)GLYCINE: A research chemical that is an AMPA receptor agonist.
PLINABULIN: An experimental tubulin inhibitor and vascular-disrupting agent.
TETRAMETHRIN: A synthetic pyrethroid insecticide.
CHLORAMPHENICOL PALMITATE: An ester prodrug of the antibiotic chloramphenicol.
ICENTICAFTOR: An experimental potentiator of the CFTR protein.
INCADRONIC ACID: A bisphosphonate used to treat hypercalcemia.
FLUPIRTINE MALEATE: The salt of flupirtine, a centrally acting non-opioid analgesic.
CLORGILINE: A selective, irreversible monoamine oxidase A inhibitor.
PENTACHLOROPHENOL: An organochlorine compound formerly used as a pesticide and disinfectant.
KB-NB142-70: An experimental research compound.
DROXINOSTAT: An experimental histone deacetylase (HDAC) inhibitor.
METRAZOLINE OXALATE: The salt of metrazoline, a nasal decongestant.
NV-128: An experimental research compound.
PURPURIN: A natural red anthraquinone pigment.
CARBOQUONE: An alkylating agent used as a chemotherapy drug.
THIRAM: A dithiocarbamate fungicide.
KERACYANIN: An anthocyanin, a type of flavonoid pigment.
COMPOUND 2Q [PMID: 30986068]: A research compound described in the specified scientific publication.
CEFOPERAZONE: A third-generation cephalosporin antibiotic.
PENTABROMOPHENOL: An organobromine compound used as a flame retardant.
CALMODULIN: A ubiquitous calcium-binding protein that mediates many calcium signal transduction pathways.
FGFR1/2/3 INHIBITOR TYRA-200: An experimental inhibitor of FGFR kinases.
SIB-1757: A research chemical that is an mGlu5 receptor antagonist.
GANTACURIUM CHLORIDE: An experimental ultra-short-acting neuromuscular blocking agent.
OCTANOL: An eight-carbon straight-chain fatty alcohol.
[18F]FEPPG: A radiolabeled ligand for PET imaging of the translocator protein (TSPO).
MDM2 INHIBITOR AMGMDS3: An experimental inhibitor of the MDM2 protein.
QUERCETIN DIHYDRATE: The hydrated form of quercetin, a flavonoid.
PYROGALLOL: An organic compound with three hydroxyl groups, also known as 1,2,3-trihydroxybenzene.
ANFIBATIDE: An experimental disintegrin peptide that is a GPIIb/IIIa receptor antagonist.
FLAVOKAWAIN B: A kavalactone found in the kava plant.
ROTENONE: A broad-spectrum insecticide and piscicide that inhibits mitochondrial respiration.
[11C]VOLINANSERIN: A radiolabeled 5-HT2A receptor antagonist for PET imaging.
NITAZOXANIDE: A broad-spectrum antiparasitic and antiviral agent.
13-CIS-RETINAL: An isomer of retinal involved in the visual cycle.
E-7974: An experimental synthetic analog of halichondrin B.
PRALUZATAMAB RAVTANSINE: An investigational antibody-drug conjugate.
HEMATOXYLIN: A natural dye extracted from the logwood tree, used in histology.
TYRPHOSTIN 25: A research chemical that inhibits tyrosine kinases.
PROTOPORPHYRIN: A tetrapyrrole, the precursor to heme.
3-O-METHYLQUERCETIN: A methylated derivative of the flavonoid quercetin.
MECLIZINE DIHCL: The dihydrochloride salt of meclizine, a first-generation antihistamine.
SEL-24: An experimental dual PIM/FLT3 kinase inhibitor.
AURINTRICARBOXYLIC ACID: A polymeric triphenylmethane dye that inhibits protein-nucleic acid interactions.
4-METHYLHISTAMINE: A selective histamine H4 receptor agonist.
DIAPEP 277: An immunomodulatory peptide derived from human heat shock protein 60.
552-02: An experimental research compound.
IODOPHTHALEIN: A contrast medium for cholecystography.
GW493838: An experimental research compound from GlaxoSmithKline.
AGROCLAVINE: An ergot alkaloid.
ELLAGIC ACID: A natural polyphenol found in many fruits and nuts.
RECOMBINANT TYROSINASE-RELATED PROTEIN-1: A genetically engineered melanoma-associated antigen.
RECOMBINANT LYMPHOKINE: A genetically engineered version of a lymphokine protein.
PINATUZUMAB VEDOTIN: An antibody-drug conjugate targeting CD22.
VAPREOTIDE ACETATE: The salt of vapreotide, a synthetic somatostatin analog.
RESEQUINIL: An experimental immunomodulatory agent.
KY-1005: An investigational monoclonal antibody targeting OX40L.
PROPARGYLGLYCINE: An irreversible inhibitor of cystathionine gamma-lyase.
[3H]BQ123: A radiolabeled endothelin ETA receptor antagonist.
PENTYLTHIO-TZTP: A research chemical that is an M2 muscarinic receptor antagonist.
CA2+: The calcium ion, a crucial intracellular second messenger.
COMPOUND 7E [PMID: 21571530]: A research compound described in the specified scientific publication.
ILEPCIMIDE: An experimental anticonvulsant.
9,10-PHENANTHRENEQUINONE: An aromatic quinone derived from phenanthrene.
ECOTHIOPATE: An irreversible organophosphate cholinesterase inhibitor.
DIMETHISOQUIN: A topical anesthetic.
DIHYDROGAMBOGIC ACID: A derivative of gambogic acid.
DIAMIDE: A research chemical that is a thiol-oxidizing agent.
LY2181308: An antisense oligonucleotide designed to inhibit survivin.
ACETYLSULFANILAMIDE: An acetylated derivative of sulfanilamide.
TOL-101: An experimental monoclonal antibody.
1,10-PHENANTHROLINE: A heterocyclic organic compound used as a chelating agent.
RUCAPARIB CAMSYLATE: The salt of rucaparib, a PARP inhibitor for ovarian cancer.
FISOGATINIB: An investigational FGFR inhibitor.
N,N'-DIPHENYL-P-PHENYLENEDIAMINE: An antioxidant used in the rubber industry.
COMPOUND 25B [PMID: 22564207]: A research compound described in the specified scientific publication.
MRT67307: A research chemical that inhibits ULK1/2 and TBK1/IKKÎµ kinases.
COMPOUND 2 [PMID: 21105727]: A research compound described in the specified scientific publication.
SEROTONIN: A monoamine neurotransmitter, also known as 5-hydroxytryptamine (5-HT).
CHLOROPHENOTHANE: Dichlorodiphenyltrichloroethane (DDT), an organochlorine insecticide.
HS024: A peptide antagonist of the melanocortin-4 receptor.
LA3+: The lanthanum ion, used in research as a calcium channel blocker.
E319: An experimental research compound.
17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 INHIBITOR ASP9521: An experimental inhibitor of the AKR1C3 enzyme.
KI-20227: An experimental c-Fms kinase inhibitor.
6-NITROQUIPAZINE: A research chemical that is a serotonin receptor agonist.
NRF2 PEPTIDE [PMID: 23647822]: A peptide related to the NRF2 transcription factor described in the specified publication.
COMPOUND 13 [PMID: 15686941]: A research compound described in the specified scientific publication.
TRICLOFENOL: An antiseptic and disinfectant.
OCHRATOXIN A: A mycotoxin produced by several species of Aspergillus and Penicillium.
[ILE5,TRP23]PTHRP-(5-36): A synthetic analog of parathyroid hormone-related protein.
JNJ-5207787: An experimental histamine H3 receptor antagonist.
NEBULARINE: A purine nucleoside antibiotic.
ATI-355: An experimental research compound.
PLEVITREXED: An experimental antifolate agent.
TG7-171: An experimental research compound.
JORO SPIDER TOXIN: A toxin from the Joro spider that acts as a glutamate receptor antagonist.
MK-5435: An experimental research compound from Merck.
D(CH2)5[TYR(ME)2,THR4,PHE(3I,4N3)-NH29]OVT: A complex radiolabeled and photoactivatable oxytocin analog.
DICYCLOHEXYLCARBODIIMIDE: A chemical reagent used to couple amino acids during peptide synthesis.
PHENYL AMINOSALICYLATE: An ester of aminosalicylic acid.
BENZO[B]TRIPHENYLENE: A polycyclic aromatic hydrocarbon.
ASAPIPRANT: An investigational prostaglandin EP4 receptor antagonist.
ISTAROXIME: An experimental agent for acute decompensated heart failure with dual mechanisms of action.
ANTIOXIDANT: A general term for a substance that inhibits oxidation.
[125I]KISSPEPTIN-10 (HUMAN): A radiolabeled version of the human kisspeptin-10 peptide.
LM10: An experimental research compound.
AMP-PNP: A non-hydrolyzable analog of ATP.
SERTACONAZOLE NITRATE: The salt of sertaconazole, a topical azole antifungal.
SOLANIDINE: A toxic steroidal alkaloid found in plants of the nightshade family.
TG6-129: An experimental research compound.
CEPHALOTHIN: A first-generation cephalosporin antibiotic.
LINACLOTIDE: A guanylate cyclase-C agonist for irritable bowel syndrome with constipation.
AMCINONIDE: A high-potency topical corticosteroid.
VUF8504: A research chemical that is a histamine H4 receptor partial agonist.
POMIFERIN: A natural prenylated isoflavone.
JNJ-64264681: An experimental research compound from Johnson & Johnson.
HURATOXIN: A potent neurotoxin from the plant Hura crepitans.
ARASERTACONAZOLE: An experimental antifungal agent.
DABIGATRAN ETEXILATE MESYLATE: The salt of dabigatran etexilate, a prodrug of a direct thrombin inhibitor.
BETAXOLOL HYDROCHLORIDE: The salt of betaxolol, a selective beta-1 blocker used for glaucoma and hypertension.
CERULETIDE DIETHYLAMINE: The salt of ceruletide, a peptide analog of cholecystokinin.
MECASERMIN RINFABATE: A complex of recombinant human IGF-1 and its binding protein.
SERACTIDE ACETATE: The salt of seractide, a synthetic polypeptide analog of ACTH.
AMPHETAMINE SULFATE: The salt of amphetamine, a central nervous system stimulant.
FARGLITAZAR: An experimental dual PPAR alpha/gamma agonist.
ENTECAVIR ANHYDROUS: The anhydrous form of entecavir, an antiviral for hepatitis B.
TELBIVUDINE: An antiviral nucleoside analog for treating hepatitis B.
MEXILETINE HYDROCHLORIDE: The salt of mexiletine, a class Ib antiarrhythmic agent.
ARTICAINE HYDROCHLORIDE: The salt of articaine, a dental local anesthetic.
NOREPINEPHRINE BITARTRATE: The salt of norepinephrine, a catecholamine that functions as a hormone and neurotransmitter.
PRAMIPEXOLE DIHYDROCHLORIDE: The salt of pramipexole, a dopamine agonist for Parkinson's disease.
TEDIZOLID PHOSPHATE: A prodrug of tedizolid, an oxazolidinone antibiotic.
L-21649: An experimental research compound.
LY-2874455: An experimental pan-FGFR kinase inhibitor.
PWT-33587: An experimental research compound.
SULFANILAMIDE: A sulfonamide antibiotic.
XL-418: An experimental Aurora kinase inhibitor.
RPR749: An experimental research compound.
CEP-2563: An experimental focal adhesion kinase (FAK) inhibitor.
NKTR-171: An experimental peripherally acting opioid agonist.
APN1125: An experimental research compound.
BI-811283: An experimental bromodomain inhibitor.
AMP579: An experimental research compound.
MK0686: An experimental research compound from Merck.
REGRELOR DISODIUM: The salt of regrelor, an experimental P2Y12 receptor antagonist.
ETALOCIB: An experimental cyclooxygenase inhibitor.
PF-00446687: An experimental phosphodiesterase 2A inhibitor.
LANICEMINE: An experimental low-trapping NMDA receptor antagonist.
CARBOCYSTEINE: A mucolytic agent.
AMA0076: An experimental research compound.
FARAMPATOR: An experimental AMPA receptor positive allosteric modulator.
LOREDIPLON: An experimental non-benzodiazepine hypnotic.
VERCIRNON: An experimental CCR9 antagonist for Crohn's disease.
MEDI-500: An experimental monoclonal antibody.
BALUGRASTIM: A recombinant fusion protein combining G-CSF and human albumin.
TELOTRISTAT: An inhibitor of tryptophan hydroxylase for carcinoid syndrome diarrhea.
ICRUCUMAB: An investigational monoclonal antibody that targets VEGF receptor-1.
LABETUZUMAB: An investigational monoclonal antibody that targets carcinoembryonic antigen (CEA).
AMG-108: An experimental monoclonal antibody targeting interleukin-1 receptor type 1.
ONCOLYSIN CD6: An experimental oncolytic adenovirus.
MDX-447: An experimental bispecific antibody targeting EGFR and CD64.
ENCAINIDE HYDROCHLORIDE: The salt of encainide, a class Ic antiarrhythmic agent.
NITREFAZOLE: An experimental research compound.
TERODILINE HYDROCHLORIDE: The salt of terodiline, an anticholinergic and calcium channel blocker.
AHN-12: An experimental research compound.
YTTRIUM Y 90 CAPROMAB PENDETIDE: A radioimmunoconjugate for imaging prostate cancer.
ALLYLESTRENOL: A progestin.
BENPERIDOL: A potent butyrophenone antipsychotic.
MASLIMOMAB: An investigational monoclonal antibody that targets the T-cell receptor.
8H9 131I: An iodine-131 radiolabeled monoclonal antibody for cancer therapy.
IMC-GP100: An experimental bispecific T-cell engaging protein for melanoma.
SEVIRUMAB: An investigational human monoclonal antibody against cytomegalovirus.
ERAVACYCLINE DIHYDROCHLORIDE: The salt of eravacycline, a tetracycline-class antibiotic.
VEDROPREVIR: An experimental hepatitis C virus NS3/4A protease inhibitor.
MANIDIPINE: A dihydropyridine calcium channel blocker.
TENOFOVIR EXALIDEX: A prodrug of tenofovir.
ROVAFOVIR ETALAFENAMIDE: An experimental nucleotide reverse transcriptase inhibitor.
ABT-751: An experimental antimitotic agent.
ZATOLMILAST: An experimental phosphodiesterase 4 inhibitor.
GSK-256066: An experimental inhaled phosphodiesterase 4 inhibitor.
1018 ISS: An experimental immunostimulatory sequence oligonucleotide.
BUNAZOSIN: An alpha-1 adrenergic receptor antagonist.
JNJ-37822681: An experimental dopamine D2 receptor antagonist.
ELCUBRAGISTAT: An experimental neprilysin inhibitor.
REZVILUTAMIDE: An androgen receptor antagonist for prostate cancer.
M4344: An experimental research compound.
BALCINRENONE: An investigational non-steroidal mineralocorticoid receptor antagonist.
FIBRINOGEN, HUMAN: A human plasma-derived concentrate of the clotting protein fibrinogen.
RECOMBINANT HUMAN INTERLEUKIN-15: A genetically engineered form of the cytokine IL-15.
DIANICLINE: An experimental alpha-4-beta-2 nicotinic receptor partial agonist.
DIACETYLMORPHINE: Heroin, a potent opioid analgesic.
SHR-1316: An investigational monoclonal antibody targeting PD-L1.
BIFONAZOLE: A topical imidazole antifungal.
TRENIBOTULINUMTOXINE: An experimental botulinum toxin product.
NITROMIDE: A coccidiostat used in poultry.
CYAZOFAMID: A sulfonamide fungicide.
CEFOTETAN: A second-generation cephalosporin antibiotic.
SPHONDIN: A natural furanocoumarin.
R-1487: An experimental research compound.
IPRODIONE: A dicarboximide contact fungicide.
KETANSERIN TARTRATE: The salt of ketanserin, a 5-HT2A receptor antagonist.
OCTYL_GALLATE: An ester of octanol and gallic acid, used as an antioxidant.
DIPLAMINE B: A natural product.
AESCULIOSIDE IIID: A natural triterpenoid saponin.
2-MERCAPTOBENZOTHIAZOLE: An accelerator for rubber vulcanization.
ISOFLUPREDONE ACETATE: The acetate ester of isoflupredone, a corticosteroid.
CLOFLUCARBAN: An antiseptic agent.
PERVILLEINE B: A natural tropane alkaloid.
6,4'-DIMETHOXYFLAVONE: A natural O-methylated flavone.
PAULLONE: A research chemical that is an inhibitor of cyclin-dependent kinases.
PYRITHIONE SODIUM: The sodium salt of pyrithione, an antifungal and antibacterial agent.
RESACTIN A: A natural product.
(-)-U-50488: A selective kappa-opioid receptor agonist.
PHENYLPYRUVATE: A keto acid, a metabolite of phenylalanine.
ESOXYBUTYNIN: A probable misspelling of oxybutynin, a urinary antispasmodic.
A77636: A research chemical that is a selective D1 dopamine receptor agonist.
BENZOTHIAZYL DISULFIDE: An accelerator for rubber vulcanization.
GLISOFLAVONE: A natural isoflavone.
SPARSOMYCIN: An antibiotic that inhibits protein synthesis.
GW282974X: An experimental research compound from GlaxoSmithKline.
BENZO[B]FLUORANTHENE: A polycyclic aromatic hydrocarbon.
TALIPEXOLE HYDROCHLORIDE: The salt of talipexole, a dopamine agonist.
QUINACRINE: A drug formerly used as an antimalarial and antiprotozoal agent.
DICHLOROPHEN: An anthelmintic, fungicide, and bactericide.
SENNOSIDE B: A sennoside found in senna plants, used as a laxative.
4'-DEMETHYLEPIPODOPHYLLOTOXIN: The aglycone of etoposide and teniposide.
E927A: An experimental research compound.
FLUOXASTROBIN: A strobilurin fungicide.
ALPRENOLOL HYDROCHLORIDE: The salt of alprenolol, a non-selective beta-blocker.
OSTHOLE: A natural coumarin with various biological activities.
ISIS 2503: An antisense oligonucleotide designed to inhibit the production of c-Raf kinase.
RO31-8220: A research chemical that is a potent inhibitor of protein kinase C.
(S)-PROMETHAZINE: The active enantiomer of promethazine, a first-generation antihistamine.
GERONTOXANTHONE A: A natural xanthone.
ALAZANINE: An experimental research compound.
BIOALLETHrin S-CYCLOPENTENYL ISOMER: Esbiothrin, a synthetic pyrethroid insecticide.
INDOPROFEN: A non-steroidal anti-inflammatory drug (NSAID).
STILBAMIDINE: An aromatic diamidine used to treat protozoal infections.
ROBUSTIC ACID: A natural rotenoid.
CORYNANTHINE: An alkaloid that acts as an alpha-1 adrenergic receptor antagonist.
4,4'-DIMETHOXYDALBERGIONE: A natural quinone.
DICHLON: A quinone fungicide.
ANETHOLE TRITHIONE: A choleretic agent that stimulates bile secretion.
AROMATICIN: A natural sesquiterpene lactone.
FORMESTANE: A steroidal aromatase inhibitor.
QUIPAZINE: A research chemical that acts as a serotonin receptor agonist.
VASCULAR DISRUPTING AGENT BNC105P: A prodrug of the experimental vascular disrupting agent BNC105.
LORACARBEF: A carbacephem antibiotic.
PIRIQUALONE: A quinazolinone derivative with sedative properties.
BIOTIN: Vitamin B7, an essential nutrient involved in a wide range of metabolic processes.
EUPALININ A: A natural product.
DIPHENYLENEIODONIUM: An inhibitor of NADPH oxidase and nitric oxide synthase.
TELENZEPINE: A research chemical that is a selective M1 muscarinic receptor antagonist.
(R)-MELPHALAN: The R-enantiomer of the chemotherapy agent melphalan.
DIBUCAINE HYDROCHLORIDE: The salt of dibucaine, a potent long-acting local anesthetic.
HYDROXYSTILBAMIDINE: An antiprotozoal agent and fluorescent stain.
4,4'-THIODIANILINE: A chemical intermediate.
KAEMPFERIDE: A natural O-methylated flavonol.
PLUKENETIONE A: A natural product.
ALLANTOIN: A chemical compound used in cosmetics and topical drugs for its soothing properties.
CHLOROETHYLCLONIDINE: An irreversible alpha-2 adrenergic receptor antagonist.
SEPIAPTERIN: A precursor in the biosynthesis of tetrahydrobiopterin.
FENBUCONAZOLE: A triazole fungicide.
(4-CHLOROPHENYL)(MORPHOLINO)METHANETHIONE: A chemical name for a specific research compound.
ROXARSONE: An organoarsenic compound used as a feed additive in poultry.
DIETHYLTOLUAMIDE: DEET, a common active ingredient in insect repellents.
PROTOPORPHYRIN DISODIUM: The disodium salt of protoporphyrin.
HYDROXYFASUDIL: The active metabolite of the Rho-kinase inhibitor fasudil.
FISETIN: A natural flavonol with various biological activities.
GALLAMINE: A non-depolarizing neuromuscular blocking agent.
SOBUZOXANE: An experimental topoisomerase II inhibitor.
EPIBATIDINE: A potent nicotinic acetylcholine receptor agonist alkaloid from frogs.
GARDENIN: A natural polymethoxylated flavone.
CID2745687: An identifier for a chemical compound used in research databases.
IMINOSTILBENE: The chemical core of drugs like carbamazepine.
ANAZOLENE: A dye used for diagnostic purposes.
(R,S)-INDATRALINE: A racemic mixture of a non-selective monoamine transporter inhibitor.
2-IODOACETAMIDE: A research chemical that is an alkylating agent.
3-METHYLCHOLANTHRENE: A polycyclic aromatic hydrocarbon and potent carcinogen.
CHLORDANE: An organochlorine insecticide, banned in many countries.
SB 222200: A research chemical that is a neurokinin 3 (NK3) receptor antagonist.
CYANOPEPTOLIN S: A natural cyclic peptide.
PROADIFEN: A research chemical that inhibits cytochrome P450 enzymes.
BERKELEYDIONE: A natural product from a marine-derived fungus.
3-METHOXYCATECHOL: A derivative of catechol.
ARISTOYUNNOLIN A: A natural alkaloid.
HYDRASTININE HYDROCHLORIDE: The salt of hydrastinine, an alkaloid.
CHLOROGENIC ACID: A natural phenolic compound found in coffee and other plants.
TRIDOLGOSIR: An experimental antisense oligonucleotide.
CARUBICIN: An experimental anthracycline antibiotic.
GSK-299115A: An experimental research compound from GlaxoSmithKline.
ESTRADIOL ENANTHATE: A long-acting ester of estradiol.
MEPRYLCAINE: A local anesthetic.
CHALCONE: The parent compound of a class of aromatic ketones with biological activity.
SB 204741: A research chemical that is a 5-HT2B receptor antagonist.
AZEPANE: A seven-membered heterocyclic compound.
S(+)-APOMORPHINE: The active enantiomer of apomorphine, a dopamine agonist.
BIFENAZATE: An acaricide (miticide).
FERROUS SULFATE: An iron salt used to treat and prevent iron deficiency anemia.
FLAVOKAWAIN A: A kavalactone found in the kava plant.
TOSUFLOXACIN TOSYLATE: The salt of tosufloxacin, a fluoroquinolone antibiotic.
HALOFANTRINE HYDROCHLORIDE: The salt of halofantrine, an antimalarial drug.
PYRITHIONE ZINC: An antifungal and antibacterial agent used in anti-dandruff shampoos.
VOLVALERENAL D: A natural product.
PIFEXOLE: An experimental research compound.
MORONIC ACID: A natural triterpenoid.
ENROFLOXACIN: A fluoroquinolone antibiotic used in veterinary medicine.
DELAVIRDINE: A non-nucleoside reverse transcriptase inhibitor for HIV.
TUBERATOLIDE A: A natural macrolide.
ALPHA-THUJAPLICIN: Hinokitiol, a natural tropolone with antimicrobial properties.
DEOXYVASICINONE: A quinazoline alkaloid.
(S)-FLUOXETINE: The active enantiomer of the SSRI antidepressant fluoxetine.
FUMARPROTOCETRARIC ACID: A natural lichen depsidone.
GAMMA-CYHALOTHRIN: An isomer of the pyrethroid insecticide cyhalothrin.
MADOLIN T: An experimental research compound.
EOSIN_Y: A fluorescent red dye.
THONZONIUM: A surfactant and antiseptic used in ear drops.
BENZALDEHYDE: The simplest aromatic aldehyde, used in flavors and fragrances.
ACRISORCIN: A topical antiseptic.
EVOXINE: A furoquinoline alkaloid.
KHRINONE E: A natural product.
AMOROLFINE: A morpholine antifungal drug.
PHENOXYCARB: An insect growth regulator.
LINTITRIPT: An experimental alpha-5-GABA-A receptor inverse agonist.
GREEN TEA EXTRACT: A supplement derived from green tea leaves, rich in catechins.
HISTONE DEACETYLASE INHIBITOR: A class of drugs that inhibit histone deacetylase enzymes.
TEGAFUR-URACIL: A combination chemotherapy drug.
MARIJUANA: A psychoactive drug from the Cannabis plant.
CALCIUM GLUCONATE: The calcium salt of gluconic acid, used to treat hypocalcemia.
HYDRAZINE: A highly reactive inorganic compound.
ANTIPSYCHOTIC AGENT: A class of drugs used to manage psychosis.
BETA-GLUCAN: Polysaccharides of D-glucose monomers linked by beta-glycosidic bonds.
PHYTOCHEMICAL: A general term for chemical compounds produced by plants.
CHEMOPREVENTIVE AGENT: A substance used to inhibit, delay, or reverse carcinogenesis.
MAFOSFAMIDE: An active oxazaphosphorine metabolite of cyclophosphamide.
DEXTRAN SULFATE SODIUM: A sulfated polysaccharide used to induce colitis in animal models.
PROTEIN KINASE INHIBITOR: A class of drugs that block the action of protein kinases.
FAT EMULSION: A lipid emulsion used for parenteral nutrition.
HEAVY MINERAL OIL: A highly refined grade of mineral oil.
GINKGO BILOBA EXTRACT: An herbal supplement from the Ginkgo biloba tree.
MILADEMETAN TOSYLATE: The salt of an investigational MDM2 inhibitor.
ROZANOLIXIZUMAB: An investigational monoclonal antibody targeting the neonatal Fc receptor (FcRn).
ALBENDAZOLE: A benzimidazole anthelmintic drug.
NUTLIN-3: A research chemical that inhibits the p53-MDM2 interaction.
RAMATERCEPT: An experimental fusion protein that is an activin receptor ligand trap.
GLATIRAMER: An immunomodulatory drug for multiple sclerosis, a random polymer of four amino acids.
L-METHYLFOLATE: The biologically active form of vitamin B9 (folate).
ANTI-PSCA MONOCLONAL ANTIBODY AGS-1C4D4: An experimental monoclonal antibody targeting PSCA.
ALDOPHOSPHAMIDE: An active metabolite of the chemotherapy drug cyclophosphamide.
SOFOSBUVIR/VELPATASVIR: A combination antiviral drug for hepatitis C.
PITRAKINRA: An experimental recombinant human interleukin-4 variant.
PITAVASTATIN: A statin drug used to lower cholesterol.
ACETAMINOPHEN GLUCURONIDE: A major metabolite of acetaminophen (paracetamol).
ETARACIZUMAB: An investigational monoclonal antibody that targets integrin Î±vÎ²3.
ONALESPIB: An experimental Hsp90 inhibitor.
CPG 10101: An experimental Toll-like receptor 9 (TLR9) agonist.
ANDROGEN RECEPTOR ANTISENSE OLIGONUCLEOTIDE EZN-4176: An experimental antisense therapy targeting the androgen receptor.
CARICOTAMIDE: An experimental research compound.
EDIVOXETINE: An experimental selective norepinephrine reuptake inhibitor.
MAXY-G34: An experimental long-acting G-CSF.
MC-1: An experimental research compound.
MITEMCINAL: An experimental motilin receptor agonist.
NERAMEXANE: An experimental NMDA receptor antagonist.
NGX267: An experimental muscarinic M1 receptor agonist.
CANOCTAKIN: An investigational chemokine.
DDP-225: An experimental research compound.
PSN357: An experimental GPR119 receptor agonist.
ARCHEXIN: An experimental peptide that inhibits cell migration.
DG031: An experimental inhibitor of 5-lipoxygenase-activating protein (FLAP).
WX-554: An experimental research compound.
DEZOCINE: An opioid analgesic with mixed agonist-antagonist properties.
ELAFIN: An endogenous protease inhibitor.
FOSINOPRIL: An ACE inhibitor.
GASTRIN IMMUNOTOXIN: An experimental cancer therapy combining a gastrin analog with a toxin.
GLYCOPEG-GCSF: A glyco-pegylated form of granulocyte colony-stimulating factor.
TOCAINIDE: A class Ib antiarrhythmic agent.
IAP INHIBITOR HGS1029: An experimental inhibitor of apoptosis protein (IAP) antagonist.
INSM-18: An experimental tyrosine kinase inhibitor.
ZICRONAPINE: An experimental atypical antipsychotic agent.
ELSIGLUTIDE: An experimental GLP-2 receptor agonist.
CDK9 INHIBITOR AZD4573: An experimental inhibitor of cyclin-dependent kinase 9.
NISEVOKITUG: An investigational monoclonal antibody.
LIPID NANOPARTICLE ENCAPSULATED OX40L MRNA-2416: An investigational mRNA vaccine encoding the OX40L protein.
IL-2/9/15 GAMMA CHAIN RECEPTOR INHIBITOR BNZ-1: An experimental multi-cytokine inhibitor.
OSTABOLIN-C: An experimental research compound.
VIXARELIMAB: An investigational monoclonal antibody that targets the oncostatin M receptor beta.
AZD1656: An experimental glucokinase activator.
BMS-830216: An experimental research compound from Bristol-Myers Squibb.
VALZIFLOCEPT: An experimental research compound.
TASOCITINIB: An investigational Janus kinase (JAK) inhibitor.
METFORMIN GLYCINATE: A salt of the anti-diabetic drug metformin.
BIO1211: An experimental alpha-4-beta-1 integrin antagonist.
SARIPIDEM: An experimental anxiolytic and hypnotic of the imidazopyridine class.
VANADATE: An ion of the element vanadium.
RECOMBINANT ADENOVIRUS 5 ENCODING TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND: An experimental gene therapy vector for cancer.
ZD-6126: An experimental vascular-disrupting agent.
IODIPAMIDE: An iodine-containing contrast agent.
A425619: An experimental research compound.
DENDRITIC CELL VACCINE: A type of immunotherapy that uses a patient's own dendritic cells.
ALEMCINAL: An experimental motilin receptor agonist.
SERELAXIN: Recombinant human relaxin-2.
OTSSP167: An experimental MELK kinase inhibitor.
ANTI-EGFRVIII ANTIBODY DRUG CONJUGATE AMG 595: An experimental antibody-drug conjugate targeting a mutant EGFR.
QGC-001: An experimental research compound.
AUTOLOGOUS CCR4-CD30CAR-CD28-CD3ZETA-EXPRESSING T-LYMPHOCYTES: An investigational dual-antigen targeting CAR T-cell therapy.
ALLOGENEIC ANTI-CD19-CAR-CD28-IL-15-EXPRESSING NATURAL KILLER T-CELLS: An experimental allogeneic CAR-NKT cell therapy.
BEMORADAN: An experimental calcium sensitizer for heart failure.
OXILOFRINE: A sympathomimetic amine used as a stimulant.
PAN-PI3K INHIBITOR CLR457: An experimental inhibitor of all PI3K isoforms.
INTOPLICINE: An experimental DNA topoisomerase I and II inhibitor.
CIMETROPIUM BROMIDE: An antispasmodic muscarinic antagonist.
SEBELIPASE ALFA: An enzyme replacement therapy for lysosomal acid lipase deficiency.
SULODEXIDE: A mixture of glycosaminoglycans used for vascular diseases.
GMX1777: An experimental inhibitor of the NAMPT enzyme.
BQ-123: A research chemical that is a selective endothelin ETA receptor antagonist.
ALNIDITAN: An experimental 5-HT1D receptor agonist.
5-MEOT: A research chemical that is a tryptamine derivative.
AL-37350A: An experimental research compound.
N-1-ISOPROPYLTRYPTAMINE: A research chemical of the tryptamine class.
DIMETHYLTRYPTAMINE: DMT, a powerful psychedelic tryptamine.
ML347: A research chemical that is a positive allosteric modulator of the KCNQ2/5 channel.
CXCL11: A chemokine also known as I-TAC.
A-119637: An experimental research compound.
A61603: A research chemical that is a potent alpha-1a adrenergic receptor agonist.
FK-453: An experimental research compound.
MRS1093: An experimental research compound.
ANGIOTENSIN III: A peptide of the renin-angiotensin system with pressor activity.
COMPOUND 2 [PMID: 28379944]: A research compound described in the specified scientific publication.
COMPOUND 10 [PMID: 19402633]: A research compound described in the specified scientific publication.
COMPOUND 3L [PMID: 30637955]: A research compound described in the specified scientific publication.
DENOPAMINE: A selective beta-1 adrenergic receptor agonist.
CARAZOLOL: A non-selective beta-blocker.
20-HYDROXY-LTB4: A metabolite of the inflammatory mediator leukotriene B4.
COMPOUND 13A [PMID: 23639540]: A research compound described in the specified scientific publication.
GW841819X: An experimental research compound from GlaxoSmithKline.
COMPOUND 1 [PMID: 25408830]: A research compound described in the specified scientific publication.
TP-472: An experimental research compound.
COMPOUND 36 [PMID: 21958547]: A research compound described in the specified scientific publication.
EXAMPLE A225 [WO2012170976A2]: A chemical compound described in the specified patent application.
CHMFL-BTK-11: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
[DES-PHE9,DES-ARG10]KALLIDIN: An analog of kallidin that is a bradykinin B1 receptor agonist.
JMV1431: An experimental research compound.
NVP-SAA164: An experimental research compound from Novartis.
[D-LYS1,DES-ARG10]KALLIDIN: A modified analog of kallidin.
[DES-ARG10]ICATIBANT: A metabolite of the bradykinin B2 receptor antagonist icatibant.
NDT9513727: An experimental research compound.
LACTOMEDIN 1: An experimental research compound.
E7: An experimental research compound.
BAYK 8644: A research chemical that is an L-type calcium channel agonist.
NI2+: The nickel ion, a transition metal element.
PETESICATIB: An investigational spleen tyrosine kinase (Syk) inhibitor.
BMS-681: An experimental research compound from Bristol-Myers Squibb.
FLU-CCL3: A fluorescently labeled version of the chemokine CCL3.
ML315: A research chemical that is an inhibitor of the deubiquitinase USP10.
MW05: An experimental research compound.
NVP 231: An experimental research compound from Novartis.
ACT-777991: An investigational P2Y12 receptor antagonist.
COMPOUND 3 [PMID: 19097791]: A research compound described in the specified scientific publication.
FASCAPLYSIN: A natural marine alkaloid with CDK4 inhibitory and antibacterial properties.
ULECACICLIB: An investigational CDK2 inhibitor.
TANUXICICLIB: An investigational CDK4/6 inhibitor.
THZ1: A research chemical that is a covalent inhibitor of CDK7.
COMPOUND 20 [BERGERON ET AL., 2016]: A research compound described in the specified scientific publication.
LTE4: Leukotriene E4, an inflammatory lipid mediator.
UFP-512: A research chemical that is a selective delta-opioid receptor agonist.
[D-ALA2]DELTORPHIN II: A synthetic opioid peptide that is a potent delta-opioid receptor agonist.
AT-076: An experimental Aurora kinase inhibitor.
ICED-2: An experimental research compound.
PEROSPIRONE: An atypical antipsychotic that acts on serotonin and dopamine receptors.
L-NNA: N(G)-Nitro-L-arginine, a research chemical that inhibits nitric oxide synthase.
COMPOUND 2G [PMID: 27390066]: A research compound described in the specified scientific publication.
PD159790: An experimental research compound.
TULMIMETOSTAT: An investigational dual LSD1/HDAC6 inhibitor.
BI-4142: An experimental research compound.
CATEQUENTINIB: An investigational multi-kinase inhibitor.
COMPOUND 7 [NGUYEN ET AL., 2023]: A research compound described in the specified scientific publication.
TOCERANIB: A multi-kinase inhibitor used in veterinary medicine for canine mast cell tumors.
SAFIT1: An experimental research compound.
COMPOUND 18E [PMID: 31670517]: A research compound described in the specified scientific publication.
COMPOUND R-(-)-5F [PMID: 22607879]: A research compound described in the specified scientific publication.
FMET-ILE-VAL-THR-LEU-PHE: A synthetic chemoattractant peptide.
QUIN-C1: An experimental research compound.
ATLA2: An experimental research compound.
LXA4: Lipoxin A4, a specialized pro-resolving lipid mediator.
SRI37892: An experimental research compound.
RO4938581: An experimental negative allosteric modulator of GABA-A receptors.
ZK93423: A research chemical that is an inverse agonist at the benzodiazepine site of GABA-A receptors.
TP003: An experimental research compound.
[35S]TBPS: A radiolabeled convulsant that binds to the chloride channel of the GABA-A receptor.
GAL-B2-DPEG24: A modified galanin analog.
M617: An experimental galanin receptor ligand.
M40: A peptide antagonist of galanin receptors.
M1151: An experimental research compound.
BPH-742: An experimental research compound.
CONCANAVALIN A: A lectin (carbohydrate-binding protein) originally extracted from the jack-bean.
NS3763: A research chemical that inhibits cyclooxygenase enzymes.
SELFOTEL: An experimental NMDA receptor antagonist.
GNRH I: Gonadotropin-releasing hormone I, the primary regulator of the reproductive axis.
[3H]N-METHYL-SSR504734: A radiolabeled glycine transporter 1 inhibitor.
COMPOUND 15 [PMID: 25411721]: A research compound described in the specified scientific publication.
D-23487: An experimental research compound.
FD-1: An experimental research compound.
SERINE: A non-essential amino acid.
BALANOL: A natural product that is a potent inhibitor of protein kinase C.
GUANYLYL CYCLASE-ACTIVATING PROTEIN 2: A calcium-binding protein involved in phototransduction.
GRP94 INHIBITOR 54: A research chemical that inhibits the GRP94 heat shock protein.
COMPOUND 30 [PMID: 37057760]: A research compound described in the specified scientific publication.
NEXTURASTAT A: An experimental histone deacetylase 6 (HDAC6) inhibitor.
2-(3-IODOPHENYL)HISTAMINE: A research chemical related to histamine.
BURIMAMIDE: A research chemical that was the first histamine H2 receptor antagonist developed.
IMPROMIDINE: A research chemical that is a potent histamine H2 receptor agonist.
ARPROMIDINE: A research chemical that is a histamine H2 receptor agonist.
A-317920: An experimental research compound.
FUB 349: An experimental research compound.
COMPOUND 2 [DREYER ET AL., 1991]: A research compound described in the specified scientific publication.
LYSOPHOSPHATIDYLSERINE: A signaling lipid molecule.
GPR15L: The ligand for the G protein-coupled receptor 15.
COMPOUND 5 [NOBLE ET AL., 1992]: A research compound described in the specified scientific publication.
HOMOERIODICTYOL: A natural flavanone found in some plants.
GDC-0214: An experimental research compound from Genentech.
COMPOUND 19A [PMID: 24359159]: A research compound described in the specified scientific publication.
DYNORPHIN A: An endogenous opioid peptide that is the primary ligand for the kappa-opioid receptor.
SALVINORIN A: A potent kappa-opioid receptor agonist and psychoactive compound from the Salvia divinorum plant.
CHMFL-KIT-8140: An experimental inhibitor of the KIT kinase.
COMPOUND 6LI [CHAN ET AL., 2022]: A research compound described in the specified scientific publication.
RIMTUZALCAP: An investigational LCAT activator.
CM-TPMF: An experimental research compound.
KB-130015: An experimental research compound.
CORREOLIDE: A natural product with ion channel modulating activity.
COMPOUND 7U [PMID: 24775305]: A research compound described in the specified scientific publication.
3-HYDROXYBENZYLHYDRAZINE: A chemical intermediate.
NIK SMI1: An experimental inhibitor of the NIK kinase.
ACETYL-PODOCARPIC DIMER: A derivative of a natural diterpenoid.
2-OLEOYL-LPA: A species of lysophosphatidic acid.
COMPOUND 20C [PMID: 34181850]: A research compound described in the specified scientific publication.
TINODASERTIB: An investigational dual aurora/JAK kinase inhibitor.
ASIP [90-132 (L89Y)]: A modified fragment of agouti-signaling protein.
AC-HMCH-(6-16)-NH2: A modified fragment of melanin-concentrating hormone.
CFMMC: An experimental research compound.
[11C]MMTP: A radiolabeled tracer for PET imaging.
(2R,3R)-APDC: A research chemical that is a group II metabotropic glutamate receptor agonist.
JNJ-40068782: An experimental mGlu2 receptor negative allosteric modulator.
MSC2032964A: An experimental research compound.
BQCA: A research chemical that is a positive allosteric modulator of the M1 muscarinic receptor.
G100: An experimental research compound.
LY2033298: An experimental mGlu2/3 receptor positive allosteric modulator.
METHOCTRAMINE: A research chemical that is a selective M2 muscarinic receptor antagonist.
MCN-A-343: A research chemical that is a selective M1 muscarinic receptor agonist.
LITHOCHOLYLCHOLINE: A derivative of a secondary bile acid.
STRYCHNINE: A highly toxic alkaloid that is a glycine receptor antagonist.
BTK INHIBITOR: A class of drugs that block Bruton's tyrosine kinase.
UH-AH 37: An experimental research compound.
2-METHOXY-&ALPHA;,&BETA;-DIDEHYDRO-AGOMELATINE: A derivative of the antidepressant agomelatine.
UCM1341: An experimental research compound.
ABBV-257: An experimental research compound from AbbVie.
GKT136901: An experimental dual NOX1/4 inhibitor.
RELUTRIGINE: An investigational sodium channel blocker.
PF-04885614: An experimental research compound from Pfizer.
BATRACHOTOXIN: A potent cardiotoxic and neurotoxic steroidal alkaloid from poison dart frogs.
PYRROLOPYRIMIDINE 48 [PMID: 22318156]: A research compound described in the specified scientific publication.
GSK-3179106: An experimental research compound from GlaxoSmithKline.
HEXAMETHONIUM: A ganglionic blocker formerly used as an antihypertensive agent.
PHA-543613: A research chemical that is an alpha-7 nicotinic acetylcholine receptor agonist.
PD157672: An experimental research compound.
[125I]NEUROMEDIN U-25 (HUMAN): A radiolabeled version of the human neuropeptide neuromedin U-25.
ONTAMALIMAB: An investigational monoclonal antibody targeting MAdCAM-1.
[3H]CCK-8 (HUMAN, MOUSE, RAT): A radiolabeled version of cholecystokinin-8.
L-366,682: An experimental research compound.
[MPA1,D-TYR(ET)2,D-TIC7]OT: A complex synthetic oxytocin analog.
MRS2567: An experimental research compound.
BEPAFANT: An experimental antagonist of platelet-activating factor (PAF).
RO 25-1553: A research chemical that is a vasopressin V1A receptor antagonist.
ISOX-CHA-CHG-ALA-ARG-DPR(4FB)-NH2: A complex synthetic peptide.
LANIFIBRANOR: An investigational pan-PPAR agonist.
15-DEOXY-&DELTA;-12,14-PROSTAGLANDIN J2: An endogenous PPAR gamma agonist.
AUTOLOGOUS CD123CAR-CD28-CD3ZETA-EGFRT-EXPRESSING T LYMPHOCYTES MB-102: An investigational CAR T-cell therapy targeting CD123.
FMOC-L-LEUCINE: A protected form of the amino acid leucine used in peptide synthesis.
COMPOUND 12B [PMID: 31465220]: A research compound described in the specified scientific publication.
ECF309: An experimental research compound.
COMPOUND 7 [PMID: 31955578]: A research compound described in the specified scientific publication.
RPI-MN: An experimental research compound.
STX-478: An experimental PI3K alpha inhibitor.
COMPOUND 15A [PMID: 32069401]: A research compound described in the specified scientific publication.
BC11-38: An experimental research compound.
SCH51866: An experimental research compound.
BAY607550: An experimental phosphodiesterase 2 inhibitor.
PF-04957325: An experimental phosphodiesterase 2A inhibitor.
(+)-S20: An experimental research compound.
[125I]PRRP-20 (HUMAN): A radiolabeled version of human prolactin-releasing peptide-20.
[125I][NLE8,21,TYR34]PTH-(1-34)-NH2 (RAT): A radiolabeled analog of rat parathyroid hormone.
[D-TRP12,TYR34]PTH-(7-34) (BOVINE): A peptide antagonist of the parathyroid hormone receptor.
PTHRP-(1-34) (HUMAN): The N-terminal fragment of human parathyroid hormone-related protein.
VER-246608: An experimental Hsp90 inhibitor.
COMPOUND 14 [SCHNUTE ET AL., 2023]: A research compound described in the specified scientific publication.
H3 AC-B10-27(13-17 HC): A hybrid peptide of relaxin-3 and INSL5.
VPC03090-P: An experimental research compound.
BMS-986104 DERIVATIVE 12: A chemical derivative of an experimental drug from Bristol-Myers Squibb.
ST-2191: An experimental research compound.
COMPOUND 15 [PMID: 33738061]: A research compound described in the specified scientific publication.
ARN-3236: An experimental androgen receptor antagonist.
BPTI-K15R/R17G: A modified form of bovine pancreatic trypsin inhibitor (aprotinin).
PB-28: A research chemical that is a sigma-2 receptor agonist.
COMPOUND 8 [PMID: 19191557]: A research compound described in the specified scientific publication.
COMPOUND 14 [PMID: 19191557]: A research compound described in the specified scientific publication.
NC 8-12: An experimental research compound.
[D-TYR8]CYN 154806: A modified somatostatin receptor antagonist.
IN-NODAGATOC: A somatostatin receptor antagonist for imaging.
DES-AA5-[D-TRP8]SRIF: A modified analog of somatostatin.
[111IN,90Y]DOTA-NOC: A radiolabeled peptide for imaging and therapy of neuroendocrine tumors.
GNE-064: An experimental research compound from Genentech.
BAFF: B-cell activating factor, a cytokine that promotes B-cell survival.
OM-1700: An experimental research compound.
COMPOUND 15 [PMID: 35450354]: A research compound described in the specified scientific publication.
DIPROVOCIM-1: An experimental Toll-like receptor 1/2 agonist.
N-0385: An experimental research compound.
POLYGODIAL: A natural sesquiterpenoid with antifungal and pungent properties.
OAG: 1-oleoyl-2-acetyl-sn-glycerol, a research chemical that activates protein kinase C.
AMG517: An experimental TRPV1 channel antagonist.
[3H]A778317: A radiolabeled research compound.
COMPOUND 21 [PMID: 23312943]: A research compound described in the specified scientific publication.
HIMB1636-MMAE: An experimental antibody-drug conjugate.
SBP-7455: An experimental polyamine analog for cancer therapy.
KSQ-4279: An investigational USP1 inhibitor.
COMPOUND 15 [PMID: 24900237]: A research compound described in the specified scientific publication.
[ARG16]CHICKEN SECRETIN: A modified form of chicken secretin.
VIP: Vasoactive intestinal peptide, a neuropeptide with widespread effects.
ANTI-PD-L1 MONOCLONAL ANTIBODY: A class of immunotherapy drugs that block the PD-L1 immune checkpoint.
PD1 INHIBITOR: A class of immunotherapy drugs that block the PD-1 immune checkpoint receptor.
DORDAVIPRONE: An investigational non-steroidal progesterone receptor agonist.
SOTRASTAURIN ACETATE: The salt of sotrastaurin, an experimental protein kinase C inhibitor.
AZD8329: An experimental EP4 receptor antagonist.
RP-6306: An investigational PKMYT1 kinase inhibitor.
PLX7486: An experimental CSF1R kinase inhibitor.
ERK1/2 INHIBITOR ERAS-007: An experimental inhibitor of the ERK1/2 kinases.
VILANTEROL TRIFENATATE: The salt of vilanterol, a long-acting beta-2 adrenergic agonist.
ANTHRANILIC ACID: An aromatic acid used in the synthesis of dyes and perfumes.
YTTRIUM (90Y) CLIVATUZUMAB TETRAXETAN: A radioimmunoconjugate for pancreatic cancer therapy.
CYAMEMAZINE: An atypical antipsychotic of the phenothiazine class.
GSK1511931: An experimental research compound from GlaxoSmithKline.
TOLUDESVENLAFAXINE: An experimental serotonin-norepinephrine reuptake inhibitor.
HALOPROGIN: A topical antifungal agent.
CBS-3595: An experimental research compound.
ML381: A research chemical that is an inhibitor of NRF2.
CINOXACIN: A quinolone antibiotic.
AZD-3759: An experimental EGFR kinase inhibitor that crosses the blood-brain barrier.
(2S,4S)-KETOCONAZOLE: An isomer of the antifungal drug ketoconazole.
PEPTIDE 30 [PMID: 27019010]: A peptide described in the specified scientific publication.
CAULIBUGULONE B: A natural product from a marine bryozoan.
6-BENZYLAMINOPURINE: A synthetic cytokinin plant hormone.
METRIFUDIL: An experimental research compound.
PYRAZOLOACRIDINE: An experimental antineoplastic agent.
ARTICAINE: A local anesthetic used primarily in dentistry.
CP-461: An experimental research compound.
TAFLUPOSIDE: An experimental research compound.
CALCIUM: An essential mineral for life.
PAMREVLUMAB: An investigational monoclonal antibody that targets connective tissue growth factor (CTGF).
DIDS: 4,4'-Diisothiocyano-2,2'-stilbenedisulfonic acid, an anion transport inhibitor.
GAL-B2-C8: A modified galanin analog.
MESO-DAP: Meso-diaminopimelic acid, a component of some bacterial cell walls.
LACTULOSE: A non-absorbable sugar used as a laxative and to treat hepatic encephalopathy.
NS1643: A research chemical that activates the KCNQ1 potassium channel.
RMC-5552: An investigational bi-steric mTORC1 inhibitor.
PROLINE: A non-essential amino acid.
BI-836858: An investigational monoclonal antibody targeting IGF-1 and IGF-2.
COMPOUND 10H [PMID: 20832306]: A research compound described in the specified scientific publication.
DINITRO CRESOL: An organic compound used as a herbicide and insecticide.
HEXAHYDRODIFENIDOL: A derivative of the anticholinergic drug difenidol.
LGD-6972: An investigational glucagon receptor antagonist.
MGS-0210: An experimental research compound.
AKT INHIBITOR LY2780301: An experimental inhibitor of the Akt kinase.
GSK8612: An experimental IKK2 kinase inhibitor.
R3/I5: A chimeric peptide of relaxin-3 and INSL5.
MEDI-3617: An experimental monoclonal antibody.
PI3KBETA INHIBITOR AZD8186: An experimental inhibitor of the PI3K beta isoform.
METHIDATHION: An organophosphate insecticide.
PALMITOYL-CARNITINE: An ester of palmitic acid and carnitine.
CICLOPIROX OLAMINE: The salt of ciclopirox, a topical antifungal agent.
CY3B-TELENZEPINE: A fluorescently labeled antagonist of the M1 muscarinic receptor.
SCUTELLARIN: A flavonoid glycoside with various biological activities.
ZAURATEGRAST: An experimental alpha-4 integrin antagonist.
(-)-STEPHOLIDINE: A natural alkaloid with both D1 agonist and D2 antagonist properties.
CLOXYQUIN: An antiseptic and disinfectant.
URIC ACID: A product of purine metabolism in the human body.
(R)-DOI: The active enantiomer of DOI, a 5-HT2A/2C receptor agonist.
PF0998425: An experimental research compound from Pfizer.
MEPTAZINOL: An opioid analgesic with mixed agonist-antagonist properties.
CHRYSOPHANOL: An anthraquinone found in rhubarb with various biological activities.
ETHER: A class of organic compounds containing an ether group.
ALT-803: An experimental IL-15 superagonist complex.
SITAXENTAN: An endothelin-A receptor antagonist.
LAPACHOL: A natural naphthoquinone with various biological activities.
ER819762: An experimental research compound.
CONTEZOLID: An investigational oxazolidinone antibiotic.
ANHYDROUS DEXTROSE: A form of glucose without water of crystallization.
JNJ-47965567: An experimental BACE1 inhibitor.
BSAB (CD89-CD20): An experimental bispecific antibody.
COMPOUND 10 [PMID: 15482906]: A research compound described in the specified scientific publication.
GENTAMICIN SULFATE: The salt of gentamicin, an aminoglycoside antibiotic.
ABP-700: An investigational positive allosteric modulator of GABA-A receptors.
NBTGR: An experimental research compound.
DIFLUBENZURON: An insect growth regulator of the benzoylurea class.
4-APPES: An experimental research compound.
PG 99-465: An experimental research compound.
GEPOTIDACIN: An investigational triazaacenaphthylene antibiotic.
GLUFOSFAMIDE: An experimental alkylating agent for cancer therapy.
CP466722: An experimental research compound.
TRIAMCINOLONE HEXACETONIDE: A long-acting ester of the corticosteroid triamcinolone.
RIMITEROL: A short-acting beta-2 adrenergic agonist.
ANTISAUVAGINE: A peptide antagonist of corticotropin-releasing factor receptors.
PGJ2: Prostaglandin J2, an endogenous pro-inflammatory mediator.
COMPOUND 36 [PMID: 21273063]: A research compound described in the specified scientific publication.
VEGFE: Vascular endothelial growth factor E, a viral homolog of VEGF-A.
COAGULATION FACTOR IX (RECOMBINANT), GLYCOPEGYLATED: A long-acting glycopegylated form of Factor IX.
THIOLUTIN: A natural product antibiotic.
&ALPHA;-ERGOCRYPTINE: An ergot alkaloid.
ASN06356088: An experimental research compound.
COMPOUND 25AP [PMID: 37796543]: A research compound described in the specified scientific publication.
CEFATRIZINE: A cephalosporin antibiotic.
SUBSTANCE P: A neuropeptide of the tachykinin family, involved in pain and inflammation.
BTP2: A research chemical that inhibits store-operated calcium entry.
SC-51322: A research chemical that is a prostaglandin EP1 receptor antagonist.
MRS2698: An experimental research compound.
SELATINIB: An investigational kinase inhibitor.
12-EPI-SALVINORIN A: An isomer of the psychoactive compound salvinorin A.
ROBLITINIB: An investigational FGFR inhibitor.
PHLORIZIN: A natural glucoside that inhibits SGLT1 and SGLT2.
ME4: An experimental research compound.
SCOPOLETIN: A natural coumarin with various biological activities.
NOVOKININ: An experimental research compound.
OSANETANT: An experimental neurokinin 3 (NK3) receptor antagonist.
BEPERMINOGENE PERPLASMID: An experimental gene therapy for peripheral artery disease.
PIDNARULEX: An investigational MCL1 inhibitor.
PF-05241328: An experimental research compound from Pfizer.
ZACOPRIDE: An experimental 5-HT4 agonist and 5-HT3 antagonist.
ALEXIDINE DIHYDROCHLORIDE: The salt of alexidine, a bisbiguanide antiseptic.
PACLITAXEL POLIGLUMEX: A polymer-drug conjugate of the chemotherapy agent paclitaxel.
EPOFOLATE: An experimental folate-targeted therapy.
XESTOSPONGIN C: A natural product that is a potent inhibitor of the IP3 receptor.
ASTX029: An investigational EED inhibitor.
NITROBLUE TETRAZOLIUM: A dye used in biochemical assays.
LADIRATUZUMAB VEDOTIN: An antibody-drug conjugate targeting LIV-1.
BM213: An experimental research compound.
CHLOROTOXIN: A peptide from scorpion venom that binds to glioma cells.
AMPRELOXETINE: An investigational norepinephrine reuptake inhibitor.
BELANTAMAB MAFODOTIN-BLMF: An antibody-drug conjugate targeting BCMA for multiple myeloma.
L-165461: An experimental research compound.
APG-1387: An investigational IAP antagonist.
ETHYLKETOCYCLAZOCINE: An opioid analgesic that is a potent kappa-opioid receptor agonist.
PHENIRAMINE: A first-generation antihistamine.
MONOCLONAL ANTIBODY 3H1 ANTI-IDIOTYPE VACCINE: An experimental cancer vaccine.
CARMOXIROLE: An experimental dopamine agonist.
FELCISETRAG: An experimental 5-HT2A receptor antagonist.
ECRAPROST: An experimental prostacyclin analog.
PACTIMIBE: An experimental acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor.
MRS1088: An experimental research compound.
COMPOUND 38 [PMID: 24915291]: A research compound described in the specified scientific publication.
S-222611: An experimental research compound.
UROLININ: An experimental research compound.
HEPATITIS B VACCINE: A vaccine that prevents hepatitis B.
AC-RYYRWK-NH2: A synthetic peptide.
BIM 23030: An experimental somatostatin analog.
JNJ-26483327: An experimental histamine H4 receptor antagonist.
KHK-2866: An experimental monoclonal antibody.
MK-3577: An experimental research compound from Merck.
DEXCHLORPHENIRAMINE MALEATE: The salt of dexchlorpheniramine, the active enantiomer of chlorpheniramine.
ENAPOTAMAB VEDOTIN: An antibody-drug conjugate targeting AXL.
L-156,602: An experimental research compound.
PAPAVERINE HYDROCHLORIDE: The salt of papaverine, an opium alkaloid used as a vasodilator.
METRELEPTIN: Recombinant human leptin, used to treat lipodystrophy.
INTETUMUMAB: An investigational monoclonal antibody that targets CD51.
CYCLOVALONE: A choleretic agent.
COMPOUND 3 [PMID: 29633584]: A research compound described in the specified scientific publication.
SATAVAPTAN: An experimental vasopressin V2 receptor antagonist.
BENZPIPERYLON: A non-steroidal anti-inflammatory drug (NSAID).
HISTAMINE PHOSPHATE: The phosphate salt of histamine.
METHOTREXATE SODIUM: The salt of methotrexate, an antifolate chemotherapy and immunosuppressive drug.
INDOXIMOD: An experimental inhibitor of the IDO pathway for cancer immunotherapy.
LY-465608: An experimental research compound from Eli Lilly.
PENTAMETHYLQUERCETIN: A permethylated derivative of the flavonoid quercetin.
5-HYDROXYINDOLEACETIC ACID: The main metabolite of serotonin.
MESORIDAZINE BESYLATE: The salt of mesoridazine, a typical antipsychotic.
DRUGSATFDA.NDA:016727: An FDA application identifier for a specific drug.
TENELIGLIPTIN: A dipeptidyl peptidase-4 (DPP-4) inhibitor.
AZATADINE: A first-generation antihistamine.
ONVATILIMAB: An investigational monoclonal antibody targeting PD-1.
ESTROGENS, CONJUGATED SYNTHETIC A: A mixture of synthetic conjugated estrogens.
OLICERIDINE: An opioid agonist that is a G-protein biased ligand at the mu-opioid receptor.
CONESSINE: A steroidal alkaloid with histamine H3 receptor antagonist activity.
LG-100268: An experimental retinoid X receptor (RXR) agonist.
ERGOCORNINE: An ergot alkaloid.
1-HYDROXY-4-ETHOXYBENZENE: A chemical intermediate.
CCL19: A chemokine, also known as MIP-3-beta.
(S)-&ALPHA;-METHYLHISTAMINE: The S-enantiomer of a histamine receptor agonist.
MRS2905: An experimental research compound.
PIPERIDOLATE: An anticholinergic drug.
TIOCARLIDE: An antitubercular agent of the thiourea class.
GRAVEOLINE: A natural furoquinoline alkaloid.
7-NITROINDAZOLE: A research chemical that is a selective inhibitor of neuronal nitric oxide synthase.
DEL-22379: An experimental inhibitor of the ERBB2-ERBB3 protein-protein interaction.
PEGCETACOPLAN: A pegylated peptide that targets complement component C3.
HARMALINE: A fluorescent psychoactive alkaloid of the harmala alkaloid group.
CD30 LIGAND: The protein that binds to the CD30 receptor, also known as TNFSF8.
SNAP 37889: An experimental neurokinin 3 (NK3) receptor antagonist.
LOBARIC ACID: A natural lichen depsidone.
XANTHOHUMOL: A prenylated chalcone from hops with various biological activities.
AES-103: An experimental research compound.
LYSERGIDE: Lysergic acid diethylamide (LSD), a potent psychedelic drug.
COMPOUND 41 [PMID: 25000588]: A research compound described in the specified scientific publication.
AMG-167: An experimental monoclonal antibody from Amgen.
HSP90 INHIBITOR: A class of drugs that block the Hsp90 heat shock protein.
COBOMARSEN: An antisense oligonucleotide targeting beta-catenin.
CARBINOXAMINE MALEATE: The salt of carbinoxamine, a first-generation antihistamine.
FLUPHENAZINE DECANOATE: A long-acting injectable ester of the antipsychotic fluphenazine.
GANIRELIX ACETATE: The salt of ganirelix, a gonadotropin-releasing hormone (GnRH) antagonist.
SECRETIN HUMAN, SYNTHETIC: A synthetic version of the human hormone secretin.
ALMOTRIPTAN MALATE: The salt of almotriptan, a 5-HT1B/1D receptor agonist for migraines.
HEXAFLUORENIUM BROMIDE: The salt of hexafluorenium, a neuromuscular blocking agent.
HYDROCODONE POLISTIREX: An extended-release formulation of the opioid hydrocodone.
ISOPROTERENOL SULFATE: The salt of isoproterenol, a non-selective beta-adrenergic agonist.
BALSALAZIDE DISODIUM: The salt of balsalazide, a prodrug of mesalazine.
PHENOXYBENZAMINE HYDROCHLORIDE: The salt of phenoxybenzamine, an irreversible alpha-adrenergic blocker.
DOCOSANOL: A saturated fatty alcohol used topically for cold sores.
CRILVASTATIN: An experimental HMG-CoA reductase inhibitor (statin).
TROPLASMINOGEN ALFA: A truncated form of human plasminogen.
MIVACURIUM CHLORIDE: A short-acting non-depolarizing neuromuscular blocking agent.
SB236057: A research chemical that is a 5-HT1B receptor antagonist.
SERGOLEXOLE: An experimental dopamine agonist.
LY53857: A research chemical that is a 5-HT2 receptor antagonist.
DROXIDOPA: A prodrug of norepinephrine for treating neurogenic orthostatic hypotension.
NALOXEGOL: A peripherally acting mu-opioid receptor antagonist for opioid-induced constipation.
AS-703988: An experimental MEK kinase inhibitor.
CAL-263: An experimental research compound.
PLX-5622: An experimental CSF1R kinase inhibitor.
SCIO-323: An experimental research compound.
AZD3161: An experimental research compound from AstraZeneca.
DELUCEMINE: An experimental NMDA receptor antagonist.
SR16234: An experimental selective estrogen receptor modulator (SERM).
SODELGLITAZAR: An experimental dual PPAR alpha/delta agonist.
TRICIRIBINE PHOSPHATE: The phosphate salt of triciribine, an experimental Akt kinase inhibitor.
ZSTK-474: An experimental pan-class I PI3K inhibitor.
GSK163090: An experimental research compound from GlaxoSmithKline.
CRINECERFONT: An investigational corticotropin-releasing factor 1 (CRF1) receptor antagonist.
CP-601927: An experimental research compound.
TOSEDOSTAT: An experimental aminopeptidase inhibitor.
CARMEGLIPTIN: An investigational dipeptidyl peptidase-4 (DPP-4) inhibitor.
NERAMEXANE MESYLATE: The salt of neramexane, an experimental NMDA receptor antagonist.
DAPRODUSTAT: An oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor for anemia.
BEXAGLIFLOZIN: An SGLT2 inhibitor for type 2 diabetes.
TAPLITUMOMAB PAPTOX: An immunotoxin consisting of an anti-EpCAM antibody linked to a toxin.
MLNM-2201: An experimental research compound.
ARGIPRESSIN TANNATE: A salt of argipressin, a synthetic form of vasopressin.
BICIROMAB BRALLOBARBITAL: An experimental research compound.
GSK-1995057: An experimental research compound from GlaxoSmithKline.
CD24FC: An experimental fusion protein for autoimmune diseases.
TOLOXATONE: A selective, reversible monoamine oxidase A inhibitor.
MOFEZOLAC: A non-steroidal anti-inflammatory drug (NSAID).
REMIMAZOLAM BESYLATE: The salt of remimazolam, an ultra-short-acting benzodiazepine sedative.
SOFPIRONIUM BROMIDE: An anticholinergic agent for hyperhidrosis.
POTASSIUM OXYBATE: The potassium salt of gamma-hydroxybutyrate.
GSK-1521498: An experimental melanocortin-4 receptor antagonist.
SERPLULIMAB: An investigational monoclonal antibody targeting PD-1.
CJM-112: An experimental monoclonal antibody targeting interleukin-17A.
PERZINFOTEL: An experimental NMDA receptor antagonist.
TAS-117: An experimental dual Akt/mTOR inhibitor.
BMS-275183: An experimental research compound from Bristol-Myers Squibb.
RO-24-7429: An experimental inhibitor of the HIV Tat protein.
ATN-161: A peptide that is an alpha-5-beta-1 integrin antagonist.
RG-7636: An experimental research compound from Roche.
EPCORITAMAB: A bispecific antibody targeting CD3 and CD20 for lymphoma.
MARALIXIBAT CHLORIDE: The salt of maralixibat, an ileal bile acid transporter (IBAT) inhibitor.
RO-0622: An experimental research compound from Roche.
EP-100: An experimental research compound.
BMS-707035: An experimental research compound from Bristol-Myers Squibb.
BAZLITORAN: An investigational TRPA1 channel antagonist.
ENPATORAN: An investigational dual TLR7/8 antagonist.
LACIDIPINE: A dihydropyridine calcium channel blocker.
BEPRANEMAB: An investigational monoclonal antibody targeting the Tau protein.
MIBAVADEMAB: An investigational monoclonal antibody.
PHYSODIC ACID: A natural lichen depsidone.
PHENETHYLISOTHIOCYANATE: A natural isothiocyanate from cruciferous vegetables with potential anticancer properties.
OXOPURPUREINE: A natural alkaloid.
CERIVASTATIN SODIUM: The salt of cerivastatin, a statin drug withdrawn from the market.
FUCHSIN, BASIC: A magenta dye, a mixture of rosanilin, pararosanilin, and new fuchsin.
2'-HYDROXYCHALCONE: A chalcone compound.
PROFLAVINE: A topical acridine antiseptic.
IOPHENOXIC ACID: An iodine-containing contrast agent for cholecystography.
NICOXAMAT: A chemical compound.
ALTRENOGEST: A synthetic progestin used in veterinary medicine.
TRIFLUPROMAZINE HYDROCHLORIDE: The salt of triflupromazine, a typical antipsychotic.
MURUCOIDIN V: A natural product.
METHYL ISOBUTYL KETONE: An organic solvent.
AZD9272: An experimental research compound from AstraZeneca.
IDEBENONE: A synthetic analog of coenzyme Q10 with antioxidant properties.
BERKELEYACETAL C: A natural product from a marine-derived fungus.
RO 40-6055: An experimental research compound from Roche.
DIHYDROERGOCRISTINE MESYLATE: The salt of an ergot alkaloid.
NAFTIDROFURYL: A peripheral vasodilator.
THEONELLASTEROL G: A natural sterol from a marine sponge.
TANSHINONE IIA SULFONATE: A water-soluble derivative of a compound from Salvia miltiorrhiza.
PERVILLEINE D: A natural tropane alkaloid.
IODOFORM: A crystalline organoiodine compound used as an antiseptic.
DOBUTAMINE HYDROCHLORIDE: The salt of dobutamine, a beta-1 adrenergic agonist.
SCLAREOL: A natural bicyclic diterpene alcohol.
TREQUINSIN: A research chemical that is a phosphodiesterase inhibitor.
QUINALDINE BLUE: A fluorescent dye.
THIOCORALINE: A natural cyclic depsipeptide with anticancer activity.
AKT INHIBITOR IV: A research chemical that inhibits the Akt kinase.
TOLYLFLUANID: A fungicide.
N- (9-FLUORENYLMETHOXYCARBONYL)-L-LEUCINE: Fmoc-Leu, a protected form of leucine used in peptide synthesis.
SHINFLAVANONE: A natural flavonoid.
BROMODIOLONE: An anticoagulant rodenticide.
5,7-DIHYDROXY-4-METHYLCOUMARIN: A coumarin derivative.
QUESTIOMYCIN B: A phenoxazinone antibiotic.
ANISOMYCIN: A pyrrolidine antibiotic that inhibits protein synthesis.
AESCULIOSIDE IIE: A natural triterpenoid saponin.
DIMETHYLADENINE: A methylated derivative of the nucleobase adenine.
HEPTACHLOR: An organochlorine insecticide, banned in many countries.
LEVISOPRENALINE: The levorotatory isomer of isoproterenol.
NITROFURAZONE: A nitrofuran antibacterial agent.
NITROBLUE TETRAZOLIUM CHLORIDE: The chloride salt of nitroblue tetrazolium, a dye for biochemical assays.
2-ACETYLAMINOFLUORENE: A carcinogenic aromatic amine used in research.
OXOTREMORINE METHIODIDE: The methiodide salt of a muscarinic acetylcholine receptor agonist.
PENTOSALEN: A furanocoumarin.
PESUDOGINSENOSIDE RP1 METHYL ESTER: A probable misspelling of pseudoginsenoside RP1 methyl ester.
FENITROTHION: An organophosphate insecticide.
CHLORPYRIFOS: An organophosphate insecticide.
CHLOROTRIPHENYLSTANNANE: An organotin compound.
DICHLOROISOPROTERENOL: A research chemical that was the first beta-blocker developed.
TOLUENE DIISOCYANATE: An organic compound used in the production of polyurethanes.
INDOCATE: An experimental research compound.
DOLASTATIN 12: A natural cytostatic peptide from a sea hare.
(S)-FELODIPINE: The S-enantiomer of felodipine, a calcium channel blocker.
PNU-99194A: A research chemical that is a D3 dopamine receptor agonist.
2-MERCAPTOPYRIMIDINE: A thionated pyrimidine.
DIMETHYLSPINGOSINE: A probable misspelling of dimethylsphingosine, a protein kinase C inhibitor.
BANOXANTRONE: An experimental topoisomerase II inhibitor.
CITRONELLOL: A natural acyclic monoterpenoid alcohol.
DIHYDREXIDINE HYDROCHLORIDE: The salt of dihydrexidine, a full efficacy D1 dopamine receptor agonist.
ACRIDONE: A heterocyclic chemical compound.
3-FORMYLINDOLE: A derivative of indole.
ALLITRIDIN: A compound derived from garlic.
DIHYDROXIDINE: A research chemical that is a full efficacy D1 dopamine receptor agonist.
LEMILDIPINE: A dihydropyridine calcium channel blocker.
THIOSALICYLIC ACID: An organosulfur compound, an analog of salicylic acid.
BISLEUCONOTHINE A: A natural product.
AESCULIOSIDE IIIC: A natural triterpenoid saponin.
BENORILATE: A codrug of paracetamol and aspirin.
4-AMINOPHENOL: An organic compound, a metabolite of paracetamol.
HYMENOIC ACID: A natural product.
OXYPHENISATIN ACETATE: The acetate ester of oxyphenisatin, a laxative.
DIENOCHLOR: An organochlorine acaricide.
GSK-625137A: An experimental research compound from GlaxoSmithKline.
TRIBROMSALAN: An antiseptic agent.
KINETIN RIBOSIDE: A derivative of the plant hormone kinetin.
MONASTROL: A research chemical that is a selective inhibitor of the Eg5 kinesin motor protein.
AVOCADYNE ACETATE: An acetylated derivative of a natural polyacetylene.
L701324: A research chemical that is a neurokinin 1 (NK1) receptor antagonist.
GALUTEOLIN: A flavone, a structural isomer of luteolin.
LICOFLAVANONE A: A natural retrochalcone from licorice root.
NS1619: A research chemical that activates large-conductance calcium-activated potassium (BK) channels.
N-DOCOSATETRA-7,10,13,16-ENOYLETHANOLAMINE: An endocannabinoid-like lipid.
DEHYDROEPIANDROSTERONE ACETATE: The acetate ester of DHEA, a steroid prohormone.
TANGERETIN: A polymethoxylated flavone found in tangerine peel.
PHYLLODULCIN: A natural dihydroisocoumarin used as a sweetener.
NAPHTHOQUINONE: A class of organic compounds structurally related to naphthalene.
GW829115X: An experimental research compound from GlaxoSmithKline.
FRAXETIN: A natural coumarin.
THIOPERAMIDE: A research chemical that is a potent histamine H3 and H4 receptor antagonist.
TETRAHYDROCURCUMIN: A major metabolite of curcumin.
THIDIAZURON: A plant growth regulator.
CHONDROITIN SULFATES: A class of sulfated glycosaminoglycans that are components of cartilage.
IL-5: Interleukin-5, a cytokine that stimulates B-cell growth and eosinophil activity.
POLY IC: Polyinosinic:polycytidylic acid, a synthetic analog of double-stranded RNA that stimulates TLR3.
FGF-6: Fibroblast growth factor 6, a protein involved in development and cell growth.
PIMONIDAZOLE: A nitroimidazole compound used as a marker for hypoxia in cells.
UREA: A nitrogen-containing organic compound, a major component of urine.
THERAPEUTIC AUTOLOGOUS DENDRITIC CELLS: A type of personalized immunotherapy using a patient's own dendritic cells.
LISOFYLLINE: A synthetic methylxanthine with anti-inflammatory properties.
NITROSOUREA COMPOUND: A class of alkylating agents used in chemotherapy.
BMS-986260: An investigational oral lysophosphatidic acid receptor 1 (LPA 1) antagonist.
GREEN TEA LEAF EXTRACT: An herbal supplement containing polyphenols such as catechins.
GUANIDINIUM CATION: The protonated form of guanidine.
NTQ1062: An experimental research compound.
BACILLUS CALMETTE-GUERIN ANTIGEN: An antigen from the attenuated BCG strain of Mycobacterium bovis.
L-744,832: A research chemical that is a farnesyltransferase inhibitor.
PRUNETIN: A natural O-methylated isoflavone.
BMS-986224: An investigational monoclonal antibody.
BUCILLAMINE: A thiol drug with immunomodulatory properties.
BCY15291: An experimental research compound.
BENAZEPRILAT: The active metabolite of the ACE inhibitor benazepril.
A1P: An experimental research compound.
CPFPX: A research chemical that is a selective A1 adenosine receptor antagonist.
MRS7469: An experimental research compound.
L-97-1: An experimental research compound.
EPLONTERSEN: An antisense oligonucleotide for hereditary transthyretin-mediated amyloidosis.
METHIONINE: An essential amino acid.
MRS1066: An experimental research compound.
4-{2-[(7-AMINO-2-FURAN-2-YL[1,2,4]TRIAZOLO[1,5-A][1,3,5]TRIAZIN-5-YL)AMINO]ETHYL}PHENOL: A selective A2A adenosine receptor antagonist.
AB-NECA: A research chemical that is a potent A1 adenosine receptor agonist.
EMTRICITABINE/TENOFOVIR/EFAVIRENZ: A combination antiretroviral drug for HIV.
VUTRISIRAN: An RNA interference (RNAi) therapeutic for hereditary transthyretin-mediated amyloidosis.
FALDAPREVIR: An experimental hepatitis C virus NS3/4A protease inhibitor.
PAMAQUINE: An 8-aminoquinoline antimalarial drug.
METABUTETHAMINE: A local anesthetic.
I-ABA: An experimental research compound.
VIC 1911: An experimental research compound.
EFATUTAZONE: An experimental PPAR gamma agonist.
ADRIXETINIB: An investigational JAK2 inhibitor.
CUSTIRSEN: An antisense oligonucleotide designed to inhibit the production of clusterin.
GASTRIN-RELEASING PEPTIDE: A neuropeptide that stimulates gastrin release and gut motility.
[D-PHE6]BOMBESIN(6-13)METHYL ESTER: A methyl ester of a bombesin analog.
DEXANABINOL: A synthetic non-psychotropic cannabinoid with neuroprotective properties.
G4460: An experimental research compound.
COMPOUND J [PMID: 21907142]: A research compound described in the specified scientific publication.
GTI-2501: An antisense oligonucleotide targeting R1, a subunit of ribonucleotide reductase.
GSI-136: An experimental research compound.
HGS-TR2J: An experimental research compound.
ICA-105665: An experimental KCNQ potassium channel opener.
T-0509: An experimental research compound.
INTERFERON BETA: A cytokine of the interferon family used to treat multiple sclerosis.
COMPOUND 6 [PMID: 34553947]: A research compound described in the specified scientific publication.
KAI-1455: An experimental research compound.
OSI-461: An experimental dual PDE4/PDE5 inhibitor.
ICI 118551: A research chemical that is a selective beta-2 adrenergic receptor antagonist.
GIRENTUXIMAB: An experimental monoclonal antibody targeting carbonic anhydrase IX.
BIC1: An experimental research compound.
CINTIRORGON: An investigational androgen receptor antagonist.
DECITABINE AND CEDAZURIDINE: A combination drug for myelodysplastic syndromes.
UMBRALISIB: A dual PI3K-delta and CK1-epsilon inhibitor for lymphoma.
M826: An experimental research compound.
Z944: An experimental T-type calcium channel blocker.
ANX-005: An investigational monoclonal antibody that targets the C1q complement protein.
TIPRELESTAT: An experimental neutrophil elastase inhibitor.
BL-1021: An experimental research compound.
OLORINAB: An investigational cannabinoid CB2 receptor agonist.
AZD1940: An experimental CXCR2 chemokine receptor antagonist.
PF-514273: An experimental research compound from Pfizer.
[125I]GASTRIN: A radiolabeled version of the hormone gastrin.
GLAXO-11P: An experimental research compound from GlaxoSmithKline.
AX-024: An experimental research compound.
CHEMERIN: A chemoattractant protein that is a ligand for the CMKLR1 receptor.
S-26D [PMID: 37883692]: A research compound described in the specified scientific publication.
[3H]RESOLVIN E1: A radiolabeled version of the lipid mediator Resolvin E1.
LANDIPIRDINE: An experimental research compound.
CDK INHIBITOR 4.35: A research chemical that inhibits cyclin-dependent kinases.
PFK-158: An experimental inhibitor of the PFKFB3 enzyme.
PHENYLTOLOXAMINE: A first-generation antihistamine with anticholinergic properties.
MORPHINE GLUCURONIDE: A major active metabolite of morphine.
MANAGLINAT DIALANETIL: A prodrug of managlinat, an experimental anti-diabetic agent.
DOXAPRAM: A respiratory stimulant.
BL-1020: An experimental antipsychotic agent.
ORGANON: An abbreviation, likely referring to a compound developed by the Organon company.
[125I]CXCL11 (HUMAN): A radiolabeled version of the human chemokine CXCL11.
ISOTHIOUREA-1A: A research chemical that is a nitric oxide synthase inhibitor.
T134: An experimental HIV fusion inhibitor.
COMPOUND 10 [PMID: 31663733]: A research compound described in the specified scientific publication.
GRC-6211: An experimental TRPV1 channel antagonist.
COMPOUND 7P [PMID: 7861416]: A research compound described in the specified scientific publication.
AZALANSTAT: An experimental inhibitor of lanosterol synthase.
COMPOUND 1 [XIAO ET AL. 2014]: A research compound described in the specified scientific publication.
PAZOPANIB HYDROCHLORIDE: The salt of pazopanib, a multi-kinase inhibitor for cancer.
BROMO-DEAZA-SAH: A research chemical that is an inhibitor of histone methyltransferases.
XMT-1001: An experimental polymer-drug conjugate of camptothecin.
15-DEOXY-&DELTA;12,14-PGJ2: An endogenous PPAR gamma agonist.
AM-461: An experimental research compound.
DARBUFELONE: An experimental dual COX/LOX inhibitor.
ATX-101: Deoxycholic acid, an injectable drug used for reducing submental fat.
UNC9975: An experimental research compound.
RAD-140: An investigational selective androgen receptor modulator (SARM).
ETHYL 3-[(E)-2-AMINO-1-CYANOETHENYL]-6,7-DICHLORO-1-METHYL-1H-INDOLE-2-CARBOXYLATE: A chemical name for a specific research compound.
FROVOCIMAB: An investigational monoclonal antibody.
IMMUCIN: A class of potent transition-state analog inhibitors of purine nucleoside phosphorylase.
AMISELIMOD: An investigational sphingosine-1-phosphate receptor 1 modulator.
TOZULERISTIDE: An investigational tumor-targeting fluorescent agent.
BELOTECAN: An experimental topoisomerase I inhibitor.
N-SULFOGLUCOSAMINE SULFOHYDROLASE RECOMBINANT: Recombinant sulfamidase, an enzyme replacement therapy for MPS IIIA.
USISTAPIDE: An investigational MTP inhibitor.
CAR T-CELLS AMG 119: An investigational CAR T-cell therapy from Amgen.
ANTI-MET/EGFR MONOCLONAL ANTIBODY LY3164530: An experimental bispecific antibody.
AFM-11: An experimental bispecific antibody targeting CD19 and CD3.
EPIREGULIN: A ligand for the epidermal growth factor receptor (EGFR).
SWE101: An experimental research compound.
17-PHENYL-&OMEGA;-TRINOR-PGE2: A synthetic prostaglandin E2 analog and EP1/EP3 receptor agonist.
IMLUNESTRANT: An investigational selective estrogen receptor degrader (SERD).
RES7011: An experimental research compound.
COMPOUND 27 [PMID: 19854648]: A research compound described in the specified scientific publication.
PRAMIRACETAM: A nootropic agent of the racetam class.
SULANEMADLIN: An investigational MDM2 inhibitor.
DRF-1042: An experimental research compound.
AUTOLOGOUS ANTI-CD19 CAR T-CELLS IM19: An investigational CAR T-cell therapy targeting CD19.
NERINETIDE: An experimental neuroprotective peptide.
ML351: A research chemical that is a potent inhibitor of the enzyme G6PD.
(+)-BUTACLAMOL: The active enantiomer of butaclamol, a research antipsychotic.
GR 218,231: A research chemical that is a vasopressin V1A receptor antagonist.
MPDT: An experimental research compound.
REC 15/3079: An experimental research compound.
TFMPP: A piperazine derivative with serotonergic activity.
NORFLUOXETINE: The major active metabolite of the antidepressant fluoxetine.
WAY-163909: An experimental 5-HT2C receptor agonist.
TIOSPIRONE: An experimental antipsychotic agent of the azapirone class.
ECF506: An experimental research compound.
PD173955: A research chemical that is an FGFR inhibitor.
RISVODETINIB: An investigational polo-like kinase 4 (PLK4) inhibitor.
KH7: A research chemical that is an inhibitor of soluble adenylyl cyclase.
IK-862: An investigational HIF-2Î± translation inhibitor.
BENZYLCYSTEINE: A derivative of the amino acid cysteine.
5-CL-5-DEOXY-(&PLUSMN;)-ENBA: A research chemical that is an A1 adenosine receptor agonist.
AS70: An experimental research compound.
WRC-0571: An experimental research compound.
LUF5981: An experimental research compound.
MRS5151: An experimental research compound.
LUF6096: An experimental research compound.
NDI-091143: An experimental research compound.
5-BUTYL-METHYL IMMIDAZOLE CARBOXYLATE 30: A chemical name for a specific research compound.
LARTESERTIB: An investigational CDK4/6 inhibitor.
GSK143: An experimental research compound from GlaxoSmithKline.
[PHE13]BOMBESIN: A modified analog of the peptide bombesin.
MK-7725: An experimental orexin-2 receptor antagonist.
BRL 37344: A research chemical that is a potent beta-3 adrenergic receptor agonist.
SOLABEGRON: An experimental beta-3 adrenergic receptor agonist.
CICLOPROLOL: A beta-blocker.
BIIL 260: An experimental LFA-1 antagonist.
BAY-299: An experimental research compound from Bayer.
BAZ2-ICR: An experimental bromodomain inhibitor.
NI-57: An experimental research compound.
COMPOUND 5A [PMID: 31287314]: A research compound described in the specified scientific publication.
GAT100: An experimental research compound.
COMPOUND C2 [PMID: 29990428]: A research compound described in the specified scientific publication.
JNJ-17156516: An experimental research compound from Johnson & Johnson.
SR144528: A research chemical that is a potent CB2 cannabinoid receptor antagonist.
HIV-TAT: A regulatory protein of the human immunodeficiency virus.
[125I]CCL2 (HUMAN): A radiolabeled version of the human chemokine CCL2 (MCP-1).
VCCL4: A viral chemokine.
CCL20-SEAP(HIS)6: A recombinant fusion protein of CCL20 and secreted alkaline phosphatase.
CCL1: A chemokine also known as I-309.
VMIP-II: A viral chemokine-like protein used in research.
ZWB67: An experimental research compound.
COMPOUND 25 [PMID: 20855207]: A research compound described in the specified scientific publication.
S-(-)CPP: The active enantiomer of CPP, an NMDA receptor antagonist.
BIIB021: An experimental Hsp90 inhibitor.
MS049: A research chemical that is an inhibitor of type I protein arginine methyltransferases.
COMPOUND 17F [PMID: 19632837]: A research compound described in the specified scientific publication.
EMACTUZUMAB: An investigational monoclonal antibody that targets the CSF1 receptor.
5&BETA;-PREGNANE-3,20-DIONE: A metabolite of progesterone.
[125I]UROCORTIN 1 (MOUSE, RAT): A radiolabeled version of the rodent urocortin 1 peptide.
K31440: An experimental research compound.
CXCL6: A chemokine also known as granulocyte chemotactic protein 2 (GCP-2).
ART812: An experimental research compound.
COMPOUND 13 [CHEN ET AL., 2016]: A research compound described in the specified scientific publication.
SGC0946: A research chemical that is a potent inhibitor of the DOT1L histone methyltransferase.
S-5751: An experimental research compound.
SB269652: An experimental research compound.
BETA-ERGOCRIPTINE: An ergot alkaloid.
GARCINOL: A natural polyisoprenylated benzophenone derivative with antioxidant properties.
PERENOSTOBART: An investigational monoclonal antibody.
EGFR/ERBB-2/ERBB-4 INHIBITOR: A class of drugs that block multiple kinases in the ErbB family.
COMPOUND 6G [PMID: 30633509]: A research compound described in the specified scientific publication.
ZK118182: An experimental research compound.
GW848687X: An experimental research compound from GlaxoSmithKline.
CR6086: An experimental research compound.
UNC0321: A research chemical that is an inhibitor of the G9a/GLP histone methyltransferases.
A-366: An experimental research compound.
INDIRUBIN DERIVATIVE E804: A synthetic derivative of the natural product indirubin.
HPG1860: An experimental research compound.
DMCM: A research chemical that is an inverse agonist at the benzodiazepine site of GABA-A receptors.
ETAZOLATE HYDROCHLORIDE: The salt of etazolate, an anxiolytic of the pyrazolopyridine class.
5-ME-IAA: A research chemical.
GALANIN(2-30) (HUMAN): A fragment of human galanin neuropeptide.
[125I][TYR26]GALANIN (HUMAN): A radiolabeled version of human galanin.
GAL-B5: An experimental research compound.
(S)-EF-1520: An experimental research compound.
GERANYLGERANYL DIPHOSPHATE: An intermediate in the biosynthesis of terpenes and sterols.
LY503430: An experimental AMPA receptor positive allosteric modulator.
CX546: An experimental AMPA receptor positive allosteric modulator.
LY404187: An experimental research compound from Eli Lilly.
ATPA: A research chemical that is a selective AMPA/kainate receptor agonist.
NCGC607: An experimental research compound.
[3H]CPP: A radiolabeled competitive NMDA receptor antagonist.
CGP37849: A research chemical that is a competitive NMDA receptor antagonist.
CU2+: The copper ion, an essential trace element.
TWS119: A research chemical that is an inhibitor of GSK-3 beta.
N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE: A chemical name for a specific research compound.
(S)-3-PHENYLLACTIC ACID: The S-enantiomer of phenyllactic acid.
COMPOUND 1QÂ  [PMID: 18029181]: A research compound described in the specified scientific publication.
3-HYDROXYOCTANOIC ACID: A medium-chain hydroxy fatty acid.
COMPOUND 2 [PMID: 15546730]: A research compound described in the specified scientific publication.
N-ETHYLHISTAMINE: A derivative of histamine.
COMPOUND 36J [PMID: 21536438]: A research compound described in the specified scientific publication.
AS1907417: An experimental research compound.
AR231453: An experimental 5-HT2C receptor agonist.
RTI-13951-33: An experimental research compound.
GSK3008348: An experimental research compound from GlaxoSmithKline.
THEAFLAVIN: A type of polyphenol found in black tea.
SAKURANETIN: A natural flavanone with phytoalexin activity.
CYCLAMATE: An artificial sweetener.
SACCHARIN: An artificial sweetener.
LACTUCOPICRIN: A bitter sesquiterpene lactone from wild lettuce.
COMPOUND 13AC [PMID: 33256400]: A research compound described in the specified scientific publication.
BIBF-1202: An experimental research compound.
LUF7244: An experimental research compound.
3-BICYCLO[2.2.1]HEPT-2-YL-BENZENE-1,2-DIOL: A chemical name for a specific research compound.
3-IODOTYROSINE: An intermediate in the synthesis of thyroid hormones.
[125I]SHU9119: A radiolabeled antagonist of melanocortin receptors.
D6808: An experimental research compound.
DIMETHYLALLYL DIPHOSPHATE: An intermediate in the mevalonate pathway.
GE-137: An experimental research compound.
VU0364770: An experimental research compound.
VU0092145: An experimental research compound.
DEXFOSFOSERINE: A nootropic agent.
AMN082: A research chemical that is a selective mGlu7 receptor agonist.
BAY-885: An experimental research compound from Bayer.
COMPOUND 36 [PMID: 32429662]: A research compound described in the specified scientific publication.
JJKK 048: An experimental research compound.
S20928: An experimental research compound.
[125I]DIV880: A radiolabeled research compound.
COMPOUND 22 [PMID: 30457869]: A research compound described in the specified scientific publication.
COMPOUND 111 [PMID: 37918435]: A research compound described in the specified scientific publication.
PHA-709829: An experimental research compound.
SCH486757: An experimental research compound.
JMV2004: An experimental research compound.
[3H]EYF: A radiolabeled peptide.
NAG 26: An experimental research compound.
5-OXO-20-HETE: An eicosanoid lipid mediator.
5-OXO-15-HETE: An eicosanoid lipid mediator.
JNJ-10397049: An experimental 5-HT2A receptor antagonist.
AMG28: An experimental research compound from Amgen.
AZ10606120: A research chemical that is a potent P2X7 receptor antagonist.
COMPOUND 16I [PMID: 31525963]: A research compound described in the specified scientific publication.
KN62: A research chemical that inhibits CaM kinase II.
REACTIVE BLUE-2: A triazine dye that acts as an antagonist at some P2Y receptors.
COMPOUND 58L [PMID: 30843696]: A research compound described in the specified scientific publication.
5BRUTP: A modified uridine nucleotide.
URIDINE-5'-DIPHOSPHATE: A nucleotide that is a precursor for UTP.
2-FUROYL-LIGRL[N[3H]PROPIONYL]-O-NH2: A radiolabeled peptide agonist of PAR2.
[3H]2-FUROYL-LIGRL-NH2: A radiolabeled peptide agonist of PAR2.
YD-3: An experimental antagonist of protease-activated receptor 2 (PAR2).
PIK-75: A research chemical that is an inhibitor of the PI3K alpha isoform.
(R)-5-DIPHOSPHOMEVALONATE: The R-enantiomer of an intermediate in the mevalonate pathway.
COMPOUND 14K [PMID: 21982499]: A research compound described in the specified scientific publication.
COMPOUND 8H [PMID: 21561767]: A research compound described in the specified scientific publication.
SBC-115,337: An experimental research compound.
ONX-0914: An experimental immunoproteasome inhibitor.
SZM679: An experimental research compound.
3-FLUORO-4-{[(2R)-2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-2-NAPHTHALENYL)ACETYL]AMINO}BENZOIC ACID: A chemical name for a specific ROR gamma-t inverse agonist.
ROCK INHIBITOR 3: A research chemical that inhibits Rho-associated kinase (ROCK).
RESENCATINIB: An investigational TRK kinase inhibitor.
GSK429286A: An experimental TRPV4 channel antagonist.
INSL5: Insulin-like peptide 5, a peptide hormone of the relaxin family.
MINIMISED RELAXIN-3 ANALOGUE 3: A synthetic, shortened analog of the peptide hormone relaxin-3.
AMISELIMOD PHOSPHATE: The phosphate salt of amiselimod, an S1P receptor modulator.
KH064: An experimental research compound.
DES-ALA1,2,5-[D-TRP8,IAMP9]SRIF: A modified analog of somatostatin.
[111IN,90Y]DOTA-OC: A radiolabeled octreotide analog for imaging and therapy.
MC2050: An experimental research compound.
RT3: An experimental research compound.
LPS: Lipopolysaccharide, a major component of the outer membrane of Gram-negative bacteria.
IFETROBAN: An experimental thromboxane A2 receptor antagonist.
[125I]BOP: A radiolabeled research compound.
KW-3635: An experimental A1 adenosine receptor antagonist.
GSK417651A: An experimental research compound from GlaxoSmithKline.
HC-070: An experimental research compound.
KB-R7943: A research chemical that inhibits the reverse mode of the Na+/Ca2+ exchanger.
SAR7334: An experimental TRPC6 channel inhibitor.
SH045: An experimental research compound.
9-PHENANTHROL: A research chemical that is an inhibitor of the TRPM4 channel.
EPIPREGNANOLONE SULPHATE: A sulfated neurosteroid.
PRU-12: An experimental research compound.
NAVOXIMOD: An investigational IDO1 inhibitor.
D(CH2)5[D-ILE2,ILE4,ALA-NH2]AVP: A synthetic vasopressin analog and V2 receptor antagonist.
COMPOUND 41 [PMID: 35436124]: A research compound described in the specified scientific publication.
OPC-21268: An experimental vasopressin V1A receptor antagonist.
TTFB: An experimental research compound.
LETETRESGENE AUTOLEUCEL: An investigational gene therapy.
FGFR4 INHIBITOR H3B-6527: An experimental inhibitor of the FGFR4 kinase.
BRD4 INHIBITOR PLX2853: An experimental inhibitor of the BRD4 protein.
HMN-214: An experimental oral taxane analog.
HJC0152: An experimental research compound.
FGFR3 INHIBITOR TYRA-300: An investigational inhibitor of the FGFR3 kinase.
LUXEPTINIB: An investigational multi-kinase inhibitor.
ONO-7475: An experimental AXL/MER kinase inhibitor.
MULTI-AGC KINASE INHIBITOR AT13148: An experimental multi-kinase inhibitor.
DEPATUXIZUMAB MAFODOTIN: An antibody-drug conjugate targeting a mutant form of EGFR.
DBPR-108: An experimental research compound.
ORSELLINIC ACID: A natural phenolic acid, a key building block in many secondary metabolites.
GUSPERIMUS TRIHYDROCHLORIDE: The salt of gusperimus, an immunosuppressive agent.
COMPOUND 21B [PMID: 12723954]: A research compound described in the specified scientific publication.
[3H]RAUWOLSCINE: A radiolabeled alpha-2 adrenergic receptor antagonist.
GYKI53655: A research chemical that is a non-competitive AMPA receptor antagonist.
IMB-808: An experimental research compound.
CONCIZUMAB: An investigational monoclonal antibody that targets tissue factor pathway inhibitor.
LUVADAXISTAT: An investigational PDE10 inhibitor.
AMYLMETACRESOL: A mild antiseptic used in throat lozenges.
MOLINATE: A thiocarbamate herbicide.
TERUTROBAN: An experimental thromboxane receptor antagonist.
TOPIROXOSTAT: A non-purine xanthine oxidase inhibitor for gout.
ML277: A research chemical that is a potent activator of the Kir2.1 potassium channel.
GEMCITABINE TRIPHOSPHATE: The active triphosphate metabolite of the chemotherapy drug gemcitabINE.
GSK3685032: An investigational androgen receptor antagonist.
IRON CARBONYL: An organoiron compound.
MOLIDUSTAT: An investigational hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor.
[125I]APELIN-13: A radiolabeled version of the apelin-13 peptide.
CINOBUFAGIN: A cardiotoxic bufadienolide steroid from toad venom.
ZARDAVERINE: A phosphodiesterase inhibitor.
PIPAMPERONE: A typical antipsychotic of the butyrophenone class.
E-6201: An experimental research compound.
IDRABIOTAPARINUX SODIUM: The salt of an ultra-long-acting Factor Xa inhibitor.
HEPALATIDE: An experimental research compound.
IRX-4204: An experimental retinoid X receptor (RXR) agonist.
CHARYBDOTOXIN-GLU32 ANALOG: A modified form of a peptide toxin that blocks potassium channels.
5-FLUOROURIDINE: A fluorinated pyrimidine analog.
MM3122: An experimental research compound.
HYPERBARIC OXYGEN: Medical use of oxygen at a level higher than atmospheric pressure.
HSP90 INHIBITOR DEBIO 0932: An experimental inhibitor of the Hsp90 heat shock protein.
GXTX-1E: A peptide toxin that inhibits mechanosensitive ion channels.
(+)-LSD: The active dextrorotatory isomer of lysergic acid diethylamide.
QUINOSOL: An antiseptic and disinfectant.
2-OLEOYL GLYCEROL: An endocannabinoid lipid.
DAMNACANTHAL: A natural anthraquinone with inhibitory effects on p56lck tyrosine kinase.
CARBINOXAMINE: A first-generation antihistamine.
OMBURTAMAB I-131: An iodine-131 radiolabeled monoclonal antibody for neuroblastoma.
SAGE-718: An investigational neuroactive steroid and NMDA receptor positive allosteric modulator.
COMPOUND 24 [PMID: 23441572]: A research compound described in the specified scientific publication.
REGLITAZAR: An experimental PPAR gamma agonist.
CYPRODINIL: An anilinopyrimidine fungicide.
AD5075: An experimental research compound.
TENAPANOR HYDROCHLORIDE: The salt of tenapanor, an inhibitor of the NHE3 sodium/hydrogen exchanger.
SET2: An experimental research compound.
INDINAVIR SULFATE: The salt of indinavir, an HIV protease inhibitor.
NB-ACETYLTRYPTAMINE: A derivative of tryptamine.
PEGAMOTECAN: A pegylated conjugate of the camptothecin derivative exatecan.
CCL8: A chemokine also known as monocyte chemoattractant protein-2 (MCP-2).
ATC0065: An experimental research compound.
BOP: An experimental research compound.
COMPOUND 15C [PMID: 21536437]: A research compound described in the specified scientific publication.
DILEVALOL HYDROCHLORIDE: The salt of dilevalol, a beta-blocker with vasodilating properties.
HYDROXYSTILBAMIDINE ISETHIONATE: The isethionate salt of a fluorescent antiprotozoal agent.
2-METHYL-5,7,8-TRIMETHOXYISOFLAVONE: A methoxylated isoflavone.
GLUTARAL: A dialdehyde used as a disinfectant and fixative.
GLPG-0974: An experimental free fatty acid receptor 2 antagonist.
TOLIMIDONE: A pyrimidinone derivative with tranquillizing properties.
BENZYL ISOTHIOCYANATE: An isothiocyanate found in plants of the mustard family.
PENCYCURON: A phenylurea fungicide.
CDC2-LIKE KINASE INHIBITOR: A class of drugs that inhibit Cdc2-like kinases (CLKs).
GSK-180736A: An experimental research compound from GlaxoSmithKline.
LACUTAMAB: An investigational monoclonal antibody targeting KIR3DL2.
MAGNESIUM SULFATE ANHYDROUS: The anhydrous salt of magnesium sulfate.
COMPOUND 31 [PMID: 31259550]: A research compound described in the specified scientific publication.
COMPOUND 4 [PMID: 27074625]: A research compound described in the specified scientific publication.
DAZOXIBEN: An experimental thromboxane synthase inhibitor.
TALAZOPARIB TOSYLATE: The salt of talazoparib, a PARP inhibitor.
NETOGLITAZONE: An experimental thiazolidinedione anti-diabetic agent.
MG-132: A research chemical that is a potent proteasome inhibitor.
INCB-38579: An experimental research compound from Incyte Corporation.
PF-06835919: An experimental research compound from Pfizer.
PERFLUNAFENE: An experimental perfluorocarbon emulsion.
GANODERIC ACID TR: A triterpenoid from the Ganoderma mushroom.
ANTI-EGFR MONOCLONAL ANTIBODY GT-MAB 5.2-GEX: An experimental glyco-engineered monoclonal antibody.
E2012: An experimental gamma-secretase modulator for Alzheimer's disease.
DIOXYBENZONE: An organic compound used in sunscreens.
HYALURONIC ACID: A naturally occurring polysaccharide found in connective tissues.
XD14: An experimental research compound.
ARGIOTOXIN: A polyamine toxin from spider venom that blocks glutamate receptors.
Z-PRO-PROLINAL: A research chemical that inhibits prolyl endopeptidase.
BPH-675: An experimental research compound.
MEBANAZINE: A monoamine oxidase inhibitor (MAOI).
COMPOUND 46C [PMID: 29350534]: A research compound described in the specified scientific publication.
RPSGL-IG: An experimental research compound.
[35S]IBUTAMOREN: A radiolabeled ghrelin receptor agonist.
GSK-2018682: An experimental research compound from GlaxoSmithKline.
SELEPRESSIN: An experimental vasopressin V1a receptor agonist.
HUMAN GIP(1-30)NH2: An amidated fragment of human gastric inhibitory polypeptide.
ACEMETACIN: A non-steroidal anti-inflammatory drug (NSAID).
[125I]GLP-1-(7-36)-AMIDE: A radiolabeled version of glucagon-like peptide-1.
PARAOXON: An organophosphate cholinesterase inhibitor, the active metabolite of parathion.
HOMIDIUM: An trypanocidal agent used in veterinary medicine.
AZD9567: An experimental non-steroidal glucocorticoid receptor modulator.
STROPHANTHIDIN: The aglycone of strophanthin, a cardiac glycoside.
FLTCHAAR: An experimental research compound.
N1-DANSYL-SPERMINE: A fluorescently labeled polyamine.
MRE-269: An experimental cannabinoid CB2 receptor agonist.
PIPLARTINE: A natural amide alkaloid with various biological activities.
ELAPEGADEMASE-LVLR: An enzyme replacement therapy for adenosine deaminase deficiency.
ML162: A research chemical that is an inhibitor of NRF2.
SB 207710: A research chemical that is a 5-HT4 receptor antagonist.
COMPOUND 25 [PMID: 32105470]: A research compound described in the specified scientific publication.
PICROTIN: A component of picrotoxin, a GABA-A receptor antagonist.
TULOBUTEROL: A long-acting beta-2 adrenergic agonist.
LY2090314: An experimental GSK-3 inhibitor.
5-(NONYLOXY)-TRYPTAMINE: A tryptamine derivative with 5-HT1D receptor agonist activity.
LDN-214117: An experimental research compound.
GNF4877: An experimental research compound.
COMPOUND 30 [PMID: 21757343]: A research compound described in the specified scientific publication.
COMPOUND 4-3 [PMID: 34027661]: A research compound described in the specified scientific publication.
DORAVIRINE: A non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV.
CINNAMIC ACID: An organic acid found in cinnamon and shea butter.
L-817,818: An experimental research compound.
(S)-CHLOROSUCCINIC ACID: The S-enantiomer of a succinic acid derivative.
FIBOFLAPON: An experimental research compound.
COMPOUND 51 [MALLINGER ET AL., 2016]: A research compound described in the specified scientific publication.
BAYU9773: An experimental neprilysin inhibitor.
LEUCETTINE L41: A research chemical that is an inhibitor of CLK/DYRK kinases.
VUF 8430: A research chemical that is a histamine H4 receptor agonist.
LYSOPHOSPHATIDYLETHANOLAMINE: A signaling lipid molecule.
PRASUGREL HYDROCHLORIDE: The salt of prasugrel, a P2Y12 receptor antagonist antiplatelet drug.
DD-03-171: An experimental research compound.
COMPOUND 1 [PMID: 21273063]: A research compound described in the specified scientific publication.
NCRW0005-F05: An experimental research compound.
NEUROKININ B: A neuropeptide of the tachykinin family.
GLYMIDINE: An oral anti-diabetic drug of the sulfonylurea class.
AR291903: An experimental research compound.
PBI-4547: An experimental research compound.
BI605906: An experimental research compound.
CCP: An experimental research compound.
INSULIN PURIFIED PORK: A regular, short-acting insulin preparation derived from pork.
INSULIN-LIKE GROWTH FACTOR 2: A protein hormone with a similar structure to insulin.
PHENYLPROPANOLAMINE HYDROCHLORIDE: The salt of phenylpropanolamine, a sympathomimetic used as a decongestant.
BEXOTEGRAST: An investigational allosteric integrin inhibitor.
HYDROCODONE BITARTRATE: The salt of hydrocodone, an opioid analgesic.
TAKINIB: An investigational kinase inhibitor.
PF-06426779: An experimental research compound from Pfizer.
EP 157: An experimental research compound.
TIGECYCLINE: A glycylcycline antibiotic.
FINAFLOXACIN: A fluoroquinolone antibiotic.
LS-104: An experimental research compound.
LY-3009120: An experimental pan-RAF kinase inhibitor.
LY-2606368: An experimental CHK1 kinase inhibitor.
PLX-7486: An experimental CSF1R kinase inhibitor.
TRICETAMIDE: An experimental sedative.
LEQ506: An experimental research compound.
SERIDOPIDINE: An experimental research compound.
GSK159802: An experimental research compound from GlaxoSmithKline.
PBF-999: An experimental research compound.
FADOLMIDINE HYDROCHLORIDE: The salt of fadolmidine, an alpha-2 adrenergic receptor agonist.
ITACITINIB: An investigational Janus kinase (JAK) inhibitor.
BECAMPANEL: An experimental AMPA receptor antagonist.
MIBAMPATOR: An experimental AMPA receptor positive allosteric modulator.
GANTENERUMAB: An investigational monoclonal antibody targeting amyloid beta.
CANTUZUMAB RAVTANSINE: An antibody-drug conjugate targeting MUC1.
IC14: An investigational monoclonal antibody targeting CD14.
FENCLOFENAC: A non-steroidal anti-inflammatory drug (NSAID).
METHAPYRILENE FUMARATE: An antihistamine of the ethylenediamine class, withdrawn due to hepatotoxicity.
VERALIPRIDE: A dopamine D2 antagonist used as an antipsychotic and antiemetic.
RG-7444: An experimental immunocytokine for cancer therapy.
90Y-CT84.66: A radioimmunoconjugate being investigated for cancer treatment.
HUMAN C1-ESTERASE INHIBITOR: A protein used to treat hereditary angioedema.
CADAZOLID: An experimental oxazolidinone antibiotic.
BELAPECTIN: A galectin-3 inhibitor being studied for liver fibrosis and cancer.
ABIVERTINIB MALEATE: An experimental tyrosine kinase inhibitor for cancer and COVID-19.
FIRIBASTAT: An experimental drug for hypertension, targeting the brain renin-angiotensin system.
AMG553: An experimental monoclonal antibody.
PF-00217830: An experimental phosphodiesterase 10A (PDE10A) inhibitor.
OBEFAZIMOD: An experimental immunomodulatory drug.
RO-7121661: An investigational oral SERD (Selective Estrogen Receptor Degrader) for breast cancer.
LORPUCITINIB: An experimental JAK1/TYK2 inhibitor for autoimmune diseases.
DAXDILIMAB: An experimental monoclonal antibody targeting ILT7 for autoimmune diseases.
AZD-9164: An experimental compound developed by AstraZeneca.
ETHACRIDINE LACTATE: An antiseptic and abortifacient compound.
VEGFA: Vascular Endothelial Growth Factor A, a protein that stimulates vasculogenesis and angiogenesis.
THUNBERGINOL B: A natural isocoumarin compound found in plants like Hydrangea.
BUFALIN: A cardiotonic steroid originally isolated from toad venom.
SPERMIDINE: A natural polyamine involved in cellular metabolism.
BENZTROPINE MESYLATE: An anticholinergic drug used to treat Parkinson's disease symptoms.
MELENGESTROL ACETATE: A synthetic progestin used in veterinary medicine.
MARGATOXIN: A peptide toxin from scorpion venom that blocks potassium channels.
DEMETHYLZEYLASTERONE: A natural triterpenoid compound.
HOMOVANILLIC ACID: A major metabolite of dopamine.
PHENYLSTIBONIC ACID: An organoantimony compound.
2-PICOLINIC ACID: A natural organic compound and an isomer of nicotinic acid.
KASANOSIN B: A natural diterpenoid compound.
SHU9119: A potent melanocortin receptor antagonist.
2,3-DIHYDROXY-6,7-DICHLOROQUINOXALINE: A competitive AMPA/kainate receptor antagonist, known as DCQX.
SAPPANONE A DIMETHYL ETHER: A synthetic derivative of a natural homoisoflavonoid.
LAVENDUSTIN C: A tyrosine kinase inhibitor derived from a microbial source.
MUNDULONE ACETATE: A natural isoflavonoid compound.
P-HYDROXYCINNAMALDEHYDE: A natural phenolic compound.
MECARBAM: An organophosphate insecticide and acaricide.
ZAPA: An abbreviation for Z-Ala-Pro-OH, a GABA-A receptor modulator.
ISOFENPHOS: An organophosphate insecticide.
OBTUSAQUINONE: A natural quinone compound.
ALLYL ISOTHIOCYANATE: The organosulfur compound that gives mustard and wasabi their pungent taste.
MAPROTILINE HYDROCHLORIDE: A tetracyclic antidepressant.
3,4-DIMETHOXYDALBERGIONE: A natural quinone compound from Dalbergia species.
HARMALOL HYDROCHLORIDE: A fluorescent alkaloid from the harmala plant family.
PENICILLIOL A: A natural polyketide compound.
NOLATREXED: An antifolate drug investigated as a cancer therapy.
CYSTAMINE: An aminothiol that can act as a radioprotective agent.
GSK-1000163A: An experimental compound from GlaxoSmithKline.
DALMELITINIB: An investigational JAK inhibitor.
CFMTI: A research compound, a selective melatonin MT2 receptor ligand.
AZD8529: An experimental GABA-B receptor positive allosteric modulator.
VU0155041: An experimental positive allosteric modulator of the M1 muscarinic acetylcholine receptor.
BERGAPTOL: A natural furanocoumarin found in citrus fruits.
DIHYDRODAPHNODORIN B: A natural flavanone compound.
ARSANILIC ACID: An organoarsenic compound used in animal feed.
COMPOUND 11 [PMID: 20638279]: A research compound described in the cited scientific literature.
EOSIN: A fluorescent reddish dye used in histology and as an antiseptic.
EDGEWORIN: A natural daphnane diterpenoid.
BENZODROCORTISONE: A synthetic glucocorticoid steroid.
XAP044: An experimental positive allosteric modulator of the GABA-B receptor.
BENOXATHIAN HYDROCHLORIDE: An experimental alpha-1 adrenergic antagonist.
HYDROXYTYROSOL: A potent antioxidant polyphenol found in olive oil.
EUPARIN: A natural benzofuran derivative.
KARANJIN: A furanoflavonoid from the karanja tree with insecticidal properties.
PROCYMIDONE: A dicarboximide fungicide.
ACLARUBICIN HYDROCHLORIDE: An anthracycline antibiotic used in chemotherapy.
ACEPROMAZINE: A phenothiazine tranquilizer and antiemetic used primarily in veterinary medicine.
MIRIPIRIUM: A disinfectant and antiseptic agent.
RHETSININE: A natural alkaloid compound.
ALDISIN: A synthetic compound with anti-inflammatory properties.
PUTRESCINE DIHYDROCHLORIDE: The salt form of putrescine, a foul-smelling polyamine.
MECETRONIUM: A quaternary ammonium compound used as an antiseptic.
COMPOUND 12 [PMID: 27448772]: An experimental chemical described in the referenced scientific paper.
GENIPIN: A natural crosslinking agent derived from the gardenia fruit.
MAHANIMBINE: A carbazole alkaloid from the curry tree with various biological activities.
THIAMINE: Vitamin B1, an essential nutrient.
ANDROSTENEDIOL: A steroid hormone that is a metabolite of DHEA.
DEOXYSAPPANONE B TRIMETHYL ETHER: A synthetic derivative of a natural homoisoflavonoid.
TRIPHENYL PHOSPHATE: An organophosphate compound used as a plasticizer and flame retardant.
DEXAMETHASONE DIPROPIONATE: A synthetic corticosteroid with anti-inflammatory properties.
CROCIN: A natural carotenoid chemical that is a primary component of saffron.
CHLORHEXIDINE DIACETATE: An antiseptic and disinfectant salt of chlorhexidine.
TRACHEAL CYTOTOXIN: A toxic fragment of peptidoglycan produced by Bordetella pertussis.
CARBOXYMETHYL-TRIMETHYL-ARSONIUM: An organoarsenic compound.
FOSPIRATE: An organophosphate insecticide.
CHOLESTAN-3BETA,5ALPHA,6BETA-TRIOL: A sterol that is an oxidation product of cholesterol.
LORECLEZOLE: An anticonvulsant drug that acts as a GABA-A receptor modulator.
FOLATE ANTAGONIST: A class of drugs that interfere with the action of folic acid.
ST 638: A selective inhibitor of the tyrosine kinase associated with the T-cell antigen receptor.
LUTEIN: A carotenoid found in green leafy vegetables, important for eye health.
CARDIOPROTECTIVE AGENT: A substance that protects the heart from damage.
COMPOUND 8 [PMID: 24044867]: A research compound described in the specified scientific publication.
PROPYLENE GLYCOL: A synthetic organic compound used as a solvent and humectant.
PROTEIN SYNTHESIS INHIBITOR: A substance that stops or slows cell growth by disrupting protein production.
DIDEMNIN B: A cyclic depsipeptide with antiviral and antitumor activities.
MONOCLONAL ANTIBODY R24: An antibody targeting ganglioside GD3, studied for melanoma treatment.
FARNESYLTRANSFERASE/GERANYLGERANYLTRANSFERASE INHIBITOR L-778,123: An experimental dual enzyme inhibitor studied for cancer.
RECOMBINANT C5A: A genetically engineered version of the C5a anaphylatoxin protein.
MONOCLONAL ANTIBODY 11D10: A research antibody.
MJN110: An experimental compound.
DIETHYLNORSPERMINE: A synthetic polyamine analogue with antitumor activity.
ME36: An experimental compound.
COMPOUND 30 [PMID: 15953724]: A research compound described in the referenced scientific paper.
TERODILINE: A calcium channel blocker and anticholinergic drug.
BRUCINE N-OXIDE: A derivative of the toxic alkaloid brucine.
DEXETIMIDE: An anticholinergic drug.
DASABUVIR: A direct-acting antiviral drug used to treat Hepatitis C.
DUBORIMYCIN: An anthracycline antibiotic, also known as pyrromycin.
ALOSETRON: A 5-HT3 antagonist for severe diarrhea-predominant irritable bowel syndrome (IBS-D).
[125I]SD6: A radiolabeled peptide ligand for somatostatin receptors.
RALOXIFEN: A selective estrogen receptor modulator (SERM) used for osteoporosis.
NALORPHINE: An opioid receptor antagonist used to reverse opioid overdose.
[LEU]ENKEPHALIN: An endogenous opioid peptide neurotransmitter.
MB07811: An experimental research chemical.
COMPOUND 5 [STECULA ET AL., 2020]: A research compound described in the cited 2020 publication.
PALTIMATRECTINIB: An experimental BCR-ABL tyrosine kinase inhibitor.
MODIFIED VACCINIA ANKARA-BAVARIAN NORDIC: A replication-deficient viral vector used in vaccines.
ZZL-7: An experimental compound that acts as a dual inhibitor of ROCK and NOX enzymes.
AGATOLIMOD SODIUM: An experimental Toll-like receptor 9 (TLR9) agonist for cancer immunotherapy.
3-BROMO-7NI: A selective inhibitor of neuronal nitric oxide synthase (nNOS).
STX107: An experimental antisense oligonucleotide for treating genetic diseases.
TAFA-93: An experimental peptide compound.
CZS-241: An experimental compound.
OBINEPITIDE: An experimental peptide dual agonist for Y2 and Y4 receptors.
MUSCARINE: A natural alkaloid that acts as a muscarinic acetylcholine receptor agonist.
HTERT VACCINE V934/V935: An experimental cancer vaccine targeting the hTERT antigen.
CITATUZUMAB BOGATOX: An antibody-drug conjugate targeting the EpCAM antigen for cancer therapy.
&ALPHA;-CONOTOXIN RGIA: A peptide toxin from cone snails that blocks nicotinic acetylcholine receptors.
TC-2559: A selective agonist for the alpha4beta2 nicotinic acetylcholine receptor.
&ALPHA;-CONOTOXIN TXIA: A peptide toxin from cone snails that blocks nicotinic acetylcholine receptors.
METOCURINE: A non-depolarizing neuromuscular blocking agent.
PNU-282987: A selective agonist for the alpha7 nicotinic acetylcholine receptor.
&ALPHA;-CONOTOXIN MII: A peptide toxin from cone snails that potently blocks nicotinic acetylcholine receptors.
[3H]LEU-N/OFQ: A radiolabeled nociceptin/orphanin FQ peptide derivative.
FLUDROCORTISONE: A synthetic corticosteroid with mineralocorticoid activity.
NEUROPEPTIDE FF: An endogenous opioid-modulating neuropeptide.
[3H]N/OFQ: Tritiated nociceptin/orphanin FQ, used as a radioligand in research.
[125I][TYR11]DES-BR-NPB-23: A radiolabeled ligand for neuropeptide B/W receptors.
[125I]NPFF: A radiolabeled version of neuropeptide FF for receptor binding studies.
NCGC 84: An experimental positive allosteric modulator of the D1 dopamine receptor.
JMV458: A research peptide, an antagonist for the neurotensin receptor.
KB-004: An experimental monoclonal antibody targeting EphA3 for cancer treatment.
ANTI-MUC16/MMAE ANTIBODY-DRUG CONJUGATE DMUC4064A: An experimental antibody-drug conjugate for cancers expressing MUC16.
EMERFETAMAB: An investigational monoclonal antibody targeting the basophil surface antigen CD203c.
AMREDOBRESIB: An experimental ALK2 kinase inhibitor.
COMPOUND 11 [PMID: 15261275]: A research compound described in the referenced scientific publication.
HTL6641: An experimental adenosine A1 receptor antagonist.
BGP-15: An experimental PARP inhibitor with insulin-sensitizing properties.
JH112: An experimental research compound.
DPOC-4088: An experimental research compound.
DANAVOREXTON: An experimental orexin-2 receptor agonist for treating narcolepsy.
IL-94: An experimental compound.
5-BDBD: An experimental positive allosteric modulator of the P2X4 receptor.
GLISOXEPIDE: An oral anti-diabetic drug of the sulfonylurea class.
TERTOMOTIDE: A cancer vaccine consisting of a peptide from the hTERT protein.
DOVITINIB LACTATE: An oral tyrosine kinase inhibitor that targets VEGFR, PDGFR, and FGFR.
MLN-2704: An antibody-drug conjugate targeting PSMA for prostate cancer therapy.
ICARIIN: A flavonoid glycoside, the main active component of Horny Goat Weed.
RECOMBINANT MODIFIED VACCINIA ANKARA-5T4 VACCINE: An experimental cancer vaccine targeting the 5T4 oncofetal antigen.
EMEPEPIMUT-S: A synthetic peptide vaccine for HER2-positive breast cancer.
VADASTUXIMAB TALIRINE: An antibody-drug conjugate targeting CD33 for acute myeloid leukemia.
SOLANEZUMAB: An experimental monoclonal antibody for Alzheimer's disease targeting amyloid-beta.
DASOTRALINE: An experimental dopamine and norepinephrine reuptake inhibitor.
BRL35135: A research compound that acts as a beta-3 adrenergic receptor agonist.
AUTOLOGOUS ANTI-BCMA-CAR-4-1BB-CD3ZETA-EXPRESSING MEMORY T-LYMPHOCYTES BB21217: A CAR-T cell therapy targeting BCMA for multiple myeloma.
ONAPRISTONE: A progesterone receptor antagonist investigated for cancer treatment.
BMS-394136: An experimental research compound.
CIPATINIB: An experimental tyrosine kinase inhibitor.
ALMITRINE: A respiratory stimulant that acts on peripheral chemoreceptors.
CERIVASTATIN: A statin drug, withdrawn from the market due to rhabdomyolysis risk.
FENDRIX: A vaccine for hepatitis B.
TOCOTRIENOLS: A group of chemicals belonging to the vitamin E family.
PEG-CONJUGATED TLR7/8 AGONIST NKTR-262: An experimental immunotherapy agent.
MYCOBACTERIUM TUBERCULOSIS ARABINOMANNAN Z-100: An immunomodulator used as an adjunct in cancer therapy.
TAK-593: An experimental antibody-drug conjugate targeting guanylyl cyclase C.
[3H]GR 113808: A radiolabeled selective 5-HT4 receptor antagonist.
ICI 169369: A selective 5-HT2A receptor antagonist.
[3H]5-CT: Tritiated 5-carboxamidotryptamine, a radioligand for serotonin receptors.
[14C]METHYLAMINE: Radiocarbon-labeled methylamine used in metabolic studies.
JNJ-63576253: An experimental dual P2X7 receptor and NLRP3 inflammasome antagonist.
APELIN RECEPTOR EARLY ENDOGENOUS LIGAND: An endogenous peptide ligand for the apelin receptor, also known as Elabela.
PSB-10: A selective adenosine A3 receptor antagonist.
LY303336: A research chemical, a non-peptidic NK1 receptor antagonist.
EXP3174: The active metabolite of the angiotensin II receptor blocker losartan.
[LEU8]-PHYLLOLITORIN: A synthetic analogue of the bombesin-like peptide phyllolitorin.
ZANZALINTINIB: An experimental multikinase inhibitor targeting TAM kinases and VEGFR.
APRIL: A Proliferation-Inducing Ligand, a cytokine in the tumor necrosis factor (TNF) superfamily.
COMPOUND 1 [PMID: 25719566]: A research chemical described in the cited scientific article.
A804598: A selective antagonist for the TRPA1 ion channel.
LP99: An experimental selective serotonin 5-HT7 receptor agonist.
BIIB068: An experimental monoclonal antibody that acts as an antagonist of the BTLA receptor.
MRS2211: A selective antagonist for the P2Y13 receptor.
DBRD9: An experimental compound.
COMPOUND 25 [PMID: 31260299]: A research compound described in the specified scientific literature.
SOFNOBRUTINIB: An investigational Bruton's tyrosine kinase (BTK) inhibitor.
R-954: A research chemical, a selective antagonist for the human P2Y1 receptor.
NG29: An experimental positive allosteric modulator of the CB1 cannabinoid receptor.
&ALPHA;.&BETA;-METHYLENE-2-THIO-UDP: A chemically modified uridine diphosphate molecule.
B-9430: An experimental compound.
ANI9: An experimental compound.
COMPOUND 27 [PMID: 18337095]: A research chemical described in the referenced publication.
PETCM: An antagonist of the formyl peptide receptor 2 (FPR2).
CV-3988: A synthetic antagonist of platelet-activating factor (PAF).
CCL26: A chemokine, also known as Eotaxin-3, that attracts eosinophils.
GW766994: An experimental tryptase inhibitor.
COMPOUND 39 [PMID: 31742400]: A research compound described in the specified scientific paper.
TL12-186: An experimental PROTAC that degrades BTK protein.
AZD4619: An experimental cell cycle inhibitor targeting polo-like kinase 1 (PLK1).
SULFOPIN: A research chemical.
CXCL12H25R (MONOMER): A monomeric form of a variant of the chemokine CXCL12.
AZD5069: A selective antagonist for the CXCR2 chemokine receptor.
[125I]CXCL10 (HUMAN): Radioiodinated human CXCL10 chemokine for receptor binding studies.
PI-3065: An experimental selective inhibitor of the p110-delta isoform of PI3K.
6-BROMOINDIRUBIN-3'-OXIME: A synthetic indirubin derivative that acts as a CDK inhibitor.
CDK12 INHIBITOR 2: A research chemical designed to inhibit Cyclin-Dependent Kinase 12.
COMPOUND 51 [CROSIGNANI ET AL., 2011]: A research compound described in the cited 2011 publication.
COMPOUND 13E [PMID: 31811124]: A research compound described in the specified scientific literature.
PN6047: An experimental kappa-opioid receptor agonist.
OICR-8268: An experimental research chemical.
(-)-CYCLAZOCINE: A benzomorphan opioid that acts as a mixed agonist-antagonist.
COMPOUND 16 [PMID: 31498617]: A research compound detailed in the referenced scientific publication.
QUADAZOCINE: A long-acting opioid antagonist.
KU-0060648: An experimental dual inhibitor of mTORC1 and mTORC2.
PT2385: An experimental inhibitor of HIF-2alpha for treating renal cell carcinoma.
COMPOUND 10L [PMID: 24556381]: A research compound described in the specified scientific paper.
AMIVANTAMAB: A bispecific antibody targeting EGFR and MET for non-small cell lung cancer.
TUG-905: A research chemical, a GPR120/FFA4 receptor agonist.
COMPOUND B [PMID:18477808]: A research chemical described in the cited publication.
COMPOUND 1L [PMID: 16644217]: A research compound from the specified scientific literature.
AMG-837: An experimental GPR40 (FFA1) receptor agonist for type 2 diabetes.
FGF-19: Fibroblast Growth Factor 19, a hormone involved in bile acid regulation.
[3H]LXA4: Tritiated Lipoxin A4, a radioligand used in research on lipid mediators.
CGEN-855A: An experimental peptide agonist for the Mas-related G protein-coupled receptor X1.
ISOPROPYLUREIDO-FLFLF: A synthetic peptide antagonist of the formyl peptide receptor.
FMET-MET-TYR-ALA-LEU-PHE: A synthetic peptide.
HUMANIN: An endogenous micro-peptide with neuroprotective and cytoprotective effects.
HP(2-20): A peptide fragment from Helicobacter pylori with antibacterial activity.
FZM1.8: An experimental research chemical.
GAL-B2: A synthetic analogue of the neuropeptide galanin.
[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID): A complex bisphosphonate compound.
NNC 92-1687: An experimental research chemical.
CLOBETASOL PROPIONATE: A very potent topical corticosteroid.
LY339434: An experimental selective dopamine D1 receptor agonist.
[3H]NFPS: A radiolabeled selective antagonist for the nociceptin/orphanin FQ (NOP) receptor.
IN-3: An experimental compound.
HS-142-1: A non-peptide antagonist of natriuretic peptide receptors.
COMPOUND 42 [PMID: 22420767]: A research chemical described in the specified scientific publication.
BML-281: A research chemical that acts as an inhibitor of histone deacetylase 6 (HDAC6).
COMPOUND 20 [PMID: 22136433]: A research compound from the cited scientific literature.
(S)-DIMETINDENE: The active enantiomer of dimetindene, an antihistamine and anticholinergic.
IMMETHRIDINE: A potent and selective histamine H3 receptor agonist.
YODA1: A selective agonist of the Piezo1 mechanosensitive ion channel.
ABT-239: An experimental histamine H3 receptor antagonist.
GT2394: An experimental histamine H3 receptor inverse agonist.
COMPOUND 3A [PMID: 18606542]: A research compound described in the specified scientific publication.
[123I]IODOPROXYFAN: A radioiodinated ligand for the histamine H3 receptor used in SPECT imaging.
COMPOUND 9A [PATIL ET AL., 1989]: A research compound described in the cited 1989 publication.
PROKINETICIN-2: An endogenous peptide that regulates circadian rhythms and other physiological processes.
CHGB (511-532): A peptide fragment of Chromogranin B.
AG 1024: An experimental inhibitor of the IGF-1 receptor tyrosine kinase.
DKFZ?51: An experimental research chemical.
DYNORPHIN-(1-11): A peptide fragment of the endogenous opioid dynorphin A.
BI-2493: An experimental research chemical.
ICA-105574: An experimental opener of KCNQ potassium channels.
(3R,4S)-293B: A stereoisomer of a research compound that modulates potassium channels.
IKS124: An experimental compound.
ML213: A selective opener of the KCNQ2/KCNQ4 potassium channels.
EB-42486: An experimental research chemical.
HCG: Human Chorionic Gonadotropin, a hormone produced during pregnancy.
LIMKI3: An experimental inhibitor of LIM domain kinase (LIMK).
RJW100: An experimental compound.
24(S), 25-EPOXYCHOLESTEROL: An endogenous oxysterol that acts as a ligand for liver X receptors (LXR).
UCM-05194: An experimental compound.
VPC32183: An experimental antagonist for the lysophosphatidic acid (LPA) receptor.
GSK-LSD1: An experimental inhibitor of the enzyme Lysine-Specific Demethylase 1 (LSD1).
P-GUANIDINOBENZOYL-MCH-(7-17): A synthetic peptide derivative.
TETRALIN_UREA ANALOGUE (7O): A specific research chemical from a series of tetralin urea analogues.
A-794282: An experimental research chemical.
LY456236: An experimental positive allosteric modulator of the AMPA receptor.
LY456066: An experimental compound.
(S)-4C3HPG: A selective agonist for the group II metabotropic glutamate receptors.
(R,S)-4-PPG: A research chemical used in glutamate receptor studies.
JNK INHIBITOR IX: A specific research chemical that inhibits c-Jun N-terminal kinases (JNK).
COMPOUND 4 [PMID: 18163548]: A research compound described in the cited scientific publication.
PF-06767832: An experimental research chemical from Pfizer.
T?95: An experimental research chemical.
PCS1055: An experimental adenosine A2B receptor antagonist.
PDGF RECEPTOR TYROSINE KINASE INHIBITOR IV: A research chemical that inhibits platelet-derived growth factor receptor.
ZYKLOPHIN: A peptide-based kappa-opioid receptor antagonist with peripheral restriction.
GW853606: An experimental research chemical.
ACONITINE: A highly toxic neurotoxin alkaloid derived from Aconitum plants.
DS-1971A: An experimental inhibitor of sirtuin-1 (SIRT1).
BEFETUPITANT: An experimental NK1 receptor antagonist.
YM44778: An experimental antagonist for the neurotensin receptor 1 (NTS1).
EMLENOFLAST: An experimental inhibitor of phosphodiesterase-4 (PDE4).
CCT129957: An experimental research chemical.
SSR 146977: A selective antagonist for the neurotensin NTS1 receptor.
ML130: A selective antagonist for the orphan G-protein coupled receptor GPR35.
OMAVELOXOLONE: A drug for Friedreich's ataxia that activates the Nrf2 pathway.
CRAC CHANNEL INHIBITOR 5B [PMID: 26256403]: A research chemical that blocks CRAC channels.
[THR4,GLY7]OT: An analogue of oxytocin.
L023103: An experimental research chemical.
[MPA1,D-TYR(ET)2,D-TIC7,D-TIC9]OT: A highly selective oxytocin receptor antagonist.
4-THIO-UTP: A uridine triphosphate analogue used in molecular biology.
MRS2927: An experimental research chemical.
2-AMINO-URIDINE-5'-MONOPHOSPHATE: A modified nucleotide monophosphate.
TIM-38: An experimental compound.
CMP5 [PMID: 25742700]: A research compound described in the specified scientific publication.
DRF 2519: An experimental compound.
ZETOMIPZOMIB: An experimental immunoproteasome inhibitor.
SB-219994: A research chemical, a competitive antagonist at the human P2X7 receptor.
AD-5061: An experimental compound.
AMG319: An experimental selective inhibitor of phosphoinositide 3-kinase delta (PI3KÎ´).
PI 3-KG INHIBITOR II: A research chemical that inhibits Class I phosphoinositide 3-kinases.
COMPOUND 20F [PMID: 28520415]: A research chemical described in the specified scientific literature.
AZD8154: An experimental dual inhibitor of PI3K beta and delta isoforms.
MK-8189: An experimental phosphodiesterase 10 (PDE10) inhibitor.
ORG2058: A synthetic progestin used in research.
PROMEGESTONE: A synthetic progestin hormone.
S 17092: An experimental selective imidazoline I2 receptor ligand.
[3H]PEMETREXED: Tritiated pemetrexed, a radiolabeled antifolate chemotherapy drug.
INDOLE-3-PROPIONIC ACID: A natural compound from gut microbiota with neuroprotective properties.
[ILE5,TRP23]PTHRP-(1-36) (HUMAN): A synthetic analogue of human parathyroid hormone-related protein (PTHrP).
[ILE5,TRP23,TYR36]PTHRP-(1-36)-NH2 (HUMAN): A synthetic analogue of human parathyroid hormone-related protein (PTHrP).
[D-TRP12]PTH-(7-34) (BOVINE): A synthetic antagonist of the parathyroid hormone receptor.
[TRP23]PTHRP-(1-36) (HUMAN): A synthetic analogue of human parathyroid hormone-related protein (PTHrP).
COMPOUND 25E [PMID: 25875054]: A research chemical described in the cited scientific article.
GSK963: An experimental TRPV4 channel antagonist.
COMPOUND III [PMID: 29351497]: A research compound from the specified scientific publication.
B3C: A research chemical that inhibits the human SGLT1 transporter.
REMOGLIFLOZIN: An SGLT2 inhibitor drug used to treat type 2 diabetes.
TAS05567: An experimental research compound.
SYK INHIBITOR: A drug that blocks the action of spleen tyrosine kinase (Syk).
L-363,377: A research chemical, a somatostatin receptor agonist.
CGP 23996: An experimental GABA-B receptor antagonist.
COMPOUND 31 [PMID: 29968758]: A research compound described in the specified scientific literature.
COMPOUND II [PMID: 21329883]: A research chemical described in the referenced scientific paper.
BAY-985: An experimental selective MTH1 inhibitor.
POLY(I:C): A synthetic dsRNA that acts as a TLR3 agonist to mimic viral infections.
CU-CPT8M: An experimental research compound.
GDC-0334: An experimental research chemical from Genentech.
APV206690A: An experimental compound.
ML-SA5: A synthetic agonist of the TRPML cation channels.
[3H]VESAMICOL: A radiolabeled compound that inhibits the vesicular acetylcholine transporter.
3-KETO-LITHOCHOLIC ACID: A metabolite of lithocholic acid, a secondary bile acid.
D(CH2)5[TYR(ET)2,VAL4,DES-GLY9]AVP: A synthetic vasopressin V1a receptor antagonist.
TOLINAPANT: An experimental IAP (inhibitor of apoptosis protein) antagonist for cancer therapy.
NPY-(20-36) (PIG): A C-terminal fragment of porcine Neuropeptide Y.
NEUROPEPTIDE Y-(3-36): A metabolite of Neuropeptide Y that binds to Y2 and Y5 receptors.
ANTI-CTLA-4 MONOCLONAL ANTIBODY: A class of immunotherapy drugs that block the CTLA-4 checkpoint.
BRAF INHIBITOR: A targeted cancer therapy drug that blocks the BRAF protein kinase.
ANTI-PD-1 MONOCLONAL ANTIBODY MEDI0680: An experimental checkpoint inhibitor antibody targeting the PD-1 receptor.
MTOR INHIBITOR: A class of drugs that inhibit the mechanistic target of rapamycin (mTOR).
NAQUOTINIB: An investigational third-generation EGFR tyrosine kinase inhibitor.
MEK INHIBITOR IMM-1-104: An experimental drug that inhibits MEK in the MAPK/ERK pathway.
BAY1217389: An experimental dual inhibitor of TORC1/2 and PI3K.
FGFR/CSF-1R INHIBITOR 3D185: A research compound that inhibits both FGFR and CSF-1R kinases.
RIBOCICLIB SUCCINATE: A CDK4/6 inhibitor drug used to treat breast cancer.
FOSFOSAL: An analgesic, antipyretic, and anti-inflammatory drug.
COMPOUND T.14: A research chemical.
FLOPROPIONE: An antispasmodic drug.
MAGNOLOL: A bioactive lignan found in the bark of the Houpu magnolia tree.
AFLOQUALONE: A quinazolinone derivative with muscle relaxant properties.
ZANOTERONE: A nonsteroidal antiandrogen.
CSC: An abbreviation for ciglitazone, a thiazolidinedione antidiabetic drug.
V3 PEPTIDE: A peptide from the third variable loop (V3) of the HIV envelope protein.
MMP13 TRACER [18F]5J: A radiolabeled tracer for PET imaging of matrix metalloproteinase 13.
PDE4 INHIBITOR 16: A specific research chemical that inhibits phosphodiesterase 4.
HYDROXYAMINE: An inorganic compound, likely a misspelling of hydroxylamine (NH2OH).
RET INHIBITOR FHND5071: An experimental compound designed to inhibit the RET proto-oncogene.
SCY-635: An experimental cyclophilin inhibitor with anti-HCV activity.
OLESOXIME: An experimental neuroprotective agent that binds to mitochondrial proteins.
MRS2500: A potent and selective P2Y12 receptor antagonist.
CID16197121: A research chemical, identified by its PubChem CID.
SL-176: An experimental research chemical.
OBOVATAL: A natural lignan compound with various biological activities.
BUTORPHANOL TARTRATE: An opioid analgesic with mixed agonist-antagonist activity.
ARBACLOFEN PLACARBIL: A prodrug of arbaclofen, a GABA-B receptor agonist.
UDP-GLUCOSE: Uridine diphosphate glucose, a key intermediate in carbohydrate metabolism.
AZD3229: An experimental Aurora B kinase inhibitor.
NECROSTATIN-1S: A specific and potent inhibitor of RIPK1 kinase.
RINDOPEPIMUT: An experimental peptide vaccine for glioblastoma targeting EGFRvIII.
METHOPRENE ACID: A metabolite of methoprene, an insect growth regulator.
COMPOUND 29 [MOSLIN ET AL., 2017]: A research compound described in the cited 2017 publication.
MM 11253: An experimental compound.
DIMETACRINE: A tricyclic antidepressant.
CHOLESTYRAMINE RESIN: A bile acid sequestrant used to lower cholesterol.
AG-24322: An experimental research chemical.
CAY10583: A research chemical that acts as a prostanoid EP4 receptor antagonist.
D[CHA4]AVP: A synthetic analogue of arginine vasopressin.
COMPOUND 8 [PMID: 25898023]: A research compound described in the specified scientific publication.
PEGENZILEUKIN: An experimental long-acting form of interleukin-2 (IL-2).
COMPOUND 17B [PMID: 35286086]: A research compound detailed in the cited 2022 publication.
ELEDOISIN: A peptide from the tachykinin family, originally from octopus salivary glands.
COMPOUND 9 [PMID: 26006010]: A research chemical described in the specified scientific paper.
AK-2292: An experimental compound.
RIVOGLITAZONE: A thiazolidinedione drug for type 2 diabetes.
ADOPRAZINE: An experimental drug with mixed 5-HT1A agonist and D2 antagonist properties.
IFABOTUZUMAB: An experimental monoclonal antibody targeting the tumor antigen G250/MN/CAIX.
PMBA: A research chemical, p-methoxy-N-benzyl-amphetamine.
ABT-299: An experimental PARP inhibitor.
2-CL-ADP(&ALPHA;-BH3): A chemically modified analogue of adenosine diphosphate (ADP).
HTERT-LAMP MRNA-LOADED AUTOLOGOUS DENDRITIC CELL VACCINE GRNVAC1: An experimental personalized cancer vaccine.
MGD-010: An experimental bispecific antibody (DART) targeting CD32B and CD79B.
COMPOUND 13 [PMID: 15925511]: A research compound described in the referenced publication.
BROMODIPHENHYDRAMINE HYDROCHLORIDE: An antihistamine with anticholinergic properties.
MONOMETHYL AURISTATIN E: A potent antimitotic agent used as a payload in antibody-drug conjugates.
[125I]CCL17 (HUMAN): Radioiodinated human CCL17 chemokine for receptor binding studies.
ANALOG 31 [PMID:18543899]: A specific research compound described in the cited scientific paper.
CCK-58: A full-length cholecystokinin peptide containing 58 amino acids.
BAY27-9955: An experimental non-steroidal mineralocorticoid receptor antagonist.
FRANGULIN B: A natural anthraquinone glycoside.
ACQ090: An experimental compound.
SAMURACICLIB: An experimental selective inhibitor of cyclin-dependent kinase 7 (CDK7).
&ALPHA;-NETA: An alpha-naphthyl analogue of estetrol, an estrogen receptor ligand.
CYT007-TNFQB: An experimental therapeutic vaccine targeting tumor necrosis factor (TNF).
DNMT1 MIXED-BACKBONE ANTISENSE OLIGONUCLEOTIDE MG 98: An experimental antisense drug targeting DNA methyltransferase 1.
NP-1815-PX: An experimental compound.
RECOMBINANT OX40 LIGAND: A genetically engineered protein that activates the OX40 receptor on T-cells.
SELICRELUMAB: An experimental monoclonal antibody that acts as a CD40 agonist.
ATRACTYLENOLIDE I: A natural sesquiterpene lactone found in Atractylodes rhizomes.
SAR405: An experimental inhibitor of the VPS34 lipid kinase.
SIBEPRENLIMAB: An experimental monoclonal antibody targeting the cytokine APRIL.
SANGIVAMYCIN: A pyrrolopyrimidine antibiotic that inhibits protein kinase C.
TIK-301: An experimental cell therapy product.
5-OXO-12-HETE: A metabolite of arachidonic acid.
COMPOUND 10B [PMID: 26222319]: A research chemical described in the cited scientific publication.
SAPPANONE A TRIMETHYL ETHER: A synthetic derivative of a natural homoisoflavonoid.
TAG-72 ANTIGEN: Tumor-associated glycoprotein 72, a biomarker for certain cancers.
COMPOUND 1 [PMID: 22465637]: A research compound described in the specified scientific paper.
GGTI-2418: An experimental geranylgeranyltransferase I (GGTase-I) inhibitor.
FRAX597: An experimental inhibitor of Group I p21-activated kinases (PAK).
D(CH2)5[D-ILE2,ILE4]AVP: A synthetic vasopressin V2 receptor antagonist.
L659989: A research chemical, a selective antagonist of the tachykinin NK2 receptor.
LYNGBYABELLIN A: A cyclic depsipeptide from cyanobacteria with cytotoxic activity.
COMPOUND 40 [PMID: 33470814]: A research chemical described in the cited 2021 publication.
ISOKOBUSONE: A natural diterpenoid compound.
DIABZI-4: An experimental research chemical.
CUMENE HYDROPEROXIDE: An organic peroxide used in chemical synthesis.
AGN 191976: An experimental inverse agonist for the retinoic acid receptor.
PYRIDINE: A basic heterocyclic organic compound.
COMPOUND 5 [PMID: 21741839]: A research compound described in the specified scientific literature.
TD-2749: An experimental research chemical.
RS 67333: A partial agonist of the 5-HT4 receptor.
SRC KINASE INHIBITOR I: A research chemical that inhibits Src family kinases.
SB-269970: A selective antagonist/inverse agonist of the 5-HT7 serotonin receptor.
LY2109761: An experimental dual inhibitor of TGF-beta receptor kinases.
OAADPR: O-acetyl-ADP-ribose, a cellular signaling molecule.
MENERBA: A brand name for a medicinal product.
CIMIFUGIN: A chromone derivative isolated from the roots of Saposhnikovia divaricata.
I-BOC-MET-LEU-PHE: A protected form of the fMLP chemotactic peptide.
PF-03758309: An experimental inhibitor of p21-activated kinase 4 (PAK4).
SOR-C13: An experimental peptide drug targeting the TRPV6 calcium channel for cancer therapy.
ALOBRESIB: An experimental BET bromodomain inhibitor.
GW0072: A selective agonist for the peroxisome proliferator-activated receptor gamma (PPAR-gamma).
EN67: An experimental research chemical.
KBP5209: An experimental research chemical.
EN450: An experimental research chemical.
SOTICLESTAT: An experimental inhibitor of the enzyme cholesterol 24-hydroxylase (CYP46A1).
GSK-249320: An experimental research chemical from GlaxoSmithKline.
JNJ-27141491: An experimental research chemical from Johnson & Johnson.
BI-1950: An experimental research chemical from Boehringer Ingelheim.
VECURONIUM BROMIDE: A non-depolarizing neuromuscular blocking agent used in anesthesia.
GALR3ANT: A peptide antagonist for the galanin receptor type 3.
DVDAVP: A synthetic analogue of the hormone vasopressin.
PROKINETICIN-2&BETA;: An isoform of the prokineticin-2 peptide.
[PHAA1,D-TYR(ME)2,ARG6,TYR-NH29]AVP: A synthetic analogue of arginine vasopressin.
[125I][TYR3,THR8]OCTREOTIDE: A radioiodinated analogue of somatostatin used in medical imaging.
FORSYTHOSIDE B: A natural phenylethanoid glycoside found in Forsythia plants.
DICHLOFLUANID: A broad-spectrum fungicide.
[TBAA1,D-TYR(ET)2,VAL4,LYS6,ARG-NH28,DES-GLY9]AVP: A synthetic analogue of arginine vasopressin.
AR-20.5: An experimental research chemical.
OCLACITINIB: A Janus kinase (JAK) inhibitor used in veterinary medicine.
FENBENDAZOLE: A broad-spectrum benzimidazole anthelmintic for gastrointestinal parasites.
XMD17-109: An experimental inhibitor of MAP4K4.
SYK INHIBITOR III: A research chemical that inhibits spleen tyrosine kinase (Syk).
DEFOSLIMOD: An experimental immunomodulator that targets NF-kappaB.
XCL1: A chemokine, also known as lymphotactin, involved in the immune response.
[SAR1,ALA8]ANG-II: A synthetic analogue of angiotensin II, used as a receptor antagonist.
[125I]XCL1 (HUMAN): Radioiodinated human XCL1 chemokine for receptor binding studies.
RO116-9132/238: An experimental compound.
BIM 23127: A synthetic somatostatin analogue.
SUVODIRSEN: An antisense oligonucleotide drug for Duchenne muscular dystrophy.
DESIDUSTAT: An experimental drug that inhibits HIF prolyl-hydroxylase to treat anemia.
ISONIAZID / PYRAZINAMIDE / RIFAMPIN: A combination drug regimen for treating tuberculosis.
ORVACABTAGENE AUTOLEUCEL: A CAR-T cell therapy targeting BCMA for multiple myeloma.
CARBETAPENTANE: An antitussive (cough suppressant) agent.
VCE-004.3: A synthetic cannabinoid derivative with anti-inflammatory properties.
NAVAFENTEROL: An experimental long-acting beta-2 agonist and M3 antagonist (LAMA/LABA).
RIDOGREL: A thromboxane A2 synthase inhibitor and receptor antagonist.
INSULIN ZINC SUSP PURIFIED PORK: An intermediate-acting insulin preparation derived from pigs.
INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN: An intermediate-acting human insulin preparation (NPH insulin).
PROPOXYPHENE NAPSYLATE: An opioid analgesic, withdrawn due to cardiac toxicity.
SERMORELIN ACETATE: A synthetic analogue of growth hormone-releasing hormone (GHRH).
BETAMETHASONE ACETATE: A synthetic glucocorticoid steroid with anti-inflammatory properties.
FLURBIPROFEN SODIUM: A nonsteroidal anti-inflammatory drug (NSAID).
MYCOPHENOLATE MOFETIL HYDROCHLORIDE: The salt form of an immunosuppressant drug.
PANCURONIUM BROMIDE: A non-depolarizing neuromuscular blocking agent.
ROLAPITANT HYDROCHLORIDE: A neurokinin-1 (NK1) receptor antagonist for preventing chemotherapy-induced nausea.
PX-102: An experimental compound.
AZD-6918: An experimental research chemical from AstraZeneca.
CB-189625: An experimental research compound.
BIBO3304: A potent, non-peptide antagonist of the neuropeptide Y Y1 receptor.
GSK239512: An experimental histamine H3 receptor inverse agonist.
ALTINICLINE: An agonist for nicotinic acetylcholine receptors.
COMPOUND 6 [PMID: 10395480]: A research compound described in the cited scientific literature.
[125I]NPY (HUMAN, MOUSE, RAT): Radioiodinated neuropeptide Y for receptor binding studies.
GILTERITINIB FUMARATE: An AXL/FLT3 inhibitor used to treat acute myeloid leukemia.
SIPONIMOD FUMARATE: A sphingosine-1-phosphate receptor modulator used for multiple sclerosis.
RIMEGEPANT SULFATE: A CGRP receptor antagonist for the acute treatment of migraine.
FOSTEMSAVIR TROMETHAMINE: An HIV-1 attachment inhibitor prodrug.
MEPIRODIPINE: A dihydropyridine calcium channel blocker.
MAGNESIUM OXYBATE: The magnesium salt of gamma-hydroxybutyrate (GHB), used for narcolepsy.
MIRIKIZUMAB: A monoclonal antibody targeting the p19 subunit of IL-23 for ulcerative colitis.
UK-500001: An inhibitor of the mitochondrial pyruvate carrier.
SENAPARIB: An experimental PARP inhibitor for cancer therapy.
5-METHOXYTRYPTAMINE: A tryptamine derivative related to serotonin and melatonin.
3-HYDROXYANTHRANILIC ACID: A metabolite in the kynurenine pathway of tryptophan metabolism.
NILE RED: A lipophilic fluorescent stain used in cell biology.
CYTIDINE 3'-MONOPHOSPHATE: A nucleotide, a component of RNA.
MELITRACEN: A tricyclic antidepressant.
REDIOCIDE A: A natural product with biological activity.
DICARBONODITHIOIMIDIC DIAMIDE: A chemical compound.
CLINAFLOXACIN: A fluoroquinolone antibiotic.
BENZETHONIUM: A synthetic quaternary ammonium salt used as an antiseptic and disinfectant.
CYNAROPICRIN: A natural sesquiterpene lactone with anti-inflammatory properties.
PERSEITOL: A seven-carbon sugar alcohol found in avocado.
GW682841X: An experimental research chemical from GlaxoSmithKline.
NIACINAMIDE: A form of vitamin B3, used in dermatology and as a dietary supplement.
GETIACAULEIN: A natural diterpenoid compound.
OCTRIZOLE: A benzotriazole UV absorber used in plastics and cosmetics.
ISOXANTHOPTERIN: A pteridine compound, a metabolic product in many organisms.
TETRACONAZOLE: A triazole fungicide.
PHTHALYLSULFATHIAZOLE: A sulfonamide antimicrobial agent.
BROMEBRIC ACID: A lipid-lowering agent.
COUMAPHOS: An organophosphate insecticide and acaricide.
MORUSINOL: A natural prenylated flavonoid.
FLUNARIZINE DIHYDROCHLORIDE: A calcium channel blocker used for migraine prophylaxis.
DAZOMET: A soil fumigant and biocide.
GW305074X: An experimental research chemical from GlaxoSmithKline.
DEGUELIN: A natural rotenoid with chemopreventive properties.
CCT244747: An experimental inhibitor of the checkpoint kinase Chk1.
PROSULTIAMINE: A synthetic derivative of thiamine (vitamin B1).
CINOBUFOTALIN: A cardiotonic steroid found in toad venom.
BROMOCICLEN: A cyclodiene insecticide.
2,3,4'-TRIHYDROXY-4-METHOXYBENZOPHENONE: A benzophenone derivative, often used as a UV filter.
GW795493X: An experimental research chemical from GlaxoSmithKline.
IPCONAZOLE: A triazole fungicide.
CALANOLIDE A: A non-nucleoside reverse transcriptase inhibitor from a tropical plant.
COPPER CHLORIDE: An inorganic copper salt.
1-NITROPYRENE: A nitrated polycyclic aromatic hydrocarbon, a known mutagen.
DIAZOOXONORLEUCINE: A glutamine antagonist with antitumor properties.
APAZIQUONE: A bioreductive prodrug activated to an alkylating agent in hypoxic conditions.
CARBASALATE CALCIUM: A soluble salt complex of aspirin, used as an analgesic.
CASIMERSEN: An antisense oligonucleotide drug for Duchenne muscular dystrophy.
TAS-108: An experimental selective estrogen receptor modulator (SERM).
HE3286: An experimental synthetic steroid analogue with immunomodulatory effects.
TRIPTORELIN PAMOATE: A gonadotropin-releasing hormone (GnRH) agonist.
MONOCLONAL ANTIBODY 11D10 ANTI-IDIOTYPE VACCINE: An experimental cancer vaccine.
LEVOLEUCOVORIN: The active levo-isomer of leucovorin, used in chemotherapy.
MAVEROPEPIMUT-S: An experimental peptide vaccine targeting survivin for cancer therapy.
HUMAN INTERLEUKIN-2: A cytokine that regulates the activities of white blood cells.
DA-6886: An experimental compound.
AAV1-FS344: A gene therapy product designed to deliver the follistatin 344 gene.
SUVN-502: An experimental 5-HT6 receptor antagonist for Alzheimer's disease.
RAXOFELAST: An antioxidant drug that inhibits lipid peroxidation.
APADOLINE: An experimental kappa-opioid receptor agonist with analgesic properties.
SODIUM PYRUVATE: The sodium salt of pyruvic acid, an intermediate in metabolism.
PENCICLOVIR: An antiviral drug used to treat herpes simplex virus infections.
MM-093: An experimental recombinant human alpha-fetoprotein.
GI-6207: An experimental cancer vaccine targeting the CEA protein.
ARC FUSION PROTEIN SL-279252: An experimental immunomodulatory fusion protein.
ANTI-PD-L1/CD137 BISPECIFIC ANTIBODY MCLA-145: An experimental bispecific antibody for cancer immunotherapy.
TRANSFERRIN RECEPTOR-TARGETED ANTI-RRM2 SIRNA CALAA-01: An experimental RNAi therapeutic for cancer.
MAZAPERTINE SUCCINATE: An experimental dopamine D2 and 5-HT1A receptor antagonist.
APL-501: An experimental research chemical.
DIAPLASININ: A natural dimeric naphthoquinone.
IRX-5183: An experimental selective retinoic acid receptor alpha (RARÎ±) agonist.
XBP1-US/XBP1-SP/CD138/CS1 MULTIPEPTIDE VACCINE PVX-410: An experimental multi-peptide cancer vaccine.
PYRIDOXAMINE: A form of vitamin B6.
4-ACRYLOYLPHENOL: A chemical compound.
TANDOSPIRONE: An anxiolytic and antidepressant drug of the azapirone class.
COMPOUND 4G [PMID: 22220592]: A research compound described in the cited scientific literature.
DU172: An experimental research chemical.
ALLOXAZINE: A heterocyclic organic compound.
TRV023: An experimental compound.
PD 165929: An experimental research chemical.
[D-PHE6, LEU13, CPA14,&PSI;13-14]BOMBESIN-(6-14): A synthetic bombesin receptor antagonist.
[D-PHE6]BOMBESIN(6-13)PROPYLAMIDE: A synthetic bombesin receptor antagonist.
AC-GRP-(20-26)-METHYLESTER: A synthetic peptide fragment of gastrin-releasing peptide.
NIHP: An experimental compound.
LK 204-545: An experimental research chemical.
CP105696: An experimental glycine receptor antagonist.
(R)-EF-1520: An experimental compound.
12S-HETE: 12-Hydroxyeicosatetraenoic acid, a lipid mediator from arachidonic acid.
UAWJ9-36-3: An experimental research chemical.
C7683: An experimental compound.
AM2201: A potent synthetic cannabinoid.
SCH.336: An experimental compound.
BMS-202: An experimental research chemical.
GASTRIN-14: A 14-amino acid form of the peptide hormone gastrin.
GNF2133: An experimental research chemical.
GR 63799: An experimental research chemical.
MK-2894: An experimental positive allosteric modulator of the M1 muscarinic receptor.
ENDOTHELIN-2: An endogenous potent vasoconstrictor peptide.
EDONENTAN ANHYDROUS: An experimental dual endothelin ETA/ETB receptor antagonist.
L-&BETA;-BA: L-beta-N-oxalyl-L-alpha,beta-diaminopropionic acid, a neurotoxin.
L655708: A selective inverse agonist for the alpha5-containing GABAA receptors.
PZ-II-029: An experimental research chemical.
WFW-ISN-NH2: A synthetic peptide.
TIRZEPATIDE: A dual GIP and GLP-1 receptor agonist for type 2 diabetes and weight loss.
[125I]GLUCAGON (HUMAN, MOUSE, RAT): Radioiodinated glucagon for receptor binding studies.
ORG 214007-0: An experimental positive allosteric modulator of GABAA receptors.
[3H]L689560: A radiolabeled antagonist for the glycine site of the NMDA receptor.
DEXTRORPHAN: A metabolite of dextromethorphan with NMDA antagonist activity.
BILOBALIDE: A terpenoid found in the Ginkgo biloba tree.
PHENCYCLIDINE: A dissociative hallucinogenic drug, also known as PCP.
S-ALLYLGLYCINE: An amino acid analogue.
3,5-DIHYDROXYBENZOIC ACID: A natural phenolic acid.
DIMAPRIT: A selective agonist for the histamine H2 receptor.
N-&ALPHA;-METHYLHISTAMINE: A selective agonist for the histamine H3 receptor.
COMPOUND 29 [PMID: 1527791]: A research compound described in the cited 1992 publication.
COMPOUND 3 [PMID: 21310611]: A research compound described in the specified scientific literature.
(S)-N-OLEOYLTYROSINOL: An endogenous lipid signaling molecule.
AS1535907: An experimental research chemical.
1-OLEOYL GLYCEROL: A monoglyceride.
ASN04450772: An experimental research chemical.
ZELATRIAZIN (TAK-041): An experimental GPR81 receptor agonist.
DL-175: An experimental research chemical.
3-HYDROXYLAURIC ACID: A hydroxylated fatty acid.
AR305352: An experimental research chemical.
CTOP: A selective mu-opioid receptor antagonist peptide.
NS9283: A positive allosteric modulator of alpha4beta2 nicotinic acetylcholine receptors.
[125I]&ALPHA;-BUNGAROTOXIN: Radioiodinated alpha-bungarotoxin, a potent nicotinic receptor antagonist.
[125I]SP (HUMAN, MOUSE, RAT): Radioiodinated Substance P for receptor binding studies.
YM49598: An experimental research chemical.
GR100679: An experimental NK2 receptor antagonist.
[125I]L703,606: A radioiodinated antagonist for the tachykinin NK1 receptor.
NEUROPEPTIDE W-23: An endogenous neuropeptide that binds to GPR7 and GPR8.
OREXIN-A: An endogenous neuropeptide regulating arousal, wakefulness, and appetite.
[125I]D(CH2)5[TYR(ME)2,THR4,ORN8,TYR-NH29]OVT: A radioiodinated oxytocin/vasopressin receptor ligand.
COMPOUND 1 [PMID: 33547286]: A research compound described in the cited 2021 scientific publication.
[3H]T-516: A radiolabeled research compound.
LSN2424100: An experimental positive allosteric modulator of the M1 muscarinic receptor.
PQA-18: An experimental research chemical.
NF778: An experimental antagonist of the P2X1 receptor.
IP5I: An inositol polyphosphate 5-phosphatase inhibitor.
PSB-12054: An experimental research chemical.
MRS2603: An experimental research chemical.
2-THIOUTP: A uridine triphosphate analogue.
ENANTIO PAF C-16: The enantiomer of platelet-activating factor.
TRANS-CINNAMOYL-LIGRLO [N-[3H]PROPIONYL]-NH2: A radiolabeled peptide related to proteinase-activated receptors.
(DES 1-8) A-CHAIN INSL3 ANALOGUE: A modified analogue of Insulin-like peptide 3.
INSL5 AMIDE (HUMAN): An amidated form of human Insulin-like peptide 5.
EST73502: An experimental research chemical.
COMPOUND 28XVII [PMID: 8809154]: A research compound described in the cited publication.
GA-KE88: An experimental research chemical.
PRL-2970: An experimental research chemical.
SNX281: An experimental STING agonist for cancer immunotherapy.
BASROPARIB: An experimental ATP-citrate lyase (ACLY) inhibitor.
LOXORIBINE: An imidazoquinoline derivative that acts as a Toll-like receptor 7 (TLR7) agonist.
CARBOCYCLIC THROMBOXANE A2: A stable analogue of thromboxane A2.
I-BOP: A stable, selective agonist for the thromboxane A2 receptor.
SG-094: An experimental research chemical.
CHLOROBENZYLIDENE MALONONITRILE: The primary component of CS gas, a riot control agent.
AC1903: An experimental ACVR1/ALK2 inhibitor.
GEA 3162: A nitric oxide donor compound.
LARIXYL ACETATE: A natural compound found in larch trees.
COMPOUND 6 [PMID: 29579323]: A research compound described in the specified scientific literature.
SN-2: An experimental research chemical.
COMPOUND 74A [PMID: 27077528]: A research compound described in the cited publication.
GSK-BZ DERIVATIVE 2B: A specific derivative of a research compound from GlaxoSmithKline.
COMPOUND 1A [PMID: 18573659]: A research compound described in the specified scientific paper.
DAVP: Desamino-vasopressin, another name for the drug desmopressin.
VNA932: An experimental glucose-6-phosphate dehydrogenase (G6PD) inhibitor.
D[LEU4]AVP: A synthetic analogue of arginine vasopressin.
GR231118: A selective neuropeptide Y Y1 receptor antagonist.
KC-130: An experimental compound.
IMIPRAMINE PAMOATE: A salt form of the tricyclic antidepressant imipramine.
COMPOUND 24 [PMID: 20346665]: A research compound described in the specified scientific literature.
ANTI-CEA CAR T CELLS: CAR-T cells engineered to target carcinoembryonic antigen (CEA).
A(9-26)INSL3: A peptide fragment of Insulin-like peptide 3.
GALANIN(3-30) (HUMAN): A fragment of the human neuropeptide galanin.
AC-98170: An experimental research chemical.
LINPERLISIB: An experimental PI3K delta inhibitor.
[PHAA1,D-TYR(ET)2,LYS6,DES-GLY9]AVP: A synthetic analogue of arginine vasopressin.
METHYLSAMIDORPHAN: The N-methylated derivative of samidorphan, an opioid antagonist.
IBERIOTOXIN: A peptide toxin that blocks calcium-activated potassium channels.
BMS-820132: An experimental positive allosteric modulator of the D1 dopamine receptor.
NSC212069: An experimental research chemical.
ACETYLSALICYLIC ACID/DIPYRIDAMOLE: A combination drug used to reduce the risk of stroke.
FIBATUZUMAB: An experimental monoclonal antibody targeting the CD319 antigen.
BMS753: An experimental research chemical.
GALANIN(2-11): A fragment of the neuropeptide galanin that acts as a receptor agonist.
CENICRIVIROC MESYLATE: An experimental dual antagonist of CCR2 and CCR5 chemokine receptors.
COMPOUND 18 [PMID: 34212719]: A research compound described in the cited 2021 publication.
BX-430: An experimental research chemical.
ONC212: An experimental imipridone compound with anti-cancer activity.
WYE-354: An experimental inhibitor of mTORC1 and mTORC2.
VIOMYCIN SULFATE: A polypeptide antibiotic used to treat tuberculosis.
IODOPROXYFAN: A selective antagonist/inverse agonist for the histamine H3 receptor.
ARGININE BUTYRATE: A salt investigated for sickle cell disease and cystic fibrosis.
MANGIFERIN HEPTASULFATE: A sulfated derivative of mangiferin.
COMPOUND 17D [PMID: 23099093]: A research chemical described in the cited publication.
MODIMELANOTIDE: A synthetic peptide analogue of alpha-melanocyte-stimulating hormone.
PENICILLIOL B: A natural compound isolated from fungi.
4F-MT-45: A synthetic opioid analgesic.
D5261: An experimental research chemical.
APA: An abbreviation, possibly for a research compound.
PLAZOMICIN SULFATE: An aminoglycoside antibiotic for complicated urinary tract infections.
LERSIVIRINE: A non-nucleoside reverse transcriptase inhibitor (NNRTI).
FENPYROXYMATE: A pyrazole acaricide (miticide).
JCAR014: An investigational CD19-targeted CAR T-cell therapy.
PHENAZINE: A heterocyclic organic compound, parent of many dyes and antibiotics.
AVOTERMIN: Recombinant human transforming growth factor beta 3 (TGF-Î²3).
PIM KINASE INHIBITOR LGH447: An experimental compound that inhibits Pim kinases.
YSFKPMPLAR: A peptide sequence.
COMPOUND 6B [PMID: 22749870]: A research chemical described in the cited publication.
TQB3804: An experimental anaplastic lymphoma kinase (ALK) inhibitor.
[3H]LYS-[DES-ARG9]BK: A radiolabeled bradykinin B1 receptor agonist.
LY2140023: An experimental agonist of metabotropic glutamate receptors 2 and 3.
SLC-0111: An experimental inhibitor of carbonic anhydrase IX.
COMPOUND 5 [PMID: 21838328]: A research compound described in the specified scientific literature.
PREGNENOLONE-16&ALPHA;-CARBONITRILE: A synthetic steroid used in research.
A-1331852: An experimental BCL-XL inhibitor.
GALINPEPIMUT-S: An experimental peptide vaccine targeting Wilms Tumor 1 (WT1).
DIOSMIN: A flavone glycoside used as a phlebotonic and vascular-protecting agent.
GALANIN(D-TRP2) (PIG): A porcine galanin analogue.
DIAZIQUONE: An aziridinyl-benzoquinone with antineoplastic activity.
AMRUBICIN: An anthracycline drug used for lung cancer.
RESOLVIN E1: A lipid mediator derived from omega-3 fatty acids with anti-inflammatory properties.
RCI-0879: An experimental research chemical.
3,5-DICAFFEOYLQUINIC ACID: A derivative of caffeic acid found in plants.
SGI-1027: An experimental inhibitor of DNA methyltransferase (DNMT).
ISOQUINOLINE 17 [PMID: 30122040]: A research compound described in the cited publication.
COMPOUND 26 [PMID: 16190743]: A research compound described in the specified scientific literature.
TAXOL C: A natural taxane compound related to paclitaxel.
ISOVANILLIN: An isomer of vanillin, used as a flavoring agent.
LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS: A salt of the opioid levopropoxyphene.
SIMAZINE: A triazine herbicide.
GEMTUZUMAB: An antibody-drug conjugate targeting CD33 for acute myeloid leukemia.
SC-41930: A research chemical, a selective EP1 receptor antagonist.
FIBRIN SEALANT: A biological adhesive used to control bleeding during surgery.
CCX-354: An experimental inhibitor of the chemokine receptor CCR1.
NVP-CLR457: An experimental research chemical.
OSILODROSTAT PHOSPHATE: An inhibitor of aldosterone synthase for Cushing's disease.
COMPOUND 10 [PMID: 18759424]: A research compound described in the specified scientific paper.
METHYL ISOCYANATE: A highly toxic chemical intermediate.
DOXYLAMINE SUCCINATE: An antihistamine used as a sleeping aid and for morning sickness.
HALOPERIDOL LACTATE: The lactate salt of haloperidol, a typical antipsychotic drug.
GNF362: An experimental research chemical.
ZED1227: An experimental transglutaminase 2 inhibitor for celiac disease.
COHUMULONE: A bitter alpha-acid found in hops.
CANGITOXIN II: A toxin, likely from a venomous animal.
COMPOUND 9 [PMID: 23472952]: A research compound described in the cited scientific publication.
VRT-043198: An experimental inhibitor of the S100A9 protein.
AZD7687: An experimental research chemical from AstraZeneca.
NERIDRONIC ACID: A bisphosphonate drug used to treat bone diseases.
SCANDENIN: A natural isoflavone compound.
MITOGLITAZONE: A thiazolidinedione drug that acts as a PPAR agonist.
BAY-545: An experimental research chemical.
IBANDRONATE SODIUM: A bisphosphonate drug used to treat osteoporosis.
[PRO34]PYY (HUMAN): A synthetic analogue of human Peptide YY.
GW829906X: An experimental research chemical from GlaxoSmithKline.
ALECTINIB HYDROCHLORIDE: An anaplastic lymphoma kinase (ALK) inhibitor for lung cancer.
AG-13958: An experimental research chemical.
RG-7652: An experimental toll-like receptor 7 (TLR7) agonist.
NADH: Nicotinamide adenine dinucleotide, a crucial coenzyme in metabolic redox reactions.
SX-682: An experimental CXCR1/2 inhibitor for cancer therapy.
NDT-19795: An experimental research chemical.
(+)-UH232: A dopamine D2 receptor antagonist.
RECOMBINANT FIBROBLAST GROWTH FACTOR 3: A genetically engineered version of the FGF3 protein.
ONO-AE3-237: An experimental research chemical.
LEVOCABASTINE HYDROCHLORIDE: An antihistamine used in eye drops and nasal sprays.
ACETOPHENAZINE MALEATE: A typical antipsychotic of the phenothiazine class.
ETHIONAMIDE: An antibiotic used to treat tuberculosis.
CYCRIMINE HYDROCHLORIDE: An anticholinergic drug used to treat Parkinson's disease.
SUFENTANIL CITRATE: A potent synthetic opioid analgesic.
LEVORPHANOL TARTRATE: An opioid analgesic.
DONEPEZIL HYDROCHLORIDE: An acetylcholinesterase inhibitor used for Alzheimer's disease.
TESAMORELIN ACETATE: A synthetic analogue of growth hormone-releasing hormone (GHRH).
AMLODIPINE MALEATE: The maleate salt of amlodipine, a calcium channel blocker for hypertension.
INDACATEROL MALEATE: A long-acting beta-2 agonist (LABA) for treating COPD.
EUROPIUM-LABELLED INSL3: Europium-labeled Insulin-like peptide 3, used in assays.
PROPARGITE: An organosulfur miticide.
BMS-779788: An experimental research chemical.
ILX23-7553: An experimental research chemical.
LY-2811376: An experimental beta-secretase 1 (BACE1) inhibitor.
TA-5493: An experimental research chemical.
RISOVALISIB: An experimental PI3K/mTOR inhibitor.
ADC3680: An experimental research chemical.
LADARIXIN: An experimental allosteric inhibitor of CXCR1/2 chemokine receptors.
CAL: An abbreviation for a chemical, possibly related to calcitriol or calcium.
AZ9773: An experimental research chemical.
CLIVATUZUMAB TETRAXETAN: A radioimmunoconjugate targeting MUC1 for pancreatic cancer.
DUTETRABENAZINE: A deuterated form of tetrabenazine, a vesicular monoamine transporter 2 (VMAT2) inhibitor.
IMMURAIT-LL2: A radioimmunoconjugate, also known as yttrium (90Y) epratuzumab tetrazetan.
SIBROTUZUMAB: An experimental monoclonal antibody targeting the FAP protein.
PF-03732010: An experimental research chemical from Pfizer.
ONASEMNOGENE ABEPARVOVEC-XIOI: A gene therapy for spinal muscular atrophy.
TAZEMETOSTAT HYDROBROMIDE: An EZH2 inhibitor for treating certain cancers.
LEVAMLODIPINE MALEATE: The active (S)-enantiomer of amlodipine.
SUTEZOLID: An experimental oxazolidinone antibiotic for tuberculosis.
ISLATRAVIR: An experimental nucleoside reverse transcriptase translocation inhibitor (NRTTI) for HIV.
BAY1436032: An experimental allosteric inhibitor of mutant isocitrate dehydrogenase 1 (IDH1).
TANEXABAN: An experimental factor Xa inhibitor.
BRIVOLIGIDE: An experimental research chemical.
2-[(FORMYL-HYDROXY-AMINO)-METHYL]-HEPTANOIC ACID [1-(2-HYDROXYMETHYL-PYRROLIDINE-1-CARBONYL)-2-METHYL-PROPYL]-AMIDE: A complex organic compound, likely a research chemical.
ALTISSIMACOUMARIN F: A natural coumarin compound.
COCHINCHINENIN C: A natural chalcone derivative.
L-750,667: An experimental research chemical, an NK1 receptor antagonist.
PROPANIL: A contact herbicide.
CAULIBUGULONE D: A natural marine compound.
CHLOROACETIC ACID: A chemical precursor used in the production of various compounds.
EUPATORIN: A natural flavonoid compound.
CANTHARIDIC_ACID: A variant spelling of cantharidin, a toxic blistering agent.
GW827106X: An experimental research chemical from GlaxoSmithKline.
THYMIDINE MONOPHOSPHATE: A nucleotide, a component of DNA.
HARMALOL: A fluorescent alkaloid from the harmala plant family.
TRIM: An abbreviation, possibly for trimethoprim or another research compound.
4-METHYLBENZOIC ACID METHYL ESTER: A chemical compound.
MALONIC ACID: A dicarboxylic acid.
4-METHYLTHIOAMPHETAMINE: A psychoactive designer drug of the amphetamine class.
ACEQUINOCYL: A naphthoquinone derivative used as an acaricide.
(S)-PINACIDIL: The active enantiomer of pinacidil, a potassium channel opener.
CONICASTEROL B: A natural sterol compound.
ARBACLOFEN: The active R-enantiomer of baclofen, a GABA-B receptor agonist.
SULFURIC ACID: A highly corrosive mineral acid.
CITROPTEN: A natural furanocoumarin found in citrus essential oils.
TORMENTIC ACID METHYL ESTER: A derivative of a natural triterpenoid.
BENZYLACETONE: A fragrant organic compound.
TH0318: An experimental research chemical.
RETINYLRETINOATE: A derivative of retinol (vitamin A).
INDOXACARB: An oxadiazine insecticide.
DALAZATIDE: An experimental immunomodulatory peptide.
BMS-564929: An experimental selective androgen receptor modulator (SARM).
METHYLEUGENOL: A natural organic compound found in various essential oils.
EFBEMALENOGRASTIM ALFA: A long-acting recombinant granulocyte colony-stimulating factor (G-CSF).
SALICYLALDEHYDE THIOSEMICARBAZONE: A chemical compound with potential biological activity.
ROBOTNIKININ: An experimental peptide.
[125I]C3A (HUMAN): Radioiodinated human complement component 3a.
DIDECYLDIMETHYLAMMONIUM CHLORIDE: A quaternary ammonium compound used as a disinfectant.
FRAXIDIN METHYL ETHER: A derivative of the natural coumarin fraxidin.
STIROFOS: An organophosphate insecticide.
ARACHIDONYL TRIFLUOROMETHYL KETONE: An inhibitor of phospholipase A2.
APRAMIDE A: A natural cyclic peptide.
BENANSERIN HYDROCHLORIDE: A serotonin receptor antagonist.
SPIRADOLINE: An experimental kappa-opioid receptor agonist.
OXYQUINOLINE SULFATE: An antiseptic and disinfectant agent.
CYCLANDELATE: A vasodilator drug.
BERKELEYACETAL B: A natural product isolated from fungi.
NEPAPRAZOLE: An experimental proton pump inhibitor.
ELIPRODIL: An antagonist of the NMDA receptor.
CYCLIC CRYPEVEIC: A cyclic peptide.
NITRALIN: A dinitroaniline herbicide.
BENSULIDE: An organophosphate herbicide.
ISOBERGAPTENE: An isomer of bergapten, a natural furanocoumarin.
GAMBOGENIC ACID: A derivative of gambogic acid, a natural xanthonoid.
DIBENZOYLMETHANE: An organic compound used in sunscreen and as a chemical intermediate.
DEMETHYL-CANTHARIDIN: A demethylated derivative of cantharidin.
BYROSTATIN 1: A misspelling of Bryostatin 1, a marine macrolide with antineoplastic activity.
(R)-IBUPROPHEN: The inactive enantiomer of ibuprofen.
2-PHENYL-1H-INDOLE: A chemical compound based on the indole structure.
7-HYDROXY ISOFLAVONE: A basic isoflavone structure.
AMPEROZIDE HYDROCHLORIDE: An atypical antipsychotic.
BEMESETRON: A 5-HT3 receptor antagonist.
2-NITROANISOLE: An organic chemical compound.
BENZO[DEF]CHRYSENE: A polycyclic aromatic hydrocarbon, also known as benzo[a]pyrene.
[18F]FLUORORASAGILINE: A radiolabeled tracer for imaging monoamine oxidase B (MAO-B).
GENERIC DRUG: A pharmaceutical drug that is equivalent to a brand-name drug.
PROCARBAZINE: An alkylating agent used in chemotherapy.
MUC-1 ANTIGEN: A mucin protein that is overexpressed in many cancers.
MONOCLONAL ANTIBODY SGN-14: An experimental monoclonal antibody.
SODIUM SALICYLATE: The sodium salt of salicylic acid, an NSAID.
DIHYDROTESTOSTERONE: A potent androgen hormone derived from testosterone.
IPOMEANOL: A toxic furanoterpenoid produced by sweet potatoes.
BENZENE: A basic aromatic hydrocarbon, a known carcinogen.
SPARTEINE: A plant alkaloid used as an antiarrhythmic agent.
HYDRALAZINE / ISOSORBIDE DINITRATE: A combination drug used to treat heart failure.
DRUGSATFDA.NDA:021717: A reference to a New Drug Application file at the FDA.
DELEOBUVIR: An experimental non-nucleoside HCV polymerase inhibitor.
C-MET INHIBITOR MK2461: An experimental compound that inhibits the c-Met receptor tyrosine kinase.
S-3304: An experimental compound.
HALETHAZOLE: An antifungal agent.
TSP-1 MIMETIC FUSION PROTEIN CVX-045: An experimental anti-angiogenic protein.
CHF 4227: An experimental compound.
DENENICOKIN: An experimental immunomodulator.
GNRH PHARMACCINE: An experimental therapeutic vaccine targeting GnRH.
HUMANIZED SMART ANTI-IL-12 ANTIBODY: An experimental monoclonal antibody targeting interleukin-12.
INCB3284: An experimental CCR2 chemokine receptor antagonist.
BISEGLIPTIN: An experimental dipeptidyl peptidase-4 (DPP-4) inhibitor.
TST10088: An experimental research chemical.
TOPICAL POTASSIUM DOBESILATE: A topical formulation of potassium dobesilate for vascular disorders.
GOLOTIMOD: A synthetic peptide immunomodulator.
IL-21: Interleukin-21, a pleiotropic cytokine.
INOSINE 5'-MONOPHOSPHATE DEHYDROGENASE INHIBITOR FF-10501-01: An experimental IMPDH inhibitor.
DISITERTIDE: An experimental peptide drug.
GALLOPAMIL: A calcium channel blocker.
GUAIACOL: A naturally occurring organic compound used as a precursor to flavorants.
KW-2478: An experimental HSP90 inhibitor.
ND7001: An experimental phosphodiesterase 2 (PDE2) inhibitor.
NEMORUBICIN: An experimental anthracycline antibiotic.
RISLENEMDAZ: An experimental NMDA receptor antagonist.
ABT-126: An experimental alpha-7 nicotinic receptor agonist and 5-HT3 antagonist.
CHLORMERODRIN: A mercurial diuretic.
POTASSIUM CHLORIDE: An electrolyte supplement.
TIFENAZOXIDE: An experimental compound.
FACT COMPLEX-TARGETING CURAXIN CBL0137: An experimental anti-cancer agent targeting the FACT complex.
BAY-1082439: An experimental PI3K inhibitor.
BUTYLSCOPOLAMINE: An antispasmodic drug derived from scopolamine.
ACETYLGLUCOSAMINE: An amino sugar, a monosaccharide derivative of glucose.
ALVESPIMYCIN HYDROCHLORIDE: The salt form of an experimental HSP90 inhibitor.
VIDUTOLIMOD: An experimental Toll-like receptor 9 (TLR9) agonist.
GR79236: A selective adenosine A1 receptor agonist.
BAY-320: An experimental research chemical.
CHS-828: An experimental cytotoxic agent.
HIRUDIN: A naturally occurring peptide in leech saliva that is a direct thrombin inhibitor.
MLS000536924: A research chemical identified by its MLS number.
GR 125,743: A selective 5-HT1D receptor antagonist.
RS-30199: An experimental CCR8 chemokine receptor antagonist.
[3H]N-METHYL-AZ10419369: A radiolabeled P2X7 receptor antagonist.
(+)-NORFENFLURAMINE: The active metabolite of fenfluramine, a serotonin-releasing agent.
YM348: An experimental antagonist of the AMPA receptor.
FLUMBATINIB: An experimental FLT3/KIT inhibitor.
LRE1: An experimental research chemical.
COMPOUND 12C [PMID: 16516466]: A research compound described in the cited publication.
MS15: An experimental research chemical.
5-METHYLURAPIDIL: A derivative of urapidil, an alpha-1 adrenoceptor antagonist.
NS383: An experimental research chemical.
[125I]AB-MECA: A radioiodinated adenosine A3 receptor agonist.
LY2886721: An experimental BACE1 inhibitor for Alzheimer's disease.
CL316243: A selective beta-3 adrenergic receptor agonist.
ZALOSPIRONE: An anxiolytic agent of the azapirone class.
GSK2801: An experimental BET bromodomain inhibitor.
CALINDOL: An experimental research chemical.
CITIBRASINE: An experimental compound.
GV150013: An experimental NMDA receptor antagonist.
[3H]SUMATRIPTAN: Tritiated sumatriptan, a radiolabeled 5-HT1B/1D receptor agonist.
CCL4: A chemokine, also known as Macrophage Inflammatory Protein-1 beta (MIP-1Î²).
65PF: An experimental research chemical.
AH10-7: An experimental research chemical.
CD70: A protein on the surface of immune cells, a target for cancer therapy.
COMPOUND 11D [DOI: 10.1039/C0MD00194E]: A research compound described in the cited publication.
LABETUZUMAB GOVITECAN: An antibody-drug conjugate targeting CEA.
CYCLIC ADENOSINE MONOPHOSPHATE: A second messenger important in many biological processes, known as cAMP.
ZIFAXABAN: An experimental oral Factor Xa inhibitor.
GW406381: An experimental antagonist of the 5-HT6 receptor.
&ALPHA;-HELICAL CRF: A peptide antagonist of corticotropin-releasing factor (CRF) receptors.
NBI27914: A peptide antagonist of the corticotropin-releasing factor (CRF) receptor.
ADRENOMEDULLIN 2/INTERMEDIN: An endogenous peptide hormone related to the calcitonin family.
CT-(8-32) (SALMON): A peptide fragment of salmon calcitonin.
P'-GERANYL 2-FLUOROMEVALONATE 5-DIPHOSPHATE: A fluorinated analogue used in biochemical studies.
COMPOUND 1 [PMID: 31477924]: A research compound described in the cited 2019 publication.
ART558: An experimental research chemical.
C-MET INHIBITOR AMG 337: An experimental compound that inhibits the c-Met receptor.
13,14-DIHYDRO-15-KETO-PGD2: A metabolite of prostaglandin D2.
ECOPIPAM HYDROCHLORIDE: An experimental selective dopamine D1/D5 receptor antagonist.
A412997: An experimental research chemical.
COMPOUND 1 [PMID: 20080612]: A research compound described in the specified scientific literature.
TCS 2510: A selective orexin 2 receptor antagonist.
CP734432: An experimental research chemical.
KMN-159: An experimental research chemical.
13,14-DIHYDRO-PGE1: A metabolite of prostaglandin E1.
L-798,106: An antagonist of the oxytocin receptor.
[3H]NITROBENZYLMERCAPTOPURINE RIBONUCLEOSIDE: A radiolabeled inhibitor of nucleoside transport.
DRAFLAZINE: A nucleoside transport inhibitor.
KF24345: An experimental adenosine A1 receptor antagonist.
MF 498: An experimental research chemical.
GW 627368: A selective antagonist for the prostanoid EP4 receptor.
BMS-193884: An antagonist of the endothelin A (ETA) receptor.
[125I]BQ3020: A radioiodinated selective endothelin B (ETB) receptor agonist.
A192621: An experimental research chemical.
COMPOUND 39 [PMID: 36127295]: A research compound described in the cited 2022 publication.
JNJ1661010: An experimental histamine H3 receptor antagonist.
NE58027: An experimental research chemical.
[3H]L655708: A radiolabeled selective inverse agonist for alpha5-GABAA receptors.
GAL-(K)4: A synthetic peptide related to galanin.
GAL-B2-C10: A modified galanin analogue.
GALANIN(1-12): An N-terminal fragment of the neuropeptide galanin.
[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID: A complex organic phosphonate compound.
HM01: An experimental research chemical.
GLUCAGON-LIKE PEPTIDE 1-(7-37): An active form of the incretin hormone GLP-1.
BETP: An experimental positive allosteric modulator of the mGluR5 receptor.
ZK112993: The active enantiomer of the progestin levonorgestrel.
GLYT1 INHIBITOR 27A: A specific research chemical that inhibits the glycine transporter 1.
9-HYDROXYOCTADECADIENOIC ACID: A hydroxylated fatty acid derived from linoleic acid.
LTD4: Leukotriene D4, a potent inflammatory mediator.
ASN04885796: An experimental research chemical.
ML193: A selective inhibitor of the potassium channel Kir2.1.
COMPOUND 48/80: A mixture used in research to induce mast cell degranulation.
LEI-401: An experimental inhibitor of monoacylglycerol lipase (MAGL).
MK-0429: An experimental dipeptidyl peptidase-4 (DPP-4) inhibitor.
EMAVUSERTIB: An experimental IRAK4 kinase inhibitor.
IFN-&BETA;: Interferon beta, a cytokine used to treat multiple sclerosis.
THEAFLAVIN-3?O-GALLATE: A specific theaflavin polyphenol found in black tea.
JAK3 INHIBITOR 32: A specific research chemical that inhibits Janus kinase 3.
SEBETRALSTAT: An experimental oral plasma kallikrein inhibitor.
[D-TYR-14C]TAK-448: A radiolabeled gonadotropin-releasing hormone (GnRH) antagonist.
4-FLUOROBENZOYL-FGLRW-NH2: A synthetic peptide.
[125I]KISSPEPTIN-54 (HUMAN): Radioiodinated human kisspeptin-54 for receptor binding studies.
CHARYBDOTOXIN: A peptide toxin from scorpion venom that blocks potassium channels.
MK-499: An experimental drug that blocks the hERG potassium channel.
VARIANT MCH: A variant of the melanin-concentrating hormone.
XL388: An experimental dual PI3K/mTOR inhibitor.
METATINIB: An experimental tyrosine kinase inhibitor.
PHENYLACETYL-ARG-VAL-ARG-4-AMIDINOBENZYLAMIDE: A synthetic peptide that acts as a protease inhibitor.
GUMARONTINIB: An experimental c-Met tyrosine kinase inhibitor.
L-AP4: L-2-Amino-4-phosphonobutyric acid, a selective agonist for group III metabotropic glutamate receptors.
VU2957: An experimental positive allosteric modulator of the mGluR4 receptor.
COMPOUND 18 [PMID: 21927650]: A research compound described in the cited scientific literature.
EGLUMEGAD: An experimental mGluR2/3 receptor agonist.
COMPOUND 16D [TAO ET AL., 2009]: A research compound described in the cited 2009 publication.
D-AP4: D-2-Amino-4-phosphonobutanoic acid, an isomer of L-AP4.
BIX02189: An experimental inhibitor of MEK5.
COMPOUND 5 [PMID: 28038940]: A research compound described in the specified scientific literature.
COMPOUND 26 [PMID: 24673130]: A research compound described in the specified scientific literature.
RS 39066: An experimental research chemical.
(R)-ND-336: An experimental inhibitor of matrix metalloproteinase-13 (MMP-13).
MAGLI 432: An experimental research chemical.
AZD1236: An experimental antagonist of the P2Y12 receptor.
[NLEU13,GLU14]MOTILIN (HUMAN): A synthetic analogue of the human hormone motilin.
EG01377: An experimental antagonist of the orphan G protein-coupled receptor GPR55.
GR-389988: An experimental research chemical.
NEUROMEDIN S-33: A 33-amino acid form of the neuropeptide neuromedin S.
SHA 68R: An experimental research chemical.
CP-1: An experimental research chemical.
[ALA11, D-LEU15]OREXIN-B: A synthetic antagonist of orexin receptors.
OREXIN-B: An endogenous neuropeptide involved in regulating sleep and appetite.
PSB-12062: An experimental research chemical.
ARL66096: An ATPase inhibitor.
MRS2950: An experimental research chemical.
UDP N-ACETYL-GLUCOSAMINE: Uridine diphosphate N-acetylglucosamine, a key precursor in biosynthesis.
UDP-&BETA;-S: A chemically modified uridine diphosphate molecule.
EXAMPLE 2 [WO2013026797A1]: A specific compound described in the cited patent application.
TRIAZINE COMPOUND PC10: A research chemical based on the triazine structure.
COMPOUND 69 [PMID: 19136975]: A research compound described in the specified scientific literature.
MULTI-LEU (ML)-PEPTIDE: A synthetic peptide.
SGC707: An experimental PRMT3 inhibitor.
MT47-100: An experimental research chemical.
RIPK2 INHIBITOR 8: A specific research chemical from a series that inhibits RIPK2.
CCG-4986: An experimental research chemical that inhibits RhoA signaling.
R3/I5- SMBIT: An experimental research chemical.
CYM5181: An experimental research chemical.
BD-1063: An antagonist of the sigma-1 receptor.
COMPOUND 17 [PMID: 23570514]: A research compound described in the specified scientific literature.
COMPOUND 59 [PMID: 30889352]: A research compound described in the cited 2019 publication.
ER-27319: An experimental antagonist of the IL-1 receptor.
L-362,855: An experimental somatostatin receptor agonist.
ANALOG 30 [PMID:18543899]: A specific research compound described in the cited scientific paper.
BIM 23059: A synthetic somatostatin analogue.
EXAMPLE 15 [WO2015079413]: A specific compound described in the cited patent application.
CRX-555: An experimental research chemical.
I-SAP: Saporin conjugated to an antibody, a type of immunotoxin.
CADPR: Cyclic ADP-ribose, an intracellular second messenger.
EVP-21: An experimental research chemical.
SF-11: An experimental research chemical.
6-IODO-NORDIHYDROCAPSAICIN: An analogue of capsaicin that acts as a TRPV1 antagonist.
RWJ-56423: An experimental research chemical.
AZ3146: An experimental inhibitor of the kinase MPS1.
RN1734: An antagonist of the TRPV4 ion channel.
TWEAK: Tumor necrosis factor-like weak inducer of apoptosis, a cytokine.
COMPOUND 6 [PMID: 17948018]: A research compound described in the specified scientific literature.
[3H]NELIVAPTAN: A radiolabeled vasopressin V1b receptor antagonist.
D[PEN1,TYR(ME)2]AVP: A synthetic analogue of arginine vasopressin.
NPY: Neuropeptide Y, an endogenous peptide neurotransmitter.
TYRPHOSTIN AG 1296: An inhibitor of the PDGF receptor tyrosine kinase.
CLK INHIBITOR CTX-712: An experimental compound that inhibits Cdc2-like kinases (CLK).
NAPABUCASIN: An experimental cancer stemness inhibitor.
7-OXOCALLITRISIC ACID, METHYL ESTER: A derivative of a natural diterpenoid.
KUSHENOL A: A natural flavonoid compound.
NITROVIN: An antibacterial agent used in animal feed.
CALCDPWW: A synthetic peptide.
DENINTUZUMAB: An experimental antibody-drug conjugate.
PHANTASMIDINE: A natural alkaloid that acts on nicotinic acetylcholine receptors.
WJYK50: An experimental research chemical.
MILNACIPRAN HYDROCHLORIDE: A serotonin-norepinephrine reuptake inhibitor (SNRI) for fibromyalgia.
PFI-3: An experimental inhibitor of the SMARCA4/SMARCA2 bromodomains.
NE10575: An experimental research chemical.
PARA-COUMARIC ACID: A natural phenolic compound found in many plants.
MK-7110: An experimental CGRP receptor antagonist for migraine.
HER2 INHIBITOR CP-724,714: An experimental tyrosine kinase inhibitor targeting HER2.
ASTRAGALIN: A natural flavonoid glycoside.
THERAPEUTIC AUTOLOGOUS LYMPHOCYTES: A cell therapy using a patient's own lymphocytes.
MOC31-PE: An immunotoxin consisting of an antibody linked to Pseudomonas exotoxin.
RIPK3 INHIBITOR 42: A specific research chemical that inhibits RIPK3 kinase.
[SAR1,ILE4,ILE8]ANG-II: A synthetic analogue of angiotensin II.
ENARODUSTAT: An experimental HIF prolyl-hydroxylase inhibitor for anemia.
COMPSTATIN: A peptide inhibitor of the complement system protein C3.
BL22: An immunotoxin targeting CD22, also known as moxetumomab pasudotox.
ZINTEROL: A beta-2 adrenergic receptor agonist.
FRAXINE: A natural coumarin glucoside.
TRIS(2,3-DIBROMOPROPYL)PHOSPHATE: A brominated flame retardant.
[125I]KISSPEPTIN-13 (HUMAN): Radioiodinated human kisspeptin-13 for receptor binding studies.
CORYNEBACTERIUM GRANULOSUM P40: An immunomodulator derived from bacteria.
ATX08-001: An experimental research chemical.
GS39783: An experimental positive allosteric modulator of the GABA-B receptor.
BUTONATE: An organophosphate insecticide.
EXAMPLE 265 [WO2019097515A1]: A specific compound described in the cited patent application.
BIAFINE CREAM: A topical emulsion used for wound and burn healing.
THR10CONTULAKIN-G: A synthetic analogue of a cone snail toxin peptide.
TRIMETHOPRIM/SULFADOXINE: A combination antibiotic and antiprotozoal drug.
FERRITARG P: An experimental compound.
BRORPHINE: A potent synthetic opioid of the piperidine class.
RADRETUMAB: An experimental monoclonal antibody used in radioimmunotherapy.
RESOLVIN D1: A lipid mediator derived from omega-3 fatty acids with pro-resolving properties.
MUSCLE RELAXANT: A drug that decreases skeletal muscle tone.
TECALCET HYDROCHLORIDE: A calcimimetic agent for secondary hyperparathyroidism.
UBP302: A selective antagonist for the kainate receptor.
AZOCYCLOTIN: An organotin acaricide.
CALOTHRIXIN A: A natural compound with anti-cancer and anti-malarial activity.
BELLADONNA EXTRACT, USP: An extract from the Atropa belladonna plant containing anticholinergic alkaloids.
[125I]EYF: A radiolabeled peptide.
[3H]GASTRIN: Tritiated gastrin, a radiolabeled peptide hormone.
VEGFD: Vascular Endothelial Growth Factor D, a protein involved in lymphangiogenesis.
GESTRINONE: A synthetic steroid with anti-progestogen, anti-estrogen, and anti-gonadotropin properties.
PBIT: A selective antagonist of the melatonin MT2 receptor.
DS69910557: An experimental research chemical.
PETROSIOL A: A natural marine compound.
BASS ANTAGONIST: A substance that blocks the action of a BASS protein.
ERUCIN: An isothiocyanate found in cruciferous vegetables with potential anti-cancer effects.
ELZASONAN HYDROCHloride: An experimental dual 5-HT1B/1D receptor antagonist.
2-BROMOETHANOL: A chemical compound.
VRC-01LS: A long-acting broadly neutralizing antibody against HIV.
D4476: An inhibitor of casein kinase 1 (CK1).
TOMUZOTUXIMAB: An experimental monoclonal antibody targeting the MUC1 antigen.
ALBUVIRTIDE: A long-acting HIV fusion inhibitor.
[125I]EXENDIN-(9-39): A radioiodinated antagonist of the GLP-1 receptor.
APRINDINE: A class I antiarrhythmic agent.
TY-51469: An experimental research chemical.
T-BOC-MET-LEU-PHE: A protected form of the fMLP chemotactic peptide.
GALANIN(1-11): An N-terminal fragment of the neuropeptide galanin.
L-368,228: An experimental research chemical.
PIRMENOL: A class Ia antiarrhythmic agent.
MINNELIDE: A water-soluble prodrug of triptolide with anti-cancer activity.
L-783483: An experimental research chemical.
TALIBEGRON HYDROCHLORIDE: An experimental beta-3 adrenoceptor agonist.
ISOPROPYL ISOTHIOCYANATE: An organosulfur compound found in some plants.
GASTRIN RELEASING PEPTIDE(14-27) (HUMAN): A C-terminal fragment of human GRP.
PSB-0963: An experimental research chemical.
CHELIDAMIC ACID: A heterocyclic organic compound.
OPC-28326: An experimental vasopressin V2 receptor agonist.
GLAUCARUBINONE: A natural quassinoid with antimalarial and anticancer activity.
AZIDOPINE: A dihydropyridine calcium channel blocker used as a photoaffinity label.
LONDAMOCITINIB: An experimental Janus kinase (JAK) inhibitor.
O-ARACHIDONOYL ETHANOLAMINE: Virodhamine, an endogenous cannabinoid.
[67GA]NODAGA-[TYR3]OCTREOTIDE: A gallium-67 radiolabeled somatostatin analogue for imaging.
BELUMOSUDIL MESYLATE: A ROCK2 inhibitor for chronic graft-versus-host disease.
UP3U: An experimental research chemical.
VALERIAN ROOT EXTRACT: A herbal supplement used as a sedative.
SEPHB4-HSA: An experimental fusion protein.
PROTECTED SIPHONODICTYAL C: A chemically protected form of a natural marine compound.
BCL-2 INHIBITOR: A drug that blocks the B-cell lymphoma 2 (Bcl-2) protein.
ETOPOSIDE PHOSPHATE: A water-soluble prodrug of etoposide, a topoisomerase II inhibitor.
BIPERIDEN LACTATE: The lactate salt of biperiden, an anticholinergic drug.
SAXAGLIPTIN HYDROCHLORIDE: A dipeptidyl peptidase-4 (DPP-4) inhibitor for type 2 diabetes.
INSULIN ZINC SUSP PROMPT PURIFIED PORK: A rapid-acting insulin preparation from pigs.
S6716: An experimental research chemical.
ZICONOTIDE ACETATE: A synthetic peptide that blocks N-type calcium channels for severe pain.
MEPHENTERMINE SULFATE: A cardiac stimulant and sympathomimetic amine.
GSK-610677: An experimental research chemical.
PHE377: An experimental research chemical.
PATECLIZUMAB: An experimental monoclonal antibody targeting the CEA antigen.
L19SIP 131I: A radioimmunoconjugate used in radioimmunotherapy.
NAVEGLITAZAR: A dual PPAR alpha/gamma agonist.
SCH-708980: An experimental research chemical.
LLL12: An experimental STAT3 inhibitor.
CDP-484: An experimental research chemical.
HUPAM4: An experimental research chemical.
MARSTACIMAB: An experimental monoclonal antibody that inhibits tissue factor pathway inhibitor (TFPI).
GLPG-1205: An experimental GPR84 antagonist.
SGS-742: An experimental GABA-B receptor antagonist.
GSK-1292263: An experimental selective androgen receptor modulator (SARM).
[125I]CCL25 (HUMAN): Radioiodinated human CCL25 chemokine for receptor binding studies.
MK-4280: An experimental monoclonal antibody targeting the GITR receptor.
ZIPALERTINIB: An experimental EGFR tyrosine kinase inhibitor.
TAFOLECIMAB: An experimental monoclonal antibody.
COFORMYCIN: An adenosine deaminase inhibitor.
INSULIN ZINC, EXTENDED: A long-acting insulin preparation.
APIOL: An organic compound found in parsley and celery leaf essential oil.
CLOPERASTINE HYDROCLORIDE: A cough suppressant.
(S)-FTY720P: The active phosphorylated form of fingolimod.
AMMONIA SOLUTION, STRONG: A concentrated solution of ammonia in water.
CAULIBUGULONE C: A natural marine compound.
PINORESINOL: A lignan found in various plants.
SERICETIN DIACETATE: A derivative of a natural flavonoid.
AESCULIOSIDE IIIE: A natural triterpenoid saponin.
GW434756X: An experimental research chemical from GlaxoSmithKline.
BETANAPHTHOL: 2-Naphthol, an isomer of naphthol.
KANZONOL W: A natural prenylated flavonoid.
SALSOLINOL HYDROBROMIDE: The salt of salsolinol, a dopamine-derived alkaloid.
PIPOXOLAN HYDROCHLORIDE: An antispasmodic drug.
CINNAMIC ACID HYDROXAMATE: A chemical compound with potential biological activity.
APOCIDEINE: A natural product.
5,7-DIMETHOXYISOFLAVONE: A methoxylated isoflavone.
PARGYLINE: An irreversible monoamine oxidase B (MAO-B) inhibitor.
MANASSANTIN B: A natural lignan with neuroprotective properties.
KOJIC ACID: A natural compound used in skin care for its whitening effect.
SULFATED PENTAGALLOYLGLUCOSIDE: A sulfated derivative of a tannin.
LORGLUMIDE SODIUM: The sodium salt of lorglumide, a cholecystokinin antagonist.
BUTOCONAZOLE: An imidazole antifungal medication.
BERKELEYACETAL A: A natural product isolated from fungi.
OXYPHENISATIN: A laxative that was withdrawn from the market.
DEMETON S: An organophosphate insecticide.
TRICITRINOL B: A natural meroterpenoid compound.
ALPHA-TOCOPHEROL ACETATE: A synthetic form of Vitamin E.
NITROGEN MUSTARD HN-3: A potent alkylating agent and chemical warfare agent.
PHENYLHYDRAZINE: An organic compound used in chemical synthesis.
CARIPORIDE: An experimental inhibitor of the Na+/H+ exchanger NHE-1.
ANDROSTERONE: An androgen steroid hormone.
BENZIDINE: A carcinogenic aromatic amine.
TRIMETHYLCOLCHICINIC ACID: A derivative of colchicine.
PTAEROXYLIN: A natural chromone compound.
PYRENE: A polycyclic aromatic hydrocarbon.
PIPENZOLATE: An anticholinergic drug.
BENZOPHENONE-THIOSEMICARBAZONE: A chemical compound with potential biological activity.
6-BROMOFLAVONE: A synthetic brominated flavone.
0-HEXYL-1,3-DIAMINE-PLATINUM 2,2-DICHLORIDE: A platinum-based chemical compound.
GW819230X: An experimental research chemical from GlaxoSmithKline.
NAFTIFINE: An allylamine antifungal drug.
GSK-1023156A: An experimental research chemical.
DESMETHYLENYLNOCARDAMINE: A siderophore molecule.
PERVILLEINE F: A natural alkaloid.
POLYSIALIC ACID: A polysaccharide involved in neural development and cancer metastasis.
ZEBULARINE: A cytidine analog that acts as a DNA methyltransferase inhibitor.
RECOMBINANT MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA: A genetically engineered version of the chemokine CCL3.
XANTHINE OXIDASE INHIBITOR: A drug that blocks the enzyme xanthine oxidase, used for gout.
RECOMBINANT FIBROBLAST GROWTH FACTOR 4: A genetically engineered version of the FGF4 protein.
AROMATASE INHIBITOR: A class of drugs that suppress estrogen production, used for breast cancer.
MICRONOMICIN: An aminoglycoside antibiotic.
ELBASVIR/GRAZOPREVIR: A combination drug used to treat Hepatitis C.
VULOLISIB: An experimental dual PI3K alpha/delta inhibitor.
ANTI-NUCLEOLIN APTAMER AS1411: An experimental aptamer-based drug for cancer.
A-395: An experimental research chemical.
DECANOIC ACID: A saturated fatty acid, also known as capric acid.
MITOQUINONE MESYLATE: A mitochondria-targeted antioxidant.
PMI-001: An experimental research chemical.
PAMOIC ACID: An organic compound used to form salts of drugs to reduce solubility.
MODOTUXIMAB: An experimental monoclonal antibody.
BTK INHIBITOR TL-895: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
FELEZONEXOR: An experimental research chemical.
CSF1R INHIBITOR PLX73086: An experimental compound that inhibits the CSF1R kinase.
STM 434: An experimental research chemical.
PTI-110: An experimental research chemical.
SIMOTAXEL: An experimental taxane derivative for cancer.
GSK-2239633: An experimental research chemical.
LEUVECTIN: An experimental gene therapy product.
SAFIRONIL: A herbicide safener.
EPITALON: A synthetic tetrapeptide with purported anti-aging effects.
GADOBENATE DIMEGLUMINE: A gadolinium-based MRI contrast agent.
FUMARIC ACID: An organic acid used as a food additive and in medicine.
CDX-1135: An experimental monoclonal antibody targeting the CDX-1 receptor.
PAQUINIMOD: An experimental immunomodulator for autoimmune diseases.
P-BCMA-101: An investigational CAR-T cell therapy targeting BCMA.
IOFLUPANE I-123: A radiopharmaceutical used for SPECT imaging of dopamine transporters.
AMINOLEVULINIC ACID HYDROCHLORIDE: A photosensitizing agent used in photodynamic therapy.
L-377202: An experimental research chemical.
TOFOGLIFLOZIN: An SGLT2 inhibitor drug for type 2 diabetes.
BMS-184476: An experimental research chemical.
DIAPEP-277: An experimental peptide-based immunotherapy for type 1 diabetes.
SB 714786: An experimental research chemical.
[3H]LSD: Tritiated lysergic acid diethylamide, a radiolabeled hallucinogen.
COMPOUND 5M [PMID: 20483621]: A research compound described in the cited publication.
REC 15/2615: An experimental compound.
BCL3 INHIBITOR JS6: An experimental compound that inhibits the BCL3 protein.
COMPOUND A [PMID: 28324017]: A research compound described in the specified scientific literature.
ICI-89406: An experimental beta-2 adrenergic agonist.
BI-7273: An experimental BET bromodomain inhibitor.
BTK INHIBITOR 16 [PMID: 30122225]: A research compound described in the cited publication.
AC-LYS-[MEALA6,LEU8,DES-ARG9]BRADYKININ: A synthetic bradykinin analogue.
[3H]LYS-[LEU8][DES-ARG9]BK: A radiolabeled bradykinin B1 receptor agonist.
JPE1375: An experimental research chemical.
SB-282241: An experimental research chemical.
COMPOUND 8IC [PMID: 19081254]: A research compound described in the cited publication.
COMPOUND 12A [PMID: 29031075]: A research compound described in the cited publication.
[125I]CXCL12&ALPHA; (HUMAN): Radioiodinated human CXCL12 alpha chemokine for receptor binding studies.
T22: A peptide-based antagonist of the CXCR4 receptor.
QR-6401: An experimental research chemical.
GSK931145: An experimental research chemical from GlaxoSmithKline.
EBVACICLIB: An experimental cyclin-dependent kinase (CDK) inhibitor.
DALPICICLIB: An experimental CDK4/6 inhibitor.
LY3405105: An experimental research chemical.
R116010: An experimental research chemical.
COMPOUND 38A [PMID: 15634016]: A research compound described in the cited publication.
AMINOOXYACETIC ACID: An inhibitor of several enzymes, including GABA transaminase.
BILORPHIN: An endogenous opioid peptide derived from bile.
[3H]DELTORPHIN II: A radiolabeled selective delta-opioid receptor agonist.
COMPOUND 23N [PMID: 24900877]: A research compound described in the cited publication.
PK 11195: A selective ligand for the translocator protein (TSPO).
COMPOUND 22 [PMID: 19899765]: A research compound described in the specified scientific literature.
CPTB: An experimental positive allosteric modulator of the mGluR5 receptor.
TUG-2304: An experimental research chemical.
COMPOUND 7D [PMID: 29672049]: A research compound described in the cited publication.
SHAAGTIDE: A synthetic peptide.
[125I-TYR]AC2-26: A radioiodinated annexin A1 mimetic peptide.
GALANIN(9-25) (RAT/MOUSE): A fragment of the neuropeptide galanin.
GALANIN(1-20) (HUMAN): An N-terminal fragment of human galanin.
J18 (GALANIN ANALOGUE): A synthetic analogue of the neuropeptide galanin.
COMPOUND 51 [PMID: 18800762]: A research compound described in the specified scientific literature.
GRASP: An experimental research chemical.
HGCGR ANTAGONIST: A substance that blocks the human glucagon receptor.
ICLEPERTIN: An experimental glycine transporter-1 (GlyT1) inhibitor.
ANHYDROUS ZINC ACETATE: A form of zinc acetate without water.
[125I]CNP (HUMAN): Radioiodinated human C-type natriuretic peptide.
HISTAPRODIFEN: A selective histamine H1 receptor agonist.
2-PYRIDYLETHYLAMINE: A histamine H1 receptor agonist.
2-(2-THIAZOLYL)ETHANAMINE: A selective histamine H1 receptor agonist.
(+)-CIS-H2-PAT: An experimental research chemical.
IMPENTAMINE: A potent histamine H3 receptor agonist.
ST-1505: An experimental research chemical.
DIOLEOYLPHOSPHATIDIC ACID: A type of phosphatidic acid, a signaling lipid.
KISSPEPTIN-13: A peptide hormone that stimulates GnRH release.
JNJ303: An experimental research chemical.
NSC61610: An experimental research chemical.
H2L5186303: An experimental research chemical.
ONO-9910539: An experimental research chemical.
ALKYL OMPT: An experimental research chemical.
ONO-3080573: An experimental research chemical.
S36077: An experimental research chemical.
MS05: An experimental research chemical.
AP1189: An experimental immunomodulator.
COMPOUND 11Q [PMID: 19433355]: A research compound described in the cited publication.
FARNESYL THIODIPHOSPHATE: An analogue of farnesyl diphosphate.
ML375: A selective inhibitor of the urea transporter UT-B.
VU0238429: A positive allosteric modulator of the mGluR5 receptor.
CBOBNEA: An experimental research chemical.
COMPOUND 87 [PMID: 20942471]: A research compound described in the cited publication.
BI01383298: An experimental research chemical.
&ALPHA;-CONOTOXIN ARIB: A peptide toxin from cone snails that blocks nicotinic acetylcholine receptors.
[125I]NEUROMEDIN U-23 (RAT): Radioiodinated rat neuromedin U-23.
L-368,899: An experimental oxytocin receptor antagonist.
REV-5901: An inhibitor of leukotriene synthesis.
MRS2496: An experimental research chemical.
GYPGKF-NH2: A synthetic peptide.
MRL24: An experimental research chemical.
COMPOUND 22 [PMID: 24754609]: A research compound described in the specified scientific literature.
PF-06843195: An experimental research chemical from Pfizer.
COMPOUND 27 [PMID: 22142545]: A research compound described in the specified scientific literature.
COMPOUND 1 [PMID: 26055709]: A research compound described in the specified scientific literature.
COMPOUND 9 [LIN ET AL., 2023]: A research compound described in the cited 2023 publication.
GNF-6231: An experimental TrkB receptor agonist.
[ALA1,12,AIB3,GLN10,HARG11,TRP14,ARG19]PTH-(1-28)-NH2 (HUMAN): A synthetic analogue of parathyroid hormone.
PTHRP-(1-36): A peptide fragment of parathyroid hormone-related protein.
TINLORAFENIB: An experimental RAF/VEGFR2 inhibitor.
6.00E+11: A numerical identifier, possibly for a research compound.
ESI-09: An inhibitor of the guanine nucleotide exchange factor EPAC1.
RASGRP ACTIVATOR 1: A research chemical that activates Ras guanyl-releasing proteins.
TAS1553: An experimental research chemical.
FMK: An abbreviation for fluoromethyl ketone, a functional group in some enzyme inhibitors.
[125I]RELAXIN (HUMAN): Radioiodinated human relaxin for receptor binding studies.
AUY954: An experimental Hsp90 inhibitor.
BAY-598: An experimental research chemical.
TOFOGLIFLOZIN ANHYDROUS: The anhydrous form of tofogliflozin, an SGLT2 inhibitor.
BN-81,644: An experimental research chemical.
DIBENZOXAZEPINE: A tricyclic chemical structure, the basis for some drugs.
NITROOLEIC ACID: A nitrated fatty acid with signaling properties.
AP18: An experimental clathrin inhibitor.
OPTODARG: An experimental compound.
SB366791: A selective antagonist of the TRPV1 ion channel.
BCTC: A non-competitive antagonist of the TRPV1 channel.
AMG 9810: A competitive antagonist of the TRPV1 ion channel.
ANTI-PD1 MONOCLONAL ANTIBODY: A class of immunotherapy drugs that block the PD-1 checkpoint.
MEK-1/MEKK-1 INHIBITOR E6201: An experimental dual kinase inhibitor.
EZH2 INHIBITOR: A drug that blocks the enzyme EZH2, used for certain cancers.
SAFUSIDENIB: An experimental inhibitor of mutant isocitrate dehydrogenase 1 (IDH1).
THE-630: An experimental pan-KIT/PDGFRA inhibitor.
PFIZER COMPOUND 67 [PMID:18445527]: A research compound described in the cited publication.
AR-C118925XX: An experimental antagonist of the P2Y12 receptor.
GALANIN(1-19) (HUMAN): An N-terminal fragment of human galanin.
[ILE5,TRP23]PTHRP-(5-36) (HUMAN): A synthetic analogue of human parathyroid hormone-related protein.
PEGINESATIDE ACETATE: A synthetic peptide-based erythropoiesis-stimulating agent.
2'-EPI-TUBERATOLIDE B: An isomer of a natural marine compound.
VAMOTINIB: An experimental tyrosine kinase inhibitor.
ML297: A selective activator of the potassium channel KCNQ2.
IMNOPITANT: An experimental tachykinin NK2 receptor antagonist.
INSL5-A13NR: An experimental research chemical.
INSULIN ZINC SUSP RECOMBINANT HUMAN: A formulation of genetically engineered human insulin.
BALAGLITAZONE: A thiazolidinedione drug that acts as a PPAR-gamma agonist.
AR-9281: An experimental soluble epoxide hydrolase inhibitor.
PROPOXYPHENE HYDROCHLORIDE: The salt form of propoxyphene, an opioid analgesic.
ZOPOLRESTAT: An experimental aldose reductase inhibitor.
YTTRIUM Y 90 LABETUZUMAB: A radioimmunoconjugate targeting the CD74 antigen.
H-C[DCYS-PHE-LAGL(N&BETA;ME,BENZOYL)-DTRP-LYS-THR-PHE-CYS]-OH: A complex synthetic peptide.
BUFEXAMAC: A topical non-steroidal anti-inflammatory drug.
E1001: An experimental research chemical.
THEONELLASTEROL D: A natural marine sterol.
TUBERATOLIDE B: A natural marine compound with cytotoxic activity.
EDECESERTIB: An experimental CDC7 kinase inhibitor.
[3H]PGF2&ALPHA;: Tritiated prostaglandin F2-alpha, a radiolabeled lipid mediator.
CHLOROXYLENOL: An antiseptic and disinfectant.
M15: A galanin receptor antagonist.
INIXACICLIB: An experimental cyclin-dependent kinase (CDK) inhibitor.
COMPOUND G1 [PMID: 36689364]: A research compound described in the cited 2023 publication.
COMPOUND 22 [PMID: 17276684]: A research compound described in the specified scientific literature.
ANTI-CD7 CAR T CELLS PREPARATION: CAR-T cells engineered to target the CD7 antigen.
FLEROXACIN: A fluoroquinolone antibiotic.
LUF5831: An experimental research chemical.
LG100754: A selective antagonist for the retinoid X receptor (RXR).
LITENIMOD: An experimental Toll-like receptor 7 (TLR7) agonist.
CXCL12-(1-9): A peptide fragment of the chemokine CXCL12.
NE58062: An experimental research chemical.
AFELETECAN: An experimental topoisomerase I inhibitor.
ISO-1: An inhibitor of macrophage migration inhibitory factor (MIF).
BRASOFENSINE: A dopamine transporter inhibitor.
KN-62: An inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII).
PHENYL-&BETA;-D-GLUCOPYRANOSIDE: A chemical compound.
PF-06751979: An experimental research chemical from Pfizer.
COMPOUND 11D [PMID: 34406006]: A research compound described in the cited 2021 publication.
GIMATECAN: An experimental topoisomerase I inhibitor.
5-HYDROXYINDOLE: A metabolite of tryptophan.
MIVEBRESIB: An experimental BET bromodomain inhibitor.
VPC12249: An experimental antagonist for the lysophosphatidic acid (LPA) receptor.
MUTANT ANP: A mutated form of atrial natriuretic peptide.
TELAPRISTONE ACETATE: A selective progesterone receptor modulator.
ATOGEPANT: A CGRP receptor antagonist for the preventive treatment of migraine.
CGP-71683A: An experimental GABA-B receptor antagonist.
BENZIMIDAZOLE: A heterocyclic aromatic organic compound, a core structure in many drugs.
7-O-METHYLCRYPTOCHINONE A: A methylated derivative of a natural compound.
SALVIANOLIC ACID B: A natural polyphenolic compound from Salvia miltiorrhiza.
GW852849X: An experimental research chemical from GlaxoSmithKline.
MOEXIPRIL HYDROCHLORIDE: An ACE inhibitor used to treat hypertension.
RAXIBACUMAB: A monoclonal antibody used to treat and prevent inhalational anthrax.
OPIORPHIN: An endogenous peptide that inhibits enkephalin-degrading enzymes.
SULFANITRAN: An antibacterial agent used in veterinary medicine.
ENMD-1198: An experimental research chemical.
[125I]TYR10NPS (HUMAN): A radioiodinated ligand for the neuropeptide S receptor.
PQR620: An experimental dual PI3K/mTOR inhibitor.
[3H]PYRILAMINE: A radiolabeled antihistamine.
M195: An experimental monoclonal antibody.
PRADEMAGENE ZAMIKERACEL: An experimental gene therapy.
AXITIROME: An experimental thyromimetic agent.
MISONIDAZOLE: A radiosensitizing agent used in cancer radiotherapy.
SERATRODAST: A thromboxane A2 receptor antagonist.
CYM-50358: An agonist for the sphingosine-1-phosphate receptor 4 (S1PR4).
ANTI-EGFRVIII IMMUNOTOXIN MR1-1: An immunotoxin targeting the EGFRvIII mutation in cancer.
ZAVEGEPANT: A CGRP receptor antagonist for the acute treatment of migraine.
AZM-475271: An experimental connexin channel modulator.
CR4056: An experimental analgesic that acts as a modulator of I2 imidazoline receptors.
L-152,804: An antagonist of the cholecystokinin B (CCK2) receptor.
METHYL YELLOW: An acid-base indicator dye.
AS-19: An agonist for the 5-HT7 serotonin receptor.
BENZQUINAMIDE HYDROCHLORIDE: An antiemetic drug.
GRANISETRON HYDROCHLORIDE: A 5-HT3 antagonist used to prevent nausea and vomiting.
BETAMETHASONE BENZOATE: A synthetic glucocorticoid steroid.
PENTOLINIUM TARTRATE: A ganglionic blocking agent once used for hypertension.
DIETHYLCARBAMAZINE: An anthelmintic drug used to treat filariasis.
ASP-3026: An experimental research chemical.
MK-0533: An experimental research chemical.
NS-018: An experimental Janus kinase (JAK) inhibitor.
AZD3199: An experimental long-acting beta-2 agonist (LABA).
SQUALAMINE LACTATE: An aminosterol with anti-angiogenic properties.
CEDELIZUMAB: An experimental monoclonal antibody targeting the CD4 protein.
CABOTEGRAVIR: An integrase inhibitor for the treatment and prevention of HIV.
IERAMILIMAB: An experimental monoclonal antibody.
TIRAGOLUMAB: An experimental monoclonal antibody targeting the TIGIT immune checkpoint.
TECLISTAMAB-CQYV: A bispecific antibody targeting BCMA and CD3 for multiple myeloma.
VANUTIDE CRIDIFICAR: An experimental peptide-drug conjugate.
CROVALIMAB: An experimental monoclonal antibody that inhibits complement C5.
OLACAFTOR: A component of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy.
VILANTEROL .ALPHA.-PHENYL CINNAMATE: A component of vilanterol, a long-acting beta-2 agonist.
SVN53-67/M57-KLH PEPTIDE VACCINE: An experimental cancer vaccine targeting the survivin protein.
(+)-5-(5-BROMOTHIOPHEN-3-YL)-5-METHYL-4-OXO-4,5-DIHYDRO-FURAN-2-CARBOXYLIC ACID: A complex organic compound.
THROMBOPOIETIN: A hormone that regulates the production of platelets.
NPY-(18-36) (HUMAN, PIG): A C-terminal fragment of Neuropeptide Y.
GLIOTOXIN: A toxic metabolite produced by fungi with immunosuppressive properties.
HISPIDIN: A natural polyphenol compound.
5-HYDROXYFLAVONE: A synthetic flavone.
3-AMINOBENZAMIDE: An inhibitor of the enzyme PARP.
METHABENZTHIAZURON: A urea herbicide.
UDENAFIL: A PDE5 inhibitor used to treat erectile dysfunction.
ALPHAPRODINE HYDROCHLORIDE: A synthetic opioid analgesic.
NAMOLINE: An experimental research chemical.
CARFENTRAZONE-ETHYL: A triazolinone herbicide.
INDOMETHACIN MORPHOLINYLAMIDE: A derivative of the NSAID indomethacin.
BIPHENYL-4-AMINE: An organic compound.
LULICONAZOLE: An imidazole antifungal medication.
LOMIFYLLINE: A xanthine derivative with peripheral vasodilator effects.
L902688: An experimental research chemical.
LY382884: An experimental research chemical.
[(PF)PHE4]N/OFQ-(1-13)-NH2: A potent agonist for the nociceptin/orphanin FQ (NOP) receptor.
MRL-871: An experimental research chemical.
HOOKEROSIDE B: A natural glycoside.
RIFAMYCIN SODIUM: The sodium salt of rifamycin, an antibiotic.
BISDEMETHOXYCURCUMIN: A natural curcuminoid found in turmeric.
SANTIN: A natural flavonoid compound.
DESACETYL SALANNIN: A natural limonoid compound.
CIMIRACEMATE A: A natural compound.
PHENYLETHENYLSEMICARBAZONE: A chemical compound.
NAPROPAMIDE: A selective herbicide.
FANETIZOLE: An immunomodulatory drug.
LACTACYSTIN: A natural product that acts as a potent proteasome inhibitor.
7-METHYLXANTHINE: A metabolite of caffeine.
HARMOL HYDROCHLORIDE: The salt form of harmol, a fluorescent alkaloid.
GW827099X: An experimental research chemical from GlaxoSmithKline.
AG 1296: An inhibitor of the platelet-derived growth factor (PDGF) receptor kinase.
SAPONIN: A class of chemical compounds found in various plant species.
VIRGINIAMYCIN M1: A component of the virginiamycin antibiotic complex.
RECOMBINANT HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1 BETA: A genetically engineered version of the chemokine CCL4.
MEK INHIBITOR PD-98059: A research chemical that inhibits the MEK1 enzyme.
COBALT CO-60: A radioactive isotope of cobalt used in radiotherapy and sterilization.
TINIDAZOLE: A nitroimidazole antibiotic and antiprotozoal drug.
CARBOGEN: A mixture of carbon dioxide and oxygen gas, used as a respiratory stimulant.
NORMEPERIDINE: A major metabolite of the opioid analgesic pethidine (meperidine).
ASK-8007: An experimental compound.
PAFURAMIDINE: An experimental antiprotozoal agent.
COLLOIDAL GOLD-BOUND TUMOR NECROSIS FACTOR: An experimental cancer therapy agent using gold nanoparticles to deliver TNF.
CX-717: An ampakine compound investigated for its nootropic effects.
GANTACURIUM: An experimental non-depolarizing neuromuscular blocking agent.
ISS-1018: An experimental immunostimulatory sequence oligonucleotide.
ALDAFERMIN: A recombinant analogue of human fibroblast growth factor 19 (FGF19).
VONAPANITASE: Recombinant human elastase 1, an experimental therapeutic enzyme.
SAN-300: An experimental compound.
GIMERACIL: An inhibitor of dihydropyrimidine dehydrogenase (DPD), used with tegafur in cancer therapy.
ANTI-CEA/ANTI-HSG BISPECIFIC MONOCLONAL ANTIBODY TF2: An experimental bispecific antibody for pretargeted radioimmunotherapy.
TZP-102: An experimental ghrelin receptor agonist for diabetic gastroparesis.
ZYC300: An experimental DNA vaccine.
AVORALSTAT: An experimental plasma kallikrein inhibitor.
GSK3050002: An experimental monoclonal antibody targeting PcrV for Pseudomonas aeruginosa infections.
LINZAGOLIX: An oral GnRH receptor antagonist for uterine fibroids.
APRUTUMAB: An experimental monoclonal antibody.
MORAB-066: An experimental monoclonal antibody.
AG-858: An experimental research chemical.
CT-2584: An experimental research chemical.
ACRIDINE CARBOXAMIDE: A class of DNA-intercalating compounds studied for anti-cancer activity.
LEVOBETAXOLOL: The active S-enantiomer of betaxolol, a beta-adrenergic receptor blocker.
CAREBASTINE: The active metabolite of ebastine, a non-sedating antihistamine.
ENCALERET SULFATE: An experimental calcium-sensing receptor (CaSR) antagonist.
GRANOTAPIDE: An experimental microsomal triglyceride transfer protein (MTP) inhibitor.
CYCLIZINE LACTATE: The lactate salt of cyclizine, an antihistamine used for nausea and vomiting.
ASFOTASE ALFA: A recombinant human tissue-nonspecific alkaline phosphatase for hypophosphatasia.
EZABENLIMAB: An experimental anti-PD-1 monoclonal antibody.
GLYCOVIR: An experimental antiviral agent.
SODIUM TAUROCHOLATE: A primary bile salt involved in the digestion of fats.
ALPHA-CONOTOXIN VC 1.1: A peptide toxin from cone snails that targets nicotinic acetylcholine receptors.
PALIRODEN: An experimental 5-HT1A receptor agonist.
PROMESTRIENE: A synthetic estrogen used topically for vaginal atrophy.
CIRMTUZUMAB: An experimental monoclonal antibody targeting the ROR1 antigen.
PKUMDL_MH_1001: An identifier for a research compound.
LY293284: An experimental research chemical.
U92016A: An experimental research chemical.
S-14506: An experimental thromboxane A2 receptor antagonist.
BUPIVACAINE HYDROCHLORIDE: A local anesthetic of the amide type.
SDZ-216525: An experimental research chemical.
PSEUDOEPHEDRINE SULFATE: A salt of pseudoephedrine, a sympathomimetic drug used as a decongestant.
DROTRECOGIN ALFA (ACTIVATED): Recombinant human activated protein C, withdrawn from the market.
E55888: An experimental research chemical.
A134974: An experimental research chemical.
FD1: An experimental research chemical.
TDI-11861: An experimental research chemical.
FASIDOTRIL: An experimental dual inhibitor of ACE and neutral endopeptidase.
ML233: A selective inhibitor of the potassium channel Kir4.1.
ELABELA/TODDLER-32: A 32-amino acid form of the peptide hormone Elabela.
MM54: A synthetic antagonist for the formyl peptide receptor 2 (FPR2).
MRS1065: An experimental research chemical.
DEXNIGULDIPINE: The active dextrorotatory enantiomer of niguldipine, a calcium channel blocker.
MPC-MECA: A research chemical, a selective agonist for the adenosine A3 receptor.
GARTISERTIB: An experimental ATP-competitive AKT inhibitor.
PF-8380: An inhibitor of autotaxin.
BI-2545: An experimental research chemical.
RANATENSIN: A bombesin-like peptide originally isolated from frog skin.
[125I]GRP (HUMAN): Radioiodinated human gastrin-releasing peptide.
[D-ARG1,D-TRP7,9,LEU11]SUBSTANCE P: A synthetic peptide antagonist of the substance P (NK1) receptor.
EXAMPLE 98 [WO2011020806]: A specific compound described in the cited patent application.
AZ3971: An experimental research chemical.
NDD-825: An experimental research chemical.
U75302: An antagonist of the leukotriene B4 (LTB4) receptor BLT1.
ONO-4057: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
BMX-IN-1: An experimental inhibitor of the BMX kinase.
OF-1: An experimental research chemical.
SB-423562: An experimental research chemical.
ATF936: An experimental research chemical.
CCL28: A chemokine involved in mucosal immunity.
ATIBUCLIMAB: An experimental monoclonal antibody.
[3H]MARAVIROC: A radiolabeled CCR5 receptor antagonist used in research.
INEBILIZUMAB: A monoclonal antibody targeting CD19 for neuromyelitis optica spectrum disorder.
CCR5 ANTAGONIST 34: A specific research chemical that antagonizes the CCR5 receptor.
MONZOSERTIB: An experimental Mps1 kinase inhibitor.
GATX2: An experimental research chemical.
BMS PYRAZOLE INHIBITOR 7F: A specific research chemical developed by Bristol Myers Squibb.
ERIBAXABAN: An experimental Factor Xa inhibitor.
ADRENOMEDULLIN: An endogenous peptide hormone with potent vasodilator activity.
CXCL8: A chemokine, also known as Interleukin-8 (IL-8), a major mediator of inflammation.
[3H]BWA868C: A radiolabeled prostanoid DP1 receptor agonist.
IBUPROFEN LYSINE: The lysine salt of ibuprofen, a rapidly absorbed formulation of the NSAID.
[125I]SCH23982: A radioiodinated antagonist for the dopamine D1 receptor.
A-381393: An experimental antagonist of the P2X7 receptor.
COMPOUND 49 [PMID: 36529947]: A research compound described in the cited 2022 publication.
FIRMONERTINIB: An experimental EGFR tyrosine kinase inhibitor.
BEFOTERTINIB: An experimental third-generation EGFR tyrosine kinase inhibitor.
MF266-1: An experimental research chemical.
11-DEOXY-PGE1: A synthetic analogue of prostaglandin E1.
CJ-042794: An antagonist of the prostanoid EP4 receptor.
ONO-AE-248: An experimental antagonist of the prostanoid EP3 receptor.
GW4064: An agonist for the farnesoid X receptor (FXR).
APRAGLUTIDE: An experimental long-acting GLP-2 analogue.
GLUCAGON-LIKE PEPTIDE 2: An endogenous peptide hormone that promotes intestinal growth.
[35S]ACPPB: A radiolabeled research compound.
COMPOUND 2 [PMID: 31932225]: A research compound described in the cited 2020 publication.
COMPOUND 20F [PMID: 21536438]: A research compound described in the cited publication.
SEA: Staphylococcal enterotoxin A, a superantigen produced by Staphylococcus aureus.
COMPOUND 3J [PMID: 21444206]: A research compound described in the cited publication.
COMPOUND 1 [PMID: 24900608]: A research compound described in the specified scientific literature.
YL-365: An experimental research chemical.
6-N-OCTYLAMINOURACIL: A chemical compound.
OSTN (115-133): A peptide fragment of osteocrin.
CGEN-857: An experimental research chemical.
CAROTEGRAST: An experimental alpha-4 integrin antagonist.
BIRT 377: An allosteric inhibitor of LFA-1.
LUPULONE: A beta-acid found in hops with antibacterial properties.
PLX5622: An experimental inhibitor of colony-stimulating factor 1 receptor (CSF1R).
SHK TOXIN: A peptide toxin from a sea anemone that blocks potassium channels.
COMPOUND 23A [PMID: 33417743]: A research compound described in the cited 2021 publication.
THIQ: An experimental research chemical.
COMPOUND 7B [PMID: 17583500]: A research compound described in the specified scientific literature.
IMAPRELIMAB: An experimental monoclonal antibody.
CTEP: An experimental negative allosteric modulator of the mGluR5 receptor.
COMPOUND 16M [PMID: 19931453]: A research compound described in the cited publication.
COMPOUND 31 [PMID: 23374866]: A research compound described in the specified scientific literature.
7ACC2: An experimental research chemical.
EM-523: An experimental research chemical.
ISOAMYL-AGOMELATINE: A derivative of the antidepressant agomelatine.
7NI: 7-Nitroindazole, an inhibitor of nitric oxide synthase.
WAGLERIN-1: A peptide toxin from viper venom that acts on nicotinic acetylcholine receptors.
&ALPHA;-CONOTOXIN AUIB: A peptide toxin from cone snails that targets nicotinic acetylcholine receptors.
[3H]A-585539: A radiolabeled selective alpha7 nicotinic receptor agonist.
NEUROPEPTIDE K: A tachykinin peptide derived from the preprotachykinin-A gene.
CPN-223: An experimental research chemical.
Y-RFRP-3: A research peptide related to RFamide peptides.
AC263093: An experimental research chemical.
(R)-YNT-3708: An experimental research chemical.
[3H]EMPA: A radiolabeled research compound.
RO3: An experimental research chemical.
PF-04905428: An experimental research chemical from Pfizer.
COMPOUND 4 [PMID: 22984835]: A research compound described in the cited scientific publication.
N4-PHENYLETHOXYCYTIDINE-5'-TRIPHOSPHATE: A modified nucleotide triphosphate.
SCH 40338: An experimental research chemical.
GSK2292767: An experimental research chemical.
T0156: An experimental research chemical.
PKR-A: An experimental research chemical.
CICLOPIROX: An antifungal agent used topically.
HPN: An experimental research chemical.
CD2665: A synthetic retinoid that acts as an antagonist for retinoic acid receptors.
BIX 02565: An experimental research chemical.
WNN0109-C011: An experimental research chemical.
EUROPIUM-LABELLED MOUSE INSL5: Europium-labeled mouse Insulin-like peptide 5 for assays.
(+)-SKF 10.047: N-allylnormetazocine, a ligand for sigma and opioid receptors.
SRT1720: An experimental SIRT1 activator.
MDL-800: An experimental research chemical.
DES-AA1,2,5,12,13-[D-TRP8]SRIF: A synthetic somatostatin analogue.
BIM 23058: A synthetic somatostatin analogue.
SST3-ODN-8: An experimental oligonucleotide.
STING AGONIST 2: A research chemical designed to activate the STING pathway.
COMPOUND 13 [PMID: 23098072]: A research compound described in the cited publication.
EP 171: An experimental research chemical.
VAPIPROST: A selective EP3 prostanoid receptor antagonist.
[125I]SQ-29548: A radioiodinated thromboxane receptor antagonist.
LBA: An experimental research chemical.
PENTAFLUORO-TRITYL CLOTRIMAZOLE ANALOGUE 29A: A derivative of the antifungal clotrimazole.
MALIC ACID: An organic acid found in fruits, used as a food additive.
[125I]BAY 55-9837: A radioiodinated research chemical.
D(CH2)5[D-ILE2,ILE4,TYR-NH29]AVP: A synthetic vasopressin analogue.
[125I]D(CH2)5[D-TYR(ET)2,ILE4,TYR-NH29]AVP: A radioiodinated vasopressin analogue.
XCL2: A chemokine also known as SCYB16.
C-MET INHIBITOR: A drug that blocks the c-Met receptor tyrosine kinase.
IDH2 MUTANT INHIBITOR SH1573: An experimental compound that inhibits mutant IDH2.
RET INHIBITOR APS03118: An experimental compound that inhibits the RET proto-oncogene.
GSK2830371: An experimental HIV maturation inhibitor.
PIPERAQUINE: An antimalarial drug.
[125I]KISSPEPTIN-14 (HUMAN): Radioiodinated human kisspeptin-14 for receptor binding studies.
SC-22716: An experimental research chemical.
PF-04236921: An experimental research chemical.
DICHLOROXYLENOL: A chlorinated phenol compound used as a disinfectant.
COMPOUND 2C [PMID: 2153213]: A research compound described in the cited 1990 publication.
COMPOUND 24 [PMID: 16451050]: A research compound described in the specified scientific literature.
MELANIN-CONCENTRATING HORMONE: An endogenous cyclic peptide hormone that regulates appetite.
ERYTHROMYCIN ESTOLATE: An ester of the macrolide antibiotic erythromycin.
[125I]CT (SALMON): Radioiodinated salmon calcitonin.
TASIDOTIN HYDROCHLORIDE: A synthetic peptide analogue with anticancer activity.
NORFENFLURAMINE: The active metabolite of fenfluramine, a serotonin-releasing agent.
CI-988: A selective antagonist of the cholecystokinin B (CCK2) receptor.
DG051: An experimental antagonist of the leukotriene A4 hydrolase.
A-908292: An experimental research chemical.
1-HYDROXY-6-(4-HYDROXY-PHENYL)-1-PHENYL-HEXAN-3-ONE (ENANTIOMERIC MIX): A chemical compound.
COMPOUND 2 [PMID: 21939274]: A research compound described in the cited publication.
MJN228: An experimental research chemical.
GW542573X: An experimental research chemical from GlaxoSmithKline.
PYRAFLUFEN-ETHYL: A protoporphyrinogen oxidase inhibitor used as a herbicide.
ISOGINKGETIN: A natural biflavonoid compound.
[125I]CCL8 (HUMAN): Radioiodinated human CCL8 chemokine for receptor binding studies.
MN-305: An experimental research chemical.
[3H]D[CHA4]AVP: A radiolabeled vasopressin analogue.
ACASUNLIMAB: An experimental monoclonal antibody.
(S,R)-MEFLOQUINE: An isomer of the antimalarial drug mefloquine.
RO-5458640: An experimental research chemical.
ELSILIMOMAB: An experimental monoclonal antibody targeting interleukin-6.
COMPOUND 4G [PMID: 30893553]: A research compound described in the cited 2019 publication.
BETA-GENTIOBIOSE: A disaccharide sugar.
PYRVINIUM PAMOATE: An anthelmintic drug used for pinworm infections.
(HYDROXYMETHYLPHENYL)AGOMELATINE: A derivative of the antidepressant agomelatine.
HINSL5: A8-21 (T9R): A synthetic analogue of Insulin-like peptide 5.
METHYLLYCACONITINE: A norditerpenoid alkaloid that acts as a potent nicotinic receptor antagonist.
SB 612111: A selective antagonist of the neuropeptide Y Y5 receptor.
USMARAPRIDE: An experimental drug that acts on serotonin and dopamine receptors.
MK 1903: An experimental inverse agonist for the GPR142 receptor.
BI6015: An experimental research chemical.
TELEOCIDIN B: A tumor promoter that activates protein kinase C.
AZERCABTAGENE ZAPRELEUCEL: An investigational CAR T-cell therapy.
VAPITADINE DIHYDROCHLORIDE: A non-sedating antihistamine.
(RS)-PPCC: A research chemical, a phenylglycine derivative used in glutamate receptor studies.
BAG-1: An experimental research chemical.
TENOFOVIR ALAFENAMIDE FUMARATE: A prodrug of tenofovir, an antiviral for HIV and hepatitis B.
GW642125X: An experimental research chemical from GlaxoSmithKline.
BPI-9016: An experimental c-Met inhibitor.
XL-019: An experimental research chemical.
GS-9667: An experimental non-nucleoside inhibitor of HCV NS5B polymerase.
BMS-189532: An experimental research chemical.
XEN403: An experimental research chemical.
COMPOUND 57 [PMID: 26155854]: A research compound described in the specified scientific literature.
GATIPOTUZUMAB: An experimental monoclonal antibody.
4'-METHOXY-AURONE: A methoxylated aurone compound.
BIIB-015: An experimental research chemical.
LUT014: An experimental research chemical.
SF-22: An experimental research chemical.
ANTIPYRINE: An analgesic and antipyretic drug.
AR234958: An experimental research chemical.
GW876790X: An experimental research chemical from GlaxoSmithKline.
ALOE VERA GEL: A gel derived from the aloe vera plant, used in cosmetics and for skin ailments.
FOSINOPRIL SODIUM: An ACE inhibitor used to treat hypertension.
ANTAZOLINE PHOSPHATE: An antihistamine and antiarrhythmic drug.
METOPROLOL FUMARATE: The fumarate salt of metoprolol, a beta-blocker.
ALLOPURINOL SODIUM: A soluble form of allopurinol, used for gout.
DANAPAROID SODIUM: An anticoagulant consisting of a mixture of heparanoids.
INSULIN ASPART PROTAMINE RECOMBINANT: A formulation of insulin aspart with protamine for intermediate action.
INSULIN LISPRO-AABC: An ultra-rapid acting formulation of insulin lispro.
BRETYLIUM TOSYLATE: A class III antiarrhythmic agent.
LY-3007113: An experimental research chemical.
MK-1496: An experimental research chemical.
VICRIVIROC MALEATE: An experimental CCR5 receptor antagonist for HIV.
HEMAY-022: An experimental research chemical.
MLN3126: An experimental CCR9 antagonist for inflammatory bowel disease.
IRDABISANT: An experimental histamine H3 receptor antagonist/inverse agonist.
BI113823: An experimental Pan-RAF kinase inhibitor.
IMD-2560: An experimental research chemical.
TEZOSENTAN: An endothelin receptor antagonist.
PF-04531083: An experimental research chemical.
NERELIMOMAB: An experimental monoclonal antibody targeting TNF-alpha.
CG250 177LU: A radioimmunoconjugate targeting the G250 antigen.
AL-901: An experimental research chemical.
IGOVOMAB: An experimental monoclonal antibody targeting the CA-125 antigen.
CORTIVAZOL: A synthetic glucocorticoid.
MDX-1303: An experimental research chemical.
RHIGM12B7: An experimental research chemical.
OZENOXACIN: A quinolone antibiotic used topically for impetigo.
SCY 635: An experimental cyclophilin inhibitor.
ISCALIMAB: An experimental monoclonal antibody targeting CD40.
NIMACIMAB: An experimental monoclonal antibody.
POZELIMAB: An experimental monoclonal antibody targeting complement C5.
GIROCTOCOGENE FITELPARVOVEC: A gene therapy for Hemophilia A.
CENSAVUDINE: An experimental nucleoside reverse transcriptase inhibitor (NRTI).
HETROMBOPAG OLAMINE: A thrombopoietin receptor agonist.
TRIMETAZIDINE: An anti-anginal agent.
ROCAGLAMIDE: A natural product with anti-cancer and anti-inflammatory activity.
DIHYDROXYPHENYLGLYCINE: An amino acid analogue used in neuroscience research.
ATOROLIMUMAB: An experimental monoclonal antibody.
AVE-1642: An experimental monoclonal antibody targeting the IGF-1 receptor.
BROMOPYROGALLOL RED: A chemical dye used as an indicator.
ISOXICAM: A non-steroidal anti-inflammatory drug (NSAID).
HEXAHYDROCURCUMIN: A hydrogenated derivative of curcumin.
PERBROMOBENZENE: A fully brominated benzene molecule.
(R)-SARGACHROMENOL: An enantiomer of a natural chromenol compound.
MACLURAXANTHONE: A natural xanthone compound.
A33 131I: A radioimmunoconjugate targeting the A33 antigen.
CASEARINOL B: A natural clerodane diterpene.
BENZAMIL HYDROCHLORIDE: An amiloride analogue that blocks sodium channels.
TELOMESTATIN: A potent telomerase inhibitor.
ENLIMOMAB: An experimental monoclonal antibody targeting the ICAM-1 protein.
CSL-360: An experimental monoclonal antibody targeting the C5a receptor.
SEGESTERONE ACETATE: A synthetic progestin hormone.
CPG-52852: An experimental research chemical.
(S)-MIDODRINE: The inactive enantiomer of the vasopressor midodrine.
DARBUFELONE MESYLATE: An experimental dual COX/5-LOX inhibitor.
SANDARACOPIMARIC ACID: A natural diterpenoid.
PYROXAMINE MALEATE: An antihistamine.
SENNOSIDE A: A natural laxative compound derived from senna plants.
PIPERIDOLATE HYDROCHLORIDE: An anticholinergic and antispasmodic drug.
4,2',4',6'-TETRAHYDROXYCHALCONE: A chalcone derivative.
PHENTHOATE: An organophosphate insecticide.
ARUNCIN B: A natural product.
YESSOTOXIN: A marine polyether toxin produced by dinoflagellates.
MAKALUVAMINE F: A marine alkaloid with topoisomerase II inhibitory activity.
RETUSIN: A natural flavonoid compound.
HERNIARIN: A natural coumarin, also known as 7-methoxycoumarin.
NSC 23766: An inhibitor of the Rac1 GTPase.
(20S,21S)-7-CYCLOHEXYLFLUOROCAMPTOTHECIN: A derivative of the topoisomerase I inhibitor camptothecin.
SUPROFEN METHYL ESTER: A derivative of the NSAID suprofen.
STAUROSPORINE AGLYCON: The core structure of staurosporine, a protein kinase inhibitor.
CASTANIN: A natural product.
(S)-SARGACHROMENOL: An enantiomer of a natural chromenol compound.
PICEID: A stilbenoid glucoside, a major derivative of resveratrol.
GW678313X: An experimental research chemical from GlaxoSmithKline.
HIPPURISTANOL: A natural polyoxygenated steroid that inhibits protein synthesis.
BENZOXAZOLINONE: A heterocyclic chemical compound.
DENDROAMIDE A: A cyclic depsipeptide from a marine sponge.
CARBONIC ANHYDRASE INHIBITOR: A class of drugs that inhibit the carbonic anhydrase enzyme.
MICAFUNGIN: An echinocandin antifungal drug.
OLINVACIMAB: An experimental monoclonal antibody.
RECOMBINANT INTERLEUKIN-1-ALPHA: A genetically engineered version of the IL-1 alpha cytokine.
OLUMACOSTAT GLASARETIL: An experimental inhibitor of acetyl-CoA carboxylase.
RECOMBINANT SOLUBLE HUMAN CD4 PROTEIN: A genetically engineered soluble form of the CD4 protein.
COMPOUND 32: An experimental research chemical.
DNA METHYLTRANSFERASE INHIBITOR: A class of drugs that inhibit DNA methylation.
PRUXELUTAMIDE: An experimental androgen receptor degrader.
BUDIGALIMAB: An experimental anti-PD-1 monoclonal antibody.
CSL-324: An experimental monoclonal antibody targeting the G-CSFR.
LEVILIMAB: An experimental monoclonal antibody targeting the IL-6 receptor.
DASIGLUCAGON: A soluble glucagon analogue for severe hypoglycemia.
EPETRABOROLE: An experimental leucyl-tRNA synthetase inhibitor for tuberculosis.
AFLATOXIN B1: A potent carcinogen produced by Aspergillus fungi.
UMECLIDINIUM BROMIDE/VILANTEROL: A combination LAMA/LABA drug for COPD.
BMN-044: An experimental compound.
CARBOXYAMIDOTRIAZOLE OROTATE: A salt form of a calcium signal inhibitor.
LODAPOLIMAB: An experimental monoclonal antibody.
OCTOCOG ALFA: Recombinant human coagulation Factor VIII.
ORISMILAST: An experimental phosphodiesterase-4 (PDE4) inhibitor.
DOPEXAMINE: A synthetic catecholamine that acts as a beta-2 and dopamine receptor agonist.
FLUOROQUINOLONE: A class of broad-spectrum antibiotics.
OXEGLITAZAR: A dual PPAR alpha/gamma agonist.
KGP94: An experimental research chemical.
STAT3 INHIBITOR OPB-31121: An experimental compound that inhibits STAT3 signaling.
HU3S193: An experimental research chemical.
ROSOXACIN: A quinolone antibiotic.
AUTOLOGOUS ANTI-CD19 CAR-T CELLS TBI-1501: An investigational CD19-targeted CAR T-cell therapy.
KITE-585: An investigational CAR T-cell therapy targeting BCMA.
ALACEPRIL: An ACE inhibitor drug.
BMS-188797: An experimental neutral endopeptidase inhibitor.
CL-329167: An experimental research chemical.
PBT-1033: An experimental research chemical.
AZETIRELIN: A thyrotropin-releasing hormone (TRH) analogue.
BO1: An experimental research chemical.
COMPOUND 17 [PMID: 34176264]: A research compound described in the cited 2021 publication.
FIPEXIDE: A psychoactive drug with nootropic properties.
PERVILLEINE C: A natural alkaloid.
LISINOPRIL-TRYPTOPHAN: A chemical conjugate of lisinopril and tryptophan.
COMPOUND 15A: A research chemical from a specific series.
CGS 24012: An experimental research chemical.
MRS1186: An experimental research chemical.
MRS1097: An experimental research chemical.
A011: An experimental research chemical.
MEPLAZUMAB: An experimental monoclonal antibody.
EXAMPLE 20 [WO2010128058]: A specific compound described in the cited patent application.
COMPOUND 2 [PMID: 11934595]: A research compound described in the specified scientific literature.
ET BROMODOMAIN INHIBITOR: A drug that inhibits bromodomains of the BET protein family.
DBET6: An experimental PROTAC that degrades BET bromodomain proteins.
JMV1116: An experimental research chemical.
KALLIDIN: An endogenous kinin peptide, also known as Lys-bradykinin.
COMPOUND 17 [PMID: 24257095]: A research compound described in the specified scientific literature.
POM2-C-HMBP: A research chemical that acts as a Vgamma9Vdelta2 T cell agonist.
[PHE8,&PSI;(CH2-NH)ARG9]BK: A synthetic bradykinin B2 receptor agonist.
SODIUM DIMETHYLCARBAMODITHIOATE: A chemical compound, also known as sodium dimethyldithiocarbamate.
C5APEP: A peptide antagonist of the C5a receptor.
AC-VEID-CHO: A caspase-6 inhibitor peptide.
HC-056456: An experimental research chemical.
CCL27: A chemokine involved in T-cell homing to the skin.
[125I]CCL11 (HUMAN): Radioiodinated human CCL11 chemokine (Eotaxin) for receptor binding studies.
ISOTHIOUREA-1T: An experimental research chemical.
JH-XI-10-02: An experimental research chemical.
[3H][D-ALA2]DELTORPHIN I: A radiolabeled selective delta-opioid receptor agonist.
&BETA;-ENDORPHIN: An endogenous opioid peptide neurotransmitter.
DPDPE: A selective delta-opioid receptor agonist peptide.
ECTODYSPLASIN A2: An isoform of a protein involved in ectodermal development.
AZ14117230: An experimental research chemical.
EI1: An experimental EED-EZH2 interaction inhibitor.
COMPOUND 7R [PMID: 26080733]: A research compound described in the cited publication.
SCK&BETA;8-1: An experimental research chemical.
UPAR FRAGMENT: A fragment of the urokinase plasminogen activator receptor.
F2L-[125I]TYR: A radioiodinated peptide agonist of the formyl peptide receptor.
BAY-6672: An experimental research chemical.
2,3-DIHYDRO-1,4-DITHIIN-1,1,4,4-TETROXIDE: A chemical compound, also known as Divinyl sulfone.
GALANIN(5-29) (RAT/MOUSE): A fragment of the neuropeptide galanin.
(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID: A complex bisphosphonate compound.
ORG 25543: An experimental positive allosteric modulator of GABAA receptors.
GNRH III: A specific isoform of gonadotropin-releasing hormone.
[AC-D-2NAL1,D4CPA2,D-3PAL3,6,LEU8, D-ALA10]GNRH-II: A synthetic GnRH receptor antagonist.
MERIGOLIX: An experimental oral GnRH antagonist.
COMPOUND 20 [PMID:12127536]: A research compound described in the specified scientific literature.
COMPOUND 21 [PMID: 21185185]: A research compound described in the specified scientific literature.
COMPOUND 35M [PMID: 36073117]: A research compound described in the cited 2022 publication.
KA2507: An experimental research chemical.
IMBUTAMINE: A cardiac stimulant.
A-304121: An experimental research chemical.
VUF14738: An experimental research chemical.
COMPOUND 18 [PMID: 8426367]: A research compound described in the cited 1993 publication.
CID1172084: A research chemical identified by its PubChem CID.
CP55,667: An experimental research chemical.
EXAMPLE 184 [WO2014186035]: A specific compound described in the cited patent application.
IKK-2 INHIBITOR IV: A research chemical that inhibits the IKK-beta kinase.
DIVARASIB: An experimental covalent inhibitor of KRAS G12C.
UNC1215: An experimental inhibitor of the methyllysine reader protein L3MBTL3.
COMPOUND 4 [PMID: 22533316]: A research compound described in the specified scientific literature.
OMPT: An experimental research chemical.
&ALPHA;-FLUOROMETHYLENEPHOSPHONATE: A chemical group used in designing enzyme inhibitors.
PG-106: An experimental research chemical.
[18F]FITM: A radiotracer for PET imaging of M1 muscarinic acetylcholine receptors.
[18F]MK-1312: A radiotracer for PET imaging.
LY593093: An experimental research chemical.
BODIPY-PIRENZEPINE: A fluorescently labeled antagonist of the M1 muscarinic receptor.
CO2+: A divalent cobalt cation.
A-582941: A selective agonist for the alpha7 nicotinic acetylcholine receptor.
PD 161182: An experimental research chemical.
RTI-118: A research chemical, a phenyltropane derivative that acts as a dopamine reuptake inhibitor.
NUDT7-COV-1: An experimental research chemical.
DISPROCYNIUM24: An experimental research chemical.
MRS2365: A selective agonist for the P2Y1 receptor.
DATP&ALPHA;S: A non-hydrolyzable analogue of deoxyadenosine triphosphate.
NTZDPA: An experimental research chemical.
PF-05180999: An experimental phosphodiesterase 2A (PDE2A) inhibitor.
COMPOUND 3 [PMID: 26055709]: A research compound described in the specified scientific literature.
NITROSOPRODENAFIL: A designer drug analogue of sildenafil.
45766: An experimental research chemical identifier.
[HIS5]PTH-(1-34) (HUMAN): A synthetic analogue of human parathyroid hormone.
CHOLESTEROL SULPHATE: A sulfated form of cholesterol involved in skin and cellular function.
NANOLUCIFERASE-LABELLED RELAXIN: Relaxin labeled with nanoluciferase for research assays.
GLXC-26326: An experimental research chemical.
A(C10/15S)INSL3: A synthetic analogue of Insulin-like peptide 3.
INSL3 B-CHAIN ANALOGUE: A synthetic peptide based on the B-chain of Insulin-like peptide 3.
ICANBELIMOD: An experimental sphingosine-1-phosphate receptor 1 (S1P1) modulator.
YTK-2205: An experimental research chemical.
TODRALAZINE: An antihypertensive agent.
SPRI3: An experimental research chemical.
AZ505: An experimental research chemical.
COMPOUND 21B [PMID: 31944697]: A research compound described in the cited 2020 publication.
YM-75440: An experimental research chemical.
(-)-USNIC ACID: The levorotatory isomer of usnic acid, a natural antibiotic from lichens.
1,6-HEXAMETHYLENE DIISOCYANATE: A chemical intermediate used to produce polyurethane.
GFB-8438: An experimental research chemical.
RN1747: An agonist of the TRPV4 ion channel.
TUMOUR NECROSIS FACTOR SHED FORM: The soluble form of TNF that has been cleaved from the cell membrane.
MPS1-IN-1: An experimental inhibitor of the MPS1 kinase.
IU1: An inhibitor of the ubiquitin-specific peptidase 14 (USP14).
LEXACALCITOL: A synthetic analogue of vitamin D.
ANTI-VEGF MONOCLONAL ANTIBODY: A class of drugs that inhibit vascular endothelial growth factor.
PI3K/MTOR KINASE INHIBITOR WXFL10030390: An experimental dual kinase inhibitor.
PARECOXIB SODIUM: A water-soluble prodrug of valdecoxib, a COX-2 selective NSAID.
ZOLIMOMAB ARITOX: An immunotoxin composed of a monoclonal antibody and ricin A chain.
CHLORPHENOXAMINE: An antihistamine with anticholinergic properties.
ZAMICASTAT: An experimental inhibitor of dopamine beta-hydroxylase.
NANGIBOTIDE: An experimental peptide that inhibits the TREM-1 receptor.
BALIPODECT: An experimental gene therapy.
DEXELVUCITABINE: An experimental nucleoside reverse transcriptase inhibitor.
ENIBARCIMAB: An experimental monoclonal antibody.
SCH-486757: An experimental research chemical.
AESCULIOSIDE IVC: A natural triterpenoid saponin.
GAMMA-AMINOBUTYRIC ACID: The chief inhibitory neurotransmitter in the mammalian central nervous system, known as GABA.
SULBENTINE: An antifungal agent.
BENZOHYDROXAMATE: A chemical compound.
GANODERMANONTRIOL: A triterpenoid isolated from Ganoderma lucidum mushrooms.
2-METHYLAMINOBENZOIC ACID METHYL ESTER: A chemical compound.
(R)-BICALUTAMIDE: The active enantiomer of the antiandrogen drug bicalutamide.
ZIMELDINE: A selective serotonin reuptake inhibitor (SSRI), withdrawn from the market.
KASANOSIN A: A natural diterpenoid compound.
7-BENZYLOXYCOUMARIN: A synthetic coumarin derivative.
TYROSOL SINAPATE: A natural phenolic compound.
3-ACETYLCOUMARIN: A synthetic coumarin derivative.
SKF89976A: A GABA uptake inhibitor.
O-METHYLCALOTHRIXIN A: A methylated derivative of a natural compound.
4-HYDROXYNONENAL: A toxic aldehyde produced by lipid peroxidation.
ALRESTATIN: An aldose reductase inhibitor.
EPOXYCYTOCHALASIN H: A natural mycotoxin.
ACRIDINE: A heterocyclic organic compound, the parent structure for some dyes and drugs.
ADENOVIRUS 5-CD40 LIGAND: A viral vector expressing the CD40 ligand for immunotherapy.
OFTASCEINE: A diagnostic agent used in ophthalmology, another name for fluorescein.
PHENAZOPYRIDINE: A urinary tract analgesic.
GLPG-0259: An experimental research chemical.
OREMEPERMIN ALFA: An experimental neurotrophic factor.
ANTI-GLYPICAN 3/CD3 BISPECIFIC ANTIBODY ERY974: An experimental T-cell engaging bispecific antibody.
AGONISTIC ANTI-OX40 MONOCLONAL ANTIBODY INCAGN01949: An experimental immunotherapy antibody.
GP100:209-217(210M) PEPTIDE VACCINE: An experimental peptide vaccine for melanoma.
ORE-1001: An experimental research chemical.
MELARSOPROL: An organoarsenic drug used to treat human African trypanosomiasis.
PERUVOSIDE: A cardiac glycoside.
CARCINOEMBRYONIC ANTIGEN PEPTIDE 1-6D VIRUS-LIKE REPLICON PARTICLES VACCINE: An experimental cancer vaccine.
EG5 KINESIN-RELATED MOTOR PROTEIN INHIBITOR ARQ 621: An experimental anti-mitotic cancer drug.
TRANSFERRIN RECEPTOR-TARGETED LIPOSOMAL P53 CDNA: An experimental gene therapy delivery system.
LY-2624803: An experimental research chemical.
LY-2623091: An experimental research chemical.
[11C]AZ10419369: A carbon-11 radiolabeled antagonist for the P2X7 receptor.
COMPOUND 1 [LOLLI ET AL., 2019]: A research compound described in the cited 2019 publication.
ST034307: An experimental research chemical.
BENZYLSERINE: A derivative of the amino acid serine.
RXP-407: An experimental research chemical.
CYCLO APELIN-12 (1-12): A cyclic analogue of the apelin peptide.
L-740093: An experimental research chemical.
CCL17: A chemokine that attracts T-helper 2 cells.
CCL22: A chemokine that acts as a chemoattractant for various immune cells.
LC52-0332: An experimental research chemical.
IL-34: Interleukin-34, a cytokine that binds to the CSF-1 receptor.
HIV-1 MATRIX PROTEIN P17: A structural protein of the human immunodeficiency virus.
DIOSCIN: A natural steroidal saponin.
13,14-DIHYDRO-15-KETO-PGF2&ALPHA;: A major metabolite of prostaglandin F2-alpha.
TM30089: An experimental research chemical.
1400W: A highly selective inhibitor of inducible nitric oxide synthase (iNOS).
PQ401: An experimental insulin-like growth factor-1 receptor (IGF-1R) inhibitor.
IRAK4 INHIBITOR 4B [PMID: 18474425]: A research compound described in the cited publication that inhibits IRAK4 kinase.
RO3244794: An experimental research chemical.
FK-788: An experimental research chemical.
SALICIN: A natural alcoholic Î²-glucoside, a precursor to salicylic acid.
4-NITROPHENYL-&BETA;-D-MANNOPYRANOSIDE: A chemical substrate used in enzyme assays for mannosidase activity.
MALVIDIN-3-GLUCOSIDE: An anthocyanin, a major pigment in red wine and other colored plants.
STEVIOSIDE: A natural steviol glycoside extracted from the Stevia rebaudiana plant, used as a sweetener.
CYCLOLINOPEPTIDE 1-MSO,3-MET-CL6: A modified cyclic peptide.
COMPOUND 11 [PMID: 35653642]: A research compound described in the cited 2022 publication.
VEGF RECEPTOR 2 KINASE INHIBITOR II: A research chemical that inhibits the VEGFR2 kinase.
KISSPEPTIN-28: A form of the kisspeptin peptide.
PUTRESCINE: A foul-smelling diamine formed by the breakdown of amino acids.
AT-56: An experimental research chemical.
AZ13483342: An experimental research chemical from AstraZeneca.
A-850002: An experimental research chemical.
COMPOUND 53 [PMID: 23434029]: A research compound described in the specified scientific literature.
[3H]M-MPEP: A radiolabeled negative allosteric modulator of the mGluR5 receptor.
MSOPPE: A research chemical used in studies of metabotropic glutamate receptors.
COMPOUND 5 [PMID: 24900526]: A research compound described in the specified scientific literature.
[LEU13]MOTILIN (HUMAN): A synthetic analogue of the human hormone motilin.
[PHE3,LEU13]MOTILIN (HUMAN): A synthetic analogue of the human hormone motilin.
[D-BPA5,ILE13]MOTILIN (HUMAN): A synthetic analogue of the human hormone motilin.
VU0486846: An experimental positive allosteric modulator of the M5 muscarinic receptor.
FRILUGLANSTAT: An experimental dipeptidyl peptidase 1 (DPP1) inhibitor.
THRX160209: An experimental research chemical.
SGC6870: An experimental EED-EZH2 interaction inhibitor.
RIPA-56: An inhibitor of the RIPK2 kinase.
ANTI-CD47/ANTI-PD-L1 BISPECIFIC ANTIBODY PF-07257876: An experimental bispecific antibody for cancer immunotherapy.
HSP90 INHIBITOR LAM-003: An experimental compound that inhibits Heat Shock Protein 90.
AGS62P1: An experimental research chemical.
CHLOROBENZILATE: An acaricide (miticide) that is now banned in many countries.
BOS-589: An experimental research chemical.
TRIMETHOBENZAMIDE: An antiemetic drug.
BI-4020: An experimental research chemical.
PSB-KD107: An experimental research chemical.
CRUFOMATE: An organophosphate insecticide used in veterinary medicine.
CANFOSFAMIDE HYDROCHLORIDE: The salt form of canfosfamide, a glutathione analog prodrug.
ICOTINIB HYDROCHLORIDE: An EGFR tyrosine kinase inhibitor for non-small-cell lung cancer.
ARTEMIN: A neurotrophic factor in the GDNF family of ligands.
HISPIDULIN: A natural flavonoid with various biological activities.
PHA-680632: An experimental inhibitor of Aurora kinases.
EPITESTOSTERONE: An inactive stereoisomer of the hormone testosterone.
TIAPRIDE: A selective D2/D3 dopamine receptor antagonist, used as an antipsychotic.
PEXASTIMOGENE DEVACIREPVEC: An oncolytic immunotherapy based on a modified vaccinia virus.
RP-6530: An experimental dual PI3K delta/gamma inhibitor.
DIENOGEST: A synthetic progestin used in oral contraceptives and for endometriosis.
GG-2P20: An experimental research chemical.
FURFURAL: An organic compound derived from agricultural byproducts, used in chemical synthesis.
ABT-925: An experimental dopamine D3 receptor antagonist.
ANTAQ: An experimental research chemical.
AUTOLOGOUS BCMA/TACI-TARGETED CAR T CELLS AUTO2: An investigational dual-targeted CAR T-cell therapy.
ELABELA/TODDLER-11: An 11-amino acid form of the peptide hormone Elabela.
COMPOUND 1A [PMID: 23597791]: A research compound described in the specified scientific literature.
FTORMETAZINE: An experimental antipsychotic agent.
MULTIDRUG RESISTANCE MODULATOR: A substance that counteracts multidrug resistance in cancer cells.
PFI-4: An experimental inhibitor of the BRPF1B bromodomain.
ANILERIDINE PHOSPHATE: The phosphate salt of anileridine, an opioid analgesic.
GALCANEZUMAB: A monoclonal antibody targeting CGRP for the prevention of migraine.
(+/-)-PENTAACETYLCATECHIN: A chemically modified form of the flavonoid catechin.
DEMETHYLWEDELOLACTONE: A derivative of the natural coumestan wedelolactone.
ATRASENTAN HYDROCHLORIDE: An experimental selective endothelin-A receptor antagonist.
ZK-158252: An experimental research chemical.
SQUARUNKIN A: A natural product with anti-cancer activity.
KO 143: A potent and selective inhibitor of the ABCG2 transporter.
CID16020046: A research chemical identified by its PubChem CID, a USP7 inhibitor.
WP1066: An experimental inhibitor of STAT3.
VK-II-86: An experimental research chemical.
MCH6-17: An experimental research chemical.
COMPOUND 3 [PMID: 18255300]: A research compound described in the specified scientific literature.
INSULIN ZINC, PROMPT: A rapid-acting insulin preparation.
(S)-FTY720-PHOSPHATE: The active phosphorylated form of fingolimod.
CTP-37-DT VACCINE: An experimental conjugate vaccine.
BOMBESIN ANTAGONIST: A substance that blocks the action of bombesin receptors.
DOXACURIUM: A non-depolarizing neuromuscular blocking agent.
SIALYL LEWIS X: A tetrasaccharide carbohydrate that acts as a ligand for selectins.
GW861893X: An experimental research chemical from GlaxoSmithKline.
EUROPIUM-LABELLED RELAXIN: Relaxin labeled with europium for use in immunoassays.
NF449: An antagonist of the P2X1 purinergic receptor.
GLAUCINE METHIODIDE: A derivative of the natural alkaloid glaucine.
IM-12: An experimental research chemical.
PD168,077: An experimental dopamine D4 receptor agonist.
ML169: A selective antagonist for the orphan G protein-coupled receptor GPR68.
RECOMBINANT HUMAN MONOCYTE CHEMOATTRACTANT PROTEIN-2: A genetically engineered version of the chemokine CCL8.
(S)-PIA: The S-enantiomer of N6-phenylisopropyladenosine, an adenosine receptor agonist.
DURAMYCIN: A polypeptide antibiotic that binds to phosphatidylethanolamine.
OMO-1: An experimental research chemical.
NC1: An experimental research chemical.
GO-203-2C: An experimental peptide inhibitor of MUC1-C.
MICAFUNGIN SODIUM: The sodium salt of micafungin, an echinocandin antifungal drug.
EUGENYL BENZOAT: Eugenyl benzoate, a chemical compound derived from eugenol.
S36057: An experimental research chemical.
PIRITREXIM: An antifolate drug that inhibits dihydrofolate reductase.
NITRILOTRIACETIC ACID: A chelating agent.
BUFLOMEDIL: A vasoactive drug used to treat claudication.
NEOCYCLOCITRINOL B: A natural meroterpenoid compound.
[125I]26RFA (HUMAN): Radioiodinated human 26RFa, a neuropeptide.
GW803430: An antagonist for the NK1 and NK3 tachykinin receptors.
TETRASUL: An acaricide (miticide).
SB-568849: An experimental research chemical.
FN-1501: An experimental tyrosine kinase inhibitor.
ZIMELIDINE DIHYDROCHLORIDE: The salt form of zimelidine, a withdrawn SSRI antidepressant.
DUTEPLASE: A recombinant tissue plasminogen activator.
STAT3 INHIBITOR 8Q: A specific research chemical that inhibits STAT3.
L-759,633: An experimental research chemical.
(+)-DOI: A psychedelic and serotonin 5-HT2A receptor agonist.
L-371,257: A selective antagonist of the vasopressin V1b receptor.
N-PROPYL BROMIDE: 1-Bromopropane, an organic solvent.
METHENOLONE ENANTHATE: An androgen and anabolic steroid.
DIHYDROERGOTOXINE: A mixture of ergoloid mesylates used for dementia and age-related cognitive impairment.
MEPENZOLATE BROMIDE: An anticholinergic drug.
LITHIUM CITRATE: A salt of lithium used as a mood stabilizer.
CYCLOPENTOLATE HYDROCHLORIDE: An anticholinergic drug used in eye drops to dilate the pupil.
BISOPROLOL FUMARATE: The fumarate salt of bisoprolol, a beta-blocker.
INSULIN SUSP PROTAMINE ZINC PURIFIED BEEF: A long-acting insulin preparation from cattle.
GUANETHIDINE MONOSULFATE: An antihypertensive drug.
PHENSUXIMIDE: An anticonvulsant of the succinimide class.
QAF805: An experimental research chemical.
TXA127: A pharmaceutical formulation of the peptide angiotensin (1-7).
FE 202767: An experimental research chemical.
BMS-223131: An experimental research chemical.
IMETELSTAT SODIUM: An oligonucleotide that inhibits telomerase.
DROZITUMAB: An experimental monoclonal antibody targeting the DR5 receptor.
SAFINAMIDE MESYLATE: A selective MAO-B inhibitor used for Parkinson's disease.
YTTRIUM Y 90 EPRATUZUMAB TETRAXETAN: A radioimmunoconjugate targeting CD22.
AMG-157: An experimental monoclonal antibody targeting thymic stromal lymphopoietin (TSLP).
DANOPREVIR: An HCV protease inhibitor.
QUETMOLIMAB: An experimental monoclonal antibody targeting TIM-3.
TOVINONTRINE: An experimental research chemical.
SELATOGREL: An experimental P2Y12 receptor antagonist.
CAMPTOTHECIN-20-O-PROPIONATE: A derivative of the anticancer agent camptothecin.
RAGIFILIMAB: An experimental monoclonal antibody.
CABOTEGRAVIR SODIUM: The sodium salt of cabotegravir, an HIV integrase inhibitor.
PRADEFOVIR MESYLATE: A prodrug of the antiviral adefovir.
EMVODODSTAT: An experimental research chemical.
FINOTONLIMAB: An experimental monoclonal antibody targeting TIM-3.
COSIBELIMAB: An experimental anti-PD-L1 monoclonal antibody.
ZANIDATAMAB: A bispecific antibody targeting two different domains of the HER2 receptor.
PALTUSOTINE: An experimental somatostatin receptor ligand for acromegaly.
DARIDOREXANT HYDROCHLORIDE: The salt form of daridorexant, a dual orexin receptor antagonist for insomnia.
ACALABRUTINIB MALEATE: The maleate salt of acalabrutinib, a BTK inhibitor for certain cancers.
CALPHOSTIN C: A potent inhibitor of protein kinase C.
SULFAPYRIDINE: A sulfonamide antibiotic.
NOVIFLUMURON: An insect growth regulator used as an insecticide.
CENTAUREIDIN: A natural flavonoid.
CL-976: An experimental research chemical.
VALNEMULIN: A pleuromutilin antibiotic used in veterinary medicine.
SORBIC ACID: A natural organic compound used as a food preservative.
HINOKININ: A natural lignan compound.
CHRYSENE: A polycyclic aromatic hydrocarbon.
ALPHA-PHELLANDRENE: A natural organic compound, a monoterpene.
MEBEVERINE HYDROCHLORIDE: An antispasmodic drug.
URACIL MUSTARD: An alkylating agent used in chemotherapy.
N-ACETYLSEROTONIN: A naturally occurring chemical intermediate in the synthesis of melatonin.
8-PHENYL THEOPHYLLINE: A potent and selective adenosine A1 receptor antagonist.
DESIPRAMINE HYDROCHLORIDE: A tricyclic antidepressant.
SULINDAC SULFOXIDE: A metabolite of the NSAID sulindac.
TRIFORINE: A fungicide.
DEXTROMEPROMAZINE: A phenothiazine drug.
PROTOCATECHUALDEHYDE: A natural phenolic aldehyde.
TRITON X: A family of nonionic surfactants.
FURAFYLLINE: A potent inhibitor of the CYP1A2 enzyme.
(+/-)-WIEDENDIOL B: A natural marine compound.
SITOGLUSIDE: A phytosterol glycoside.
TROLOX: A water-soluble derivative of vitamin E, used as an antioxidant standard.
KRN-7000: A synthetic glycolipid that acts as an immunostimulant.
BUTANAL: An organic compound, an aldehyde.
PHENFORMIN HYDROCHLORIDE: An oral anti-diabetic drug of the biguanide class, withdrawn in many countries.
CARMOFUR: A fluorouracil derivative used in chemotherapy.
R-(+)-METHANANDAMIDE: A stable analogue of the endocannabinoid anandamide.
RESOKAEMPFEROL: A natural flavonoid.
7-HYDROXYFLAVONE: A synthetic flavone.
PINOPHILIN A: A natural product.
GW829055X: An experimental research chemical from GlaxoSmithKline.
THIOSEMICARBAZIDE: A chemical compound.
HYDROXYTOLUIC ACID: A chemical compound.
BETAMETHASONE BUTYRATE PROPIONATE: A topical corticosteroid.
GANCAONIN L: A natural flavonoid.
2-PHENYLQUINOLINE: A heterocyclic organic compound.
LINURON: A urea-based herbicide.
(-)-ROLIPRAM: The active enantiomer of rolipram, a selective PDE4 inhibitor.
ISOPIMARIC ACID: A natural diterpenoid resin acid.
TEMEFOS: An organophosphate larvicide.
TENATOPRAZOLE: An experimental proton pump inhibitor.
7-O-METHYLCRYPTOCHINONE B: A methylated derivative of a natural compound.
RESORCINOL: A chemical compound used in resins and topical medications.
VIOLASTYRENE: A natural product.
S-METOLACHLOR: A selective herbicide.
COSMOMYCIN C: An anthracycline antibiotic.
4-NITROANILINE: An organic chemical intermediate.
SPINASAPONIN A METHYL ESTER: A derivative of a natural saponin.
PRECLAMOL: A dopamine receptor agonist.
TRIACETYLRESVERATROL: A synthetic derivative of resveratrol.
ELATOSIDE D: A natural saponin.
FUROSPONGOLIDE: A natural marine product.
MONENSIN SODIUM: The sodium salt of monensin, a polyether antibiotic and coccidiostat.
GW284372X: An experimental research chemical from GlaxoSmithKline.
ISOPROPYL PALMITATE: An emollient and thickening agent used in cosmetics.
GW627512B: An experimental research chemical.
ZINC SULFATE ANHYDROUS: The anhydrous form of zinc sulfate, a mineral supplement.
REVERSE TRANSCRIPTASE INHIBITOR: A class of antiviral drugs that block the reverse transcriptase enzyme.
NORMAL SALINE: A sterile solution of sodium chloride in water.
RECOMBINANT COLONY STIMULATING FACTOR: A genetically engineered cytokine that stimulates white blood cell production.
6-DIAZO-5-OXO-L-NORLEUCINE: A glutamine antagonist with antitumor activity.
POLYVALENT VACCINE: A vaccine designed to protect against multiple strains of a pathogen.
GENE TRANSDUCTION AGENT: A substance or vector used to introduce genetic material into cells.
IMIDAZOLE ACETIC ACID: A metabolite of histamine.
VITAMIN A PALMITATE: Retinyl palmitate, an ester of vitamin A.
CUCURBITACIN E: A toxic tetracyclic triterpenoid found in some plants.
APD791: An experimental 5-HT2A receptor antagonist.
P-AMINOHIPPURATE: A substance used in medical tests to measure renal plasma flow.
CHLORALIN: An experimental research chemical.
FISPEMIFENE: A selective estrogen receptor modulator (SERM).
QUINOXALINE: A heterocyclic organic compound, a building block for many drugs.
MILVETEROL: An experimental beta-2 adrenergic agonist.
GUAIFENESIN: An expectorant used to treat coughs.
PALOMID 529: An experimental research chemical.
GW832467X: An experimental research chemical from GlaxoSmithKline.
FENCHLORAZOL-ETHYL: A herbicide safener.
AG-270: An experimental inhibitor of MAT2A for cancer therapy.
EFMARODOCOKIN ALFA: An experimental form of interleukin-22.
ARM-210: An experimental activator of the ryanodine receptor RyR1.
ALTISSIMACOUMARIN E: A natural coumarin compound.
LISTERIA MONOCYTOGENES-LLO-PSA VACCINE ADXS31-142: An experimental cancer immunotherapy.
APOMINE: An experimental research chemical.
ANTI-EGFR MONOCLONAL ANTIBODY EMD 55900: An experimental antibody targeting the epidermal growth factor receptor.
RADIOSUMIN B: A natural product.
PREGNENOLONE: A steroid hormone, a precursor to many other steroid hormones.
MEBEVERINE: An antispasmodioc drug.
ETHYL VANILLIN: A synthetic flavoring agent similar to vanillin.
DESMOSDUMOTIN C: A natural flavonoid.
PACHYRRIZINE: A natural rotenoid.
TGAAG-76: An experimental research chemical.
ALT-801: An experimental immunomodulatory fusion protein.
TALIGLUCERASE ALFA: A recombinant human glucocerebrosidase for Gaucher disease.
LIPUSTOBART: An experimental monoclonal antibody.
P70S6K/AKT INHIBITOR M-2698: An experimental dual kinase inhibitor.
CHLORPHENTERMINE HYDROCHLORIDE: A sympathomimetic amine used as an appetite suppressant.
DOXORUBICIN-ELUTING BEADS: A transarterial chemoembolization (TACE) agent for liver cancer.
BENZYL BENZOATE: An organic compound used as a medication and insect repellent.
ALUMINUM: A chemical element and metal.
ABILIFY MAINTENA: A long-acting injectable formulation of the antipsychotic aripiprazole.
TYROSINE: A non-essential amino acid.
OLEOYL-ESTRONE: An ester of estrone involved in fat metabolism.
H05: An experimental research chemical.
LY314228: An experimental research chemical.
EGIS-7625: An experimental research chemical.
SB656104: An experimental research chemical.
WS-898: An experimental research chemical.
COMPOUND 2 [PMID: 22380603]: A research compound described in the specified scientific literature.
RHO-TIA: An experimental research chemical.
ARD-69: An experimental research chemical.
CPS4: An experimental research chemical.
MRS1177: An experimental research chemical.
[LEU14]BOMBESIN: A synthetic analogue of the peptide bombesin.
ML-18: An experimental research chemical.
NMU (104-114): A peptide fragment of neuromedin U.
AC-PHE-TRP-ALA-HIS(&TAU;BZL)-NIP-GLY-ARG-NH2: A complex synthetic peptide.
ME BROMODOMAIN INHIBITOR: A drug that inhibits methyl-lysine reading bromodomains.
COMPOUND 15 [HAY ET AL., 2013]: A research compound described in the cited 2013 publication.
DUAL BRD4/PLK1 INHIBITOR 23: A research chemical that inhibits both BRD4 and PLK1.
PFI-1: An experimental inhibitor of BET bromodomains.
R-715: An experimental research chemical.
FR167344: An experimental research chemical.
ALBUTENSIN A: An experimental research chemical.
N-METHYL-PHE-LYS-PRO-D-CHA-TRP-D-ARG-CO2H: A synthetic peptide.
W54011: An antagonist of the complement C5a receptor.
EU-DTPA-HC3A: A europium-labeled chelating agent for immunoassays.
COMPOUND 19 [PMID: 8831774]: A research compound described in the cited 1996 publication.
K777: An experimental cysteine protease inhibitor.
MDMB-FUBINACA: A potent synthetic cannabinoid.
MC148R: An experimental research chemical.
CCL15: A chemokine also known as MIP-1 delta.
RS-136270: An experimental research chemical.
APLAVIROC: An experimental CCR5 receptor antagonist for HIV.
XL413: An experimental research chemical.
FK-881: An experimental research chemical.
CXCL13: A chemokine that plays a key role in B-cell trafficking.
CXCR4 ANTAGONIST 22: A research chemical that antagonizes the CXCR4 receptor.
CDK2 INHIBITOR III: A research chemical that inhibits cyclin-dependent kinase 2.
CIMPUCICLIB: An experimental CDK4/6 inhibitor.
BSJ-04-132: An experimental research chemical.
BAXDROSTAT: An experimental aldosterone synthase inhibitor.
COMPOUND 7C [PMID: 22041175]: A research compound described in the cited publication.
POBILUKAST: An experimental leukotriene D4 receptor antagonist.
LEI105: An experimental inhibitor of monoacylglycerol lipase (MAGL).
KT-109: An experimental research chemical.
PF-07202954: An experimental research chemical from Pfizer.
COMPOUND 1 [PMID: 18507370]: A research compound described in the specified scientific literature.
PF-06821497: An experimental research chemical from Pfizer.
REZIVERTINIB: An experimental third-generation EGFR tyrosine kinase inhibitor.
MS154: An experimental research chemical.
DIMETHYL GAMBOGATE: A derivative of the natural product gambogic acid.
TUG-770: An agonist for the free fatty acid receptor 1 (GPR40).
AMG7703: An experimental research chemical.
GRIFOLIC ACID: A natural farnesyl-hydroquinone compound.
NCG21: An experimental research chemical.
DM-CHX: An experimental research chemical.
COMPOUND 34F [PMID: 37535845]: A research compound described in the cited 2023 publication.
CAPROMAB PENDETIDE: A monoclonal antibody used for imaging prostate cancer.
BMS-986235: An experimental TYK2 inhibitor.
1R-11: An experimental research chemical.
GALANIN-LIKE PEPTIDE: An endogenous neuropeptide involved in metabolic regulation.
NNC0640: An experimental research chemical.
S-DESCHLOROKETAMINE: A designer drug analogue of ketamine.
CONANTOKIN-G: A peptide toxin from cone snails that acts as an NMDA receptor antagonist.
LY2365109: An experimental research chemical.
GNRH II: A second isoform of gonadotropin-releasing hormone found in many vertebrates.
G15: An antagonist of the G protein-coupled estrogen receptor (GPER).
INT-767: An experimental dual FXR/TGR5 agonist.
XYT528B: An experimental research chemical.
SANP: An experimental research chemical.
SNX0723: An experimental research chemical.
COMPOUND 5B [PMID: 17358052]: A research compound described in the cited publication.
COMPOUND 3 [PMID: 21650226]: A research compound described in the specified scientific literature.
(-)-TRANS-H2-PAT: An experimental research chemical.
OXO-ARPROMIDINE: An experimental research chemical.
GALEGENIMAB: An experimental monoclonal antibody.
COMPOUND 1E [PMID: 2153213]: A research compound described in the cited 1990 publication.
COMPOUND 83 [PMID: 23888932]: A research compound described in the cited publication.
CID2440433: A research chemical identified by its PubChem CID.
[3H]ILOPROST: A radiolabeled synthetic analogue of prostacyclin.
PEPTIDE 234: An experimental peptide.
LY3499446: An experimental research chemical.
MAST CELL DEGRANULATING PEPTIDE: A peptide from bee venom that causes mast cell degranulation.
L735821: An experimental research chemical.
COMPOUND 7 [PMID: 22533316]: A research compound described in the specified scientific literature.
LCK INHIBITOR: A drug that blocks the lymphocyte-specific protein tyrosine kinase (Lck).
PF-06447475: An experimental phosphodiesterase 4D (PDE4D) inhibitor.
24(S)-HYDROXYCHOLESTEROL: An endogenous oxysterol involved in cholesterol metabolism in the brain.
GRI977143: An experimental research chemical.
COMPOUND 17 [PMID: 17125263]: A research compound described in the specified scientific literature.
COMPOUND 4B [PMID: 19683441]: A research compound described in the cited publication.
MNI-135: An experimental research chemical.
VU0483605: An experimental research chemical.
FP0429: An experimental research chemical.
AC-42: A positive allosteric modulator and agonist of the M1 muscarinic receptor.
BENZOQUINAZOLINONE 12: A research chemical based on the benzoquinazolinone structure.
[3H]PIRENZEPINE: A radiolabeled selective M1 muscarinic receptor antagonist.
AQ-RA 741: A selective antagonist of the M2 muscarinic acetylcholine receptor.
S24773: An experimental research chemical.
GS-458967: An experimental research chemical.
GNE-616: An experimental research chemical.
CANF4-23: An experimental research chemical.
SUBSTANCE P-(4-11): A fragment of the neuropeptide Substance P.
GSK579289A: An experimental research chemical.
HEMOKININ 1: A tachykinin peptide.
[18F]SPA-RQ: A radiotracer for PET imaging of the NK1 receptor.
GDC-2394: An experimental research chemical from Genentech.
GSK 172981: An experimental research chemical.
(R)-RO65-6570: An experimental research chemical.
CM4620: An experimental inhibitor of store-operated calcium entry (SOCE).
MRS4458: An experimental research chemical.
2-O-METHYL-PAF C-18: A derivative of platelet-activating factor.
RENCOFILSTAT: An experimental research chemical.
GW6471: An antagonist of the peroxisome proliferator-activated receptor alpha (PPARÎ±).
EDAGLITAZONE: A thiazolidinedione drug that acts as a PPAR agonist.
CP-775146: An experimental phosphodiesterase 2 (PDE2) inhibitor.
LY134046: An experimental research chemical.
ROGINOLISIB: An experimental PI3K inhibitor.
CX-5279: An experimental research chemical.
GARCINOIC ACID: A natural compound derived from gambogic acid.
[ALA1,12,AIB3,GLN10,HARG11,TRP14,ARG19]PTH-(1-34)-NH2: A synthetic analogue of parathyroid hormone.
AZD7545: An experimental glucokinase activator.
DMAMCL: An experimental research chemical.
BENZAMIDE: An organic compound, the parent structure for some drugs.
(B7-33)H2: A relaxin-2 peptide analogue.
SM 21: An experimental research chemical.
J-104123: An experimental research chemical.
SQ-109: An experimental diamine antibiotic for tuberculosis.
L-779,976: An experimental research chemical.
BIM 23034: A synthetic somatostatin analogue.
4'-METHOXYCHALCONE: A chemical compound of the chalcone class.
NOC-ATE: An experimental research chemical.
MPI-0485520: An experimental research chemical.
COMPOUND 5G [PMID: 21571530]: A research compound described in the cited publication.
TRPVICIN: An experimental research chemical.
GOLIDOCITINIB: An experimental Janus kinase (JAK) inhibitor.
3-N3-PHPA-LVA: An experimental research chemical.
PYY-(3-36): A major circulating form of the hormone Peptide YY.
ANTI-EGFR MONOCLONAL ANTIBODY: A class of drugs that target the epidermal growth factor receptor.
MEK INHIBITOR CI-1040: An experimental inhibitor of the MEK1/2 kinases.
BUTYL 2-AMINOBENZOATE: A chemical compound, also known as Butyl anthranilate.
ERK1/2 INHIBITOR JSI-1187: An experimental compound that inhibits ERK1/2 signaling.
FGF RECEPTOR ANTAGONIST HGS1036: An experimental monoclonal antibody targeting FGFR.
CX-5461: An experimental selective inhibitor of RNA polymerase I.
DONECOPRIDE: An experimental drug with mixed 5-HT4 agonist and D2 antagonist properties.
[35S]NON-PEPTIDE OT ANTAGONIST: A radiolabeled non-peptide oxytocin receptor antagonist.
PROTOPORPHYRIN IX CONTAINING CO: A chemical complex.
BALOXAVIR MARBOXIL: An antiviral drug for influenza that inhibits cap-dependent endonuclease.
COMPOUND RAC-16 [PMID: 15603962]: A racemic research compound described in the cited publication.
ISOPIMPINELLIN: A natural furanocoumarin.
RS-39604: An experimental research chemical.
CXCL12&BETA;: An isoform of the chemokine CXCL12.
4-(N-PROPYL)AMINO-3-NITROBENZOIC ACID: A chemical compound.
ARX201: An experimental research chemical.
DIBROMOTYROSINE: A brominated derivative of the amino acid tyrosine.
RHO KINASE INHIBITOR IV: A research chemical that inhibits Rho-associated protein kinase (ROCK).
COMPOUND 8C [PMID: 28760529]: A research compound described in the cited publication.
VLX1570: An experimental inhibitor of the proteasome's deubiquitinating activity.
TIPELUKAST: An experimental leukotriene receptor antagonist.
N-(4-CHLOROPHENYL)-2-[(PYRIDIN-4-YLMETHYL)AMINO]BENZAMIDE: A chemical compound, a DYRK1A kinase inhibitor.
LY-2300559: An experimental research chemical.
NU-7026: An inhibitor of DNA-dependent protein kinase (DNA-PK).
MAP4: Microtubule-associated protein 4.
CCR2-RA-[R]: An experimental antagonist of the CCR2 chemokine receptor.
COMPOUND 18C [PMID: 25901531]: A research compound described in the cited publication.
GARCINOLIC ACID: A natural compound related to gambogic acid.
LUFIRONIL: An experimental research chemical.
PEPTIDE 5 [PMID: 28562585]: An experimental peptide described in the cited publication.
5-HT-MODULINE: An endogenous tetrapeptide that modulates serotonin transmission.
MULTI-SUBTYPE NATURAL HUMAN LEUKOCYTE INTERFERON ALPHA: A mixture of natural interferon alpha subtypes.
CHLORISONDAMINE: A ganglionic blocker.
TALIZUMAB: An experimental monoclonal antibody targeting IgE.
RECOMBINANT INTERLEUKIN-17: A genetically engineered version of the IL-17 cytokine.
BIM 23023: A synthetic somatostatin analogue.
SKA-31: An activator of small- and intermediate-conductance calcium-activated potassium channels.
NOLPITANTIUM: An antagonist of the tachykinin NK1 receptor.
COMPOUND 5D [PMID: 25815150]: A research compound described in the cited publication.
GERONTOXANTHONE B: A natural xanthone compound.
SBP-3264: An experimental research chemical.
S36541: An experimental research chemical.
HYP 9: An experimental research chemical.
LIPIDYL PSEUDOPTERANE D: A lipid-conjugated derivative of a natural product.
S-(-)CPB: An experimental research chemical.
PF-07062119: An experimental research chemical from Pfizer.
SULISOBENZONE: A chemical ingredient used in sunscreens.
ALRT 1550: An experimental retinoid X receptor (RXR) agonist.
FLAZALONE: An anti-inflammatory agent.
THERAPEUTIC ESTROGEN: A formulation of estrogen used for hormone replacement therapy.
FR194921: An experimental research chemical.
TTP889: An experimental research chemical.
L-367,773: An experimental research chemical.
CLOCINNAMOX: An irreversible antagonist of the mu-opioid receptor.
[125I]CCL20 (HUMAN): Radioiodinated human CCL20 chemokine for receptor binding studies.
XY101: An experimental research chemical.
CIPROFLOXACIN HYDROCHLORIDE: The salt form of ciprofloxacin, a fluoroquinolone antibiotic.
INTERMEDINE: An endogenous peptide hormone, also known as Adrenomedullin 2.
[125I]SB258585: A radioiodinated selective 5-HT6 receptor antagonist.
PIRITREXIM ISETHIONATE: The isethionate salt of piritrexim, a DHFR inhibitor.
VISNAGIN: A natural furanochromone with vasodilator properties.
DESULFATED GASTRIN-14: A form of the gastrin-14 peptide lacking sulfation.
TRIFLUPERIDOL HYDROCHLORIDE: The salt form of trifluperidol, a typical antipsychotic.
SLG: An experimental research chemical.
APRATOXIN F: A natural cyclic depsipeptide from cyanobacteria.
PBD150: An experimental research chemical.
PSN375963: An experimental GPR40 (FFA1) receptor agonist.
COMPOUND 36 [PMID: 34843241]: A research compound described in the cited 2021 publication.
THIOCYCLAM HYDROGEN OXALATE: A nereistoxin analogue insecticide.
CYROMAZINE: An insect growth regulator.
COMPOUND 6J [PMID: 27219676]: A research compound described in the cited publication.
FORIGERIMOD ACETATE: An immunomodulatory peptide.
DEXBUDESONIDE: The active R-epimer of the corticosteroid budesonide.
TETRA-IODOPHENOLPHTHALEIN: A chemical compound.
5PAM523: An experimental research chemical.
DESULFATED GASTRIN-17: A non-sulfated form of the gastrin-17 peptide.
TAVOLIMAB: An experimental monoclonal antibody targeting the costimulatory molecule ICOS.
APETX2: A peptide toxin from a sea anemone that inhibits the ASIC3 channel.
NQN-1: An experimental research chemical.
COMPOUND 1 [WO2012007375]: A specific compound described in the cited patent application.
10,10-DIFLUORO TXA2: A fluorinated analogue of thromboxane A2.
NOCARDAMINE: A cyclic siderophore produced by various microorganisms.
FLUORODEOXYGLUCOSE F18: A radioactive glucose analog used in PET imaging.
MILREBRUTINIB: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
BEVASIRANIB SODIUM: An experimental siRNA therapeutic targeting VEGF.
[125I][HIS9]GHRELIN (HUMAN): A radioiodinated analogue of human ghrelin.
TEI-9063: An experimental research chemical.
COMPOUND 12 [PMID: 22521646]: A research compound described in the specified scientific literature.
FLUFENAMATE: A non-steroidal anti-inflammatory drug (NSAID).
GSK8814: An experimental research chemical.
(R)-2H [PMID:19625189]: A research compound described in the cited publication.
COMPOUND 1F [PMID: 2153213]: A research compound described in the cited 1990 publication.
(S)-NIMODIPINE: The active enantiomer of the calcium channel blocker nimodipine.
PHENFORMIN: An oral anti-diabetic drug of the biguanide class.
THIETHYLPERAZINE MALEATE: A phenothiazine antiemetic.
DIPHENYLPYRALINE HYDROCHLORIDE: An antihistamine.
CETRORELIX ACETATE: A GnRH antagonist used in assisted reproduction.
INSULIN ZINC SUSP BEEF: An insulin preparation derived from cattle.
INSULIN SUSP ISOPHANE PURIFIED PORK: An intermediate-acting insulin from pigs (NPH).
INSULIN ZINC SUSP EXTENDED RECOMBINANT HUMAN: A long-acting recombinant human insulin.
INSULIN SUSP ISOPHANE BEEF: An intermediate-acting insulin from cattle (NPH).
MORPHINE SULFATE: The sulfate salt of morphine, a potent opioid analgesic.
HYDROCORTISONE CYPIONATE: An ester of the corticosteroid hydrocortisone.
GERANIIN: A natural ellagitannin.
DEXTROAMPHETAMINE SACCHARATE: A salt of dextroamphetamine, a CNS stimulant.
BEDAQUILINE FUMARATE: The fumarate salt of bedaquiline, an antibiotic for tuberculosis.
AS-602868: An experimental IKK2 inhibitor.
PL-225B: An experimental research chemical.
KC-706: An experimental anti-inflammatory agent.
ABT-288: An experimental histamine H3 receptor antagonist.
BROLUCIZUMAB: A monoclonal antibody fragment targeting VEGF-A for wet AMD.
CDP-860: An experimental pegylated Fab' fragment targeting PDGF-beta receptor.
BENFLUOREX: An anorectic and lipid-lowering drug, withdrawn from the market.
HUMIK-BETA-1: An experimental monoclonal antibody.
CCR5MAB004: An experimental monoclonal antibody targeting the CCR5 receptor.
MLN-01: An experimental research chemical.
FOSTEMSAVIR: An HIV-1 attachment inhibitor.
CETUXIMAB SAROTALOCAN: An antibody-photosensitizer conjugate for photoimmunotherapy.
APRICITABINE: An experimental nucleoside reverse transcriptase inhibitor (NRTI).
GSK-364735: An experimental research chemical.
ELVUCITABINE: An experimental nucleoside reverse transcriptase inhibitor (NRTI).
NILOTINIB HYDROCHLORIDE MONOHYDRATE: The salt form of nilotinib, a BCR-ABL tyrosine kinase inhibitor.
NEVANIMIBE: An experimental acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor.
MK-0941: An experimental research chemical.
PF-03049423: An experimental research chemical from Pfizer.
DANBURSTOTUG: An experimental monoclonal antibody.
EX-527: A selective inhibitor of the sirtuin SIRT1.
CHAULMOOGRIC ACID, ETHYL ESTER: An ester of a fatty acid once used to treat leprosy.
TRIMETHIDINIUM: A ganglionic blocking agent previously used for hypertension.
R-RUGULACTONE: A natural product.
TOMATINE: A toxic glycoalkaloid found in stems and leaves of tomato plants.
SOPHORIDINE: A quinolizidine alkaloid with various biological activities.
GSK-319347A: An experimental research chemical.
CEPHALOSPORIN C ZINC SALT: A salt of cephalosporin C, a beta-lactam antibiotic.
GANODERIOL F: A triterpenoid isolated from Ganoderma lucidum mushrooms.
LEAD DIACETATE TRIHYDRATE: A toxic lead salt, also known as sugar of lead.
RUFLOXACIN: A fluoroquinolone antibiotic.
MAKALUVAMINE C TFA SALT: The salt form of makaluvamine C, a marine alkaloid.
METHYL ALCOHOL: Methanol, a toxic alcohol used as a solvent and fuel.
MEZLOCILLIN: A penicillin-type antibiotic.
TECNAZENE: A fungicide and potato sprouting inhibitor.
METHYL ABIETATE: An ester of abietic acid, a resin acid.
APRINDINE HYDROCHLORIDE: A class I antiarrhythmic agent.
CLEBOPRIDE MALEATE: The salt form of clebopride, a dopamine D2 antagonist used as an antiemetic.
DEXVERAPAMIL: The dextrorotatory isomer of verapamil.
HYDROCORTISONE HEMISUCCINATE: A water-soluble ester of the corticosteroid hydrocortisone.
NITROFEN: A diphenyl ether herbicide.
OPIPRAMOL: A tricyclic compound with anxiolytic and antidepressant properties.
5-DEMETHYLNOBILETIN: A natural polymethoxylated flavone.
ORSELLINIC ACID, ETHYL ESTER: An ester of a phenolic compound.
BIPHENYL: An organic aromatic compound.
(-)-CAMPHOR: The active enantiomer of camphor, a topical analgesic.
4'-HYDROXY-FLAVANONE: A natural flavanone compound.
ISOSILYBIN A: An isomer of silibinin, a component of silymarin from milk thistle.
FPL-55712: An antagonist of cysteinyl leukotriene receptors.
4'-HYDROXYCHALCONE: A chemical compound of the chalcone class.
TAMARIXETIN: A natural O-methylated flavonol.
TAURODEOXYCHOLIC ACID: A secondary bile acid.
IOPANOIC ACID: An iodine-containing radiocontrast agent for cholecystography.
GARDENIN B: A natural polymethoxylated flavone.
EPITIOSTANOL: An anabolic steroid.
AMINOCARB: A carbamate insecticide.
RICCARDI C: A natural product.
DIHYDRO-OBLIQUIN: A natural product.
(R)-EDELFOSINE: The active enantiomer of edelfosine, an experimental anticancer lipid.
4-METHOXYCINNAMIC ACID: A natural phenolic compound.
MADOLIN U: An experimental research chemical.
SODIUM SULFATE ANHYDROUS: The anhydrous salt of sulfuric acid, used as a laxative.
OMBITASVIR: An antiviral drug that inhibits HCV NS5A.
ANNAMYCIN: An experimental liposomal anthracycline for cancer.
MATRIX METALLOPROTEINASE INHIBITOR: A drug that blocks matrix metalloproteinase enzymes.
DNA INTERCALATING AGENT: A substance that inserts between the base pairs of a DNA double helix.
GDNF: Glial cell line-derived neurotrophic factor, a protein that promotes neuron survival.
PHOTOFRIN: A photosensitizer drug used in photodynamic therapy for cancer.
CHINESE HERBS: A general term for medicinal plants used in Traditional Chinese Medicine.
AN-9: An experimental research chemical.
N-ACETYLASPARTIC ACID: An amino acid derivative abundant in the brain.
MEPHEDRONE: A synthetic stimulant drug of the cathinone class.
TAS-102: A combination anticancer drug consisting of trifluridine and tipiracil.
CNGRC PEPTIDE-TNF ALPHA CONJUGATE: An experimental therapy linking a tumor-homing peptide to TNF-alpha.
PF-04605412: An experimental research chemical from Pfizer.
TYROSINE HYDROXYLASE INHIBITOR: A drug that blocks the enzyme tyrosine hydroxylase.
HORSE ANTI-MOUSE ANTI-LYMPHOCYTE SERUM: An immunosuppressive agent.
TROFOSFAMIDE: An alkylating agent related to cyclophosphamide.
LURTOTECAN: A topoisomerase I inhibitor.
PERFLUBRON: A perfluorocarbon liquid used as a contrast agent and in liquid breathing.
GINKGO: An extract from the Ginkgo biloba tree, used as a dietary supplement.
TRX1: Thioredoxin-1, a protein with antioxidant functions.
VIMNERIXIN: An experimental CXCR2 chemokine receptor antagonist.
PF-06671008: An experimental IRAK4 inhibitor.
AUTOLOGOUS MAGE-A3/A6-SPECIFIC TCR GENE-ENGINEERED LYMPHOCYTES KITE-718: An investigational T-cell receptor (TCR) therapy.
AEM-28: An experimental research chemical.
OMBURTAMAB: A radioiodinated monoclonal antibody targeting B7-H3.
PENTAMIDINE: An antimicrobial drug used for pneumonia and leishmaniasis.
TOSAGESTIN: An experimental research chemical.
CELL DIFFERENTIATING AGENT: A substance that induces cells to differentiate into specialized cell types.
GEMCITABINE ELAIDATE: A lipid-conjugated prodrug of the chemotherapy agent gemcitabine.
HC-TOXIN: A cyclic tetrapeptide mycotoxin that inhibits histone deacetylase.
CERTOLIZUMAB: A monoclonal antibody fragment targeting TNF-alpha.
4-HYDROXYBENZALDEHYDE: A natural phenolic aldehyde.
IMMUNOCONJUGATE: A substance formed by linking an antibody to another molecule, such as a drug or toxin.
DIMETHYLMYLERAN: An alkylating agent used in chemotherapy.
SRX-246: An experimental vasopressin V1a receptor antagonist.
GLPG-0492: An experimental research chemical.
BMS-903452: An experimental research chemical.
MENINGOCOCCAL GROUP B VACCINE: A vaccine to prevent infections caused by Neisseria meningitidis group B.
ANTI-CD123 CAR T CELLS PREPARATION: CAR-T cells engineered to target the CD123 antigen.
INULIN: A natural polysaccharide and dietary fiber.
BRETYLIUM: An antiarrhythmic agent.
EMEPRONIUM: An anticholinergic drug.
PIRBUTEROL: A short-acting beta-2 adrenergic receptor agonist.
DESMETHEYLASTEMIZOLE: A misspelling of desmethylastemizole, a metabolite of the antihistamine astemizole.
[125I]LSD: Radioiodinated lysergic acid diethylamide, a research radioligand.
COMPOUND 33A [PMID: 35944901]: A research compound described in the cited 2022 publication.
COMPOUND 21 [PMID: 23981033]: A research compound described in the specified scientific literature.
QUINAPRILAT: The active metabolite of the ACE inhibitor quinapril.
COMPOUND 21 [PMID: 34855405]: A research compound described in the cited 2021 publication.
[125I][NLE75,TYR77]APELIN-36 (HUMAN): A radioiodinated analogue of human apelin-36.
3-ISOBUTYL-8-PYRROLIDINOXANTHINE: A chemical compound.
AS100: An experimental research chemical.
MRS5698: An experimental P2Y14 receptor antagonist.
COMPOUND 46 [PMID: 16451062]: A research compound described in the specified scientific literature.
EXAMPLE 2 [WO2013054185]: A specific compound described in the cited patent application.
BAG-2: An experimental research chemical.
BAY86-7548: An experimental research chemical.
[125I][D-TYR6,&BETA;-ALA11,PHE13,NLE14]BOMBESIN-(6-14): A radioiodinated bombesin receptor antagonist.
LY2811376: An experimental BACE1 inhibitor for Alzheimer's disease.
COMPOUND 4 [PMID: 19954973]: A research compound described in the specified scientific literature.
ENCALERET: An experimental calcium-sensing receptor (CaSR) antagonist.
AM11542: An experimental research chemical.
[3H]HU-243: A radiolabeled potent synthetic cannabinoid.
AM7499: An experimental research chemical.
AG-041R: An experimental research chemical.
[125I]CCL1 (HUMAN): Radioiodinated human CCL1 chemokine for receptor binding studies.
PHENYLGLYCINE-01: An experimental research chemical.
PF-477736: An experimental inhibitor of the checkpoint kinase Chk1.
COMPOUND 20 [PMID: 12372533]: A research compound described in the specified scientific literature.
LY3022855: An experimental research chemical.
METHYL 5-[(4-TERT-BUTYLBENZOYL)AMINO]-2H-1,2,4-TRIAZOLE-3-CARBOXYLATE: A chemical compound.
[125I]ANTISAUVAGINE: A radioiodinated peptide antagonist of corticotropin-releasing factor receptors.
KBP-088: An experimental research chemical.
SDF1 P2G: A synthetic variant of the chemokine CXCL12.
CX549: An experimental research chemical.
DIPHOSPHOGLYCOLYL PROLINE: A chemical compound.
DDR-IN-1: An experimental inhibitor of discoidin domain receptor (DDR) kinases.
NEPICASTAT: An inhibitor of dopamine beta-hydroxylase.
UNC9994: An experimental research chemical.
C646: An inhibitor of the histone acetyltransferase p300.
L-826266: An experimental research chemical.
16&ALPHA;-HYDROXYESTRONE: An estrogen metabolite.
NEUREGULIN-1: A protein that mediates cell-cell signaling and is critical for nervous system development.
DIARYLPROPIONITRILE: A selective estrogen receptor beta (ERÎ²) agonist.
[18F]ET-1 (HUMAN, MOUSE, RAT): A radiolabeled version of the peptide endothelin-1.
SB234551: An experimental research chemical.
RO 46-8443: An experimental research chemical.
PIRIDRONIC ACID: A bisphosphonate drug.
BRETAZENIL: A partial agonist of the GABAA receptor.
LAU159: An experimental research chemical.
GALMIC: A non-peptide agonist for galanin receptors.
COMPOUND 12 [PMID: 12014956]: A research compound described in the specified scientific literature.
L-692,429: An experimental growth hormone secretagogue.
[125I]GLP-1-(7-37) (HUMAN): A radioiodinated form of the incretin hormone GLP-1.
ORFORGLIPRON: An experimental oral, non-peptide GLP-1 receptor agonist.
COMPOUND 17 [PMID: 15686906]: A research compound described in the specified scientific literature.
COMPOUND 8G [PMID: 21444206]: A research compound described in the cited publication.
COMPOUND 23 [PMID: 21444206]: A research compound described in the cited publication.
SPHINGOSYLPHOSPHORYLCHOLINE: A lysophospholipid with various signaling functions.
JNJ-63533054: An experimental research chemical.
7&BETA;, 25-DIHYDROXYCHOLESTEROL: An endogenous oxysterol.
ASN04421891: An experimental research chemical.
NEUROPEPTIDE HEAD ACTIVATOR: A neuropeptide found in Hydra that stimulates head regeneration.
CP55,244: A synthetic cannabinoid receptor agonist.
[3H]RIMONABANT: A radiolabeled cannabinoid CB1 receptor inverse agonist.
PIBTU: An experimental research chemical.
COMPOUND 7 [WO2012007375]: A specific compound described in the cited patent application.
INOSITOL 2,4,5-TRISPHOSPHATE: An isomer of the second messenger IP3.
BMY 45778: An experimental research chemical.
GOITRIN: A sulfur-containing compound found in cruciferous vegetables that can interfere with thyroid hormone synthesis.
WXFL10203614: An experimental research chemical.
BL-1249: An agonist of the TRPV1 ion channel.
&ALPHA;-PROPYLDOPACETAMIDE: A chemical compound related to dopamine metabolites.
RY764: An experimental research chemical.
COMPOUND 11C [PMID: 17929793]: A research compound described in the cited publication.
GSK1331268: An experimental research chemical.
LU AF21934: An experimental positive allosteric modulator of the M1 muscarinic receptor.
VU0400195: An experimental research chemical.
ESAXERENONE: A non-steroidal mineralocorticoid receptor blocker.
COMPOUND 3A [PIPIONNE ET AL, 2018]: A research compound described in the cited 2018 publication.
IACS-52825: An experimental research chemical.
PIRLINDOLE: A reversible inhibitor of monoamine oxidase A (RIMA) antidepressant.
ONO-4817: An experimental research chemical.
LAZABEMIDE: A reversible inhibitor of monoamine oxidase B (RIMA-B).
MUSCARINIC TOXIN 2: A peptide toxin from green mamba venom that targets muscarinic receptors.
NIK-21273: An experimental research chemical.
J-113397: A selective antagonist for the nociceptin/orphanin FQ (NOP) receptor.
[111IN]DOTA-DLVT: An indium-111 radiolabeled peptide for imaging.
GUE1654: An experimental research chemical.
ACT-335827: An experimental research chemical.
COMPOUND 1 [PMID: 24930776]: A research compound described in the specified scientific literature.
YNT-185: A selective agonist for the delta-opioid receptor.
2-THIO-UDP: A uridine diphosphate analogue.
3-PHENACYL-UDP: A derivative of uridine diphosphate.
MRS4062: An experimental research chemical.
PSB1114: An experimental research chemical.
AY77: An experimental research chemical.
JBI-589: An experimental inhibitor of the enzyme LSD1.
IS20: An experimental research chemical.
MIT1: An experimental research chemical.
KBP-7018: An experimental research chemical.
PLOGOSERTIB: An experimental Aurora kinase A inhibitor.
COMPOUND 2 [PMID: 19097784]: A research compound described in the specified scientific literature.
WLL-VS: An experimental research chemical.
NIC-0102: An experimental research chemical.
CC-90005: An experimental cereblon E3 ligase modulator (CELMoD).
PKCBETA INHIBITOR: A drug that blocks the beta isoform of protein kinase C.
PKC&THETA; INHIBITOR 14: A research chemical that inhibits the theta isoform of protein kinase C.
RO 41-5253: An experimental research chemical.
A1120: An experimental research chemical.
H3 14S18 STAPLED B-CHAIN: A synthetic stapled peptide.
A(10-24)INSL3: A peptide fragment of Insulin-like peptide 3.
COMPOUND 10D [PMID: 34855388]: A research compound described in the cited 2021 publication.
COMPOUND 6F [PMID: 35476936]: A research compound described in the cited 2022 publication.
SK1-I: An experimental sphingosine kinase 1 inhibitor.
ROME: An experimental research chemical.
SIFA-ASN(ACNH-&BETA;-GLC)-TYR3-OCTREOTATE: A modified somatostatin analogue.
KB-141: A selective thyroid hormone receptor-beta (TRÎ²) agonist.
GSK329: An experimental research chemical.
FLAGELLIN: A protein that is the main component of bacterial flagella and a TLR5 agonist.
MT-8: An experimental research chemical.
SAG: An agonist of the Smoothened receptor in the Hedgehog signaling pathway.
BI 749327: An experimental research chemical.
ADP RIBOSE: Adenosine diphosphate ribose, a molecule involved in cell signaling.
SF-21: An experimental research chemical.
SB-706375: An experimental research chemical.
[11C]DTBZ: A carbon-11 radiolabeled tracer for imaging VMAT2.
4-CL-CINNAMOYL-C[DCYS-4PAL-DTRP-ORN-VAL-CYS]-HIS-AMIDE: A complex synthetic peptide.
[125I]D(CH2)5[D-TYR(ET)2,VAL4,TYR-NH29]AVP: A radioiodinated vasopressin V1a receptor antagonist.
REBEMADLIN: An experimental MDM2 inhibitor.
CDK INHIBITOR SNS-032: An experimental inhibitor of cyclin-dependent kinases.
PICOPLATIN: A platinum-based chemotherapy agent.
ALK INHIBITOR NVL-655: An experimental anaplastic lymphoma kinase (ALK) inhibitor.
ENBEZOTINIB: An experimental research chemical.
FUMAGILLIN: An antibiotic and angiogenesis inhibitor.
TOXAPHENE: A mixture of chlorinated camphenes, used as an insecticide.
LYS-COA: A chemical conjugate of lysine and coenzyme A.
VUF14862: An experimental research chemical.
HTMT: An experimental research chemical.
HR1405-01: An experimental research chemical.
DIMETHYLAMINOETHANOL: An organic compound used as a precursor to other chemicals.
PLAZINEMDOR: An experimental research chemical.
TUROCTOCOG ALFA: A recombinant human coagulation Factor VIII with a truncated B-domain.
T0070907: A selective antagonist for the peroxisome proliferator-activated receptor gamma (PPAR-gamma).
E-52862: An experimental sigma-1 receptor antagonist.
DNAL-CYC(CYS-TYR-DTRP-ORN-VAL)-NAL-NH2: A complex synthetic peptide.
AVE0847: An experimental research chemical.
PHENYL SALICYLATE: An organic compound with antiseptic properties.
EDELFOSINE: An experimental anticancer agent that is a synthetic ether lipid.
CN-105: An experimental neuroprotective peptide.
&BETA;-PHENYLETHYLAMINE: A natural trace amine with psychoactive and stimulant effects.
MONOETHANOLAMINE: An organic chemical compound used as a solvent and chemical intermediate.
COMPOUND 54: An experimental research chemical.
&ALPHA;-CGRP: Alpha-calcitonin gene-related peptide, a neuropeptide involved in pain and vasodilation.
CD19-TARGETED CAR T2 CELLS: Chimeric Antigen Receptor T-cells engineered to target the CD19 antigen.
COMPOUND 30 [PMID: 23414845]: A research compound described in the specified scientific literature.
LAMELLARIN D: A marine alkaloid with cytotoxic and topoisomerase I inhibitory activity.
IMC-EB10: An experimental monoclonal antibody.
ALLICIN: The organosulfur compound that gives garlic its characteristic aroma and has antimicrobial properties.
BEROTRALSTAT HYDROCHLORIDE: An oral plasma kallikrein inhibitor for hereditary angioedema.
SCH 900271: An experimental research chemical.
TETRACYCLINE PHOSPHATE COMPLEX: A formulation of the antibiotic tetracycline.
IMIDAFENACIN: An anticholinergic drug for overactive bladder.
CHLORPROGUANIL: An antimalarial drug.
INHIBITOR CB3: An experimental research chemical.
RO 25-1392: An experimental research chemical.
COMPOUND 20O [PMID: 22984835]: A research compound described in the cited publication.
F2L: A synthetic peptide agonist of formyl peptide receptors.
GM-CSF-ENCODING ONCOLYTIC ADENOVIRUS CGTG-102: An oncolytic virus engineered to express GM-CSF.
(S)-WILLARDIINE: An AMPA/kainate receptor agonist.
GSK-2256098: An experimental focal adhesion kinase (FAK) inhibitor.
OLSALAZINE SODIUM: The sodium salt of olsalazine, a drug for ulcerative colitis.
RIBAVIRIN MONOPHOSPHATE: The phosphorylated form of the antiviral drug ribavirin.
LIQUIRITIN: A flavonoid glycoside found in licorice.
LY255283: An experimental leukotriene B4 receptor antagonist.
THIOPHENE: A heterocyclic organic compound.
ACETANILIDE: A chemical compound, one of the first analgesic and antipyretic drugs.
DARUISOLINE: A natural alkaloid.
[125I]CATHEPSIN G (HUMAN): Radioiodinated human cathepsin G for research.
I-BET282: An experimental research chemical.
AZD-8165: An experimental research chemical.
GW-274150: A selective inhibitor of inducible nitric oxide synthase (iNOS).
ZINC PROTOPORPHYRIN IX: A fluorescent molecule formed during heme synthesis.
ARD-266: An experimental research chemical.
AS94: An experimental research chemical.
[125I]&ALPHA;-CONOTOXIN MII: A radioiodinated peptide toxin that blocks nicotinic receptors.
ACTEIN: A triterpene glycoside from black cohosh.
DAUNORUBICIN CITRATE: The salt form of daunorubicin, an anthracycline chemotherapy drug.
ACEBUTOLOL HYDROCHLORIDE: A beta-blocker used for hypertension and arrhythmias.
DARUNAVIR ETHANOLATE: The ethanolate form of darunavir, an HIV protease inhibitor.
CIPRALISANT MALEATE: An experimental histamine H3 receptor antagonist.
JTS-653: An experimental gastroprotective agent.
ICM3: An experimental research chemical.
F16SIP 131I: A radioimmunoconjugate.
TRX-1: Thioredoxin-1, a protein with antioxidant functions.
INDALPINE: A selective serotonin reuptake inhibitor (SSRI).
AS-1409: An experimental research chemical.
DAPIVIRINE: A non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV prevention.
SELUMETINIB SULFATE: The sulfate salt of selumetinib, a MEK1/2 inhibitor.
MK-0736: An experimental research chemical.
.ALPHA.1-PROTEINASE INHIBITOR HUMAN: Alpha-1 antitrypsin, a protein used to treat A1AT deficiency.
PF-5190457: An experimental FAAH inhibitor.
AZD4205: An experimental Janus kinase 1 (JAK1) inhibitor.
ARBUTIN: A glycoside extracted from the bearberry plant, used as a skin-lightening agent.
CAMLIPIXANT: An experimental P2X3 receptor antagonist.
AUSTOCYSTIN D: A natural mycotoxin.
CRYPTOCHINONE A: A natural product.
LEPTOMYCIN B: A potent inhibitor of nuclear export.
SCARLET RED: An azo dye.
11-CIS-RETINAL: A form of vitamin A, the chromophore of the retina.
MOROLIC ACID: A natural triterpenoid.
OXIBENDAZOLE: A benzimidazole anthelmintic for veterinary use.
PYRIDINE-2,5-DICARBOXYLIC ACID: A chemical compound.
HERACLENOL: A natural furanocoumarin.
AP-7: An experimental NMDA receptor antagonist.
GW819077X: An experimental research chemical from GlaxoSmithKline.
3-HYDROXYCOUMARIN: A derivative of coumarin.
GTP: Guanosine triphosphate, a nucleotide vital for energy transfer and signaling.
VALACYCLOVIR: An antiviral drug, a prodrug of acyclovir.
(1R)-TRANS-TETRAMETHRIN: An isomer of the pyrethroid insecticide tetramethrin.
SOLOMONSTEROL B: A natural marine sterol.
PITTSBURGH COMPOUND B: A radioactive analog of thioflavin T used in PET imaging for amyloid plaques.
STROBOPININ: A natural flavonoid.
PREDNISOLONE SODIUM SUCCINATE: A water-soluble salt of the corticosteroid prednisolone.
(R)-PROCYCLIDINE: The active enantiomer of the anticholinergic drug procyclidine.
GSK369796: An experimental research chemical.
MENATETRENONE: A form of vitamin K2.
ERGOSTEROL PEROXIDE: A natural sterol peroxide found in fungi.
ECHINOMYCIN: A quinoxaline antibiotic that intercalates into DNA.
BROMUCONAZOLE: A triazole fungicide.
ALLO-OCIMENE: A monoterpene found in a variety of plants.
AMODIAQUINE DIHYDROCHLORIDE: An antimalarial drug.
SELECTIVE ESTROGEN RECEPTOR DEGRADER AZD9496: An experimental oral SERD for breast cancer.
FLUORESCEIN SODIUM: A fluorescent dye used in diagnostics, particularly in ophthalmology.
CEFAMANDOLE NAFATE: A second-generation cephalosporin antibiotic.
2-ETHOXYCARBONYL-2-ETHOXYOXALOYLOXYDIHYDROCHRYSIN DIMETHYL ETHER: A complex chemical compound.
TRIAZINATE: An antifolate chemotherapy agent.
DHA-PACLITAXEL: A conjugate of docosahexaenoic acid and the anticancer drug paclitaxel.
EXPECTORANT: A medication that helps clear mucus from the airways.
ASULACRINE ISETHIONATE: The salt of an experimental anticancer agent.
PROGESTERONE ANTAGONIST: A drug that blocks the effects of progesterone.
MDM2 ANTAGONIST RO5045337: An experimental compound that inhibits the MDM2 protein.
ACETAMINOPHEN / CAFFEINE / DIHYDROCODEINE: A combination analgesic drug.
VILTOLARSEN: An antisense oligonucleotide for Duchenne muscular dystrophy.
AURORA A KINASE INHIBITOR MK5108: An experimental compound that inhibits Aurora A kinase.
VELIGROTUG: An experimental monoclonal antibody.
AVACINCAPTAD PEGOL: A pegylated aptamer that inhibits complement C5.
AS1409: An experimental research chemical.
CG0070: An oncolytic adenovirus engineered to express GM-CSF.
FLOVAGATRAN: An experimental direct thrombin inhibitor.
DEXTROMETHORPHAN/QUINIDINE: A combination drug for pseudobulbar affect.
NPS-2143: An antagonist of the calcium-sensing receptor (CaSR).
CREMOPHOR EL: A nonionic surfactant used to solubilize drugs.
PEMZIVIPTADIL: An experimental research chemical.
ETHYLMORPHINE: An opioid analgesic and antitussive.
PELCITOCLAX: An experimental BCL-2/BCL-XL inhibitor.
MK-1454: An experimental STING agonist.
BET INHIBITOR RO6870810: An experimental compound that inhibits BET bromodomain proteins.
ONO-7579: An experimental BACE1 inhibitor.
BRANAPLAM: An experimental RNA splicing modulator for spinal muscular atrophy.
MS-1819: An experimental research chemical.
HYALURONATE SODIUM: The sodium salt of hyaluronic acid, used for osteoarthritis and in cosmetics.
NCX 1022: An experimental research chemical.
DEXTOFISOPAM: The dextrorotatory enantiomer of tofisopam.
GMA-161: An experimental research chemical.
NEBRACETAM: A nootropic drug of the racetam family.
JNJ-39393406: An experimental histamine H4 receptor antagonist.
OT-551: An experimental eye drop with antioxidant properties.
SAFOTIBANT: An experimental bradykinin B2 receptor antagonist.
SOMAVARATAN: An experimental long-acting growth hormone.
SABARUBICIN: An experimental anthracycline antibiotic.
MDR MODULATOR CBT-1: An experimental agent designed to reverse multidrug resistance.
RECOMBINANT HUMAN ENDOSTATIN: A genetically engineered form of endostatin, an anti-angiogenic protein.
VITAMIN D3 ANALOGUE ILX23-7553: An experimental synthetic analogue of vitamin D3.
RIMIDUCID: A homodimerizing agent used to activate genetically modified cells.
MOCRAVIMOD HYDROCHLORIDE: An experimental sphingosine-1-phosphate receptor modulator.
DIPROTEVERINE: A vasodilator and antispasmodic drug.
L-772,405: An experimental research chemical.
COMPOUND 3B [PMID:28943244]: A research compound described in the cited 2017 publication.
ENVONALKIB: An experimental ROS1/NTRK inhibitor.
SNAP5089: An experimental research chemical.
PXS-4728A: An experimental inhibitor of amine oxidases.
TRANDOLAPRILAT: The active metabolite of the ACE inhibitor trandolapril.
(-)-RO 363: An experimental research chemical.
GDC-0834: An experimental Bruton's tyrosine kinase (BTK) inhibitor.
[DES-ARG11]T-KININ: A metabolite of the peptide T-kinin.
[DES-PRO8,DES-PHE9,DES-ARG10]KALLIDIN: A metabolite of the peptide kallidin.
[LEU8,DES-ARG9]BRADYKININ: A bradykinin B1 receptor agonist.
C3A: Complement component 3a, an anaphylatoxin involved in inflammation.
INHIBITOR E18: An experimental research chemical.
[THI5,8,D-PHE7]BRADYKININ: A selective bradykinin B2 receptor antagonist.
NDT9520492: An experimental research chemical.
MONNA: An experimental research chemical.
DCDPC: An experimental research chemical.
PRALNACASAN: An experimental inhibitor of interleukin-1 beta converting enzyme (ICE).
RO116-4875/608: An experimental compound.
SX-517: An experimental research chemical.
ENITOCICLIB: An experimental CDK2/4/6 inhibitor.
5H3'FPE: An experimental research chemical.
DYNORPHIN A-(1-13): A fragment of the endogenous opioid peptide dynorphin A.
COMPOUND 19 [PMID: 35925768]: A research compound described in the cited 2022 publication.
BRD9185: An experimental research chemical.
BMS-214662: An experimental farnesyltransferase inhibitor.
IGE HEAVY CHAIN: The heavy chain component of the Immunoglobulin E antibody.
N-VALERIC ACID: A straight-chain alkyl carboxylic acid.
LATANOPROST (FREE ACID FORM): The active form of the prostaglandin analogue latanoprost.
BPH-715: An experimental research chemical.
LEO 134310: An experimental research chemical.
ONFASPRODIL: An experimental NMDA receptor antagonist.
D-24710: An experimental research chemical.
G-1: An agonist of the G protein-coupled estrogen receptor (GPER).
UCL-2138: An experimental research chemical.
VUF 4904: An experimental research chemical.
AZD4017: An experimental acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) inhibitor.
GLPDGG PEPTIDE [PMID: 20494585]: An experimental peptide described in the cited publication.
COMPOUND 58 [PMID: 21273063]: A research compound described in the specified scientific literature.
LODOXAMIDE TROMETHAMINE: A mast cell stabilizer used in eye drops for allergies.
GSK575594A: An experimental research chemical.
PAMP-12 (HUMAN): A 12-amino acid fragment of proadrenomedullin.
NTE-2: An experimental research chemical.
LEPZACITINIB: An experimental Janus kinase (JAK) inhibitor.
LY97241: An experimental research chemical.
COMPOUND 10 [PMID: 22533316]: A research compound described in the specified scientific literature.
COMPOUND 1 [GOTTELAND ET AL., 1997]: A research compound described in the cited 1997 publication.
COMPOUND 8 [PMID: 22533316]: A research compound described in the specified scientific literature.
MLI-2: An experimental LRRK2 kinase inhibitor.
AZ12260493: An experimental research chemical from AstraZeneca.
COMPOUND 22M [PMID: 19831390]: A research compound described in the cited publication.
TCLPA5: An experimental research chemical.
S36540: An experimental research chemical.
COMPOUND 10I [PMID: 23084894]: A research compound described in the cited publication.
HEPATOCYTE GROWTH FACTOR: A morphogenic factor that regulates cell growth and motility.
FARNESOL: A natural sesquiterpene alcohol found in many essential oils.
RO4491533: An experimental neurokinin-1 (NK1) receptor antagonist.
CIS-10 [PMID: 15771457]: A research compound described in the cited publication.
COMPOUND 3 [PMID: 31804822]: A research compound described in the cited 2019 publication.
LY2119620: An experimental p70S6K inhibitor.
UCSF4226: An experimental research chemical.
IIK7: An experimental research chemical.
BMS-986121: An experimental research chemical.
&MU;-CONOTOXIN GIIIA: A peptide toxin from cone snails that blocks sodium channels.
&BETA;-SCORPION TOXIN CN2: A toxin from scorpion venom that modulates sodium channels.
N-ME-AMINOPYRIMIDINONE 9: A research chemical.
RGIA4: An experimental research chemical.
COMPOUND 8D [PMID: 24999562]: A research compound described in the cited publication.
L-366,875: An experimental research chemical.
L-366,509: An experimental research chemical.
GLAXOSMITHKLINE COMPOUND 5H [PMID:20542694]: A research compound described in the cited publication.
TZD18: An experimental research chemical.
[125I]SB-236636: A radioiodinated research chemical.
GW7845: An experimental selective PPAR-gamma modulator.
SB-219993: An experimental research chemical.
HS-173: An experimental phosphatidylinositol 3-kinase (PI3K) inhibitor.
CZC 24832: An experimental research chemical.
MTK458: An experimental research chemical.
[125I]PRRP31: A radioiodinated peptide ligand.
TIP39-(9-39) (HUMAN/BOVINE): A fragment of tuberoinfundibular peptide of 39 residues.
[TYR36]-PTHRP-(1-36) AMIDE (HUMAN): A synthetic analogue of human parathyroid hormone-related protein.
TIP39-(7-39) (MOUSE): A fragment of tuberoinfundibular peptide of 39 residues.
COMPOUND 1 [PMID: 31465224]: A research compound described in the cited 2019 publication.
LV-2211: An experimental research chemical.
INSL3 [A(5-26):B(7-27)]: A truncated analogue of Insulin-like peptide 3.
LY2584702: An experimental p70S6 kinase inhibitor.
NIBR-0213: An experimental research chemical.
SLB736: An experimental research chemical.
COMPOUND 1J [PMID: 26314925]: A research compound described in the cited publication.
COMPOUND 16 [PMID: 19097778]: A research compound described in the specified scientific literature.
SERGLIFLOZIN: An SGLT2 inhibitor.
COMPOUND 14I [PMID: 37204466]: A research compound described in the cited 2023 publication.
MALTOTRIOSE-[125I][TYR3,THR8]OCTREOTIDE: A modified radioiodinated somatostatin analogue.
NNC269100: An experimental small-conductance calcium-activated potassium (SK) channel blocker.
COMPOPOUND 5 [PMID: 23232060]: A research compound described in the specified scientific literature.
ASP7663: An experimental research chemical.
CHLOROPICRIN: A chemical compound used as a broad-spectrum antimicrobial, fumigant, and pesticide.
BENZYL BROMIDE: An organic compound used in chemical synthesis.
PF-05105679: An experimental phosphodiesterase 1 (PDE1) inhibitor.
APV207094A: An experimental compound.
GSK1016790A: A potent agonist of the TRPV4 ion channel.
VERBASCOSIDE: A natural phenylethanoid glycoside with antioxidant and anti-inflammatory properties.
LUVIXASERTIB: An experimental WEE1 kinase inhibitor.
U-II-(4-11) (HUMAN): A peptide fragment of human urotensin-II.
T-690: An experimental research chemical.
FMS586: An experimental research chemical.
PEGARGIMINASE: Pegylated arginine deiminase, an experimental anticancer enzyme therapy.
MEK INHIBITOR GDC-0623: An experimental compound that inhibits MEK kinase.
PAN-RAF INHIBITOR XP-102: An experimental compound that inhibits multiple RAF kinases.
VADACABTAGENE LERALEUCEL: An investigational CD19-targeted CAR T-cell therapy.
TECHNETIUM TC 99M SESTAMIBI: A radiopharmaceutical used in cardiac imaging.
LY3023703: An experimental research chemical.
METARAMINOL BITARTRATE: A sympathomimetic amine used to treat hypotension.
SULPROSTONE: A prostaglandin E2 analogue used to induce abortion and labor.
PRALIDOXIME CHLORIDE: An antidote to organophosphate poisoning.
P32 [PMID: 27108698]: An experimental peptide described in the cited publication.
3&BETA;-HYDROXYDIHYDROCOSTUNOLIDE: A natural sesquiterpene lactone.
GALANIN(9-29) (RAT/MOUSE): A fragment of the neuropeptide galanin.
D-(-)-AMYGDALIN: A cyanogenic glycoside found in the pits of many fruits.
MRTX0902: An experimental SOS1 inhibitor.
AVI-4557: An experimental research chemical.
7-CHLOROKYNURENIC ACID: An antagonist at the glycine site of the NMDA receptor.
GGSTOP: An experimental inhibitor of GGTase-I.
NIP: An experimental research chemical.
PF-06649298: An experimental research chemical from Pfizer.
GANTOFIBAN: An experimental GPIIb/IIIa receptor antagonist.
PROLACTIN G129R: A mutant form of the hormone prolactin that acts as a receptor antagonist.
COMPOUND 1 [CRUZ-L&OACUTE;PEZ ET AL., 2019]: A research compound described in the cited 2019 publication.
BIIE0246: A selective antagonist of the neuropeptide Y Y2 receptor.
AMIBEGRON HYDROCHLORIDE: An experimental beta-3 adrenoceptor agonist.
4-OME-ARM1: An experimental research chemical.
AZ7188: An experimental research chemical.
PROBE 2.1 [PMID: 24187130]: An experimental probe chemical described in the cited publication.
NALTALIMIDE: An experimental research chemical.
PODOCARIC ACID: A natural diterpenoid.
A27.15: An experimental research chemical.
COMPOUND 3V [PMID: 27390066]: A research compound described in the cited 2016 publication.
MAUROTOXIN: A peptide toxin from scorpion venom that blocks potassium channels.
RADIOPROTECTIN-1: An experimental research chemical.
HOMO-AMPA: An analogue of the neurotransmitter AMPA.
FGFR4 ANTAGONIST INCB062079: An experimental compound that antagonizes the FGFR4 receptor.
LUNA18: An experimental research chemical.
BMS-911172: An experimental research chemical.
COMPOUND 11D [PMID: 23981898]: A research compound described in the cited publication.
COMPOUND III [PMID: 24045148]: A research compound described in the specified scientific literature.
[3H]GR100679: A radiolabeled NK2 receptor antagonist.
RU28318: An experimental research chemical.
CIFEA: An experimental research chemical.
[3-IODO-TYR6]U-II-(4-11) (HUMAN): A radioiodinated fragment of human urotensin-II.
RWJ-351647: An experimental research chemical.
AZX-100: An experimental peptide analogue of microfibril-associated glycoprotein 4.
ABT-670: An experimental selective dopamine D4 receptor agonist.
FELBINAC: A non-steroidal anti-inflammatory drug (NSAID) used topically.
YTTRIUM Y 90 TACATUZUMAB TETRAXETAN: A radioimmunoconjugate targeting the alpha-fetoprotein for liver cancer.
N-METHYL-PHE-LYS-PRO-D-CHA-CHA-D-ARG-CO2H: A complex synthetic peptide.
COMPOUND 5G [PMID: 36385925]: A research compound described in the cited 2022 publication.
METAGLIDASEN: An experimental glucose-lowering agent.
CACA: An experimental research chemical.
BIMOCLOMOL: An experimental heat shock protein co-inducer.
COMPOUND 13 [PMID: 35653642]: A research compound described in the cited 2022 publication.
SOMATREM: A synthetic version of human growth hormone.
CILASTATIN SODIUM: An inhibitor of the renal enzyme dehydropeptidase, co-administered with imipenem.
DIHYDROCODEINE BITARTRATE: The salt form of dihydrocodeine, an opioid analgesic.
PIRBUTEROL ACETATE: The salt form of pirbuterol, a short-acting beta-2 agonist.
DOXAPRAM HYDROCHLORIDE: A respiratory stimulant.
PF-05019702: An experimental research chemical from Pfizer.
CLX-0921: An experimental research chemical.
LY2452473: An experimental kappa-opioid receptor antagonist.
SD-0006: An experimental research chemical.
GW590735: An experimental PPAR alpha/delta agonist.
ND0801: An experimental research chemical.
SIMOTINIB: An experimental EGFR tyrosine kinase inhibitor.
ECHOTHIOPHATE: An irreversible acetylcholinesterase inhibitor used in eye drops for glaucoma.
IDRAPARINUX SODIUM: An experimental long-acting synthetic anticoagulant.
SERGLIFLOZIN ETABONATE: A prodrug of sergliflozin, an SGLT2 inhibitor.
ATOLTIVIMAB: A component of a monoclonal antibody combination for Ebola virus disease.
SHR-4640: An experimental URAT1 inhibitor for gout.
TAZOBACTAM SODIUM: The sodium salt of tazobactam, a beta-lactamase inhibitor.
RATANIAPHENOL II: A natural phenolic compound.
MAKALUVAMINE E: A marine alkaloid with cytotoxic activity.
DIPHENYLETHER: An organic compound, the parent structure for some herbicides and drugs.
CALOTHRIXIN B: A natural compound with anti-cancer activity.
NAPHTHYLAMINE: An aromatic amine.
TILNOPROFEN ARBAMEL: A prodrug of the NSAID tilnoprofen.
GW831090X: An experimental research chemical from GlaxoSmithKline.
DERRUSNIN: A natural flavonoid compound.
YEZOQUINOLIDE: A natural product.
LY-2183240: An experimental cannabinoid CB1 receptor antagonist.
CEFPODOXIME PROXETIL: A prodrug of the cephalosporin antibiotic cefpodoxime.
DITHIANON: A quinone fungicide.
METACRESOL: An isomer of cresol, used as a disinfectant and preservative.
HYDRAZOBENZENE: An aromatic organic compound.
SUVANINE'S SODIUM SALT: The salt form of a natural marine sesterterpenoid.
CAMBENDAZOLE: A benzimidazole anthelmintic.
GW301784X: An experimental research chemical from GlaxoSmithKline.
TRIMETHYL-OCTADECYL-AMMONIUM CHLORIDE: A quaternary ammonium compound.
BRIVUDINE PHOSPHORAMIDATE: A prodrug of the antiviral brivudine.
POLYVALENT MELANOMA VACCINE: A cancer vaccine designed to target multiple melanoma antigens.
HIV VACCINE: A vaccine intended to prevent or treat infection by the human immunodeficiency virus.
TALC: A clay mineral used in pharmaceuticals and cosmetics.
VIT-100: An experimental research chemical.
VANILLOID: A class of chemical compounds that includes capsaicin and vanillin.
POTASSIUM CITRATE ANHYDROUS: The anhydrous salt of potassium citrate, used to treat kidney stones.
SODIUM METAARSENITE: A toxic inorganic arsenic compound.
ERYTHROPOIESIS-STIMULATING AGENT: A substance that stimulates the production of red blood cells.
ANTI-CD27L ANTIBODY-DRUG CONJUGATE AMG 172: An experimental antibody-drug conjugate.
MULTI-GLIOBLASTOMA-PEPTIDE-TARGETING AUTOLOGOUS DENDRITIC CELL VACCINE ICT-107: An experimental personalized cancer vaccine.
IRX-2: An experimental immunotherapy consisting of a mixture of cytokines.
ALUNACEDASE ALFA: Recombinant human hyaluronidase.
ANTI-ERBB3 MONOCLONAL ANTIBODY CDX-3379: An experimental monoclonal antibody targeting the HER3 receptor.
GUANINE: One of the four main nucleobases found in DNA and RNA.
LANPERISONE: A muscle relaxant.
PORPHOBILINOGEN: An intermediate in the biosynthesis of porphyrins.
ANTI-MESOTHELIN CAR T CELLS PREPARATION: CAR-T cells engineered to target the mesothelin antigen.
ANTI-CD38 CAR T CELLS PREPARATION: CAR-T cells engineered to target the CD38 antigen.
GW-813893: An experimental research chemical.
COMPOUND 34 [PMID: 20866075]: A research compound described in the specified scientific literature.
LY 165,163: An experimental selective dopamine D2 receptor agonist.
AS96: An experimental research chemical.
BMS-303141: An experimental research chemical.
[D-PHE6, STAT13, LEU14}BN(6-14): A synthetic bombesin receptor antagonist.
NB-360: An experimental research chemical.
EXAMPLE 92 [WO2012095521]: A specific compound described in the cited patent application.
HYDROXYETHYLAMINE TRANSITION-STATE INHIBITOR 1: A research chemical designed to inhibit proteases.
VICASINABIN: An experimental peripheral cannabinoid CB2 receptor agonist.
JMV180: An experimental biased agonist of the ghrelin receptor.
ML398: A selective inhibitor of the deubiquitinase USP1.
DBPR112: An experimental FLT3 inhibitor.
AMPHIREGULIN: A growth factor that is a member of the EGF family.
19(R)-OH-PGE2: 19-hydroxyprostaglandin E2, a natural prostaglandin.
[SAR1, D-ALA12]GALANIN(1-16): A synthetic analogue of the neuropeptide galanin.
MGIPANT-1: An experimental research chemical.
NYX-2925: An experimental modulator of the NMDA receptor.
IPN60090: An experimental research chemical.
GT-0198: An experimental research chemical.
D-LACTIC ACID: The D-isomer of lactic acid.
SELIFORANT: An experimental histamine H4 receptor antagonist.
GPR15L (71-81): A peptide fragment of the GPR15 ligand.
COMPOUND 1A [PMID: 24900311]: A research compound described in the specified scientific literature.
LP-360924: An experimental research chemical.
6-NONYLPYRIDINE-2,4-DIOL: A chemical compound.
T1117: An experimental research chemical.
SACUBITRILAT: The active metabolite of sacubitril, a neprilysin inhibitor.
PHYLLOMEDUSIN: A tachykinin peptide found in the skin of frogs.
[3H]SP (HUMAN, MOUSE, RAT): Tritiated Substance P, a radioligand for the NK1 receptor.
YM44781: An experimental research chemical.
UFP-102: An experimental research chemical.
RF9: An antagonist of neuropeptide FF and neuropeptide Y receptors.
OX-40 LIGAND: A costimulatory molecule expressed on activated antigen-presenting cells.
SB-410220: An experimental research chemical.
[3H]SB-674042: A radiolabeled antagonist of the orexin-1 receptor.
BJG-05-039: An experimental research chemical.
A317491: An experimental antagonist for the P2X3 and P2X2/3 receptors.
INS49266: An experimental research chemical.
[3H]PSB-0413: A radiolabeled research chemical.
AR-C126313: An experimental research chemical.
INS48823: An experimental research chemical.
RLF-(A11-B10)-ISOPEPTIDE AMIDEA26 (XA11-B10): A modified relaxin peptide analogue.
VPC23019: An antagonist of the sphingosine-1-phosphate receptor 1 (S1PR1).
BMS-986166: An experimental lysophosphatidic acid receptor 1 (LPA1) antagonist.
SI306: An experimental research chemical.
ANALOG 3 [PMID:18543899]: A specific research compound described in the cited scientific paper.
SIFA-ASN(ACNH-&BETA;-GLC)-PEG-TYR3-OCTREOTATE: A modified somatostatin analogue.
COMPOUND 53 [PMID: 33038794]: A research compound described in the cited 2020 publication.
YZM18: An experimental research chemical.
[125I]SAP: Radioiodinated substance P.
[3H]SQ-29548: A radiolabeled thromboxane receptor antagonist.
AM-0902: An experimental research chemical.
TRPV6 INHIBITOR CIS-22â€‰A: An experimental compound that inhibits the TRPV6 calcium channel.
NSC600684: An experimental research chemical.
EXAMPLE 25 [WO2018228934]: A specific compound described in the cited patent application.
CALCITRIOL-26,23-LACTONE: A metabolite of calcitriol (active vitamin D).
NPY-(16-36) (PIG): A C-terminal fragment of porcine Neuropeptide Y.
MTOR KINASE INHIBITOR PP242: An experimental compound that inhibits mTOR kinase.
EFIZONERIMOD: An experimental fusion protein for HIV treatment.
BCL-2 INHIBITOR BCL201: An experimental compound that inhibits the Bcl-2 protein.
SURVAXM: An experimental peptide vaccine targeting survivin.
IOPOFOSINE: An experimental research chemical.
CORTICOSTEROID: A class of steroid hormones produced in the adrenal cortex or synthetically.
LY2928057: An experimental research chemical.
DENIFANSTAT: An experimental fatty acid synthase (FASN) inhibitor.
PANCOPRIDE: A mixed 5-HT4 agonist and D2 antagonist.
AMOCARZINE: An anthelmintic drug for filariasis.
NCX-1000: An experimental nitric oxide-donating derivative of ursodeoxycholic acid.
FLUTROPIUM BROMIDE: An anticholinergic bronchodilator.
CHLAMYDOCIN: A cyclic tetrapeptide with cytostatic activity.
IMRECOXIB: A selective COX-2 inhibitor.
CXD-101: An experimental histone deacetylase (HDAC) inhibitor.
AZD-3839: An experimental BACE1 inhibitor for Alzheimer's disease.
VESTRONIDASE ALFA-VJBK: A recombinant human beta-glucuronidase for Sly syndrome.
AUTOLOGOUS ANTI-BCMA-CAR-EXPRESSING CD4+/CD8+ T-LYMPHOCYTES FCARH143: An investigational BCMA-targeted CAR T-cell therapy.
AUTOLOGOUS ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T-CELLS SJCAR19: An investigational CD19-targeted CAR T-cell therapy.
PROPIVERINE: An anticholinergic drug for overactive bladder.
ALLOGENEIC CD123-SPECIFIC UNIVERSAL CAR123-EXPRESSING T-LYMPHOCYTES: An off-the-shelf CAR T-cell therapy targeting CD123.
BI 2536: An experimental inhibitor of polo-like kinase 1 (Plk1).
FIDARESTAT: An aldose reductase inhibitor.
2-BROMO-LSD: A derivative of lysergic acid diethylamide that lacks psychedelic effects.
RAMIPRILAT: The active metabolite of the ACE inhibitor ramipril.
COMPOUND 9F [PMID: 24412111]: A research compound described in the cited publication.
L-748328: An experimental research chemical.
12R-HETE: 12-Hydroxyeicosatetraenoic acid, a lipid mediator.
BZT-7: An experimental research chemical.
LFM-A13: An experimental inhibitor of Bruton's tyrosine kinase (BTK).
COMPOUND 71 [WO2018191577A1]: A specific compound described in the cited patent application.
CGI560: An experimental research chemical.
NPC-349: An experimental research chemical.
BAY-524: An experimental research chemical.
SNX482: A peptide toxin that selectively blocks a subtype of calcium channels.
L873724: An experimental research chemical.
TETRONOTHIODIN: A natural product.
CBIQ: An experimental research chemical.
GLYH-101: An experimental chloride channel modulator.
DS96432529: An experimental research chemical.
ONO-2570366: An experimental research chemical.
NURULIMAB: An experimental monoclonal antibody.
DELTORPHIN II: An endogenous delta-opioid receptor agonist peptide.
ZY15557: An experimental research chemical.
6-FLUOROMEVALONATE 5-DIPHOSPHATE: A fluorinated analogue used in biochemical studies.
SGC-CBP30: An experimental chemical probe for the CREBBP bromodomain.
BPIQ-I: An experimental research chemical.
JND3229: An experimental research chemical.
COMPOUND 3F [FESTA ET AL., 2019]: A research compound described in the cited 2019 publication.
HWL-088: An experimental research chemical.
(S)-CETIRIZINE: The inactive enantiomer of the antihistamine cetirizine.
TUG-1197: An experimental GPR120/FFA4 receptor agonist.
FMS-RELATED TYROSINE KINASE 3 LIGAND: A cytokine that regulates the proliferation of hematopoietic cells.
3570-0208 [PMID:19807662]: A research compound described in the cited publication.
CYCLOSPORIN H: An immunosuppressive cyclic peptide related to cyclosporin A.
F PEPTIDE: An experimental peptide.
MHC BINDING PEPTIDE: A peptide fragment of an antigen that binds to Major Histocompatibility Complex molecules.
13,14-DIHYDRO-16-M-CHLOROPHENOXY-W-TETRANOR-PGF1&ALPHA;: A synthetic prostaglandin analogue.
PBP10: An experimental peptide.
GR 175737: An experimental research chemical.
C108297: An experimental research chemical.
ST-1478: An experimental research chemical.
AZD2906: An experimental research chemical from AstraZeneca.
5-METHYL NICOTINIC ACID: A derivative of nicotinic acid (niacin).
COMPOUND (+)17A [PMID: 20363624]: A research compound described in the cited publication.
DFGYVAE: A peptide sequence.
COMPOUND 11NN [PMID: 1656041]: A research compound described in the cited 1992 publication.
CIPRALISANT: An experimental histamine H3 receptor antagonist.
COMPOUND 2F [PMID: 2153213]: A research compound described in the cited 1990 publication.
TEPP-46: An experimental activator of the enzyme pyruvate kinase M2 (PKM2).
FPYVAE PEPTIDE [PMID: 20494585]: An experimental peptide described in the cited publication.
ALA(1-NAPH)-PRO-CN: A synthetic peptide derivative.
COMPOUND 29 [PMID: 15686906]: A research compound described in the specified scientific literature.
GSK3145095: An experimental research chemical from GlaxoSmithKline.
COMPOUND 24 [PMID: 15955699]: A research compound described in the specified scientific literature.
A(4-24)(F23A)H2: A synthetic peptide analogue.
A(&DELTA;10/15C)INSL3: A modified analogue of Insulin-like peptide 3.
TY-52156: An experimental gastrin/CCK2 receptor antagonist.
AS1269574: An experimental PI3K gamma inhibitor.
COMPOUND 18 [PMID: 32330443]: A research compound described in the cited 2020 publication.
J-104118: An experimental research chemical.
1-ALLYL-2-[3-(ISOPROPYLAMINO)PROPOXY]-9H-CARBAZOLE: A chemical compound.
SLF1081851: An experimental research chemical.
TAN-67: A selective delta-opioid receptor agonist.
COMPOUND 1C [BROWN ET AL., 1997]: A research compound described in the cited 1997 publication.
COMPOUND 1B [PMID: 9871762]: A research compound described in the cited publication.
COMPOUND 16G [PMID: 35507418]: A research compound described in the cited 2022 publication.
ANGIOPOIETIN-4: A protein involved in angiogenesis.
GSK2193874: An experimental 5-lipoxygenase-activating protein (FLAP) inhibitor.
(S)-VU0637120: An experimental research chemical.
DAROMUN: An experimental immunocytokine.
TRK INHIBITOR: A drug that blocks the tropomyosin receptor kinase (Trk) family of proteins.
ICOVAMENIB: An experimental menin-MLL inhibitor.
RLY-2608: An experimental mutant-selective PI3K alpha inhibitor.
CYT-500 177LU: A radioimmunoconjugate.
IMC-1C11: An experimental monoclonal antibody.
EPITUMOMAB: An experimental monoclonal antibody.
BRE-3 90Y: An experimental radioimmunoconjugate.
ACORAFLOXACIN: An experimental fluoroquinolone antibiotic.
CAVOSONSTAT: An experimental inducible nitric oxide synthase (iNOS) inhibitor.
GSK-2586881: An experimental research chemical.
(-)-&ALPHA;-THUJONE: The active isomer of thujone, a ketone found in some plants like wormwood.
TERN-101: An experimental farnesoid X receptor (FXR) agonist.
PEUCENIN: A natural chromone derivative.
GRACILIN A: A natural marine diterpenoid.
NS3623: An experimental opener of small- and intermediate-conductance calcium-activated potassium channels.
TK05: An experimental research chemical.
DIHYDROGUAIARETIC ACID: A natural lignan with antioxidant properties.
GW827105X: An experimental research chemical from GlaxoSmithKline.
EXIFONE: A benzophenone derivative used for cerebrovascular disorders.
CALYCULIN A: A potent inhibitor of protein phosphatases 1 and 2A.
DECYL DIHYDROGEN PHOSPHATE: A chemical compound.
CEFPIROME: A fourth-generation cephalosporin antibiotic.
VOACAMINE: A bisindole alkaloid.
HIMEIC ACID A: A natural product.
OCTHILINONE: A biocide used as a preservative.
CYANIN: A type of anthocyanin pigment.
GLYCYROL: A natural coumestan.
OXOLINIC ACID: A quinolone antibiotic.
AZEPEXOLE: An alpha-2 adrenergic agonist.
PHENYLETHYL ALCOHOL: An organic compound with a pleasant floral odor, used in perfumes.
PHATHALIMIDE: A misspelling of Phthalimide, a chemical intermediate.
PYRROLIDINE MCHR1 ANTAGONIST 1: A research chemical that antagonizes the melanin-concentrating hormone receptor 1.
COMPOUND (R)-10H [PMID: 22490048]: A research compound described in the cited publication.
GW695874X: An experimental research chemical from GlaxoSmithKline.
SULFACARBAMIDE: A sulfonamide antibiotic.
VU0650786: An experimental research chemical.
DALBERGIONE: A class of quinone compounds from Dalbergia species.
TOPOISOMERASE-II-BETA INHIBITOR RACEMIC XK469: An experimental anticancer agent targeting topoisomerase II beta.
AMINOLEVULINIC ACID: An endogenous non-proteinogenic amino acid.
MICELLAR PACLITAXEL: A formulation of the chemotherapy drug paclitaxel using micelles.
BOVINE PITUITARY EXTRACT: An extract from the pituitary glands of cattle.
PURINE ANTAGONIST: A substance that inhibits the synthesis or function of purines.
TRIVALENT INFLUENZA VACCINE: An influenza vaccine that contains three different flu strains.
ANTIPLATELET AGENT: A drug that decreases platelet aggregation and inhibits thrombus formation.
NEDOMETINIB: An experimental tyrosine kinase inhibitor.
PNEUMOCOCCAL POLYVALENT VACCINE: A vaccine against Streptococcus pneumoniae.
HUANG LIAN: The dried rhizome of Coptis chinensis, used in Traditional Chinese Medicine.
SODIUM NITRATE: An inorganic salt used as a preservative and in chemical synthesis.
SULFACETAMIDE: A sulfonamide antibiotic, often used in eye drops.
13-DEOXYDOXORUBICIN: An analogue of the chemotherapy drug doxorubicin.
ICO-007: An experimental research chemical.
[3H]DIMETHYL-W84: A radiolabeled research chemical.
REMLARSEN: An experimental antisense oligonucleotide.
PF-06747143: An experimental research chemical from Pfizer.
IODINE I 124 OMBURTAMAB: A radioiodinated form of omburtamab used in PET imaging.
METHANESULFONYL FLUORIDE: A chemical reagent that inhibits serine proteases.
DA-8031: An experimental research chemical.
BONE METASTASIS TARGETING PEPTIDE-11: An experimental peptide for targeting bone metastases.
ALOGABAT: An experimental research chemical.
GLPG-1837: An experimental cystic fibrosis transmembrane conductance regulator (CFTR) modulator.
NEXOPAMIL: An experimental research chemical.
ELAPEGADEMASE: A recombinant adenosine deaminase for ADA-SCID.
SEPTIDE: A selective neurokinin-1 (NK1) receptor agonist peptide.
AUTOLOGOUS MESOTHELIN-SPECIFIC CAR-T CELLS: CAR-T cells from a patient, engineered to target mesothelin.
[3H]P-MPPF: A radiolabeled selective 5-HT1A receptor antagonist.
LYSERGIC ACID: A precursor for a range of ergoline alkaloids, including LSD.
5-FLUOROTRYPTAMINE: A fluorinated analogue of serotonin.
T2328: An experimental research chemical.
PD 154740: An experimental research chemical.
CONTULAKIN-G: A peptide toxin from cone snails that acts as a neurotensin receptor agonist.
[125I][GLP65NLE75,TYR77]APELIN-13: A radioiodinated analogue of apelin-13.
CYCLO APELIN-12 (7-12): A cyclic fragment of the apelin peptide.
TARLATAMAB: A bispecific T-cell engager (BiTE) targeting DLL3 and CD3.
KL044: An experimental research chemical.
COMPOUND 18 [PMID: 15664838]: A research compound described in the specified scientific literature.
L-367,938: An experimental research chemical.
CV-6209: A potent antagonist of platelet-activating factor (PAF).
C391: An experimental research chemical.
PRISTANIC ACID: A branched-chain fatty acid.
AVE1231: An experimental research chemical.
TRAM-34: A selective blocker of the KCa3.1 potassium channel.
VU0134992: An experimental negative allosteric modulator of the mGluR4 receptor.
&ALPHA;-DENDROTOXIN: A peptide toxin from mamba venom that blocks potassium channels.
MCL0129: An experimental research chemical.
VABAMETKIB: An experimental FAK/Pro-apoptotic kinase inhibitor.
COMPOUND 12E [PMID: 22266036]: A research compound described in the cited publication.
GERANYL DIPHOSPHATE: An intermediate in the biosynthesis of terpenes and steroids.
COMPOUND 7 [PMID: 20638279]: A research compound described in the specified scientific literature.
COMPOUND 24 [PMID: 23374867]: A research compound described in the specified scientific literature.
VU0359516: A positive allosteric modulator of the M1 muscarinic acetylcholine receptor.
COMPOUND 47 [PMID: 21295468]: A research compound described in the specified scientific literature.
ACDPP: An experimental research chemical.
CARBOXYATRACTYLOSIDE: A potent inhibitor of the mitochondrial ADP/ATP carrier.
GS-444217: An experimental research chemical.
COMPOUND 56 [PMID: 36136378]: A research compound described in the cited 2022 publication.
CL82198: An experimental research chemical.
ARP100: An experimental research chemical.
BEFLOXATONE: A reversible inhibitor of monoamine oxidase A (RIMA).
[BPA1,ILE13]MOTILIN (HUMAN): A synthetic analogue of the human hormone motilin.
VU0029767: An experimental research chemical.
BOMPPA: An experimental research chemical.
UCM1014: An experimental research chemical.
GYPGQV-NH2: A synthetic peptide.
SCH-900229: An experimental research chemical.
[125I]BH-MIT1: A radioiodinated research chemical.
DOOKU1: An experimental research chemical.
COMPOUND I [PMID: 29351497]: A research compound described in the specified scientific literature.
GSK583: An experimental RIPK1 kinase inhibitor.
AGN193836: A pan-retinoic acid receptor (RAR) antagonist.
BMS614: An experimental research chemical.
DENFIVONTINIB HYDROCHLORIDE: The salt form of an experimental FGFR inhibitor.
LV-2186: An experimental research chemical.